assays_Des,assays_ASCETY,assays_CONFSCO,assays_CHI,assays_CURB,assays_SASI,assays_CI,assays_ASTY,assays_RELTY,assays_SI,assays_ASSI,assays_TISI,assays_ASSOR,assays_ASSTET,assays_ASSSTR,assays_T,assays_VARII,assays_DOI,assays_ASSTAI,assays_ASSCATE,assays_ASSTIS,assays_BFOR,assays_ASSUBCELFR
Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,1,CHEMBL618647,Intermediate,,,A,N,1,7524,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,1,CHEMBL618648,Intermediate,,,A,N,1,7525,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,1,CHEMBL618649,Intermediate,,,A,N,1,7526,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,1,CHEMBL618650,Intermediate,,,A,N,1,7527,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,1,CHEMBL618651,Intermediate,,,A,N,1,7528,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,1,CHEMBL876497,Intermediate,,,A,N,1,7529,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,1,CHEMBL618652,Intermediate,,,A,N,1,7530,2048.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Lung,BAO_0000218,
Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,1,CHEMBL618653,Intermediate,,,A,N,1,7531,2048.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Lung,BAO_0000218,
Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,1,CHEMBL618654,Intermediate,,,A,N,1,7532,2048.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Lung,BAO_0000218,
Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,1,CHEMBL618655,Intermediate,,,A,N,1,7533,,Rattus norvegicus,,,50597,,6351,10116.0,,,BAO_0000218,
Compound was tested for solubility in water,,1,CHEMBL618656,Intermediate,,,A,N,1,7534,,Rattus norvegicus,,,50597,,1465,10116.0,,,BAO_0000218,
Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,0,CHEMBL618657,Intermediate,,,P,U,1,7535,,,,,22229,,5182,,,,BAO_0000100,
Solubility was determined,,1,CHEMBL618658,Intermediate,,,A,N,1,7536,,Rattus norvegicus,,,50597,,17847,10116.0,,,BAO_0000218,
solubility in water (ug/mL) at 37 degree C.,,1,CHEMBL618659,Intermediate,,,A,N,1,7537,,Rattus norvegicus,,,50597,,15339,10116.0,,,BAO_0000218,
First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,1,CHEMBL618660,Intermediate,,,A,N,1,7538,,Rattus norvegicus,,,50597,,5202,10116.0,,,BAO_0000218,
In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,1,CHEMBL618661,Intermediate,,,A,N,1,7539,,Rattus norvegicus,,,50597,,1088,10116.0,,,BAO_0000218,
Half life in rats,,1,CHEMBL873807,Intermediate,,,A,N,1,7540,,Rattus norvegicus,,,50597,,3169,10116.0,,,BAO_0000218,
Half life in Dawley rat,,1,CHEMBL618662,Intermediate,,,A,N,1,7541,,Rattus norvegicus,,,50597,,5353,10116.0,,,BAO_0000218,
Half life period after 3 mg/kg iv administration,,1,CHEMBL618663,Intermediate,,,A,N,1,7542,,Rattus norvegicus,In vivo,,50597,,2864,10116.0,,,BAO_0000218,
Half life period after 3 mg/kg iv administration in rat,,1,CHEMBL618664,Intermediate,,,A,N,1,7543,,Rattus norvegicus,In vivo,,50597,,2864,10116.0,,,BAO_0000218,
Half life period after 3 mg/kg iv administration in the rat,,1,CHEMBL618665,Intermediate,,,A,N,1,7544,,Rattus norvegicus,In vivo,,50597,,2864,10116.0,,,BAO_0000218,
Half life period in female Sprague-Dawley rats,,1,CHEMBL876498,Intermediate,,,A,N,1,7545,,Rattus norvegicus,,,50597,,6362,10116.0,,,BAO_0000218,
Half life period in rat,,1,CHEMBL618666,Intermediate,,,A,N,1,7546,,Rattus norvegicus,,,50597,,6249,10116.0,,,BAO_0000218,
Half-life in rats was determined,,1,CHEMBL620440,Intermediate,,,A,N,1,7547,,Rattus norvegicus,,,50597,,3169,10116.0,,,BAO_0000218,
Half-life in rats with metabolic oxidation,,1,CHEMBL620441,Intermediate,,,A,N,1,7548,,Rattus norvegicus,,,50597,,3169,10116.0,,,BAO_0000218,
Half-life in rats,,1,CHEMBL620442,Intermediate,,,A,N,1,7549,,Rattus norvegicus,,,50597,,3169,10116.0,,,BAO_0000218,
T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,1,CHEMBL620443,Intermediate,,,A,N,1,7550,,Rattus norvegicus,In vivo,,50597,,17260,10116.0,,,BAO_0000218,
T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,1,CHEMBL620444,Intermediate,,,A,N,1,7551,,Rattus norvegicus,In vivo,,50597,,17260,10116.0,,,BAO_0000218,
T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,1,CHEMBL620445,Intermediate,,,A,N,1,7552,,Rattus norvegicus,In vivo,,50597,,17260,10116.0,,,BAO_0000218,
T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,1,CHEMBL620446,Intermediate,,,A,N,1,7553,,Rattus norvegicus,In vivo,,50597,,17260,10116.0,,,BAO_0000218,
Biological half-life measured in plasma of rat,,1,CHEMBL620447,Intermediate,,,A,N,1,7554,1969.0,Rattus norvegicus,,,50597,,2879,10116.0,,Plasma,BAO_0000218,
Biological half-life measured in plasma of rat; 22-25,,1,CHEMBL621129,Intermediate,,,A,N,1,7555,1969.0,Rattus norvegicus,,,50597,,2879,10116.0,,Plasma,BAO_0000218,
Biological half-life measured in plasma of rat; 9-16,,1,CHEMBL621130,Intermediate,,,A,N,1,7556,1969.0,Rattus norvegicus,,,50597,,2879,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for its half life when administered intravenously in rat,,1,CHEMBL873808,Intermediate,,,A,N,1,7557,,Rattus norvegicus,In vivo,,50597,,3184,10116.0,,,BAO_0000218,
Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,1,CHEMBL876598,Intermediate,,,A,N,1,7558,,Rattus norvegicus,In vivo,,50597,,4891,10116.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,1,CHEMBL621131,Intermediate,,,A,N,1,7559,,Rattus norvegicus,In vivo,,50597,,429,10116.0,,,BAO_0000218,
Half life (T1/2) after oral administration in rat,,1,CHEMBL621132,Intermediate,,,A,N,1,7560,,Rattus norvegicus,In vivo,,50597,,5656,10116.0,,,BAO_0000218,
Half life of compound after iv administration of 20 mg/kg dose in rat,,1,CHEMBL621133,Intermediate,,,A,N,1,7561,,Rattus norvegicus,In vivo,,50597,,4413,10116.0,,,BAO_0000218,
Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,CHEMBL621312,Expert,,,A,N,1,7562,,Rattus norvegicus,In vivo,,50597,,3598,10116.0,,,BAO_0000218,
Half life of compound was determined in rat,,1,CHEMBL621313,Intermediate,,,A,N,1,7563,,Rattus norvegicus,,,50597,,17267,10116.0,,,BAO_0000218,
Half life of compound was determined in rat blood,,1,CHEMBL621314,Intermediate,,,A,N,1,7564,178.0,Rattus norvegicus,,,50597,,4727,10116.0,,Blood,BAO_0000218,
Half life at 1 mg/kg was determined in rat,,1,CHEMBL621315,Intermediate,,,A,N,1,7565,,Rattus norvegicus,In vivo,,50597,,17651,10116.0,,,BAO_0000218,
Half life at 10 mg/kg was determined in rat,,1,CHEMBL621316,Intermediate,,,A,N,1,7566,,Rattus norvegicus,In vivo,,50597,,17651,10116.0,,,BAO_0000218,
Half life in rats,,1,CHEMBL621317,Intermediate,,,A,N,1,7567,,Rattus norvegicus,,,50597,,401,10116.0,,,BAO_0000218,
Half life in rats in hours,,1,CHEMBL621318,Intermediate,,,A,N,1,7568,,Rattus norvegicus,,,50597,,4942,10116.0,,,BAO_0000218,
Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,1,CHEMBL621319,Intermediate,,,A,N,1,7569,,Rattus norvegicus,In vivo,,50597,,17735,10116.0,,,BAO_0000218,
Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,1,CHEMBL621377,Intermediate,,,A,N,1,7570,,Rattus norvegicus,In vivo,,50597,,6056,10116.0,,,BAO_0000218,
Half life was determined,,1,CHEMBL621378,Intermediate,,,A,N,1,7571,,Rattus norvegicus,,,50597,,5213,10116.0,,,BAO_0000218,
Half life after i.v. administration,,1,CHEMBL876599,Intermediate,,,A,N,1,7572,,Rattus norvegicus,In vivo,,50597,,6616,10116.0,,,BAO_0000218,
Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,1,CHEMBL621379,Intermediate,,,A,N,1,7573,,Rattus norvegicus,In vivo,,50597,,5937,10116.0,,,BAO_0000218,
Half life in rat plasma,,1,CHEMBL621380,Intermediate,,,A,N,1,7574,1969.0,Rattus norvegicus,,,50597,,5819,10116.0,,Plasma,BAO_0000218,
Half life in rat plasma; Not detected,,1,CHEMBL621381,Intermediate,,,A,N,1,7575,1969.0,Rattus norvegicus,,,50597,,5819,10116.0,,Plasma,BAO_0000218,
Half life in rats,,1,CHEMBL618515,Intermediate,,,A,N,1,7576,,Rattus norvegicus,,,50597,,6803,10116.0,,,BAO_0000218,
Half life period of compound was determined after peroral administration,,1,CHEMBL618516,Intermediate,,,A,N,1,7577,,Rattus norvegicus,In vivo,,50597,,17804,10116.0,,,BAO_0000218,
Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,1,CHEMBL618517,Intermediate,,,A,N,1,7578,,Rattus norvegicus,In vivo,,50597,,17804,10116.0,,,BAO_0000218,
Half life period in rat,,1,CHEMBL618518,Intermediate,,,A,N,1,7579,,Rattus norvegicus,,,50597,,5948,10116.0,,,BAO_0000218,
Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,1,CHEMBL618519,Intermediate,,,A,N,1,7580,,Rattus norvegicus,In vivo,,50597,,1916,10116.0,,,BAO_0000218,
Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,1,CHEMBL618698,Intermediate,,,A,N,1,7581,,Rattus norvegicus,In vivo,,50597,,1916,10116.0,,,BAO_0000218,
Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,1,CHEMBL618862,Intermediate,,,A,N,1,7582,,Rattus norvegicus,In vivo,,50597,,1916,10116.0,,,BAO_0000218,
Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,1,CHEMBL618863,Intermediate,,,A,N,1,7583,,Rattus norvegicus,In vivo,,50597,,4890,10116.0,,,BAO_0000218,
Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,1,CHEMBL618864,Intermediate,,,A,N,1,7584,,Rattus norvegicus,In vivo,,50597,,17764,10116.0,,,BAO_0000218,
Half life time in rat the dose of 2 mg/kg,,1,CHEMBL618865,Intermediate,,,A,N,1,7585,,Rattus norvegicus,In vivo,,50597,,4727,10116.0,,,BAO_0000218,
Half-life 24 hr after 10 mg/kg iv administration in rats,,1,CHEMBL618866,Intermediate,,,A,N,1,7586,,Rattus norvegicus,In vivo,,50597,,17509,10116.0,,,BAO_0000218,
Half-life 24 hr after 2 mg/kg iv administration in rats,,1,CHEMBL618867,Intermediate,,,A,N,1,7587,,Rattus norvegicus,In vivo,,50597,,17509,10116.0,,,BAO_0000218,
Half-life consistent with the observed metabolic steady state in rats,,1,CHEMBL875828,Intermediate,,,A,N,1,7588,,Rattus norvegicus,,,50597,,6597,10116.0,,,BAO_0000218,
Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,1,CHEMBL618868,Intermediate,,,A,N,1,7589,,Rattus norvegicus,In vivo,,50597,,17735,10116.0,,,BAO_0000218,
Half-life for oxidative metabolic stability was determined using male human,,1,CHEMBL618869,Intermediate,,,A,N,1,7590,,Rattus norvegicus,,,50597,,6597,10116.0,,,BAO_0000218,
"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,1,CHEMBL618870,Intermediate,,,A,N,1,7591,,Rattus norvegicus,In vivo,,50597,,17670,10116.0,,,BAO_0000218,
Half-life in rat plasma,,1,CHEMBL618871,Intermediate,,,A,N,1,7592,1969.0,Rattus norvegicus,,,50597,,1696,10116.0,,Plasma,BAO_0000218,
Half-life in rat plasma was determined,,1,CHEMBL618872,Intermediate,,,A,N,1,7593,1969.0,Rattus norvegicus,,,50597,,1742,10116.0,,Plasma,BAO_0000218,
Half-life in rats was determined,,1,CHEMBL873816,Intermediate,,,A,N,1,7594,,Rattus norvegicus,,,50597,,17800,10116.0,,,BAO_0000218,
Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,0,CHEMBL618873,Autocuration,,,A,U,1,7595,,,,,22224,,12923,,,,BAO_0000218,
Area under curve after oral dose of 0.1 mg//kg,,0,CHEMBL621602,Autocuration,,,A,U,1,7596,,,,,22224,,11954,,,,BAO_0000019,
Area under curve after oral dose of 0.3 mg/kg,,0,CHEMBL621603,Autocuration,,,A,U,1,7597,,,,,22224,,11954,,,,BAO_0000218,
Area under curve after oral dose of 1 mg/kg,,0,CHEMBL621604,Autocuration,,,A,U,1,7598,,,,,22224,,11954,,,,BAO_0000218,
Area under curve after oral dose of 10 mg/kg,,0,CHEMBL621605,Autocuration,,,A,U,1,7599,,,,,22224,,11954,,,,BAO_0000218,
Area under curve after oral dose of 23.4 mg/kg,,0,CHEMBL621606,Autocuration,,,A,U,1,7600,,,,,22224,,11954,,,,BAO_0000218,
Area under curve after oral dose of 3 mg/kg,,0,CHEMBL621607,Autocuration,,,A,U,1,7601,,,,,22224,,11954,,,,BAO_0000218,
Area under curve after oral dose of 3.87 mg/kg,,0,CHEMBL621608,Autocuration,,,A,U,1,7602,,,,,22224,,11954,,,,BAO_0000218,
Area under curve was determined,,0,CHEMBL621609,Autocuration,,,A,U,1,7603,,,,,22224,,5237,,,,BAO_0000019,
Area under curve at a dose of 10 mg/kg,,0,CHEMBL621610,Autocuration,,,A,U,1,7604,,,,,22224,,4026,,,,BAO_0000218,
Area under curve was determined; ND=No data,,1,CHEMBL621611,Intermediate,,,A,N,1,7605,,Rattus norvegicus,,,50597,,5237,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,1,CHEMBL621612,Intermediate,,,A,N,1,7606,,Rattus norvegicus,,,50597,,14793,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,1,CHEMBL622308,Intermediate,,,A,N,1,7607,,Rattus norvegicus,,,50597,,14793,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,1,CHEMBL622309,Intermediate,,,A,N,1,7608,,Rattus norvegicus,,,50597,,14793,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,1,CHEMBL622310,Intermediate,,,A,N,1,7609,,Rattus norvegicus,,,50597,,14793,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,1,CHEMBL622311,Intermediate,,,A,N,1,7610,,Rattus norvegicus,,,50597,,14793,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,1,CHEMBL622312,Intermediate,,,A,N,1,7611,,Rattus norvegicus,,,50597,,14793,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,1,CHEMBL622931,Intermediate,,,A,N,1,7612,,Rattus norvegicus,,,50597,,14793,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,1,CHEMBL622932,Intermediate,,,A,N,1,7613,,Rattus norvegicus,,,50597,,14793,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,1,CHEMBL622736,Intermediate,,,A,N,1,7614,1969.0,Rattus norvegicus,,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,1,CHEMBL622737,Intermediate,,,A,N,1,7615,1969.0,Rattus norvegicus,,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,1,CHEMBL622738,Intermediate,,,A,N,1,7616,1969.0,Rattus norvegicus,,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,1,CHEMBL622739,Intermediate,,,A,N,1,7617,1969.0,Rattus norvegicus,,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,1,CHEMBL622740,Intermediate,,,A,N,1,7618,1969.0,Rattus norvegicus,,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,1,CHEMBL622741,Intermediate,,,A,N,1,7619,1969.0,Rattus norvegicus,,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,1,CHEMBL622742,Intermediate,,,A,N,1,7620,1969.0,Rattus norvegicus,,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,1,CHEMBL622743,Intermediate,,,A,N,1,7621,1969.0,Rattus norvegicus,,,50597,,14793,10116.0,,Plasma,BAO_0000218,
AUC in mice,,1,CHEMBL622744,Intermediate,,,A,N,1,7622,1969.0,Mus musculus,,,50594,,11637,10090.0,,Plasma,BAO_0000218,
Area under curve was measured from the graph obtained from concentration Vs time,,0,CHEMBL624134,Autocuration,,,A,U,1,7623,,,,,22224,,11149,,,,BAO_0000019,
Area under curve value of compound per hour after oral administration,,0,CHEMBL624135,Autocuration,,,A,U,1,7624,,,,,22224,,10016,,,,BAO_0000019,
Area under curve was determined after oral administration in rats,,1,CHEMBL624136,Intermediate,,,A,N,1,7625,,Rattus norvegicus,,,50597,,17796,10116.0,,,BAO_0000218,
Area under curve was determined after oral administration in rats; No data,,1,CHEMBL624137,Intermediate,,,A,N,1,7626,,Rattus norvegicus,,,50597,,17796,10116.0,,,BAO_0000218,
Area under curve was determined after oral administration in rats;No data,,1,CHEMBL624320,Intermediate,,,A,N,1,7627,,Rattus norvegicus,,,50597,,17796,10116.0,,,BAO_0000218,
Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,1,CHEMBL624321,Intermediate,,,A,N,1,7628,,Canis lupus familiaris,,,50588,,12923,9615.0,,,BAO_0000218,
Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,1,CHEMBL624322,Intermediate,,,A,N,1,7629,,Rattus norvegicus,,,50597,,15372,10116.0,,,BAO_0000218,
Area under curve was determined for the compound after iv dose of 5.06 in rats,,1,CHEMBL624323,Intermediate,,,A,N,1,7630,,Rattus norvegicus,,,50597,,15372,10116.0,,,BAO_0000218,
Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,1,CHEMBL624324,Intermediate,,,A,N,1,7631,,Rattus norvegicus,,,50597,,15372,10116.0,,,BAO_0000218,
Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,1,CHEMBL624325,Intermediate,,,A,N,1,7632,,Rattus norvegicus,,,50597,,15372,10116.0,,,BAO_0000218,
Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,1,CHEMBL624326,Intermediate,,,A,N,1,7633,,Rattus norvegicus,,,50597,,15372,10116.0,,,BAO_0000218,
Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,1,CHEMBL624327,Intermediate,,,A,N,1,7634,,Rattus norvegicus,,,50597,,15372,10116.0,,,BAO_0000218,
Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,1,CHEMBL624328,Intermediate,,,A,N,1,7635,,Rattus norvegicus,,,50597,,15372,10116.0,,,BAO_0000218,
Area under curve was determined in Dogs after peroral administration,,1,CHEMBL627848,Intermediate,,,A,N,1,7636,,Canis lupus familiaris,,,50588,,14169,9615.0,,,BAO_0000218,
Area under curve was determined in Rats after peroral administration,,1,CHEMBL627849,Intermediate,,,A,N,1,7637,,Rattus norvegicus,,,50597,,14169,10116.0,,,BAO_0000218,
Area under curve was determined in carotid blood of rat when administered intradermally,,1,CHEMBL627850,Intermediate,,,A,N,1,7638,,Rattus norvegicus,,,50597,,14258,10116.0,,,BAO_0000218,
Area under curve was determined in portal blood of rat when administered intradermally,,1,CHEMBL627851,Intermediate,,,A,N,1,7639,,Rattus norvegicus,,,50597,,14258,10116.0,,,BAO_0000218,
Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,1,CHEMBL627852,Intermediate,,,A,N,1,7640,,Mus musculus,,,50594,,15011,10090.0,,,BAO_0000218,
Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,1,CHEMBL627853,Intermediate,,,A,N,1,7641,,Mus musculus,,,50594,,15011,10090.0,,,BAO_0000218,
Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,1,CHEMBL627854,Intermediate,,,A,N,1,7642,,Mus musculus,,,50594,,15011,10090.0,,,BAO_0000218,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,1,CHEMBL627855,Intermediate,,,A,N,1,7643,,Mus musculus,,,50594,,15011,10090.0,,,BAO_0000218,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,1,CHEMBL627856,Intermediate,,,A,N,1,7644,,Mus musculus,,,50594,,15011,10090.0,,,BAO_0000218,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,1,CHEMBL875339,Intermediate,,,A,N,1,7645,,Mus musculus,,,50594,,15011,10090.0,,,BAO_0000218,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,1,CHEMBL627857,Intermediate,,,A,N,1,7646,,Mus musculus,,,50594,,15011,10090.0,,,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,1,CHEMBL627858,Intermediate,,,A,N,1,7647,2106.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Spleen,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,1,CHEMBL627859,Intermediate,,,A,N,1,7648,178.0,Rattus norvegicus,,,50597,,10130,10116.0,,Blood,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,1,CHEMBL627860,Intermediate,,,A,N,1,7649,955.0,Rattus norvegicus,,,50597,,10130,10116.0,,Brain,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,1,CHEMBL627019,Intermediate,,,A,N,1,7650,948.0,Rattus norvegicus,,,50597,,10130,10116.0,,Heart,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,1,CHEMBL627020,Intermediate,,,A,N,1,7651,2107.0,Rattus norvegicus,,,50597,,10130,10116.0,,Liver,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,1,CHEMBL627021,Intermediate,,,A,N,1,7652,2048.0,Rattus norvegicus,,,50597,,10130,10116.0,,Lung,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,1,CHEMBL627022,Intermediate,,,A,N,1,7653,2385.0,Rattus norvegicus,,,50597,,10130,10116.0,,Muscle tissue,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,1,CHEMBL627023,Intermediate,,,A,N,1,7654,,Rattus norvegicus,,,50597,,10130,10116.0,,,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,1,CHEMBL627024,Intermediate,,,A,N,1,7655,2106.0,Rattus norvegicus,,,50597,,10130,10116.0,,Spleen,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,1,CHEMBL627025,Intermediate,,,A,N,1,7656,2046.0,Rattus norvegicus,,,50597,,10130,10116.0,,Thyroid gland,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,1,CHEMBL627026,Intermediate,,,A,N,1,7657,2113.0,Rattus norvegicus,,,50597,,10130,10116.0,,Kidney,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,1,CHEMBL627027,Intermediate,,,A,N,1,7658,178.0,Rattus norvegicus,,,50597,,10130,10116.0,,Blood,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,1,CHEMBL627028,Intermediate,,,A,N,1,7659,955.0,Rattus norvegicus,,,50597,,10130,10116.0,,Brain,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,1,CHEMBL627029,Intermediate,,,A,N,1,7660,948.0,Rattus norvegicus,,,50597,,10130,10116.0,,Heart,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,1,CHEMBL627030,Intermediate,,,A,N,1,7661,2113.0,Rattus norvegicus,,,50597,,10130,10116.0,,Kidney,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,1,CHEMBL627031,Intermediate,,,A,N,1,7662,2107.0,Rattus norvegicus,,,50597,,10130,10116.0,,Liver,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,1,CHEMBL627032,Intermediate,,,A,N,1,7663,2048.0,Rattus norvegicus,,,50597,,10130,10116.0,,Lung,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,1,CHEMBL627033,Intermediate,,,A,N,1,7664,2385.0,Rattus norvegicus,,,50597,,10130,10116.0,,Muscle tissue,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,1,CHEMBL627034,Intermediate,,,A,N,1,7665,,Rattus norvegicus,,,50597,,10130,10116.0,,,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,1,CHEMBL627035,Intermediate,,,A,N,1,7666,2106.0,Rattus norvegicus,,,50597,,10130,10116.0,,Spleen,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,1,CHEMBL627036,Intermediate,,,A,N,1,7667,2046.0,Rattus norvegicus,,,50597,,10130,10116.0,,Thyroid gland,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,1,CHEMBL875340,Intermediate,,,A,N,1,7668,178.0,Rattus norvegicus,,,50597,,10130,10116.0,,Blood,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,1,CHEMBL627037,Intermediate,,,A,N,1,7669,948.0,Rattus norvegicus,,,50597,,10130,10116.0,,Heart,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,1,CHEMBL627038,Intermediate,,,A,N,1,7670,2113.0,Rattus norvegicus,,,50597,,10130,10116.0,,Kidney,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,1,CHEMBL627039,Intermediate,,,A,N,1,7671,2107.0,Rattus norvegicus,,,50597,,10130,10116.0,,Liver,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,1,CHEMBL627040,Intermediate,,,A,N,1,7672,2385.0,Rattus norvegicus,,,50597,,10130,10116.0,,Muscle tissue,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,1,CHEMBL624663,Intermediate,,,A,N,1,7673,2106.0,Rattus norvegicus,,,50597,,10130,10116.0,,Spleen,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,1,CHEMBL625963,Intermediate,,,A,N,1,7674,2046.0,Rattus norvegicus,,,50597,,10130,10116.0,,Thyroid gland,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,1,CHEMBL876799,Intermediate,,,A,N,1,7675,955.0,Rattus norvegicus,,,50597,,10130,10116.0,,Brain,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,1,CHEMBL626133,Intermediate,,,A,N,1,7676,2048.0,Rattus norvegicus,,,50597,,10130,10116.0,,Lung,BAO_0000218,
In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,1,CHEMBL626134,Intermediate,,,A,N,1,7677,,Rattus norvegicus,,,50597,,10130,10116.0,,,BAO_0000218,
In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,1,CHEMBL626135,Intermediate,,,A,N,1,7678,,Rattus norvegicus,,,50597,,6295,10116.0,,,BAO_0000218,
In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,1,CHEMBL626136,Intermediate,,,A,N,1,7679,,Rattus norvegicus,,,50597,,6296,10116.0,,,BAO_0000218,
In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,1,CHEMBL626137,Intermediate,,,A,N,1,7680,,Rattus norvegicus,,,50597,,6296,10116.0,,,BAO_0000218,
In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,1,CHEMBL626138,Intermediate,,,A,N,1,7681,,Rattus norvegicus,,,50597,,6295,10116.0,,,BAO_0000218,
In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,1,CHEMBL626139,Intermediate,,,A,N,1,7682,,Rattus norvegicus,,,50597,,6296,10116.0,,,BAO_0000218,
C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,1,CHEMBL626140,Intermediate,,,A,N,1,7683,,Rattus norvegicus,In vivo,,50597,,17260,10116.0,,,BAO_0000218,
C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,1,CHEMBL626141,Intermediate,,,A,N,1,7684,,Rattus norvegicus,In vivo,,50597,,17260,10116.0,,,BAO_0000218,
C24h in rat p.o. at 20 mg/kg concentration,,1,CHEMBL626142,Intermediate,,,A,N,1,7685,,Rattus norvegicus,,,50597,,17686,10116.0,,,BAO_0000218,
Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,1,CHEMBL627930,Intermediate,,,A,N,1,7686,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,1,CHEMBL627931,Intermediate,,,A,N,1,7687,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,1,CHEMBL627932,Intermediate,,,A,N,1,7688,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,1,CHEMBL627933,Intermediate,,,A,N,1,7689,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,1,CHEMBL627934,Intermediate,,,A,N,1,7690,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,1,CHEMBL627935,Intermediate,,,A,N,1,7691,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,1,CHEMBL627936,Intermediate,,,A,N,1,7692,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,1,CHEMBL627937,Intermediate,,,A,N,1,7693,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,1,CHEMBL627938,Intermediate,,,A,N,1,7694,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,1,CHEMBL627939,Intermediate,,,A,N,1,7695,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,1,CHEMBL627940,Intermediate,,,A,N,1,7696,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,1,CHEMBL627941,Intermediate,,,A,N,1,7697,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,1,CHEMBL876800,Intermediate,,,A,N,1,7698,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,1,CHEMBL627942,Intermediate,,,A,N,1,7699,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,1,CHEMBL627943,Intermediate,,,A,N,1,7700,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,1,CHEMBL627944,Intermediate,,,A,N,1,7701,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,1,CHEMBL627945,Intermediate,,,A,N,1,7702,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,1,CHEMBL628584,Intermediate,,,A,N,1,7703,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA at 15 min,,1,CHEMBL628585,Intermediate,,,A,N,1,7704,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,1,CHEMBL628586,Intermediate,,,A,N,1,7705,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA at 30 min,,1,CHEMBL628587,Intermediate,,,A,N,1,7706,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,1,CHEMBL628588,Intermediate,,,A,N,1,7707,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,1,CHEMBL628589,Intermediate,,,A,N,1,7708,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,1,CHEMBL625304,Intermediate,,,A,N,1,7709,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,1,CHEMBL625305,Intermediate,,,A,N,1,7710,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,1,CHEMBL625306,Intermediate,,,A,N,1,7711,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,1,CHEMBL625307,Intermediate,,,A,N,1,7712,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,1,CHEMBL625308,Intermediate,,,A,N,1,7713,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,1,CHEMBL627740,Intermediate,,,A,N,1,7714,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,1,CHEMBL627741,Intermediate,,,A,N,1,7715,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,1,CHEMBL627742,Intermediate,,,A,N,1,7716,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,1,CHEMBL627743,Intermediate,,,A,N,1,7717,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,1,CHEMBL627744,Intermediate,,,A,N,1,7718,178.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Blood,BAO_0000218,
Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,1,CHEMBL627745,Intermediate,,,A,N,1,7719,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,1,CHEMBL627746,Intermediate,,,A,N,1,7720,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,1,CHEMBL627747,Intermediate,,,A,N,1,7721,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,1,CHEMBL876810,Intermediate,,,A,N,1,7722,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,1,CHEMBL627748,Intermediate,,,A,N,1,7723,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,1,CHEMBL627749,Intermediate,,,A,N,1,7724,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,1,CHEMBL627750,Intermediate,,,A,N,1,7725,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,1,CHEMBL618728,Intermediate,,,A,N,1,7726,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,1,CHEMBL618729,Intermediate,,,A,N,1,7727,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA at 15 min,,1,CHEMBL618730,Intermediate,,,A,N,1,7728,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,1,CHEMBL618731,Intermediate,,,A,N,1,7729,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA at 30 min,,1,CHEMBL618732,Intermediate,,,A,N,1,7730,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,1,CHEMBL618733,Intermediate,,,A,N,1,7731,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,1,CHEMBL618734,Intermediate,,,A,N,1,7732,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,1,CHEMBL618735,Intermediate,,,A,N,1,7733,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,1,CHEMBL876602,Intermediate,,,A,N,1,7734,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,1,CHEMBL618736,Intermediate,,,A,N,1,7735,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,1,CHEMBL618737,Intermediate,,,A,N,1,7736,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,1,CHEMBL618738,Intermediate,,,A,N,1,7737,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,1,CHEMBL618739,Intermediate,,,A,N,1,7738,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,1,CHEMBL618740,Intermediate,,,A,N,1,7739,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,1,CHEMBL618741,Intermediate,,,A,N,1,7740,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,1,CHEMBL618742,Intermediate,,,A,N,1,7741,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,1,CHEMBL618743,Intermediate,,,A,N,1,7742,10000001.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Bone,BAO_0000218,
Half-life from rat plasma at a single oral dose of 25 mg/kg,,1,CHEMBL618744,Intermediate,,,A,N,1,7743,1969.0,Rattus norvegicus,In vivo,,50597,,17752,10116.0,,Plasma,BAO_0000218,
Half-life in male rat,,1,CHEMBL618745,Intermediate,,,A,N,1,7744,,Rattus norvegicus,,,50597,,5610,10116.0,,,BAO_0000218,
Half-life in rat after peroral administration at 10 mg/kg concentration,,1,CHEMBL620479,Intermediate,,,A,N,1,7745,,Rattus norvegicus,In vivo,,50597,,5939,10116.0,,,BAO_0000218,
Half-life in rat after peroral administration at 5 mg/kg concentration,,1,CHEMBL620480,Intermediate,,,A,N,1,7746,,Rattus norvegicus,In vivo,,50597,,5939,10116.0,,,BAO_0000218,
Half-life in rat at a dose of 3 mg/kg,,1,CHEMBL620481,Intermediate,,,A,N,1,7747,,Rattus norvegicus,In vivo,,50597,,17771,10116.0,,,BAO_0000218,
Half-life was evaluated in rats,,1,CHEMBL620482,Intermediate,,,A,N,1,7748,,Rattus norvegicus,,,50597,,1974,10116.0,,,BAO_0000218,
Half-life was measured in rat,,1,CHEMBL876603,Intermediate,,,A,N,1,7749,,Rattus norvegicus,,,50597,,4239,10116.0,,,BAO_0000218,
Half-life period for the compound was determined in rats at 50 mg/kg dose,,1,CHEMBL620483,Intermediate,,,A,N,1,7750,,Rattus norvegicus,In vivo,,50597,,6681,10116.0,,,BAO_0000218,
Half-life period in rats after intravenous administration at 5 mg/kg,,1,CHEMBL620484,Intermediate,,,A,N,1,7751,,Rattus norvegicus,In vivo,,50597,,17752,10116.0,,,BAO_0000218,
Half-life period in rat at 10 mg/kg,,1,CHEMBL620485,Intermediate,,,A,N,1,7752,,Rattus norvegicus,In vivo,,50597,,6046,10116.0,,,BAO_0000218,
"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,1,CHEMBL620486,Intermediate,,,A,N,1,7753,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,1,CHEMBL620487,Intermediate,,,A,N,1,7754,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,1,CHEMBL620488,Intermediate,,,A,N,1,7755,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
Half-life time in rat the dose of 2 mg/kg,,1,CHEMBL620489,Intermediate,,,A,N,1,7756,,Rattus norvegicus,In vivo,,50597,,4727,10116.0,,,BAO_0000218,
Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,1,CHEMBL620490,Intermediate,,,A,N,1,7757,,Rattus norvegicus,In vivo,,50597,,1088,10116.0,,,BAO_0000218,
In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,1,CHEMBL620491,Intermediate,,,A,N,1,7758,,Rattus norvegicus,In vivo,,50597,,5610,10116.0,,,BAO_0000218,
"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,1,CHEMBL876604,Intermediate,,,A,N,1,7759,1969.0,Rattus norvegicus,In vivo,,50597,,3032,10116.0,,Plasma,BAO_0000218,
Oral half life was determined,,1,CHEMBL620492,Intermediate,,,A,N,1,7760,,Rattus norvegicus,In vivo,,50597,,5199,10116.0,,,BAO_0000218,
"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,1,CHEMBL620493,Intermediate,,,A,N,1,7761,,Rattus norvegicus,In vivo,,50597,,14941,10116.0,,,BAO_0000218,
Pharmacokinetic property (t1/2) in rat,,1,CHEMBL620494,Intermediate,,,A,N,1,7762,,Rattus norvegicus,In vivo,,50597,,4408,10116.0,,,BAO_0000218,
Plasma elimination half-life was determined,,1,CHEMBL620495,Intermediate,,,A,N,1,7763,1969.0,Rattus norvegicus,,,50597,,2552,10116.0,,Plasma,BAO_0000218,
Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,1,CHEMBL620496,Intermediate,,,A,N,1,7764,1969.0,Rattus norvegicus,In vivo,,50597,,5199,10116.0,,Plasma,BAO_0000218,
Plasma half life was observed after intravenous administration in rat,,1,CHEMBL620497,Intermediate,,,A,N,1,7765,1969.0,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,Plasma,BAO_0000218,
Plasma half-life was determined,,1,CHEMBL620498,Intermediate,,,A,N,1,7766,1969.0,Rattus norvegicus,,,50597,,1465,10116.0,,Plasma,BAO_0000218,
Plasma half-life following oral administration in Fisher rats,,1,CHEMBL620499,Intermediate,,,A,N,1,7767,1969.0,Rattus norvegicus,In vivo,,50597,,1446,10116.0,,Plasma,BAO_0000218,
Plasma half-life in rat,,1,CHEMBL620500,Intermediate,,,A,N,1,7768,1969.0,Rattus norvegicus,,,50597,,6824,10116.0,,Plasma,BAO_0000218,
Plasmatic Half-life after intravenous administration to rat,,1,CHEMBL873809,Intermediate,,,A,N,1,7769,1969.0,Rattus norvegicus,In vivo,,50597,,17533,10116.0,,Plasma,BAO_0000218,
T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,1,CHEMBL620501,Intermediate,,,A,N,1,7770,,Rattus norvegicus,In vivo,,50597,,5979,10116.0,,,BAO_0000218,
Terminal half life after intravenous administration (1 mg/kg) in rat,,1,CHEMBL620502,Intermediate,,,A,N,1,7771,,Rattus norvegicus,In vivo,,50597,,4689,10116.0,,,BAO_0000218,
Terminal half life in Rat at a oral dose of 5 mg/kg,,1,CHEMBL620503,Intermediate,,,A,N,1,7772,,Rattus norvegicus,In vivo,,50597,,4689,10116.0,,,BAO_0000218,
Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,1,CHEMBL620504,Intermediate,,,A,N,1,7773,,Rattus norvegicus,In vivo,,50597,,2463,10116.0,,,BAO_0000218,
Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,1,CHEMBL876605,Intermediate,,,A,N,1,7774,,Rattus norvegicus,In vivo,,50597,,4883,10116.0,,,BAO_0000218,
Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,1,CHEMBL620505,Intermediate,,,A,N,1,7775,,Rattus norvegicus,In vivo,,50597,,4883,10116.0,,,BAO_0000218,
plasma half life was observed after intravenous administration in rat,,1,CHEMBL873811,Intermediate,,,A,N,1,7776,1969.0,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,Plasma,BAO_0000218,
Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,CHEMBL624016,Expert,,,A,N,1,7777,,Rattus norvegicus,In vivo,,50597,,3598,10116.0,,,BAO_0000218,
Half life of compound determined in rat,,1,CHEMBL624017,Intermediate,,,A,N,1,7778,,Rattus norvegicus,,,50597,,4576,10116.0,,,BAO_0000218,
Mean residence time determined in rat,,1,CHEMBL624018,Intermediate,,,A,N,1,7779,,Rattus norvegicus,,,50597,,4576,10116.0,,,BAO_0000218,
Plasma half life determined in rat,,1,CHEMBL624019,Intermediate,,,A,N,1,7780,,Rattus norvegicus,,,50597,,4576,10116.0,,,BAO_0000218,
Compound was evaluated for Tmax in brain after intravenous administration in male rats,,1,CHEMBL624020,Intermediate,,,A,N,1,7781,955.0,Rattus norvegicus,In vivo,,50597,,4910,10116.0,,Brain,BAO_0000218,
Compound was evaluated for pharmacokinetic parameter maximum time period,,1,CHEMBL624201,Intermediate,,,A,N,1,7782,,Rattus norvegicus,In vivo,,50597,,4891,10116.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,1,CHEMBL872528,Intermediate,,,A,N,1,7783,,Rattus norvegicus,In vivo,,50597,,429,10116.0,,,BAO_0000218,
In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL624202,Intermediate,,,A,N,1,7784,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL624203,Intermediate,,,A,N,1,7785,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL624350,Intermediate,,,A,N,1,7786,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL621320,Intermediate,,,A,N,1,7787,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,1,CHEMBL621321,Intermediate,,,A,N,1,7788,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
Maximum time (Tmax) required to reach Cmax in rats,,1,CHEMBL621322,Intermediate,,,A,N,1,7789,,Rattus norvegicus,,,50597,,4026,10116.0,,,BAO_0000218,
Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,1,CHEMBL621323,Intermediate,,,A,N,1,7790,,Rattus norvegicus,In vivo,,50597,,4890,10116.0,,,BAO_0000218,
Maximum time of clearance of compound in rats after peroral administration,,1,CHEMBL621324,Intermediate,,,A,N,1,7791,,Rattus norvegicus,In vivo,,50597,,6571,10116.0,,,BAO_0000218,
Maximum time at the dose of 2 mg/kg in rat,,1,CHEMBL621325,Intermediate,,,A,N,1,7792,,Rattus norvegicus,,,50597,,4727,10116.0,,,BAO_0000218,
Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,1,CHEMBL875837,Intermediate,,,A,N,1,7793,1969.0,Rattus norvegicus,In vivo,,50597,,17651,10116.0,,Plasma,BAO_0000218,
Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,1,CHEMBL621326,Intermediate,,,A,N,1,7794,1969.0,Rattus norvegicus,In vivo,,50597,,17651,10116.0,,Plasma,BAO_0000218,
Tmax in Guinea pig (PO dose),,1,CHEMBL621327,Intermediate,,,A,N,1,7795,,Rattus norvegicus,In vivo,,50597,,14465,10116.0,,,BAO_0000218,
"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,1,CHEMBL621328,Intermediate,,,A,N,1,7796,,Rattus norvegicus,In vivo,,50597,,14941,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (Tmax) in rat,,1,CHEMBL621329,Intermediate,,,A,N,1,7797,,Rattus norvegicus,In vivo,,50597,,5960,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (Tmax) was estimated,,1,CHEMBL621330,Intermediate,,,A,N,1,7798,,Rattus norvegicus,In vivo,,50597,,5022,10116.0,,,BAO_0000218,
Pharmacokinetic property (Tmax) in rat,,1,CHEMBL621331,Intermediate,,,A,N,1,7799,,Rattus norvegicus,In vivo,,50597,,4408,10116.0,,,BAO_0000218,
Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,1,CHEMBL621332,Intermediate,,,A,N,1,7800,,Rattus norvegicus,In vivo,,50597,,5983,10116.0,,,BAO_0000218,
T max in Rat at a oral dose of 5 mg/kg,,1,CHEMBL621333,Intermediate,,,A,N,1,7801,,Rattus norvegicus,In vivo,,50597,,4689,10116.0,,,BAO_0000218,
T max was determined at 10 mg/kg po dose in rats,,1,CHEMBL621334,Intermediate,,,A,N,1,7802,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,1,CHEMBL621335,Intermediate,,,A,N,1,7803,,Mus musculus,,,50594,,15011,10090.0,,,BAO_0000218,
Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,1,CHEMBL621336,Intermediate,,,A,N,1,7804,,Canis lupus familiaris,,,50588,,14180,9615.0,,,BAO_0000218,
Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,1,CHEMBL621337,Intermediate,,,A,N,1,7805,,Rattus norvegicus,,,50597,,14180,10116.0,,,BAO_0000218,
Area under curve was measured after i.v. administration into Beagle dog.,,1,CHEMBL621338,Intermediate,,,A,N,1,7806,,Canis lupus familiaris,,,50588,,14599,9615.0,,,BAO_0000218,
Area under curve was measured after iv administration into Beagle dog,,1,CHEMBL875838,Intermediate,,,A,N,1,7807,,Canis lupus familiaris,,,50588,,14599,9615.0,,,BAO_0000218,
Area under curve was measured after po administration into Beagle dog,,1,CHEMBL621339,Intermediate,,,A,N,1,7808,,Canis lupus familiaris,,,50588,,14599,9615.0,,,BAO_0000218,
Area under curve was measured after po administration into Beagle dog.,,1,CHEMBL621340,Intermediate,,,A,N,1,7809,,Canis lupus familiaris,,,50588,,14599,9615.0,,,BAO_0000218,
Area under curve was measured at peroral dose of 3 mg/kg,,0,CHEMBL621341,Autocuration,,,A,U,1,7810,,,,,22224,,15675,,,,BAO_0000218,
Area under curve was measured by using concentration Vs time,,0,CHEMBL621342,Autocuration,,,A,U,1,7811,,,,,22224,,12706,,,,BAO_0000019,
Area under curve was measured by using concentration Vs time; not tested,,0,CHEMBL621343,Autocuration,,,A,U,1,7812,,,,,22224,,12706,,,,BAO_0000019,
Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,1,CHEMBL621344,Intermediate,,,A,N,1,7813,,Mus musculus,,,50594,,9750,10090.0,,,BAO_0000218,
Area under curve(AUC) was measured in mice after oral administration.,,1,CHEMBL621345,Intermediate,,,A,N,1,7814,,Mus musculus,,,50594,,9750,10090.0,,,BAO_0000218,
Area under curve(AUC) value of the compound,,0,CHEMBL621346,Autocuration,,,A,U,1,7815,,,,,22224,,14691,,,,BAO_0000019,
Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,0,CHEMBL621347,Autocuration,,,A,U,1,7816,,,,,22224,,14691,,,,BAO_0000218,
Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,1,CHEMBL621348,Intermediate,,,A,N,1,7817,,Canis lupus familiaris,,,50588,,14691,9615.0,,,BAO_0000218,
Area under curve(carotid artery) was determined by the availability in blood,,0,CHEMBL621349,Autocuration,,,A,U,1,7818,178.0,,,,22224,,2939,,,Blood,BAO_0000019,
Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,0,CHEMBL621350,Autocuration,,,A,U,1,7819,178.0,,,,22224,,2939,,,Blood,BAO_0000019,
Area under curve(carotid artery) was determined by the availability in blood; No data,,0,CHEMBL875839,Autocuration,,,A,U,1,7820,178.0,,,,22224,,2939,,,Blood,BAO_0000019,
Area under curve(portal vein) was determined by the availability in blood,,0,CHEMBL620211,Autocuration,,,A,U,1,7821,178.0,,,,22224,,2939,,,Blood,BAO_0000019,
Area under curve(portal vein) was determined by the availability in blood; ND means no data,,0,CHEMBL620212,Autocuration,,,A,U,1,7822,178.0,,,,22224,,2939,,,Blood,BAO_0000019,
Area under curve(portal vein) was determined by the availability in blood; No data,,0,CHEMBL620213,Autocuration,,,A,U,1,7823,178.0,,,,22224,,2939,,,Blood,BAO_0000019,
"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,1,CHEMBL620214,Intermediate,,,A,N,1,7824,1969.0,Macaca mulatta,,,50797,,9552,9544.0,,Plasma,BAO_0000218,
"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,1,CHEMBL620215,Intermediate,,,A,N,1,7825,1969.0,Macaca mulatta,,,50797,,9552,9544.0,,Plasma,BAO_0000218,
Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,1,CHEMBL620216,Intermediate,,,A,N,1,7826,1969.0,Macaca mulatta,,,50797,,9552,9544.0,,Plasma,BAO_0000218,
"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,1,CHEMBL620888,Intermediate,,,A,N,1,7827,1969.0,Canis lupus familiaris,,,50588,,9552,9615.0,,Plasma,BAO_0000218,
"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,1,CHEMBL620889,Intermediate,,,A,N,1,7828,1969.0,Canis lupus familiaris,,,50588,,9552,9615.0,,Plasma,BAO_0000218,
Area under plasma concentration vs time curve observed in rats for 0-3 h,,0,CHEMBL620890,Autocuration,,,A,U,1,7829,1969.0,,,,22224,,9552,,,Plasma,BAO_0000019,
Area under plasma time curve determined in male rat,,1,CHEMBL620891,Intermediate,,,A,N,1,7830,1969.0,Rattus norvegicus,,,50597,,11911,10116.0,,Plasma,BAO_0000218,
Area under the MAP curve measured over 5 min.,,0,CHEMBL620892,Autocuration,,,A,U,1,7831,,,,,22224,,16618,,,,BAO_0000019,
Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,1,CHEMBL621079,Intermediate,,,A,N,1,7832,,Mus musculus,,,50594,,14387,10090.0,,,BAO_0000218,
Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,1,CHEMBL621080,Intermediate,,,A,N,1,7833,,Mus musculus,,,50594,,14387,10090.0,,,BAO_0000218,
Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,1,CHEMBL621081,Intermediate,,,A,N,1,7834,,Canis lupus familiaris,,,50588,,12836,9615.0,,,BAO_0000218,
Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,1,CHEMBL621082,Intermediate,,,A,N,1,7835,,Cricetinae,,,100712,,12836,10026.0,,,BAO_0000218,
Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,1,CHEMBL621083,Intermediate,,,A,N,1,7836,,Rattus norvegicus,,,50597,,12836,10116.0,,,BAO_0000218,
Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,1,CHEMBL621084,Intermediate,,,A,N,1,7837,,Canis lupus familiaris,,,50588,,14339,9615.0,,,BAO_0000218,
Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,1,CHEMBL621085,Intermediate,,,A,N,1,7838,,Canis lupus familiaris,,,50588,,14339,9615.0,,,BAO_0000218,
Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,1,CHEMBL621086,Intermediate,,,A,N,1,7839,,Canis lupus familiaris,,,50588,,14339,9615.0,,,BAO_0000218,
Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,1,CHEMBL621087,Intermediate,,,A,N,1,7840,,Canis lupus familiaris,,,50588,,10524,9615.0,,,BAO_0000218,
Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,1,CHEMBL622607,Intermediate,,,A,N,1,7841,,Canis lupus familiaris,,,50588,,9994,9615.0,,,BAO_0000218,
Serum AUC in marmosets (IV dose),,1,CHEMBL622608,Intermediate,,,A,N,1,7842,,Canis lupus familiaris,,,50588,,11325,9615.0,,,BAO_0000218,
Area under the curve after intravenous administration at a dose of 10 umol/kg,,0,CHEMBL624481,Autocuration,,,A,U,1,7843,,,,,22224,,12536,,,,BAO_0000019,
Area under the curve after intravenous administration at a dose of 2 umol/kg,,0,CHEMBL624482,Autocuration,,,A,U,1,7844,,,,,22224,,12536,,,,BAO_0000019,
Area under the curve after intravenous administration at a dose of 4 umol/kg,,0,CHEMBL624483,Autocuration,,,A,U,1,7845,,,,,22224,,12536,,,,BAO_0000019,
Area under the curve after intravenous administration at a dose of 40 umol/kg,,0,CHEMBL624484,Autocuration,,,A,U,1,7846,,,,,22224,,12536,,,,BAO_0000019,
Area under the curve after intravenous administration at a dose of 5 umol/kg,,0,CHEMBL624485,Autocuration,,,A,U,1,7847,,,,,22224,,12536,,,,BAO_0000019,
Area under the curve for fumarate salt was evaluated in F344 Rats.,,1,CHEMBL624486,Intermediate,,,A,N,1,7848,,Rattus norvegicus,,,50597,,15556,10116.0,,,BAO_0000218,
Area under the curve for the compound was calculated.,,0,CHEMBL624487,Autocuration,,,A,U,1,7849,,,,,22224,,2809,,,,BAO_0000019,
Area under the curve in concentration/ time,,0,CHEMBL624488,Autocuration,,,A,U,1,7850,,,,,22224,,9511,,,,BAO_0000019,
Area under the curve administered intraintestinal in rats.,,1,CHEMBL624489,Intermediate,,,A,N,1,7851,,Rattus norvegicus,,,50597,,12818,10116.0,,,BAO_0000218,
Area under the curve administered intravenously in rats.,,1,CHEMBL625184,Intermediate,,,A,N,1,7852,,Rattus norvegicus,,,50597,,12818,10116.0,,,BAO_0000218,
Area under the curve during intravenous administration,,0,CHEMBL625185,Autocuration,,,A,U,1,7853,,,,,22224,,15118,,,,BAO_0000019,
Area under the curve during intravenous administration; Not determined,,0,CHEMBL875954,Autocuration,,,A,U,1,7854,,,,,22224,,15118,,,,BAO_0000019,
Area under the curve during systemic administration,,0,CHEMBL625186,Autocuration,,,A,U,1,7855,,,,,22224,,15118,,,,BAO_0000019,
Area under the curve during systemic administration; Not determined,,0,CHEMBL625187,Autocuration,,,A,U,1,7856,,,,,22224,,15118,,,,BAO_0000019,
Area under the curve was calculated for the compound.,,0,CHEMBL625188,Autocuration,,,A,U,1,7857,,,,,22224,,2632,,,,BAO_0000019,
Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,1,CHEMBL625189,Intermediate,,,A,N,1,7858,,Canis lupus familiaris,,,50588,,14346,9615.0,,,BAO_0000218,
Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,1,CHEMBL625190,Intermediate,,,A,N,1,7859,,Canis lupus familiaris,,,50588,,14346,9615.0,,,BAO_0000218,
Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,1,CHEMBL621733,Intermediate,,,A,N,1,7860,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,1,CHEMBL621734,Intermediate,,,A,N,1,7861,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,1,CHEMBL621735,Intermediate,,,A,N,1,7862,,Rattus norvegicus,,,50597,,11149,10116.0,,,BAO_0000218,
Clearance of the drug was measured in the plasma of rat; No data,,1,CHEMBL621736,Intermediate,,,A,N,1,7863,1969.0,Rattus norvegicus,,,50597,,17796,10116.0,,Plasma,BAO_0000218,
The pharmacokinetic parameter plasma clearance in vivo in rats,,1,CHEMBL621737,Intermediate,,,A,N,1,7864,1969.0,Rattus norvegicus,,,50597,,5247,10116.0,,Plasma,BAO_0000218,
Plasma clearance at the dose of 2 mg/kg in rat,,1,CHEMBL621738,Intermediate,,,A,N,1,7865,,Rattus norvegicus,,,50597,,4727,10116.0,,,BAO_0000218,
CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,1,CHEMBL622806,Intermediate,,,A,N,1,7866,,Rattus norvegicus,In vivo,,50597,,5654,10116.0,,,BAO_0000218,
CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,1,CHEMBL623519,Intermediate,,,A,N,1,7867,,Rattus norvegicus,In vivo,,50597,,5654,10116.0,,,BAO_0000218,
CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,1,CHEMBL623520,Intermediate,,,A,N,1,7868,,Rattus norvegicus,In vivo,,50597,,17260,10116.0,,,BAO_0000218,
Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,1,CHEMBL623521,Intermediate,,,A,N,1,7869,,Rattus norvegicus,In vivo,,50597,,17065,10116.0,,,BAO_0000218,
Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,1,CHEMBL623522,Intermediate,,,A,N,1,7870,,Rattus norvegicus,In vivo,,50597,,17671,10116.0,,,BAO_0000218,
Clearance rate in rat,,1,CHEMBL623523,Intermediate,,,A,N,1,7871,,Rattus norvegicus,In vivo,,50597,,6672,10116.0,,,BAO_0000218,
Clearance rate in rat,,1,CHEMBL623690,Intermediate,,,A,N,1,7872,,Rattus norvegicus,In vivo,,50597,,6673,10116.0,,,BAO_0000218,
Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL623691,Intermediate,,,A,N,1,7873,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL623692,Intermediate,,,A,N,1,7874,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL623693,Intermediate,,,A,N,1,7875,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL623694,Intermediate,,,A,N,1,7876,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Clearance of compound after iv administration of 20 mg/kg dose in rat,,1,CHEMBL623695,Intermediate,,,A,N,1,7877,,Rattus norvegicus,In vivo,,50597,,4413,10116.0,,,BAO_0000218,
Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,1,CHEMBL623696,Intermediate,,,A,N,1,7878,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,1,CHEMBL623697,Intermediate,,,A,N,1,7879,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,0,CHEMBL623698,Intermediate,,,A,U,1,7880,1969.0,Macaca mulatta,In vivo,,22224,,5005,9544.0,,Plasma,BAO_0000218,
Compound was tested for its plasma clearance rate in Sprague Dawley rats,,0,CHEMBL623699,Intermediate,,,A,U,1,7881,1969.0,Rattus norvegicus,In vivo,,22224,,5005,10116.0,,Plasma,BAO_0000218,
Mean (%CV) PK parameters for CL(mL/min/kg).,,1,CHEMBL623700,Intermediate,,,A,N,1,7882,,Rattus norvegicus,In vivo,,50597,,15765,10116.0,,,BAO_0000218,
Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,1,CHEMBL623701,Intermediate,,,A,N,1,7883,,Rattus norvegicus,In vivo,,50597,,3747,10116.0,,,BAO_0000218,
Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,1,CHEMBL623702,Intermediate,,,A,N,1,7884,1969.0,Rattus norvegicus,In vivo,,50597,,16366,10116.0,,Plasma,BAO_0000218,
Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,1,CHEMBL623703,Intermediate,,,A,N,1,7885,,Rattus norvegicus,In vivo,,50597,,4199,10116.0,,,BAO_0000218,
Plasma clearance in rat was determined,,1,CHEMBL623704,Intermediate,,,A,N,1,7886,,Rattus norvegicus,In vivo,,50597,,17267,10116.0,,,BAO_0000218,
Plasma clearance in rat after administration of 2 mg/kg iv,,1,CHEMBL623705,Intermediate,,,A,N,1,7887,,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,,BAO_0000218,
Plasma clearance in rat after administration of 2 mg/kg iv,,1,CHEMBL623706,Intermediate,,,A,N,1,7888,,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,,BAO_0000218,
Plasma clearance was determined,,1,CHEMBL623707,Intermediate,,,A,N,1,7889,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL623708,Intermediate,,,A,N,1,7890,,Rattus norvegicus,In vivo,,50597,,5960,10116.0,,,BAO_0000218,
Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,1,CHEMBL623709,Intermediate,,,A,N,1,7891,,Rattus norvegicus,In vivo,,50597,,5937,10116.0,,,BAO_0000218,
Plasma clearance in rat by iv administration,,1,CHEMBL623710,Intermediate,,,A,N,1,7892,,Rattus norvegicus,In vivo,,50597,,5871,10116.0,,,BAO_0000218,
Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,1,CHEMBL623711,Intermediate,,,A,N,1,7893,,Rattus norvegicus,In vivo,,50597,,5874,10116.0,,,BAO_0000218,
Plasma clearance in rat p.o.,,1,CHEMBL623712,Intermediate,,,A,N,1,7894,,Rattus norvegicus,In vivo,,50597,,6504,10116.0,,,BAO_0000218,
Plasma clearance in rats,,1,CHEMBL623713,Intermediate,,,A,N,1,7895,,Rattus norvegicus,In vivo,,50597,,6803,10116.0,,,BAO_0000218,
Plasma clearance was determined; ND denotes no data,,1,CHEMBL623714,Intermediate,,,A,N,1,7896,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
Plasma clearance was determined; ND denotes not determined,,1,CHEMBL623715,Intermediate,,,A,N,1,7897,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,1,CHEMBL623716,Intermediate,,,A,N,1,7898,,Rattus norvegicus,In vivo,,50597,,1916,10116.0,,,BAO_0000218,
Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,1,CHEMBL622980,Intermediate,,,A,N,1,7899,,Rattus norvegicus,In vivo,,50597,,5199,10116.0,,,BAO_0000218,
Plasma administration to rats,,1,CHEMBL622981,Intermediate,,,A,N,1,7900,,Rattus norvegicus,In vivo,,50597,,16367,10116.0,,,BAO_0000218,
Plasma clearance of the compound in female Sprague-Dawley rats,,1,CHEMBL622982,Intermediate,,,A,N,1,7901,,Rattus norvegicus,In vivo,,50597,,6362,10116.0,,,BAO_0000218,
Plasma clearance was observed after intravenous administration in rat,,1,CHEMBL622983,Intermediate,,,A,N,1,7902,,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,,BAO_0000218,
Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,1,CHEMBL622984,Intermediate,,,A,N,1,7903,,Rattus norvegicus,In vivo,,50597,,6215,10116.0,,,BAO_0000218,
Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,1,CHEMBL622985,Intermediate,,,A,N,1,7904,,Rattus norvegicus,In vivo,,50597,,1466,10116.0,,,BAO_0000218,
plasma clearance was observed after intravenous administration in rat,,1,CHEMBL623631,Intermediate,,,A,N,1,7905,1969.0,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,Plasma,BAO_0000218,
In vivo CL/F determined,,1,CHEMBL623632,Intermediate,,,A,N,1,7906,,Rattus norvegicus,In vivo,,50597,,4723,10116.0,,,BAO_0000218,
Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,1,CHEMBL623633,Intermediate,,,A,N,1,7907,1969.0,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,1,CHEMBL623634,Intermediate,,,A,N,1,7908,1969.0,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,Plasma,BAO_0000218,
Compound was tested for the lower blood clearance in rat,,1,CHEMBL623635,Intermediate,,,A,N,1,7909,,Rattus norvegicus,In vivo,,50597,,5213,10116.0,,,BAO_0000218,
Evaluated for the low clearance in rat (in vivo),,1,CHEMBL621195,Intermediate,,,A,N,1,7910,,Rattus norvegicus,In vivo,,50597,,4687,10116.0,,,BAO_0000218,
Pharmacokinetic property (CLb)of the compound was determined in rat,,1,CHEMBL621196,Intermediate,,,A,N,1,7911,,Rattus norvegicus,In vivo,,50597,,3371,10116.0,,,BAO_0000218,
Rapid clearance after intravenous administration in rat was determined,,1,CHEMBL875287,Intermediate,,,A,N,1,7912,,Rattus norvegicus,In vivo,,50597,,4690,10116.0,,,BAO_0000218,
Clearance measured in rat,,1,CHEMBL621197,Intermediate,,,A,N,1,7913,,Rattus norvegicus,In vivo,,50597,,5702,10116.0,,,BAO_0000218,
Compound was evaluated for plasma clearance in rat,,1,CHEMBL621198,Intermediate,,,A,N,1,7914,1969.0,Rattus norvegicus,In vivo,,50597,,740,10116.0,,Plasma,BAO_0000218,
Low plasma clearance was calculated in rat,,1,CHEMBL621199,Intermediate,,,A,N,1,7915,1969.0,Rattus norvegicus,In vivo,,50597,,4853,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic property (Clp) in rat,,1,CHEMBL621200,Intermediate,,,A,N,1,7916,,Rattus norvegicus,In vivo,,50597,,5789,10116.0,,,BAO_0000218,
Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,1,CHEMBL621201,Intermediate,,,A,N,1,7917,,Rattus norvegicus,In vivo,,50597,,4527,10116.0,,,BAO_0000218,
Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,1,CHEMBL621202,Intermediate,,,A,N,1,7918,,Rattus norvegicus,In vivo,,50597,,4527,10116.0,,,BAO_0000218,
Plasma clearance after IV dosing at 0.5 mg/kg in rat,,1,CHEMBL621203,Intermediate,,,A,N,1,7919,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Plasma clearance after IV dosing at 1 mg/kg in rat,,1,CHEMBL621204,Intermediate,,,A,N,1,7920,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,1,CHEMBL621205,Intermediate,,,A,N,1,7921,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,1,CHEMBL621206,Intermediate,,,A,N,1,7922,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,1,CHEMBL621207,Intermediate,,,A,N,1,7923,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,1,CHEMBL621208,Intermediate,,,A,N,1,7924,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,1,CHEMBL621209,Intermediate,,,A,N,1,7925,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,1,CHEMBL876484,Intermediate,,,A,N,1,7926,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,1,CHEMBL621210,Intermediate,,,A,N,1,7927,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,1,CHEMBL621211,Intermediate,,,A,N,1,7928,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,1,CHEMBL621212,Intermediate,,,A,N,1,7929,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA at 15 min,,1,CHEMBL621213,Intermediate,,,A,N,1,7930,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,1,CHEMBL621214,Intermediate,,,A,N,1,7931,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA at 30 min,,1,CHEMBL621215,Intermediate,,,A,N,1,7932,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,1,CHEMBL621216,Intermediate,,,A,N,1,7933,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,1,CHEMBL621217,Intermediate,,,A,N,1,7934,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,1,CHEMBL621218,Intermediate,,,A,N,1,7935,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,1,CHEMBL621219,Intermediate,,,A,N,1,7936,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,1,CHEMBL621220,Intermediate,,,A,N,1,7937,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,1,CHEMBL621221,Intermediate,,,A,N,1,7938,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,1,CHEMBL621222,Intermediate,,,A,N,1,7939,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,1,CHEMBL621223,Intermediate,,,A,N,1,7940,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,1,CHEMBL876485,Intermediate,,,A,N,1,7941,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,1,CHEMBL621224,Intermediate,,,A,N,1,7942,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,1,CHEMBL621225,Intermediate,,,A,N,1,7943,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,1,CHEMBL621226,Intermediate,,,A,N,1,7944,948.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Heart,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,1,CHEMBL621227,Intermediate,,,A,N,1,7945,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,1,CHEMBL621228,Intermediate,,,A,N,1,7946,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,1,CHEMBL621229,Intermediate,,,A,N,1,7947,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,1,CHEMBL621230,Intermediate,,,A,N,1,7948,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,1,CHEMBL621231,Intermediate,,,A,N,1,7949,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,1,CHEMBL621232,Intermediate,,,A,N,1,7950,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,1,CHEMBL621233,Intermediate,,,A,N,1,7951,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,1,CHEMBL621234,Intermediate,,,A,N,1,7952,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,1,CHEMBL621235,Intermediate,,,A,N,1,7953,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,1,CHEMBL621236,Intermediate,,,A,N,1,7954,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,1,CHEMBL621237,Intermediate,,,A,N,1,7955,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,1,CHEMBL876486,Intermediate,,,A,N,1,7956,2113.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,1,CHEMBL622436,Intermediate,,,A,N,1,7957,160.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Intestine,BAO_0000218,
Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,1,CHEMBL622437,Intermediate,,,A,N,1,7958,160.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Intestine,BAO_0000218,
Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,1,CHEMBL622438,Intermediate,,,A,N,1,7959,160.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Intestine,BAO_0000218,
Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,1,CHEMBL622439,Intermediate,,,A,N,1,7960,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,1,CHEMBL622440,Intermediate,,,A,N,1,7961,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,1,CHEMBL622441,Intermediate,,,A,N,1,7962,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,1,CHEMBL622442,Intermediate,,,A,N,1,7963,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,1,CHEMBL622443,Intermediate,,,A,N,1,7964,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,1,CHEMBL622444,Intermediate,,,A,N,1,7965,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,1,CHEMBL622445,Intermediate,,,A,N,1,7966,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,1,CHEMBL622446,Intermediate,,,A,N,1,7967,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,1,CHEMBL622447,Intermediate,,,A,N,1,7968,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,1,CHEMBL622448,Intermediate,,,A,N,1,7969,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,1,CHEMBL622449,Intermediate,,,A,N,1,7970,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,1,CHEMBL622450,Intermediate,,,A,N,1,7971,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,1,CHEMBL622451,Intermediate,,,A,N,1,7972,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA at 15 min,,1,CHEMBL622452,Intermediate,,,A,N,1,7973,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,1,CHEMBL622453,Intermediate,,,A,N,1,7974,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA at 30 min,,1,CHEMBL622454,Intermediate,,,A,N,1,7975,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,1,CHEMBL622455,Intermediate,,,A,N,1,7976,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,1,CHEMBL876024,Intermediate,,,A,N,1,7977,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
T max was determined at 3 mg/kg po dose in rats,,1,CHEMBL622456,Intermediate,,,A,N,1,7978,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL622457,Intermediate,,,A,N,1,7979,,Rattus norvegicus,In vivo,,50597,,15078,10116.0,,,BAO_0000218,
"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL622458,Intermediate,,,A,N,1,7980,,Rattus norvegicus,In vivo,,50597,,15078,10116.0,,,BAO_0000218,
The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,1,CHEMBL622459,Intermediate,,,A,N,1,7981,,Rattus norvegicus,,,50597,,15022,10116.0,,,BAO_0000218,
The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,1,CHEMBL873343,Intermediate,,,A,N,1,7982,,Rattus norvegicus,,,50597,,15022,10116.0,,,BAO_0000218,
The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,1,CHEMBL622460,Intermediate,,,A,N,1,7983,,Rattus norvegicus,,,50597,,15022,10116.0,,,BAO_0000218,
Time for maximum plasma concentration determined in rat,,1,CHEMBL622461,Intermediate,,,A,N,1,7984,1969.0,Rattus norvegicus,,,50597,,4576,10116.0,,Plasma,BAO_0000218,
Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,1,CHEMBL622462,Intermediate,,,A,N,1,7985,1969.0,Rattus norvegicus,In vivo,,50597,,6681,10116.0,,Plasma,BAO_0000218,
Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,1,CHEMBL622463,Intermediate,,,A,N,1,7986,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,1,CHEMBL622464,Intermediate,,,A,N,1,7987,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,1,CHEMBL622465,Intermediate,,,A,N,1,7988,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,1,CHEMBL622466,Intermediate,,,A,N,1,7989,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,1,CHEMBL622467,Intermediate,,,A,N,1,7990,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Time of maximum plasma concentration in rat,,1,CHEMBL622468,Intermediate,,,A,N,1,7991,1969.0,Rattus norvegicus,,,50597,,6824,10116.0,,Plasma,BAO_0000218,
"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,1,CHEMBL876025,Intermediate,,,A,N,1,7992,1969.0,Rattus norvegicus,,,50597,,6685,10116.0,,Plasma,BAO_0000218,
"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,1,CHEMBL622469,Intermediate,,,A,N,1,7993,1969.0,Rattus norvegicus,,,50597,,6685,10116.0,,Plasma,BAO_0000218,
"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,1,CHEMBL622470,Intermediate,,,A,N,1,7994,1969.0,Rattus norvegicus,,,50597,,6685,10116.0,,Plasma,BAO_0000218,
Time required to reach maximum concentration (Cmax) after oral administration in rat,,1,CHEMBL622471,Intermediate,,,A,N,1,7995,,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,,BAO_0000218,
Time required to reach maximum concentration in rat plasma,,1,CHEMBL622472,Intermediate,,,A,N,1,7996,1969.0,Rattus norvegicus,,,50597,,1742,10116.0,,Plasma,BAO_0000218,
Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,1,CHEMBL622473,Intermediate,,,A,N,1,7997,1969.0,Rattus norvegicus,In vivo,,50597,,2774,10116.0,,Plasma,BAO_0000218,
Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,1,CHEMBL624282,Intermediate,,,A,N,1,7998,1969.0,Rattus norvegicus,In vivo,,50597,,5199,10116.0,,Plasma,BAO_0000218,
Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,1,CHEMBL624283,Intermediate,,,A,N,1,7999,1969.0,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,Plasma,BAO_0000218,
Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,1,CHEMBL624284,Intermediate,,,A,N,1,8000,1969.0,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,Plasma,BAO_0000218,
Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,1,CHEMBL624285,Intermediate,,,A,N,1,8001,1969.0,Rattus norvegicus,In vivo,,50597,,1916,10116.0,,Plasma,BAO_0000218,
Time to reach Cmax after oral administration to rats,,1,CHEMBL624286,Intermediate,,,A,N,1,8002,,Rattus norvegicus,In vivo,,50597,,16367,10116.0,,,BAO_0000218,
Time to reach Cmax when a dose of 1 mg/kg is administered orally,,1,CHEMBL624287,Intermediate,,,A,N,1,8003,,Rattus norvegicus,In vivo,,50597,,16366,10116.0,,,BAO_0000218,
Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,1,CHEMBL624288,Intermediate,,,A,N,1,8004,,Rattus norvegicus,,,50597,,216,10116.0,,,BAO_0000218,
Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,1,CHEMBL624289,Intermediate,,,A,N,1,8005,1969.0,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,Plasma,BAO_0000218,
Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,1,CHEMBL873344,Intermediate,,,A,N,1,8006,1969.0,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,Plasma,BAO_0000218,
Tmax after peroral administration (10 mg/kg) was determined in rat,,1,CHEMBL619623,Intermediate,,,A,N,1,8007,,Rattus norvegicus,In vivo,,50597,,6215,10116.0,,,BAO_0000218,
Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,CHEMBL621399,Expert,,,A,N,1,8008,,Rattus norvegicus,In vivo,,50597,,3598,10116.0,,,BAO_0000218,
Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,1,CHEMBL621400,Intermediate,,,A,N,1,8009,,Rattus norvegicus,In vivo,,50597,,4527,10116.0,,,BAO_0000218,
"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,1,CHEMBL621401,Intermediate,,,A,N,1,8010,,Rattus norvegicus,In vivo,,50597,,17670,10116.0,,,BAO_0000218,
Tmax was determined,,1,CHEMBL621402,Intermediate,,,A,N,1,8011,,Rattus norvegicus,,,50597,,1465,10116.0,,,BAO_0000218,
Tmax was determined,,1,CHEMBL621403,Intermediate,,,A,N,1,8012,,Rattus norvegicus,,,50597,,2552,10116.0,,,BAO_0000218,
Tmax after oral administration in rat,,1,CHEMBL621121,Intermediate,,,A,N,1,8013,,Rattus norvegicus,In vivo,,50597,,5656,10116.0,,,BAO_0000218,
Tmax after peroral administration in rats at 2.4 uM/kg,,1,CHEMBL872525,Intermediate,,,A,N,1,8014,,Rattus norvegicus,In vivo,,50597,,17764,10116.0,,,BAO_0000218,
Tmax in male rat,,1,CHEMBL621122,Intermediate,,,A,N,1,8015,,Rattus norvegicus,,,50597,,5610,10116.0,,,BAO_0000218,
Tmax in rat at 10 mg/kg,,1,CHEMBL621123,Intermediate,,,A,N,1,8016,,Rattus norvegicus,In vivo,,50597,,6046,10116.0,,,BAO_0000218,
Tmax in rat by po administration at a dose of 40 mg/kg,,1,CHEMBL621124,Intermediate,,,A,N,1,8017,,Rattus norvegicus,In vivo,,50597,,5874,10116.0,,,BAO_0000218,
Tmax in rats,,1,CHEMBL621125,Intermediate,,,A,N,1,8018,,Rattus norvegicus,,,50597,,17596,10116.0,,,BAO_0000218,
Tmax was measured in rats after peroral administration at 5 mg/kg,,1,CHEMBL621126,Intermediate,,,A,N,1,8019,,Rattus norvegicus,In vivo,,50597,,17804,10116.0,,,BAO_0000218,
Tmax value after oral dose at a dose of 10 mg/kg in rats.,,1,CHEMBL621127,Intermediate,,,A,N,1,8020,,Rattus norvegicus,In vivo,,50597,,1908,10116.0,,,BAO_0000218,
Tmax value after administration of 20 mg/Kg oral dose in rat,,1,CHEMBL621128,Intermediate,,,A,N,1,8021,,Rattus norvegicus,In vivo,,50597,,2959,10116.0,,,BAO_0000218,
Tmax value at a dose of 10 mg/kg in male SD rats,,1,CHEMBL618263,Intermediate,,,A,N,1,8022,,Rattus norvegicus,In vivo,,50597,,6757,10116.0,,,BAO_0000218,
Tmax value at a dose of 100 mg/kg in male SD rats,,1,CHEMBL618264,Intermediate,,,A,N,1,8023,,Rattus norvegicus,In vivo,,50597,,6757,10116.0,,,BAO_0000218,
Tmax value at a dose of 50 mg/kg in male SD rats,,1,CHEMBL618265,Intermediate,,,A,N,1,8024,,Rattus norvegicus,In vivo,,50597,,6757,10116.0,,,BAO_0000218,
Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,1,CHEMBL618266,Intermediate,,,A,N,1,8025,1969.0,Rattus norvegicus,In vivo,,50597,,4186,10116.0,,Plasma,BAO_0000218,
time required to reach maximum concentration (Cmax) after oral administration in rat,,1,CHEMBL618267,Intermediate,,,A,N,1,8026,,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,1,CHEMBL618450,Intermediate,,,A,N,1,8027,1088.0,Rattus norvegicus,,,50597,,429,10116.0,,Urine,BAO_0000218,
Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,1,CHEMBL618451,Intermediate,,,A,N,1,8028,1088.0,Rattus norvegicus,,,50597,,429,10116.0,,Urine,BAO_0000218,
Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,1,CHEMBL618452,Intermediate,,,A,N,1,8029,,Rattus norvegicus,,,50597,,5546,10116.0,,,BAO_0000218,
Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,1,CHEMBL618453,Intermediate,,,A,N,1,8030,1088.0,Rattus norvegicus,,,50597,,3173,10116.0,,Urine,BAO_0000218,
Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,1,CHEMBL618454,Intermediate,,,A,N,1,8031,1088.0,Rattus norvegicus,,,50597,,3173,10116.0,,Urine,BAO_0000218,
Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,1,CHEMBL618455,Intermediate,,,A,N,1,8032,1088.0,Rattus norvegicus,,,50597,,3173,10116.0,,Urine,BAO_0000218,
Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,1,CHEMBL618456,Intermediate,,,A,N,1,8033,,Rattus norvegicus,In vivo,,50597,,4257,10116.0,,,BAO_0000218,
Compound distribution in rat tissues was determined,,1,CHEMBL618457,Intermediate,,,A,N,1,8034,,Rattus norvegicus,In vivo,,50597,,6011,10116.0,,,BAO_0000218,
Volume of distribution was evaluated in rat,,1,CHEMBL618458,Intermediate,,,A,N,1,8035,,Rattus norvegicus,In vivo,,50597,,5472,10116.0,,,BAO_0000218,
Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,1,CHEMBL618459,Intermediate,,,A,N,1,8036,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,1,CHEMBL876733,Intermediate,,,A,N,1,8037,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,1,CHEMBL618460,Intermediate,,,A,N,1,8038,,Canis lupus familiaris,,,50588,,14346,9615.0,,,BAO_0000218,
Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,1,CHEMBL618461,Intermediate,,,A,N,1,8039,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined after oral administration (300 uM/Kg),,0,CHEMBL618462,Autocuration,,,A,U,1,8040,,,,,22224,,15469,,,,BAO_0000019,
Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,1,CHEMBL618463,Intermediate,,,A,N,1,8041,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,1,CHEMBL618464,Intermediate,,,A,N,1,8042,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,1,CHEMBL618465,Intermediate,,,A,N,1,8043,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,1,CHEMBL618466,Intermediate,,,A,N,1,8044,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,1,CHEMBL618467,Intermediate,,,A,N,1,8045,,Rattus norvegicus,,,50597,,14346,10116.0,,,BAO_0000218,
Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,1,CHEMBL618468,Intermediate,,,A,N,1,8046,,Rattus norvegicus,,,50597,,15372,10116.0,,,BAO_0000218,
Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,1,CHEMBL618469,Intermediate,,,A,N,1,8047,1969.0,Canis lupus familiaris,,,50588,,12935,9615.0,,Plasma,BAO_0000218,
Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,1,CHEMBL618470,Intermediate,,,A,N,1,8048,1969.0,Canis lupus familiaris,,,50588,,12935,9615.0,,Plasma,BAO_0000218,
Plasma drug AUC in rat (PO dose),,0,CHEMBL618471,Autocuration,,,A,U,1,8049,,,,,22224,,14813,,,,BAO_0000218,
Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,1,CHEMBL618472,Intermediate,,,A,N,1,8050,,Mus musculus,,,50594,,15792,10090.0,,,BAO_0000218,
Area under was determined at a dose of 30 mg/kg,,0,CHEMBL618473,Autocuration,,,A,U,1,8051,,,,,22224,,3579,,,,BAO_0000218,
Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,1,CHEMBL621699,Intermediate,,,A,N,1,8052,,Mustela putorius furo,,,50506,,12487,9669.0,,,BAO_0000218,
Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,1,CHEMBL621700,Intermediate,,,A,N,1,8053,,Rattus norvegicus,,,50597,,12487,10116.0,,,BAO_0000218,
Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,1,CHEMBL621701,Intermediate,,,A,N,1,8054,,Rattus norvegicus,,,50597,,12487,10116.0,,,BAO_0000218,
Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,1,CHEMBL621702,Intermediate,,,A,N,1,8055,,Mustela putorius furo,,,50506,,12487,9669.0,,,BAO_0000218,
Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,1,CHEMBL621703,Intermediate,,,A,N,1,8056,,Canis lupus familiaris,,,50588,,12487,9615.0,,,BAO_0000218,
Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,1,CHEMBL621704,Intermediate,,,A,N,1,8057,,Canis lupus familiaris,,,50588,,12487,9615.0,,,BAO_0000218,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,1,CHEMBL624259,Intermediate,,,A,N,1,8058,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,1,CHEMBL624260,Intermediate,,,A,N,1,8059,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,1,CHEMBL624430,Intermediate,,,A,N,1,8060,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,1,CHEMBL624431,Intermediate,,,A,N,1,8061,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,1,CHEMBL624432,Intermediate,,,A,N,1,8062,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,1,CHEMBL624433,Intermediate,,,A,N,1,8063,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,1,CHEMBL624434,Intermediate,,,A,N,1,8064,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,1,CHEMBL624435,Intermediate,,,A,N,1,8065,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,1,CHEMBL618570,Intermediate,,,A,N,1,8066,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,1,CHEMBL618571,Intermediate,,,A,N,1,8067,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,1,CHEMBL618572,Intermediate,,,A,N,1,8068,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,1,CHEMBL618573,Intermediate,,,A,N,1,8069,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,1,CHEMBL619267,Intermediate,,,A,N,1,8070,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,1,CHEMBL619431,Intermediate,,,A,N,1,8071,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,1,CHEMBL619432,Intermediate,,,A,N,1,8072,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,1,CHEMBL619433,Intermediate,,,A,N,1,8073,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
AUC in mice after oral dose (50 mg/kg),,0,CHEMBL619434,Autocuration,,,A,U,1,8074,1969.0,,,,22224,,13298,,,Plasma,BAO_0000218,
Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,1,CHEMBL619435,Intermediate,,,A,N,1,8075,1977.0,Mus musculus,,,50594,,12226,10090.0,,Serum,BAO_0000218,
AUC (0-4 hr) ug/ml/h,,0,CHEMBL619436,Autocuration,,,A,U,1,8076,1969.0,,,,22224,,12634,,,Plasma,BAO_0000019,
Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,1,CHEMBL619437,Intermediate,,,A,N,1,8077,,Rattus norvegicus,,,50597,,14810,10116.0,,,BAO_0000218,
Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,0,CHEMBL619438,Autocuration,,,A,U,1,8078,,,,,22224,,13889,,,,BAO_0000218,
Compound was evaluated for Area under curve in mice,,1,CHEMBL619439,Intermediate,,,A,N,1,8079,,Mus musculus,,,50594,,10018,10090.0,,,BAO_0000218,
Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,1,CHEMBL619440,Intermediate,,,A,N,1,8080,,Rattus norvegicus,,,50597,,8758,10116.0,,,BAO_0000218,
Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,0,CHEMBL619441,Autocuration,,,F,U,1,8081,,,,,22224,,8758,,,,BAO_0000218,
Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,1,CHEMBL619442,Intermediate,,,A,N,1,8082,,Rattus norvegicus,,,50597,,8758,10116.0,,,BAO_0000218,
Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,0,CHEMBL875156,Autocuration,,,A,U,1,8083,,,,,22224,,2249,,,,BAO_0000019,
Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,0,CHEMBL619443,Autocuration,,,A,U,1,8084,,,,,22224,,2249,,,,BAO_0000019,
Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,0,CHEMBL619444,Autocuration,,,A,U,1,8085,,,,,22224,,2249,,,,BAO_0000019,
Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,0,CHEMBL623464,Autocuration,,,A,U,1,8086,,,,,22224,,2249,,,,BAO_0000019,
Compound was evaluated for area under curve when administered through oral route in mouse,,1,CHEMBL623465,Intermediate,,,A,N,1,8087,,Mus musculus,,,50594,,15115,10090.0,,,BAO_0000218,
Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,1,CHEMBL623466,Intermediate,,,A,N,1,8088,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,1,CHEMBL623467,Intermediate,,,A,N,1,8089,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL623468,Intermediate,,,A,N,1,8090,,Rattus norvegicus,In vivo,,50597,,6249,10116.0,,,BAO_0000218,
Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,1,CHEMBL622660,Intermediate,,,A,N,1,8091,,Rattus norvegicus,In vivo,,50597,,2463,10116.0,,,BAO_0000218,
Plasma clearance rate in Sprague-Dawley rats,,1,CHEMBL622661,Intermediate,,,A,N,1,8092,,Rattus norvegicus,In vivo,,50597,,4969,10116.0,,,BAO_0000218,
CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,1,CHEMBL622662,Intermediate,,,F,N,1,8093,,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,,BAO_0000218,
Pharmacokinetic property (total body clearance) in rat,,1,CHEMBL622663,Intermediate,,,A,N,1,8094,,Rattus norvegicus,In vivo,,50597,,3457,10116.0,,,BAO_0000218,
Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,1,CHEMBL622664,Intermediate,,,A,N,1,8095,,Rattus norvegicus,In vivo,,50597,,5983,10116.0,,,BAO_0000218,
In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,1,CHEMBL622665,Intermediate,,,A,N,1,8096,,Rattus norvegicus,,,50597,,6295,10116.0,,,BAO_0000218,
In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,1,CHEMBL622666,Intermediate,,,A,N,1,8097,,Rattus norvegicus,,,50597,,6296,10116.0,,,BAO_0000218,
Cl in rat i.v. at 2 mg/kg concentration,,1,CHEMBL621615,Intermediate,,,A,N,1,8098,,Rattus norvegicus,In vivo,,50597,,17686,10116.0,,,BAO_0000218,
Clearance of compound after intravenous administration in rats at 24 uM/kg,,1,CHEMBL621616,Intermediate,,,A,N,1,8099,,Rattus norvegicus,In vivo,,50597,,17764,10116.0,,,BAO_0000218,
Clearance was determined,,1,CHEMBL621617,Intermediate,,,A,N,1,8100,,Rattus norvegicus,In vivo,,50597,,5503,10116.0,,,BAO_0000218,
Clearance by intravenous administration of 3.4 mg/kg in rat,,1,CHEMBL621618,Intermediate,,,A,N,1,8101,,Rattus norvegicus,In vivo,,50597,,4368,10116.0,,,BAO_0000218,
Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,1,CHEMBL621619,Intermediate,,,A,N,1,8102,,Rattus norvegicus,In vivo,,50597,,6005,10116.0,,,BAO_0000218,
Clearance rate after i.v. administration in rats,,1,CHEMBL621620,Intermediate,,,A,N,1,8103,,Rattus norvegicus,In vivo,,50597,,5031,10116.0,,,BAO_0000218,
Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,1,CHEMBL621786,Intermediate,,,A,N,1,8104,,Rattus norvegicus,In vivo,,50597,,4890,10116.0,,,BAO_0000218,
Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,1,CHEMBL621787,Intermediate,,,A,N,1,8105,,Rattus norvegicus,In vivo,,50597,,5182,10116.0,,,BAO_0000218,
Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,1,CHEMBL621788,Intermediate,,,A,N,1,8106,,Rattus norvegicus,In vivo,,50597,,5979,10116.0,,,BAO_0000218,
Clearance (Cl) after oral administration in rat,,1,CHEMBL621789,Intermediate,,,A,N,1,8107,,Rattus norvegicus,In vivo,,50597,,5656,10116.0,,,BAO_0000218,
Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,1,CHEMBL621790,Intermediate,,,A,N,1,8108,,Rattus norvegicus,In vivo,,50597,,17804,10116.0,,,BAO_0000218,
Compound was tested for plasma clearance in rat,,1,CHEMBL621791,Intermediate,,,A,N,1,8109,1969.0,Rattus norvegicus,In vivo,,50597,,4839,10116.0,,Plasma,BAO_0000218,
In vitro microsome metabolism clearance in rat was determined,,1,CHEMBL621792,Intermediate,,,A,N,1,8110,,Rattus norvegicus,In vitro,,50597,,5041,10116.0,,,BAO_0000218,Microsomes
In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,1,CHEMBL621793,Intermediate,,,A,N,1,8111,,Rattus norvegicus,In vitro,,50597,,5041,10116.0,,,BAO_0000218,Microsomes
In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL621794,Intermediate,,,A,N,1,8112,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo plasma clearance was determined,,1,CHEMBL621795,Intermediate,,,A,N,1,8113,1969.0,Rattus norvegicus,In vivo,,50597,,5496,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,1,CHEMBL621796,Intermediate,,,A,N,1,8114,,Rattus norvegicus,In vivo,,50597,,5739,10116.0,,,BAO_0000218,
Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Hepatocyte,1,CHEMBL621797,Intermediate,,401.0,A,N,1,8115,2107.0,Rattus norvegicus,In vivo,,50597,,5676,10116.0,,Liver,BAO_0000218,
Pharmacokinetic property (Plasma clearance) was measured in rat,,1,CHEMBL621798,Intermediate,,,A,N,1,8116,,Rattus norvegicus,In vivo,,50597,,4239,10116.0,,,BAO_0000218,
Pharmacokinetic property (clearance) in rat i.v.,,1,CHEMBL621799,Intermediate,,,A,N,1,8117,,Rattus norvegicus,In vivo,,50597,,5676,10116.0,,,BAO_0000218,
"Plasma Clearance was evaluated in rats, iv",,1,CHEMBL621800,Intermediate,,,A,N,1,8118,,Rattus norvegicus,In vivo,,50597,,1918,10116.0,,,BAO_0000218,
Plasma clearance (in vivo) in rats was determined,,1,CHEMBL621801,Intermediate,,,A,N,1,8119,,Rattus norvegicus,In vivo,,50597,,17800,10116.0,,,BAO_0000218,
Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,1,CHEMBL621802,Intermediate,,,A,N,1,8120,,Rattus norvegicus,In vivo,,50597,,6056,10116.0,,,BAO_0000218,
Plasma clearance was determined,,1,CHEMBL618596,Intermediate,,,A,N,1,8121,,Rattus norvegicus,In vivo,,50597,,5496,10116.0,,,BAO_0000218,
Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,1,CHEMBL618597,Intermediate,,,A,N,1,8122,,Rattus norvegicus,In vivo,,50597,,5939,10116.0,,,BAO_0000218,
Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,1,CHEMBL618598,Intermediate,,,A,N,1,8123,,Rattus norvegicus,In vivo,,50597,,5939,10116.0,,,BAO_0000218,
Plasma clearance in rats,,1,CHEMBL618599,Intermediate,,,A,N,1,8124,,Rattus norvegicus,In vivo,,50597,,17752,10116.0,,,BAO_0000218,
Plasma clearance rate determined in rat,,1,CHEMBL618600,Intermediate,,,A,N,1,8125,,Rattus norvegicus,In vivo,,50597,,4576,10116.0,,,BAO_0000218,
Plasma clearance was determined in rat,,1,CHEMBL618601,Intermediate,,,A,N,1,8126,,Rattus norvegicus,In vivo,,50597,,6011,10116.0,,,BAO_0000218,
Plasma clearance was determined,,1,CHEMBL618602,Intermediate,,,A,N,1,8127,,Rattus norvegicus,In vivo,,50597,,5510,10116.0,,,BAO_0000218,
Plasma clearance value in rat,,1,CHEMBL618603,Intermediate,,,A,N,1,8128,,Rattus norvegicus,In vivo,,50597,,5948,10116.0,,,BAO_0000218,
Clearance rate constant using isolated perfused rat liver (IPRL) assay,,1,CHEMBL618604,Intermediate,,,A,N,1,8129,2107.0,Rattus norvegicus,Ex vivo,,50597,,6125,10116.0,,Liver,BAO_0000218,
Clearance in rat,,1,CHEMBL618605,Intermediate,,,A,N,1,8130,,Rattus norvegicus,In vivo,,50597,,4839,10116.0,,,BAO_0000218,
Total body clearance in rat i.v. at 2 mg/kg concentration,,1,CHEMBL618606,Intermediate,,,A,N,1,8131,,Rattus norvegicus,In vivo,,50597,,17686,10116.0,,,BAO_0000218,
Clearance of compound in rats after intravenous administration,,1,CHEMBL618607,Intermediate,,,A,N,1,8132,,Rattus norvegicus,In vivo,,50597,,6571,10116.0,,,BAO_0000218,
Clearance after iv administration to rats,,1,CHEMBL618608,Intermediate,,,A,N,1,8133,,Rattus norvegicus,In vivo,,50597,,3364,10116.0,,,BAO_0000218,
Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,1,CHEMBL618609,Intermediate,,,A,N,1,8134,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,1,CHEMBL618610,Intermediate,,,A,N,1,8135,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,1,CHEMBL618611,Intermediate,,,A,N,1,8136,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,1,CHEMBL618612,Intermediate,,,A,N,1,8137,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,1,CHEMBL618613,Intermediate,,,A,N,1,8138,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,1,CHEMBL621076,Intermediate,,,A,N,1,8139,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,1,CHEMBL621077,Intermediate,,,A,N,1,8140,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,1,CHEMBL621078,Intermediate,,,A,N,1,8141,,Rattus norvegicus,In vivo,,50597,,17670,10116.0,,,BAO_0000218,
Clearance in rat,,1,CHEMBL621251,Intermediate,,,A,N,1,8142,,Rattus norvegicus,In vivo,,50597,,5970,10116.0,,,BAO_0000218,
Clearance in rat after oral administration at 10 mg/kg,,1,CHEMBL621252,Intermediate,,,A,N,1,8143,,Rattus norvegicus,In vivo,,50597,,6495,10116.0,,,BAO_0000218,
Clearance in rat.,,1,CHEMBL621253,Intermediate,,,A,N,1,8144,,Rattus norvegicus,In vivo,,50597,,4590,10116.0,,,BAO_0000218,
Clearance rate following an oral dose of 20 mg/kg in rats,,1,CHEMBL621254,Intermediate,,,A,N,1,8145,,Rattus norvegicus,In vivo,,50597,,6193,10116.0,,,BAO_0000218,
Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,1,CHEMBL621255,Intermediate,,,A,N,1,8146,,Rattus norvegicus,In vivo,,50597,,2832,10116.0,,,BAO_0000218,
Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,1,CHEMBL621256,Intermediate,,,A,N,1,8147,1969.0,Rattus norvegicus,In vivo,,50597,,1052,10116.0,,Plasma,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,1,CHEMBL621257,Intermediate,,,A,N,1,8148,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,1,CHEMBL621258,Intermediate,,,A,N,1,8149,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,1,CHEMBL621259,Intermediate,,,A,N,1,8150,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,1,CHEMBL621260,Intermediate,,,A,N,1,8151,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,1,CHEMBL876494,Intermediate,,,A,N,1,8152,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,1,CHEMBL621261,Intermediate,,,A,N,1,8153,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,1,CHEMBL621262,Intermediate,,,A,N,1,8154,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,1,CHEMBL621263,Intermediate,,,A,N,1,8155,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,1,CHEMBL621264,Intermediate,,,A,N,1,8156,2107.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Liver,BAO_0000218,
Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,1,CHEMBL621265,Intermediate,,,A,N,1,8157,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,1,CHEMBL621266,Intermediate,,,A,N,1,8158,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,1,CHEMBL621267,Intermediate,,,A,N,1,8159,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,1,CHEMBL621268,Intermediate,,,A,N,1,8160,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,1,CHEMBL621269,Intermediate,,,A,N,1,8161,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,1,CHEMBL621270,Intermediate,,,A,N,1,8162,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,1,CHEMBL621271,Intermediate,,,A,N,1,8163,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,1,CHEMBL621272,Intermediate,,,A,N,1,8164,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,1,CHEMBL621273,Intermediate,,,A,N,1,8165,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,1,CHEMBL621274,Intermediate,,,A,N,1,8166,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,1,CHEMBL876495,Intermediate,,,A,N,1,8167,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,1,CHEMBL621275,Intermediate,,,A,N,1,8168,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,1,CHEMBL621276,Intermediate,,,A,N,1,8169,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,1,CHEMBL621277,Intermediate,,,A,N,1,8170,2385.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,1,CHEMBL621278,Intermediate,,,A,N,1,8171,160.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Intestine,BAO_0000218,
Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,1,CHEMBL621279,Intermediate,,,A,N,1,8172,160.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Intestine,BAO_0000218,
Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,1,CHEMBL621280,Intermediate,,,A,N,1,8173,160.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Intestine,BAO_0000218,
Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,1,CHEMBL621281,Intermediate,,,A,N,1,8174,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,1,CHEMBL621282,Intermediate,,,A,N,1,8175,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,1,CHEMBL621283,Intermediate,,,A,N,1,8176,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,1,CHEMBL621284,Intermediate,,,A,N,1,8177,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,1,CHEMBL621285,Intermediate,,,A,N,1,8178,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,1,CHEMBL621286,Intermediate,,,A,N,1,8179,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,1,CHEMBL623220,Intermediate,,,A,N,1,8180,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,1,CHEMBL623221,Intermediate,,,A,N,1,8181,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,1,CHEMBL876029,Intermediate,,,A,N,1,8182,2106.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,1,CHEMBL623222,Intermediate,,,A,N,1,8183,945.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Stomach,BAO_0000218,
Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,1,CHEMBL623223,Intermediate,,,A,N,1,8184,945.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Stomach,BAO_0000218,
Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,1,CHEMBL621445,Intermediate,,,A,N,1,8185,945.0,Rattus norvegicus,In vivo,,50597,,9866,10116.0,,Stomach,BAO_0000218,
Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621446,Intermediate,,,A,N,1,8186,178.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Blood,BAO_0000218,
Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621447,Intermediate,,,A,N,1,8187,178.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Blood,BAO_0000218,
Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619681,Intermediate,,,A,N,1,8188,178.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Blood,BAO_0000218,
Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619682,Intermediate,,,A,N,1,8189,178.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Blood,BAO_0000218,
Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619683,Intermediate,,,A,N,1,8190,178.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Blood,BAO_0000218,
Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619684,Intermediate,,,A,N,1,8191,955.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Brain,BAO_0000218,
Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619685,Intermediate,,,A,N,1,8192,955.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Brain,BAO_0000218,
Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619686,Intermediate,,,A,N,1,8193,955.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Brain,BAO_0000218,
Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619687,Intermediate,,,A,N,1,8194,955.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Brain,BAO_0000218,
Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619688,Intermediate,,,A,N,1,8195,955.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Brain,BAO_0000218,
Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619689,Intermediate,,,A,N,1,8196,948.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Heart,BAO_0000218,
Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619690,Intermediate,,,A,N,1,8197,948.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Heart,BAO_0000218,
Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619691,Intermediate,,,A,N,1,8198,948.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Heart,BAO_0000218,
Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,1,CHEMBL619692,Intermediate,,,A,N,1,8199,,Rattus norvegicus,In vivo,,50597,,6062,10116.0,,,BAO_0000218,
Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,CHEMBL619693,Expert,,,A,N,1,8200,,Rattus norvegicus,,,50597,,3598,10116.0,,,BAO_0000218,
Vc value after IV dose at a dose of 5 mg/kg in rats.,,1,CHEMBL619694,Intermediate,,,A,N,1,8201,,Rattus norvegicus,In vivo,,50597,,1908,10116.0,,,BAO_0000218,
Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,1,CHEMBL619695,Intermediate,,,A,N,1,8202,,Rattus norvegicus,In vivo,,50597,,17596,10116.0,,,BAO_0000218,
Compound was evaluated for pharmacokinetic parameter volume of distribution,,1,CHEMBL619696,Intermediate,,,A,N,1,8203,,Rattus norvegicus,In vivo,,50597,,4891,10116.0,,,BAO_0000218,
Compound was evaluated for volume of distribution in rat,,1,CHEMBL619697,Intermediate,,,A,N,1,8204,,Rattus norvegicus,In vivo,,50597,,740,10116.0,,,BAO_0000218,
Steady state volume distribution was determined; steady state(ss),,1,CHEMBL619698,Intermediate,,,A,N,1,8205,,Rattus norvegicus,In vivo,,50597,,16366,10116.0,,,BAO_0000218,
Steady state volume of distribution after iv administration to rats,,1,CHEMBL619699,Intermediate,,,A,N,1,8206,,Rattus norvegicus,In vivo,,50597,,3364,10116.0,,,BAO_0000218,
Steady state volume of distribution dosing at 3 mg/kg iv,,1,CHEMBL619700,Intermediate,,,A,N,1,8207,,Rattus norvegicus,In vivo,,50597,,2552,10116.0,,,BAO_0000218,
The compound was evaluated for volume of distribution in rat,,1,CHEMBL619701,Intermediate,,,A,N,1,8208,,Rattus norvegicus,In vivo,,50597,,406,10116.0,,,BAO_0000218,
The compound was tested for volume of distribution in rat,,1,CHEMBL619702,Intermediate,,,A,N,1,8209,,Rattus norvegicus,In vivo,,50597,,12500,10116.0,,,BAO_0000218,
The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,1,CHEMBL620335,Intermediate,,,A,N,1,8210,,Rattus norvegicus,In vivo,,50597,,12500,10116.0,,,BAO_0000218,
Volume distribution (VD) after oral administration in rat,,1,CHEMBL620336,Intermediate,,,A,N,1,8211,,Rattus norvegicus,In vivo,,50597,,5656,10116.0,,,BAO_0000218,
Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,1,CHEMBL620337,Intermediate,,,A,N,1,8212,,Rattus norvegicus,In vivo,,50597,,17671,10116.0,,,BAO_0000218,
Volume distribution in rat,,1,CHEMBL620520,Intermediate,,,A,N,1,8213,,Rattus norvegicus,In vivo,,50597,,1094,10116.0,,,BAO_0000218,
Volume distribution in rat,,1,CHEMBL620521,Intermediate,,,A,N,1,8214,,Rattus norvegicus,In vivo,,50597,,5833,10116.0,,,BAO_0000218,
Volume distribution in rat after peroral administration at 10 mg/kg,,1,CHEMBL875825,Intermediate,,,A,N,1,8215,,Rattus norvegicus,In vivo,,50597,,5939,10116.0,,,BAO_0000218,
Volume distribution in rat after peroral administration at 5 mg/kg,,1,CHEMBL620522,Intermediate,,,A,N,1,8216,,Rattus norvegicus,In vivo,,50597,,5939,10116.0,,,BAO_0000218,
Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,1,CHEMBL620523,Intermediate,,,A,N,1,8217,,Rattus norvegicus,In vivo,,50597,,6005,10116.0,,,BAO_0000218,
Volume of distribution in rat.,,1,CHEMBL620524,Intermediate,,,A,N,1,8218,,Rattus norvegicus,In vivo,,50597,,1696,10116.0,,,BAO_0000218,
Volume of distribution in rat,,1,CHEMBL620525,Intermediate,,,A,N,1,8219,,Rattus norvegicus,In vivo,,50597,,6672,10116.0,,,BAO_0000218,
Volume of distribution in rat,,1,CHEMBL620526,Intermediate,,,A,N,1,8220,,Rattus norvegicus,In vivo,,50597,,6673,10116.0,,,BAO_0000218,
Volume of distribution in rat by iv administration,,1,CHEMBL620527,Intermediate,,,A,N,1,8221,,Rattus norvegicus,In vivo,,50597,,5871,10116.0,,,BAO_0000218,
Volume of distribution in rats,,1,CHEMBL620528,Intermediate,,,A,N,1,8222,,Rattus norvegicus,In vivo,,50597,,6803,10116.0,,,BAO_0000218,
Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,1,CHEMBL620529,Intermediate,,,A,N,1,8223,,Rattus norvegicus,In vivo,,50597,,5199,10116.0,,,BAO_0000218,
Volume distribution at the dose of 2 mg/kg in rat,,1,CHEMBL620530,Intermediate,,,A,N,1,8224,,Rattus norvegicus,,,50597,,4727,10116.0,,,BAO_0000218,
Steady state volume of distribution was determined,,1,CHEMBL620531,Intermediate,,,A,N,1,8225,,Rattus norvegicus,In vivo,,50597,,16367,10116.0,,,BAO_0000218,
Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,0,CHEMBL620532,Intermediate,,,A,U,1,8226,,Macaca mulatta,In vivo,,22224,,5005,9544.0,,,BAO_0000218,
Compound was tested for its plasma volume distribution in Sprague Dawley rats,,0,CHEMBL620533,Intermediate,,,A,U,1,8227,,Rattus norvegicus,In vivo,,22224,,5005,10116.0,,,BAO_0000218,
Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,0,CHEMBL620534,Intermediate,,,A,U,1,8228,,Rattus norvegicus,In vivo,,22224,,5005,10116.0,,,BAO_0000218,
Mean (%CV) PK parameters for Vdss(mL/kg).,,1,CHEMBL620535,Intermediate,,,A,N,1,8229,,Rattus norvegicus,In vivo,,50597,,15765,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,1,CHEMBL875826,Intermediate,,,A,N,1,8230,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,1,CHEMBL620536,Intermediate,,,A,N,1,8231,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,1,CHEMBL620537,Intermediate,,,A,N,1,8232,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,1,CHEMBL618526,Intermediate,,,A,N,1,8233,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,1,CHEMBL618527,Intermediate,,,A,N,1,8234,,Rattus norvegicus,In vivo,,50597,,5739,10116.0,,,BAO_0000218,
Pharmacokinetic property (Vdss) in rat,,1,CHEMBL618528,Intermediate,,,A,N,1,8235,,Rattus norvegicus,In vivo,,50597,,5789,10116.0,,,BAO_0000218,
Pharmacokinetic property (vdss) was measured in rat,,1,CHEMBL618529,Intermediate,,,A,N,1,8236,,Rattus norvegicus,In vivo,,50597,,4239,10116.0,,,BAO_0000218,
Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,1,CHEMBL618530,Intermediate,,,A,N,1,8237,,Rattus norvegicus,In vivo,,50597,,4709,10116.0,,,BAO_0000218,
Volume of distribution in rat,,1,CHEMBL618531,Intermediate,,,A,N,1,8238,,Rattus norvegicus,In vivo,,50597,,6642,10116.0,,,BAO_0000218,
The pharmacokinetic parameter volume of distribution in vivo in rats,,1,CHEMBL618532,Intermediate,,,A,N,1,8239,,Rattus norvegicus,In vivo,,50597,,5247,10116.0,,,BAO_0000218,
Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,1,CHEMBL618533,Intermediate,,,F,N,1,8240,,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,,BAO_0000218,
Vdss in rat i.v. at 2 mg/kg concentration,,1,CHEMBL618534,Intermediate,,,A,N,1,8241,,Rattus norvegicus,In vivo,,50597,,17686,10116.0,,,BAO_0000218,
Volume distribution after intravenous administration (1 mg/kg) in rat,,1,CHEMBL618535,Intermediate,,,A,N,1,8242,,Rattus norvegicus,In vivo,,50597,,4689,10116.0,,,BAO_0000218,
Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,1,CHEMBL618536,Intermediate,,,A,N,1,8243,,Rattus norvegicus,In vivo,,50597,,5654,10116.0,,,BAO_0000218,
Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,1,CHEMBL618537,Intermediate,,,A,N,1,8244,,Rattus norvegicus,In vivo,,50597,,5654,10116.0,,,BAO_0000218,
Volume distribution at a dose of 10 uM/kg in rat was determined,,1,CHEMBL618538,Intermediate,,,A,N,1,8245,,Rattus norvegicus,In vivo,,50597,,4527,10116.0,,,BAO_0000218,
Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,1,CHEMBL618539,Intermediate,,,A,N,1,8246,,Rattus norvegicus,In vivo,,50597,,4521,10116.0,,,BAO_0000218,
Volume distribution was calculated in rat,,1,CHEMBL618540,Intermediate,,,A,N,1,8247,,Rattus norvegicus,In vivo,,50597,,6057,10116.0,,,BAO_0000218,
Volume distribution was determined,,1,CHEMBL618541,Intermediate,,,A,N,1,8248,,Rattus norvegicus,In vivo,,50597,,5510,10116.0,,,BAO_0000218,
Volume of distribution after intravenous administration was evaluated in rat,,1,CHEMBL618542,Intermediate,,,A,N,1,8249,,Rattus norvegicus,In vivo,,50597,,2938,10116.0,,,BAO_0000218,
Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,1,CHEMBL622544,Intermediate,,,A,N,1,8250,,Rattus norvegicus,In vivo,,50597,,6679,10116.0,,,BAO_0000218,
"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,1,CHEMBL622545,Intermediate,,,A,N,1,8251,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,1,CHEMBL622546,Intermediate,,,A,N,1,8252,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,1,CHEMBL622547,Intermediate,,,A,N,1,8253,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
Volume of distribution in steady state was determined in rat,,1,CHEMBL622548,Intermediate,,,A,N,1,8254,,Rattus norvegicus,In vivo,,50597,,5145,10116.0,,,BAO_0000218,
Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,1,CHEMBL622549,Intermediate,,,A,N,1,8255,,Rattus norvegicus,In vivo,,50597,,6467,10116.0,,,BAO_0000218,
Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,1,CHEMBL622550,Intermediate,,,A,N,1,8256,,Rattus norvegicus,In vivo,,50597,,6467,10116.0,,,BAO_0000218,
Compound was evaluated for area under curve when administered through oral route to mouse,,1,CHEMBL622551,Intermediate,,,A,N,1,8257,,Mus musculus,,,50594,,15115,10090.0,,,BAO_0000218,
Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,1,CHEMBL622552,Intermediate,,,A,N,1,8258,,Rattus norvegicus,,,50597,,8758,10116.0,,,BAO_0000218,
Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,1,CHEMBL622553,Intermediate,,,A,N,1,8259,,Rattus norvegicus,,,50597,,8758,10116.0,,,BAO_0000218,
Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,0,CHEMBL622554,Autocuration,,,F,U,1,8260,,,In vivo,,22224,,8267,,,,BAO_0000218,
Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,1,CHEMBL622555,Intermediate,,,A,N,1,8261,,Canis lupus familiaris,,,50588,,8267,9615.0,,,BAO_0000218,
Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,1,CHEMBL622556,Intermediate,,,A,N,1,8262,,Mus musculus,,,50594,,14239,10090.0,,,BAO_0000218,
Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,1,CHEMBL622557,Intermediate,,,A,N,1,8263,,Mus musculus,,,50594,,14239,10090.0,,,BAO_0000218,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,1,CHEMBL622558,Intermediate,,,A,N,1,8264,178.0,Mus musculus,,,50594,,10754,10090.0,,Blood,BAO_0000218,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,1,CHEMBL622559,Intermediate,,,A,N,1,8265,178.0,Mus musculus,,,50594,,10754,10090.0,,Blood,BAO_0000218,
Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,1,CHEMBL622560,Intermediate,,,A,N,1,8266,,Canis lupus familiaris,,,50588,,10754,9615.0,,,BAO_0000218,
Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,1,CHEMBL622561,Intermediate,,,A,N,1,8267,,Rattus norvegicus,,,50597,,14681,10116.0,,,BAO_0000218,
Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,1,CHEMBL622562,Intermediate,,,A,N,1,8268,,Rattus norvegicus,,,50597,,14681,10116.0,,,BAO_0000218,
Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,1,CHEMBL622563,Intermediate,,,A,N,1,8269,,Rattus norvegicus,,,50597,,14681,10116.0,,,BAO_0000218,
Concentration of compound in Central nervous system,,0,CHEMBL622564,Autocuration,,,A,U,1,8270,,,,,22224,,13118,,,,BAO_0000019,
Concentration of compound in Central nervous system; Not detectable,,0,CHEMBL622565,Autocuration,,,A,U,1,8271,,,,,22224,,13118,,,,BAO_0000019,
"Concentration of diester in the blood, following oral administration in mice",,1,CHEMBL622566,Intermediate,,,A,N,1,8272,,Mus musculus,,,50594,,13318,10090.0,,,BAO_0000218,
"Concentration of monoester in the blood, following oral administration in mice",,1,CHEMBL624515,Intermediate,,,A,N,1,8273,,Mus musculus,,,50594,,13318,10090.0,,,BAO_0000218,
Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,1,CHEMBL624516,Intermediate,,,A,N,1,8274,,Mus musculus,,,50594,,13318,10090.0,,,BAO_0000218,
Evaluated for Pharmacokinetic property: Area under the curve,,0,CHEMBL624517,Autocuration,,,A,U,1,8275,,,,,22224,,15692,,,,BAO_0000019,
In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,1,CHEMBL624518,Intermediate,,,A,N,1,8276,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,1,CHEMBL624519,Intermediate,,,A,N,1,8277,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,1,CHEMBL624520,Intermediate,,,A,N,1,8278,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,1,CHEMBL624521,Intermediate,,,A,N,1,8279,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,1,CHEMBL624522,Intermediate,,,A,N,1,8280,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,1,CHEMBL624523,Intermediate,,,A,N,1,8281,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,1,CHEMBL624409,Intermediate,,,A,N,1,8282,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,1,CHEMBL624410,Intermediate,,,A,N,1,8283,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,1,CHEMBL624411,Intermediate,,,A,N,1,8284,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,1,CHEMBL623531,Intermediate,,,A,N,1,8285,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,1,CHEMBL623532,Intermediate,,,A,N,1,8286,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,1,CHEMBL623533,Intermediate,,,A,N,1,8287,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,1,CHEMBL623534,Intermediate,,,A,N,1,8288,,Macaca fascicularis,,,100710,,14839,9541.0,,,BAO_0000218,
In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,1,CHEMBL623535,Intermediate,,,A,N,1,8289,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,1,CHEMBL623536,Intermediate,,,A,N,1,8290,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,1,CHEMBL623537,Intermediate,,,A,N,1,8291,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,1,CHEMBL623538,Intermediate,,,A,N,1,8292,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,1,CHEMBL623539,Intermediate,,,A,N,1,8293,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,1,CHEMBL623540,Intermediate,,,A,N,1,8294,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,1,CHEMBL623541,Intermediate,,,A,N,1,8295,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,1,CHEMBL623542,Intermediate,,,A,N,1,8296,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,1,CHEMBL623543,Intermediate,,,A,N,1,8297,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,1,CHEMBL623544,Intermediate,,,A,N,1,8298,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,1,CHEMBL623545,Intermediate,,,A,N,1,8299,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,1,CHEMBL623546,Intermediate,,,A,N,1,8300,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,1,CHEMBL623547,Intermediate,,,A,N,1,8301,1969.0,Rattus norvegicus,In vivo,,50597,,5408,10116.0,,Plasma,BAO_0000218,
High i.v. clearance in Dawley rats,,1,CHEMBL623548,Intermediate,,,A,N,1,8302,,Rattus norvegicus,In vivo,,50597,,6827,10116.0,,,BAO_0000218,
In vitro clearance in rat liver microsomes,,1,CHEMBL623549,Intermediate,,,A,N,1,8303,2107.0,Rattus norvegicus,In vitro,,50597,,17538,10116.0,,Liver,BAO_0000218,Microsomes
Intrinsic clearance in rat liver microsomes was determined,,1,CHEMBL623550,Intermediate,,,A,N,1,8304,2107.0,Rattus norvegicus,In vitro,,50597,,6331,10116.0,,Liver,BAO_0000218,Microsomes
Intrinsic clearance in rat hepatocytes was determined,Hepatocyte,1,CHEMBL875276,Intermediate,,401.0,A,N,1,8305,2107.0,Rattus norvegicus,In vitro,,50597,,5948,10116.0,,Liver,BAO_0000218,
Plasma Clearance was determined,,1,CHEMBL621872,Intermediate,,,A,N,1,8306,,Rattus norvegicus,In vivo,,50597,,4026,10116.0,,,BAO_0000218,
Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,1,CHEMBL621873,Intermediate,,,A,N,1,8307,,Rattus norvegicus,In vivo,,50597,,6647,10116.0,,,BAO_0000218,
Plasma clearance in rat.,,1,CHEMBL621874,Intermediate,,,A,N,1,8308,,Rattus norvegicus,In vivo,,50597,,1696,10116.0,,,BAO_0000218,
Plasma clearance in rats,,1,CHEMBL621875,Intermediate,,,A,N,1,8309,,Rattus norvegicus,In vivo,,50597,,6597,10116.0,,,BAO_0000218,
Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,1,CHEMBL621876,Intermediate,,,A,N,1,8310,,Rattus norvegicus,In vivo,,50597,,347,10116.0,,,BAO_0000218,
Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,1,CHEMBL621877,Intermediate,,,A,N,1,8311,,Rattus norvegicus,In vivo,,50597,,16423,10116.0,,,BAO_0000218,
Plasma clearance was measured in rat,,1,CHEMBL621878,Intermediate,,,A,N,1,8312,,Rattus norvegicus,In vivo,,50597,,2879,10116.0,,,BAO_0000218,
Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,1,CHEMBL621879,Intermediate,,,A,N,1,8313,,Rattus norvegicus,In vivo,,50597,,4883,10116.0,,,BAO_0000218,
"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,1,CHEMBL621880,Intermediate,,,A,N,1,8314,1969.0,Rattus norvegicus,In vivo,,50597,,5328,10116.0,,Plasma,BAO_0000218,
The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,1,CHEMBL621881,Intermediate,,,A,N,1,8315,,Rattus norvegicus,In vivo,,50597,,5160,10116.0,,,BAO_0000218,
Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,1,CHEMBL621882,Intermediate,,,A,N,1,8316,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
Total clearance at 1 mg/kg was determined in rat,,1,CHEMBL875283,Intermediate,,,A,N,1,8317,,Rattus norvegicus,In vivo,,50597,,17651,10116.0,,,BAO_0000218,
Total clearance at 10 mg/kg was determined in rat,,1,CHEMBL621883,Intermediate,,,A,N,1,8318,,Rattus norvegicus,In vivo,,50597,,17651,10116.0,,,BAO_0000218,
Clearance in rat,,1,CHEMBL621884,Intermediate,,,A,N,1,8319,,Rattus norvegicus,In vivo,,50597,,6596,10116.0,,,BAO_0000218,
Plasma clearance rate determined in rats,,1,CHEMBL621885,Intermediate,,,A,N,1,8320,,Rattus norvegicus,In vivo,,50597,,4796,10116.0,,,BAO_0000218,
Clearance of compound in rat was evaluated,,1,CHEMBL621886,Intermediate,,,A,N,1,8321,,Rattus norvegicus,In vivo,,50597,,6850,10116.0,,,BAO_0000218,
Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,1,CHEMBL621887,Intermediate,,,A,N,1,8322,1969.0,Rattus norvegicus,In vivo,,50597,,5932,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic property (blood clearance) in rat,,1,CHEMBL621888,Intermediate,,,A,N,1,8323,,Rattus norvegicus,In vivo,,50597,,3371,10116.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL621889,Intermediate,,,A,N,1,8324,,Rattus norvegicus,In vivo,,50597,,2083,10116.0,,,BAO_0000218,
Plasma clearance in rats,,1,CHEMBL621890,Intermediate,,,A,N,1,8325,,Rattus norvegicus,In vivo,,50597,,4942,10116.0,,,BAO_0000218,
Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,1,CHEMBL621891,Intermediate,,,A,N,1,8326,2107.0,Rattus norvegicus,In vitro,,50597,,6838,10116.0,,Liver,BAO_0000218,Microsomes
Clearance in Dawley rat,,1,CHEMBL621892,Intermediate,,,A,N,1,8327,,Rattus norvegicus,In vivo,,50597,,5353,10116.0,,,BAO_0000218,
Clearance rat,,1,CHEMBL621893,Intermediate,,,A,N,1,8328,,Rattus norvegicus,In vivo,,50597,,6641,10116.0,,,BAO_0000218,
Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,1,CHEMBL621894,Intermediate,,,A,N,1,8329,,Rattus norvegicus,In vivo,,50597,,6641,10116.0,,,BAO_0000218,
Clearance rat; Not determined,,1,CHEMBL621895,Intermediate,,,A,N,1,8330,,Rattus norvegicus,In vivo,,50597,,6641,10116.0,,,BAO_0000218,
Clearance rate was determined in rat at a dose of 1 mpk i.v.,,1,CHEMBL875284,Intermediate,,,A,N,1,8331,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,1,CHEMBL618699,Intermediate,,,A,N,1,8332,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,1,CHEMBL618700,Intermediate,,,A,N,1,8333,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,1,CHEMBL618701,Intermediate,,,A,N,1,8334,,Rattus norvegicus,In vivo,,50597,,6211,10116.0,,,BAO_0000218,
"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,1,CHEMBL876600,Intermediate,,,A,N,1,8335,1969.0,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,Plasma,BAO_0000218,
Clearance of compound in rat after 1 mg/kg i.v. administration,,1,CHEMBL618702,Intermediate,,,A,N,1,8336,,Rattus norvegicus,In vivo,,50597,,6570,10116.0,,,BAO_0000218,
Compound was evaluated for Hepatic clearance in rat,,1,CHEMBL618703,Intermediate,,,A,N,1,8337,,Rattus norvegicus,In vivo,,50597,,3341,10116.0,,,BAO_0000218,
In vivo clearance after 5 mg/kg dose,,1,CHEMBL618704,Intermediate,,,A,N,1,8338,,Rattus norvegicus,In vivo,,50597,,4891,10116.0,,,BAO_0000218,
Compound was tested for plasma clearance in rats,,1,CHEMBL618705,Intermediate,,,A,N,1,8339,1969.0,Rattus norvegicus,In vivo,,50597,,1094,10116.0,,Plasma,BAO_0000218,
Hepatic clearance after intravenous administration was evaluated in rat,,1,CHEMBL618706,Intermediate,,,A,N,1,8340,,Rattus norvegicus,In vivo,,50597,,2938,10116.0,,,BAO_0000218,
Lower clearance in rat (i.v.) at 0.5 mpk,,1,CHEMBL618707,Intermediate,,,A,N,1,8341,,Rattus norvegicus,In vivo,,50597,,17853,10116.0,,,BAO_0000218,
Pharmacokinetic parameter expressed as plasma clearance in rat,,1,CHEMBL618708,Intermediate,,,A,N,1,8342,1969.0,Rattus norvegicus,In vivo,,50597,,6049,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic property (Clp) in rat,,1,CHEMBL618709,Intermediate,,,A,N,1,8343,,Rattus norvegicus,In vivo,,50597,,5789,10116.0,,,BAO_0000218,
Plasma clearance in Sprague-Dawley rats,,1,CHEMBL618710,Intermediate,,,A,N,1,8344,,Rattus norvegicus,In vivo,,50597,,4514,10116.0,,,BAO_0000218,
Plasma clearance (Clp) in rat,,1,CHEMBL618711,Intermediate,,,A,N,1,8345,,Rattus norvegicus,In vivo,,50597,,6448,10116.0,,,BAO_0000218,
Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,1,CHEMBL618712,Intermediate,,,A,N,1,8346,,Rattus norvegicus,In vivo,,50597,,6062,10116.0,,,BAO_0000218,
Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,1,CHEMBL618713,Intermediate,,,A,N,1,8347,,Rattus norvegicus,In vivo,,50597,,5710,10116.0,,,BAO_0000218,
Plasma clearance after intravenous administration of 1 mg/kg in rat,,1,CHEMBL618714,Intermediate,,,A,N,1,8348,,Rattus norvegicus,In vivo,,50597,,4709,10116.0,,,BAO_0000218,
Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,1,CHEMBL618715,Intermediate,,,A,N,1,8349,,Rattus norvegicus,In vivo,,50597,,4521,10116.0,,,BAO_0000218,
Plasma clearance in rat was determined,,1,CHEMBL618716,Intermediate,,,A,N,1,8350,,Rattus norvegicus,In vivo,,50597,,1742,10116.0,,,BAO_0000218,
Plasma clearance measured in rat,,1,CHEMBL876601,Intermediate,,,A,N,1,8351,,Rattus norvegicus,In vivo,,50597,,6057,10116.0,,,BAO_0000218,
Plasma clearance was calculated in rat,,1,CHEMBL618717,Intermediate,,,A,N,1,8352,,Rattus norvegicus,In vivo,,50597,,6057,10116.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL618718,Intermediate,,,A,N,1,8353,,Rattus norvegicus,In vivo,,50597,,5145,10116.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL618719,Intermediate,,,A,N,1,8354,,Rattus norvegicus,In vivo,,50597,,5833,10116.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL618720,Intermediate,,,A,N,1,8355,,Rattus norvegicus,In vivo,,50597,,6453,10116.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL618721,Intermediate,,,A,N,1,8356,,Rattus norvegicus,In vivo,,50597,,6640,10116.0,,,BAO_0000218,
Plasma clearance in rats,,1,CHEMBL621477,Intermediate,,,A,N,1,8357,,Rattus norvegicus,In vivo,,50597,,6305,10116.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL621478,Intermediate,,,A,N,1,8358,,Rattus norvegicus,In vivo,,50597,,6642,10116.0,,,BAO_0000218,
Plasma clearance was evaluated in rat,,1,CHEMBL621479,Intermediate,,,A,N,1,8359,,Rattus norvegicus,In vivo,,50597,,5472,10116.0,,,BAO_0000218,
Plasma clearance was evaluated in rat; Not tested,,1,CHEMBL621480,Intermediate,,,A,N,1,8360,,Rattus norvegicus,In vivo,,50597,,5472,10116.0,,,BAO_0000218,
Plasma clearance rate was determined for the compound in rat,,1,CHEMBL621481,Intermediate,,,A,N,1,8361,,Rattus norvegicus,In vivo,,50597,,5144,10116.0,,,BAO_0000218,
"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,1,CHEMBL621482,Intermediate,,,A,N,1,8362,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,1,CHEMBL621483,Intermediate,,,A,N,1,8363,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,1,CHEMBL621484,Intermediate,,,A,N,1,8364,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621485,Intermediate,,,A,N,1,8365,948.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Heart,BAO_0000218,
Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621486,Intermediate,,,A,N,1,8366,948.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Heart,BAO_0000218,
Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621487,Intermediate,,,A,N,1,8367,160.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Intestine,BAO_0000218,
Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621488,Intermediate,,,A,N,1,8368,160.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Intestine,BAO_0000218,
Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621489,Intermediate,,,A,N,1,8369,160.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Intestine,BAO_0000218,
Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621490,Intermediate,,,A,N,1,8370,160.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Intestine,BAO_0000218,
Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621491,Intermediate,,,A,N,1,8371,160.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Intestine,BAO_0000218,
Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621492,Intermediate,,,A,N,1,8372,2113.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Kidney,BAO_0000218,
Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,1,CHEMBL621493,Intermediate,,,A,N,1,8373,2113.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Kidney,BAO_0000218,
Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621494,Intermediate,,,A,N,1,8374,2113.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Kidney,BAO_0000218,
Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621495,Intermediate,,,A,N,1,8375,2113.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Kidney,BAO_0000218,
Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621496,Intermediate,,,A,N,1,8376,2113.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Kidney,BAO_0000218,
Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621497,Intermediate,,,A,N,1,8377,2107.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Liver,BAO_0000218,
Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621498,Intermediate,,,A,N,1,8378,2107.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Liver,BAO_0000218,
Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL621499,Intermediate,,,A,N,1,8379,2107.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Liver,BAO_0000218,
Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,1,CHEMBL618634,Intermediate,,,A,N,1,8380,2107.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Liver,BAO_0000218,
Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL618635,Intermediate,,,A,N,1,8381,2107.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Liver,BAO_0000218,
Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL618636,Intermediate,,,A,N,1,8382,2048.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Lung,BAO_0000218,
Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619737,Intermediate,,,A,N,1,8383,2048.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Lung,BAO_0000218,
Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL619738,Intermediate,,,A,N,1,8384,2048.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Lung,BAO_0000218,
Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL624329,Intermediate,,,A,N,1,8385,2048.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Lung,BAO_0000218,
Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL624330,Intermediate,,,A,N,1,8386,2048.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Lung,BAO_0000218,
Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL624331,Intermediate,,,A,N,1,8387,2385.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL624332,Intermediate,,,A,N,1,8388,2385.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL624333,Intermediate,,,A,N,1,8389,2385.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL624334,Intermediate,,,A,N,1,8390,2385.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL624335,Intermediate,,,A,N,1,8391,2385.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL620016,Intermediate,,,A,N,1,8392,2106.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Spleen,BAO_0000218,
Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL620169,Intermediate,,,A,N,1,8393,2106.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Spleen,BAO_0000218,
Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL620170,Intermediate,,,A,N,1,8394,2106.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Spleen,BAO_0000218,
Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,1,CHEMBL620171,Intermediate,,,A,N,1,8395,2106.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Spleen,BAO_0000218,
Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL620172,Intermediate,,,A,N,1,8396,2106.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Spleen,BAO_0000218,
Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL620173,Intermediate,,,A,N,1,8397,945.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Stomach,BAO_0000218,
Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,1,CHEMBL620174,Intermediate,,,A,N,1,8398,945.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Stomach,BAO_0000218,
Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL620175,Intermediate,,,A,N,1,8399,945.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Stomach,BAO_0000218,
Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL620176,Intermediate,,,A,N,1,8400,945.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Stomach,BAO_0000218,
Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,1,CHEMBL620177,Intermediate,,,A,N,1,8401,945.0,Rattus norvegicus,In vivo,,50597,,13950,10116.0,,Stomach,BAO_0000218,
Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620178,Intermediate,,,A,N,1,8402,2037.0,Rattus norvegicus,,,50597,,13950,10116.0,,Cerebellum,BAO_0000218,
Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620179,Intermediate,,,A,N,1,8403,2037.0,Rattus norvegicus,,,50597,,13950,10116.0,,Cerebellum,BAO_0000218,
Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620180,Intermediate,,,A,N,1,8404,,Rattus norvegicus,,,50597,,13950,10116.0,,,BAO_0000218,
Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,1,CHEMBL620181,Intermediate,,,A,N,1,8405,,Rattus norvegicus,In vivo,,50597,,6570,10116.0,,,BAO_0000218,
Volume of distribution of compound in rats after intravenous administration,,1,CHEMBL620182,Intermediate,,,A,N,1,8406,,Rattus norvegicus,In vivo,,50597,,6571,10116.0,,,BAO_0000218,
Volume of distribution in rat,,1,CHEMBL620183,Intermediate,,,A,N,1,8407,,Rattus norvegicus,In vivo,,50597,,6453,10116.0,,,BAO_0000218,
Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,1,CHEMBL620184,Intermediate,,,A,N,1,8408,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,1,CHEMBL620185,Intermediate,,,A,N,1,8409,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,1,CHEMBL620186,Intermediate,,,A,N,1,8410,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Volume of distribution was determined in Dawley rat,,1,CHEMBL620187,Intermediate,,,A,N,1,8411,,Rattus norvegicus,In vivo,,50597,,5353,10116.0,,,BAO_0000218,
Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,1,CHEMBL620188,Intermediate,,,A,N,1,8412,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Volume of distribution was reported in Sprague-Dawley rat,,1,CHEMBL620189,Intermediate,,,A,N,1,8413,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Volumes of distribution in rat after peroral administration,,1,CHEMBL620190,Intermediate,,,A,N,1,8414,,Rattus norvegicus,In vivo,,50597,,6641,10116.0,,,BAO_0000218,
Volumes of distribution in rat after po administration,,1,CHEMBL620191,Intermediate,,,A,N,1,8415,,Rattus norvegicus,In vivo,,50597,,6641,10116.0,,,BAO_0000218,
Volumes of distribution in rat after po administration; Not determined,,1,CHEMBL620192,Intermediate,,,A,N,1,8416,,Rattus norvegicus,In vivo,,50597,,6641,10116.0,,,BAO_0000218,
Pharmacokinetic property (Volume) in rat i.v.,,1,CHEMBL620193,Intermediate,,,A,N,1,8417,,Rattus norvegicus,In vivo,,50597,,5676,10116.0,,,BAO_0000218,
Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,1,CHEMBL620194,Intermediate,,,A,N,1,8418,,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,,BAO_0000218,
"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,1,CHEMBL876730,Intermediate,,,A,N,1,8419,,Rattus norvegicus,In vivo,,50597,,17670,10116.0,,,BAO_0000218,
Volume distribution in rat after oral administration at 10 mg/kg,,1,CHEMBL620195,Intermediate,,,A,N,1,8420,,Rattus norvegicus,In vivo,,50597,,6495,10116.0,,,BAO_0000218,
Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,1,CHEMBL620196,Intermediate,,,A,N,1,8421,,Rattus norvegicus,In vivo,,50597,,5408,10116.0,,,BAO_0000218,
Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,1,CHEMBL620197,Intermediate,,,A,N,1,8422,,Rattus norvegicus,In vivo,,50597,,4883,10116.0,,,BAO_0000218,
Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,1,CHEMBL620198,Intermediate,,,A,N,1,8423,,Rattus norvegicus,In vivo,,50597,,6647,10116.0,,,BAO_0000218,
Volume of distribution in rats,,1,CHEMBL620199,Intermediate,,,A,N,1,8424,,Rattus norvegicus,In vivo,,50597,,6495,10116.0,,,BAO_0000218,
Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,1,CHEMBL620200,Intermediate,,,A,N,1,8425,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,1,CHEMBL620201,Intermediate,,,A,N,1,8426,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL620202,Intermediate,,,A,N,1,8427,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL620203,Intermediate,,,A,N,1,8428,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,1,CHEMBL620204,Intermediate,,,A,N,1,8429,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL620205,Intermediate,,,A,N,1,8430,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (Vss) in rat,,1,CHEMBL624664,Intermediate,,,A,N,1,8431,,Rattus norvegicus,In vivo,,50597,,5960,10116.0,,,BAO_0000218,
Pharmacokinetic property (Volume) in rat i.v.,,1,CHEMBL624665,Intermediate,,,A,N,1,8432,,Rattus norvegicus,In vivo,,50597,,5676,10116.0,,,BAO_0000218,
Pharmacokinetic property (Vss) in rat,,1,CHEMBL624666,Intermediate,,,A,N,1,8433,,Rattus norvegicus,,,50597,,5948,10116.0,,,BAO_0000218,
Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,1,CHEMBL624667,Intermediate,,,A,N,1,8434,,Rattus norvegicus,In vivo,,50597,,5979,10116.0,,,BAO_0000218,
Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL624668,Intermediate,,,A,N,1,8435,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL624669,Intermediate,,,A,N,1,8436,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL624670,Intermediate,,,A,N,1,8437,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL624671,Intermediate,,,A,N,1,8438,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Steady state volume distribution in rat,,1,CHEMBL624672,Intermediate,,,A,N,1,8439,,Rattus norvegicus,In vivo,,50597,,6448,10116.0,,,BAO_0000218,
"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,1,CHEMBL624673,Intermediate,,,A,N,1,8440,1969.0,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,Plasma,BAO_0000218,
Steady state volume of distribution determined in rat,,1,CHEMBL624674,Intermediate,,,A,N,1,8441,,Rattus norvegicus,In vivo,,50597,,4576,10116.0,,,BAO_0000218,
Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,1,CHEMBL624675,Intermediate,,,A,N,1,8442,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,1,CHEMBL621728,Intermediate,,,A,N,1,8443,,Rattus norvegicus,In vivo,,50597,,1466,10116.0,,,BAO_0000218,
Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,1,CHEMBL621729,Intermediate,,,A,N,1,8444,,Rattus norvegicus,,,50597,,5182,10116.0,,,BAO_0000218,
Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,1,CHEMBL621730,Intermediate,,,A,N,1,8445,,Rattus norvegicus,,,50597,,5182,10116.0,,,BAO_0000218,
Volume distribution in rat after administration of 2 mg/kg iv,,1,CHEMBL621731,Intermediate,,,A,N,1,8446,,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,,BAO_0000218,
Volume distribution in rat after administration of 2 mg/kg iv,,1,CHEMBL621732,Intermediate,,,A,N,1,8447,,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,,BAO_0000218,
Volume in steady state distribution value was determined,,1,CHEMBL621908,Intermediate,,,A,N,1,8448,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
Volume in steady state distribution value was determined; ND denotes no data,,1,CHEMBL875347,Intermediate,,,A,N,1,8449,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
Volume in steady state distribution value was determined; ND denotes not determined,,1,CHEMBL621909,Intermediate,,,A,N,1,8450,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,1,CHEMBL621910,Intermediate,,,A,N,1,8451,,Rattus norvegicus,In vivo,,50597,,17065,10116.0,,,BAO_0000218,
Volume of distribution at steady state was evaluated in rats,,1,CHEMBL621911,Intermediate,,,A,N,1,8452,,Rattus norvegicus,In vivo,,50597,,6597,10116.0,,,BAO_0000218,
Volume of distribution at steady state was observed after intravenous administration in rat,,1,CHEMBL621912,Intermediate,,,A,N,1,8453,,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,,BAO_0000218,
Volume of distribution in steady state was determined in rat,,1,CHEMBL621913,Intermediate,,,A,N,1,8454,,Rattus norvegicus,In vivo,,50597,,6485,10116.0,,,BAO_0000218,
Volume of distribution in steady state was determined in rat,,1,CHEMBL621914,Intermediate,,,A,N,1,8455,,Rattus norvegicus,In vivo,,50597,,17655,10116.0,,,BAO_0000218,
Volume of distribution after i.v. administration,,1,CHEMBL621915,Intermediate,,,A,N,1,8456,,Rattus norvegicus,In vivo,,50597,,6616,10116.0,,,BAO_0000218,
Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,1,CHEMBL621916,Intermediate,,,A,N,1,8457,,Rattus norvegicus,In vivo,,50597,,1916,10116.0,,,BAO_0000218,
"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,1,CHEMBL621917,Intermediate,,,A,N,1,8458,2107.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Liver,BAO_0000218,
"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,1,CHEMBL621918,Intermediate,,,A,N,1,8459,2107.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Liver,BAO_0000218,
Biodistribution of compound (oxidized form) in spleen tissue,,1,CHEMBL621919,Intermediate,,,A,N,1,8460,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,1,CHEMBL621920,Intermediate,,,A,N,1,8461,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,1,CHEMBL621921,Intermediate,,,A,N,1,8462,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,1,CHEMBL622401,Intermediate,,,A,N,1,8463,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,1,CHEMBL875348,Intermediate,,,A,N,1,8464,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,1,CHEMBL622402,Intermediate,,,A,N,1,8465,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,1,CHEMBL622403,Intermediate,,,A,N,1,8466,178.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Blood,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,1,CHEMBL622404,Intermediate,,,A,N,1,8467,178.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Blood,BAO_0000218,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,1,CHEMBL622405,Intermediate,,,A,N,1,8468,955.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Brain,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,1,CHEMBL622406,Intermediate,,,A,N,1,8469,955.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Brain,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,1,CHEMBL622407,Intermediate,,,A,N,1,8470,955.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Brain,BAO_0000218,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,1,CHEMBL622408,Intermediate,,,A,N,1,8471,948.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Heart,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,1,CHEMBL622409,Intermediate,,,A,N,1,8472,948.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Heart,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,1,CHEMBL622410,Intermediate,,,A,N,1,8473,948.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Heart,BAO_0000218,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,1,CHEMBL622411,Intermediate,,,A,N,1,8474,2113.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Kidney,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,1,CHEMBL627864,Intermediate,,,A,N,1,8475,2113.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Kidney,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,1,CHEMBL627865,Intermediate,,,A,N,1,8476,2113.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Kidney,BAO_0000218,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,1,CHEMBL627866,Intermediate,,,A,N,1,8477,2107.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Liver,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,1,CHEMBL627751,Intermediate,,,A,N,1,8478,2107.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Liver,BAO_0000218,
Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,1,CHEMBL627752,Intermediate,,,A,N,1,8479,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,1,CHEMBL627753,Intermediate,,,A,N,1,8480,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,1,CHEMBL627754,Intermediate,,,A,N,1,8481,2106.0,Mus musculus,In vivo,,50594,,16438,10090.0,,Spleen,BAO_0000218,
Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,1,CHEMBL627755,Intermediate,,,A,N,1,8482,,Mus musculus,,,50594,,12467,10090.0,,,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627756,Intermediate,,,A,N,1,8483,955.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Brain,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627757,Intermediate,,,A,N,1,8484,955.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Brain,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627758,Intermediate,,,A,N,1,8485,955.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Brain,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627759,Intermediate,,,A,N,1,8486,955.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Brain,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627760,Intermediate,,,A,N,1,8487,955.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Brain,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627761,Intermediate,,,A,N,1,8488,955.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Brain,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,1,CHEMBL876811,Intermediate,,,A,N,1,8489,948.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Heart,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627762,Intermediate,,,A,N,1,8490,948.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Heart,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627763,Intermediate,,,A,N,1,8491,948.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Heart,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627764,Intermediate,,,A,N,1,8492,948.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Heart,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627765,Intermediate,,,A,N,1,8493,948.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Heart,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627766,Intermediate,,,A,N,1,8494,948.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Heart,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627767,Intermediate,,,A,N,1,8495,2113.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Kidney,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627768,Intermediate,,,A,N,1,8496,2113.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Kidney,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL628422,Intermediate,,,A,N,1,8497,2113.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Kidney,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL628423,Intermediate,,,A,N,1,8498,2113.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Kidney,BAO_0000218,
Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,1,CHEMBL628424,Intermediate,,,A,N,1,8499,,Rattus norvegicus,In vivo,,50597,,5089,10116.0,,,BAO_0000218,
Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,1,CHEMBL628425,Intermediate,,,A,N,1,8500,,Rattus norvegicus,In vivo,,50597,,5089,10116.0,,,BAO_0000218,
Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,1,CHEMBL628426,Intermediate,,,A,N,1,8501,,Rattus norvegicus,In vivo,,50597,,4257,10116.0,,,BAO_0000218,
Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,1,CHEMBL628427,Intermediate,,,A,N,1,8502,,Rattus norvegicus,In vivo,,50597,,6679,10116.0,,,BAO_0000218,
Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,1,CHEMBL626938,Intermediate,,,A,N,1,8503,,Rattus norvegicus,In vivo,,50597,,5546,10116.0,,,BAO_0000218,
Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,1,CHEMBL626939,Intermediate,,,A,N,1,8504,,Rattus norvegicus,In vivo,,50597,,6141,10116.0,,,BAO_0000218,
Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,1,CHEMBL626940,Intermediate,,,A,N,1,8505,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,1,CHEMBL626941,Intermediate,,,A,N,1,8506,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Plasma clearance was reported in Sprague-Dawley rat,,1,CHEMBL626942,Intermediate,,,A,N,1,8507,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Plasma clearance after intravenous administration (1 mg/kg) in rat,,1,CHEMBL876812,Intermediate,,,A,N,1,8508,,Rattus norvegicus,In vivo,,50597,,4689,10116.0,,,BAO_0000218,
Plasma clearance of compound in rats was evaluated,,1,CHEMBL626943,Intermediate,,,A,N,1,8509,,Rattus norvegicus,In vivo,,50597,,6848,10116.0,,,BAO_0000218,
Plasma clearance of compound in rats was evaluated; ND indicates not determined,,1,CHEMBL626944,Intermediate,,,A,N,1,8510,,Rattus norvegicus,In vivo,,50597,,6848,10116.0,,,BAO_0000218,
Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,1,CHEMBL626945,Intermediate,,,A,N,1,8511,,Rattus norvegicus,In vivo,,50597,,6467,10116.0,,,BAO_0000218,
Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,1,CHEMBL626946,Intermediate,,,A,N,1,8512,,Rattus norvegicus,In vivo,,50597,,6467,10116.0,,,BAO_0000218,
Plasma clearance rate in Sprague-Dawley rats,,1,CHEMBL626856,Intermediate,,,A,N,1,8513,,Rattus norvegicus,In vivo,,50597,,4956,10116.0,,,BAO_0000218,
Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,1,CHEMBL626857,Intermediate,,,A,N,1,8514,,Rattus norvegicus,In vivo,,50597,,5529,10116.0,,,BAO_0000218,
The compound was evaluated for plasma clearance in rat,,1,CHEMBL626858,Intermediate,,,A,N,1,8515,1969.0,Rattus norvegicus,In vivo,,50597,,406,10116.0,,Plasma,BAO_0000218,
Total plasma clearance in rat,,1,CHEMBL627018,Intermediate,,,A,N,1,8516,1969.0,Rattus norvegicus,In vivo,,50597,,17655,10116.0,,Plasma,BAO_0000218,
Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,1,CHEMBL625331,Intermediate,,,A,N,1,8517,178.0,Rattus norvegicus,In vivo,,50597,,3293,10116.0,,Blood,BAO_0000218,
Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,1,CHEMBL625332,Intermediate,,,A,N,1,8518,178.0,Rattus norvegicus,In vivo,,50597,,4075,10116.0,,Blood,BAO_0000218,
C max was determined at 10 mg/kg po dose in rats,,1,CHEMBL877590,Intermediate,,,A,N,1,8519,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
C max was determined at 3 mg/kg po dose in rats,,1,CHEMBL625333,Intermediate,,,A,N,1,8520,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Cmax after repeated oral dose of compound at 1 mg/kg in rats,,1,CHEMBL625334,Intermediate,,,A,N,1,8521,,Rattus norvegicus,In vivo,,50597,,17594,10116.0,,,BAO_0000218,
Cmax after single intravenous bolus of 1 mg/kg in rats,,1,CHEMBL625335,Intermediate,,,A,N,1,8522,,Rattus norvegicus,In vivo,,50597,,17594,10116.0,,,BAO_0000218,
Cmax of compound at 5 mg/kg after po administration was determined in rat,,1,CHEMBL625336,Intermediate,,,A,N,1,8523,,Rattus norvegicus,In vivo,,50597,,4762,10116.0,,,BAO_0000218,
Cmax 24 hr after 10 mg/kg oral administration in rats,,1,CHEMBL625337,Intermediate,,,A,N,1,8524,,Rattus norvegicus,In vivo,,50597,,17509,10116.0,,,BAO_0000218,
Cmax 24 hr after 2 mg/kg oral administration in rats,,1,CHEMBL625338,Intermediate,,,A,N,1,8525,,Rattus norvegicus,In vivo,,50597,,17509,10116.0,,,BAO_0000218,
Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,1,CHEMBL625339,Intermediate,,,A,N,1,8526,1969.0,Rattus norvegicus,In vivo,,50597,,1466,10116.0,,Plasma,BAO_0000218,
Cmax in rat after administration of 2 mg/kg iv,,1,CHEMBL625340,Intermediate,,,A,N,1,8527,,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,,BAO_0000218,
Cmax in rat after administration of 2 mg/kg iv,,1,CHEMBL625341,Intermediate,,,A,N,1,8528,,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,,BAO_0000218,
Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,1,CHEMBL622687,Intermediate,,,A,N,1,8529,,Rattus norvegicus,In vivo,,50597,,3169,10116.0,,,BAO_0000218,
Cmax wa determined in rat plasma at 30 mg/kg after po administration,,1,CHEMBL622688,Intermediate,,,A,N,1,8530,1969.0,Rattus norvegicus,In vivo,,50597,,6515,10116.0,,Plasma,BAO_0000218,
Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,1,CHEMBL622689,Intermediate,,,A,N,1,8531,178.0,Rattus norvegicus,In vivo,,50597,,11149,10116.0,,Blood,BAO_0000218,
Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,1,CHEMBL620295,Intermediate,,,A,N,1,8532,178.0,Rattus norvegicus,In vivo,,50597,,11149,10116.0,,Blood,BAO_0000218,
Cmax after 10 mg/kg oral administration in rat,,1,CHEMBL620296,Intermediate,,,A,N,1,8533,,Rattus norvegicus,In vivo,,50597,,17858,10116.0,,,BAO_0000218,
Cmax after IV dosing at 0.5 mg/kg in rat; no data,,1,CHEMBL620297,Intermediate,,,A,N,1,8534,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Cmax after IV dosing at 1 mg/kg in rat; no data,,1,CHEMBL620298,Intermediate,,,A,N,1,8535,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Cmax after oral administration at 20 mpk in rats,,1,CHEMBL620299,Intermediate,,,A,N,1,8536,,Rattus norvegicus,In vivo,,50597,,4426,10116.0,,,BAO_0000218,
Cmax after oral administration at 20 mpk in rats; Not performed.,,1,CHEMBL620300,Intermediate,,,A,N,1,8537,,Rattus norvegicus,In vivo,,50597,,4426,10116.0,,,BAO_0000218,
Cmax after oral administration at 20 mpk in rats d; Not performed.,,1,CHEMBL620301,Intermediate,,,A,N,1,8538,,Rattus norvegicus,In vivo,,50597,,4426,10116.0,,,BAO_0000218,
Cmax after oral administration in rat,,1,CHEMBL620302,Intermediate,,,A,N,1,8539,,Rattus norvegicus,In vivo,,50597,,5656,10116.0,,,BAO_0000218,
Cmax after oral administration at a dose of 2 mg/kg in rat,,1,CHEMBL620303,Intermediate,,,A,N,1,8540,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Cmax after oral administration at a dose of 4 mg/kg in rat,,1,CHEMBL620304,Intermediate,,,A,N,1,8541,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Cmax in rats after 20 mg/kg oral dose,,1,CHEMBL620305,Intermediate,,,A,N,1,8542,,Rattus norvegicus,In vivo,,50597,,6113,10116.0,,,BAO_0000218,
Cmax after peroral administration in rats at 2.4 uM/kg,,1,CHEMBL620306,Intermediate,,,A,N,1,8543,,Rattus norvegicus,In vivo,,50597,,17764,10116.0,,,BAO_0000218,
Cmax at the dose of 2 mg/Kg administered perorally in rats,,1,CHEMBL620307,Intermediate,,,A,N,1,8544,,Rattus norvegicus,In vivo,,50597,,4756,10116.0,,,BAO_0000218,
Cmax at the dose of 5 mg/Kg administered perorally in rats,,1,CHEMBL620308,Intermediate,,,A,N,1,8545,,Rattus norvegicus,In vivo,,50597,,4756,10116.0,,,BAO_0000218,
Cmax by administering at 20 mg/kg p.o. in rats,,1,CHEMBL620309,Intermediate,,,A,N,1,8546,,Rattus norvegicus,In vivo,,50597,,6402,10116.0,,,BAO_0000218,
Cmax in male rat,,1,CHEMBL620310,Intermediate,,,A,N,1,8547,,Rattus norvegicus,In vivo,,50597,,5610,10116.0,,,BAO_0000218,
Cmax in rat,,1,CHEMBL620311,Intermediate,,,A,N,1,8548,,Rattus norvegicus,In vivo,,50597,,5207,10116.0,,,BAO_0000218,
Cmax in rat,,1,CHEMBL620312,Intermediate,,,A,N,1,8549,,Rattus norvegicus,In vivo,,50597,,6011,10116.0,,,BAO_0000218,
Cmax in rat,,1,CHEMBL620313,Intermediate,,,A,N,1,8550,,Rattus norvegicus,In vivo,,50597,,6504,10116.0,,,BAO_0000218,
Cmax in rat at 10 mg/kg,,1,CHEMBL620314,Intermediate,,,A,N,1,8551,,Rattus norvegicus,In vivo,,50597,,6046,10116.0,,,BAO_0000218,
Cmax in rat at the dose of 1 mg/kg i.v.,,1,CHEMBL620315,Intermediate,,,A,N,1,8552,,Rattus norvegicus,In vivo,,50597,,6504,10116.0,,,BAO_0000218,
Cmax in rat by po administration at a dose of 40 mg/kg,,1,CHEMBL620316,Intermediate,,,A,N,1,8553,,Rattus norvegicus,In vivo,,50597,,5874,10116.0,,,BAO_0000218,
Cmax in rat p.o. at 20 mg/kg concentration,,1,CHEMBL620317,Intermediate,,,A,N,1,8554,,Rattus norvegicus,In vivo,,50597,,17686,10116.0,,,BAO_0000218,
Cmax in rats,,1,CHEMBL620318,Intermediate,,,A,N,1,8555,,Rattus norvegicus,In vivo,,50597,,5836,10116.0,,,BAO_0000218,
Cmax in rats,,1,CHEMBL620319,Intermediate,,,A,N,1,8556,,Rattus norvegicus,In vivo,,50597,,17596,10116.0,,,BAO_0000218,
Cmax was evaluated after 20 uM/kg of peroral administration,,1,CHEMBL620320,Intermediate,,,A,N,1,8557,,Rattus norvegicus,In vivo,,50597,,16423,10116.0,,,BAO_0000218,
Cmax was measured in rats after peroral administration at 3 mg/kg,,1,CHEMBL620321,Intermediate,,,A,N,1,8558,,Rattus norvegicus,In vivo,,50597,,17804,10116.0,,,BAO_0000218,
Cmax value after oral dose at a dose of 10 mg/kg in rats.,,1,CHEMBL620322,Intermediate,,,A,N,1,8559,,Rattus norvegicus,In vivo,,50597,,1908,10116.0,,,BAO_0000218,
Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620323,Intermediate,,,A,N,1,8560,,Rattus norvegicus,,,50597,,13950,10116.0,,,BAO_0000218,
Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620324,Intermediate,,,A,N,1,8561,1870.0,Rattus norvegicus,,,50597,,13950,10116.0,,Frontal cortex,BAO_0000218,
Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620325,Intermediate,,,A,N,1,8562,1870.0,Rattus norvegicus,,,50597,,13950,10116.0,,Frontal cortex,BAO_0000218,
Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620326,Intermediate,,,A,N,1,8563,10000000.0,Rattus norvegicus,,,50597,,13950,10116.0,,Hippocampus,BAO_0000218,
Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620327,Intermediate,,,A,N,1,8564,10000000.0,Rattus norvegicus,,,50597,,13950,10116.0,,Hippocampus,BAO_0000218,
Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620328,Intermediate,,,A,N,1,8565,,Rattus norvegicus,,,50597,,13950,10116.0,,,BAO_0000218,
Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620329,Intermediate,,,A,N,1,8566,,Rattus norvegicus,,,50597,,13950,10116.0,,,BAO_0000218,
Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620330,Intermediate,,,A,N,1,8567,1891.0,Rattus norvegicus,,,50597,,13950,10116.0,,Midbrain,BAO_0000218,
Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL875286,Intermediate,,,A,N,1,8568,1891.0,Rattus norvegicus,,,50597,,13950,10116.0,,Midbrain,BAO_0000218,
Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620331,Intermediate,,,A,N,1,8569,,Rattus norvegicus,,,50597,,13950,10116.0,,,BAO_0000218,
Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620332,Intermediate,,,A,N,1,8570,,Rattus norvegicus,,,50597,,13950,10116.0,,,BAO_0000218,
Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620333,Intermediate,,,A,N,1,8571,2435.0,Rattus norvegicus,,,50597,,13950,10116.0,,Striatum,BAO_0000218,
Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,CHEMBL620334,Intermediate,,,A,N,1,8572,2435.0,Rattus norvegicus,,,50597,,13950,10116.0,,Striatum,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL621015,Intermediate,,,A,N,1,8573,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL621016,Intermediate,,,A,N,1,8574,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL621191,Intermediate,,,A,N,1,8575,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL621192,Intermediate,,,A,N,1,8576,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL621193,Intermediate,,,A,N,1,8577,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL621194,Intermediate,,,A,N,1,8578,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL624204,Intermediate,,,A,N,1,8579,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL624205,Intermediate,,,A,N,1,8580,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL624206,Intermediate,,,A,N,1,8581,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL624207,Intermediate,,,A,N,1,8582,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL624208,Intermediate,,,A,N,1,8583,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL624209,Intermediate,,,A,N,1,8584,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL624210,Intermediate,,,A,N,1,8585,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL624211,Intermediate,,,A,N,1,8586,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL624212,Intermediate,,,A,N,1,8587,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL624213,Intermediate,,,A,N,1,8588,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL876611,Intermediate,,,A,N,1,8589,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL624214,Intermediate,,,A,N,1,8590,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL624215,Intermediate,,,A,N,1,8591,178.0,Rattus norvegicus,,,50597,,16434,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL624216,Intermediate,,,A,N,1,8592,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL624217,Intermediate,,,A,N,1,8593,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL624218,Intermediate,,,A,N,1,8594,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL624219,Intermediate,,,A,N,1,8595,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL624220,Intermediate,,,A,N,1,8596,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL624221,Intermediate,,,A,N,1,8597,178.0,Rattus norvegicus,,,50597,,16435,10116.0,,Blood,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL624222,Intermediate,,,A,N,1,8598,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL624223,Intermediate,,,A,N,1,8599,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL624224,Intermediate,,,A,N,1,8600,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL624225,Intermediate,,,A,N,1,8601,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,1,CHEMBL622420,Intermediate,,,A,N,1,8602,,Rattus norvegicus,In vivo,,50597,,17764,10116.0,,,BAO_0000218,
Volume of steady state distribution after i.v. administration in rats,,1,CHEMBL622421,Intermediate,,,A,N,1,8603,,Rattus norvegicus,In vivo,,50597,,5031,10116.0,,,BAO_0000218,
Vss after intravenous administration (5.0 mg/kg) was determined in rat,,1,CHEMBL622422,Intermediate,,,A,N,1,8604,,Rattus norvegicus,In vivo,,50597,,6215,10116.0,,,BAO_0000218,
Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,1,CHEMBL622423,Intermediate,,,A,N,1,8605,,Rattus norvegicus,In vivo,,50597,,17671,10116.0,,,BAO_0000218,
Vss was determined,,1,CHEMBL622424,Intermediate,,,A,N,1,8606,,Rattus norvegicus,In vivo,,50597,,17752,10116.0,,,BAO_0000218,
Vss in rat,,1,CHEMBL622425,Intermediate,,,A,N,1,8607,,Rattus norvegicus,In vivo,,50597,,6596,10116.0,,,BAO_0000218,
Vss was evaluated after 10 uM/kg of intra arterial administration,,1,CHEMBL876612,Intermediate,,,A,N,1,8608,,Rattus norvegicus,In vivo,,50597,,16423,10116.0,,,BAO_0000218,
volume of distribution at steady state was observed after intravenous administration in rat,,1,CHEMBL622426,Intermediate,,,A,N,1,8609,,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,,BAO_0000218,
Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,1,CHEMBL622427,Intermediate,,,A,N,1,8610,,Rattus norvegicus,In vivo,,50597,,6062,10116.0,,,BAO_0000218,
Pharmacokinetic (PK) parameter Vz in rat,,1,CHEMBL622428,Intermediate,,,A,N,1,8611,,Rattus norvegicus,In vivo,,50597,,5874,10116.0,,,BAO_0000218,
Volume distribution in rats,,1,CHEMBL622429,Intermediate,,,A,N,1,8612,,Rattus norvegicus,In vivo,,50597,,4942,10116.0,,,BAO_0000218,
Volume of distribution in rat; No data,,1,CHEMBL622430,Intermediate,,,A,N,1,8613,,Rattus norvegicus,In vivo,,50597,,17796,10116.0,,,BAO_0000218,
Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,1,CHEMBL622431,Intermediate,,,A,N,1,8614,,Rattus norvegicus,In vivo,,50597,,4890,10116.0,,,BAO_0000218,
% absorption predicted from in vitro rat ileum transport studies,,1,CHEMBL622432,Intermediate,,,A,N,1,8615,2116.0,Rattus norvegicus,,,50597,,15765,10116.0,,Ileum,BAO_0000218,
Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,1,CHEMBL622433,Intermediate,,,A,N,1,8616,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,1,CHEMBL622434,Intermediate,,,A,N,1,8617,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,1,CHEMBL622435,Intermediate,,,A,N,1,8618,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,1,CHEMBL618748,Intermediate,,,A,N,1,8619,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,1,CHEMBL618749,Intermediate,,,A,N,1,8620,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,1,CHEMBL618750,Intermediate,,,A,N,1,8621,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,1,CHEMBL618751,Intermediate,,,A,N,1,8622,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,1,CHEMBL618752,Intermediate,,,A,N,1,8623,,Rattus norvegicus,In vivo,,50597,,13569,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL618753,Intermediate,,,A,N,1,8624,,Rattus norvegicus,In vivo,,50597,,4576,10116.0,,,BAO_0000218,
Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,1,CHEMBL618754,Intermediate,,,A,N,1,8625,1969.0,Rattus norvegicus,In vivo,,50597,,750,10116.0,,Plasma,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL618755,Intermediate,,,A,N,1,8626,,Rattus norvegicus,In vivo,,50597,,750,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL618756,Intermediate,,,A,N,1,8627,,Rattus norvegicus,In vivo,,50597,,4590,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL618757,Intermediate,,,A,N,1,8628,,Rattus norvegicus,In vivo,,50597,,1716,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL618758,Intermediate,,,A,N,1,8629,,Rattus norvegicus,In vivo,,50597,,1974,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 30 mg/kg),,1,CHEMBL621088,Intermediate,,,A,N,1,8630,,Rattus norvegicus,In vivo,,50597,,4502,10116.0,,,BAO_0000218,
Pharmacokinetic property (cLogP) in rat,,1,CHEMBL621089,Intermediate,,,A,N,1,8631,,Rattus norvegicus,,,50597,,3371,10116.0,,,BAO_0000218,
Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,1,CHEMBL621090,Intermediate,,,F,N,1,8632,178.0,Rattus norvegicus,,,50597,,9099,10116.0,,Blood,BAO_0000218,
Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,1,CHEMBL621091,Intermediate,,,F,N,1,8633,178.0,Rattus norvegicus,,,50597,,9099,10116.0,,Blood,BAO_0000218,
Clearance in rat.,,1,CHEMBL876731,Intermediate,,,A,N,1,8634,,Rattus norvegicus,In vivo,,50597,,4590,10116.0,,,BAO_0000218,
Compound was evaluated for its clearance when administered intravenously in rat,,1,CHEMBL621092,Intermediate,,,A,N,1,8635,,Rattus norvegicus,In vivo,,50597,,3184,10116.0,,,BAO_0000218,
Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,1,CHEMBL621093,Intermediate,,,A,N,1,8636,,Rattus norvegicus,In vivo,,50597,,16456,10116.0,,,BAO_0000218,
Blood: Brain distribution ratio is determined in rat,,1,CHEMBL621094,Intermediate,,,A,N,1,8637,,Rattus norvegicus,,,50597,,4199,10116.0,,,BAO_0000218,
Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,1,CHEMBL621095,Intermediate,,,A,N,1,8638,,Rattus norvegicus,,,50597,,4199,10116.0,,,BAO_0000218,
Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,1,CHEMBL621096,Intermediate,,,A,N,1,8639,,Rattus norvegicus,,,50597,,4199,10116.0,,,BAO_0000218,
"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL621097,Intermediate,,,A,N,1,8640,2113.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Kidney,BAO_0000218,
Percent dose excreted in 0-48 hours administered ip to male rat,,1,CHEMBL621098,Intermediate,,,F,N,1,8641,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621099,Intermediate,,,A,N,1,8642,2037.0,Rattus norvegicus,,,50597,,11977,10116.0,,Cerebellum,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621100,Intermediate,,,A,N,1,8643,2037.0,Rattus norvegicus,,,50597,,11977,10116.0,,Cerebellum,BAO_0000218,
Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL621101,Intermediate,,,A,N,1,8644,2037.0,Rattus norvegicus,,,50597,,11977,10116.0,,Cerebellum,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621102,Intermediate,,,A,N,1,8645,2037.0,Rattus norvegicus,,,50597,,11977,10116.0,,Cerebellum,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL876732,Intermediate,,,A,N,1,8646,2037.0,Rattus norvegicus,,,50597,,11977,10116.0,,Cerebellum,BAO_0000218,
Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621103,Intermediate,,,A,N,1,8647,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621104,Intermediate,,,A,N,1,8648,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL621105,Intermediate,,,A,N,1,8649,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621106,Intermediate,,,A,N,1,8650,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621107,Intermediate,,,A,N,1,8651,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621108,Intermediate,,,A,N,1,8652,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621109,Intermediate,,,A,N,1,8653,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL621110,Intermediate,,,A,N,1,8654,2113.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Kidney,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL621111,Intermediate,,,A,N,1,8655,2113.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Kidney,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,1,CHEMBL622541,Intermediate,,,A,N,1,8656,2107.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Liver,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL622542,Intermediate,,,A,N,1,8657,2107.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Liver,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL622543,Intermediate,,,A,N,1,8658,2107.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Liver,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624412,Intermediate,,,A,N,1,8659,2107.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Liver,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624413,Intermediate,,,A,N,1,8660,2107.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Liver,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624414,Intermediate,,,A,N,1,8661,2107.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Liver,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624415,Intermediate,,,A,N,1,8662,2048.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Lung,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624416,Intermediate,,,A,N,1,8663,2048.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Lung,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624417,Intermediate,,,A,N,1,8664,2048.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Lung,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624418,Intermediate,,,A,N,1,8665,2048.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Lung,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624419,Intermediate,,,A,N,1,8666,2048.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Lung,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624420,Intermediate,,,A,N,1,8667,2048.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Lung,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624421,Intermediate,,,A,N,1,8668,2385.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624422,Intermediate,,,A,N,1,8669,2385.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL624423,Intermediate,,,A,N,1,8670,2385.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL625123,Intermediate,,,A,N,1,8671,2385.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL625124,Intermediate,,,A,N,1,8672,2385.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL625125,Intermediate,,,A,N,1,8673,2385.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,1,CHEMBL625126,Intermediate,,,A,N,1,8674,14.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Zone of skin,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626947,Intermediate,,,A,N,1,8675,14.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Zone of skin,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626948,Intermediate,,,A,N,1,8676,14.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Zone of skin,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626949,Intermediate,,,A,N,1,8677,14.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Zone of skin,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626950,Intermediate,,,A,N,1,8678,14.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Zone of skin,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626951,Intermediate,,,A,N,1,8679,14.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Zone of skin,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626952,Intermediate,,,A,N,1,8680,2106.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Spleen,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626953,Intermediate,,,A,N,1,8681,2106.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Spleen,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626954,Intermediate,,,A,N,1,8682,2106.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Spleen,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626955,Intermediate,,,A,N,1,8683,2106.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Spleen,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626956,Intermediate,,,A,N,1,8684,2106.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Spleen,BAO_0000218,
Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626957,Intermediate,,,A,N,1,8685,2106.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Spleen,BAO_0000218,
Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626958,Intermediate,,,A,N,1,8686,178.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Blood,BAO_0000218,
Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626959,Intermediate,,,A,N,1,8687,178.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Blood,BAO_0000218,
Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626960,Intermediate,,,A,N,1,8688,178.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Blood,BAO_0000218,
Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL626961,Intermediate,,,A,N,1,8689,178.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Blood,BAO_0000218,
Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627589,Intermediate,,,A,N,1,8690,178.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Blood,BAO_0000218,
Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,1,CHEMBL627590,Intermediate,,,A,N,1,8691,178.0,Mus musculus,In vivo,,50594,,17208,10090.0,,Blood,BAO_0000218,
Time taken for EC90 was determined when tested in mouse,,1,CHEMBL627591,Intermediate,,,A,N,1,8692,,Mus musculus,,,50594,,3132,10090.0,,,BAO_0000218,
Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,1,CHEMBL627592,Intermediate,,,A,N,1,8693,,Mus musculus,,,50594,,3132,10090.0,,,BAO_0000218,
At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,1,CHEMBL627593,Intermediate,,,A,N,1,8694,,Mus musculus,In vivo,,50594,,16597,10090.0,,,BAO_0000218,
Half life in mice,,1,CHEMBL627594,Intermediate,,,A,N,1,8695,,Mus musculus,,,50594,,5727,10090.0,,,BAO_0000218,
Half life period in mouse after 10 mg/Kg dose,,1,CHEMBL876813,Intermediate,,,A,N,1,8696,,Mus musculus,In vivo,,50594,,5302,10090.0,,,BAO_0000218,
Half life period in mouse after 10 mg/kg dose,,1,CHEMBL627595,Intermediate,,,A,N,1,8697,,Mus musculus,In vivo,,50594,,5302,10090.0,,,BAO_0000218,
Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,1,CHEMBL627596,Intermediate,,,A,N,1,8698,,Mus musculus,In vivo,,50594,,6348,10090.0,,,BAO_0000218,
Cmax value at 5 mg/kg po was determined in rat,,1,CHEMBL627597,Intermediate,,,A,N,1,8699,,Rattus norvegicus,In vivo,,50597,,5964,10116.0,,,BAO_0000218,
Cmax value evaluated in rat,,1,CHEMBL627598,Intermediate,,,A,N,1,8700,,Rattus norvegicus,In vivo,,50597,,6078,10116.0,,,BAO_0000218,
Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,1,CHEMBL627599,Intermediate,,,A,N,1,8701,955.0,Rattus norvegicus,In vivo,,50597,,5206,10116.0,,Brain,BAO_0000218,
Cmax value after administration of 20 mg/Kg oral dose in rat,,1,CHEMBL627600,Intermediate,,,A,N,1,8702,,Rattus norvegicus,In vivo,,50597,,2959,10116.0,,,BAO_0000218,
Cmax value at 1 mg/kg po in rat,,1,CHEMBL627601,Intermediate,,,A,N,1,8703,,Rattus norvegicus,In vivo,,50597,,5964,10116.0,,,BAO_0000218,
Cmax value at 5 mg/kg po in rat,,1,CHEMBL627776,Intermediate,,,A,N,1,8704,,Rattus norvegicus,In vivo,,50597,,5964,10116.0,,,BAO_0000218,
Cmax value at a dose of 10 mg/kg in male SD rats,,1,CHEMBL627777,Intermediate,,,A,N,1,8705,,Rattus norvegicus,In vivo,,50597,,6757,10116.0,,,BAO_0000218,
Cmax value at a dose of 100 mg/kg in male SD rats,,1,CHEMBL627778,Intermediate,,,A,N,1,8706,,Rattus norvegicus,In vivo,,50597,,6757,10116.0,,,BAO_0000218,
Cmax value at a dose of 50 mg/kg in male SD rats,,1,CHEMBL627779,Intermediate,,,A,N,1,8707,,Rattus norvegicus,In vivo,,50597,,6757,10116.0,,,BAO_0000218,
Cmax value in rats at 10 mg/kg,,1,CHEMBL876814,Intermediate,,,A,N,1,8708,,Rattus norvegicus,In vivo,,50597,,17617,10116.0,,,BAO_0000218,
Cmax value was evaluated in rats at a dose of 20 mg/kg,,1,CHEMBL627780,Intermediate,,,A,N,1,8709,,Rattus norvegicus,In vivo,,50597,,1445,10116.0,,,BAO_0000218,
Cmax value was determined after peroral administration of 20 mg/kg in rat,,1,CHEMBL627781,Intermediate,,,A,N,1,8710,,Rattus norvegicus,In vivo,,50597,,6082,10116.0,,,BAO_0000218,
Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,1,CHEMBL627782,Intermediate,,,A,N,1,8711,,Rattus norvegicus,In vivo,,50597,,1446,10116.0,,,BAO_0000218,
Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,1,CHEMBL627783,Intermediate,,,A,N,1,8712,1969.0,Rattus norvegicus,In vivo,,50597,,5407,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,1,CHEMBL627784,Intermediate,,,A,N,1,8713,1969.0,Rattus norvegicus,In vivo,,50597,,2690,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,1,CHEMBL627785,Intermediate,,,A,N,1,8714,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,1,CHEMBL627786,Intermediate,,,A,N,1,8715,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,1,CHEMBL627787,Intermediate,,,A,N,1,8716,1969.0,Rattus norvegicus,In vivo,,50597,,4891,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,1,CHEMBL627788,Intermediate,,,A,N,1,8717,1969.0,Rattus norvegicus,In vivo,,50597,,2807,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,1,CHEMBL626579,Intermediate,,,A,N,1,8718,1969.0,Rattus norvegicus,In vivo,,50597,,2807,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,1,CHEMBL626580,Intermediate,,,A,N,1,8719,1969.0,Rattus norvegicus,In vivo,,50597,,2807,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,1,CHEMBL876815,Intermediate,,,A,N,1,8720,,Rattus norvegicus,In vivo,,50597,,3634,10116.0,,,BAO_0000218,
Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,1,CHEMBL626581,Intermediate,,,A,N,1,8721,1969.0,Rattus norvegicus,In vivo,,50597,,1881,10116.0,,Plasma,BAO_0000218,
Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,1,CHEMBL626582,Intermediate,,,A,N,1,8722,1969.0,Rattus norvegicus,In vivo,,50597,,1881,10116.0,,Plasma,BAO_0000218,
Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,1,CHEMBL626583,Intermediate,,,A,N,1,8723,,Rattus norvegicus,In vivo,,50597,,429,10116.0,,,BAO_0000218,
In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL626205,Intermediate,,,A,N,1,8724,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL626206,Intermediate,,,A,N,1,8725,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL626207,Intermediate,,,A,N,1,8726,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL623882,Intermediate,,,A,N,1,8727,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,1,CHEMBL623883,Intermediate,,,A,N,1,8728,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,1,CHEMBL623884,Intermediate,,,A,N,1,8729,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,1,CHEMBL623885,Intermediate,,,A,N,1,8730,1969.0,Rattus norvegicus,In vivo,,50597,,3032,10116.0,,Plasma,BAO_0000218,
In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,1,CHEMBL623886,Intermediate,,,A,N,1,8731,1969.0,Rattus norvegicus,In vivo,,50597,,6295,10116.0,,Plasma,BAO_0000218,
Maximal concentration in rat was determined,,1,CHEMBL623887,Intermediate,,,A,N,1,8732,,Rattus norvegicus,In vivo,,50597,,6619,10116.0,,,BAO_0000218,
Maximal concentration after i.v. administration,,1,CHEMBL623888,Intermediate,,,A,N,1,8733,,Rattus norvegicus,In vivo,,50597,,6616,10116.0,,,BAO_0000218,
Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,1,CHEMBL623889,Intermediate,,,A,N,1,8734,1969.0,Rattus norvegicus,In vivo,,50597,,3249,10116.0,,Plasma,BAO_0000218,
Maximal plasma concentration in rat after oral administration at 50 mg/kg,,1,CHEMBL623890,Intermediate,,,A,N,1,8735,1969.0,Rattus norvegicus,In vivo,,50597,,17791,10116.0,,Plasma,BAO_0000218,
Cmax in rat plasma after oral dose (50 mg/Kg),,1,CHEMBL623891,Intermediate,,,A,N,1,8736,1969.0,Rattus norvegicus,In vivo,,50597,,17791,10116.0,,Plasma,BAO_0000218,
Maximal plasma concentration was determined.,,1,CHEMBL623892,Intermediate,,,A,N,1,8737,1969.0,Rattus norvegicus,In vivo,,50597,,1360,10116.0,,Plasma,BAO_0000218,
Maximal plasma drug concentration was determined,,1,CHEMBL623893,Intermediate,,,A,N,1,8738,1969.0,Rattus norvegicus,In vivo,,50597,,2552,10116.0,,Plasma,BAO_0000218,
Maximal concentration in rats after peroral administration,,1,CHEMBL877616,Intermediate,,,A,N,1,8739,,Rattus norvegicus,In vivo,,50597,,6571,10116.0,,,BAO_0000218,
Maximum concentration in rat after 2 mg/kg peroral administration,,1,CHEMBL623894,Intermediate,,,A,N,1,8740,,Rattus norvegicus,In vivo,,50597,,6570,10116.0,,,BAO_0000218,
Maximum concentration in rat plasma after 5 mg/kg oral gavage,,1,CHEMBL623895,Intermediate,,,A,N,1,8741,1969.0,Rattus norvegicus,In vivo,,50597,,6567,10116.0,,Plasma,BAO_0000218,
Maximum concentration of compound in rat was evaluated.,,1,CHEMBL623896,Intermediate,,,A,N,1,8742,,Rattus norvegicus,In vivo,,50597,,3031,10116.0,,,BAO_0000218,
Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,1,CHEMBL623897,Intermediate,,,A,N,1,8743,,Rattus norvegicus,In vivo,,50597,,3436,10116.0,,,BAO_0000218,
Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,1,CHEMBL623898,Intermediate,,,A,N,1,8744,,Rattus norvegicus,In vivo,,50597,,3436,10116.0,,,BAO_0000218,
Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,1,CHEMBL623899,Intermediate,,,A,N,1,8745,,Rattus norvegicus,In vivo,,50597,,2083,10116.0,,,BAO_0000218,
Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,1,CHEMBL623900,Intermediate,,,A,N,1,8746,,Rattus norvegicus,In vivo,,50597,,3436,10116.0,,,BAO_0000218,
Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,1,CHEMBL623901,Intermediate,,,A,N,1,8747,,Rattus norvegicus,In vivo,,50597,,4527,10116.0,,,BAO_0000218,
Maximum concentration was evaluated in rats,,1,CHEMBL623902,Intermediate,,,A,N,1,8748,,Rattus norvegicus,In vivo,,50597,,1974,10116.0,,,BAO_0000218,
Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,1,CHEMBL623903,Intermediate,,,A,N,1,8749,1359.0,Rattus norvegicus,In vivo,,50597,,3307,10116.0,,Cerebrospinal fluid,BAO_0000218,
Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,1,CHEMBL623904,Intermediate,,,A,N,1,8750,1969.0,Rattus norvegicus,In vivo,,50597,,3307,10116.0,,Plasma,BAO_0000218,
Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,1,CHEMBL877617,Intermediate,,,A,N,1,8751,1969.0,Rattus norvegicus,In vivo,,50597,,1916,10116.0,,Plasma,BAO_0000218,
Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,1,CHEMBL623905,Intermediate,,,A,N,1,8752,,Rattus norvegicus,In vivo,,50597,,1500,10116.0,,,BAO_0000218,
Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,1,CHEMBL623906,Intermediate,,,A,N,1,8753,,Rattus norvegicus,In vivo,,50597,,1500,10116.0,,,BAO_0000218,
Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,1,CHEMBL623907,Intermediate,,,A,N,1,8754,1969.0,Rattus norvegicus,In vivo,,50597,,4186,10116.0,,Plasma,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL623908,Intermediate,,,A,N,1,8755,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL623909,Intermediate,,,A,N,1,8756,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL623910,Intermediate,,,A,N,1,8757,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL623911,Intermediate,,,A,N,1,8758,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL623912,Intermediate,,,A,N,1,8759,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL624616,Intermediate,,,A,N,1,8760,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL624617,Intermediate,,,A,N,1,8761,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL624618,Intermediate,,,A,N,1,8762,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL624619,Intermediate,,,A,N,1,8763,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL624794,Intermediate,,,A,N,1,8764,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL624795,Intermediate,,,A,N,1,8765,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL623921,Intermediate,,,A,N,1,8766,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL623922,Intermediate,,,A,N,1,8767,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL623923,Intermediate,,,A,N,1,8768,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL623924,Intermediate,,,A,N,1,8769,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL623925,Intermediate,,,A,N,1,8770,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL623926,Intermediate,,,A,N,1,8771,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL623927,Intermediate,,,A,N,1,8772,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL623928,Intermediate,,,A,N,1,8773,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL623929,Intermediate,,,A,N,1,8774,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL623930,Intermediate,,,A,N,1,8775,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL623931,Intermediate,,,A,N,1,8776,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL622165,Intermediate,,,A,N,1,8777,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL621249,Intermediate,,,A,N,1,8778,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL621250,Intermediate,,,A,N,1,8779,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL621448,Intermediate,,,A,N,1,8780,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL621449,Intermediate,,,A,N,1,8781,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL621450,Intermediate,,,A,N,1,8782,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL621451,Intermediate,,,A,N,1,8783,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL621452,Intermediate,,,A,N,1,8784,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL621453,Intermediate,,,A,N,1,8785,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL621454,Intermediate,,,A,N,1,8786,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL621455,Intermediate,,,A,N,1,8787,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL621456,Intermediate,,,A,N,1,8788,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL625145,Intermediate,,,A,N,1,8789,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL875847,Intermediate,,,A,N,1,8790,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL625146,Intermediate,,,A,N,1,8791,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL625147,Intermediate,,,A,N,1,8792,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL625148,Intermediate,,,A,N,1,8793,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL625149,Intermediate,,,A,N,1,8794,955.0,Rattus norvegicus,,,50597,,16434,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL625150,Intermediate,,,A,N,1,8795,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL625151,Intermediate,,,A,N,1,8796,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL625152,Intermediate,,,A,N,1,8797,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL625153,Intermediate,,,A,N,1,8798,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL625154,Intermediate,,,A,N,1,8799,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL625155,Intermediate,,,A,N,1,8800,955.0,Rattus norvegicus,,,50597,,16435,10116.0,,Brain,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL625156,Intermediate,,,A,N,1,8801,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624354,Intermediate,,,A,N,1,8802,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624355,Intermediate,,,A,N,1,8803,10000000.0,Rattus norvegicus,,,50597,,11977,10116.0,,Hippocampus,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624356,Intermediate,,,A,N,1,8804,10000000.0,Rattus norvegicus,,,50597,,11977,10116.0,,Hippocampus,BAO_0000218,
Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624357,Intermediate,,,A,N,1,8805,10000000.0,Rattus norvegicus,,,50597,,11977,10116.0,,Hippocampus,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624358,Intermediate,,,A,N,1,8806,10000000.0,Rattus norvegicus,,,50597,,11977,10116.0,,Hippocampus,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624359,Intermediate,,,A,N,1,8807,2435.0,Rattus norvegicus,,,50597,,11977,10116.0,,Striatum,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624360,Intermediate,,,A,N,1,8808,2435.0,Rattus norvegicus,,,50597,,11977,10116.0,,Striatum,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL624361,Intermediate,,,A,N,1,8809,2435.0,Rattus norvegicus,,,50597,,11977,10116.0,,Striatum,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624362,Intermediate,,,A,N,1,8810,2435.0,Rattus norvegicus,,,50597,,11977,10116.0,,Striatum,BAO_0000218,
Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624363,Intermediate,,,A,N,1,8811,2435.0,Rattus norvegicus,,,50597,,11977,10116.0,,Striatum,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624364,Intermediate,,,A,N,1,8812,178.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Blood,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624365,Intermediate,,,A,N,1,8813,178.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Blood,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624366,Intermediate,,,A,N,1,8814,178.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Blood,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624367,Intermediate,,,A,N,1,8815,178.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Blood,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624368,Intermediate,,,A,N,1,8816,955.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Brain,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL624369,Intermediate,,,A,N,1,8817,955.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Brain,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL624370,Intermediate,,,A,N,1,8818,955.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Brain,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625069,Intermediate,,,A,N,1,8819,955.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Brain,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625070,Intermediate,,,A,N,1,8820,955.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Brain,BAO_0000218,
Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL626051,Intermediate,,,A,N,1,8821,948.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Heart,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL626052,Intermediate,,,A,N,1,8822,948.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Heart,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL626053,Intermediate,,,A,N,1,8823,948.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Heart,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL626054,Intermediate,,,A,N,1,8824,948.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Heart,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL626055,Intermediate,,,A,N,1,8825,948.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Heart,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL626056,Intermediate,,,A,N,1,8826,2113.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Kidney,BAO_0000218,
Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL626057,Intermediate,,,A,N,1,8827,2113.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Kidney,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625193,Intermediate,,,A,N,1,8828,2113.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Kidney,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625194,Intermediate,,,A,N,1,8829,2113.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Kidney,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625195,Intermediate,,,A,N,1,8830,2107.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Liver,BAO_0000218,
Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625196,Intermediate,,,A,N,1,8831,2107.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Liver,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL625197,Intermediate,,,A,N,1,8832,2107.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Liver,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625198,Intermediate,,,A,N,1,8833,2107.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Liver,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL627929,Intermediate,,,A,N,1,8834,2107.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Liver,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL627074,Intermediate,,,A,N,1,8835,2048.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Lung,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL627075,Intermediate,,,A,N,1,8836,2048.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Lung,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL627076,Intermediate,,,A,N,1,8837,2048.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Lung,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL627077,Intermediate,,,A,N,1,8838,2048.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Lung,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL627078,Intermediate,,,A,N,1,8839,2048.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Lung,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL627079,Intermediate,,,A,N,1,8840,2385.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Muscle tissue,BAO_0000218,
Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,1,CHEMBL873824,Intermediate,,,A,N,1,8841,,Mus musculus,In vivo,,50594,,4573,10090.0,,,BAO_0000218,
Half life in mouse plasma was determined at dose 25 mg/kg,,1,CHEMBL627080,Intermediate,,,A,N,1,8842,1969.0,Mus musculus,In vivo,,50594,,3132,10090.0,,Plasma,BAO_0000218,
Half life was determined,,1,CHEMBL627081,Intermediate,,,A,N,1,8843,,Mus musculus,,,50594,,17718,10090.0,,,BAO_0000218,
Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,1,CHEMBL627082,Intermediate,,,A,N,1,8844,,Mus musculus,In vivo,,50594,,17728,10090.0,,,BAO_0000218,
Half-life in male mice after 1 mg/kg intravenous dose,,1,CHEMBL627083,Intermediate,,,A,N,1,8845,,Mus musculus,In vivo,,50594,,5961,10090.0,,,BAO_0000218,
Half life in mice plasma,,1,CHEMBL627085,Intermediate,,,A,N,1,8847,1969.0,Mus musculus,,,50594,,17731,10090.0,,Plasma,BAO_0000218,
Half life in mouse,,1,CHEMBL627086,Intermediate,,,A,N,1,8848,,Mus musculus,,,50594,,17592,10090.0,,,BAO_0000218,
Half life in mouse plasma at dose 25 mg/kg,,1,CHEMBL627087,Intermediate,,,A,N,1,8849,1969.0,Mus musculus,In vivo,,50594,,3132,10090.0,,Plasma,BAO_0000218,
Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,1,CHEMBL627088,Intermediate,,,A,N,1,8850,,Mus musculus,In vivo,,50594,,17729,10090.0,,,BAO_0000218,
Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,1,CHEMBL627089,Intermediate,,,A,N,1,8851,,Mus musculus,In vivo,,50594,,17729,10090.0,,,BAO_0000218,
Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,1,CHEMBL627090,Intermediate,,,A,N,1,8852,,Mus musculus,In vivo,,50594,,17729,10090.0,,,BAO_0000218,
Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,1,CHEMBL627091,Intermediate,,,A,N,1,8853,,Mus musculus,In vivo,,50594,,3277,10090.0,,,BAO_0000218,
"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,1,CHEMBL627092,Intermediate,,,A,N,1,8854,,Mus musculus,In vivo,,50594,,3760,10090.0,,,BAO_0000218,
"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,1,CHEMBL876785,Intermediate,,,A,N,1,8855,,Mus musculus,In vivo,,50594,,3760,10090.0,,,BAO_0000218,
Half-life by iv administration in mouse,,1,CHEMBL627093,Intermediate,,,A,N,1,8856,,Mus musculus,In vivo,,50594,,2862,10090.0,,,BAO_0000218,
Half-life by oral administration in mouse,,1,CHEMBL627094,Intermediate,,,A,N,1,8857,,Mus musculus,In vivo,,50594,,2862,10090.0,,,BAO_0000218,
Half-life in mice,,1,CHEMBL627095,Intermediate,,,A,N,1,8858,,Mus musculus,,,50594,,5980,10090.0,,,BAO_0000218,
Half-life using mouse brain homogenate,,1,CHEMBL627096,Intermediate,,,A,N,1,8859,955.0,Mus musculus,,,50594,,6159,10090.0,,Brain,BAO_0000218,
Half-life was measured in mice,,1,CHEMBL627097,Intermediate,,,A,N,1,8860,,Mus musculus,,,50594,,6254,10090.0,,,BAO_0000218,
Half-life was measured in mouse after an iv dose of 1 mg/kg,,1,CHEMBL627098,Intermediate,,,A,N,1,8861,,Mus musculus,In vivo,,50594,,6062,10090.0,,,BAO_0000218,
Half-life period was determined in mouse blood,,1,CHEMBL627099,Intermediate,,,A,N,1,8862,178.0,Mus musculus,,,50594,,1574,10090.0,,Blood,BAO_0000218,
"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,1,CHEMBL627100,Intermediate,,,A,N,1,8863,955.0,Mus musculus,,,50594,,56,10090.0,,Brain,BAO_0000218,
Plasma half life in mouse,,1,CHEMBL627101,Intermediate,,,A,N,1,8864,1969.0,Mus musculus,,,50594,,993,10090.0,,Plasma,BAO_0000218,
Stability of the peptide in the presence of mouse serum,,1,CHEMBL627102,Intermediate,,,A,N,1,8865,,Mus musculus,,,50594,,6652,10090.0,,,BAO_0000218,
Terminal half life of compound was determined in mouse,,1,CHEMBL627103,Intermediate,,,A,N,1,8866,,Mus musculus,,,50594,,17852,10090.0,,,BAO_0000218,
Terminal half life was evaluated in mice after intravenous administration,,1,CHEMBL627104,Intermediate,,,A,N,1,8867,,Mus musculus,In vivo,,50594,,2675,10090.0,,,BAO_0000218,
Terminal half life was evaluated in mice after oral administration,,1,CHEMBL627105,Intermediate,,,A,N,1,8868,,Mus musculus,In vivo,,50594,,2675,10090.0,,,BAO_0000218,
The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,1,CHEMBL876786,Intermediate,,,A,N,1,8869,,Mus musculus,,,50594,,499,10090.0,,,BAO_0000218,
The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,1,CHEMBL873825,Intermediate,,,A,N,1,8870,,Mus musculus,,,50594,,499,10090.0,,,BAO_0000218,
The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,1,CHEMBL627106,Intermediate,,,A,N,1,8871,,Mus musculus,,,50594,,499,10090.0,,,BAO_0000218,
half life period is evaluated by administering intravenously at 25 mg/kg in mice,,1,CHEMBL626336,Intermediate,,,A,N,1,8872,,Mus musculus,In vivo,,50594,,14239,10090.0,,,BAO_0000218,
"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,1,CHEMBL877462,Intermediate,,,A,N,1,8873,,Mus musculus,In vivo,,50594,,5506,10090.0,,,BAO_0000218,
"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,1,CHEMBL626337,Intermediate,,,A,N,1,8874,,Mus musculus,In vivo,,50594,,5506,10090.0,,,BAO_0000218,
Half life after intraperitoneal administration of 100 mg/kg in mice,,1,CHEMBL626338,Intermediate,,,A,N,1,8875,,Mus musculus,,,50594,,17734,10090.0,,,BAO_0000218,
Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,1,CHEMBL626339,Intermediate,,,A,N,1,8876,,Mus musculus,In vivo,,50594,,17728,10090.0,,,BAO_0000218,
Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,1,CHEMBL626340,Intermediate,,,A,N,1,8877,,Mus musculus,In vivo,,50594,,17728,10090.0,,,BAO_0000218,
Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,1,CHEMBL625377,Intermediate,,,A,N,1,8878,,Mus musculus,In vivo,,50594,,17728,10090.0,,,BAO_0000218,
Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,1,CHEMBL625378,Intermediate,,,A,N,1,8879,,Mus musculus,In vivo,,50594,,17728,10090.0,,,BAO_0000218,
Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,1,CHEMBL625379,Intermediate,,,A,N,1,8880,,Mus musculus,In vivo,,50594,,17728,10090.0,,,BAO_0000218,
Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,0,CHEMBL625380,Autocuration,,,A,U,1,8881,,Sus scrofa,,,22224,,14294,9823.0,,,BAO_0000251,Microsomes
Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,0,CHEMBL625381,Autocuration,,,A,U,1,8882,,Sus scrofa,,,22224,,14294,9823.0,,,BAO_0000251,Microsomes
Stability to porcine renal DHP-I,,0,CHEMBL625382,Autocuration,,,A,U,1,8883,,Sus scrofa,,,22224,,6056,9823.0,,,BAO_0000019,
Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,0,CHEMBL873828,Autocuration,,,A,U,1,8884,,Sus scrofa,In vivo,,22224,,1317,9823.0,,,BAO_0000218,
Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,0,CHEMBL625383,Autocuration,,,A,U,1,8885,,Sus scrofa,In vivo,,22224,,1317,9823.0,,,BAO_0000218,
Half-life of the parent prodrug in porcine esterase solution,,0,CHEMBL625384,Autocuration,,,A,U,1,8886,,Sus scrofa,,,22224,,5229,9823.0,,,BAO_0000019,
"First order rate constant, k was determined in in pig liver Esterase",,0,CHEMBL625385,Autocuration,,,A,U,1,8887,,Sus scrofa,,,22224,,4231,9823.0,,,BAO_0000019,
Half life of the in pig liver Esterase,,0,CHEMBL625386,Autocuration,,,A,U,1,8888,2107.0,Sus scrofa,,,22224,,4231,9823.0,,Liver,BAO_0000221,
Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,0,CHEMBL623571,Autocuration,,,A,U,1,8889,2107.0,Sus scrofa,,,22224,,5318,9823.0,,Liver,BAO_0000221,
Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,0,CHEMBL623572,Autocuration,,,A,U,1,8890,2107.0,Sus scrofa,,,22224,,5318,9823.0,,Liver,BAO_0000221,
Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,0,CHEMBL623573,Autocuration,,,A,U,1,8891,2107.0,Sus scrofa,,,22224,,5318,9823.0,,Liver,BAO_0000221,
Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,0,CHEMBL623574,Autocuration,,,A,U,1,8892,2107.0,Sus scrofa,,,22224,,3305,9823.0,,Liver,BAO_0000221,
Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,0,CHEMBL623575,Autocuration,,,A,U,1,8893,2107.0,Sus scrofa,,,22224,,3305,9823.0,,Liver,BAO_0000221,
Half-life in the presence of pig liver esterase(PLE) was evaluated.,,0,CHEMBL623749,Autocuration,,,A,U,1,8894,2107.0,Sus scrofa,,,22224,,2842,9823.0,,Liver,BAO_0000221,
Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,0,CHEMBL623750,Autocuration,,,A,U,1,8895,2107.0,Sus scrofa,,,22224,,2842,9823.0,,Liver,BAO_0000221,
Half-life in vitro in pig liver,,0,CHEMBL623751,Autocuration,,,A,U,1,8896,2107.0,Sus scrofa,In vitro,,22224,,889,9823.0,,Liver,BAO_0000221,
Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,0,CHEMBL623752,Autocuration,,,A,U,1,8897,2107.0,Sus scrofa,,,22224,,1904,9823.0,,Liver,BAO_0000221,
Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,1,CHEMBL623753,Intermediate,,,A,N,1,8898,1969.0,Rattus norvegicus,In vivo,,50597,,4186,10116.0,,Plasma,BAO_0000218,
Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,1,CHEMBL623754,Intermediate,,,A,N,1,8899,1969.0,Rattus norvegicus,In vivo,,50597,,2774,10116.0,,Plasma,BAO_0000218,
Maximum concentration in rat plasma was determined,,1,CHEMBL623755,Intermediate,,,A,N,1,8900,1969.0,Rattus norvegicus,In vivo,,50597,,1742,10116.0,,Plasma,BAO_0000218,
Maximum concentration in rats,,1,CHEMBL623756,Intermediate,,,A,N,1,8901,,Rattus norvegicus,In vivo,,50597,,3169,10116.0,,,BAO_0000218,
Maximum concentration in rats at 1-2 hours,,1,CHEMBL623757,Intermediate,,,A,N,1,8902,,Rattus norvegicus,In vivo,,50597,,3169,10116.0,,,BAO_0000218,
Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,1,CHEMBL623758,Intermediate,,,A,N,1,8903,,Rattus norvegicus,In vivo,,50597,,2081,10116.0,,,BAO_0000218,
Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,1,CHEMBL623759,Intermediate,,,A,N,1,8904,955.0,Rattus norvegicus,In vivo,,50597,,3307,10116.0,,Brain,BAO_0000218,
Maximum concentration at the dose of 2 mg/kg in rat,,1,CHEMBL623760,Intermediate,,,A,N,1,8905,,Rattus norvegicus,In vivo,,50597,,4727,10116.0,,,BAO_0000218,
Maximum concentration was evaluated in rats,,1,CHEMBL623761,Intermediate,,,A,N,1,8906,,Rattus norvegicus,In vivo,,50597,,6597,10116.0,,,BAO_0000218,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,1,CHEMBL623762,Intermediate,,,A,N,1,8907,1969.0,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,Plasma,BAO_0000218,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,1,CHEMBL877594,Intermediate,,,A,N,1,8908,1969.0,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,Plasma,BAO_0000218,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,1,CHEMBL623763,Intermediate,,,A,N,1,8909,1969.0,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,Plasma,BAO_0000218,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,1,CHEMBL623764,Intermediate,,,A,N,1,8910,1969.0,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,Plasma,BAO_0000218,
Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,1,CHEMBL623765,Intermediate,,,A,N,1,8911,1969.0,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,Plasma,BAO_0000218,
Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,1,CHEMBL623766,Intermediate,,,A,N,1,8912,178.0,Rattus norvegicus,In vivo,,50597,,2591,10116.0,,Blood,BAO_0000218,
Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,1,CHEMBL623767,Intermediate,,,A,N,1,8913,178.0,Rattus norvegicus,In vivo,,50597,,2591,10116.0,,Blood,BAO_0000218,
Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,1,CHEMBL623768,Intermediate,,,A,N,1,8914,178.0,Rattus norvegicus,In vivo,,50597,,2591,10116.0,,Blood,BAO_0000218,
Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,1,CHEMBL623769,Intermediate,,,A,N,1,8915,1969.0,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,1,CHEMBL623770,Intermediate,,,A,N,1,8916,1969.0,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,1,CHEMBL623771,Intermediate,,,A,N,1,8917,1969.0,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,1,CHEMBL623772,Intermediate,,,A,N,1,8918,1969.0,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,1,CHEMBL623773,Intermediate,,,A,N,1,8919,1969.0,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,1,CHEMBL623774,Intermediate,,,A,N,1,8920,1969.0,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,1,CHEMBL623775,Intermediate,,,A,N,1,8921,1969.0,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,Plasma,BAO_0000218,
Cmax in rat (PO dose),,1,CHEMBL623776,Intermediate,,,A,N,1,8922,,Rattus norvegicus,In vivo,,50597,,14465,10116.0,,,BAO_0000218,
Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL622191,Intermediate,,,A,N,1,8923,1969.0,Rattus norvegicus,In vivo,,50597,,4723,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL622192,Intermediate,,,A,N,1,8924,1969.0,Rattus norvegicus,In vivo,,50597,,4723,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration determined in rat,,1,CHEMBL622193,Intermediate,,,A,N,1,8925,1969.0,Rattus norvegicus,In vivo,,50597,,4576,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,1,CHEMBL622194,Intermediate,,,A,N,1,8926,1969.0,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,1,CHEMBL622195,Intermediate,,,A,N,1,8927,1969.0,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration in rat,,1,CHEMBL622196,Intermediate,,,A,N,1,8928,1969.0,Rattus norvegicus,In vivo,,50597,,6824,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,1,CHEMBL622197,Intermediate,,,A,N,1,8929,1969.0,Rattus norvegicus,In vivo,,50597,,17065,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,1,CHEMBL622198,Intermediate,,,A,N,1,8930,1969.0,Rattus norvegicus,In vivo,,50597,,2932,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,1,CHEMBL622199,Intermediate,,,A,N,1,8931,1969.0,Rattus norvegicus,In vivo,,50597,,2932,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration of compound was measured in rat,,1,CHEMBL622200,Intermediate,,,A,N,1,8932,1969.0,Rattus norvegicus,In vivo,,50597,,2879,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration after 20 mg/kg oral administration in rat,,1,CHEMBL622201,Intermediate,,,A,N,1,8933,1969.0,Rattus norvegicus,In vivo,,50597,,2864,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration after oral administration to rats,,1,CHEMBL623990,Intermediate,,,A,N,1,8934,1969.0,Rattus norvegicus,In vivo,,50597,,16367,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,1,CHEMBL623991,Intermediate,,,A,N,1,8935,1969.0,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,Plasma,BAO_0000218,
"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,1,CHEMBL623992,Intermediate,,,A,N,1,8936,1969.0,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,1,CHEMBL623993,Intermediate,,,A,N,1,8937,1969.0,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,1,CHEMBL623994,Intermediate,,,A,N,1,8938,1969.0,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,1,CHEMBL623995,Intermediate,,,F,N,1,8939,1969.0,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,1,CHEMBL623996,Intermediate,,,F,N,1,8940,1969.0,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,1,CHEMBL623997,Intermediate,,,F,N,1,8941,1969.0,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration dosed orally in rats,,1,CHEMBL623998,Intermediate,,,A,N,1,8942,1969.0,Rattus norvegicus,In vivo,,50597,,4516,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration dosed orally in rats after 6 hours,,1,CHEMBL623999,Intermediate,,,A,N,1,8943,1969.0,Rattus norvegicus,In vivo,,50597,,4516,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,1,CHEMBL624000,Intermediate,,,A,N,1,8944,1969.0,Rattus norvegicus,In vivo,,50597,,4516,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,1,CHEMBL624001,Intermediate,,,A,N,1,8945,1969.0,Rattus norvegicus,In vivo,,50597,,5199,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration in rat after po administration,,1,CHEMBL624002,Intermediate,,,A,N,1,8946,1969.0,Rattus norvegicus,In vivo,,50597,,17538,10116.0,,Plasma,BAO_0000218,
"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,1,CHEMBL624003,Intermediate,,,A,N,1,8947,1969.0,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,Plasma,BAO_0000218,
"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,1,CHEMBL624004,Intermediate,,,A,N,1,8948,1969.0,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,Plasma,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL624005,Intermediate,,,A,N,1,8949,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL624006,Intermediate,,,A,N,1,8950,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL624007,Intermediate,,,A,N,1,8951,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL624008,Intermediate,,,A,N,1,8952,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL624009,Intermediate,,,A,N,1,8953,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL874387,Intermediate,,,A,N,1,8954,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL624010,Intermediate,,,A,N,1,8955,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL624011,Intermediate,,,A,N,1,8956,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL624012,Intermediate,,,A,N,1,8957,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL624013,Intermediate,,,A,N,1,8958,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL624736,Intermediate,,,A,N,1,8959,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL624737,Intermediate,,,A,N,1,8960,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL624738,Intermediate,,,A,N,1,8961,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL624739,Intermediate,,,A,N,1,8962,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL624740,Intermediate,,,A,N,1,8963,948.0,Rattus norvegicus,,,50597,,16434,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL624896,Intermediate,,,A,N,1,8964,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL624897,Intermediate,,,A,N,1,8965,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL624108,Intermediate,,,A,N,1,8966,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL624109,Intermediate,,,A,N,1,8967,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL624110,Intermediate,,,A,N,1,8968,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL624111,Intermediate,,,A,N,1,8969,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL624112,Intermediate,,,A,N,1,8970,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL624113,Intermediate,,,A,N,1,8971,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL619709,Intermediate,,,A,N,1,8972,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL619710,Intermediate,,,A,N,1,8973,948.0,Rattus norvegicus,,,50597,,16435,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL619711,Intermediate,,,A,N,1,8974,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL619712,Intermediate,,,A,N,1,8975,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL619713,Intermediate,,,A,N,1,8976,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL619714,Intermediate,,,A,N,1,8977,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL619715,Intermediate,,,A,N,1,8978,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL619716,Intermediate,,,A,N,1,8979,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL619717,Intermediate,,,A,N,1,8980,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL619718,Intermediate,,,A,N,1,8981,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL619719,Intermediate,,,A,N,1,8982,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL875329,Intermediate,,,A,N,1,8983,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL619720,Intermediate,,,A,N,1,8984,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL619721,Intermediate,,,A,N,1,8985,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL619722,Intermediate,,,A,N,1,8986,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL619723,Intermediate,,,A,N,1,8987,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL619724,Intermediate,,,A,N,1,8988,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL619725,Intermediate,,,A,N,1,8989,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL619726,Intermediate,,,A,N,1,8990,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL619727,Intermediate,,,A,N,1,8991,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL619728,Intermediate,,,A,N,1,8992,2113.0,Rattus norvegicus,,,50597,,16434,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL619729,Intermediate,,,A,N,1,8993,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL619730,Intermediate,,,A,N,1,8994,2385.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL619731,Intermediate,,,A,N,1,8995,2385.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL619732,Intermediate,,,A,N,1,8996,2385.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL619733,Intermediate,,,A,N,1,8997,2385.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL619734,Intermediate,,,A,N,1,8998,2385.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL619735,Intermediate,,,A,N,1,8999,14.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Zone of skin,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL875330,Intermediate,,,A,N,1,9000,14.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Zone of skin,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL628465,Intermediate,,,A,N,1,9001,14.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Zone of skin,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL628466,Intermediate,,,A,N,1,9002,14.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Zone of skin,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL628467,Intermediate,,,A,N,1,9003,14.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Zone of skin,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL628468,Intermediate,,,A,N,1,9004,2106.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Spleen,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL628469,Intermediate,,,A,N,1,9005,2106.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Spleen,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL628470,Intermediate,,,A,N,1,9006,2106.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Spleen,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL628471,Intermediate,,,A,N,1,9007,2106.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Spleen,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL628472,Intermediate,,,A,N,1,9008,2106.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Spleen,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625191,Intermediate,,,A,N,1,9009,2046.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL625192,Intermediate,,,A,N,1,9010,2046.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,CHEMBL875337,Intermediate,,,A,N,1,9011,2046.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL626341,Intermediate,,,A,N,1,9012,2046.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL626342,Intermediate,,,A,N,1,9013,2046.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,CHEMBL621943,Intermediate,,,A,N,1,9014,2107.0,Rattus norvegicus,In vivo,,50597,,11977,10116.0,,Liver,BAO_0000218,
Half life in rats,,1,CHEMBL621944,Intermediate,,,A,N,1,9015,,Rattus norvegicus,,,50597,,3748,10116.0,,,BAO_0000218,
Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,1,CHEMBL621945,Intermediate,,,A,N,1,9016,,Rattus norvegicus,,,50597,,15765,10116.0,,,BAO_0000218,
Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,1,CHEMBL621946,Intermediate,,,A,N,1,9017,,Rattus norvegicus,,,50597,,4871,10116.0,,,BAO_0000218,
Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,1,CHEMBL621947,Intermediate,,,A,N,1,9018,,Rattus norvegicus,,,50597,,4871,10116.0,,,BAO_0000218,
Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,1,CHEMBL621948,Intermediate,,,A,N,1,9019,,Rattus norvegicus,,,50597,,4872,10116.0,,,BAO_0000218,
Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,1,CHEMBL621949,Intermediate,,,A,N,1,9020,,Rattus norvegicus,,,50597,,4872,10116.0,,,BAO_0000218,
Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,1,CHEMBL621950,Intermediate,,,A,N,1,9021,,Rattus norvegicus,,,50597,,5413,10116.0,,,BAO_0000218,
Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,1,CHEMBL621951,Intermediate,,,A,N,1,9022,,Rattus norvegicus,,,50597,,5413,10116.0,,,BAO_0000218,
Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,1,CHEMBL621952,Intermediate,,,A,N,1,9023,178.0,Rattus norvegicus,In vivo,,50597,,15272,10116.0,,Blood,BAO_0000218,
Stability (%) in rat liver microsomes,,1,CHEMBL621953,Intermediate,,,A,N,1,9024,2107.0,Rattus norvegicus,,,50597,,4689,10116.0,,Liver,BAO_0000218,
Area under curve was calculated after intravenous administration,,1,CHEMBL621954,Intermediate,,,A,N,1,9025,,Rattus norvegicus,,,50597,,6057,10116.0,,,BAO_0000218,
Area under the curve was calculated after iv administration in rat,,1,CHEMBL621955,Intermediate,,,A,N,1,9026,,Rattus norvegicus,,,50597,,6057,10116.0,,,BAO_0000218,
Area under the curve was calculated in rat after peroral administration,,1,CHEMBL621956,Intermediate,,,A,N,1,9027,,Rattus norvegicus,,,50597,,6057,10116.0,,,BAO_0000218,
Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,1,CHEMBL621957,Intermediate,,,A,N,1,9028,,Rattus norvegicus,,,50597,,6211,10116.0,,,BAO_0000218,
Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,1,CHEMBL621958,Intermediate,,,A,N,1,9029,,Rattus norvegicus,,,50597,,5710,10116.0,,,BAO_0000218,
Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,1,CHEMBL621959,Intermediate,,,A,N,1,9030,,Rattus norvegicus,,,50597,,5710,10116.0,,,BAO_0000218,
Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,1,CHEMBL621960,Intermediate,,,A,N,1,9031,,Rattus norvegicus,,,50597,,17853,10116.0,,,BAO_0000218,
Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,1,CHEMBL621961,Intermediate,,,A,N,1,9032,,Rattus norvegicus,,,50597,,17853,10116.0,,,BAO_0000218,
p value of the compound,,1,CHEMBL621962,Intermediate,,,A,N,1,9033,,Rattus norvegicus,,,50597,,15765,10116.0,,,BAO_0000218,
p value of the compound,,1,CHEMBL876787,Intermediate,,,F,N,1,9034,,Rattus norvegicus,,,50597,,15765,10116.0,,,BAO_0000218,
p value of the compound,,1,CHEMBL621963,Intermediate,,,A,N,1,9035,,Rattus norvegicus,,,50597,,15765,10116.0,,,BAO_0000218,
pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,CHEMBL622637,Intermediate,,,A,N,1,9036,945.0,Rattus norvegicus,,,50597,,6175,10116.0,,Stomach,BAO_0000218,
pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,CHEMBL622638,Intermediate,,,A,N,1,9037,945.0,Rattus norvegicus,,,50597,,6175,10116.0,,Stomach,BAO_0000218,
pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,CHEMBL626561,Intermediate,,,A,N,1,9038,945.0,Rattus norvegicus,,,50597,,6175,10116.0,,Stomach,BAO_0000218,
Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,0,CHEMBL626562,Autocuration,,,F,U,1,9039,,Oryctolagus cuniculus,,,22224,,7991,9986.0,,,BAO_0000019,
Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,0,CHEMBL626563,Autocuration,,,A,U,1,9040,,Oryctolagus cuniculus,,,22224,,429,9986.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,0,CHEMBL626564,Autocuration,,,A,U,1,9041,,Oryctolagus cuniculus,,,22224,,429,9986.0,,,BAO_0000218,
Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,0,CHEMBL626565,Autocuration,,,A,U,1,9042,,Oryctolagus cuniculus,In vivo,,22224,,6253,9986.0,,,BAO_0000218,
Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,0,CHEMBL626566,Autocuration,,,A,U,1,9043,,Oryctolagus cuniculus,In vivo,,22224,,6253,9986.0,,,BAO_0000218,
Clearance rate in rabbits,,0,CHEMBL626567,Autocuration,,,A,U,1,9044,,Oryctolagus cuniculus,In vivo,,22224,,3615,9986.0,,,BAO_0000218,
Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,0,CHEMBL626568,Autocuration,,,A,U,1,9045,,Oryctolagus cuniculus,In vivo,,22224,,4059,9986.0,,,BAO_0000218,
Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,0,CHEMBL626569,Autocuration,,,A,U,1,9046,,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,,BAO_0000218,
Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,0,CHEMBL626570,Autocuration,,,A,U,1,9047,,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,,BAO_0000218,
Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,0,CHEMBL626571,Autocuration,,,A,U,1,9048,,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,0,CHEMBL626572,Autocuration,,,A,U,1,9049,,Oryctolagus cuniculus,In vivo,,22224,,429,9986.0,,,BAO_0000218,
Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,0,CHEMBL626573,Autocuration,,,A,U,1,9050,1969.0,Oryctolagus cuniculus,In vivo,,22224,,4059,9986.0,,Plasma,BAO_0000218,
Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,0,CHEMBL626574,Autocuration,,,A,U,1,9051,2107.0,Oryctolagus cuniculus,,,22224,,9659,9986.0,,Liver,BAO_0000251,Microsomes
Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,0,CHEMBL626575,Autocuration,,,A,U,1,9052,2107.0,Oryctolagus cuniculus,,,22224,,9659,9986.0,,Liver,BAO_0000251,Microsomes
Dose at which bioavailability of intravenously administered compound was tested in rabbit,,0,CHEMBL626576,Autocuration,,,A,U,1,9053,,Oryctolagus cuniculus,,,22224,,3639,9986.0,,,BAO_0000218,
Dose at which bioavailability of perorally administered compound was tested in rabbit,,0,CHEMBL626577,Autocuration,,,A,U,1,9054,,Oryctolagus cuniculus,,,22224,,3639,9986.0,,,BAO_0000218,
The compound was tested for its bioavailability in rabbit (by oral dosage).,,0,CHEMBL626578,Autocuration,,,A,U,1,9055,,Oryctolagus cuniculus,In vivo,,22224,,3639,9986.0,,,BAO_0000218,
Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,0,CHEMBL625263,Autocuration,,,A,U,1,9056,,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,,BAO_0000218,
Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,0,CHEMBL625264,Autocuration,,,A,U,1,9057,,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,,BAO_0000218,
Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,0,CHEMBL625265,Autocuration,,,A,U,1,9058,,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,,BAO_0000218,
Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,0,CHEMBL625266,Autocuration,,,A,U,1,9059,,Oryctolagus cuniculus,,,22224,,14294,9986.0,,,BAO_0000251,Microsomes
Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,0,CHEMBL876796,Autocuration,,,A,U,1,9060,,Oryctolagus cuniculus,,,22224,,14294,9986.0,,,BAO_0000251,Microsomes
Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,0,CHEMBL625267,Autocuration,,,A,U,1,9061,,Oryctolagus cuniculus,In vivo,,22224,,429,9986.0,,,BAO_0000218,
Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,0,CHEMBL625268,Autocuration,,,A,U,1,9062,1969.0,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,Plasma,BAO_0000218,
Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,0,CHEMBL625269,Autocuration,,,A,U,1,9063,1969.0,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,Plasma,BAO_0000218,
Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,0,CHEMBL624689,Autocuration,,,A,U,1,9064,1969.0,Oryctolagus cuniculus,In vivo,,22224,,5124,9986.0,,Plasma,BAO_0000218,
Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,0,CHEMBL624690,Autocuration,,,A,U,1,9065,,Oryctolagus cuniculus,In vivo,,22224,,429,9986.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,0,CHEMBL624691,Autocuration,,,A,U,1,9066,1088.0,Oryctolagus cuniculus,,,22224,,429,9986.0,,Urine,BAO_0000218,
Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,0,CHEMBL624692,Autocuration,,,A,U,1,9067,1088.0,Oryctolagus cuniculus,,,22224,,429,9986.0,,Urine,BAO_0000218,
The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,0,CHEMBL624693,Autocuration,,,A,U,1,9068,,Oryctolagus cuniculus,In vivo,,22224,,4059,9986.0,,,BAO_0000218,
Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,0,CHEMBL624694,Autocuration,,,A,U,1,9069,,Oryctolagus cuniculus,In vivo,,22224,,4137,9986.0,,,BAO_0000218,
In vitro Biological half-life in crude homogenate of rabbit renal cortex,,0,CHEMBL877596,Autocuration,,,A,U,1,9070,,Oryctolagus cuniculus,In vitro,,22224,,11672,9986.0,,,BAO_0000221,
Time within which only 10% of the drug was degraded,,0,CHEMBL624695,Autocuration,,,A,U,1,9071,,Oryctolagus cuniculus,,,22224,,12886,9986.0,,,BAO_0000019,
Half life period in rabbit liver homogenate,,0,CHEMBL624696,Autocuration,,,A,U,1,9072,2107.0,Oryctolagus cuniculus,,,22224,,3853,9986.0,,Liver,BAO_0000221,
Half life value in rabbits,,0,CHEMBL624697,Autocuration,,,A,U,1,9073,,Oryctolagus cuniculus,,,22224,,3615,9986.0,,,BAO_0000019,
Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,0,CHEMBL624698,Autocuration,,,A,U,1,9074,178.0,Oryctolagus cuniculus,In vivo,,22224,,6253,9986.0,,Blood,BAO_0000218,
Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,0,CHEMBL624699,Autocuration,,,A,U,1,9075,178.0,Oryctolagus cuniculus,In vivo,,22224,,6253,9986.0,,Blood,BAO_0000218,
Half-life period in rabbits following intravenous administration at 2 mg/kg,,0,CHEMBL624700,Autocuration,,,A,U,1,9076,,Oryctolagus cuniculus,In vivo,,22224,,6077,9986.0,,,BAO_0000218,
AUC 0-8 hr value in rats at 10 mg/kg,,1,CHEMBL622903,Intermediate,,,A,N,1,9077,1969.0,Rattus norvegicus,,,50597,,17617,10116.0,,Plasma,BAO_0000218,
AUC after administration at 2000 mg/kg/day in rats,,1,CHEMBL622904,Intermediate,,,A,N,1,9078,1969.0,Rattus norvegicus,,,50597,,17594,10116.0,,Plasma,BAO_0000218,
AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,1,CHEMBL622905,Intermediate,,,A,N,1,9079,1969.0,Rattus norvegicus,,,50597,,6149,10116.0,,Plasma,BAO_0000218,
AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,1,CHEMBL622906,Intermediate,,,A,N,1,9080,1969.0,Rattus norvegicus,,,50597,,17260,10116.0,,Plasma,BAO_0000218,
AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,1,CHEMBL622907,Intermediate,,,A,N,1,9081,1969.0,Rattus norvegicus,,,50597,,17260,10116.0,,Plasma,BAO_0000218,
AUC in rat after oral administration at 10.5 mg/kg dose,,1,CHEMBL622908,Intermediate,,,A,N,1,9082,1969.0,Rattus norvegicus,,,50597,,6644,10116.0,,Plasma,BAO_0000218,
AUC in rat after oral administration at 11.2 mg/kg dose,,1,CHEMBL622909,Intermediate,,,A,N,1,9083,1969.0,Rattus norvegicus,,,50597,,6644,10116.0,,Plasma,BAO_0000218,
AUC in rat after oral administration at 9.7 mg/kg dose,,1,CHEMBL622910,Intermediate,,,A,N,1,9084,1969.0,Rattus norvegicus,,,50597,,6644,10116.0,,Plasma,BAO_0000218,
AUC in rat brain after oral administration at 10 mg/kg,,1,CHEMBL622911,Intermediate,,,A,N,1,9085,955.0,Rattus norvegicus,,,50597,,6495,10116.0,,Brain,BAO_0000218,
AUC in rat p.o.,,1,CHEMBL622912,Intermediate,,,A,N,1,9086,1969.0,Rattus norvegicus,,,50597,,6504,10116.0,,Plasma,BAO_0000218,
AUC in rat p.o. at 20 mg/kg concentration,,1,CHEMBL622913,Intermediate,,,A,N,1,9087,1969.0,Rattus norvegicus,,,50597,,17686,10116.0,,Plasma,BAO_0000218,
AUC in rat plasma after oral administration at 10 mg/kg,,1,CHEMBL622914,Intermediate,,,A,N,1,9088,1969.0,Rattus norvegicus,,,50597,,6495,10116.0,,Plasma,BAO_0000218,
AUC in rats,,1,CHEMBL622915,Intermediate,,,A,N,1,9089,1969.0,Rattus norvegicus,,,50597,,216,10116.0,,Plasma,BAO_0000218,
AUC value after IV dose at a dose of 5 mg/kg in rats.,,1,CHEMBL622916,Intermediate,,,A,N,1,9090,1969.0,Rattus norvegicus,,,50597,,1908,10116.0,,Plasma,BAO_0000218,
AUC value after oral dose at a dose of 10 mg/kg in rats.,,1,CHEMBL622917,Intermediate,,,A,N,1,9091,1969.0,Rattus norvegicus,,,50597,,1908,10116.0,,Plasma,BAO_0000218,
"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,1,CHEMBL622918,Intermediate,,,A,N,1,9092,1969.0,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,1,CHEMBL622919,Intermediate,,,A,N,1,9093,1969.0,Rattus norvegicus,In vivo,,50597,,216,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in rat,,1,CHEMBL622920,Intermediate,,,A,N,1,9094,1969.0,Rattus norvegicus,In vivo,,50597,,6049,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,1,CHEMBL622921,Intermediate,,,A,N,1,9095,1969.0,Rattus norvegicus,In vivo,,50597,,2463,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,1,CHEMBL622922,Intermediate,,,A,N,1,9096,1969.0,Rattus norvegicus,In vivo,,50597,,6679,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,1,CHEMBL622923,Intermediate,,,A,N,1,9097,1969.0,Rattus norvegicus,In vivo,,50597,,6681,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,1,CHEMBL877604,Intermediate,,,A,N,1,9098,1969.0,Rattus norvegicus,In vivo,,50597,,4890,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,1,CHEMBL622924,Intermediate,,,A,N,1,9099,1969.0,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,1,CHEMBL622925,Intermediate,,,A,N,1,9100,1969.0,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,1,CHEMBL622926,Intermediate,,,A,N,1,9101,1969.0,Rattus norvegicus,In vivo,,50597,,16366,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,1,CHEMBL623625,Intermediate,,,A,N,1,9102,1969.0,Rattus norvegicus,In vivo,,50597,,6227,10116.0,,Plasma,BAO_0000218,
Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,CHEMBL623626,Expert,,,A,N,1,9103,1969.0,Rattus norvegicus,In vivo,,50597,,3598,10116.0,,Plasma,BAO_0000218,
Maximum plasma drug concentration was determined,,1,CHEMBL623627,Intermediate,,,A,N,1,9104,1969.0,Rattus norvegicus,In vivo,,50597,,1465,10116.0,,Plasma,BAO_0000218,
Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,1,CHEMBL623628,Intermediate,,,A,N,1,9105,,Rattus norvegicus,In vivo,,50597,,4368,10116.0,,,BAO_0000218,
Mean peak plasma concentration was observed after intravenous administration in rat,,1,CHEMBL623629,Intermediate,,,A,N,1,9106,1969.0,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,Plasma,BAO_0000218,
Mean peak plasma concentration was observed after oral administration in rat,,1,CHEMBL623630,Intermediate,,,A,N,1,9107,1969.0,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,Plasma,BAO_0000218,
Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,1,CHEMBL623804,Intermediate,,,A,N,1,9108,,Rattus norvegicus,In vivo,,50597,,5355,10116.0,,,BAO_0000218,
Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,1,CHEMBL623805,Intermediate,,,A,N,1,9109,,Rattus norvegicus,In vivo,,50597,,5355,10116.0,,,BAO_0000218,
Peak oral plasma concentration was determined in rats by oral administration,,1,CHEMBL623806,Intermediate,,,A,N,1,9110,1969.0,Rattus norvegicus,In vivo,,50597,,1567,10116.0,,Plasma,BAO_0000218,
Peak plasma concentration (Cmax) was determined,,1,CHEMBL623807,Intermediate,,,A,N,1,9111,1969.0,Rattus norvegicus,In vivo,,50597,,4026,10116.0,,Plasma,BAO_0000218,
Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,1,CHEMBL623808,Intermediate,,,A,N,1,9112,1969.0,Rattus norvegicus,In vivo,,50597,,6193,10116.0,,Plasma,BAO_0000218,
Peak plasma concentration (Cmax) in rats,,1,CHEMBL623809,Intermediate,,,A,N,1,9113,1969.0,Rattus norvegicus,In vivo,,50597,,4026,10116.0,,Plasma,BAO_0000218,
Peak plasma concentration at 1 mg/kg peroral administration,,1,CHEMBL623810,Intermediate,,,A,N,1,9114,1969.0,Rattus norvegicus,In vivo,,50597,,6485,10116.0,,Plasma,BAO_0000218,
Peak plasma concentration in rat,,1,CHEMBL623811,Intermediate,,,A,N,1,9115,1969.0,Rattus norvegicus,In vivo,,50597,,17655,10116.0,,Plasma,BAO_0000218,
"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,1,CHEMBL623812,Intermediate,,,A,N,1,9116,1969.0,Rattus norvegicus,In vivo,,50597,,14941,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,1,CHEMBL877605,Intermediate,,,A,N,1,9117,,Rattus norvegicus,In vivo,,50597,,5394,10116.0,,,BAO_0000218,
Pharmacokinetic property (Cmax) in rat,,1,CHEMBL623813,Intermediate,,,A,N,1,9118,,Rattus norvegicus,In vivo,,50597,,4408,10116.0,,,BAO_0000218,
Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,1,CHEMBL623814,Intermediate,,,A,N,1,9119,,Rattus norvegicus,In vivo,,50597,,5983,10116.0,,,BAO_0000218,
Cmax in rat after 3mg/kg oral dose,,1,CHEMBL623815,Intermediate,,,A,N,1,9120,,Rattus norvegicus,In vivo,,50597,,4878,10116.0,,,BAO_0000218,
Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,1,CHEMBL623816,Intermediate,,,A,N,1,9121,,Rattus norvegicus,In vivo,Sprague-Dawley,50597,,5862,10116.0,,,BAO_0000218,
Cmax in rats after 20 mg/kg oral dose,,1,CHEMBL623145,Intermediate,,,A,N,1,9122,,Rattus norvegicus,In vivo,,50597,,4517,10116.0,,,BAO_0000218,
Cmax in rat plasma after 30mg/kg oral dose,,1,CHEMBL623146,Intermediate,,,A,N,1,9123,1969.0,Rattus norvegicus,In vivo,,50597,,5932,10116.0,,Plasma,BAO_0000218,
Plasma concentration after oral administration of 100 mg/kg to rats,,1,CHEMBL623147,Intermediate,,,A,N,1,9124,1969.0,Rattus norvegicus,In vivo,,50597,,5436,10116.0,,Plasma,BAO_0000218,
Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,1,CHEMBL623042,Intermediate,,,A,N,1,9125,955.0,Rattus norvegicus,In vivo,,50597,,4910,10116.0,,Brain,BAO_0000218,
Tested for the Cmax in rat at 10 mg/kg per orally,,1,CHEMBL623043,Intermediate,,,A,N,1,9126,,Rattus norvegicus,In vivo,,50597,,4950,10116.0,,,BAO_0000218,
"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL623044,Intermediate,,,A,N,1,9127,,Rattus norvegicus,In vivo,,50597,,15078,10116.0,,,BAO_0000218,
"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL623045,Intermediate,,,A,N,1,9128,,Rattus norvegicus,In vivo,,50597,,15078,10116.0,,,BAO_0000218,
Bioavailability as oral Cmax in rats at 30 mins,,1,CHEMBL623046,Intermediate,,,A,N,1,9129,,Rattus norvegicus,In vivo,,50597,,3360,10116.0,,,BAO_0000218,
Bioavailability as oral Cmax in rats at 6hr,,1,CHEMBL623226,Intermediate,,,A,N,1,9130,,Rattus norvegicus,In vivo,,50597,,3360,10116.0,,,BAO_0000218,
The maximum concentration of compound was measured at the dose of 100 umol/kg,,1,CHEMBL623227,Intermediate,,,A,N,1,9131,,Rattus norvegicus,In vivo,,50597,,15022,10116.0,,,BAO_0000218,
The maximum concentration of compound was measured at the dose of 300 umol/kg,,1,CHEMBL623228,Intermediate,,,A,N,1,9132,,Rattus norvegicus,In vivo,,50597,,15022,10116.0,,,BAO_0000218,
The maximum concentration of compound was measured at the dose of 30 umol/kg,,1,CHEMBL623229,Intermediate,,,A,N,1,9133,,Rattus norvegicus,In vivo,,50597,,15022,10116.0,,,BAO_0000218,
The maximum plasma levels for the compounds were determined by LC-MS.,,1,CHEMBL623230,Intermediate,,,A,N,1,9134,1969.0,Rattus norvegicus,In vivo,,50597,,5160,10116.0,,Plasma,BAO_0000218,
mean peak plasma concentration was observed after intravenous administration in rat,,1,CHEMBL623231,Intermediate,,,A,N,1,9135,1969.0,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,Plasma,BAO_0000218,
mean peak plasma concentration was observed after oral administration in rat,,1,CHEMBL623232,Intermediate,,,A,N,1,9136,1969.0,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,Plasma,BAO_0000218,
Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,1,CHEMBL623233,Intermediate,,,A,N,1,9137,,Rattus norvegicus,,,50597,,4709,10116.0,,,BAO_0000218,
Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,1,CHEMBL623234,Intermediate,,,A,N,1,9138,,Rattus norvegicus,,,50597,,3535,10116.0,,,BAO_0000218,
Concentration in plasma (portal) following oral dose in rats at 1 hr,,1,CHEMBL623235,Intermediate,,,A,N,1,9139,,Rattus norvegicus,,,50597,,3535,10116.0,,,BAO_0000218,
Concentration in plasma (portal) following oral dose in rats at 2 hr,,1,CHEMBL623236,Intermediate,,,A,N,1,9140,,Rattus norvegicus,,,50597,,3535,10116.0,,,BAO_0000218,
Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,1,CHEMBL623237,Intermediate,,,A,N,1,9141,,Rattus norvegicus,,,50597,,3535,10116.0,,,BAO_0000218,
Concentration in plasma (systemic) following oral dose in rats at 1 hr,,1,CHEMBL623238,Intermediate,,,A,N,1,9142,,Rattus norvegicus,,,50597,,3535,10116.0,,,BAO_0000218,
Concentration in plasma (systemic) following oral dose in rats at 2 hr,,1,CHEMBL623239,Intermediate,,,A,N,1,9143,,Rattus norvegicus,,,50597,,3535,10116.0,,,BAO_0000218,
Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,0,CHEMBL623240,Intermediate,,,A,U,1,9144,1969.0,Rattus norvegicus,In vivo,,22224,,5005,10116.0,,Plasma,BAO_0000218,
"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,1,CHEMBL623241,Intermediate,,,A,N,1,9145,1898.0,Rattus norvegicus,,,50597,,6326,10116.0,,Hypothalamus,BAO_0000218,
"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,1,CHEMBL623242,Intermediate,,,A,N,1,9146,1898.0,Rattus norvegicus,,,50597,,6326,10116.0,,Hypothalamus,BAO_0000218,
"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,1,CHEMBL874394,Intermediate,,,A,N,1,9147,,Rattus norvegicus,,,50597,,6326,10116.0,,,BAO_0000218,
"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,1,CHEMBL623243,Intermediate,,,A,N,1,9148,,Rattus norvegicus,,,50597,,6326,10116.0,,,BAO_0000218,
Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL623244,Intermediate,,,A,N,1,9149,,Rattus norvegicus,,,50597,,17411,10116.0,,,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL623245,Intermediate,,,A,N,1,9150,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL623246,Intermediate,,,A,N,1,9151,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL623247,Intermediate,,,A,N,1,9152,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL623248,Intermediate,,,A,N,1,9153,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL623249,Intermediate,,,A,N,1,9154,2113.0,Rattus norvegicus,,,50597,,16435,10116.0,,Kidney,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL625072,Intermediate,,,A,N,1,9155,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL625073,Intermediate,,,A,N,1,9156,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL625074,Intermediate,,,A,N,1,9157,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL625075,Intermediate,,,A,N,1,9158,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL625076,Intermediate,,,A,N,1,9159,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL625077,Intermediate,,,A,N,1,9160,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL625078,Intermediate,,,A,N,1,9161,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL874395,Intermediate,,,A,N,1,9162,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL625079,Intermediate,,,A,N,1,9163,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL625080,Intermediate,,,A,N,1,9164,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL625081,Intermediate,,,A,N,1,9165,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL625082,Intermediate,,,A,N,1,9166,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL625083,Intermediate,,,A,N,1,9167,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL625084,Intermediate,,,A,N,1,9168,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL625085,Intermediate,,,A,N,1,9169,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL625086,Intermediate,,,A,N,1,9170,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL625087,Intermediate,,,A,N,1,9171,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL625088,Intermediate,,,A,N,1,9172,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL622205,Intermediate,,,A,N,1,9173,2107.0,Rattus norvegicus,,,50597,,16434,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL622206,Intermediate,,,A,N,1,9174,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL622207,Intermediate,,,A,N,1,9175,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL622366,Intermediate,,,A,N,1,9176,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL622367,Intermediate,,,A,N,1,9177,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL875331,Intermediate,,,A,N,1,9178,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL622368,Intermediate,,,A,N,1,9179,2107.0,Rattus norvegicus,,,50597,,16435,10116.0,,Liver,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL622369,Intermediate,,,A,N,1,9180,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL622370,Intermediate,,,A,N,1,9181,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL622371,Intermediate,,,A,N,1,9182,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL622372,Intermediate,,,A,N,1,9183,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL622373,Intermediate,,,A,N,1,9184,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL622374,Intermediate,,,A,N,1,9185,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL622375,Intermediate,,,A,N,1,9186,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL622376,Intermediate,,,A,N,1,9187,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL622377,Intermediate,,,A,N,1,9188,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL622378,Intermediate,,,A,N,1,9189,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL622379,Intermediate,,,A,N,1,9190,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL622380,Intermediate,,,A,N,1,9191,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL622381,Intermediate,,,A,N,1,9192,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL622382,Intermediate,,,A,N,1,9193,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL622383,Intermediate,,,A,N,1,9194,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,CHEMBL875332,Intermediate,,,A,N,1,9195,945.0,Rattus norvegicus,,,50597,,6175,10116.0,,Stomach,BAO_0000218,
pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,CHEMBL622384,Intermediate,,,A,N,1,9196,945.0,Rattus norvegicus,,,50597,,6175,10116.0,,Stomach,BAO_0000218,
pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,CHEMBL622385,Intermediate,,,A,N,1,9197,945.0,Rattus norvegicus,,,50597,,6175,10116.0,,Stomach,BAO_0000218,
pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,CHEMBL622386,Intermediate,,,A,N,1,9198,945.0,Rattus norvegicus,,,50597,,6175,10116.0,,Stomach,BAO_0000218,
The compound was tested for the plasma binding in rat,,1,CHEMBL622387,Intermediate,,,A,N,1,9199,,Rattus norvegicus,,,50597,,10839,10116.0,,,BAO_0000218,
"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,1,CHEMBL622388,Intermediate,,,A,N,1,9200,,Rattus norvegicus,,,50597,,16459,10116.0,,,BAO_0000218,
"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,1,CHEMBL622389,Intermediate,,,A,N,1,9201,,Rattus norvegicus,,,50597,,16459,10116.0,,,BAO_0000218,
"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,1,CHEMBL622390,Intermediate,,,A,N,1,9202,,Rattus norvegicus,,,50597,,16459,10116.0,,,BAO_0000218,
Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,1,CHEMBL622391,Intermediate,,,A,N,1,9203,,Rattus norvegicus,,,50597,,16459,10116.0,,,BAO_0000218,
Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,1,CHEMBL622392,Intermediate,,,A,N,1,9204,,Rattus norvegicus,,,50597,,16459,10116.0,,,BAO_0000218,
Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,1,CHEMBL622393,Intermediate,,,A,N,1,9205,,Rattus norvegicus,,,50597,,16459,10116.0,,,BAO_0000218,
Plasma level at 2 hr after administration of the compound,,1,CHEMBL622394,Intermediate,,,A,N,1,9206,,Rattus norvegicus,,,50597,,3278,10116.0,,,BAO_0000218,
plasma level at 2 hr after administration of the compound,,1,CHEMBL622395,Intermediate,,,A,N,1,9207,,Rattus norvegicus,,,50597,,3278,10116.0,,,BAO_0000218,
Stability in rat serum measured as % recovery at 1 min,,1,CHEMBL622396,Intermediate,,,A,N,1,9208,1977.0,Rattus norvegicus,,,50597,,4684,10116.0,,Serum,BAO_0000218,
Stability in rat serum measured as % recovery at 10 min,,1,CHEMBL624894,Intermediate,,,A,N,1,9209,1977.0,Rattus norvegicus,,,50597,,4684,10116.0,,Serum,BAO_0000218,
Stability in rat serum measured as % recovery at 10 mins,,1,CHEMBL624895,Intermediate,,,A,N,1,9210,1977.0,Rattus norvegicus,,,50597,,4684,10116.0,,Serum,BAO_0000218,
Stability in rat serum measured as % recovery at 2 hr,,1,CHEMBL624058,Intermediate,,,A,N,1,9211,1977.0,Rattus norvegicus,,,50597,,4684,10116.0,,Serum,BAO_0000218,
Stability in rat serum measured as % recovery at 3 min,,1,CHEMBL624059,Intermediate,,,A,N,1,9212,1977.0,Rattus norvegicus,,,50597,,4684,10116.0,,Serum,BAO_0000218,
Stability in rat serum measured as % recovery at 3 mins,,1,CHEMBL624060,Intermediate,,,A,N,1,9213,1977.0,Rattus norvegicus,,,50597,,4684,10116.0,,Serum,BAO_0000218,
Stability in rat serum measured as % recovery at 5 min,,1,CHEMBL624061,Intermediate,,,A,N,1,9214,1977.0,Rattus norvegicus,,,50597,,4684,10116.0,,Serum,BAO_0000218,
Stability in rat serum measured as % recovery at 5 mins,,1,CHEMBL624062,Intermediate,,,A,N,1,9215,1977.0,Rattus norvegicus,,,50597,,4684,10116.0,,Serum,BAO_0000218,
Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,1,CHEMBL624063,Intermediate,,,A,N,1,9216,,Rattus norvegicus,In vivo,,50597,,16456,10116.0,,,BAO_0000218,
Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,1,CHEMBL624064,Intermediate,,,A,N,1,9217,,Rattus norvegicus,In vivo,,50597,,16456,10116.0,,,BAO_0000218,
Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,1,CHEMBL624065,Intermediate,,,A,N,1,9218,1969.0,Rattus norvegicus,,,50597,,723,10116.0,,Plasma,BAO_0000218,
Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,1,CHEMBL624066,Intermediate,,,A,N,1,9219,1969.0,Rattus norvegicus,,,50597,,723,10116.0,,Plasma,BAO_0000218,
Half life tested in mature male rat at a dose of 30 mg/kg,,1,CHEMBL877490,Intermediate,,,A,N,1,9220,,Rattus norvegicus,In vivo,,50597,,5160,10116.0,,,BAO_0000218,
Half life after intravenous administration of 1 mg/kg in rat,,1,CHEMBL874442,Intermediate,,,A,N,1,9221,,Rattus norvegicus,In vivo,,50597,,4709,10116.0,,,BAO_0000218,
Half life period after administration (30 mg/kg) in rat,,1,CHEMBL626890,Intermediate,,,A,N,1,9222,,Rattus norvegicus,In vivo,,50597,,5633,10116.0,,,BAO_0000218,
Half life period in rat after 5 mg/Kg dose,,1,CHEMBL626891,Intermediate,,,A,N,1,9223,,Rattus norvegicus,In vivo,,50597,,5302,10116.0,,,BAO_0000218,
Half life period in rat after 5 mg/kg dose,,1,CHEMBL626892,Intermediate,,,A,N,1,9224,,Rattus norvegicus,In vivo,,50597,,5302,10116.0,,,BAO_0000218,
Half life period was determined,,1,CHEMBL626893,Intermediate,,,A,N,1,9225,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Half life period was evaluated in rat,,1,CHEMBL626894,Intermediate,,,A,N,1,9226,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Half life period was evaluated in rat; 0.5-1.0,,1,CHEMBL626895,Intermediate,,,A,N,1,9227,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Half life period was evaluated in rat; 5.9-7.5,,1,CHEMBL626896,Intermediate,,,A,N,1,9228,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Half-life in rat plasma,,1,CHEMBL626897,Intermediate,,,A,N,1,9229,1969.0,Rattus norvegicus,,,50597,,14512,10116.0,,Plasma,BAO_0000218,
Half-life time in rat was determined,,1,CHEMBL626898,Intermediate,,,A,N,1,9230,,Rattus norvegicus,,,50597,,6230,10116.0,,,BAO_0000218,
Terminal half-life after iv administration to rats,,1,CHEMBL626899,Intermediate,,,A,N,1,9231,,Rattus norvegicus,In vivo,,50597,,3364,10116.0,,,BAO_0000218,
Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,1,CHEMBL626900,Intermediate,,,A,N,1,9232,,Rattus norvegicus,In vivo,,50597,,6874,10116.0,,,BAO_0000218,
Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,1,CHEMBL626901,Intermediate,,,A,N,1,9233,,Rattus norvegicus,,,50597,,857,10116.0,,,BAO_0000218,
Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,1,CHEMBL626902,Intermediate,,,A,N,1,9234,,Rattus norvegicus,In vivo,,50597,,858,10116.0,,,BAO_0000218,
Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,1,CHEMBL626903,Intermediate,,,A,N,1,9235,,Rattus norvegicus,In vivo,,50597,,858,10116.0,,,BAO_0000218,
Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,1,CHEMBL874443,Intermediate,,,A,N,1,9236,,Rattus norvegicus,In vivo,,50597,,5355,10116.0,,,BAO_0000218,
Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,1,CHEMBL626904,Intermediate,,,A,N,1,9237,,Rattus norvegicus,In vivo,,50597,,5355,10116.0,,,BAO_0000218,
Half life in rats,,1,CHEMBL626905,Intermediate,,,A,N,1,9238,,Rattus norvegicus,,,50597,,6305,10116.0,,,BAO_0000218,
Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,1,CHEMBL873830,Intermediate,,,A,N,1,9239,1969.0,Rattus norvegicus,In vivo,,50597,,13501,10116.0,,Plasma,BAO_0000218,
Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,1,CHEMBL626906,Intermediate,,,A,N,1,9240,,Rattus norvegicus,In vivo,,50597,,17594,10116.0,,,BAO_0000218,
Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,1,CHEMBL631076,Intermediate,,,A,N,1,9241,1969.0,Rattus norvegicus,In vivo,,50597,,4186,10116.0,,Plasma,BAO_0000218,
Biological half-life was measured in plasma of rats,,1,CHEMBL631077,Intermediate,,,A,N,1,9242,1969.0,Rattus norvegicus,,,50597,,2932,10116.0,,Plasma,BAO_0000218,
Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,1,CHEMBL631078,Intermediate,,,A,N,1,9243,,Rattus norvegicus,In vivo,,50597,,17065,10116.0,,,BAO_0000218,
Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,1,CHEMBL631079,Intermediate,,,A,N,1,9244,,Rattus norvegicus,In vivo,,50597,,15765,10116.0,,,BAO_0000218,
Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,1,CHEMBL631080,Intermediate,,,A,N,1,9245,,Rattus norvegicus,In vivo,,50597,,2713,10116.0,,,BAO_0000218,
Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,1,CHEMBL631081,Intermediate,,,A,N,1,9246,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,1,CHEMBL631239,Intermediate,,,A,N,1,9247,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for plasma half life in rat,,1,CHEMBL631240,Intermediate,,,A,N,1,9248,1969.0,Rattus norvegicus,,,50597,,740,10116.0,,Plasma,BAO_0000218,
AUC value at a dose of 5 mg/kg (p.o.) in rats,,1,CHEMBL631241,Intermediate,,,A,N,1,9249,1969.0,Rattus norvegicus,,,50597,,6597,10116.0,,Plasma,BAO_0000218,
AUC value after administration of 20 mg/Kg oral dose in rat,,1,CHEMBL631242,Intermediate,,,A,N,1,9250,1969.0,Rattus norvegicus,,,50597,,2959,10116.0,,Plasma,BAO_0000218,
AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,1,CHEMBL631243,Intermediate,,,A,N,1,9251,1969.0,Rattus norvegicus,,,50597,,17594,10116.0,,Plasma,BAO_0000218,
AUC0-96 after administration at 50 mg/kg,,1,CHEMBL874444,Intermediate,,,A,N,1,9252,1969.0,Rattus norvegicus,,,50597,,17596,10116.0,,Plasma,BAO_0000218,
AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,1,CHEMBL631244,Intermediate,,,A,N,1,9253,1969.0,Rattus norvegicus,,,50597,,17594,10116.0,,Plasma,BAO_0000218,
"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,1,CHEMBL631245,Intermediate,,,A,N,1,9254,,Rattus norvegicus,,,50597,,3293,10116.0,,,BAO_0000218,
Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,1,CHEMBL627162,Intermediate,,,A,N,1,9255,,Rattus norvegicus,,,50597,,6757,10116.0,,,BAO_0000218,
Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,1,CHEMBL627163,Intermediate,,,A,N,1,9256,,Rattus norvegicus,,,50597,,6757,10116.0,,,BAO_0000218,
Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,1,CHEMBL627164,Intermediate,,,A,N,1,9257,,Rattus norvegicus,,,50597,,6757,10116.0,,,BAO_0000218,
Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,1,CHEMBL627165,Intermediate,,,A,N,1,9258,2113.0,Rattus norvegicus,,,50597,,5979,10116.0,,Kidney,BAO_0000218,
Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,1,CHEMBL627166,Intermediate,,,A,N,1,9259,,Rattus norvegicus,,,50597,,5979,10116.0,,,BAO_0000218,
Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,1,CHEMBL627167,Intermediate,,,A,N,1,9260,,Rattus norvegicus,,,50597,,5979,10116.0,,,BAO_0000218,
Area under curve (AUC) at a dose of 30 mg/kg in rats,,1,CHEMBL627822,Intermediate,,,A,N,1,9261,,Rattus norvegicus,,,50597,,4026,10116.0,,,BAO_0000218,
Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,1,CHEMBL627823,Intermediate,,,A,N,1,9262,,Rattus norvegicus,,,50597,,5355,10116.0,,,BAO_0000218,
Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,1,CHEMBL627824,Intermediate,,,A,N,1,9263,,Rattus norvegicus,,,50597,,5355,10116.0,,,BAO_0000218,
Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,1,CHEMBL627825,Intermediate,,,A,N,1,9264,,Rattus norvegicus,,,50597,,5355,10116.0,,,BAO_0000218,
Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,1,CHEMBL627826,Intermediate,,,A,N,1,9265,,Rattus norvegicus,,,50597,,5633,10116.0,,,BAO_0000218,
Area under curve (Pharmacokinetic property) was determined,,1,CHEMBL627827,Intermediate,,,A,N,1,9266,,Rattus norvegicus,,,50597,,1716,10116.0,,,BAO_0000218,
Area under curve (Pharmacokinetic property) of the compound; Not determined,,1,CHEMBL627828,Intermediate,,,A,N,1,9267,,Rattus norvegicus,,,50597,,1716,10116.0,,,BAO_0000218,
Area under curve after intravenous administration (1 mg/kg) in rat,,1,CHEMBL627829,Intermediate,,,A,N,1,9268,,Rattus norvegicus,,,50597,,4689,10116.0,,,BAO_0000218,
Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,1,CHEMBL627830,Intermediate,,,A,N,1,9269,,Rattus norvegicus,,,50597,,4527,10116.0,,,BAO_0000218,
Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,1,CHEMBL627831,Intermediate,,,A,N,1,9270,,Rattus norvegicus,,,50597,,4527,10116.0,,,BAO_0000218,
Area under curve in male SD rats was observed after oral administration in rat,,1,CHEMBL627832,Intermediate,,,A,N,1,9271,,Rattus norvegicus,,,50597,,15662,10116.0,,,BAO_0000218,
Area under curve of compound after iv administration of 20 mg/kg dose in rat,,1,CHEMBL627833,Intermediate,,,A,N,1,9272,,Rattus norvegicus,,,50597,,4413,10116.0,,,BAO_0000218,
Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,CHEMBL627834,Expert,,,A,N,1,9273,,Rattus norvegicus,,,50597,,3598,10116.0,,,BAO_0000218,
Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,1,CHEMBL628004,Expert,,,A,N,1,9274,,Rattus norvegicus,,,50597,,3598,10116.0,,,BAO_0000218,
Area under curve at 5 mg/kg po was determined in rat,,1,CHEMBL628005,Intermediate,,,A,N,1,9275,,Rattus norvegicus,,,50597,,5964,10116.0,,,BAO_0000218,
Area under curve in Rat at a oral dose of 5 mg/kg,,1,CHEMBL628006,Intermediate,,,A,N,1,9276,,Rattus norvegicus,,,50597,,4689,10116.0,,,BAO_0000218,
Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,1,CHEMBL628007,Intermediate,,,A,N,1,9277,,Rattus norvegicus,,,50597,,4186,10116.0,,,BAO_0000218,
Area under curve was determined,,1,CHEMBL625676,Intermediate,,,A,N,1,9278,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,1,CHEMBL631309,Intermediate,,,A,N,1,9279,,Rattus norvegicus,,,50597,,17858,10116.0,,,BAO_0000218,
Area under curve after intravenous administration at 3 mg/kg,,1,CHEMBL631310,Intermediate,,,A,N,1,9280,,Rattus norvegicus,,,50597,,17804,10116.0,,,BAO_0000218,
Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,1,CHEMBL631311,Intermediate,,,A,N,1,9281,,Rattus norvegicus,,,50597,,6106,10116.0,,,BAO_0000218,
Area under curve at 4 hr in rat,,1,CHEMBL631312,Intermediate,,,A,N,1,9282,,Rattus norvegicus,,,50597,,5964,10116.0,,,BAO_0000218,
Area under curve at a dose of 30 mg/kg,,1,CHEMBL631313,Intermediate,,,A,N,1,9283,,Rattus norvegicus,,,50597,,4026,10116.0,,,BAO_0000218,
Area under curve at the dose of 2 mg/Kg administered perorally in rats,,1,CHEMBL631314,Intermediate,,,A,N,1,9284,,Rattus norvegicus,,,50597,,4756,10116.0,,,BAO_0000218,
Area under curve at the dose of 5 mg/Kg administered perorally in rats,,1,CHEMBL631315,Intermediate,,,A,N,1,9285,,Rattus norvegicus,,,50597,,4756,10116.0,,,BAO_0000218,
Area under curve for a 2-mpk po dose in SD rats,,1,CHEMBL631316,Intermediate,,,A,N,1,9286,,Rattus norvegicus,,,50597,,5862,10116.0,,,BAO_0000218,
Area under curve in SD rats,,1,CHEMBL631317,Intermediate,,,A,N,1,9287,,Rattus norvegicus,,,50597,,5862,10116.0,,,BAO_0000218,
Area under curve in rat after oral administration at 13 mg/kg dose,,1,CHEMBL874471,Intermediate,,,A,N,1,9288,,Rattus norvegicus,,,50597,,6644,10116.0,,,BAO_0000218,
Area under curve in rat by po administration at 0-24 hr,,1,CHEMBL631318,Intermediate,,,A,N,1,9289,,Rattus norvegicus,,,50597,,5871,10116.0,,,BAO_0000218,
Area under curve in rat plasma,,1,CHEMBL631319,Intermediate,,,A,N,1,9290,1969.0,Rattus norvegicus,,,50597,,5919,10116.0,,Plasma,BAO_0000218,
Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,1,CHEMBL631320,Intermediate,,,A,N,1,9291,,Rattus norvegicus,,,50597,,5939,10116.0,,,BAO_0000218,
Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,1,CHEMBL631321,Intermediate,,,A,N,1,9292,,Rattus norvegicus,,,50597,,5939,10116.0,,,BAO_0000218,
Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,1,CHEMBL631322,Intermediate,,,A,N,1,9293,,Rattus norvegicus,,,50597,,10,10116.0,,,BAO_0000218,
Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,1,CHEMBL631323,Intermediate,,,A,N,1,9294,,Rattus norvegicus,,,50597,,11149,10116.0,,,BAO_0000218,
Area under curve value in rat at a dose of 5 mg/kg,,1,CHEMBL631324,Intermediate,,,A,N,1,9295,,Rattus norvegicus,,,50597,,5302,10116.0,,,BAO_0000218,
Area under curve was determined after oral administration in rats,,1,CHEMBL631325,Intermediate,,,A,N,1,9296,,Rattus norvegicus,,,50597,,17796,10116.0,,,BAO_0000218,
Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,1,CHEMBL631326,Intermediate,,,A,N,1,9297,,Rattus norvegicus,,,50597,,4890,10116.0,,,BAO_0000218,
Area under curve was determined after peroral administration in rat,,1,CHEMBL631327,Intermediate,,,A,N,1,9298,,Rattus norvegicus,,,50597,,6011,10116.0,,,BAO_0000218,
Area under curve was determined at a dose 30 mpk administered orally.,,1,CHEMBL631328,Intermediate,,,A,N,1,9299,,Rattus norvegicus,,,50597,,5375,10116.0,,,BAO_0000218,
Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,1,CHEMBL631329,Intermediate,,,A,N,1,9300,,Rattus norvegicus,,,50597,,17764,10116.0,,,BAO_0000218,
Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,1,CHEMBL627217,Intermediate,,,A,N,1,9301,,Rattus norvegicus,,,50597,,4368,10116.0,,,BAO_0000218,
Area under curve was determined in male rat,,1,CHEMBL626352,Intermediate,,,A,N,1,9302,,Rattus norvegicus,,,50597,,5610,10116.0,,,BAO_0000218,
Area under curve was determined in rat after PO administration,,1,CHEMBL626353,Intermediate,,,A,N,1,9303,,Rattus norvegicus,,,50597,,5833,10116.0,,,BAO_0000218,
Area under curve was determined in rat after a 3 mg/kg of oral dose,,1,CHEMBL626354,Intermediate,,,A,N,1,9304,,Rattus norvegicus,,,50597,,4257,10116.0,,,BAO_0000218,
Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,1,CHEMBL626355,Intermediate,,,A,N,1,9305,,Rattus norvegicus,,,50597,,5937,10116.0,,,BAO_0000218,
Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,1,CHEMBL626356,Intermediate,,,A,N,1,9306,,Rattus norvegicus,,,50597,,5932,10116.0,,,BAO_0000218,
Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,1,CHEMBL626357,Intermediate,,,A,N,1,9307,,Rattus norvegicus,,,50597,,5932,10116.0,,,BAO_0000218,
Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL626358,Intermediate,,,A,N,1,9308,,Rattus norvegicus,,,50597,,17411,10116.0,,,BAO_0000218,
Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL626359,Intermediate,,,A,N,1,9309,,Rattus norvegicus,,,50597,,17411,10116.0,,,BAO_0000218,
Peak plasma concentration in rat at a dose of 3 mg/kg,,1,CHEMBL626360,Intermediate,,,A,N,1,9310,1969.0,Rattus norvegicus,,,50597,,17771,10116.0,,Plasma,BAO_0000218,
Plasma concentration at 2 hr in rats was evaluated.,,1,CHEMBL626361,Intermediate,,,A,N,1,9311,,Rattus norvegicus,,,50597,,1628,10116.0,,,BAO_0000218,
Plasma concentration at 2 hr in rats was evaluated; Not available,,1,CHEMBL626362,Intermediate,,,A,N,1,9312,,Rattus norvegicus,,,50597,,1628,10116.0,,,BAO_0000218,
Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL626363,Intermediate,,,A,N,1,9313,,Rattus norvegicus,,,50597,,17411,10116.0,,,BAO_0000218,
Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,1,CHEMBL626970,Intermediate,,,A,N,1,9314,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,1,CHEMBL626971,Intermediate,,,A,N,1,9315,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,1,CHEMBL626972,Intermediate,,,A,N,1,9316,1969.0,Rattus norvegicus,,,50597,,4910,10116.0,,Plasma,BAO_0000218,
Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,1,CHEMBL626973,Intermediate,,,A,N,1,9317,1969.0,Rattus norvegicus,,,50597,,4910,10116.0,,Plasma,BAO_0000218,
Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,1,CHEMBL626974,Intermediate,,,A,N,1,9318,1969.0,Rattus norvegicus,,,50597,,4910,10116.0,,Plasma,BAO_0000218,
Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,1,CHEMBL874592,Intermediate,,,A,N,1,9319,1969.0,Rattus norvegicus,,,50597,,4910,10116.0,,Plasma,BAO_0000218,
Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,1,CHEMBL626975,Intermediate,,,A,N,1,9320,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,1,CHEMBL626976,Intermediate,,,A,N,1,9321,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,1,CHEMBL626977,Intermediate,,,A,N,1,9322,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,1,CHEMBL626978,Intermediate,,,A,N,1,9323,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
PK study was carried to determine the relative absorption ranking in rat.,,1,CHEMBL626979,Intermediate,,,A,N,1,9324,,Rattus norvegicus,,,50597,,16427,10116.0,,,BAO_0000218,
Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,1,CHEMBL626980,Intermediate,,,A,N,1,9325,1969.0,Rattus norvegicus,In vivo,,50597,,4689,10116.0,,Plasma,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,1,CHEMBL626981,Intermediate,,,A,N,1,9326,178.0,Rattus norvegicus,,,50597,,11450,10116.0,,Blood,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,1,CHEMBL626982,Intermediate,,,A,N,1,9327,178.0,Rattus norvegicus,,,50597,,11450,10116.0,,Blood,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,1,CHEMBL626983,Intermediate,,,A,N,1,9328,178.0,Rattus norvegicus,,,50597,,11450,10116.0,,Blood,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,1,CHEMBL622522,Intermediate,,,A,N,1,9329,178.0,Rattus norvegicus,,,50597,,11450,10116.0,,Blood,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,1,CHEMBL622523,Intermediate,,,A,N,1,9330,178.0,Rattus norvegicus,,,50597,,11450,10116.0,,Blood,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,1,CHEMBL622524,Intermediate,,,A,N,1,9331,178.0,Rattus norvegicus,,,50597,,11450,10116.0,,Blood,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,1,CHEMBL622525,Intermediate,,,A,N,1,9332,955.0,Rattus norvegicus,,,50597,,11450,10116.0,,Brain,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,1,CHEMBL622526,Intermediate,,,A,N,1,9333,955.0,Rattus norvegicus,,,50597,,11450,10116.0,,Brain,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,1,CHEMBL619849,Intermediate,,,A,N,1,9334,955.0,Rattus norvegicus,,,50597,,11450,10116.0,,Brain,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,1,CHEMBL619850,Intermediate,,,A,N,1,9335,955.0,Rattus norvegicus,,,50597,,11450,10116.0,,Brain,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,1,CHEMBL623864,Intermediate,,,A,N,1,9336,955.0,Rattus norvegicus,,,50597,,11450,10116.0,,Brain,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,1,CHEMBL623865,Intermediate,,,A,N,1,9337,955.0,Rattus norvegicus,,,50597,,11450,10116.0,,Brain,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,1,CHEMBL623866,Intermediate,,,A,N,1,9338,948.0,Rattus norvegicus,,,50597,,11450,10116.0,,Heart,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,1,CHEMBL623867,Intermediate,,,A,N,1,9339,948.0,Rattus norvegicus,,,50597,,11450,10116.0,,Heart,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,1,CHEMBL877615,Intermediate,,,A,N,1,9340,948.0,Rattus norvegicus,,,50597,,11450,10116.0,,Heart,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,1,CHEMBL623868,Intermediate,,,A,N,1,9341,948.0,Rattus norvegicus,,,50597,,11450,10116.0,,Heart,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,1,CHEMBL623869,Intermediate,,,A,N,1,9342,948.0,Rattus norvegicus,,,50597,,11450,10116.0,,Heart,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,1,CHEMBL623870,Intermediate,,,A,N,1,9343,948.0,Rattus norvegicus,,,50597,,11450,10116.0,,Heart,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL623871,Intermediate,,,A,N,1,9344,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL623872,Intermediate,,,A,N,1,9345,2048.0,Rattus norvegicus,,,50597,,16434,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL622129,Intermediate,,,A,N,1,9346,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL622130,Intermediate,,,A,N,1,9347,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL622131,Intermediate,,,A,N,1,9348,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL622132,Intermediate,,,A,N,1,9349,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL622133,Intermediate,,,A,N,1,9350,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL622134,Intermediate,,,A,N,1,9351,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL622135,Intermediate,,,A,N,1,9352,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL622136,Intermediate,,,A,N,1,9353,2048.0,Rattus norvegicus,,,50597,,16435,10116.0,,Lung,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL622137,Intermediate,,,A,N,1,9354,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL622138,Intermediate,,,A,N,1,9355,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL623017,Intermediate,,,A,N,1,9356,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL623018,Intermediate,,,A,N,1,9357,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL623019,Intermediate,,,A,N,1,9358,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL623020,Intermediate,,,A,N,1,9359,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL623021,Intermediate,,,A,N,1,9360,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL623022,Intermediate,,,A,N,1,9361,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL623023,Intermediate,,,A,N,1,9362,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL623024,Intermediate,,,A,N,1,9363,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL623025,Intermediate,,,A,N,1,9364,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL620545,Intermediate,,,A,N,1,9365,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL620546,Intermediate,,,A,N,1,9366,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL620547,Intermediate,,,A,N,1,9367,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL620548,Intermediate,,,A,N,1,9368,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL620549,Intermediate,,,A,N,1,9369,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL620550,Intermediate,,,A,N,1,9370,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL620551,Intermediate,,,A,N,1,9371,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL620552,Intermediate,,,A,N,1,9372,2385.0,Rattus norvegicus,,,50597,,16434,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL620553,Intermediate,,,A,N,1,9373,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL620554,Intermediate,,,A,N,1,9374,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL875845,Intermediate,,,A,N,1,9375,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL620555,Intermediate,,,A,N,1,9376,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL620556,Intermediate,,,A,N,1,9377,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL620557,Intermediate,,,A,N,1,9378,2385.0,Rattus norvegicus,,,50597,,16435,10116.0,,Muscle tissue,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL620558,Intermediate,,,A,N,1,9379,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL620559,Intermediate,,,A,N,1,9380,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL622939,Intermediate,,,A,N,1,9381,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL622940,Intermediate,,,A,N,1,9382,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL622941,Intermediate,,,A,N,1,9383,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL622942,Intermediate,,,A,N,1,9384,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL622943,Intermediate,,,A,N,1,9385,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL622944,Intermediate,,,A,N,1,9386,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL622945,Intermediate,,,A,N,1,9387,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL622946,Intermediate,,,A,N,1,9388,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Compound was evaluated for terminal half life in rat,,1,CHEMBL622947,Intermediate,,,A,N,1,9389,,Rattus norvegicus,,,50597,,3341,10116.0,,,BAO_0000218,
Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,1,CHEMBL622948,Intermediate,,,A,N,1,9390,1969.0,Rattus norvegicus,In vivo,,50597,,3634,10116.0,,Plasma,BAO_0000218,
Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,1,CHEMBL622949,Intermediate,,,A,N,1,9391,1969.0,Rattus norvegicus,In vivo,,50597,,3634,10116.0,,Plasma,BAO_0000218,
Compound was tested for its half life in rat,,1,CHEMBL622950,Intermediate,,,A,N,1,9392,,Rattus norvegicus,,,50597,,4839,10116.0,,,BAO_0000218,
Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,0,CHEMBL622951,Intermediate,,,A,U,1,9393,1969.0,Macaca mulatta,In vivo,,22224,,5005,9544.0,,Plasma,BAO_0000218,
Compound was tested for its plasma half life in Sprague Dawley rats,,0,CHEMBL622952,Intermediate,,,A,U,1,9394,1969.0,Rattus norvegicus,,,22224,,5005,10116.0,,Plasma,BAO_0000366,
Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,0,CHEMBL622953,Intermediate,,,A,U,1,9395,1969.0,Rattus norvegicus,,,22224,,5005,10116.0,,Plasma,BAO_0000366,
Compound was tested for plasma half-life period in rat,,1,CHEMBL873818,Intermediate,,,A,N,1,9396,1969.0,Rattus norvegicus,,,50597,,1094,10116.0,,Plasma,BAO_0000218,
Elimination half life after i.v. administration of compound in rats,,1,CHEMBL622954,Intermediate,,,A,N,1,9397,,Rattus norvegicus,In vivo,,50597,,5031,10116.0,,,BAO_0000218,
Elimination half-life after IV dosing at 0.5 mg/kg in rat,,1,CHEMBL622955,Intermediate,,,A,N,1,9398,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Elimination half-life after IV dosing at 1 mg/kg in rat,,1,CHEMBL875229,Intermediate,,,A,N,1,9399,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,1,CHEMBL622956,Intermediate,,,A,N,1,9400,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,1,CHEMBL622957,Intermediate,,,A,N,1,9401,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,1,CHEMBL622958,Intermediate,,,A,N,1,9402,955.0,Rattus norvegicus,In vivo,,50597,,5408,10116.0,,Brain,BAO_0000218,
Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,1,CHEMBL622959,Intermediate,,,A,N,1,9403,1969.0,Rattus norvegicus,In vivo,,50597,,5408,10116.0,,Plasma,BAO_0000218,
Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,1,CHEMBL622960,Intermediate,,,A,N,1,9404,955.0,Rattus norvegicus,In vivo,,50597,,5408,10116.0,,Brain,BAO_0000218,
Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,1,CHEMBL622961,Intermediate,,,A,N,1,9405,1969.0,Rattus norvegicus,In vivo,,50597,,5408,10116.0,,Plasma,BAO_0000218,
Evaluated for the half life in rat (in vivo),,1,CHEMBL622962,Intermediate,,,A,N,1,9406,,Rattus norvegicus,In vivo,,50597,,4687,10116.0,,,BAO_0000218,
Hafl life in rat,,1,CHEMBL622963,Intermediate,,,A,N,1,9407,,Rattus norvegicus,,,50597,,6640,10116.0,,,BAO_0000218,
Hafl life rat,,1,CHEMBL622964,Intermediate,,,A,N,1,9408,,Rattus norvegicus,,,50597,,6640,10116.0,,,BAO_0000218,
Hafl life rat,,1,CHEMBL622965,Intermediate,,,A,N,1,9409,,Rattus norvegicus,,,50597,,6641,10116.0,,,BAO_0000218,
Hafl life rat; Not determined,,1,CHEMBL622966,Intermediate,,,A,N,1,9410,,Rattus norvegicus,,,50597,,6640,10116.0,,,BAO_0000218,
Hafl life rat; Not determined,,1,CHEMBL622967,Intermediate,,,A,N,1,9411,,Rattus norvegicus,,,50597,,6641,10116.0,,,BAO_0000218,
Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL622968,Intermediate,,,A,N,1,9412,2113.0,Rattus norvegicus,In vivo,,50597,,17411,10116.0,,Kidney,BAO_0000218,
Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL622969,Intermediate,,,A,N,1,9413,2107.0,Rattus norvegicus,In vivo,,50597,,17411,10116.0,,Liver,BAO_0000218,
Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL875327,Intermediate,,,A,N,1,9414,2048.0,Rattus norvegicus,In vivo,,50597,,17411,10116.0,,Lung,BAO_0000218,
Half life in rat after 1 mg/kg i.v. administration,,1,CHEMBL628638,Intermediate,,,A,N,1,9415,,Rattus norvegicus,In vivo,,50597,,6570,10116.0,,,BAO_0000218,
Half life in rat after 2 mg/kg peroral administration,,1,CHEMBL628639,Intermediate,,,A,N,1,9416,,Rattus norvegicus,In vivo,,50597,,6570,10116.0,,,BAO_0000218,
Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL625840,Intermediate,,,A,N,1,9417,,Rattus norvegicus,In vivo,,50597,,17411,10116.0,,,BAO_0000218,
Half life of 10 mg/kg oral dose determined in rats,,1,CHEMBL625841,Intermediate,,,A,N,1,9418,,Rattus norvegicus,In vivo,,50597,,4722,10116.0,,,BAO_0000218,
Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL625842,Intermediate,,,A,N,1,9419,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL625843,Intermediate,,,A,N,1,9420,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL625844,Intermediate,,,A,N,1,9421,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL873822,Intermediate,,,A,N,1,9422,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL625845,Intermediate,,,A,N,1,9423,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL627059,Intermediate,,,A,N,1,9424,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL627060,Intermediate,,,A,N,1,9425,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,1,CHEMBL627061,Intermediate,,,A,N,1,9426,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Half life of compound at 5 mg/kg after po administration was determined in rat,,1,CHEMBL627709,Intermediate,,,A,N,1,9427,,Rattus norvegicus,In vivo,,50597,,4762,10116.0,,,BAO_0000218,
Half life of compound determined after intravenous administration to rat,,1,CHEMBL627710,Intermediate,,,A,N,1,9428,,Rattus norvegicus,In vivo,,50597,,5327,10116.0,,,BAO_0000218,
Half life of compound was determined in rat,,1,CHEMBL627711,Intermediate,,,A,N,1,9429,,Rattus norvegicus,,,50597,,4847,10116.0,,,BAO_0000218,
Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,1,CHEMBL627712,Intermediate,,,A,N,1,9430,1969.0,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,Plasma,BAO_0000218,
Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL627713,Intermediate,,,A,N,1,9431,,Rattus norvegicus,In vivo,,50597,,4723,10116.0,,,BAO_0000218,
Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL627714,Intermediate,,,A,N,1,9432,,Rattus norvegicus,In vivo,,50597,,4723,10116.0,,,BAO_0000218,
Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,0,CHEMBL627889,Intermediate,,,A,U,1,9433,,Macaca fascicularis,In vivo,,22224,,4256,9541.0,,,BAO_0000218,
Half life determined in rat by intravenous administration,,0,CHEMBL627890,Intermediate,,,A,U,1,9434,,Rattus norvegicus,In vivo,,22224,,4256,10116.0,,,BAO_0000218,
Half life determined in rats after iv administration,,1,CHEMBL627891,Intermediate,,,A,N,1,9435,,Rattus norvegicus,In vivo,,50597,,4722,10116.0,,,BAO_0000218,
Half life in rat plasma after administration of 2 mg/kg iv,,1,CHEMBL627892,Intermediate,,,A,N,1,9436,1969.0,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,Plasma,BAO_0000218,
Half life in rat plasma after administration of 2 mg/kg iv,,1,CHEMBL627893,Intermediate,,,A,N,1,9437,1969.0,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,Plasma,BAO_0000218,
Half life in rat plasma was determined,,1,CHEMBL627894,Intermediate,,,A,N,1,9438,1969.0,Rattus norvegicus,,,50597,,1435,10116.0,,Plasma,BAO_0000218,
Half life in rat plasma was determined; NA means not applicable,,1,CHEMBL627895,Intermediate,,,A,N,1,9439,1969.0,Rattus norvegicus,,,50597,,1435,10116.0,,Plasma,BAO_0000218,
Half life in rat was tested,,1,CHEMBL627896,Intermediate,,,A,N,1,9440,,Rattus norvegicus,,,50597,,5206,10116.0,,,BAO_0000218,
Half life measured in rat plasma,,1,CHEMBL627897,Intermediate,,,A,N,1,9441,1969.0,Rattus norvegicus,,,50597,,6080,10116.0,,Plasma,BAO_0000218,
Half life recorded in rats,,1,CHEMBL627898,Intermediate,,,A,N,1,9442,,Rattus norvegicus,,,50597,,4449,10116.0,,,BAO_0000218,
Half life was calculated,,1,CHEMBL627899,Intermediate,,,A,N,1,9443,,Rattus norvegicus,,,50597,,6057,10116.0,,,BAO_0000218,
Half life was calculated in rat,,1,CHEMBL873823,Intermediate,,,A,N,1,9444,,Rattus norvegicus,,,50597,,6057,10116.0,,,BAO_0000218,
Half life was determined,,1,CHEMBL627900,Intermediate,,,A,N,1,9445,,Rattus norvegicus,,,50597,,3747,10116.0,,,BAO_0000218,
Half life after 10 mg/kg oral administration in rat,,1,CHEMBL627901,Intermediate,,,A,N,1,9446,,Rattus norvegicus,In vivo,,50597,,17858,10116.0,,,BAO_0000218,
Half life after administering orally a dose of 10 mg/kg to a fasting rat,,1,CHEMBL627902,Intermediate,,,A,N,1,9447,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Half life after administering orally a dose of 30 mg/kg,,1,CHEMBL627903,Intermediate,,,A,N,1,9448,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,1,CHEMBL627904,Intermediate,,,A,N,1,9449,,Rattus norvegicus,,,50597,,5031,10116.0,,,BAO_0000218,
Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,1,CHEMBL627905,Intermediate,,,A,N,1,9450,,Rattus norvegicus,,,50597,,4722,10116.0,,,BAO_0000218,
Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,1,CHEMBL627906,Intermediate,,,A,N,1,9451,,Rattus norvegicus,,,50597,,6078,10116.0,,,BAO_0000218,
Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,1,CHEMBL627907,Intermediate,,,A,N,1,9452,,Rattus norvegicus,,,50597,,6078,10116.0,,,BAO_0000218,
Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,1,CHEMBL876783,Intermediate,,,A,N,1,9453,,Rattus norvegicus,,,50597,,6078,10116.0,,,BAO_0000218,
Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,1,CHEMBL627908,Intermediate,,,A,N,1,9454,,Rattus norvegicus,,,50597,,6078,10116.0,,,BAO_0000218,
Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,1,CHEMBL627909,Intermediate,,,A,N,1,9455,,Rattus norvegicus,,,50597,,17065,10116.0,,,BAO_0000218,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,1,CHEMBL627910,Intermediate,,,A,N,1,9456,,Rattus norvegicus,,,50597,,1353,10116.0,,,BAO_0000218,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,1,CHEMBL627911,Intermediate,,,A,N,1,9457,,Rattus norvegicus,,,50597,,1353,10116.0,,,BAO_0000218,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,1,CHEMBL627912,Intermediate,,,A,N,1,9458,,Rattus norvegicus,,,50597,,1353,10116.0,,,BAO_0000218,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,1,CHEMBL627913,Intermediate,,,A,N,1,9459,,Rattus norvegicus,,,50597,,1353,10116.0,,,BAO_0000218,
Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,1,CHEMBL627914,Intermediate,,,A,N,1,9460,,Rattus norvegicus,,,50597,,1353,10116.0,,,BAO_0000218,
Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,1,CHEMBL627915,Intermediate,,,A,N,1,9461,,Rattus norvegicus,,,50597,,16423,10116.0,,,BAO_0000218,
Area under the curve was evaluated after 20 uM/kg of peroral administration,,1,CHEMBL627916,Intermediate,,,A,N,1,9462,,Rattus norvegicus,,,50597,,16423,10116.0,,,BAO_0000218,
Area under the curve was measured in rat after an iv dose of 1 mg/kg,,1,CHEMBL627917,Intermediate,,,A,N,1,9463,,Rattus norvegicus,,,50597,,6062,10116.0,,,BAO_0000218,
Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,1,CHEMBL627918,Intermediate,,,A,N,1,9464,,Rattus norvegicus,,,50597,,6056,10116.0,,,BAO_0000218,
Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,1,CHEMBL627919,Intermediate,,,A,N,1,9465,,Rattus norvegicus,,,50597,,5182,10116.0,,,BAO_0000218,
Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,1,CHEMBL627920,Intermediate,,,A,N,1,9466,,Rattus norvegicus,,,50597,,6410,10116.0,,,BAO_0000218,
Area under the curve was evaluated at an oral dose of 30 mg/kg,,1,CHEMBL627921,Intermediate,,,A,N,1,9467,,Rattus norvegicus,,,50597,,6410,10116.0,,,BAO_0000218,
Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL627922,Intermediate,,,A,N,1,9468,,Rattus norvegicus,,,50597,,4723,10116.0,,,BAO_0000218,
Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL876784,Intermediate,,,A,N,1,9469,,Rattus norvegicus,,,50597,,4723,10116.0,,,BAO_0000218,
Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL627923,Intermediate,,,A,N,1,9470,,Rattus norvegicus,,,50597,,4723,10116.0,,,BAO_0000218,
Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL626208,Intermediate,,,A,N,1,9471,,Rattus norvegicus,,,50597,,4723,10116.0,,,BAO_0000218,
Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL626209,Intermediate,,,A,N,1,9472,,Rattus norvegicus,,,50597,,4723,10116.0,,,BAO_0000218,
Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL626210,Intermediate,,,A,N,1,9473,,Rattus norvegicus,,,50597,,4723,10116.0,,,BAO_0000218,
Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,1,CHEMBL627994,Intermediate,,,A,N,1,9474,1969.0,Rattus norvegicus,,,50597,,2463,10116.0,,Plasma,BAO_0000218,
Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,1,CHEMBL627995,Intermediate,,,A,N,1,9475,,Rattus norvegicus,,,50597,,4709,10116.0,,,BAO_0000218,
Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,1,CHEMBL627996,Intermediate,,,A,N,1,9476,,Rattus norvegicus,,,50597,,4075,10116.0,,,BAO_0000218,
Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,1,CHEMBL627997,Intermediate,,,A,N,1,9477,,Rattus norvegicus,,,50597,,5394,10116.0,,,BAO_0000218,
Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,1,CHEMBL627998,Intermediate,,,A,N,1,9478,,Rattus norvegicus,,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,1,CHEMBL628640,Intermediate,,,A,N,1,9479,,Rattus norvegicus,,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,1,CHEMBL628641,Intermediate,,,A,N,1,9480,,Rattus norvegicus,,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,1,CHEMBL628642,Intermediate,,,A,N,1,9481,,Rattus norvegicus,,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for area under the curve expressed as (h*ug/ml),,1,CHEMBL628643,Intermediate,,,A,N,1,9482,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Compound was tested for area under curve in rat,,1,CHEMBL628644,Intermediate,,,A,N,1,9483,,Rattus norvegicus,,,50597,,2591,10116.0,,,BAO_0000218,
Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,1,CHEMBL628645,Intermediate,,,A,N,1,9484,,Rattus norvegicus,,,50597,,6567,10116.0,,,BAO_0000218,
Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,1,CHEMBL628646,Intermediate,,,A,N,1,9485,,Rattus norvegicus,,,50597,,6211,10116.0,,,BAO_0000218,
Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,1,CHEMBL628647,Intermediate,,,A,N,1,9486,,Rattus norvegicus,,,50597,,5529,10116.0,,,BAO_0000218,
Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,1,CHEMBL628648,Intermediate,,,A,N,1,9487,,Rattus norvegicus,,,50597,,5408,10116.0,,,BAO_0000218,
Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,1,CHEMBL625358,Intermediate,,,A,N,1,9488,,Rattus norvegicus,,,50597,,5408,10116.0,,,BAO_0000218,
Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,1,CHEMBL625359,Intermediate,,,A,N,1,9489,,Rattus norvegicus,,,50597,,5408,10116.0,,,BAO_0000218,
Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,1,CHEMBL625360,Intermediate,,,A,N,1,9490,,Rattus norvegicus,,,50597,,5408,10116.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,1,CHEMBL625361,Intermediate,,,A,N,1,9491,,Rattus norvegicus,,,50597,,429,10116.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,1,CHEMBL625362,Intermediate,,,A,N,1,9492,,Rattus norvegicus,,,50597,,429,10116.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,1,CHEMBL625363,Intermediate,,,A,N,1,9493,,Rattus norvegicus,,,50597,,429,10116.0,,,BAO_0000218,
Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,1,CHEMBL625364,Intermediate,,,A,N,1,9494,,Rattus norvegicus,,,50597,,4796,10116.0,,,BAO_0000218,
In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL625365,Intermediate,,,A,N,1,9495,,Rattus norvegicus,,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL625366,Intermediate,,,A,N,1,9496,,Rattus norvegicus,,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL625367,Intermediate,,,A,N,1,9497,,Rattus norvegicus,,,50597,,5974,10116.0,,,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,1,CHEMBL625368,Intermediate,,,A,N,1,9498,2113.0,Rattus norvegicus,,,50597,,11450,10116.0,,Kidney,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,1,CHEMBL625369,Intermediate,,,A,N,1,9499,2113.0,Rattus norvegicus,,,50597,,11450,10116.0,,Kidney,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,1,CHEMBL625370,Intermediate,,,A,N,1,9500,2113.0,Rattus norvegicus,,,50597,,11450,10116.0,,Kidney,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,1,CHEMBL625371,Intermediate,,,A,N,1,9501,2113.0,Rattus norvegicus,,,50597,,11450,10116.0,,Kidney,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,1,CHEMBL625372,Intermediate,,,A,N,1,9502,2113.0,Rattus norvegicus,,,50597,,11450,10116.0,,Kidney,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,1,CHEMBL625373,Intermediate,,,A,N,1,9503,2113.0,Rattus norvegicus,,,50597,,11450,10116.0,,Kidney,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,1,CHEMBL625374,Intermediate,,,A,N,1,9504,2107.0,Rattus norvegicus,,,50597,,11450,10116.0,,Liver,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,1,CHEMBL877593,Intermediate,,,A,N,1,9505,2107.0,Rattus norvegicus,,,50597,,11450,10116.0,,Liver,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,1,CHEMBL625375,Intermediate,,,A,N,1,9506,2107.0,Rattus norvegicus,,,50597,,11450,10116.0,,Liver,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,1,CHEMBL625376,Intermediate,,,A,N,1,9507,2107.0,Rattus norvegicus,,,50597,,11450,10116.0,,Liver,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,1,CHEMBL621973,Intermediate,,,A,N,1,9508,2107.0,Rattus norvegicus,,,50597,,11450,10116.0,,Liver,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,1,CHEMBL621974,Intermediate,,,A,N,1,9509,2107.0,Rattus norvegicus,,,50597,,11450,10116.0,,Liver,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,1,CHEMBL621975,Intermediate,,,A,N,1,9510,2048.0,Rattus norvegicus,,,50597,,11450,10116.0,,Lung,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,1,CHEMBL622166,Intermediate,,,A,N,1,9511,2048.0,Rattus norvegicus,,,50597,,11450,10116.0,,Lung,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,1,CHEMBL622167,Intermediate,,,A,N,1,9512,2048.0,Rattus norvegicus,,,50597,,11450,10116.0,,Lung,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,1,CHEMBL622168,Intermediate,,,A,N,1,9513,2048.0,Rattus norvegicus,,,50597,,11450,10116.0,,Lung,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,1,CHEMBL622169,Intermediate,,,A,N,1,9514,2048.0,Rattus norvegicus,,,50597,,11450,10116.0,,Lung,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,1,CHEMBL622170,Intermediate,,,A,N,1,9515,2048.0,Rattus norvegicus,,,50597,,11450,10116.0,,Lung,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,1,CHEMBL622171,Intermediate,,,A,N,1,9516,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,1,CHEMBL622172,Intermediate,,,A,N,1,9517,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,1,CHEMBL622173,Intermediate,,,A,N,1,9518,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,1,CHEMBL622174,Intermediate,,,A,N,1,9519,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,1,CHEMBL622175,Intermediate,,,A,N,1,9520,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,1,CHEMBL622176,Intermediate,,,A,N,1,9521,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,1,CHEMBL622177,Intermediate,,,A,N,1,9522,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,1,CHEMBL622178,Intermediate,,,A,N,1,9523,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,1,CHEMBL622179,Intermediate,,,A,N,1,9524,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,1,CHEMBL622180,Intermediate,,,A,N,1,9525,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL622181,Intermediate,,,A,N,1,9526,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL622182,Intermediate,,,A,N,1,9527,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL622183,Intermediate,,,A,N,1,9528,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL622184,Intermediate,,,A,N,1,9529,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL622185,Intermediate,,,A,N,1,9530,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL622186,Intermediate,,,A,N,1,9531,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL622187,Intermediate,,,A,N,1,9532,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL625002,Intermediate,,,A,N,1,9533,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL622090,Intermediate,,,A,N,1,9534,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL622091,Intermediate,,,A,N,1,9535,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL622092,Intermediate,,,A,N,1,9536,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL622093,Intermediate,,,A,N,1,9537,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL622094,Intermediate,,,A,N,1,9538,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL622095,Intermediate,,,A,N,1,9539,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL622264,Intermediate,,,A,N,1,9540,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL622265,Intermediate,,,A,N,1,9541,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL622266,Intermediate,,,A,N,1,9542,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL622267,Intermediate,,,A,N,1,9543,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL622268,Intermediate,,,A,N,1,9544,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL622269,Intermediate,,,A,N,1,9545,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL625071,Intermediate,,,A,N,1,9546,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL621621,Intermediate,,,A,N,1,9547,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL621622,Intermediate,,,A,N,1,9548,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL621623,Intermediate,,,A,N,1,9549,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL621624,Intermediate,,,A,N,1,9550,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL621625,Intermediate,,,A,N,1,9551,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL621626,Intermediate,,,A,N,1,9552,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL621627,Intermediate,,,A,N,1,9553,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL621628,Intermediate,,,A,N,1,9554,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL875328,Intermediate,,,A,N,1,9555,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL621629,Intermediate,,,A,N,1,9556,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL621630,Intermediate,,,A,N,1,9557,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL621631,Intermediate,,,A,N,1,9558,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL621632,Intermediate,,,A,N,1,9559,2106.0,Rattus norvegicus,,,50597,,16434,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL621633,Intermediate,,,A,N,1,9560,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL621634,Intermediate,,,A,N,1,9561,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL621635,Intermediate,,,A,N,1,9562,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL621636,Intermediate,,,A,N,1,9563,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL621637,Intermediate,,,A,N,1,9564,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL621638,Intermediate,,,A,N,1,9565,2106.0,Rattus norvegicus,,,50597,,16435,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL618883,Intermediate,,,A,N,1,9566,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,CHEMBL618884,Intermediate,,,A,N,1,9567,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL628627,Intermediate,,,A,N,1,9568,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL628628,Intermediate,,,A,N,1,9569,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,CHEMBL628629,Intermediate,,,A,N,1,9570,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Half life after administering orally a dose of 3 mg/kg,,1,CHEMBL628630,Intermediate,,,A,N,1,9571,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Half life after administering orally a dose of 3 mg/kg to a fasting rat,,1,CHEMBL628631,Intermediate,,,A,N,1,9572,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Half life after administering intravenously a dose of 1 mg/kg,,1,CHEMBL628632,Intermediate,,,A,N,1,9573,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Half life after oral dosing in rats,,1,CHEMBL628633,Intermediate,,,A,N,1,9574,,Rattus norvegicus,In vivo,,50597,,526,10116.0,,,BAO_0000218,
Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,1,CHEMBL628634,Intermediate,,,A,N,1,9575,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Half life by intravenous administration of 3.4 mg/kg in rat,,1,CHEMBL627789,Intermediate,,,A,N,1,9576,,Rattus norvegicus,In vivo,,50597,,4368,10116.0,,,BAO_0000218,
Half life in rat,,1,CHEMBL627790,Intermediate,,,A,N,1,9577,,Rattus norvegicus,,,50597,,3371,10116.0,,,BAO_0000218,
Half life in rat,,1,CHEMBL627791,Intermediate,,,A,N,1,9578,,Rattus norvegicus,,,50597,,6448,10116.0,,,BAO_0000218,
Half life in rat,,1,CHEMBL627792,Intermediate,,,A,N,1,9579,,Rattus norvegicus,,,50597,,6453,10116.0,,,BAO_0000218,
Half life in rat after intravenous administration of the compound,,1,CHEMBL627793,Intermediate,,,A,N,1,9580,,Rattus norvegicus,In vivo,,50597,,4353,10116.0,,,BAO_0000218,
Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,1,CHEMBL627794,Intermediate,,,A,N,1,9581,1969.0,Rattus norvegicus,In vivo,,50597,,4353,10116.0,,Plasma,BAO_0000218,
Half life in rat after po administration of the compound,,1,CHEMBL627795,Intermediate,,,A,N,1,9582,,Rattus norvegicus,In vivo,,50597,,4353,10116.0,,,BAO_0000218,
Half life in rat after po administration of the compound; ND means Not determined,,1,CHEMBL627796,Intermediate,,,A,N,1,9583,,Rattus norvegicus,In vivo,,50597,,4353,10116.0,,,BAO_0000218,
Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,1,CHEMBL875335,Intermediate,,,A,N,1,9584,1969.0,Rattus norvegicus,In vivo,,50597,,4353,10116.0,,Plasma,BAO_0000218,
Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,1,CHEMBL627797,Intermediate,,,A,N,1,9585,1969.0,Rattus norvegicus,In vivo,,50597,,4353,10116.0,,Plasma,BAO_0000218,
Half life in rat i.v.,,1,CHEMBL627798,Intermediate,,,A,N,1,9586,,Rattus norvegicus,In vivo,,50597,,5789,10116.0,,,BAO_0000218,
Half life in rat i.v. at 2 mg/kg concentration,,1,CHEMBL627799,Intermediate,,,A,N,1,9587,,Rattus norvegicus,In vivo,,50597,,17686,10116.0,,,BAO_0000218,
Half life in rats,,1,CHEMBL627800,Intermediate,,,A,N,1,9588,,Rattus norvegicus,,,50597,,6495,10116.0,,,BAO_0000218,
Half life in rats after intravenous administration,,1,CHEMBL627801,Intermediate,,,A,N,1,9589,,Rattus norvegicus,In vivo,,50597,,484,10116.0,,,BAO_0000218,
Half life in rats at the dose of 1.0 mpk by i.v. administration,,1,CHEMBL627802,Intermediate,,,A,N,1,9590,,Rattus norvegicus,In vivo,,50597,,6467,10116.0,,,BAO_0000218,
Half life in rat,,1,CHEMBL627803,Expert,,,A,N,1,9591,,Rattus norvegicus,,,50597,,6642,10116.0,,,BAO_0000218,
Half life was evaluated after intravenous administration to rats,,1,CHEMBL873820,Intermediate,,,A,N,1,9592,,Rattus norvegicus,In vivo,,50597,,16367,10116.0,,,BAO_0000218,
Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,1,CHEMBL627804,Intermediate,,,A,N,1,9593,,Rattus norvegicus,,,50597,,1369,10116.0,,,BAO_0000218,
Half life was evaluated in rat,,1,CHEMBL627805,Intermediate,,,A,N,1,9594,,Rattus norvegicus,,,50597,,5472,10116.0,,,BAO_0000218,
Half life was evaluated in rat,,1,CHEMBL627806,Intermediate,,,A,N,1,9595,,Rattus norvegicus,,,50597,,6049,10116.0,,,BAO_0000218,
Half life was evaluated in rat; Not tested,,1,CHEMBL627107,Intermediate,,,A,N,1,9596,,Rattus norvegicus,,,50597,,5472,10116.0,,,BAO_0000218,
Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,1,CHEMBL627108,Intermediate,,,A,N,1,9597,,Rattus norvegicus,In vivo,,50597,,16366,10116.0,,,BAO_0000218,
Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,1,CHEMBL627109,Intermediate,,,A,N,1,9598,,Rattus norvegicus,In vivo,,50597,,11149,10116.0,,,BAO_0000218,
Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,1,CHEMBL627110,Intermediate,,,A,N,1,9599,178.0,Rattus norvegicus,In vivo,,50597,,11149,10116.0,,Blood,BAO_0000218,
Half life was measured in monkey at dose of 10 mg/kg by po administration,,0,CHEMBL627111,Intermediate,,,A,U,1,9600,,Primates,In vivo,,22224,,2891,9443.0,,,BAO_0000218,
Half life was measured in monkey at dose of 10 mg/kg by po administration,,0,CHEMBL627112,Intermediate,,,A,U,1,9601,,Primates,In vivo,,22224,,2891,9443.0,,,BAO_0000218,
Half life was measured in rat at dose of 30 mg/kg by iv administration,,0,CHEMBL627113,Intermediate,,,A,U,1,9602,,Rattus norvegicus,In vivo,,22224,,2891,10116.0,,,BAO_0000218,
Half life was measured in rat at dose of 30 mg/kg by po administration,,0,CHEMBL627114,Intermediate,,,A,U,1,9603,,Rattus norvegicus,In vivo,,22224,,2891,10116.0,,,BAO_0000218,
Half life (t1/2) was determined,,1,CHEMBL627115,Intermediate,,,A,N,1,9604,,Rattus norvegicus,,,50597,,4026,10116.0,,,BAO_0000218,
Half life period at a dose of 10 uM/kg in rat was determined,,1,CHEMBL627116,Intermediate,,,A,N,1,9605,,Rattus norvegicus,,,50597,,4527,10116.0,,,BAO_0000218,
Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,1,CHEMBL627117,Intermediate,,,A,N,1,9606,,Rattus norvegicus,In vivo,,50597,,4527,10116.0,,,BAO_0000218,
Half life period was determined,,1,CHEMBL627118,Intermediate,,,A,N,1,9607,,Rattus norvegicus,,,50597,,5503,10116.0,,,BAO_0000218,
Half life period after intravenous administration at 20 mpk in rats,,1,CHEMBL627119,Intermediate,,,A,N,1,9608,,Rattus norvegicus,In vivo,,50597,,4426,10116.0,,,BAO_0000218,
Half life period after intravenous administration at 20 mpk in rats; Not performed.,,1,CHEMBL627120,Intermediate,,,A,N,1,9609,,Rattus norvegicus,In vivo,,50597,,4426,10116.0,,,BAO_0000218,
Half life period after intravenous administration in rat,,1,CHEMBL626922,Intermediate,,,A,N,1,9610,,Rattus norvegicus,In vivo,,50597,,6109,10116.0,,,BAO_0000218,
Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,1,CHEMBL626923,Intermediate,,,A,N,1,9611,,Rattus norvegicus,In vivo,,50597,,5654,10116.0,,,BAO_0000218,
Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,1,CHEMBL626924,Intermediate,,,A,N,1,9612,,Rattus norvegicus,In vivo,,50597,,5654,10116.0,,,BAO_0000218,
Half life period in 80% rat plasma at 37 degree Centigrade,,1,CHEMBL626925,Intermediate,,,A,N,1,9613,1969.0,Rattus norvegicus,,,50597,,4755,10116.0,,Plasma,BAO_0000218,
Half life period in SD rats,,1,CHEMBL626926,Intermediate,,,A,N,1,9614,,Rattus norvegicus,,,50597,,5862,10116.0,,,BAO_0000218,
Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,1,CHEMBL626927,Intermediate,,,A,N,1,9615,1969.0,Rattus norvegicus,,,50597,,1515,10116.0,,Plasma,BAO_0000218,
Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,1,CHEMBL626928,Intermediate,,,A,N,1,9616,1969.0,Rattus norvegicus,,,50597,,1515,10116.0,,Plasma,BAO_0000218,
Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1,CHEMBL626929,Intermediate,,,A,N,1,9617,1969.0,Rattus norvegicus,,,50597,,1515,10116.0,,Plasma,BAO_0000218,
Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1,CHEMBL626930,Intermediate,,,A,N,1,9618,1969.0,Rattus norvegicus,,,50597,,1515,10116.0,,Plasma,BAO_0000218,
Half life period in rat,,1,CHEMBL626931,Intermediate,,,A,N,1,9619,,Rattus norvegicus,,,50597,,5960,10116.0,,,BAO_0000218,
Half life period in rat,,1,CHEMBL626932,Intermediate,,,A,N,1,9620,,Rattus norvegicus,,,50597,,6103,10116.0,,,BAO_0000218,
Half life period in rat,,1,CHEMBL626933,Intermediate,,,A,N,1,9621,,Rattus norvegicus,,,50597,,6317,10116.0,,,BAO_0000218,
Half life period in rat after oral administration at 10.5 mg/kg dose,,1,CHEMBL873826,Intermediate,,,A,N,1,9622,,Rattus norvegicus,In vivo,,50597,,6644,10116.0,,,BAO_0000218,
Half life period in rat after oral administration at 11.2 mg/kg dose,,1,CHEMBL626934,Intermediate,,,A,N,1,9623,,Rattus norvegicus,In vivo,,50597,,6644,10116.0,,,BAO_0000218,
Half life period in rat after oral administration at 13 mg/kg dose,,1,CHEMBL626935,Intermediate,,,A,N,1,9624,,Rattus norvegicus,In vivo,,50597,,6644,10116.0,,,BAO_0000218,
Half life period in rat after oral administration at 9.7 mg/kg dose,,1,CHEMBL626936,Intermediate,,,A,N,1,9625,,Rattus norvegicus,In vivo,,50597,,6644,10116.0,,,BAO_0000218,
In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL626937,Intermediate,,,A,N,1,9626,,Rattus norvegicus,,,50597,,5974,10116.0,,,BAO_0000218,
In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,1,CHEMBL625906,Intermediate,,,A,N,1,9627,,Rattus norvegicus,,,50597,,6295,10116.0,,,BAO_0000218,
In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,1,CHEMBL625907,Intermediate,,,A,N,1,9628,,Rattus norvegicus,,,50597,,6296,10116.0,,,BAO_0000218,
PK study was carried to determine AUC (area under curve) value in rat,,1,CHEMBL625908,Intermediate,,,A,N,1,9629,,Rattus norvegicus,,,50597,,16427,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC after intravenous administration to rats,,1,CHEMBL625909,Intermediate,,,A,N,1,9630,,Rattus norvegicus,,,50597,,16367,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC after oral administration to rats,,1,CHEMBL625910,Intermediate,,,A,N,1,9631,,Rattus norvegicus,,,50597,,16367,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,1,CHEMBL625911,Intermediate,,,A,N,1,9632,,Rattus norvegicus,,,50597,,16365,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,1,CHEMBL625912,Intermediate,,,A,N,1,9633,,Rattus norvegicus,,,50597,,16365,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,1,CHEMBL626538,Intermediate,,,A,N,1,9634,,Rattus norvegicus,,,50597,,16365,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,1,CHEMBL876794,Intermediate,,,A,N,1,9635,,Rattus norvegicus,,,50597,,16365,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,1,CHEMBL626539,Intermediate,,,A,N,1,9636,,Rattus norvegicus,,,50597,,16365,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,1,CHEMBL626540,Intermediate,,,A,N,1,9637,,Rattus norvegicus,,,50597,,16365,10116.0,,,BAO_0000218,
Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,1,CHEMBL626541,Intermediate,,,A,N,1,9638,,Rattus norvegicus,,,50597,,5394,10116.0,,,BAO_0000218,
Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,1,CHEMBL626542,Intermediate,,,A,N,1,9639,,Rattus norvegicus,,,50597,,5394,10116.0,,,BAO_0000218,
Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,1,CHEMBL626543,Intermediate,,,A,N,1,9640,,Rattus norvegicus,,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,1,CHEMBL626544,Intermediate,,,A,N,1,9641,,Rattus norvegicus,,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,1,CHEMBL626545,Intermediate,,,A,N,1,9642,,Rattus norvegicus,,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,1,CHEMBL626546,Intermediate,,,A,N,1,9643,,Rattus norvegicus,,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter area under curve was reported,,1,CHEMBL626547,Intermediate,,,A,N,1,9644,,Rattus norvegicus,,,50597,,5334,10116.0,,,BAO_0000218,
Pharmacokinetic property (AUC) in rat,,1,CHEMBL626548,Intermediate,,,A,N,1,9645,,Rattus norvegicus,,,50597,,4408,10116.0,,,BAO_0000218,
Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,1,CHEMBL626549,Intermediate,,,A,N,1,9646,,Rattus norvegicus,,,50597,,5983,10116.0,,,BAO_0000218,
Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,1,CHEMBL626550,Intermediate,,,A,N,1,9647,,Rattus norvegicus,,,50597,,4397,10116.0,,,BAO_0000218,
Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,1,CHEMBL626551,Intermediate,,,A,N,1,9648,,Rattus norvegicus,,,50597,,4397,10116.0,,,BAO_0000218,
Pharmacokinetic property was determined,,1,CHEMBL623777,Intermediate,,,A,N,1,9649,,Rattus norvegicus,,,50597,,5491,10116.0,,,BAO_0000218,
Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,1,CHEMBL623778,Intermediate,,,A,N,1,9650,,Rattus norvegicus,,,50597,,5491,10116.0,,,BAO_0000218,
Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,1,CHEMBL623779,Intermediate,,,A,N,1,9651,,Rattus norvegicus,,,50597,,5491,10116.0,,,BAO_0000218,
Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,1,CHEMBL623780,Intermediate,,,A,N,1,9652,1969.0,Rattus norvegicus,,,50597,,4199,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,1,CHEMBL622015,Intermediate,,,A,N,1,9653,1969.0,Rattus norvegicus,,,50597,,4199,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,1,CHEMBL622016,Intermediate,,,A,N,1,9654,1969.0,Rattus norvegicus,,,50597,,4199,10116.0,,Plasma,BAO_0000218,
"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,1,CHEMBL622017,Intermediate,,,A,N,1,9655,,Rattus norvegicus,,,50597,,5173,10116.0,,,BAO_0000218,
"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,1,CHEMBL622018,Intermediate,,,A,N,1,9656,,Rattus norvegicus,,,50597,,5173,10116.0,,,BAO_0000218,
"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,1,CHEMBL622019,Intermediate,,,A,N,1,9657,,Rattus norvegicus,,,50597,,5173,10116.0,,,BAO_0000218,
"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,1,CHEMBL622020,Intermediate,,,A,N,1,9658,,Rattus norvegicus,,,50597,,5173,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,1,CHEMBL622021,Intermediate,,,A,N,1,9659,,Rattus norvegicus,,,50597,,16366,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,1,CHEMBL622022,Intermediate,,,A,N,1,9660,,Rattus norvegicus,,,50597,,16366,10116.0,,,BAO_0000218,
Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,1,CHEMBL622023,Intermediate,,,A,N,1,9661,,Rattus norvegicus,,,50597,,5327,10116.0,,,BAO_0000218,
Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,1,CHEMBL622024,Intermediate,,,A,N,1,9662,,Rattus norvegicus,,,50597,,6681,10116.0,,,BAO_0000218,
Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,1,CHEMBL622693,Intermediate,,,A,N,1,9663,,Rattus norvegicus,,,50597,,12873,10116.0,,,BAO_0000218,
Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,1,CHEMBL622694,Intermediate,,,A,N,1,9664,,Rattus norvegicus,,,50597,,12873,10116.0,,,BAO_0000218,
"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,1,CHEMBL622695,Intermediate,,,A,N,1,9665,,Rattus norvegicus,,,50597,,6685,10116.0,,,BAO_0000218,
"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,1,CHEMBL622696,Intermediate,,,A,N,1,9666,,Rattus norvegicus,,,50597,,6685,10116.0,,,BAO_0000218,
"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,1,CHEMBL622697,Intermediate,,,A,N,1,9667,,Rattus norvegicus,,,50597,,6685,10116.0,,,BAO_0000218,
"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,1,CHEMBL622874,Intermediate,,,A,N,1,9668,,Rattus norvegicus,,,50597,,6619,10116.0,,,BAO_0000218,
"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,1,CHEMBL622875,Intermediate,,,A,N,1,9669,,Rattus norvegicus,,,50597,,6619,10116.0,,,BAO_0000218,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,1,CHEMBL622876,Intermediate,,,A,N,1,9670,,Rattus norvegicus,,,50597,,10363,10116.0,,,BAO_0000218,
Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,1,CHEMBL622877,Intermediate,,,A,N,1,9671,,Rattus norvegicus,,,50597,,4796,10116.0,,,BAO_0000218,
Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,1,CHEMBL622878,Intermediate,,,A,N,1,9672,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,1,CHEMBL622879,Intermediate,,,A,N,1,9673,1969.0,Rattus norvegicus,,,50597,,4910,10116.0,,Plasma,BAO_0000218,
Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,1,CHEMBL877602,Intermediate,,,A,N,1,9674,,Rattus norvegicus,,,50597,,4839,10116.0,,,BAO_0000218,
"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL622880,Intermediate,,,A,N,1,9675,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL622881,Intermediate,,,A,N,1,9676,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL622882,Intermediate,,,A,N,1,9677,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL622883,Intermediate,,,A,N,1,9678,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,1,CHEMBL622884,Intermediate,,,A,N,1,9679,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,1,CHEMBL622885,Intermediate,,,A,N,1,9680,2046.0,Rattus norvegicus,,,50597,,11450,10116.0,,Thyroid gland,BAO_0000218,
Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,1,CHEMBL622886,Intermediate,,,A,N,1,9681,,Rattus norvegicus,,,50597,,8151,10116.0,,,BAO_0000218,
Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,1,CHEMBL622887,Intermediate,,,A,N,1,9682,,Rattus norvegicus,,,50597,,8151,10116.0,,,BAO_0000218,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,1,CHEMBL622888,Intermediate,,,A,N,1,9683,1088.0,Rattus norvegicus,,,50597,,8151,10116.0,,Urine,BAO_0000218,
"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622889,Intermediate,,,A,N,1,9684,178.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Blood,BAO_0000218,
"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622890,Intermediate,,,A,N,1,9685,178.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Blood,BAO_0000218,
"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622891,Intermediate,,,A,N,1,9686,178.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Blood,BAO_0000218,
"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL877603,Intermediate,,,A,N,1,9687,178.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Blood,BAO_0000218,
"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622892,Intermediate,,,A,N,1,9688,955.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Brain,BAO_0000218,
"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622893,Intermediate,,,A,N,1,9689,955.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Brain,BAO_0000218,
"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622894,Intermediate,,,A,N,1,9690,955.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Brain,BAO_0000218,
"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622895,Intermediate,,,A,N,1,9691,955.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Brain,BAO_0000218,
Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,1,CHEMBL622896,Intermediate,,,A,N,1,9692,955.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Brain,BAO_0000218,
"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622897,Intermediate,,,A,N,1,9693,948.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Heart,BAO_0000218,
"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622898,Intermediate,,,A,N,1,9694,948.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Heart,BAO_0000218,
"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622899,Intermediate,,,A,N,1,9695,948.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Heart,BAO_0000218,
"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622900,Intermediate,,,A,N,1,9696,2113.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Kidney,BAO_0000218,
"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624114,Intermediate,,,A,N,1,9697,2113.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Kidney,BAO_0000218,
"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL624115,Intermediate,,,A,N,1,9698,2113.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Kidney,BAO_0000218,
"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624116,Intermediate,,,A,N,1,9699,2113.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Kidney,BAO_0000218,
"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL624117,Intermediate,,,A,N,1,9700,2107.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Liver,BAO_0000218,
"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624118,Intermediate,,,A,N,1,9701,2107.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Liver,BAO_0000218,
"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL624119,Intermediate,,,A,N,1,9702,2107.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Liver,BAO_0000218,
"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624120,Intermediate,,,A,N,1,9703,2107.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Liver,BAO_0000218,
"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL624121,Intermediate,,,A,N,1,9704,2048.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Lung,BAO_0000218,
"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624122,Intermediate,,,A,N,1,9705,2048.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Lung,BAO_0000218,
"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL624123,Intermediate,,,A,N,1,9706,2048.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Lung,BAO_0000218,
"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624124,Intermediate,,,A,N,1,9707,2048.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Lung,BAO_0000218,
"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL624125,Intermediate,,,A,N,1,9708,2385.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624126,Intermediate,,,A,N,1,9709,2385.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL624127,Intermediate,,,A,N,1,9710,2385.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624128,Intermediate,,,A,N,1,9711,2385.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL624129,Intermediate,,,A,N,1,9712,14.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Zone of skin,BAO_0000218,
"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL624130,Intermediate,,,A,N,1,9713,14.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Zone of skin,BAO_0000218,
"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622340,Intermediate,,,A,N,1,9714,14.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Zone of skin,BAO_0000218,
"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622341,Intermediate,,,A,N,1,9715,14.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Zone of skin,BAO_0000218,
"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622342,Intermediate,,,A,N,1,9716,160.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Intestine,BAO_0000218,
"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622343,Intermediate,,,A,N,1,9717,160.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Intestine,BAO_0000218,
"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622344,Intermediate,,,A,N,1,9718,160.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Intestine,BAO_0000218,
"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622345,Intermediate,,,A,N,1,9719,160.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Intestine,BAO_0000218,
"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622346,Intermediate,,,A,N,1,9720,2106.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Spleen,BAO_0000218,
"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622347,Intermediate,,,A,N,1,9721,2106.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Spleen,BAO_0000218,
"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622348,Intermediate,,,A,N,1,9722,2106.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Spleen,BAO_0000218,
"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622349,Intermediate,,,A,N,1,9723,2106.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Spleen,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,CHEMBL622350,Intermediate,,,A,N,1,9724,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,CHEMBL622351,Intermediate,,,A,N,1,9725,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,CHEMBL622352,Intermediate,,,A,N,1,9726,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,CHEMBL622353,Intermediate,,,A,N,1,9727,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,CHEMBL622354,Intermediate,,,A,N,1,9728,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,CHEMBL622355,Intermediate,,,A,N,1,9729,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,CHEMBL622356,Intermediate,,,A,N,1,9730,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,CHEMBL622357,Intermediate,,,A,N,1,9731,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,CHEMBL622358,Intermediate,,,A,N,1,9732,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,CHEMBL622359,Intermediate,,,A,N,1,9733,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,CHEMBL874393,Intermediate,,,A,N,1,9734,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL622872,Intermediate,,,A,N,1,9735,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL622873,Intermediate,,,A,N,1,9736,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL623047,Intermediate,,,A,N,1,9737,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL623048,Intermediate,,,A,N,1,9738,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL623049,Intermediate,,,A,N,1,9739,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL623050,Intermediate,,,A,N,1,9740,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL623051,Intermediate,,,A,N,1,9741,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL623052,Intermediate,,,A,N,1,9742,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL626343,Intermediate,,,A,N,1,9743,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,CHEMBL626344,Intermediate,,,A,N,1,9744,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,CHEMBL626345,Intermediate,,,A,N,1,9745,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,CHEMBL626346,Intermediate,,,A,N,1,9746,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,CHEMBL626347,Intermediate,,,A,N,1,9747,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,CHEMBL626348,Intermediate,,,A,N,1,9748,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,CHEMBL626349,Intermediate,,,A,N,1,9749,,Rattus norvegicus,,,50597,,16434,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,CHEMBL626350,Intermediate,,,F,N,1,9750,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,CHEMBL626351,Intermediate,,,A,N,1,9751,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,CHEMBL627650,Intermediate,,,A,N,1,9752,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,CHEMBL627651,Intermediate,,,F,N,1,9753,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,CHEMBL627652,Intermediate,,,A,N,1,9754,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,CHEMBL627653,Intermediate,,,A,N,1,9755,,Rattus norvegicus,,,50597,,16435,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,1,CHEMBL627654,Intermediate,,,A,N,1,9756,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,1,CHEMBL627835,Intermediate,,,A,N,1,9757,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,1,CHEMBL627836,Intermediate,,,A,N,1,9758,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,1,CHEMBL627837,Intermediate,,,A,N,1,9759,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,1,CHEMBL627838,Intermediate,,,A,N,1,9760,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,1,CHEMBL875338,Intermediate,,,A,N,1,9761,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,1,CHEMBL627839,Intermediate,,,A,N,1,9762,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,1,CHEMBL627840,Intermediate,,,A,N,1,9763,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,1,CHEMBL627841,Intermediate,,,A,N,1,9764,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,1,CHEMBL627842,Intermediate,,,A,N,1,9765,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,1,CHEMBL627843,Intermediate,,,A,N,1,9766,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,1,CHEMBL627844,Intermediate,,,A,N,1,9767,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,1,CHEMBL627845,Intermediate,,,A,N,1,9768,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Half life period in rat by iv administration at a dose of 3 mg/kg,,1,CHEMBL627846,Intermediate,,,A,N,1,9769,,Rattus norvegicus,In vivo,,50597,,5874,10116.0,,,BAO_0000218,
Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,1,CHEMBL627847,Intermediate,,,A,N,1,9770,1969.0,Rattus norvegicus,,,50597,,1515,10116.0,,Plasma,BAO_0000218,
Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,1,CHEMBL873821,Intermediate,,,A,N,1,9771,1969.0,Rattus norvegicus,,,50597,,1515,10116.0,,Plasma,BAO_0000218,
Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1,CHEMBL626079,Intermediate,,,A,N,1,9772,1969.0,Rattus norvegicus,,,50597,,1515,10116.0,,Plasma,BAO_0000218,
Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1,CHEMBL626080,Intermediate,,,A,N,1,9773,1969.0,Rattus norvegicus,,,50597,,1515,10116.0,,Plasma,BAO_0000218,
Half life period was evaluated in rat plasma,,1,CHEMBL626081,Intermediate,,,A,N,1,9774,1969.0,Rattus norvegicus,,,50597,,5491,10116.0,,Plasma,BAO_0000218,
Half life period was evaluated in rat plasma; Not tested,,1,CHEMBL875344,Intermediate,,,A,N,1,9775,1969.0,Rattus norvegicus,,,50597,,5491,10116.0,,Plasma,BAO_0000218,
Half life period was evaluated in rats,,1,CHEMBL626082,Intermediate,,,A,N,1,9776,,Rattus norvegicus,,,50597,,1918,10116.0,,,BAO_0000218,
"Half life period was evaluated in rats, iv",,1,CHEMBL626250,Intermediate,,,A,N,1,9777,,Rattus norvegicus,In vivo,,50597,,1918,10116.0,,,BAO_0000218,
Half life period after intravenous administration at 5 mg/kg in rat,,1,CHEMBL626251,Intermediate,,,A,N,1,9778,,Rattus norvegicus,In vivo,,50597,,6113,10116.0,,,BAO_0000218,
Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,1,CHEMBL626252,Intermediate,,,A,N,1,9779,,Rattus norvegicus,In vivo,,50597,,5546,10116.0,,,BAO_0000218,
Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,1,CHEMBL626253,Intermediate,,,A,N,1,9780,,Rattus norvegicus,In vivo,,50597,,5553,10116.0,,,BAO_0000218,
Half life stability of compound was evaluated in rat plasma,,1,CHEMBL626254,Intermediate,,,A,N,1,9781,1969.0,Rattus norvegicus,,,50597,,4188,10116.0,,Plasma,BAO_0000218,
Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,1,CHEMBL626255,Intermediate,,,A,N,1,9782,,Rattus norvegicus,In vivo,,50597,,6215,10116.0,,,BAO_0000218,
Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,1,CHEMBL626256,Intermediate,,,A,N,1,9783,,Rattus norvegicus,In vivo,,50597,,6141,10116.0,,,BAO_0000218,
Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,1,CHEMBL626257,Intermediate,,,A,N,1,9784,,Rattus norvegicus,In vivo,,50597,,5182,10116.0,,,BAO_0000218,
Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,1,CHEMBL626258,Intermediate,,,A,N,1,9785,,Rattus norvegicus,In vivo,,50597,,5182,10116.0,,,BAO_0000218,
Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,1,CHEMBL626259,Intermediate,,,A,N,1,9786,,Rattus norvegicus,In vivo,,50597,,5710,10116.0,,,BAO_0000218,
Half in rat i.v.,,1,CHEMBL626260,Intermediate,,,A,N,1,9787,,Rattus norvegicus,In vivo,,50597,,5789,10116.0,,,BAO_0000218,
Half period in rat after intravenous administration,,1,CHEMBL875345,Intermediate,,,A,N,1,9788,,Rattus norvegicus,In vivo,,50597,,6011,10116.0,,,BAO_0000218,
Half-life after repeated oral dose of compound at 1 mg/kg in rats,,1,CHEMBL626261,Intermediate,,,A,N,1,9789,,Rattus norvegicus,In vivo,,50597,,17594,10116.0,,,BAO_0000218,
Half-life measured in in vitro Cathepsin B assay in rat liver,,1,CHEMBL626262,Intermediate,,,A,N,1,9790,2107.0,Rattus norvegicus,In vitro,,50597,,12357,10116.0,,Liver,BAO_0000218,
Half-life of compound was determined in rats,,1,CHEMBL626263,Intermediate,,,A,N,1,9791,,Rattus norvegicus,,,50597,,5210,10116.0,,,BAO_0000218,
Half-life at 10 mg/kg in rat upon intravenous administration,,1,CHEMBL625270,Intermediate,,,A,N,1,9792,,Rattus norvegicus,In vivo,,50597,,17596,10116.0,,,BAO_0000218,
Half-life determined in rat,,1,CHEMBL625271,Intermediate,,,A,N,1,9793,,Rattus norvegicus,,,50597,,6672,10116.0,,,BAO_0000218,
Half-life determined in rat,,1,CHEMBL625272,Intermediate,,,A,N,1,9794,,Rattus norvegicus,,,50597,,6673,10116.0,,,BAO_0000218,
Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,1,CHEMBL625273,Intermediate,,,A,N,1,9795,955.0,Rattus norvegicus,In vivo,,50597,,4910,10116.0,,Brain,BAO_0000218,
"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,1,CHEMBL625274,Intermediate,,,A,N,1,9796,1969.0,Rattus norvegicus,,,50597,,3741,10116.0,,Plasma,BAO_0000218,
Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,1,CHEMBL625275,Intermediate,,,A,N,1,9797,,Rattus norvegicus,In vivo,,50597,,17671,10116.0,,,BAO_0000218,
Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,1,CHEMBL625276,Intermediate,,,A,N,1,9798,1969.0,Rattus norvegicus,In vivo,,50597,,4910,10116.0,,Plasma,BAO_0000218,
Half-life in rat plasma,,1,CHEMBL625277,Intermediate,,,A,N,1,9799,1969.0,Rattus norvegicus,,,50597,,17537,10116.0,,Plasma,BAO_0000218,
Half-life in rat plasma was determined,,1,CHEMBL625278,Intermediate,,,A,N,1,9800,1969.0,Rattus norvegicus,,,50597,,4965,10116.0,,Plasma,BAO_0000218,
Half-life in rat plasma; Not tested,,1,CHEMBL625279,Intermediate,,,A,N,1,9801,1969.0,Rattus norvegicus,,,50597,,17537,10116.0,,Plasma,BAO_0000218,
Half-life in rat serum,,1,CHEMBL625280,Intermediate,,,A,N,1,9802,1977.0,Rattus norvegicus,,,50597,,6124,10116.0,,Serum,BAO_0000218,
Half-life in rat serum; na is not available,,1,CHEMBL876797,Intermediate,,,A,N,1,9803,1977.0,Rattus norvegicus,,,50597,,6124,10116.0,,Serum,BAO_0000218,
Half-life was calculated in rat,,1,CHEMBL625281,Intermediate,,,A,N,1,9804,,Rattus norvegicus,,,50597,,6078,10116.0,,,BAO_0000218,
Half-life was calculated in rat plasma,,1,CHEMBL873827,Intermediate,,,A,N,1,9805,1969.0,Rattus norvegicus,,,50597,,17668,10116.0,,Plasma,BAO_0000218,
Half-life was determined,,1,CHEMBL625282,Intermediate,,,A,N,1,9806,,Rattus norvegicus,,,50597,,3185,10116.0,,,BAO_0000218,
Half-life was determined,,1,CHEMBL625283,Intermediate,,,A,N,1,9807,,Rattus norvegicus,,,50597,,4883,10116.0,,,BAO_0000218,
Half-life after administration of 20 mg/Kg oral dose in rat,,1,CHEMBL625284,Intermediate,,,A,N,1,9808,,Rattus norvegicus,In vivo,,50597,,2959,10116.0,,,BAO_0000218,
Half-life after administration of 3.2 mg/kg intravenously in male rat,,1,CHEMBL625285,Intermediate,,,A,N,1,9809,,Rattus norvegicus,In vivo,,50597,,4029,10116.0,,,BAO_0000218,
Half-life after intravenous administration in female rat,,1,CHEMBL625286,Intermediate,,,A,N,1,9810,,Rattus norvegicus,In vivo,,50597,,4029,10116.0,,,BAO_0000218,
Half-life after intravenous administration in male rat,,1,CHEMBL625287,Intermediate,,,A,N,1,9811,,Rattus norvegicus,In vivo,,50597,,4029,10116.0,,,BAO_0000218,
Half-life after intravenous dose in rat,,1,CHEMBL625288,Intermediate,,,A,N,1,9812,,Rattus norvegicus,In vivo,,50597,,6180,10116.0,,,BAO_0000218,
Half-life in a rat liver homogenate preparation,,1,CHEMBL625289,Intermediate,,,A,N,1,9813,2107.0,Rattus norvegicus,,,50597,,1557,10116.0,,Liver,BAO_0000218,
Half-life in plasma of rat,,1,CHEMBL625290,Intermediate,,,A,N,1,9814,1969.0,Rattus norvegicus,,,50597,,12500,10116.0,,Plasma,BAO_0000218,
Half-life in plasma of rat at dose of 3-10 mgkg,,1,CHEMBL876798,Intermediate,,,A,N,1,9815,1969.0,Rattus norvegicus,,,50597,,12500,10116.0,,Plasma,BAO_0000218,
Half-life in rat,,1,CHEMBL625291,Intermediate,,,A,N,1,9816,,Rattus norvegicus,,,50597,,5064,10116.0,,,BAO_0000218,
Half-life in rat,,1,CHEMBL625292,Intermediate,,,A,N,1,9817,,Rattus norvegicus,,,50597,,5145,10116.0,,,BAO_0000218,
Half-life in rat,,1,CHEMBL625293,Intermediate,,,A,N,1,9818,,Rattus norvegicus,,,50597,,5147,10116.0,,,BAO_0000218,
Half-life in rat,,1,CHEMBL622832,Intermediate,,,A,N,1,9819,,Rattus norvegicus,,,50597,,5833,10116.0,,,BAO_0000218,
Half-life in rat,,1,CHEMBL622833,Intermediate,,,A,N,1,9820,,Rattus norvegicus,,,50597,,6596,10116.0,,,BAO_0000218,
Half-life in rat,,1,CHEMBL622834,Intermediate,,,A,N,1,9821,,Rattus norvegicus,,,50597,,17655,10116.0,,,BAO_0000218,
Half-life in rat after oral administration at 10 mg/kg,,1,CHEMBL622835,Intermediate,,,A,N,1,9822,,Rattus norvegicus,In vivo,,50597,,6495,10116.0,,,BAO_0000218,
Half-life in rat after po administration at a dose of 10 mg/kg,,1,CHEMBL622836,Intermediate,,,A,N,1,9823,,Rattus norvegicus,In vivo,,50597,,17538,10116.0,,,BAO_0000218,
Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,1,CHEMBL622837,Intermediate,,,A,N,1,9824,,Rattus norvegicus,In vivo,,50597,,17538,10116.0,,,BAO_0000218,
Half-life in rat at 3 mg/kg dose administered intravenously,,1,CHEMBL622838,Intermediate,,,A,N,1,9825,,Rattus norvegicus,In vivo,,50597,,10,10116.0,,,BAO_0000218,
Half-life in rat brain homogenate,,1,CHEMBL622839,Intermediate,,,A,N,1,9826,955.0,Rattus norvegicus,,,50597,,17669,10116.0,,Brain,BAO_0000218,
Half-life in rat plasma,,1,CHEMBL622840,Intermediate,,,A,N,1,9827,1969.0,Rattus norvegicus,,,50597,,17065,10116.0,,Plasma,BAO_0000218,
Half-life in rats,,1,CHEMBL622841,Intermediate,,,A,N,1,9828,,Rattus norvegicus,,,50597,,4333,10116.0,,,BAO_0000218,
Half-life in Dawley rats,,1,CHEMBL622842,Intermediate,,,A,N,1,9829,,Rattus norvegicus,,,50597,,6827,10116.0,,,BAO_0000218,
Half-life in vitro in rat plasma,,1,CHEMBL622843,Intermediate,,,A,N,1,9830,1969.0,Rattus norvegicus,In vitro,,50597,,889,10116.0,,Plasma,BAO_0000218,
Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,1,CHEMBL622844,Intermediate,,,A,N,1,9831,1969.0,Rattus norvegicus,In vitro,,50597,,889,10116.0,,Plasma,BAO_0000218,
"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,1,CHEMBL622845,Intermediate,,,A,N,1,9832,,Rattus norvegicus,,,50597,,3747,10116.0,,,BAO_0000218,
The area under the curve of compound was measured at the dose of 100 umol/kg,,1,CHEMBL622846,Intermediate,,,A,N,1,9833,,Rattus norvegicus,,,50597,,15022,10116.0,,,BAO_0000218,
The area under the curve of compound was measured at the dose of 300 umol/kg,,1,CHEMBL622847,Intermediate,,,A,N,1,9834,,Rattus norvegicus,,,50597,,15022,10116.0,,,BAO_0000218,
The area under the curve of compound was measured at the dose of 30 umol/kg,,1,CHEMBL622848,Intermediate,,,A,N,1,9835,,Rattus norvegicus,,,50597,,15022,10116.0,,,BAO_0000218,
Bioavailability as oral AUC in rats,,1,CHEMBL622849,Intermediate,,,A,N,1,9836,,Rattus norvegicus,In vivo,,50597,,3360,10116.0,,,BAO_0000218,
The plasma concentration versus time curve (AUC) was determined,,1,CHEMBL622850,Intermediate,,,A,N,1,9837,1969.0,Rattus norvegicus,,,50597,,5334,10116.0,,Plasma,BAO_0000218,
Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL876807,Intermediate,,,A,N,1,9838,,Rattus norvegicus,,,50597,,17411,10116.0,,,BAO_0000218,
Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL622851,Intermediate,,,A,N,1,9839,,Rattus norvegicus,,,50597,,17411,10116.0,,,BAO_0000218,
Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL622852,Intermediate,,,A,N,1,9840,,Rattus norvegicus,,,50597,,17411,10116.0,,,BAO_0000218,
Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,1,CHEMBL622853,Intermediate,,,A,N,1,9841,,Rattus norvegicus,,,50597,,6570,10116.0,,,BAO_0000218,
Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,1,CHEMBL622854,Intermediate,,,A,N,1,9842,,Rattus norvegicus,,,50597,,6570,10116.0,,,BAO_0000218,
Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,CHEMBL622855,Intermediate,,,A,N,1,9843,,Rattus norvegicus,,,50597,,17411,10116.0,,,BAO_0000218,
"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,1,CHEMBL622856,Intermediate,,,A,N,1,9844,1969.0,Rattus norvegicus,,,50597,,14941,10116.0,,Plasma,BAO_0000218,
"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,1,CHEMBL622857,Intermediate,,,A,N,1,9845,1969.0,Rattus norvegicus,,,50597,,14941,10116.0,,Plasma,BAO_0000218,
AUC in rat after po administration at a dose of 10 mg/kg,,1,CHEMBL622858,Intermediate,,,A,N,1,9846,1969.0,Rattus norvegicus,,,50597,,17538,10116.0,,Plasma,BAO_0000218,
Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,1,CHEMBL622859,Intermediate,,,A,N,1,9847,1969.0,Rattus norvegicus,,,50597,,17752,10116.0,,Plasma,BAO_0000218,
Area under curve value 24 hr after 10 mg/kg iv administration in rats,,1,CHEMBL622860,Intermediate,,,A,N,1,9848,,Rattus norvegicus,,,50597,,17509,10116.0,,,BAO_0000218,
Area under curve value 24 hr after 10 mg/kg oral administration in rats,,1,CHEMBL622861,Intermediate,,,A,N,1,9849,,Rattus norvegicus,,,50597,,17509,10116.0,,,BAO_0000218,
Area under curve value 24 hr after 2 mg/kg iv administration in rats,,1,CHEMBL622862,Intermediate,,,A,N,1,9850,,Rattus norvegicus,,,50597,,17509,10116.0,,,BAO_0000218,
Area under curve value 24 hr after 2 mg/kg oral administration in rats,,1,CHEMBL622863,Intermediate,,,A,N,1,9851,,Rattus norvegicus,,,50597,,17509,10116.0,,,BAO_0000218,
Area under curve value 6 hr after po administration in rat,,1,CHEMBL623817,Intermediate,,,A,N,1,9852,,Rattus norvegicus,,,50597,,17509,10116.0,,,BAO_0000218,
Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,1,CHEMBL623818,Intermediate,,,A,N,1,9853,,Rattus norvegicus,,,50597,,17717,10116.0,,,BAO_0000218,
"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,1,CHEMBL623819,Intermediate,,,A,N,1,9854,,Rattus norvegicus,,,50597,,17717,10116.0,,,BAO_0000218,
Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,1,CHEMBL623820,Intermediate,,,A,N,1,9855,,Rattus norvegicus,,,50597,,17717,10116.0,,,BAO_0000218,
Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,1,CHEMBL623821,Intermediate,,,A,N,1,9856,,Rattus norvegicus,,,50597,,17717,10116.0,,,BAO_0000218,
AUC normalized for dose (AUCN) in rat,,1,CHEMBL623822,Intermediate,,,A,N,1,9857,1969.0,Rattus norvegicus,,,50597,,6642,10116.0,,Plasma,BAO_0000218,
Area under curve in rat after p.o. administration,,1,CHEMBL623823,Intermediate,,,A,N,1,9858,,Rattus norvegicus,,,50597,,6640,10116.0,,,BAO_0000218,
Area under curve in rat after p.o. administration,,1,CHEMBL623824,Intermediate,,,A,N,1,9859,,Rattus norvegicus,,,50597,,6641,10116.0,,,BAO_0000218,
Area under curve in rat after p.o. administration; Not determined,,1,CHEMBL623825,Intermediate,,,A,N,1,9860,,Rattus norvegicus,,,50597,,6641,10116.0,,,BAO_0000218,
Area under curve in rat after peroral administration,,1,CHEMBL622070,Intermediate,,,A,N,1,9861,,Rattus norvegicus,,,50597,,6641,10116.0,,,BAO_0000218,
Area under curve (carotid artery) value of the compound,,1,CHEMBL622071,Intermediate,,,A,N,1,9862,,Rattus norvegicus,,,50597,,3603,10116.0,,,BAO_0000218,
Bioavailability expressed as the area under curve of rat carotid artery,,1,CHEMBL622072,Intermediate,,,A,N,1,9863,,Rattus norvegicus,,,50597,,3550,10116.0,,,BAO_0000218,
Area under curve in male SD rats was observed after intravenous administration in rat,,1,CHEMBL622073,Intermediate,,,A,N,1,9864,,Rattus norvegicus,,,50597,,15662,10116.0,,,BAO_0000218,
Area under curve of the compound was determined,,1,CHEMBL622074,Intermediate,,,A,N,1,9865,,Rattus norvegicus,,,50597,,17720,10116.0,,,BAO_0000218,
Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,1,CHEMBL622075,Intermediate,,,A,N,1,9866,,Rattus norvegicus,,,50597,,5407,10116.0,,,BAO_0000218,
Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,1,CHEMBL622076,Intermediate,,,A,N,1,9867,1969.0,Rattus norvegicus,,,50597,,17752,10116.0,,Plasma,BAO_0000218,
Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,1,CHEMBL622077,Intermediate,,,A,N,1,9868,1969.0,Rattus norvegicus,,,50597,,17752,10116.0,,Plasma,BAO_0000218,
Area under curve (portal vein) value of the compound,,1,CHEMBL622078,Intermediate,,,A,N,1,9869,,Rattus norvegicus,,,50597,,3603,10116.0,,,BAO_0000218,
Bioavailability expressed as the area under curve of rat portal vein,,1,CHEMBL622079,Intermediate,,,A,N,1,9870,,Rattus norvegicus,,,50597,,3550,10116.0,,,BAO_0000218,
Area Under plasma concentration time curve in rat upon peroral administration,,1,CHEMBL622080,Intermediate,,,A,N,1,9871,1969.0,Rattus norvegicus,,,50597,,17655,10116.0,,Plasma,BAO_0000218,
In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,1,CHEMBL877612,Intermediate,,,A,N,1,9872,,Rattus norvegicus,,,50597,,17582,10116.0,,,BAO_0000218,
In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,1,CHEMBL622081,Intermediate,,,A,N,1,9873,,Rattus norvegicus,,,50597,,17582,10116.0,,,BAO_0000218,
Compound was evaluated for oral bioavailability in rats,,1,CHEMBL622082,Intermediate,,,A,N,1,9874,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Compound was evaluated for oral bioavailability in rats after iv administration,,1,CHEMBL622083,Intermediate,,,A,N,1,9875,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Compound was evaluated for oral bioavailability in rats; 30-80,,1,CHEMBL622084,Intermediate,,,A,N,1,9876,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Compound was evaluated for oral bioavailability in rats; 50-60,,1,CHEMBL622085,Intermediate,,,A,N,1,9877,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Compound was evaluated for oral bioavailability in rats; no data,,1,CHEMBL622086,Intermediate,,,A,N,1,9878,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
Compound was evaluated for oral bioavailability in rats; peptide,,1,CHEMBL622087,Intermediate,,,A,N,1,9879,,Rattus norvegicus,,,50597,,17791,10116.0,,,BAO_0000218,
"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,1,CHEMBL622088,Intermediate,,,A,N,1,9880,178.0,Rattus norvegicus,,,50597,,7768,10116.0,,Blood,BAO_0000218,
"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,1,CHEMBL622089,Intermediate,,,A,N,1,9881,178.0,Rattus norvegicus,,,50597,,7768,10116.0,,Blood,BAO_0000218,
"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,1,CHEMBL623685,Intermediate,,,A,N,1,9882,178.0,Rattus norvegicus,,,50597,,7768,10116.0,,Blood,BAO_0000218,
"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,1,CHEMBL623686,Intermediate,,,A,N,1,9883,178.0,Rattus norvegicus,,,50597,,7768,10116.0,,Blood,BAO_0000218,
"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL623687,Intermediate,,,A,N,1,9884,945.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Stomach,BAO_0000218,
"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL623688,Intermediate,,,A,N,1,9885,945.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Stomach,BAO_0000218,
"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL623689,Intermediate,,,A,N,1,9886,945.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Stomach,BAO_0000218,
"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622485,Intermediate,,,A,N,1,9887,945.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Stomach,BAO_0000218,
"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622486,Intermediate,,,A,N,1,9888,2046.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Thyroid gland,BAO_0000218,
"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL877613,Intermediate,,,A,N,1,9889,2046.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Thyroid gland,BAO_0000218,
"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622487,Intermediate,,,A,N,1,9890,2046.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Thyroid gland,BAO_0000218,
"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622488,Intermediate,,,A,N,1,9891,2046.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Thyroid gland,BAO_0000218,
"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,1,CHEMBL622489,Intermediate,,,A,N,1,9892,948.0,Rattus norvegicus,In vivo,,50597,,8677,10116.0,,Heart,BAO_0000218,
Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,1,CHEMBL622490,Intermediate,,,A,N,1,9893,1088.0,Rattus norvegicus,,,50597,,6899,10116.0,,Urine,BAO_0000218,
Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,1,CHEMBL622491,Intermediate,,,A,N,1,9894,1088.0,Rattus norvegicus,,,50597,,6899,10116.0,,Urine,BAO_0000218,
Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,1,CHEMBL622492,Intermediate,,,A,N,1,9895,2107.0,Rattus norvegicus,,,50597,,6899,10116.0,,Liver,BAO_0000218,
Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,1,CHEMBL622493,Intermediate,,,A,N,1,9896,1088.0,Rattus norvegicus,,,50597,,6899,10116.0,,Urine,BAO_0000218,
Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,1,CHEMBL622494,Intermediate,,,A,N,1,9897,1088.0,Rattus norvegicus,,,50597,,6899,10116.0,,Urine,BAO_0000218,
"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,CHEMBL622495,Intermediate,,,A,N,1,9898,2385.0,Rattus norvegicus,,,50597,,8677,10116.0,,Muscle tissue,BAO_0000218,
Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,1,CHEMBL622496,Intermediate,,,A,N,1,9899,,Rattus norvegicus,,,50597,,6899,10116.0,,,BAO_0000218,
Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,1,CHEMBL622497,Intermediate,,,A,N,1,9900,1088.0,Rattus norvegicus,,,50597,,6899,10116.0,,Urine,BAO_0000218,
Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,1,CHEMBL622498,Intermediate,,,A,N,1,9901,,Rattus norvegicus,,,50597,,2189,10116.0,,,BAO_0000218,
Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,1,CHEMBL624918,Intermediate,,,A,N,1,9902,1088.0,Rattus norvegicus,,,50597,,2189,10116.0,,Urine,BAO_0000218,
Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,1,CHEMBL624919,Intermediate,,,A,N,1,9903,1088.0,Rattus norvegicus,,,50597,,2189,10116.0,,Urine,BAO_0000218,
Biodistribution of compound in rat blood after 5 min of administration,,1,CHEMBL624920,Intermediate,,,A,N,1,9904,178.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Blood,BAO_0000218,
Biodistribution of compound in rat blood after 5 min of administration.,,1,CHEMBL624921,Intermediate,,,A,N,1,9905,178.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Blood,BAO_0000218,
Biodistribution of compound in rat brain after 5 min of administration,,1,CHEMBL624922,Intermediate,,,A,N,1,9906,955.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Brain,BAO_0000218,
Biodistribution of compound in rat heart after 5 min of administration,,1,CHEMBL624923,Intermediate,,,A,N,1,9907,948.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Heart,BAO_0000218,
Biodistribution of compound in rat heart after 5 min of administration.,,1,CHEMBL624924,Intermediate,,,A,N,1,9908,948.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Heart,BAO_0000218,
Biodistribution of compound in rat kidney after 5 min of administration,,1,CHEMBL624925,Intermediate,,,A,N,1,9909,2113.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Kidney,BAO_0000218,
Biodistribution of compound in rat kidney after 5 min of administration.,,1,CHEMBL624926,Intermediate,,,A,N,1,9910,2113.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Kidney,BAO_0000218,
Biodistribution of compound in rat liver after 5 min of administration,,1,CHEMBL624927,Intermediate,,,A,N,1,9911,2107.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Liver,BAO_0000218,
Biodistribution of compound in rat liver after 5 min of administration.,,1,CHEMBL874402,Intermediate,,,A,N,1,9912,2107.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Liver,BAO_0000218,
Biodistribution of compound in rat lung after 5 min of administration,,1,CHEMBL624928,Intermediate,,,A,N,1,9913,2048.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Lung,BAO_0000218,
Biodistribution of compound in rat lung after 5 min of administration.,,1,CHEMBL624929,Intermediate,,,A,N,1,9914,2048.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Lung,BAO_0000218,
Biodistribution of compound in rat muscle after 5 min of administration,,1,CHEMBL624930,Intermediate,,,A,N,1,9915,2385.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of compound in rat muscle after 5 min of administration.,,1,CHEMBL624931,Intermediate,,,A,N,1,9916,2385.0,Rattus norvegicus,In vivo,,50597,,10839,10116.0,,Muscle tissue,BAO_0000218,
In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624932,Intermediate,,,A,N,1,9917,948.0,Rattus norvegicus,,,50597,,4043,10116.0,,Heart,BAO_0000218,
In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624933,Intermediate,,,A,N,1,9918,948.0,Rattus norvegicus,,,50597,,4043,10116.0,,Heart,BAO_0000218,
In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624934,Intermediate,,,A,N,1,9919,2107.0,Rattus norvegicus,,,50597,,4043,10116.0,,Liver,BAO_0000218,
In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624935,Intermediate,,,A,N,1,9920,2107.0,Rattus norvegicus,,,50597,,4043,10116.0,,Liver,BAO_0000218,
In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624936,Intermediate,,,A,N,1,9921,,Rattus norvegicus,,,50597,,4043,10116.0,,,BAO_0000218,
In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624937,Intermediate,,,A,N,1,9922,,Rattus norvegicus,,,50597,,4043,10116.0,,,BAO_0000218,
In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624938,Intermediate,,,A,N,1,9923,2106.0,Rattus norvegicus,,,50597,,4043,10116.0,,Spleen,BAO_0000218,
In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624939,Intermediate,,,A,N,1,9924,2106.0,Rattus norvegicus,,,50597,,4043,10116.0,,Spleen,BAO_0000218,
In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL624940,Intermediate,,,A,N,1,9925,,Rattus norvegicus,,,50597,,4043,10116.0,,,BAO_0000218,
In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,CHEMBL874403,Intermediate,,,A,N,1,9926,,Rattus norvegicus,,,50597,,4043,10116.0,,,BAO_0000218,
Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,1,CHEMBL624941,Intermediate,,,A,N,1,9927,,Rattus norvegicus,,,50597,,1446,10116.0,,,BAO_0000218,
Dose required to lower urine osmolality to 300 mOsm/kg in rat,,1,CHEMBL624942,Intermediate,,,A,N,1,9928,1088.0,Rattus norvegicus,,,50597,,9971,10116.0,,Urine,BAO_0000218,
Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,1,CHEMBL624943,Intermediate,,,A,N,1,9929,1088.0,Rattus norvegicus,,,50597,,9971,10116.0,,Urine,BAO_0000218,
% Bioavailability after 1 day of the drug administration in rats,,1,CHEMBL624944,Intermediate,,,A,N,1,9930,,Rattus norvegicus,In vivo,,50597,,5765,10116.0,,,BAO_0000218,
% Bioavailability after 4 day of the drug administration in rats,,1,CHEMBL624945,Intermediate,,,A,N,1,9931,,Rattus norvegicus,In vivo,,50597,,5765,10116.0,,,BAO_0000218,
Absolute bioavailability was evaluated in rat,,1,CHEMBL624946,Intermediate,,,A,N,1,9932,,Rattus norvegicus,In vivo,,50597,,4257,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,1,CHEMBL624947,Intermediate,,,A,N,1,9933,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,1,CHEMBL624948,Intermediate,,,A,N,1,9934,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,1,CHEMBL624949,Intermediate,,,A,N,1,9935,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,1,CHEMBL622025,Intermediate,,,A,N,1,9936,2113.0,Rattus norvegicus,,,50597,,13091,10116.0,,Kidney,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,1,CHEMBL622026,Intermediate,,,A,N,1,9937,2113.0,Rattus norvegicus,,,50597,,13091,10116.0,,Kidney,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,1,CHEMBL622027,Intermediate,,,A,N,1,9938,2113.0,Rattus norvegicus,,,50597,,13091,10116.0,,Kidney,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,1,CHEMBL622028,Intermediate,,,A,N,1,9939,2113.0,Rattus norvegicus,,,50597,,13091,10116.0,,Kidney,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,1,CHEMBL622029,Intermediate,,,A,N,1,9940,2107.0,Rattus norvegicus,,,50597,,13091,10116.0,,Liver,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,1,CHEMBL622208,Intermediate,,,A,N,1,9941,2107.0,Rattus norvegicus,,,50597,,13091,10116.0,,Liver,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,1,CHEMBL622209,Intermediate,,,A,N,1,9942,2107.0,Rattus norvegicus,,,50597,,13091,10116.0,,Liver,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,1,CHEMBL622210,Intermediate,,,A,N,1,9943,2107.0,Rattus norvegicus,,,50597,,13091,10116.0,,Liver,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,1,CHEMBL622211,Intermediate,,,A,N,1,9944,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,1,CHEMBL622212,Intermediate,,,A,N,1,9945,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,1,CHEMBL622213,Intermediate,,,A,N,1,9946,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,1,CHEMBL874404,Intermediate,,,A,N,1,9947,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,1,CHEMBL620452,Intermediate,,,A,N,1,9948,2385.0,Rattus norvegicus,,,50597,,13091,10116.0,,Muscle tissue,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,1,CHEMBL620453,Intermediate,,,A,N,1,9949,2385.0,Rattus norvegicus,,,50597,,13091,10116.0,,Muscle tissue,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,1,CHEMBL620454,Intermediate,,,A,N,1,9950,2385.0,Rattus norvegicus,,,50597,,13091,10116.0,,Muscle tissue,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,1,CHEMBL624067,Intermediate,,,A,N,1,9951,2385.0,Rattus norvegicus,,,50597,,13091,10116.0,,Muscle tissue,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,1,CHEMBL624068,Intermediate,,,A,N,1,9952,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,1,CHEMBL624069,Intermediate,,,A,N,1,9953,992.0,Rattus norvegicus,,,50597,,13091,10116.0,,Female gonad,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,1,CHEMBL624070,Intermediate,,,A,N,1,9954,992.0,Rattus norvegicus,,,50597,,13091,10116.0,,Female gonad,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,1,CHEMBL624071,Intermediate,,,A,N,1,9955,992.0,Rattus norvegicus,,,50597,,13091,10116.0,,Female gonad,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,1,CHEMBL624072,Intermediate,,,A,N,1,9956,995.0,Rattus norvegicus,,,50597,,13091,10116.0,,Uterus,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,1,CHEMBL624073,Intermediate,,,A,N,1,9957,995.0,Rattus norvegicus,,,50597,,13091,10116.0,,Uterus,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,1,CHEMBL624788,Intermediate,,,A,N,1,9958,995.0,Rattus norvegicus,,,50597,,13091,10116.0,,Uterus,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,1,CHEMBL624789,Intermediate,,,A,N,1,9959,995.0,Rattus norvegicus,,,50597,,13091,10116.0,,Uterus,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,1,CHEMBL624790,Intermediate,,,A,N,1,9960,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,1,CHEMBL624791,Intermediate,,,A,N,1,9961,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,1,CHEMBL624792,Intermediate,,,A,N,1,9962,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,1,CHEMBL624793,Intermediate,,,A,N,1,9963,,Rattus norvegicus,,,50597,,13091,10116.0,,,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,1,CHEMBL877491,Intermediate,,,A,N,1,9964,2385.0,Rattus norvegicus,,,50597,,13091,10116.0,,Muscle tissue,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,1,CHEMBL624957,Intermediate,,,A,N,1,9965,2385.0,Rattus norvegicus,,,50597,,13091,10116.0,,Muscle tissue,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,1,CHEMBL624958,Intermediate,,,A,N,1,9966,2385.0,Rattus norvegicus,,,50597,,13091,10116.0,,Muscle tissue,BAO_0000218,
Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,1,CHEMBL624959,Intermediate,,,A,N,1,9967,2385.0,Rattus norvegicus,,,50597,,13091,10116.0,,Muscle tissue,BAO_0000218,
Dissociation constant was determined,,1,CHEMBL624960,Intermediate,,,A,N,1,9968,,Rattus norvegicus,,,50597,,11977,10116.0,,,BAO_0000218,
"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,1,CHEMBL624961,Intermediate,,,A,N,1,9969,,Rattus norvegicus,,,50597,,14941,10116.0,,,BAO_0000218,
"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL624962,Intermediate,,,A,N,1,9970,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL624963,Intermediate,,,A,N,1,9971,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
Observed rate constant in 80% rat plasma at 37 degree Centigrade,,1,CHEMBL624964,Intermediate,,,A,N,1,9972,,Rattus norvegicus,,,50597,,4755,10116.0,,,BAO_0000218,
LogP value was evaluated in the in situ rat gut perfusion assay,,1,CHEMBL624965,Intermediate,,,A,N,1,9973,,Rattus norvegicus,,,50597,,589,10116.0,,,BAO_0000218,
In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,1,CHEMBL624966,Intermediate,,,A,N,1,9974,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,1,CHEMBL624967,Intermediate,,,A,N,1,9975,,Rattus norvegicus,In vivo,,50597,,5031,10116.0,,,BAO_0000218,
Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,1,CHEMBL624968,Intermediate,,,A,N,1,9976,,Rattus norvegicus,In vivo,,50597,,17764,10116.0,,,BAO_0000218,
Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,1,CHEMBL624969,Intermediate,,,A,N,1,9977,,Rattus norvegicus,,,50597,,17720,10116.0,,,BAO_0000218,
Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,1,CHEMBL624970,Expert,,,F,N,1,9978,,Rattus norvegicus,,,50597,,2862,10116.0,,,BAO_0000218,
Half-life was evaluated after 10 uM/kg of intra arterial administration,,1,CHEMBL624971,Intermediate,,,A,N,1,9979,,Rattus norvegicus,,,50597,,16423,10116.0,,,BAO_0000218,
Half-life was evaluated after 20 uM/kg of peroral administration,,1,CHEMBL624972,Intermediate,,,A,N,1,9980,,Rattus norvegicus,In vivo,,50597,,16423,10116.0,,,BAO_0000218,
Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,1,CHEMBL624973,Intermediate,,,A,N,1,9981,,Rattus norvegicus,In vivo,,50597,,6005,10116.0,,,BAO_0000218,
Half-life was evaluated in plasma of rat,,1,CHEMBL624974,Intermediate,,,A,N,1,9982,1969.0,Rattus norvegicus,,,50597,,2938,10116.0,,Plasma,BAO_0000218,
Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,1,CHEMBL624975,Intermediate,,,A,N,1,9983,,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,,BAO_0000218,
Half-life was evaluated in rats at an oral dose of 30 mg/kg,,1,CHEMBL877492,Intermediate,,,A,N,1,9984,,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,,BAO_0000218,
Half-life was measured in rat after an iv dose of 1 mg/kg,,1,CHEMBL624976,Intermediate,,,A,N,1,9985,,Rattus norvegicus,In vivo,,50597,,6062,10116.0,,,BAO_0000218,
Half-life period of compound in rats after peroral administration,,1,CHEMBL624977,Intermediate,,,A,N,1,9986,,Rattus norvegicus,In vivo,,50597,,6571,10116.0,,,BAO_0000218,
Half-life period of compound was measured in rat plasma.,,1,CHEMBL626848,Intermediate,,,A,N,1,9987,1969.0,Rattus norvegicus,,,50597,,3136,10116.0,,Plasma,BAO_0000218,
Half-life period of compound was measured in rat plasma; ND is not determined,,1,CHEMBL626849,Intermediate,,,A,N,1,9988,1969.0,Rattus norvegicus,,,50597,,3136,10116.0,,Plasma,BAO_0000218,
Half-life period of compound was measured in rat plasma; not determined,,1,CHEMBL626850,Intermediate,,,A,N,1,9989,1969.0,Rattus norvegicus,,,50597,,3136,10116.0,,Plasma,BAO_0000218,
Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,1,CHEMBL626851,Intermediate,,,A,N,1,9990,,Rattus norvegicus,In vivo,,50597,,4521,10116.0,,,BAO_0000218,
Half-life period in rat by iv administration,,1,CHEMBL626852,Intermediate,,,A,N,1,9991,,Rattus norvegicus,In vivo,,50597,,5871,10116.0,,,BAO_0000218,
Half-life period in rats following intravenous administration at 2 mg/kg,,1,CHEMBL626853,Intermediate,,,A,N,1,9992,,Rattus norvegicus,In vivo,,50597,,6077,10116.0,,,BAO_0000218,
Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,1,CHEMBL626854,Intermediate,,,A,N,1,9993,,Rattus norvegicus,In vivo,,50597,,6679,10116.0,,,BAO_0000218,
Half-life period was determined for the compound in rat,,1,CHEMBL627486,Intermediate,,,A,N,1,9994,,Rattus norvegicus,,,50597,,5144,10116.0,,,BAO_0000218,
"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,1,CHEMBL627487,Intermediate,,,A,N,1,9995,,Rattus norvegicus,In vivo,,50597,,4498,10116.0,,,BAO_0000218,
"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,1,CHEMBL627488,Intermediate,,,A,N,1,9996,,Rattus norvegicus,In vivo,,50597,,4498,10116.0,,,BAO_0000218,
Half-life value after IV dose at a dose of 5 mg/kg in rats.,,1,CHEMBL627489,Intermediate,,,A,N,1,9997,,Rattus norvegicus,In vivo,,50597,,1908,10116.0,,,BAO_0000218,
Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,1,CHEMBL627490,Intermediate,,,A,N,1,9998,,Rattus norvegicus,In vivo,,50597,,6211,10116.0,,,BAO_0000218,
Half-life was determined in rat after intravenous administration (0.5 mg/kg),,1,CHEMBL873829,Intermediate,,,A,N,1,9999,,Rattus norvegicus,In vivo,,50597,,5529,10116.0,,,BAO_0000218,
Half-life was determined in rat at a dose of 1 mpk i.v.,,1,CHEMBL627655,Intermediate,,,A,N,1,10000,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,1,CHEMBL625994,Intermediate,,,A,N,1,10001,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,1,CHEMBL625995,Intermediate,,,A,N,1,10002,,Rattus norvegicus,In vivo,,50597,,6444,10116.0,,,BAO_0000218,
Half-life in rat,,1,CHEMBL625996,Intermediate,,,A,N,1,10003,,Rattus norvegicus,,,50597,,5207,10116.0,,,BAO_0000218,
In vitro half life in rat plasma,,1,CHEMBL625850,Intermediate,,,A,N,1,10004,1969.0,Rattus norvegicus,In vitro,,50597,,530,10116.0,,Plasma,BAO_0000218,
"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,1,CHEMBL625851,Intermediate,,,A,N,1,10005,1969.0,Rattus norvegicus,In vitro,,50597,,1116,10116.0,,Plasma,BAO_0000218,
In vitro half life in rat,,1,CHEMBL625852,Intermediate,,,A,N,1,10006,,Rattus norvegicus,In vitro,,50597,,3219,10116.0,,,BAO_0000218,
In vivo half life period after intravenous administration in rat,,1,CHEMBL625853,Intermediate,,,A,N,1,10007,,Rattus norvegicus,In vivo,,50597,,6109,10116.0,,,BAO_0000218,
In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,1,CHEMBL625854,Intermediate,,,A,N,1,10008,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,1,CHEMBL874450,Intermediate,,,A,N,1,10009,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL625855,Intermediate,,,A,N,1,10010,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL625856,Intermediate,,,A,N,1,10011,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL625857,Intermediate,,,A,N,1,10012,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL873831,Intermediate,,,A,N,1,10013,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
Longer half-life in rat (i.v.) at 0.5 mpk,,1,CHEMBL625858,Intermediate,,,A,N,1,10014,,Rattus norvegicus,In vivo,,50597,,17853,10116.0,,,BAO_0000218,
Longer half-life in rat (p.o.) at 2.0 mpk,,1,CHEMBL625859,Intermediate,,,A,N,1,10015,,Rattus norvegicus,In vivo,,50597,,17853,10116.0,,,BAO_0000218,
Pharmacokinetic property (half life) in rat,,1,CHEMBL625860,Intermediate,,,A,N,1,10016,,Rattus norvegicus,,,50597,,3457,10116.0,,,BAO_0000218,
Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,1,CHEMBL625861,Intermediate,,,A,N,1,10017,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,1,CHEMBL625862,Intermediate,,,A,N,1,10018,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,1,CHEMBL625863,Intermediate,,,A,N,1,10019,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,1,CHEMBL625864,Intermediate,,,A,N,1,10020,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,1,CHEMBL625865,Intermediate,,,A,N,1,10021,,Rattus norvegicus,In vivo,,50597,,5739,10116.0,,,BAO_0000218,
Pharmacokinetic half time was determined intravenously in rats.,,1,CHEMBL625866,Intermediate,,,A,N,1,10022,,Rattus norvegicus,In vivo,,50597,,15765,10116.0,,,BAO_0000218,
Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,1,CHEMBL625867,Intermediate,,,A,N,1,10023,1969.0,Rattus norvegicus,In vivo,,50597,,6567,10116.0,,Plasma,BAO_0000218,
Plasma half life of hydrolysis of the compound,,1,CHEMBL625868,Intermediate,,,A,N,1,10024,1969.0,Rattus norvegicus,,,50597,,2448,10116.0,,Plasma,BAO_0000218,
Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,1,CHEMBL625869,Intermediate,,,A,N,1,10025,1969.0,Rattus norvegicus,In vivo,,50597,,5423,10116.0,,Plasma,BAO_0000218,
Plasma half life period was calculated in rat,,1,CHEMBL874451,Intermediate,,,A,N,1,10026,1969.0,Rattus norvegicus,,,50597,,4853,10116.0,,Plasma,BAO_0000218,
Plasma half-life in Sprague-Dawley rats,,1,CHEMBL625870,Intermediate,,,A,N,1,10027,1969.0,Rattus norvegicus,,,50597,,4514,10116.0,,Plasma,BAO_0000218,
Plasma half-life in Sprague-Dawley rats; Not determined,,1,CHEMBL625871,Intermediate,,,A,N,1,10028,1969.0,Rattus norvegicus,,,50597,,4514,10116.0,,Plasma,BAO_0000218,
Plasma half-life in rats,,1,CHEMBL625872,Intermediate,,,A,N,1,10029,1969.0,Rattus norvegicus,,,50597,,1500,10116.0,,Plasma,BAO_0000218,
Plasma half-life in rats; <MQL,,1,CHEMBL625873,Intermediate,,,A,N,1,10030,1969.0,Rattus norvegicus,,,50597,,1500,10116.0,,Plasma,BAO_0000218,
Plasma half-life period (0-8 h) was determined,,1,CHEMBL625874,Intermediate,,,A,N,1,10031,1969.0,Rattus norvegicus,,,50597,,5334,10116.0,,Plasma,BAO_0000218,
Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,1,CHEMBL625875,Intermediate,,,A,N,1,10032,1969.0,Rattus norvegicus,,,50597,,5334,10116.0,,Plasma,BAO_0000218,
Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,1,CHEMBL625876,Intermediate,,,A,N,1,10033,1969.0,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,Plasma,BAO_0000218,
Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,1,CHEMBL631258,Intermediate,,,A,N,1,10034,1969.0,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,Plasma,BAO_0000218,
Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,1,CHEMBL631259,Intermediate,,,A,N,1,10035,1969.0,Rattus norvegicus,,,50597,,4956,10116.0,,Plasma,BAO_0000218,
Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,1,CHEMBL631260,Intermediate,,,A,N,1,10036,1969.0,Rattus norvegicus,,,50597,,4956,10116.0,,Plasma,BAO_0000218,
"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,1,CHEMBL631261,Intermediate,,,A,N,1,10037,178.0,Rattus norvegicus,,,50597,,7768,10116.0,,Blood,BAO_0000218,
"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,1,CHEMBL631262,Intermediate,,,A,N,1,10038,178.0,Rattus norvegicus,,,50597,,7768,10116.0,,Blood,BAO_0000218,
"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,1,CHEMBL631263,Intermediate,,,A,N,1,10039,178.0,Rattus norvegicus,,,50597,,7768,10116.0,,Blood,BAO_0000218,
"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,1,CHEMBL631264,Intermediate,,,A,N,1,10040,,Rattus norvegicus,,,50597,,7768,10116.0,,,BAO_0000218,
"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,1,CHEMBL631265,Intermediate,,,A,N,1,10041,,Rattus norvegicus,,,50597,,7768,10116.0,,,BAO_0000218,
"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,1,CHEMBL631266,Intermediate,,,A,N,1,10042,,Rattus norvegicus,,,50597,,7768,10116.0,,,BAO_0000218,
"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,1,CHEMBL631267,Intermediate,,,A,N,1,10043,,Rattus norvegicus,,,50597,,7768,10116.0,,,BAO_0000218,
"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,1,CHEMBL631268,Intermediate,,,A,N,1,10044,,Rattus norvegicus,,,50597,,7768,10116.0,,,BAO_0000218,
"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,1,CHEMBL631269,Intermediate,,,A,N,1,10045,,Rattus norvegicus,,,50597,,7768,10116.0,,,BAO_0000218,
"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,1,CHEMBL631270,Intermediate,,,A,N,1,10046,,Rattus norvegicus,,,50597,,7768,10116.0,,,BAO_0000218,
"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,1,CHEMBL631271,Intermediate,,,A,N,1,10047,948.0,Rattus norvegicus,,,50597,,7768,10116.0,,Heart,BAO_0000218,
"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,1,CHEMBL631272,Intermediate,,,A,N,1,10048,948.0,Rattus norvegicus,,,50597,,7768,10116.0,,Heart,BAO_0000218,
"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,1,CHEMBL631273,Intermediate,,,A,N,1,10049,948.0,Rattus norvegicus,,,50597,,7768,10116.0,,Heart,BAO_0000218,
"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,1,CHEMBL631274,Intermediate,,,A,N,1,10050,948.0,Rattus norvegicus,,,50597,,7768,10116.0,,Heart,BAO_0000218,
"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,1,CHEMBL631275,Intermediate,,,A,N,1,10051,948.0,Rattus norvegicus,,,50597,,7768,10116.0,,Heart,BAO_0000218,
"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,1,CHEMBL626984,Intermediate,,,A,N,1,10052,948.0,Rattus norvegicus,,,50597,,7768,10116.0,,Heart,BAO_0000218,
"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,1,CHEMBL626985,Intermediate,,,A,N,1,10053,948.0,Rattus norvegicus,,,50597,,7768,10116.0,,Heart,BAO_0000218,
"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,1,CHEMBL626986,Intermediate,,,A,N,1,10054,2107.0,Rattus norvegicus,,,50597,,7768,10116.0,,Liver,BAO_0000218,
"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,1,CHEMBL626987,Intermediate,,,A,N,1,10055,2107.0,Rattus norvegicus,,,50597,,7768,10116.0,,Liver,BAO_0000218,
"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,1,CHEMBL626988,Intermediate,,,A,N,1,10056,2107.0,Rattus norvegicus,,,50597,,7768,10116.0,,Liver,BAO_0000218,
"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,1,CHEMBL626989,Intermediate,,,A,N,1,10057,2107.0,Rattus norvegicus,,,50597,,7768,10116.0,,Liver,BAO_0000218,
"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,1,CHEMBL626990,Intermediate,,,A,N,1,10058,2107.0,Rattus norvegicus,,,50597,,7768,10116.0,,Liver,BAO_0000218,
"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,1,CHEMBL626991,Intermediate,,,A,N,1,10059,2107.0,Rattus norvegicus,,,50597,,7768,10116.0,,Liver,BAO_0000218,
"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,1,CHEMBL626992,Intermediate,,,A,N,1,10060,2107.0,Rattus norvegicus,,,50597,,7768,10116.0,,Liver,BAO_0000218,
"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,1,CHEMBL626993,Intermediate,,,A,N,1,10061,2048.0,Rattus norvegicus,,,50597,,7768,10116.0,,Lung,BAO_0000218,
"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,1,CHEMBL874593,Intermediate,,,A,N,1,10062,2048.0,Rattus norvegicus,,,50597,,7768,10116.0,,Lung,BAO_0000218,
"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,1,CHEMBL626994,Intermediate,,,A,N,1,10063,2048.0,Rattus norvegicus,,,50597,,7768,10116.0,,Lung,BAO_0000218,
"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,1,CHEMBL626995,Intermediate,,,A,N,1,10064,2048.0,Rattus norvegicus,,,50597,,7768,10116.0,,Lung,BAO_0000218,
"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,1,CHEMBL626190,Intermediate,,,A,N,1,10065,2048.0,Rattus norvegicus,,,50597,,7768,10116.0,,Lung,BAO_0000218,
"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,1,CHEMBL626191,Intermediate,,,A,N,1,10066,2048.0,Rattus norvegicus,,,50597,,7768,10116.0,,Lung,BAO_0000218,
"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,1,CHEMBL626364,Intermediate,,,A,N,1,10067,2048.0,Rattus norvegicus,,,50597,,7768,10116.0,,Lung,BAO_0000218,
"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,1,CHEMBL626365,Intermediate,,,A,N,1,10068,2046.0,Rattus norvegicus,,,50597,,7768,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,1,CHEMBL626366,Intermediate,,,A,N,1,10069,2046.0,Rattus norvegicus,,,50597,,7768,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,1,CHEMBL626367,Intermediate,,,A,N,1,10070,2046.0,Rattus norvegicus,,,50597,,7768,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,1,CHEMBL626368,Intermediate,,,A,N,1,10071,2046.0,Rattus norvegicus,,,50597,,7768,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,1,CHEMBL626369,Intermediate,,,A,N,1,10072,2046.0,Rattus norvegicus,,,50597,,7768,10116.0,,Thyroid gland,BAO_0000218,
"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,1,CHEMBL626370,Intermediate,,,A,N,1,10073,2046.0,Rattus norvegicus,,,50597,,7768,10116.0,,Thyroid gland,BAO_0000218,
"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,1,CHEMBL626371,Intermediate,,,A,N,1,10074,,Rattus norvegicus,In vivo,,50597,,4498,10116.0,,,BAO_0000218,
"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,1,CHEMBL626372,Intermediate,,,A,N,1,10075,,Rattus norvegicus,In vivo,,50597,,4498,10116.0,,,BAO_0000218,
Bioavailability after a dose of 10 mg/kg p.o.,,1,CHEMBL626373,Intermediate,,,A,N,1,10076,,Rattus norvegicus,In vivo,,50597,,3603,10116.0,,,BAO_0000218,
Bioavailability after peroral administration (10 mg/kg) was determined in rat,,1,CHEMBL626374,Intermediate,,,A,N,1,10077,,Rattus norvegicus,In vivo,,50597,,6215,10116.0,,,BAO_0000218,
Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,1,CHEMBL626375,Intermediate,,,A,N,1,10078,,Rattus norvegicus,In vivo,,50597,,5710,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,1,CHEMBL626376,Intermediate,,,A,N,1,10079,,Rattus norvegicus,In vivo,,50597,,5710,10116.0,,,BAO_0000218,
Bioavailability in rat po was determined,,1,CHEMBL626377,Intermediate,,,A,N,1,10080,,Rattus norvegicus,In vivo,,50597,,5676,10116.0,,,BAO_0000218,
Bioavailability of compound at 10 mg/kg in rat after oral administration,,1,CHEMBL626378,Intermediate,,,A,N,1,10081,,Rattus norvegicus,In vivo,,50597,,17667,10116.0,,,BAO_0000218,
Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,1,CHEMBL626379,Intermediate,,,A,N,1,10082,,Rattus norvegicus,In vivo,,50597,,17667,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,1,CHEMBL626380,Intermediate,,,A,N,1,10083,,Rattus norvegicus,In vivo,,50597,,6848,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,1,CHEMBL626381,Intermediate,,,A,N,1,10084,,Rattus norvegicus,In vivo,,50597,,6848,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL626382,Intermediate,,,A,N,1,10085,,Rattus norvegicus,In vivo,,50597,,17267,10116.0,,,BAO_0000218,
Bioavailability in rat (Sprague-Dawley) (female),,1,CHEMBL626383,Intermediate,,,A,N,1,10086,,Rattus norvegicus,In vivo,,50597,,6362,10116.0,,,BAO_0000218,
Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,1,CHEMBL874652,Intermediate,,,A,N,1,10087,,Rattus norvegicus,In vivo,,50597,,17671,10116.0,,,BAO_0000218,
Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,1,CHEMBL626384,Intermediate,,,A,N,1,10088,,Rattus norvegicus,In vivo,,50597,,17671,10116.0,,,BAO_0000218,
Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,1,CHEMBL626385,Intermediate,,,A,N,1,10089,,Rattus norvegicus,In vivo,,50597,,4333,10116.0,,,BAO_0000218,
Bioavailability in rat at an oral dose of 2 mg/kg,,1,CHEMBL626386,Intermediate,,,A,N,1,10090,,Rattus norvegicus,In vivo,,50597,,6077,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL626387,Intermediate,,,A,N,1,10091,,Rattus norvegicus,In vivo,,50597,,3278,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL626388,Intermediate,,,A,N,1,10092,,Rattus norvegicus,In vivo,,50597,,5964,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL626389,Intermediate,,,A,N,1,10093,,Rattus norvegicus,In vivo,,50597,,4884,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL626390,Intermediate,,,A,N,1,10094,,Rattus norvegicus,In vivo,,50597,,4905,10116.0,,,BAO_0000218,
Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,1,CHEMBL626391,Intermediate,,,A,N,1,10095,,Rattus norvegicus,In vivo,,50597,,4884,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL626392,Intermediate,,,A,N,1,10096,,Rattus norvegicus,In vivo,,50597,,6850,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL626393,Intermediate,,,A,N,1,10097,,Rattus norvegicus,In vivo,,50597,,2864,10116.0,,,BAO_0000218,
Bioavailability was determined in rat,,1,CHEMBL623026,Intermediate,,,A,N,1,10098,,Rattus norvegicus,In vivo,,50597,,5780,10116.0,,,BAO_0000218,
Bioavailability,,1,CHEMBL623027,Intermediate,,,A,N,1,10099,,Rattus norvegicus,In vivo,,50597,,1465,10116.0,,,BAO_0000218,
Bioavailability,,1,CHEMBL623028,Intermediate,,,A,N,1,10100,,Rattus norvegicus,In vivo,,50597,,5199,10116.0,,,BAO_0000218,
Bioavailability in rat after 1 day dosing,,1,CHEMBL623029,Intermediate,,,A,N,1,10101,,Rattus norvegicus,In vivo,,50597,,5765,10116.0,,,BAO_0000218,
Bioavailability in rat after 4 day dosing,,1,CHEMBL623030,Intermediate,,,A,N,1,10102,,Rattus norvegicus,In vivo,,50597,,5765,10116.0,,,BAO_0000218,
Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,1,CHEMBL623031,Intermediate,,,A,N,1,10103,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Bioavailability after IV dosing at 1 mg/kg in rat; no data,,1,CHEMBL623032,Intermediate,,,A,N,1,10104,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Bioavailability after oral administration at a dose of 2 mg/kg in rat,,1,CHEMBL623033,Intermediate,,,A,N,1,10105,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Bioavailability after oral administration at a dose of 4 mg/kg in rat,,1,CHEMBL623034,Intermediate,,,A,N,1,10106,,Rattus norvegicus,In vivo,,50597,,6518,10116.0,,,BAO_0000218,
Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,1,CHEMBL623035,Intermediate,,,A,N,1,10107,,Rattus norvegicus,In vivo,,50597,,2083,10116.0,,,BAO_0000218,
Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,1,CHEMBL623036,Intermediate,,,A,N,1,10108,,Rattus norvegicus,In vivo,,50597,,17260,10116.0,,,BAO_0000218,
Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,1,CHEMBL623037,Intermediate,,,A,N,1,10109,,Rattus norvegicus,In vivo,,50597,,4956,10116.0,,,BAO_0000218,
Bioavailability by intravenous administration of 3.4 mg/kg in rat,,1,CHEMBL623038,Intermediate,,,A,N,1,10110,,Rattus norvegicus,In vivo,,50597,,4368,10116.0,,,BAO_0000218,
Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,1,CHEMBL874385,Intermediate,,,A,N,1,10111,1969.0,Rattus norvegicus,In vivo,,50597,,17752,10116.0,,Plasma,BAO_0000218,
Bioavailability in rat (Fisher) (fasted),,1,CHEMBL623039,Intermediate,,,A,N,1,10112,,Rattus norvegicus,In vivo,,50597,,1446,10116.0,,,BAO_0000218,
Bioavailability in monkey after po administration of 10 mg/kg dose,,0,CHEMBL623040,Intermediate,,,A,U,1,10113,,Primates,In vivo,,22224,,2891,9443.0,,,BAO_0000218,
Oral bioavailability in monkey (dose 10 mg/kg),,0,CHEMBL623041,Intermediate,,,A,U,1,10114,,Primates,In vivo,,22224,,2891,9443.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL623741,Intermediate,,,A,N,1,10115,,Rattus norvegicus,In vivo,,50597,,6672,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL623742,Intermediate,,,A,N,1,10116,,Rattus norvegicus,In vivo,,50597,,6673,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL623743,Intermediate,,,A,N,1,10117,,Rattus norvegicus,In vivo,,50597,,17655,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL623744,Intermediate,,,A,N,1,10118,,Rattus norvegicus,In vivo,,50597,,17796,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 2.0 mg/kg p.o.),,1,CHEMBL623745,Intermediate,,,A,N,1,10119,,Rattus norvegicus,In vivo,,50597,,17853,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,1,CHEMBL623746,Intermediate,,,A,N,1,10120,,Rattus norvegicus,In vivo,,50597,,4521,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 5 mg/kg p.o.),,1,CHEMBL623747,Intermediate,,,A,N,1,10121,,Rattus norvegicus,In vivo,,50597,,4940,10116.0,,,BAO_0000218,
Bioavailability in rat after po administration of 30 mg/kg dose,,0,CHEMBL623748,Intermediate,,,A,U,1,10122,,Rattus norvegicus,In vivo,,22224,,2891,10116.0,,,BAO_0000218,
Bioavailability in rat after po administration of 30 mg/kg dose,,0,CHEMBL623916,Intermediate,,,A,U,1,10123,,Rattus norvegicus,In vivo,,22224,,2891,10116.0,,,BAO_0000218,
Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,1,CHEMBL623917,Intermediate,,,A,N,1,10124,,Rattus norvegicus,In vivo,,50597,,4521,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 2 mg/kg i.v.),,1,CHEMBL623918,Intermediate,,,A,N,1,10125,,Rattus norvegicus,In vivo,,50597,,17686,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL874386,Intermediate,,,A,N,1,10126,,Rattus norvegicus,In vivo,,50597,,17796,10116.0,,,BAO_0000218,
Bioavailability in rat; Only traces detected in rat plasma,,1,CHEMBL623919,Intermediate,,,A,N,1,10127,1969.0,Rattus norvegicus,In vivo,,50597,,17796,10116.0,,Plasma,BAO_0000218,
Bioavailability in rat,,1,CHEMBL623920,Intermediate,,,A,N,1,10128,,Rattus norvegicus,In vivo,,50597,,5064,10116.0,,,BAO_0000218,
Bioavailability upon oral administration of compound,,1,CHEMBL623148,Intermediate,,,A,N,1,10129,,Rattus norvegicus,In vivo,,50597,,5147,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,1,CHEMBL623149,Intermediate,,,A,N,1,10130,,Rattus norvegicus,In vivo,,50597,,1916,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL623150,Intermediate,,,A,N,1,10131,,Rattus norvegicus,In vivo,,50597,,6049,10116.0,,,BAO_0000218,
"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,1,CHEMBL623151,Intermediate,,,A,N,1,10132,,Rattus norvegicus,In vivo,,50597,,1445,10116.0,,,BAO_0000218,
"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,1,CHEMBL623152,Intermediate,,,A,N,1,10133,,Rattus norvegicus,In vivo,,50597,,1445,10116.0,,,BAO_0000218,
Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,1,CHEMBL623153,Expert,,,F,N,1,10134,,Rattus norvegicus,,,50597,,2862,10116.0,,,BAO_0000218,
Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,1,CHEMBL623154,Expert,,,F,N,1,10135,,Rattus norvegicus,,,50597,,2862,10116.0,,,BAO_0000218,
In vitro and metabolic stability was determined,,1,CHEMBL623155,Intermediate,,,A,N,1,10136,,Rattus norvegicus,,,50597,,4194,10116.0,,,BAO_0000218,
In vitro metabolic stability in rat hepatocytes,,1,CHEMBL623156,Intermediate,,,A,N,1,10137,,Rattus norvegicus,,,50597,,4194,10116.0,,,BAO_0000218,
In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,1,CHEMBL623157,Intermediate,,,A,N,1,10138,,Rattus norvegicus,,,50597,,5486,10116.0,,,BAO_0000218,
Metabolic rate for compound was observed in rat hepatocytes,Hepatocyte,1,CHEMBL623158,Intermediate,,401.0,A,N,1,10139,2107.0,Rattus norvegicus,In vitro,,50597,,17582,10116.0,,Liver,BAO_0000218,
In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,1,CHEMBL623159,Intermediate,,,A,N,1,10140,,Rattus norvegicus,,,50597,,5600,10116.0,,,BAO_0000218,
Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,1,CHEMBL874390,Intermediate,,,A,N,1,10141,,Rattus norvegicus,,,50597,,14294,10116.0,,,BAO_0000218,
Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,1,CHEMBL623160,Intermediate,,,A,N,1,10142,,Rattus norvegicus,,,50597,,14294,10116.0,,,BAO_0000218,
Metabolism of compound in rat S9 microsomes; Trace,,1,CHEMBL623161,Intermediate,,,A,N,1,10143,,Rattus norvegicus,,,50597,,14294,10116.0,,,BAO_0000218,
Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,1,CHEMBL623162,Intermediate,,,A,N,1,10144,,Rattus norvegicus,,,50597,,17847,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,1,CHEMBL623163,Intermediate,,,A,N,1,10145,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,1,CHEMBL623164,Intermediate,,,A,N,1,10146,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,1,CHEMBL623165,Intermediate,,,A,N,1,10147,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,1,CHEMBL623166,Intermediate,,,A,N,1,10148,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,1,CHEMBL624983,Intermediate,,,A,N,1,10149,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,1,CHEMBL624984,Intermediate,,,A,N,1,10150,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,1,CHEMBL624985,Intermediate,,,A,N,1,10151,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,1,CHEMBL622970,Intermediate,,,A,N,1,10152,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,1,CHEMBL622971,Intermediate,,,A,N,1,10153,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,1,CHEMBL622972,Intermediate,,,A,N,1,10154,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,1,CHEMBL622973,Intermediate,,,A,N,1,10155,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,1,CHEMBL622974,Intermediate,,,A,N,1,10156,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,1,CHEMBL622975,Intermediate,,,A,N,1,10157,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,1,CHEMBL622976,Intermediate,,,A,N,1,10158,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,1,CHEMBL622977,Intermediate,,,A,N,1,10159,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,1,CHEMBL624351,Intermediate,,,A,N,1,10160,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,1,CHEMBL624352,Intermediate,,,A,N,1,10161,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,1,CHEMBL624353,Intermediate,,,A,N,1,10162,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,1,CHEMBL622397,Intermediate,,,A,N,1,10163,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,1,CHEMBL622398,Intermediate,,,A,N,1,10164,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,1,CHEMBL622399,Intermediate,,,A,N,1,10165,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,1,CHEMBL622400,Intermediate,,,A,N,1,10166,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,1,CHEMBL628428,Intermediate,,,A,N,1,10167,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,1,CHEMBL628590,Intermediate,,,A,N,1,10168,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,1,CHEMBL628591,Intermediate,,,A,N,1,10169,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,1,CHEMBL628592,Intermediate,,,A,N,1,10170,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,1,CHEMBL628593,Intermediate,,,A,N,1,10171,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,1,CHEMBL875333,Intermediate,,,A,N,1,10172,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,1,CHEMBL628594,Intermediate,,,A,N,1,10173,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,1,CHEMBL628595,Intermediate,,,A,N,1,10174,1969.0,Rattus norvegicus,,,50597,,4969,10116.0,,Plasma,BAO_0000218,
Stability in rat plasma was determined,,1,CHEMBL628596,Intermediate,,,A,N,1,10175,1969.0,Rattus norvegicus,,,50597,,6737,10116.0,,Plasma,BAO_0000218,
Stability in rat plasma was determined; ND= no data,,1,CHEMBL628597,Intermediate,,,A,N,1,10176,1969.0,Rattus norvegicus,,,50597,,6737,10116.0,,Plasma,BAO_0000218,
Tested for plasma half life period in rat (0-8 hr),,1,CHEMBL628598,Intermediate,,,A,N,1,10177,1969.0,Rattus norvegicus,,,50597,,5089,10116.0,,Plasma,BAO_0000218,
Tested for plasma half life period in rat (0-8 hr); Not determined,,1,CHEMBL628599,Intermediate,,,A,N,1,10178,1969.0,Rattus norvegicus,,,50597,,5089,10116.0,,Plasma,BAO_0000218,
Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,1,CHEMBL628600,Intermediate,,,A,N,1,10179,,Rattus norvegicus,In vivo,,50597,,1466,10116.0,,,BAO_0000218,
Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,1,CHEMBL628601,Intermediate,,,A,N,1,10180,,Rattus norvegicus,In vivo,,50597,,1466,10116.0,,,BAO_0000218,
Tested for the half life in rat,,1,CHEMBL628602,Intermediate,,,A,N,1,10181,,Rattus norvegicus,,,50597,,4950,10116.0,,,BAO_0000218,
Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,1,CHEMBL628603,Intermediate,,,A,N,1,10182,,Rattus norvegicus,In vitro,,50597,,2412,10116.0,,,BAO_0000218,
Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,1,CHEMBL628604,Intermediate,,,A,N,1,10183,,Rattus norvegicus,In vitro,,50597,,2412,10116.0,,,BAO_0000218,
Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,1,CHEMBL628605,Intermediate,,,A,N,1,10184,,Rattus norvegicus,In vitro,,50597,,2412,10116.0,,,BAO_0000218,
Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,1,CHEMBL628606,Intermediate,,,A,N,1,10185,,Rattus norvegicus,In vitro,,50597,,2412,10116.0,,,BAO_0000218,
Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,1,CHEMBL628607,Intermediate,,,A,N,1,10186,,Rattus norvegicus,In vitro,,50597,,2412,10116.0,,,BAO_0000218,
The biological half life the compound was measured at the dose of 100 umol/kg,,1,CHEMBL628608,Intermediate,,,A,N,1,10187,,Rattus norvegicus,,,50597,,15022,10116.0,,,BAO_0000218,
The biological half life the compound was measured at the dose of 30 umol/kg,,1,CHEMBL628609,Intermediate,,,A,N,1,10188,,Rattus norvegicus,,,50597,,15022,10116.0,,,BAO_0000218,
The compound was evaluated for plasma half life period in rat,,1,CHEMBL628610,Intermediate,,,A,N,1,10189,1969.0,Rattus norvegicus,,,50597,,406,10116.0,,Plasma,BAO_0000218,
"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL873819,Intermediate,,,A,N,1,10190,,Rattus norvegicus,In vivo,,50597,,15078,10116.0,,,BAO_0000218,
"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL628611,Intermediate,,,A,N,1,10191,,Rattus norvegicus,In vivo,,50597,,15078,10116.0,,,BAO_0000218,
The pharmacokinetic parameter half-life period in vivo in rats,,1,CHEMBL628612,Intermediate,,,A,N,1,10192,,Rattus norvegicus,In vivo,,50597,,5247,10116.0,,,BAO_0000218,
"The pharmacokinetic property, Half-life was determined",,1,CHEMBL628613,Intermediate,,,A,N,1,10193,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
"The pharmacokinetic property, Half-life in rat in vivo",,1,CHEMBL628614,Intermediate,,,A,N,1,10194,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
"The pharmacokinetic property, Half-life was determined; ND denotes no data",,1,CHEMBL628615,Intermediate,,,A,N,1,10195,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,1,CHEMBL628616,Intermediate,,,A,N,1,10196,,Rattus norvegicus,In vivo,,50597,,5041,10116.0,,,BAO_0000218,
The plasma half life period in rats,,1,CHEMBL627924,Intermediate,,,A,N,1,10197,1969.0,Rattus norvegicus,,,50597,,3918,10116.0,,Plasma,BAO_0000218,
The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,1,CHEMBL627925,Intermediate,,,A,N,1,10198,2107.0,Rattus norvegicus,,,50597,,2906,10116.0,,Liver,BAO_0000218,
half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,1,CHEMBL627926,Intermediate,,,A,N,1,10199,,Rattus norvegicus,In vivo,,50597,,6467,10116.0,,,BAO_0000218,
t1/2 (apparent elimination)of the compound was determined,,1,CHEMBL627927,Intermediate,,,A,N,1,10200,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
t1/2 value in rat,,1,CHEMBL627928,Intermediate,,,A,N,1,10201,,Rattus norvegicus,,,50597,,3788,10116.0,,,BAO_0000218,
Half life in rat,,1,CHEMBL627539,Intermediate,,,A,N,1,10202,,Rattus norvegicus,,,50597,,17796,10116.0,,,BAO_0000218,
"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,1,CHEMBL876790,Intermediate,,,A,N,1,10203,1969.0,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,Plasma,BAO_0000218,
Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,1,CHEMBL858186,Intermediate,,,A,N,1,10204,,Rattus norvegicus,In vivo,,50597,,5983,10116.0,,,BAO_0000218,
Half-life period in fasted rats,,1,CHEMBL627540,Intermediate,,,A,N,1,10205,,Rattus norvegicus,,,50597,,15765,10116.0,,,BAO_0000218,
Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,1,CHEMBL627541,Intermediate,,,A,N,1,10206,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,1,CHEMBL627715,Intermediate,,,A,N,1,10207,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,1,CHEMBL627716,Intermediate,,,A,N,1,10208,,Rattus norvegicus,In vivo,,50597,,429,10116.0,,,BAO_0000218,
Maximum time required to achieve Cmax was determined in rat,,1,CHEMBL627717,Intermediate,,,A,N,1,10209,,Rattus norvegicus,,,50597,,17655,10116.0,,,BAO_0000218,
Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,1,CHEMBL627718,Intermediate,,,A,N,1,10210,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,1,CHEMBL627719,Intermediate,,,A,N,1,10211,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,1,CHEMBL627720,Intermediate,,,A,N,1,10212,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,1,CHEMBL627721,Intermediate,,,A,N,1,10213,,Rattus norvegicus,In vivo,,50597,,6570,10116.0,,,BAO_0000218,
Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,1,CHEMBL627722,Intermediate,,,A,N,1,10214,,Rattus norvegicus,In vivo,,50597,,6570,10116.0,,,BAO_0000218,
Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL627723,Intermediate,,,A,N,1,10215,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL626058,Intermediate,,,A,N,1,10216,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL626059,Intermediate,,,A,N,1,10217,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL626060,Intermediate,,,A,N,1,10218,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,1,CHEMBL626061,Intermediate,,,A,N,1,10219,1969.0,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,Plasma,BAO_0000218,
Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL876791,Intermediate,,,A,N,1,10220,,Rattus norvegicus,In vivo,,50597,,4723,10116.0,,,BAO_0000218,
Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,CHEMBL626062,Intermediate,,,A,N,1,10221,,Rattus norvegicus,In vivo,,50597,,4723,10116.0,,,BAO_0000218,
Tmax at the dose of 2 mg/Kg administered perorally in rats,,1,CHEMBL626063,Intermediate,,,A,N,1,10222,,Rattus norvegicus,In vivo,,50597,,4756,10116.0,,,BAO_0000218,
Tmax at the dose of 5 mg/Kg administered perorally in rats,,1,CHEMBL626064,Intermediate,,,A,N,1,10223,,Rattus norvegicus,In vivo,,50597,,4756,10116.0,,,BAO_0000218,
tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,1,CHEMBL626065,Intermediate,,,A,N,1,10224,1969.0,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,Plasma,BAO_0000218,
tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,1,CHEMBL626066,Intermediate,,,A,N,1,10225,1969.0,Rattus norvegicus,In vivo,,50597,,17720,10116.0,,Plasma,BAO_0000218,
tmax upon peroral administration of 10.0 mg/Kg dose in rat,,1,CHEMBL626067,Intermediate,,,A,N,1,10226,,Rattus norvegicus,In vivo,,50597,,1466,10116.0,,,BAO_0000218,
Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,1,CHEMBL626068,Intermediate,,,F,N,1,10227,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,1,CHEMBL626069,Intermediate,,,F,N,1,10228,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Percent total excretion of 3-methoxyacetaminophen glucuronide,,1,CHEMBL626070,Intermediate,,,F,N,1,10229,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Percent total excretion of N-methoxyacetaminophen glucuronide,,1,CHEMBL626071,Intermediate,,,F,N,1,10230,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Percent total excretion of N-methoxyacetaminophen sulfate,,1,CHEMBL626072,Intermediate,,,F,N,1,10231,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Percent total excretion of acetaminophen,,1,CHEMBL626073,Intermediate,,,F,N,1,10232,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,1,CHEMBL626741,Intermediate,,,A,N,1,10233,2046.0,Rattus norvegicus,,,50597,,7768,10116.0,,Thyroid gland,BAO_0000218,
"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,1,CHEMBL626742,Intermediate,,,A,N,1,10234,,Rattus norvegicus,,,50597,,17655,10116.0,,,BAO_0000218,
Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,1,CHEMBL626743,Intermediate,,,A,N,1,10235,,Rattus norvegicus,,,50597,,17735,10116.0,,,BAO_0000218,
Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,1,CHEMBL876792,Intermediate,,,A,N,1,10236,,Rattus norvegicus,,,50597,,5960,10116.0,,,BAO_0000218,
Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,1,CHEMBL626744,Intermediate,,,A,N,1,10237,,Rattus norvegicus,,,50597,,17735,10116.0,,,BAO_0000218,
Compound was tested for antidiuretic activity in rats,,1,CHEMBL626745,Intermediate,,,A,N,1,10238,,Rattus norvegicus,,,50597,,7116,10116.0,,,BAO_0000218,
AUC in rat after 3mg/kg oral dose,,1,CHEMBL626746,Intermediate,,,A,N,1,10239,1969.0,Rattus norvegicus,In vivo,,50597,,4878,10116.0,,Plasma,BAO_0000218,
Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,1,CHEMBL626747,Intermediate,,,A,N,1,10240,,Rattus norvegicus,,,50597,,5939,10116.0,,,BAO_0000218,
Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,1,CHEMBL626748,Intermediate,,,A,N,1,10241,,Rattus norvegicus,,,50597,,5939,10116.0,,,BAO_0000218,
Bioavailability administered orally at a dose of 10 mg/kg to rats,,1,CHEMBL626749,Intermediate,,,A,N,1,10242,,Rattus norvegicus,,,50597,,16367,10116.0,,,BAO_0000218,
Oral Bioavailability was determined,,1,CHEMBL626750,Intermediate,,,A,N,1,10243,,Rattus norvegicus,,,50597,,16366,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL626751,Intermediate,,,A,N,1,10244,,Rattus norvegicus,,,50597,,4426,10116.0,,,BAO_0000218,
Oral bioavailability in rat; Not performed.,,1,CHEMBL626913,Intermediate,,,A,N,1,10245,,Rattus norvegicus,,,50597,,4426,10116.0,,,BAO_0000218,
Bioavailability,,1,CHEMBL626914,Intermediate,,,A,N,1,10246,,Rattus norvegicus,,,50597,,5041,10116.0,,,BAO_0000218,
Bioavailability was determined; ND denotes no data,,1,CHEMBL626915,Intermediate,,,A,N,1,10247,,Rattus norvegicus,,,50597,,5041,10116.0,,,BAO_0000218,
Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,1,CHEMBL626916,Intermediate,,,A,N,1,10248,,Rattus norvegicus,,,50597,,1500,10116.0,,,BAO_0000218,
Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,1,CHEMBL626917,Intermediate,,,A,N,1,10249,,Rattus norvegicus,,,50597,,1500,10116.0,,,BAO_0000218,
Binding towards rat plasma protein at 10 uM,,1,CHEMBL626918,Intermediate,,,A,N,1,10250,,Rattus norvegicus,,,50597,,17409,10116.0,,,BAO_0000218,
Binding towards rat plasma protein at 100 uM,,1,CHEMBL626919,Intermediate,,,A,N,1,10251,,Rattus norvegicus,,,50597,,17409,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 20 mg/kg p.o.),,1,CHEMBL626920,Intermediate,,,A,N,1,10252,,Rattus norvegicus,In vivo,,50597,,2959,10116.0,,,BAO_0000218,
Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,1,CHEMBL621976,Intermediate,,,A,N,1,10253,,Rattus norvegicus,In vivo,,50597,,13501,10116.0,,,BAO_0000218,
Bioavailability in rat after 5 mg/kg oral gavage,,1,CHEMBL877599,Intermediate,,,A,N,1,10254,,Rattus norvegicus,In vivo,,50597,,6567,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL621977,Intermediate,,,A,N,1,10255,,Rattus norvegicus,In vivo,,50597,,6571,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 1 mg/kg i.v.),,1,CHEMBL621978,Intermediate,,,A,N,1,10256,,Rattus norvegicus,In vivo,,50597,,6715,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 3 mg/kg p.o.),,1,CHEMBL621979,Intermediate,,,A,N,1,10257,,Rattus norvegicus,In vivo,,50597,,6715,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL621980,Intermediate,,,A,N,1,10258,,Rattus norvegicus,In vivo,,50597,,2932,10116.0,,,BAO_0000218,
Bioavailability of the compound in rats after administration of 30 mg/kg,,1,CHEMBL621981,Intermediate,,,A,N,1,10259,,Rattus norvegicus,In vivo,,50597,,4171,10116.0,,,BAO_0000218,
Bioavailability after administration of 10 mg/kg in rats,,1,CHEMBL621982,Intermediate,,,A,N,1,10260,,Rattus norvegicus,In vivo,,50597,,17509,10116.0,,,BAO_0000218,
Bioavailability after administration of 2 mg/kg in rats,,1,CHEMBL882953,Intermediate,,,A,N,1,10261,,Rattus norvegicus,In vivo,,50597,,17509,10116.0,,,BAO_0000218,
Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,1,CHEMBL621983,Intermediate,,,A,N,1,10262,,Rattus norvegicus,In vivo,,50597,,4527,10116.0,,,BAO_0000218,
Bioavailability in dogs was determined; high,,1,CHEMBL621984,Intermediate,,,A,N,1,10263,,Rattus norvegicus,In vivo,,50597,,4026,10116.0,,,BAO_0000218,
Bioavailability in monkey after intravenous administration at 1 mpk,,1,CHEMBL621985,Intermediate,,,A,N,1,10264,,Rattus norvegicus,In vivo,,50597,,6659,10116.0,,,BAO_0000218,
Bioavailability in monkey after peroral administration at 10 mpk,,1,CHEMBL621986,Intermediate,,,A,N,1,10265,,Rattus norvegicus,In vivo,,50597,,6659,10116.0,,,BAO_0000218,
Bioavailability in rat after intravenous administration at 1 mpk,,1,CHEMBL621987,Intermediate,,,A,N,1,10266,,Rattus norvegicus,In vivo,,50597,,6659,10116.0,,,BAO_0000218,
Bioavailability in rat after intravenous administration at 2 mpk,,1,CHEMBL877600,Intermediate,,,F,N,1,10267,,Rattus norvegicus,In vivo,,50597,,6659,10116.0,,,BAO_0000218,
Bioavailability in rat after peroral administration at 30 mpk,,1,CHEMBL621988,Intermediate,,,A,N,1,10268,,Rattus norvegicus,In vivo,,50597,,6659,10116.0,,,BAO_0000218,
Bioavailability in rat after peroral administration at at 100 mpk,,1,CHEMBL621989,Intermediate,,,F,N,1,10269,,Rattus norvegicus,In vivo,,50597,,6659,10116.0,,,BAO_0000218,
Bioavailability in rats was evaluated,,1,CHEMBL621990,Intermediate,,,A,N,1,10270,,Rattus norvegicus,In vivo,,50597,,6597,10116.0,,,BAO_0000218,
Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,1,CHEMBL621991,Intermediate,,,A,N,1,10271,,Rattus norvegicus,In vivo,,50597,,1202,10116.0,,,BAO_0000218,
Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,1,CHEMBL621992,Intermediate,,,A,N,1,10272,,Rattus norvegicus,In vivo,,50597,,1202,10116.0,,,BAO_0000218,
Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,1,CHEMBL621993,Intermediate,,,A,N,1,10273,,Rattus norvegicus,In vivo,,50597,,1202,10116.0,,,BAO_0000218,
Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,1,CHEMBL621994,Intermediate,,,A,N,1,10274,,Rattus norvegicus,In vivo,,50597,,1202,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL621995,Intermediate,,,A,N,1,10275,,Rattus norvegicus,In vivo,,50597,,5207,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL621996,Intermediate,,,A,N,1,10276,,Rattus norvegicus,In vivo,,50597,,5970,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 10 mg/kg),,1,CHEMBL621997,Intermediate,,,A,N,1,10277,,Rattus norvegicus,In vivo,,50597,,17538,10116.0,,,BAO_0000218,
Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,1,CHEMBL621998,Intermediate,,,A,N,1,10278,,Rattus norvegicus,In vivo,,50597,,17538,10116.0,,,BAO_0000218,
Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,1,CHEMBL621999,Intermediate,,,A,N,1,10279,,Rattus norvegicus,In vivo,,50597,,1466,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622000,Intermediate,,,A,N,1,10280,,Rattus norvegicus,In vivo,,50597,,2879,10116.0,,,BAO_0000218,
Bioavailability was measured in rat after oral administration; 2-4,,1,CHEMBL622001,Intermediate,,,A,N,1,10281,,Rattus norvegicus,In vivo,,50597,,2879,10116.0,,,BAO_0000218,
Bioavailability was measured in rat after oral administration; 3-7,,1,CHEMBL622002,Intermediate,,,A,N,1,10282,,Rattus norvegicus,In vivo,,50597,,2879,10116.0,,,BAO_0000218,
Bioavailability in rat (intraduodenal administration),,1,CHEMBL622003,Intermediate,,,A,N,1,10283,,Rattus norvegicus,In vivo,,50597,,3777,10116.0,,,BAO_0000218,
Bioavailability in rat (intraduodenal administration),,1,CHEMBL877601,Intermediate,,,A,N,1,10284,,Rattus norvegicus,In vivo,,50597,,3777,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL624871,Intermediate,,,A,N,1,10285,,Rattus norvegicus,In vivo,,50597,,3777,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622004,Intermediate,,,A,N,1,10286,,Rattus norvegicus,In vivo,,50597,,3777,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,1,CHEMBL882954,Intermediate,,,A,N,1,10287,,Rattus norvegicus,In vivo,,50597,,5423,10116.0,,,BAO_0000218,
Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,1,CHEMBL622005,Intermediate,,,A,N,1,10288,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,1,CHEMBL622006,Intermediate,,,A,N,1,10289,,Rattus norvegicus,In vivo,,50597,,16365,10116.0,,,BAO_0000218,
Bioavailability was measured in rat,,1,CHEMBL622007,Intermediate,,,A,N,1,10290,,Rattus norvegicus,In vivo,,50597,,4239,10116.0,,,BAO_0000218,
Bioavailability was reported,,1,CHEMBL622008,Intermediate,,,A,N,1,10291,,Rattus norvegicus,In vivo,,50597,,5438,10116.0,,,BAO_0000218,
Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,1,CHEMBL622009,Intermediate,,,A,N,1,10292,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,1,CHEMBL622010,Intermediate,,,A,N,1,10293,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,1,CHEMBL622011,Intermediate,,,A,N,1,10294,,Rattus norvegicus,In vivo,,50597,,4199,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,1,CHEMBL622012,Intermediate,,,A,N,1,10295,,Rattus norvegicus,In vivo,,50597,,4199,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,1,CHEMBL622013,Intermediate,,,A,N,1,10296,,Rattus norvegicus,In vivo,,50597,,4199,10116.0,,,BAO_0000218,
Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,1,CHEMBL622014,Intermediate,,,A,N,1,10297,,Rattus norvegicus,In vivo,,50597,,4890,10116.0,,,BAO_0000218,
Bioavailability was determined at 3 mg/kg po dose in rats,,1,CHEMBL624749,Intermediate,,,A,N,1,10298,,Rattus norvegicus,In vivo,,50597,,2792,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 2 mg/kg),,1,CHEMBL624750,Intermediate,,,A,N,1,10299,,Rattus norvegicus,In vivo,,50597,,5529,10116.0,,,BAO_0000218,
"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,1,CHEMBL624751,Intermediate,,,A,N,1,10300,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,1,CHEMBL624752,Intermediate,,,A,N,1,10301,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,1,CHEMBL624753,Intermediate,,,A,N,1,10302,,Rattus norvegicus,In vivo,,50597,,6685,10116.0,,,BAO_0000218,
Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,1,CHEMBL624754,Intermediate,,,A,N,1,10303,,Rattus norvegicus,In vivo,,50597,,6005,10116.0,,,BAO_0000218,
Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,1,CHEMBL624755,Intermediate,,,A,N,1,10304,,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,,BAO_0000218,
Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,1,CHEMBL624756,Intermediate,,,A,N,1,10305,,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL624757,Intermediate,,,A,N,1,10306,,Rattus norvegicus,In vivo,,50597,,6103,10116.0,,,BAO_0000218,
Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,1,CHEMBL624758,Intermediate,,,A,N,1,10307,,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,,BAO_0000218,
Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,1,CHEMBL622270,Intermediate,,,A,N,1,10308,,Rattus norvegicus,In vivo,,50597,,6410,10116.0,,,BAO_0000218,
Bioavailability in rat (Sprague-Dawley),,1,CHEMBL622271,Intermediate,,,A,N,1,10309,,Rattus norvegicus,In vivo,,50597,,5353,10116.0,,,BAO_0000218,
Bioavailability in rat at the dose of 2 mg/kg,,1,CHEMBL622272,Intermediate,,,A,N,1,10310,,Rattus norvegicus,In vivo,,50597,,4727,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622273,Intermediate,,,A,N,1,10311,,Rattus norvegicus,In vivo,,50597,,17804,10116.0,,,BAO_0000218,
Bioavailability in rat (cannulated) (dose 2 mg/kg),,1,CHEMBL622274,Intermediate,,,A,N,1,10312,,Rattus norvegicus,In vivo,,50597,,5809,10116.0,,,BAO_0000218,
Bioavailability value of compound in rats was determined after peroral administration,,1,CHEMBL622275,Intermediate,,,A,N,1,10313,,Rattus norvegicus,In vivo,,50597,,17804,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 20 mg/kg),,1,CHEMBL622276,Intermediate,,,A,N,1,10314,,Rattus norvegicus,In vivo,,50597,,3634,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622277,Intermediate,,,A,N,1,10315,,Rattus norvegicus,In vivo,,50597,,3341,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 5 mg/kg),,1,CHEMBL622278,Intermediate,,,A,N,1,10316,,Rattus norvegicus,In vivo,,50597,,2690,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622279,Intermediate,,,A,N,1,10317,,Rattus norvegicus,In vivo,,50597,,3184,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622280,Intermediate,,,A,N,1,10318,,Rattus norvegicus,In vivo,,50597,,740,10116.0,,,BAO_0000218,
Compound was evaluated for oral bioavailability in rats; 15-27 %,,1,CHEMBL624083,Intermediate,,,A,N,1,10319,,Rattus norvegicus,In vivo,,50597,,1806,10116.0,,,BAO_0000218,
Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,1,CHEMBL624084,Intermediate,,,A,N,1,10320,,Rattus norvegicus,In vivo,,50597,,4891,10116.0,,,BAO_0000218,
Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,1,CHEMBL624085,Intermediate,,,A,N,1,10321,,Rattus norvegicus,In vivo,,50597,,3634,10116.0,,,BAO_0000218,
Compound was tested for bioavailability in rats,,1,CHEMBL624086,Intermediate,,,A,N,1,10322,,Rattus norvegicus,In vivo,,50597,,64,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL624087,Intermediate,,,A,N,1,10323,,Rattus norvegicus,In vivo,,50597,,4839,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL624088,Intermediate,,,A,N,1,10324,,Rattus norvegicus,In vivo,,50597,,1094,10116.0,,,BAO_0000218,
Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,0,CHEMBL624089,Intermediate,,,A,U,1,10325,,Macaca mulatta,In vivo,,22224,,5005,9544.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,0,CHEMBL624090,Intermediate,,,A,U,1,10326,,Rattus norvegicus,In vivo,,22224,,5005,10116.0,,,BAO_0000218,
Evaluated for the bioavailability in rat (in vivo),,1,CHEMBL624091,Intermediate,,,A,N,1,10327,,Rattus norvegicus,In vivo,,50597,,4687,10116.0,,,BAO_0000218,
F value of compound in rats was determined after peroral administration,,1,CHEMBL624092,Intermediate,,,A,N,1,10328,,Rattus norvegicus,In vivo,,50597,,17804,10116.0,,,BAO_0000218,
In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL624093,Intermediate,,,A,N,1,10329,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL624094,Intermediate,,,A,N,1,10330,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL624095,Intermediate,,,A,N,1,10331,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,1,CHEMBL624096,Intermediate,,,A,N,1,10332,,Rattus norvegicus,In vivo,,50597,,5974,10116.0,,,BAO_0000218,
"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,1,CHEMBL624097,Intermediate,,,A,N,1,10333,,Rattus norvegicus,In vivo,,50597,,1088,10116.0,,,BAO_0000218,
Maximum fall in carotid flow in rat,,1,CHEMBL624098,Intermediate,,,A,N,1,10334,,Rattus norvegicus,In vivo,,50597,,1742,10116.0,,,BAO_0000218,
Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,1,CHEMBL874392,Intermediate,,,A,N,1,10335,,Rattus norvegicus,In vivo,,50597,,4689,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 5 mg/kg),,1,CHEMBL624099,Intermediate,,,A,N,1,10336,,Rattus norvegicus,In vivo,,50597,,2463,10116.0,,,BAO_0000218,
Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,1,CHEMBL624100,Intermediate,,,A,N,1,10337,,Rattus norvegicus,In vivo,,50597,,5654,10116.0,,,BAO_0000218,
Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,1,CHEMBL624101,Intermediate,,,A,N,1,10338,,Rattus norvegicus,In vivo,,50597,,5654,10116.0,,,BAO_0000218,
Oral bioavailability in rat (male Wistar),,1,CHEMBL624102,Intermediate,,,A,N,1,10339,,Rattus norvegicus,In vivo,,50597,,6874,10116.0,,,BAO_0000218,
Oral bioavailability after administration (30 mg/kg) in rat; good,,1,CHEMBL624103,Intermediate,,,A,N,1,10340,,Rattus norvegicus,In vivo,,50597,,5633,10116.0,,,BAO_0000218,
Oral bioavailability at the dose of 2 mg/kg in rat,,1,CHEMBL624104,Intermediate,,,A,N,1,10341,,Rattus norvegicus,In vivo,,50597,,5496,10116.0,,,BAO_0000218,
Oral bioavailability determined in rats,,1,CHEMBL624105,Intermediate,,,A,N,1,10342,,Rattus norvegicus,In vivo,,50597,,2358,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,1,CHEMBL624106,Intermediate,,,A,N,1,10343,,Rattus norvegicus,In vivo,,50597,,16456,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose single 10 mg/kg),,1,CHEMBL624107,Intermediate,,,A,N,1,10344,,Rattus norvegicus,In vivo,,50597,,5302,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose single 10 mg/kg),,1,CHEMBL623943,Intermediate,,,A,N,1,10345,,Rattus norvegicus,In vivo,,50597,,5302,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 5 mg/kg,,1,CHEMBL623944,Intermediate,,,A,N,1,10346,,Rattus norvegicus,In vivo,,50597,,5302,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,1,CHEMBL623945,Intermediate,,,A,N,1,10347,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,1,CHEMBL623946,Intermediate,,,A,N,1,10348,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,1,CHEMBL623947,Intermediate,,,A,N,1,10349,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,1,CHEMBL623948,Intermediate,,,A,N,1,10350,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,1,CHEMBL623949,Intermediate,,,A,N,1,10351,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,1,CHEMBL623950,Intermediate,,,A,N,1,10352,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,1,CHEMBL874398,Intermediate,,,A,N,1,10353,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,1,CHEMBL623951,Intermediate,,,A,N,1,10354,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,1,CHEMBL623952,Intermediate,,,A,N,1,10355,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,1,CHEMBL623953,Intermediate,,,A,N,1,10356,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,1,CHEMBL623954,Intermediate,,,A,N,1,10357,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,1,CHEMBL623955,Intermediate,,,A,N,1,10358,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,1,CHEMBL623956,Intermediate,,,A,N,1,10359,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,1,CHEMBL627807,Intermediate,,,A,N,1,10360,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,1,CHEMBL627808,Intermediate,,,A,N,1,10361,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,1,CHEMBL627809,Intermediate,,,A,N,1,10362,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,1,CHEMBL627810,Intermediate,,,A,N,1,10363,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,1,CHEMBL627811,Intermediate,,,A,N,1,10364,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,1,CHEMBL627812,Intermediate,,,A,N,1,10365,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,1,CHEMBL627813,Intermediate,,,A,N,1,10366,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,1,CHEMBL627814,Intermediate,,,A,N,1,10367,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,1,CHEMBL875336,Intermediate,,,A,N,1,10368,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,1,CHEMBL627815,Intermediate,,,A,N,1,10369,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,1,CHEMBL627816,Intermediate,,,A,N,1,10370,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,1,CHEMBL627817,Intermediate,,,A,N,1,10371,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,1,CHEMBL627818,Intermediate,,,A,N,1,10372,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,1,CHEMBL627819,Intermediate,,,A,N,1,10373,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,1,CHEMBL627820,Intermediate,,,A,N,1,10374,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,1,CHEMBL627821,Intermediate,,,A,N,1,10375,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,1,CHEMBL628464,Intermediate,,,A,N,1,10376,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,1,CHEMBL626239,Intermediate,,,A,N,1,10377,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,1,CHEMBL626240,Intermediate,,,A,N,1,10378,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,1,CHEMBL626241,Intermediate,,,A,N,1,10379,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,1,CHEMBL626242,Intermediate,,,A,N,1,10380,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,1,CHEMBL626243,Intermediate,,,A,N,1,10381,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,1,CHEMBL626244,Intermediate,,,A,N,1,10382,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,1,CHEMBL626907,Intermediate,,,A,N,1,10383,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,1,CHEMBL626908,Intermediate,,,A,N,1,10384,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,1,CHEMBL626909,Intermediate,,,A,N,1,10385,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,1,CHEMBL626910,Intermediate,,,A,N,1,10386,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
Percent total excretion of acetaminophen cysteine conjugate,,1,CHEMBL875342,Intermediate,,,F,N,1,10387,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Percent total excretion of acetaminophen glucuronide,,1,CHEMBL626911,Intermediate,,,F,N,1,10388,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Percent total excretion of acetaminophen sulfate,,1,CHEMBL626912,Intermediate,,,F,N,1,10389,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Percent total excretion of acetaminophen-mercapturic acid,,1,CHEMBL627065,Intermediate,,,F,N,1,10390,,Rattus norvegicus,,,50597,,7449,10116.0,,,BAO_0000218,
Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,1,CHEMBL627066,Intermediate,,,A,N,1,10391,1088.0,Rattus norvegicus,,,50597,,3172,10116.0,,Urine,BAO_0000218,
Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,1,CHEMBL627067,Intermediate,,,A,N,1,10392,,Rattus norvegicus,In vivo,,50597,,16456,10116.0,,,BAO_0000218,
Biodistribution of compound in rat muscle after 5 min of administration,,0,CHEMBL627068,Autocuration,,,A,U,1,10393,2385.0,ratrat,In vivo,,22224,,10839,8656.0,,Muscle tissue,BAO_0000218,
Biodistribution of compound in rat muscle after 5 min of administration.,,0,CHEMBL627069,Autocuration,,,A,U,1,10394,2385.0,ratrat,In vivo,,22224,,10839,8656.0,,Muscle tissue,BAO_0000218,
Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,0,CHEMBL627070,Autocuration,,,A,U,1,10395,,Ovis aries,In vivo,,22224,,5334,9940.0,,,BAO_0000218,
Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,0,CHEMBL627071,Autocuration,,,A,U,1,10396,,Ovis aries,In vivo,,22224,,5334,9940.0,,,BAO_0000218,
Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,0,CHEMBL627072,Autocuration,,,A,U,1,10397,,Ovis aries,In vivo,,22224,,5334,9940.0,,,BAO_0000218,
Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,0,CHEMBL627073,Autocuration,,,A,U,1,10398,,Ovis aries,In vivo,,22224,,5334,9940.0,,,BAO_0000218,
Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,0,CHEMBL625387,Autocuration,,,A,U,1,10399,,Ovis aries,In vivo,,22224,,5334,9940.0,,,BAO_0000218,
Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,0,CHEMBL625388,Autocuration,,,A,U,1,10400,,Ovis aries,In vivo,,22224,,5334,9940.0,,,BAO_0000218,
Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,0,CHEMBL625389,Autocuration,,,A,U,1,10401,1969.0,Ovis aries,In vivo,,22224,,5334,9940.0,,Plasma,BAO_0000218,
Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,0,CHEMBL875343,Autocuration,,,A,U,1,10402,1969.0,Ovis aries,In vivo,,22224,,5334,9940.0,,Plasma,BAO_0000218,
Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,1,CHEMBL876795,Intermediate,,,A,N,1,10403,,Serpentes,,,50497,,1735,8570.0,,,BAO_0000218,
Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,1,CHEMBL626552,Intermediate,,,A,N,1,10404,,Serpentes,,,50497,,1469,8570.0,,,BAO_0000218,
Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,1,CHEMBL626553,Intermediate,,,A,N,1,10405,,Serpentes,,,50497,,1336,8570.0,,,BAO_0000218,
The human biological plasma half life of the compound,,0,CHEMBL626554,Autocuration,,,A,U,1,10406,1969.0,Homo sapiens,,,22224,,12403,9606.0,,Plasma,BAO_0000366,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,1,CHEMBL626555,Intermediate,,,A,N,1,10407,1088.0,Rattus norvegicus,,,50597,,8151,10116.0,,Urine,BAO_0000218,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,1,CHEMBL626556,Intermediate,,,A,N,1,10408,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,1,CHEMBL626557,Intermediate,,,A,N,1,10409,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,1,CHEMBL626558,Intermediate,,,A,N,1,10410,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,1,CHEMBL626559,Intermediate,,,A,N,1,10411,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,1,CHEMBL626560,Intermediate,,,A,N,1,10412,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,1,CHEMBL876803,Intermediate,,,A,N,1,10413,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,1,CHEMBL627964,Intermediate,,,A,N,1,10414,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,1,CHEMBL627965,Intermediate,,,A,N,1,10415,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,1,CHEMBL627966,Intermediate,,,A,N,1,10416,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,1,CHEMBL627967,Intermediate,,,A,N,1,10417,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,1,CHEMBL627968,Intermediate,,,A,N,1,10418,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,1,CHEMBL627969,Intermediate,,,A,N,1,10419,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,1,CHEMBL627970,Intermediate,,,A,N,1,10420,,Rattus norvegicus,,,50597,,8004,10116.0,,,BAO_0000218,
Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,1,CHEMBL627971,Intermediate,,,A,N,1,10421,178.0,Rattus norvegicus,,,50597,,8004,10116.0,,Blood,BAO_0000218,
Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,1,CHEMBL627972,Intermediate,,,A,N,1,10422,178.0,Rattus norvegicus,,,50597,,8004,10116.0,,Blood,BAO_0000218,
Dissociation constant against binding to human cyclophilin A,,9,CHEMBL856029,Expert,,,B,D,1,10423,,Homo sapiens,,,180,,15917,9606.0,,,BAO_0000357,
Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,8,CHEMBL627973,Expert,,,B,H,1,10424,,Bos taurus,,,11591,,12396,9913.0,,,BAO_0000019,
-Log C was determined by performing the electroshock minimum test,,0,CHEMBL627974,Autocuration,,,A,U,1,10425,,,,,22224,,7065,,,,BAO_0000019,
-Log C was determined by performing the foot shock test,,0,CHEMBL627975,Autocuration,,,A,U,1,10426,,,,,22224,,7065,,,,BAO_0000019,
-Log C was determined by performing the incl screen test,,0,CHEMBL627976,Autocuration,,,A,U,1,10427,,,,,22224,,7065,,,,BAO_0000019,
-Log C was determined by performing the maximum electroshock test,,0,CHEMBL627977,Autocuration,,,A,U,1,10428,,,,,22224,,7065,,,,BAO_0000019,
-Log C was determined by performing the pentylenetetrazole test,,0,CHEMBL627978,Autocuration,,,A,U,1,10429,,,,,22224,,7065,,,,BAO_0000019,
Tested for experimental arotinoid inhibitory dose,,0,CHEMBL627979,Autocuration,,,A,U,1,10430,,,,,22224,,12415,,,,BAO_0000019,
Negative log transformed activity,,0,CHEMBL876804,Autocuration,,,A,U,1,10431,,,,,22224,,10256,,,,BAO_0000019,
"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,0,CHEMBL627980,Autocuration,,,A,U,1,10432,,,,,22224,,7991,,,,BAO_0000019,
Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,1,CHEMBL627981,Intermediate,,,A,N,1,10433,,Cavia porcellus,,,50512,,14342,10141.0,,,BAO_0000218,
Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,1,CHEMBL627982,Intermediate,,,A,N,1,10434,,Cavia porcellus,,,50512,,14342,10141.0,,,BAO_0000218,
Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,1,CHEMBL627983,Intermediate,,,A,N,1,10435,,Cavia porcellus,,,50512,,14342,10141.0,,,BAO_0000218,
Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,1,CHEMBL627984,Intermediate,,,A,N,1,10436,2116.0,Cavia porcellus,,,50512,,14342,10141.0,,Ileum,BAO_0000218,
Solubility in water was determined; values expressed as -log,,0,CHEMBL627985,Autocuration,,,P,U,1,10437,,,,,22229,,6047,,,,BAO_0000100,
Ratio of Kcat to that of Km was determined,,0,CHEMBL627986,Autocuration,,,A,U,1,10438,,,,,22224,,17269,,,,BAO_0000019,
Observed first order rate constant,,0,CHEMBL627987,Autocuration,,,A,U,1,10439,,,,,22224,,10026,,,,BAO_0000019,
Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,0,CHEMBL627988,Autocuration,,,A,U,1,10440,,,,,22224,,14583,,,,BAO_0000019,
Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,1,CHEMBL627989,Intermediate,,,A,N,1,10441,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,1,CHEMBL627990,Intermediate,,,A,N,1,10442,,Rattus norvegicus,In vivo,,50597,,2661,10116.0,,,BAO_0000218,
Oral Bioavailability after administration of 10 mg/kg in male rat,,1,CHEMBL876805,Intermediate,,,A,N,1,10443,,Rattus norvegicus,In vivo,,50597,,4029,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,1,CHEMBL627991,Intermediate,,,A,N,1,10444,,Rattus norvegicus,In vivo,,50597,,17735,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL627992,Intermediate,,,A,N,1,10445,,Rattus norvegicus,In vivo,,50597,,4576,10116.0,,,BAO_0000218,
Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,1,CHEMBL627993,Intermediate,,,A,N,1,10446,,Rattus norvegicus,In vivo,,50597,,17582,10116.0,,,BAO_0000218,
Oral bioavailability at 1 mg/kg was determined in rat,,1,CHEMBL622817,Intermediate,,,A,N,1,10447,,Rattus norvegicus,In vivo,,50597,,17651,10116.0,,,BAO_0000218,
Oral bioavailability at 10 mg/kg was determined in rat,,1,CHEMBL622818,Intermediate,,,A,N,1,10448,,Rattus norvegicus,In vivo,,50597,,17651,10116.0,,,BAO_0000218,
"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,1,CHEMBL622819,Intermediate,,,A,N,1,10449,,Rattus norvegicus,In vivo,,50597,,17670,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL872267,Intermediate,,,A,N,1,10450,,Rattus norvegicus,In vivo,,50597,,5045,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622820,Intermediate,,,A,N,1,10451,,Rattus norvegicus,In vivo,,50597,,1696,10116.0,,,BAO_0000218,
Oral bioavailability after intravenous administration in rats at 24 uM/kg,,1,CHEMBL622821,Intermediate,,,A,N,1,10452,,Rattus norvegicus,In vivo,,50597,,17764,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622822,Intermediate,,,A,N,1,10453,,Rattus norvegicus,In vivo,,50597,,6448,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622823,Intermediate,,,A,N,1,10454,,Rattus norvegicus,In vivo,,50597,,6596,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622824,Intermediate,,,A,N,1,10455,,Rattus norvegicus,In vivo,,50597,,17547,10116.0,,,BAO_0000218,
Oral bioavailability in rat at a dose of 3 mg/kg,,1,CHEMBL622825,Intermediate,,,A,N,1,10456,,Rattus norvegicus,In vivo,,50597,,17771,10116.0,,,BAO_0000218,
Oral bioavailability in rat after oral administration at 10 mg/kg,,1,CHEMBL622901,Intermediate,,,A,N,1,10457,,Rattus norvegicus,In vivo,,50597,,6495,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622902,Intermediate,,,A,N,1,10458,,Rattus norvegicus,In vivo,,50597,,4558,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL621844,Intermediate,,,A,N,1,10459,,Rattus norvegicus,In vivo,,50597,,17596,10116.0,,,BAO_0000218,
Oral bioavailability in Dawley rats,,1,CHEMBL621845,Intermediate,,,A,N,1,10460,,Rattus norvegicus,In vivo,,50597,,6827,10116.0,,,BAO_0000218,
Oral bioavailability,,1,CHEMBL621846,Intermediate,,,A,N,1,10461,,Rattus norvegicus,In vivo,,50597,,4026,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 30 mg/kg),,1,CHEMBL621847,Intermediate,,,A,N,1,10462,,Rattus norvegicus,In vivo,,50597,,10,10116.0,,,BAO_0000218,
Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,1,CHEMBL877609,Intermediate,,,A,N,1,10463,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 3 mg/kg i.v.),,1,CHEMBL621848,Intermediate,,,A,N,1,10464,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,1,CHEMBL621849,Intermediate,,,A,N,1,10465,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 60 mg/kg p.o.),,1,CHEMBL622030,Intermediate,,,A,N,1,10466,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Percent oral bioavailability determined in rats,,1,CHEMBL622031,Intermediate,,,A,N,1,10467,,Rattus norvegicus,In vivo,,50597,,4796,10116.0,,,BAO_0000218,
Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,1,CHEMBL622032,Intermediate,,,A,N,1,10468,,Rattus norvegicus,In vivo,,50597,,4883,10116.0,,,BAO_0000218,
The compound was evaluated for bioavailability in rats; 32-51,,1,CHEMBL622033,Intermediate,,,A,N,1,10469,,Rattus norvegicus,In vivo,,50597,,2137,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 20 mg/kg p.o.),,1,CHEMBL622034,Intermediate,,,A,N,1,10470,,Rattus norvegicus,In vivo,,50597,,2959,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622035,Intermediate,,,A,N,1,10471,,Rattus norvegicus,In vivo,,50597,,1361,10116.0,,,BAO_0000218,
Bioavailability percent in rat at the dose of 2 mg/kg,,1,CHEMBL882966,Intermediate,,,A,N,1,10472,,Rattus norvegicus,In vivo,,50597,,4727,10116.0,,,BAO_0000218,
Bioavailability was evaluated after 20 uM/kg of peroral administration,,1,CHEMBL622036,Intermediate,,,A,N,1,10473,,Rattus norvegicus,In vivo,,50597,,16423,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622037,Intermediate,,,A,N,1,10474,,Rattus norvegicus,In vivo,,50597,,5206,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622038,Intermediate,,,A,N,1,10475,,Rattus norvegicus,In vivo,,50597,,6448,10116.0,,,BAO_0000218,
Bioavailability in rats,,1,CHEMBL622039,Intermediate,,,A,N,1,10476,,Rattus norvegicus,In vivo,,50597,,17723,10116.0,,,BAO_0000218,
Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,1,CHEMBL622040,Intermediate,,,A,N,1,10477,178.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Blood,BAO_0000218,
Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,1,CHEMBL622041,Intermediate,,,A,N,1,10478,178.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Blood,BAO_0000218,
Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,1,CHEMBL622042,Intermediate,,,A,N,1,10479,178.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Blood,BAO_0000218,
Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,1,CHEMBL622043,Intermediate,,,A,N,1,10480,178.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Blood,BAO_0000218,
Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,1,CHEMBL622044,Intermediate,,,A,N,1,10481,178.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Blood,BAO_0000218,
Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,1,CHEMBL622045,Intermediate,,,A,N,1,10482,10000001.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Bone,BAO_0000218,
Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,1,CHEMBL622046,Intermediate,,,A,N,1,10483,10000001.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Bone,BAO_0000218,
Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,1,CHEMBL622047,Intermediate,,,A,N,1,10484,10000001.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Bone,BAO_0000218,
Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,1,CHEMBL877610,Intermediate,,,A,N,1,10485,10000001.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Bone,BAO_0000218,
Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,1,CHEMBL622048,Intermediate,,,A,N,1,10486,955.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Brain,BAO_0000218,
Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,1,CHEMBL622049,Intermediate,,,A,N,1,10487,955.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Brain,BAO_0000218,
Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,1,CHEMBL622050,Intermediate,,,A,N,1,10488,955.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Brain,BAO_0000218,
Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,1,CHEMBL622051,Intermediate,,,A,N,1,10489,955.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Brain,BAO_0000218,
Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,1,CHEMBL622052,Intermediate,,,A,N,1,10490,,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,,BAO_0000218,
Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,1,CHEMBL622053,Intermediate,,,A,N,1,10491,,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,,BAO_0000218,
Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,1,CHEMBL622054,Intermediate,,,A,N,1,10492,,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,,BAO_0000218,
Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,1,CHEMBL622055,Intermediate,,,A,N,1,10493,,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,,BAO_0000218,
Oral bioavailability in rats was determined; High,,1,CHEMBL622056,Intermediate,,,A,N,1,10494,,Rattus norvegicus,In vivo,,50597,,5237,10116.0,,,BAO_0000218,
Oral bioavailability in the rat was determined,,1,CHEMBL622057,Intermediate,,,A,N,1,10495,,Rattus norvegicus,In vivo,,50597,,5503,10116.0,,,BAO_0000218,
Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,1,CHEMBL628008,Intermediate,,,A,N,1,10496,,Rattus norvegicus,In vivo,,50597,,15765,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,1,CHEMBL622058,Intermediate,,,A,N,1,10497,,Rattus norvegicus,In vivo,,50597,,15660,10116.0,,,BAO_0000218,
Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL622059,Intermediate,,,A,N,1,10498,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL622060,Intermediate,,,A,N,1,10499,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL622061,Intermediate,,,A,N,1,10500,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,1,CHEMBL622062,Intermediate,,,A,N,1,10501,,Rattus norvegicus,In vivo,,50597,,5978,10116.0,,,BAO_0000218,
Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,1,CHEMBL622063,Intermediate,,,A,N,1,10502,,Rattus norvegicus,In vivo,,50597,,5656,10116.0,,,BAO_0000218,
Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,CHEMBL877611,Expert,,,A,N,1,10503,,Rattus norvegicus,In vivo,,50597,,3598,10116.0,,,BAO_0000218,
Oral bioavailability of compound in Sprague Dawley rats,,1,CHEMBL622064,Intermediate,,,A,N,1,10504,,Rattus norvegicus,In vivo,,50597,,4216,10116.0,,,BAO_0000218,
Oral bioavailability of compound in rat,,1,CHEMBL622065,Intermediate,,,A,N,1,10505,,Rattus norvegicus,In vivo,,50597,,17839,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 2 mg/kg),,1,CHEMBL622066,Intermediate,,,A,N,1,10506,,Rattus norvegicus,In vivo,,50597,,6570,10116.0,,,BAO_0000218,
Oral bioavailability of compound in rat was determined,,1,CHEMBL622067,Intermediate,,,A,N,1,10507,,Rattus norvegicus,In vivo,,50597,,5334,10116.0,,,BAO_0000218,
Oral bioavailability of compound in rats,,1,CHEMBL622068,Intermediate,,,A,N,1,10508,,Rattus norvegicus,In vivo,,50597,,6886,10116.0,,,BAO_0000218,
Oral bioavailability of compound was determined in rats,,1,CHEMBL622069,Intermediate,,,A,N,1,10509,,Rattus norvegicus,In vivo,,50597,,5210,10116.0,,,BAO_0000218,
Oral bioavailability at a dose of 30 mg/kg in rats,,1,CHEMBL624796,Intermediate,,,A,N,1,10510,,Rattus norvegicus,In vivo,,50597,,4170,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 10 mg/kg),,1,CHEMBL624797,Intermediate,,,A,N,1,10511,,Rattus norvegicus,In vivo,,50597,,6028,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 10 mg/kg),,1,CHEMBL623053,Intermediate,,,A,N,1,10512,,Rattus norvegicus,In vivo,,50597,,6028,10116.0,,,BAO_0000218,
Oral bioavailability evaluated in rat,,1,CHEMBL623054,Intermediate,,,A,N,1,10513,,Rattus norvegicus,In vivo,,50597,,6078,10116.0,,,BAO_0000218,
Oral bioavailability in fasted rat,,1,CHEMBL623055,Intermediate,,,A,N,1,10514,,Rattus norvegicus,In vivo,,50597,,6168,10116.0,,,BAO_0000218,
Oral bioavailability in fed rat,,1,CHEMBL623056,Intermediate,,,A,N,1,10515,,Rattus norvegicus,In vivo,,50597,,6168,10116.0,,,BAO_0000218,
Oral bioavailability in rat (mature male) (dose 30 mg/kg),,1,CHEMBL623057,Intermediate,,,A,N,1,10516,,Rattus norvegicus,In vivo,,50597,,5160,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623058,Intermediate,,,A,N,1,10517,,Rattus norvegicus,In vivo,,50597,,6057,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 10 mg/kg p.o.),,1,CHEMBL623059,Intermediate,,,A,N,1,10518,,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,,BAO_0000218,
Oral bioavailability in rat after administration of 10 mg/kg po,,1,CHEMBL623060,Intermediate,,,A,N,1,10519,,Rattus norvegicus,In vivo,,50597,,6535,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623061,Intermediate,,,A,N,1,10520,,Rattus norvegicus,In vivo,,50597,,4194,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623062,Intermediate,,,A,N,1,10521,,Rattus norvegicus,In vivo,,50597,,6230,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623063,Intermediate,,,A,N,1,10522,,Rattus norvegicus,In vivo,,50597,,6619,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623064,Intermediate,,,A,N,1,10523,,Rattus norvegicus,In vivo,,50597,,17607,10116.0,,,BAO_0000218,
Oral bioavailability in ratrs,,1,CHEMBL623065,Intermediate,,,A,N,1,10524,,Rattus norvegicus,In vivo,,50597,,4942,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623066,Intermediate,,,A,N,1,10525,,Rattus norvegicus,In vivo,,50597,,4942,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623067,Intermediate,,,A,N,1,10526,,Rattus norvegicus,In vivo,,50597,,6646,10116.0,,,BAO_0000218,
Oral bioavailability in rats was determined; High,,1,CHEMBL623068,Intermediate,,,A,N,1,10527,,Rattus norvegicus,In vivo,,50597,,5237,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623069,Intermediate,,,A,N,1,10528,,Rattus norvegicus,In vivo,,50597,,6646,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623070,Intermediate,,,A,N,1,10529,,Rattus norvegicus,In vivo,,50597,,4449,10116.0,,,BAO_0000218,
Oral bioavailability was calculated in rat,,1,CHEMBL623071,Intermediate,,,A,N,1,10530,,Rattus norvegicus,In vivo,,50597,,6057,10116.0,,,BAO_0000218,
Oral bioavailability,,1,CHEMBL623072,Intermediate,,,A,N,1,10531,,Rattus norvegicus,In vivo,,50597,,2552,10116.0,,,BAO_0000218,
Oral bioavailability,,1,CHEMBL623073,Intermediate,,,A,N,1,10532,,Rattus norvegicus,In vivo,,50597,,5496,10116.0,,,BAO_0000218,
Oral bioavailability,,1,CHEMBL623074,Intermediate,,,A,N,1,10533,,Rattus norvegicus,In vivo,,50597,,6484,10116.0,,,BAO_0000218,
Oral bioavailability,,1,CHEMBL623075,Intermediate,,,A,N,1,10534,,Rattus norvegicus,In vivo,,50597,,6485,10116.0,,,BAO_0000218,
Oral bioavailability after i.v. administration,,1,CHEMBL623076,Intermediate,,,A,N,1,10535,,Rattus norvegicus,In vivo,,50597,,6616,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,1,CHEMBL623077,Intermediate,,,A,N,1,10536,,Rattus norvegicus,In vivo,,50597,,4969,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley),,1,CHEMBL623078,Intermediate,,,A,N,1,10537,,Rattus norvegicus,In vivo,,50597,,5862,10116.0,,,BAO_0000218,
Oral bioavailability in Sprague-Dawley rats,,1,CHEMBL623079,Intermediate,,,A,N,1,10538,,Rattus norvegicus,In vivo,,50597,,4514,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,1,CHEMBL623080,Intermediate,,,A,N,1,10539,,Rattus norvegicus,In vivo,,50597,,4514,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,1,CHEMBL623081,Intermediate,,,A,N,1,10540,,Rattus norvegicus,In vivo,,50597,,4514,10116.0,,,BAO_0000218,
Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,1,CHEMBL623082,Intermediate,,,A,N,1,10541,,Rattus norvegicus,In vivo,,50597,,5546,10116.0,,,BAO_0000218,
Oral bioavailability in fasted rat,,1,CHEMBL874400,Intermediate,,,A,N,1,10542,,Rattus norvegicus,In vivo,,50597,,6168,10116.0,,,BAO_0000218,
Oral bioavailability in fed rat,,1,CHEMBL623083,Intermediate,,,A,N,1,10543,,Rattus norvegicus,In vivo,,50597,,6168,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623084,Intermediate,,,A,N,1,10544,,Rattus norvegicus,In vivo,,50597,,3624,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623085,Intermediate,,,A,N,1,10545,,Rattus norvegicus,In vivo,,50597,,5213,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623086,Intermediate,,,A,N,1,10546,,Rattus norvegicus,In vivo,,50597,,5496,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623087,Intermediate,,,A,N,1,10547,,Rattus norvegicus,In vivo,,50597,,5553,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623088,Intermediate,,,A,N,1,10548,,Rattus norvegicus,In vivo,,50597,,5833,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623089,Intermediate,,,A,N,1,10549,,Rattus norvegicus,In vivo,,50597,,5836,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623090,Intermediate,,,A,N,1,10550,,Rattus norvegicus,In vivo,,50597,,5865,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623091,Intermediate,,,A,N,1,10551,,Rattus norvegicus,In vivo,,50597,,5960,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623092,Intermediate,,,A,N,1,10552,,Rattus norvegicus,In vivo,,50597,,6249,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623093,Intermediate,,,A,N,1,10553,,Rattus norvegicus,In vivo,,50597,,6448,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL874401,Intermediate,,,A,N,1,10554,,Rattus norvegicus,In vivo,,50597,,6453,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623094,Intermediate,,,A,N,1,10555,,Rattus norvegicus,In vivo,,50597,,6640,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL623095,Intermediate,,,A,N,1,10556,,Rattus norvegicus,In vivo,,50597,,17607,10116.0,,,BAO_0000218,
Oral bioavailability in rat after peroral administration at 10 mg/kg,,1,CHEMBL623096,Intermediate,,,A,N,1,10557,,Rattus norvegicus,In vivo,,50597,,5939,10116.0,,,BAO_0000218,
Oral bioavailability in rat after peroral administration at 5 mg/kg,,1,CHEMBL624913,Intermediate,,,A,N,1,10558,,Rattus norvegicus,In vivo,,50597,,5939,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,1,CHEMBL624914,Intermediate,,,A,N,1,10559,,Rattus norvegicus,In vivo,,50597,,6281,10116.0,,,BAO_0000218,
Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,1,CHEMBL624915,Intermediate,,,A,N,1,10560,,Rattus norvegicus,In vivo,,50597,,5874,10116.0,,,BAO_0000218,
Oral bioavailability in rat; Not measured,,1,CHEMBL624916,Intermediate,,,A,N,1,10561,,Rattus norvegicus,In vivo,,50597,,5213,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL624917,Intermediate,,,A,N,1,10562,,Rattus norvegicus,In vivo,,50597,,4964,10116.0,,,BAO_0000218,
Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,1,CHEMBL625157,Intermediate,,,A,N,1,10563,,Rattus norvegicus,,,50597,,11020,10116.0,,,BAO_0000218,
In vitro metabolic potential in rat liver microsomes,,1,CHEMBL625158,Intermediate,,,A,N,1,10564,2107.0,Rattus norvegicus,,,50597,,6251,10116.0,,Liver,BAO_0000218,
"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,1,CHEMBL625159,Intermediate,,,A,N,1,10565,,Rattus norvegicus,In vivo,,50597,,1568,10116.0,,,BAO_0000218,
"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,1,CHEMBL625160,Intermediate,,,A,N,1,10566,,Rattus norvegicus,In vivo,,50597,,3032,10116.0,,,BAO_0000218,
Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,1,CHEMBL625161,Intermediate,,,A,N,1,10567,,Rattus norvegicus,In vivo,,50597,,3748,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL625162,Intermediate,,,A,N,1,10568,,Rattus norvegicus,In vivo,,50597,,401,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL625163,Intermediate,,,A,N,1,10569,,Rattus norvegicus,In vivo,,50597,,6512,10116.0,,,BAO_0000218,
Oral bioavailability in rats at 10 mg/kg,,1,CHEMBL625164,Intermediate,,,A,N,1,10570,,Rattus norvegicus,In vivo,,50597,,17617,10116.0,,,BAO_0000218,
Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,1,CHEMBL625165,Intermediate,,,A,N,1,10571,,Rattus norvegicus,In vivo,,50597,,6679,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL625166,Intermediate,,,A,N,1,10572,,Rattus norvegicus,In vivo,,50597,,6742,10116.0,,,BAO_0000218,
Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,1,CHEMBL625167,Intermediate,,,A,N,1,10573,,Rattus norvegicus,,,50597,,589,10116.0,,,BAO_0000218,
Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,1,CHEMBL625168,Intermediate,,,A,N,1,10574,,Rattus norvegicus,,,50597,,589,10116.0,,,BAO_0000218,
Plasma clearance of the compound,,1,CHEMBL625169,Intermediate,,,A,N,1,10575,,Rattus norvegicus,In vivo,,50597,,3185,10116.0,,,BAO_0000218,
Plasma clearance at 10 mg/kg in rat upon intravenous administration,,1,CHEMBL626264,Intermediate,,,A,N,1,10576,,Rattus norvegicus,In vivo,,50597,,17596,10116.0,,,BAO_0000218,
Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,1,CHEMBL626265,Intermediate,,,A,N,1,10577,,Rattus norvegicus,In vivo,,50597,,2713,10116.0,,,BAO_0000218,
The compound was tested for plasma clearance in rat,,1,CHEMBL626266,Intermediate,,,A,N,1,10578,1969.0,Rattus norvegicus,In vivo,,50597,,12500,10116.0,,Plasma,BAO_0000218,
The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,1,CHEMBL626267,Intermediate,,,A,N,1,10579,1969.0,Rattus norvegicus,In vivo,,50597,,12500,10116.0,,Plasma,BAO_0000218,
Plasma concentration upon oral administration of 1 mg/Kg in rats,,1,CHEMBL626268,Intermediate,,,A,N,1,10580,,Rattus norvegicus,,,50597,,2713,10116.0,,,BAO_0000218,
Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,1,CHEMBL626269,Intermediate,,,A,N,1,10581,,Rattus norvegicus,,,50597,,1446,10116.0,,,BAO_0000218,
Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,1,CHEMBL626270,Intermediate,,,A,N,1,10582,,Rattus norvegicus,,,50597,,6227,10116.0,,,BAO_0000218,
Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,1,CHEMBL626271,Intermediate,,,A,N,1,10583,,Rattus norvegicus,,,50597,,4709,10116.0,,,BAO_0000218,
"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,1,CHEMBL626272,Intermediate,,,A,N,1,10584,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,1,CHEMBL626273,Intermediate,,,A,N,1,10585,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,1,CHEMBL875346,Intermediate,,,A,N,1,10586,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,1,CHEMBL626274,Intermediate,,,A,N,1,10587,,Rattus norvegicus,,,50597,,5510,10116.0,,,BAO_0000218,
Compound was tested for protein binding in rat plasma,,1,CHEMBL626275,Intermediate,,,A,N,1,10588,,Rattus norvegicus,,,50597,,4514,10116.0,,,BAO_0000218,
Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,1,CHEMBL624646,Intermediate,,,A,N,1,10589,,Rattus norvegicus,,,50597,,2713,10116.0,,,BAO_0000218,
Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,1,CHEMBL624647,Intermediate,,,A,N,1,10590,,Rattus norvegicus,,,50597,,2713,10116.0,,,BAO_0000218,
In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,1,CHEMBL624648,Intermediate,,,A,N,1,10591,2107.0,Rattus norvegicus,,,50597,,5340,10116.0,,Liver,BAO_0000218,
Area under curve ratio was determined (po/iv) in rat,,1,CHEMBL624649,Intermediate,,,A,N,1,10592,,Rattus norvegicus,,,50597,,12058,10116.0,,,BAO_0000218,
Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,1,CHEMBL624650,Intermediate,,,A,N,1,10593,,Rattus norvegicus,,,50597,,11195,10116.0,,,BAO_0000218,
Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,1,CHEMBL624651,Intermediate,,,A,N,1,10594,,Rattus norvegicus,,,50597,,11195,10116.0,,,BAO_0000218,
Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,1,CHEMBL624652,Intermediate,,,A,N,1,10595,,Rattus norvegicus,,,50597,,11195,10116.0,,,BAO_0000218,
Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,1,CHEMBL624653,Intermediate,,,A,N,1,10596,,Rattus norvegicus,,,50597,,6495,10116.0,,,BAO_0000218,
Ratio of AUCbrain to AUCplasma,,1,CHEMBL624654,Intermediate,,,A,N,1,10597,,Rattus norvegicus,,,50597,,6078,10116.0,,,BAO_0000218,
Ratio of brain to plasma,,1,CHEMBL624655,Intermediate,,,A,N,1,10598,,Rattus norvegicus,,,50597,,5656,10116.0,,,BAO_0000218,
Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,1,CHEMBL624656,Intermediate,,,A,N,1,10599,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,1,CHEMBL624657,Intermediate,,,A,N,1,10600,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,1,CHEMBL624658,Intermediate,,,A,N,1,10601,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,1,CHEMBL624659,Intermediate,,,A,N,1,10602,,Rattus norvegicus,,,50597,,10130,10116.0,,,BAO_0000218,
Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,1,CHEMBL624660,Intermediate,,,A,N,1,10603,,Rattus norvegicus,,,50597,,10130,10116.0,,,BAO_0000218,
Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,1,CHEMBL624661,Intermediate,,,A,N,1,10604,,Rattus norvegicus,,,50597,,10130,10116.0,,,BAO_0000218,
Steady state brain :blood ratio was determined,,1,CHEMBL624662,Intermediate,,,A,N,1,10605,,Rattus norvegicus,,,50597,,5213,10116.0,,,BAO_0000218,
Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,1,CHEMBL625199,Intermediate,,,A,N,1,10606,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,1,CHEMBL625200,Intermediate,,,A,N,1,10607,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,1,CHEMBL625201,Intermediate,,,A,N,1,10608,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,1,CHEMBL625202,Intermediate,,,A,N,1,10609,,Rattus norvegicus,,,50597,,4910,10116.0,,,BAO_0000218,
Percentage recovery after 3h incubation with rat hapatocytes was determined,,1,CHEMBL625203,Intermediate,,,A,N,1,10610,,Rattus norvegicus,,,50597,,2083,10116.0,,,BAO_0000218,
Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,1,CHEMBL625204,Intermediate,,,A,N,1,10611,,Rattus norvegicus,,,50597,,2082,10116.0,,,BAO_0000218,
Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,1,CHEMBL625205,Intermediate,,,A,N,1,10612,,Rattus norvegicus,,,50597,,2082,10116.0,,,BAO_0000218,
Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,1,CHEMBL625206,Intermediate,,,A,N,1,10613,,Rattus norvegicus,,,50597,,6351,10116.0,,,BAO_0000218,
"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,0,CHEMBL625207,Autocuration,,,A,U,1,10614,,,,,22224,,14583,,,,BAO_0000019,
Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,0,CHEMBL625208,Autocuration,,,A,U,1,10615,,,,,22224,,14583,,,,BAO_0000019,
In vivo absorption in Caco-2 cell line monolayers was determined,Caco-2,1,CHEMBL625209,Intermediate,,495.0,A,N,1,10616,,Homo sapiens,,,50587,,4608,9606.0,,,BAO_0000218,
Calculated partition coefficient (clogP),,0,CHEMBL625210,Autocuration,,,P,U,1,10617,,,,,22229,,13668,,,,BAO_0000100,
Area under curve was determine after peroral administration at 10 mpk in Rat,,1,CHEMBL625211,Intermediate,,,A,N,1,10618,,Rattus norvegicus,,,50597,,5669,10116.0,,,BAO_0000218,
Area under curve was determine after peroral administration at 10 mpk in Rhesus,,1,CHEMBL625212,Intermediate,,,A,N,1,10619,,Macaca mulatta,,,50797,,5669,9544.0,,,BAO_0000218,
Area under curve was determine after peroral administration at 160 mpk in Rat,,1,CHEMBL625213,Intermediate,,,A,N,1,10620,,Rattus norvegicus,,,50597,,5669,10116.0,,,BAO_0000218,
Area under curve was determine after peroral administration at 20 mpk in Rat,,1,CHEMBL625214,Intermediate,,,A,N,1,10621,,Rattus norvegicus,,,50597,,5669,10116.0,,,BAO_0000218,
Area under curve was determine after peroral administration at 50 mpk in Rat,,1,CHEMBL874542,Intermediate,,,A,N,1,10622,,Rattus norvegicus,,,50597,,5669,10116.0,,,BAO_0000218,
Calculated partition coefficient (clogP) (AlogP),,0,CHEMBL625215,Autocuration,,,P,U,1,10623,,,,,22229,,6472,,,,BAO_0000100,
Activated partial thromboplastin time measured,,0,CHEMBL625216,Autocuration,,,A,U,1,10624,,,,,22224,,15106,,,,BAO_0000019,
Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,0,CHEMBL625217,Autocuration,,,P,U,1,10625,,,,,22224,,15207,,,,BAO_0000100,
Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,0,CHEMBL625218,Autocuration,,,P,U,1,10626,,,,,22224,,15207,,,,BAO_0000100,
AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,1,CHEMBL622864,Intermediate,,,A,N,1,10627,1969.0,Canis lupus familiaris,,,50588,,13941,9615.0,,Plasma,BAO_0000218,
AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,1,CHEMBL622865,Intermediate,,,A,N,1,10628,1969.0,Rattus norvegicus,,,50597,,13941,10116.0,,Plasma,BAO_0000218,
AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,1,CHEMBL622866,Intermediate,,,A,N,1,10629,1969.0,Rattus norvegicus,,,50597,,13941,10116.0,,Plasma,BAO_0000218,
AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,1,CHEMBL622867,Intermediate,,,A,N,1,10630,1969.0,Canis lupus familiaris,,,50588,,13941,9615.0,,Plasma,BAO_0000218,
AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,1,CHEMBL876808,Intermediate,,,A,N,1,10631,1969.0,Cavia porcellus,,,50512,,15240,10141.0,,Plasma,BAO_0000218,
AUC in brain,,0,CHEMBL627725,Autocuration,,,A,U,1,10632,955.0,,,,22224,,10655,,,Brain,BAO_0000019,
AUC in serum,,0,CHEMBL627726,Autocuration,,,A,U,1,10633,1977.0,,,,22224,,10655,,,Serum,BAO_0000019,
AUC was determined,,0,CHEMBL627727,Autocuration,,,A,U,1,10634,1969.0,,,,22224,,6504,,,Plasma,BAO_0000019,
AUC of the compound.,,0,CHEMBL627728,Autocuration,,,A,U,1,10635,1969.0,,,,22224,,10615,,,Plasma,BAO_0000019,
AUC value (0-4 hr),,0,CHEMBL627729,Autocuration,,,A,U,1,10636,1969.0,,,,22224,,10353,,,Plasma,BAO_0000019,
"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,0,CHEMBL627730,Autocuration,,,A,U,1,10637,1969.0,,,,22224,,14907,,,Plasma,BAO_0000019,
AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,0,CHEMBL627731,Autocuration,,,A,U,1,10638,1969.0,,,,22224,,14907,,,Plasma,BAO_0000019,
"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,0,CHEMBL627732,Autocuration,,,A,U,1,10639,1969.0,,,,22224,,14907,,,Plasma,BAO_0000019,
"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,0,CHEMBL627733,Autocuration,,,A,U,1,10640,1969.0,,,,22224,,14907,,,Plasma,BAO_0000019,
AUC(area under curve) was determined after intravenous administration in rats,,1,CHEMBL627734,Intermediate,,,A,N,1,10641,1969.0,Rattus norvegicus,,,50597,,16359,10116.0,,Plasma,BAO_0000218,
AUC(area under curve) was determined after oral administration in rats,,1,CHEMBL627735,Intermediate,,,A,N,1,10642,1969.0,Rattus norvegicus,,,50597,,16359,10116.0,,Plasma,BAO_0000218,
AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,1,CHEMBL627736,Intermediate,,,A,N,1,10643,1969.0,Cavia porcellus,,,50512,,15240,10141.0,,Plasma,BAO_0000218,
AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,1,CHEMBL876809,Intermediate,,,A,N,1,10644,1969.0,Rattus norvegicus,,,50597,,15240,10116.0,,Plasma,BAO_0000218,
Area Under Curve after oral dosing of 100 uM/Kg,,0,CHEMBL627737,Autocuration,,,A,U,1,10645,,,,,22224,,15469,,,,BAO_0000019,
Area Under Curve after oral dosing of 30 uM/Kg,,0,CHEMBL627738,Autocuration,,,A,U,1,10646,,,,,22224,,15469,,,,BAO_0000019,
Area Under Curve was measured by ploting the graph between concentration verses time,,0,CHEMBL627739,Autocuration,,,A,U,1,10647,,,,,22224,,13520,,,,BAO_0000019,
Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,1,CHEMBL626143,Intermediate,,,A,N,1,10648,,Canis lupus familiaris,,,50588,,17025,9615.0,,,BAO_0000218,
Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,0,CHEMBL626144,Autocuration,,,A,U,1,10649,,Simiiformes,,,22224,,17025,314293.0,,,BAO_0000218,
Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,1,CHEMBL626145,Intermediate,,,A,N,1,10650,,Oryctolagus cuniculus,,,50592,,17025,9986.0,,,BAO_0000218,
Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,1,CHEMBL626146,Intermediate,,,A,N,1,10651,,Rattus norvegicus,,,50597,,17025,10116.0,,,BAO_0000218,
Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,1,CHEMBL626147,Intermediate,,,A,N,1,10652,178.0,Rattus norvegicus,,,50597,,12032,10116.0,,Blood,BAO_0000218,
Area under curve (AUC) was determined,,0,CHEMBL626148,Autocuration,,,A,U,1,10653,,,,,22224,,10291,,,,BAO_0000019,
Area under curve (AUC) following ip administration at 1 mg/kg,,0,CHEMBL626149,Autocuration,,,A,U,1,10654,,,,,22224,,5767,,,,BAO_0000218,
Area under curve (AUC) was determined; ND is Not determined,,0,CHEMBL626150,Autocuration,,,A,U,1,10655,,,,,22224,,1434,,,,BAO_0000019,
Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,1,CHEMBL626151,Intermediate,,,A,N,1,10656,,Canis lupus familiaris,,,50588,,14925,9615.0,,,BAO_0000218,
Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,1,CHEMBL626152,Intermediate,,,A,N,1,10657,,Canis lupus familiaris,,,50588,,14925,9615.0,,,BAO_0000218,
Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,1,CHEMBL626153,Intermediate,,,A,N,1,10658,,Canis lupus familiaris,,,50588,,14925,9615.0,,,BAO_0000218,
Area under curve (AUR) was determined,,0,CHEMBL626154,Autocuration,,,A,U,1,10659,,,,,22224,,1434,,,,BAO_0000019,
Area under curve at 1 uM/dg administered intravenously,,0,CHEMBL626155,Autocuration,,,A,U,1,10660,,,,,22224,,11883,,,,BAO_0000019,
Area under curve at 10 uM/dg administered perorally,,0,CHEMBL626156,Autocuration,,,A,U,1,10661,,,,,22224,,11883,,,,BAO_0000019,
Area under curve at 2 uM/dg administered intravenously,,0,CHEMBL626157,Autocuration,,,A,U,1,10662,,,,,22224,,11883,,,,BAO_0000019,
Area under curve at 20 uM/dg administered perorally,,0,CHEMBL626158,Autocuration,,,A,U,1,10663,,,,,22224,,11883,,,,BAO_0000019,
Area under curve at a peroral dose of 3 mg/kg in dog,,1,CHEMBL626159,Intermediate,,,A,N,1,10664,,Canis lupus familiaris,,,50588,,15233,9615.0,,,BAO_0000218,
Area under curve at a peroral dose of 3 mg/kg in rat,,1,CHEMBL626160,Intermediate,,,A,N,1,10665,,Rattus norvegicus,,,50597,,15233,10116.0,,,BAO_0000218,
Area under curve at an iv dose of 1 mg/kg in dog,,1,CHEMBL626161,Intermediate,,,A,N,1,10666,,Canis lupus familiaris,,,50588,,15233,9615.0,,,BAO_0000218,
Area under curve at an iv dose of 1 mg/kg in rat,,1,CHEMBL626162,Intermediate,,,A,N,1,10667,,Rattus norvegicus,,,50597,,15233,10116.0,,,BAO_0000218,
Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,0,CHEMBL626163,Autocuration,,,A,U,1,10668,,,,,22224,,12978,,,,BAO_0000019,
Area under curve gives the effective duration for the angiotensin II antagonist effect.,,0,CHEMBL626164,Autocuration,,,A,U,1,10669,,,,,22224,,12978,,,,BAO_0000019,
Area under curve measured as conc vs time after intravenous administration to mice.,,1,CHEMBL626165,Intermediate,,,A,N,1,10670,,Mus musculus,,,50594,,11355,10090.0,,,BAO_0000218,
Area under curve measured as conc vs time after peroral administration to mice.,,1,CHEMBL626166,Intermediate,,,A,N,1,10671,,Mus musculus,,,50594,,11355,10090.0,,,BAO_0000218,
Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,1,CHEMBL626167,Intermediate,,,A,N,1,10672,,Canis lupus familiaris,,,50588,,12923,9615.0,,,BAO_0000218,
Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,1,CHEMBL626168,Intermediate,,,A,N,1,10673,,Canis lupus familiaris,,,50588,,12923,9615.0,,,BAO_0000218,
Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,1,CHEMBL877463,Intermediate,,,A,N,1,10674,,Canis lupus familiaris,,,50588,,12923,9615.0,,,BAO_0000218,
Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,1,CHEMBL626169,Intermediate,,,A,N,1,10675,,Canis lupus familiaris,,,50588,,12923,9615.0,,,BAO_0000218,
Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,1,CHEMBL626170,Intermediate,,,A,N,1,10676,948.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Heart,BAO_0000218,
Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,1,CHEMBL626171,Intermediate,,,A,N,1,10677,948.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Heart,BAO_0000218,
Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,1,CHEMBL626172,Intermediate,,,A,N,1,10678,948.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Heart,BAO_0000218,
Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,1,CHEMBL626173,Intermediate,,,A,N,1,10679,948.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Heart,BAO_0000218,
Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,1,CHEMBL626174,Intermediate,,,A,N,1,10680,2113.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Kidney,BAO_0000218,
Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,1,CHEMBL626175,Intermediate,,,A,N,1,10681,2113.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Kidney,BAO_0000218,
Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,1,CHEMBL626176,Intermediate,,,A,N,1,10682,2113.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Kidney,BAO_0000218,
Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,1,CHEMBL626177,Intermediate,,,A,N,1,10683,2113.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Kidney,BAO_0000218,
Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,1,CHEMBL622499,Intermediate,,,A,N,1,10684,2113.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Kidney,BAO_0000218,
Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,1,CHEMBL622500,Intermediate,,,A,N,1,10685,2107.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Liver,BAO_0000218,
Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,1,CHEMBL622501,Intermediate,,,A,N,1,10686,2107.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Liver,BAO_0000218,
Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,1,CHEMBL622502,Intermediate,,,A,N,1,10687,2107.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Liver,BAO_0000218,
Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,1,CHEMBL622503,Intermediate,,,A,N,1,10688,2107.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Liver,BAO_0000218,
Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,1,CHEMBL877614,Intermediate,,,A,N,1,10689,2107.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Liver,BAO_0000218,
Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,1,CHEMBL624839,Intermediate,,,A,N,1,10690,2048.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Lung,BAO_0000218,
Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,1,CHEMBL624840,Intermediate,,,A,N,1,10691,2048.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Lung,BAO_0000218,
Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,1,CHEMBL624841,Intermediate,,,A,N,1,10692,2048.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Lung,BAO_0000218,
Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,1,CHEMBL624842,Intermediate,,,A,N,1,10693,2048.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Lung,BAO_0000218,
Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,1,CHEMBL624843,Intermediate,,,A,N,1,10694,2385.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,1,CHEMBL624844,Intermediate,,,A,N,1,10695,2385.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,1,CHEMBL624845,Intermediate,,,A,N,1,10696,2385.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,1,CHEMBL621904,Intermediate,,,A,N,1,10697,2385.0,Rattus norvegicus,In vivo,,50597,,17738,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,1,CHEMBL621905,Intermediate,,,A,N,1,10698,178.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Blood,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,1,CHEMBL874382,Intermediate,,,A,N,1,10699,178.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Blood,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,1,CHEMBL621906,Intermediate,,,A,N,1,10700,178.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Blood,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,1,CHEMBL621907,Intermediate,,,A,N,1,10701,955.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Brain,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,1,CHEMBL622096,Intermediate,,,A,N,1,10702,955.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Brain,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,1,CHEMBL622097,Intermediate,,,A,N,1,10703,955.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Brain,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,1,CHEMBL622098,Intermediate,,,A,N,1,10704,948.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Heart,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,1,CHEMBL622099,Intermediate,,,A,N,1,10705,948.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Heart,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,1,CHEMBL622100,Intermediate,,,A,N,1,10706,948.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Heart,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,1,CHEMBL622101,Intermediate,,,A,N,1,10707,2113.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Kidney,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,1,CHEMBL622102,Intermediate,,,A,N,1,10708,2113.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Kidney,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,1,CHEMBL622103,Intermediate,,,A,N,1,10709,2113.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Kidney,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,1,CHEMBL622104,Intermediate,,,A,N,1,10710,2107.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Liver,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,1,CHEMBL622105,Intermediate,,,A,N,1,10711,2107.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Liver,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,1,CHEMBL622106,Intermediate,,,A,N,1,10712,2107.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Liver,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,1,CHEMBL622107,Intermediate,,,A,N,1,10713,2048.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Lung,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,1,CHEMBL622108,Intermediate,,,A,N,1,10714,2048.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Lung,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,1,CHEMBL622109,Intermediate,,,A,N,1,10715,2048.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Lung,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,1,CHEMBL622110,Intermediate,,,A,N,1,10716,2385.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,1,CHEMBL622111,Intermediate,,,A,N,1,10717,2385.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,1,CHEMBL874383,Intermediate,,,A,N,1,10718,2385.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,1,CHEMBL622112,Intermediate,,,A,N,1,10719,14.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Zone of skin,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,1,CHEMBL622113,Intermediate,,,A,N,1,10720,14.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Zone of skin,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,1,CHEMBL622114,Intermediate,,,A,N,1,10721,14.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Zone of skin,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,1,CHEMBL622115,Intermediate,,,A,N,1,10722,2106.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Spleen,BAO_0000218,
Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,1,CHEMBL622116,Intermediate,,,A,N,1,10723,2106.0,Rattus norvegicus,In vivo,,50597,,11195,10116.0,,Spleen,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622117,Intermediate,,,A,N,1,10724,,Rattus norvegicus,In vivo,,50597,,6193,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622118,Intermediate,,,A,N,1,10725,,Rattus norvegicus,In vivo,,50597,,6803,10116.0,,,BAO_0000218,
Oral bioavailability in rats at 6 mg/kg,,1,CHEMBL622119,Intermediate,,,A,N,1,10726,,Rattus norvegicus,In vivo,,50597,,6647,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 6 mg/kg),,1,CHEMBL622120,Intermediate,,,A,N,1,10727,,Rattus norvegicus,In vivo,,50597,,6647,10116.0,,,BAO_0000218,
Oral bioavailability in rats at 6 mg/kg dose; Not tested,,1,CHEMBL622121,Intermediate,,,A,N,1,10728,,Rattus norvegicus,In vivo,,50597,,6647,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622122,Intermediate,,,A,N,1,10729,,Rattus norvegicus,In vivo,,50597,,6640,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622123,Intermediate,,,A,N,1,10730,,Rattus norvegicus,In vivo,,50597,,6641,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL622124,Intermediate,,,A,N,1,10731,,Rattus norvegicus,In vivo,,50597,,6641,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL622125,Intermediate,,,A,N,1,10732,,Rattus norvegicus,In vivo,,50597,,6642,10116.0,,,BAO_0000218,
Oral bioavailability,,1,CHEMBL622126,Intermediate,,,A,N,1,10733,,Rattus norvegicus,In vivo,,50597,,5472,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,1,CHEMBL620455,Intermediate,,,A,N,1,10734,,Rattus norvegicus,In vivo,,50597,,6141,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL620456,Intermediate,,,A,N,1,10735,,Rattus norvegicus,In vivo,,50597,,4390,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL620457,Intermediate,,,A,N,1,10736,,Rattus norvegicus,In vivo,,50597,,5472,10116.0,,,BAO_0000218,
Oral bioavailability was evaluated; Not tested,,1,CHEMBL620458,Intermediate,,,A,N,1,10737,,Rattus norvegicus,In vivo,,50597,,5472,10116.0,,,BAO_0000218,
Oral bioavailability,,1,CHEMBL620459,Intermediate,,,A,N,1,10738,,Rattus norvegicus,In vivo,,50597,,5438,10116.0,,,BAO_0000218,
Oral bioavailability in rat by oral dosing,,1,CHEMBL620460,Intermediate,,,A,N,1,10739,,Rattus norvegicus,In vivo,,50597,,4883,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 10 mg/kg p.o.),,1,CHEMBL620461,Intermediate,,,A,N,1,10740,,Rattus norvegicus,In vivo,,50597,,1908,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley),,1,CHEMBL620462,Intermediate,,,A,N,1,10741,,Rattus norvegicus,In vivo,,50597,,4853,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,1,CHEMBL620463,Intermediate,,,A,N,1,10742,,Rattus norvegicus,In vivo,,50597,,4853,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,1,CHEMBL620464,Intermediate,,,A,N,1,10743,,Rattus norvegicus,In vivo,,50597,,4853,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,1,CHEMBL620465,Intermediate,,,A,N,1,10744,,Rattus norvegicus,In vivo,,50597,,4853,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,1,CHEMBL620466,Intermediate,,,A,N,1,10745,,Rattus norvegicus,In vivo,,50597,,4853,10116.0,,,BAO_0000218,
Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,1,CHEMBL620467,Intermediate,,,A,N,1,10746,,Rattus norvegicus,In vivo,,50597,,4853,10116.0,,,BAO_0000218,
Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,1,CHEMBL620468,Intermediate,,,A,N,1,10747,,Rattus norvegicus,In vivo,,50597,,4853,10116.0,,,BAO_0000218,
Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,1,CHEMBL620469,Intermediate,,,A,N,1,10748,,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,,BAO_0000218,
Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,1,CHEMBL620470,Intermediate,,,A,N,1,10749,,Rattus norvegicus,In vivo,,50597,,12873,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL620471,Intermediate,,,A,N,1,10750,,Rattus norvegicus,In vivo,,50597,,3169,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL620472,Intermediate,,,A,N,1,10751,,Rattus norvegicus,In vivo,,50597,,6305,10116.0,,,BAO_0000218,
Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,1,CHEMBL620473,Intermediate,,,A,N,1,10752,,Rattus norvegicus,In vivo,,50597,,4762,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL620474,Intermediate,,,A,N,1,10753,,Rattus norvegicus,In vivo,,50597,,17847,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,1,CHEMBL620475,Intermediate,,,A,N,1,10754,,Rattus norvegicus,In vivo,,50597,,6211,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL620476,Intermediate,,,A,N,1,10755,,Rattus norvegicus,In vivo,,50597,,6011,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL620477,Intermediate,,,A,N,1,10756,,Rattus norvegicus,In vivo,,50597,,6317,10116.0,,,BAO_0000218,
Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,1,CHEMBL620478,Intermediate,,,A,N,1,10757,,Rattus norvegicus,In vivo,,50597,,6644,10116.0,,,BAO_0000218,
Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,1,CHEMBL618768,Intermediate,,,A,N,1,10758,,Rattus norvegicus,In vivo,,50597,,6644,10116.0,,,BAO_0000218,
Oral bioavailability in rat after oral administration at 13 mg/kg dose,,1,CHEMBL618769,Intermediate,,,A,N,1,10759,,Rattus norvegicus,In vivo,,50597,,6644,10116.0,,,BAO_0000218,
Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,1,CHEMBL618770,Intermediate,,,A,N,1,10760,,Rattus norvegicus,In vivo,,50597,,6644,10116.0,,,BAO_0000218,
Oral bioavailability (dose 20 mg/kg p.o.),,1,CHEMBL618771,Intermediate,,,A,N,1,10761,,Rattus norvegicus,In vivo,,50597,,6113,10116.0,,,BAO_0000218,
Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,1,CHEMBL618772,Intermediate,,,A,N,1,10762,,Rattus norvegicus,In vivo,,50597,,5937,10116.0,,,BAO_0000218,
Oral bioavailability in rat at 10 mg/kg of the compound,,1,CHEMBL618773,Intermediate,,,A,N,1,10763,,Rattus norvegicus,In vivo,,50597,,5711,10116.0,,,BAO_0000218,
Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,1,CHEMBL875842,Intermediate,,,A,N,1,10764,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 3 mg/kg i.v.),,1,CHEMBL618774,Intermediate,,,A,N,1,10765,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,1,CHEMBL618775,Intermediate,,,A,N,1,10766,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 60 mg/kg p.o.),,1,CHEMBL618776,Intermediate,,,A,N,1,10767,,Rattus norvegicus,In vivo,,50597,,17717,10116.0,,,BAO_0000218,
Percent bioavailability (F) in rats after iv administration,,1,CHEMBL618777,Intermediate,,,A,N,1,10768,,Rattus norvegicus,In vivo,,50597,,4722,10116.0,,,BAO_0000218,
Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,1,CHEMBL618778,Intermediate,,,A,N,1,10769,,Rattus norvegicus,In vivo,,50597,,4722,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 5 uM/kg p.o.),,1,CHEMBL618779,Intermediate,,,A,N,1,10770,,Rattus norvegicus,In vivo,,50597,,4353,10116.0,,,BAO_0000218,
Oral bioavailability,,1,CHEMBL618780,Intermediate,,,A,N,1,10771,,Rattus norvegicus,In vivo,,50597,,15662,10116.0,,,BAO_0000218,
Bioavailability in rat (dose 2 mg/kg p.o.),,1,CHEMBL618781,Intermediate,,,A,N,1,10772,,Rattus norvegicus,In vivo,,50597,,4756,10116.0,,,BAO_0000218,
Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,1,CHEMBL618782,Intermediate,,,A,N,1,10773,,Rattus norvegicus,In vivo,,50597,,4756,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 20 mg/kg),,1,CHEMBL618783,Intermediate,,,A,N,1,10774,,Rattus norvegicus,In vivo,,50597,,3436,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL618784,Intermediate,,,A,N,1,10775,,Rattus norvegicus,In vivo,,50597,,17800,10116.0,,,BAO_0000218,
Percent oral bioavailability evaluated in rat,,1,CHEMBL618785,Intermediate,,,A,N,1,10776,,Rattus norvegicus,In vivo,,50597,,15762,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL618786,Intermediate,,,A,N,1,10777,,Rattus norvegicus,In vivo,,50597,,5089,10116.0,,,BAO_0000218,
Percent oral bioavailability in rat; Not determined,,1,CHEMBL618787,Intermediate,,,A,N,1,10778,,Rattus norvegicus,In vivo,,50597,,5089,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,1,CHEMBL618788,Intermediate,,,A,N,1,10779,,Rattus norvegicus,In vivo,,50597,,3185,10116.0,,,BAO_0000218,
Bioavailability in rat,,1,CHEMBL618789,Intermediate,,,A,N,1,10780,,Rattus norvegicus,In vivo,,50597,,5145,10116.0,,,BAO_0000218,
Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,1,CHEMBL618790,Intermediate,,,A,N,1,10781,,Rattus norvegicus,In vivo,,50597,,3457,10116.0,,,BAO_0000218,
Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,1,CHEMBL618791,Intermediate,,,A,N,1,10782,,Rattus norvegicus,In vivo,,50597,,3457,10116.0,,,BAO_0000218,
Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,1,CHEMBL875843,Intermediate,,,A,N,1,10783,,Rattus norvegicus,In vivo,,50597,,5983,10116.0,,,BAO_0000218,
Oral bioavailability in rat (dose 20 mg/kg p.o.),,1,CHEMBL618792,Intermediate,,,A,N,1,10784,,Rattus norvegicus,In vivo,,50597,,5739,10116.0,,,BAO_0000218,
Cmax at a dose of 30 mg/kg in rat,,1,CHEMBL623395,Intermediate,,,A,N,1,10785,,Rattus norvegicus,In vivo,,50597,,3579,10116.0,,,BAO_0000218,
Cmax in monkeys at a dose of 1 mg/kg,,0,CHEMBL623396,Autocuration,,,A,U,1,10786,,Simiiformes,In vivo,,22224,,17788,314293.0,,,BAO_0000218,
Cmax in rat,,1,CHEMBL623397,Intermediate,,,A,N,1,10787,,Rattus norvegicus,In vivo,,50597,,14956,10116.0,,,BAO_0000218,
Cmax in rats at a dose of 1 mg/kg,,1,CHEMBL623398,Intermediate,,,A,N,1,10788,,Rattus norvegicus,In vivo,,50597,,17788,10116.0,,,BAO_0000218,
Cmax was measured in mice after an oral dose of 50 mg/kg.,,1,CHEMBL623399,Intermediate,,,A,N,1,10789,,Mus musculus,In vivo,,50594,,9750,10090.0,,,BAO_0000218,
"Cmax value at a dose of 12.7 uM/kg, po",,0,CHEMBL623400,Autocuration,,,A,U,1,10790,,,In vivo,,22224,,12767,,,,BAO_0000218,
"Cmax value at a dose of 6.3 uM/kg, iv",,0,CHEMBL623401,Autocuration,,,A,U,1,10791,,,In vivo,,22224,,12767,,,,BAO_0000218,
"Cmax value at a dose of 7.1 uM/kg, iv",,0,CHEMBL623402,Autocuration,,,A,U,1,10792,,,In vivo,,22224,,12767,,,,BAO_0000218,
Cmax value of compound was determined after 1 hr,,0,CHEMBL623403,Autocuration,,,A,U,1,10793,,,In vivo,,22224,,12703,,,,BAO_0000218,
Cmax value of the compound,,0,CHEMBL623404,Autocuration,,,A,U,1,10794,,,In vivo,,22224,,15778,,,,BAO_0000218,
Cmax value administered intraintestinal in rats.,,1,CHEMBL625997,Intermediate,,,A,N,1,10795,,Rattus norvegicus,In vivo,,50597,,12818,10116.0,,,BAO_0000218,
Cmax value administered perorally was determined in rat; Not determined,,1,CHEMBL625998,Intermediate,,,A,N,1,10796,,Rattus norvegicus,In vivo,,50597,,14964,10116.0,,,BAO_0000218,
Cmax value at the dose of 2.3 mg/kg,,0,CHEMBL625999,Autocuration,,,A,U,1,10797,,,In vivo,,22224,,15808,,,,BAO_0000218,
Cmax value at the dose of 5 mg/kg,,0,CHEMBL626000,Autocuration,,,A,U,1,10798,,,In vivo,,22224,,15808,,,,BAO_0000218,
Cmax value in the period of 8 hr after dosing. ,,0,CHEMBL626001,Autocuration,,,A,U,1,10799,,,In vivo,,22224,,15778,,,,BAO_0000218,
Cmax value at a oral dose of 20 mg/kg; Not tested,,0,CHEMBL626002,Autocuration,,,A,U,1,10800,,,In vivo,,22224,,3715,,,,BAO_0000218,
Cmax value at a oral dose of 20 mg/kg,,0,CHEMBL626003,Autocuration,,,A,U,1,10801,,,In vivo,,22224,,3715,,,,BAO_0000218,
Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,1,CHEMBL626004,Intermediate,,,A,N,1,10802,,Rattus norvegicus,In vivo,,50597,,1446,10116.0,,,BAO_0000218,
Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,1,CHEMBL626005,Intermediate,,,A,N,1,10803,,Cavia porcellus,In vivo,,50512,,15240,10141.0,,,BAO_0000218,
Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,1,CHEMBL626006,Intermediate,,,A,N,1,10804,,Rattus norvegicus,In vivo,,50597,,15240,10116.0,,,BAO_0000218,
Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,1,CHEMBL626007,Intermediate,,,A,N,1,10805,1969.0,Rattus norvegicus,In vivo,,50597,,14810,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,1,CHEMBL626008,Intermediate,,,A,N,1,10806,1969.0,Mus musculus,In vivo,,50594,,14239,10090.0,,Plasma,BAO_0000218,
Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,1,CHEMBL626009,Intermediate,,,A,N,1,10807,2107.0,Canis lupus familiaris,In vivo,,50588,,12555,9615.0,,Liver,BAO_0000218,
Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,1,CHEMBL626010,Intermediate,,,A,N,1,10808,,Canis lupus familiaris,In vivo,,50588,,10754,9615.0,,,BAO_0000218,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,1,CHEMBL626011,Intermediate,,,A,N,1,10809,178.0,Mus musculus,In vivo,,50594,,10754,10090.0,,Blood,BAO_0000218,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,1,CHEMBL626012,Intermediate,,,A,N,1,10810,178.0,Mus musculus,In vivo,,50594,,10754,10090.0,,Blood,BAO_0000218,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,1,CHEMBL626013,Intermediate,,,A,N,1,10811,178.0,Mus musculus,In vivo,,50594,,10754,10090.0,,Blood,BAO_0000218,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,1,CHEMBL626014,Intermediate,,,A,N,1,10812,178.0,Mus musculus,In vivo,,50594,,10754,10090.0,,Blood,BAO_0000218,
Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,1,CHEMBL877496,Intermediate,,,A,N,1,10813,178.0,Mus musculus,In vivo,,50594,,10754,10090.0,,Blood,BAO_0000218,
Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,1,CHEMBL626015,Intermediate,,,F,N,1,10814,,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,,BAO_0000218,
Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,1,CHEMBL626016,Intermediate,,,F,N,1,10815,,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,,BAO_0000218,
Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,1,CHEMBL626017,Intermediate,,,F,N,1,10816,,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,,BAO_0000218,
Bioavailability as maximal plasma concentration in dogs,,1,CHEMBL626018,Intermediate,,,A,N,1,10817,1969.0,Canis lupus familiaris,In vivo,,50588,,13543,9615.0,,Plasma,BAO_0000218,
Bioavailability as maximal plasma concentration in dogs,,1,CHEMBL626692,Intermediate,,,A,N,1,10818,1969.0,Canis lupus familiaris,In vivo,,50588,,13543,9615.0,,Plasma,BAO_0000218,
Bioavailability as maximal plasma concentration in rats,,1,CHEMBL626693,Intermediate,,,A,N,1,10819,1969.0,Rattus norvegicus,In vivo,,50597,,13543,10116.0,,Plasma,BAO_0000218,
Bioavailability as maximal plasma concentration in rats,,0,CHEMBL626694,Autocuration,,,A,U,1,10820,1969.0,Rattus norvegicus,In vivo,,22224,,13543,10116.0,,Plasma,BAO_0000218,
Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,1,CHEMBL626695,Intermediate,,,A,N,1,10821,178.0,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,Blood,BAO_0000218,
Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,1,CHEMBL626696,Intermediate,,,A,N,1,10822,178.0,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,Blood,BAO_0000218,
Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,1,CHEMBL626697,Intermediate,,,A,N,1,10823,178.0,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,Blood,BAO_0000218,
Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,1,CHEMBL626859,Intermediate,,,A,N,1,10824,178.0,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,Blood,BAO_0000218,
Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,1,CHEMBL626860,Intermediate,,,A,N,1,10825,178.0,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,Blood,BAO_0000218,
Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,1,CHEMBL626861,Intermediate,,,A,N,1,10826,178.0,Canis lupus familiaris,In vivo,,50588,,14600,9615.0,,Blood,BAO_0000218,
Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,1,CHEMBL626296,Intermediate,,,A,N,1,10827,,Rattus norvegicus,In vivo,,50597,,14681,10116.0,,,BAO_0000218,
Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,0,CHEMBL626297,Autocuration,,,A,U,1,10828,,,In vivo,,22224,,15905,,,,BAO_0000218,
Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,0,CHEMBL626298,Autocuration,,,A,U,1,10829,1969.0,,In vivo,,22224,,15905,,,Plasma,BAO_0000218,
"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,1,CHEMBL626299,Intermediate,,,A,N,1,10830,1969.0,Rattus norvegicus,In vivo,,50597,,13304,10116.0,,Plasma,BAO_0000218,
Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,1,CHEMBL626300,Intermediate,,,A,N,1,10831,1969.0,Rattus norvegicus,In vivo,,50597,,15137,10116.0,,Plasma,BAO_0000218,
Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,1,CHEMBL626301,Intermediate,,,A,N,1,10832,1969.0,Rattus norvegicus,In vivo,,50597,,15137,10116.0,,Plasma,BAO_0000218,
Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,1,CHEMBL626962,Intermediate,,,A,N,1,10833,1969.0,Rattus norvegicus,In vivo,,50597,,15137,10116.0,,Plasma,BAO_0000218,
Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,1,CHEMBL626963,Intermediate,,,A,N,1,10834,1969.0,Rattus norvegicus,In vivo,,50597,,15137,10116.0,,Plasma,BAO_0000218,
Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,1,CHEMBL626964,Intermediate,,,A,N,1,10835,1969.0,Rattus norvegicus,In vivo,,50597,,15137,10116.0,,Plasma,BAO_0000218,
In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,1,CHEMBL626965,Intermediate,,,A,N,1,10836,1969.0,Macaca fascicularis,In vivo,,100710,,14839,9541.0,,Plasma,BAO_0000218,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,1,CHEMBL626966,Intermediate,,,A,N,1,10837,1969.0,Mus musculus,In vivo,,50594,,14839,10090.0,,Plasma,BAO_0000218,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,1,CHEMBL626967,Intermediate,,,A,N,1,10838,1969.0,Mus musculus,In vivo,,50594,,14839,10090.0,,Plasma,BAO_0000218,
In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,1,CHEMBL626968,Intermediate,,,A,N,1,10839,1969.0,Macaca fascicularis,In vivo,,100710,,14839,9541.0,,Plasma,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,1,CHEMBL626969,Intermediate,,,A,N,1,10840,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,1,CHEMBL627126,Intermediate,,,A,N,1,10841,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,1,CHEMBL631276,Intermediate,,,A,N,1,10842,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,1,CHEMBL631277,Intermediate,,,A,N,1,10843,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,1,CHEMBL631278,Intermediate,,,A,N,1,10844,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,1,CHEMBL874457,Intermediate,,,A,N,1,10845,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,1,CHEMBL631279,Intermediate,,,A,N,1,10846,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,1,CHEMBL631280,Intermediate,,,A,N,1,10847,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,1,CHEMBL631281,Intermediate,,,A,N,1,10848,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,1,CHEMBL631968,Intermediate,,,A,N,1,10849,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,1,CHEMBL631969,Intermediate,,,A,N,1,10850,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,1,CHEMBL631970,Intermediate,,,A,N,1,10851,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,1,CHEMBL631971,Intermediate,,,A,N,1,10852,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,1,CHEMBL631972,Intermediate,,,A,N,1,10853,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,1,CHEMBL630435,Intermediate,,,A,N,1,10854,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,1,CHEMBL630436,Intermediate,,,A,N,1,10855,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,1,CHEMBL630437,Intermediate,,,A,N,1,10856,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,1,CHEMBL630438,Intermediate,,,A,N,1,10857,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,1,CHEMBL630439,Intermediate,,,A,N,1,10858,948.0,Rattus norvegicus,,,50597,,8418,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,1,CHEMBL630440,Intermediate,,,A,N,1,10859,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,1,CHEMBL630441,Intermediate,,,A,N,1,10860,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,1,CHEMBL630442,Intermediate,,,A,N,1,10861,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,1,CHEMBL625234,Intermediate,,,A,N,1,10862,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,1,CHEMBL625235,Intermediate,,,A,N,1,10863,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,1,CHEMBL625236,Intermediate,,,A,N,1,10864,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,1,CHEMBL625237,Intermediate,,,A,N,1,10865,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,1,CHEMBL626125,Intermediate,,,A,N,1,10866,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,1,CHEMBL626126,Intermediate,,,A,N,1,10867,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,1,CHEMBL626127,Intermediate,,,A,N,1,10868,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,1,CHEMBL626128,Intermediate,,,A,N,1,10869,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,1,CHEMBL626129,Intermediate,,,A,N,1,10870,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,1,CHEMBL626130,Intermediate,,,A,N,1,10871,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,1,CHEMBL626131,Intermediate,,,A,N,1,10872,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,1,CHEMBL626132,Intermediate,,,A,N,1,10873,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,1,CHEMBL626752,Intermediate,,,A,N,1,10874,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,1,CHEMBL626753,Intermediate,,,A,N,1,10875,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,1,CHEMBL626754,Intermediate,,,A,N,1,10876,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,1,CHEMBL626755,Intermediate,,,A,N,1,10877,2113.0,Rattus norvegicus,,,50597,,8418,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,1,CHEMBL626756,Intermediate,,,A,N,1,10878,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,1,CHEMBL626757,Intermediate,,,A,N,1,10879,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,1,CHEMBL626758,Intermediate,,,A,N,1,10880,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,1,CHEMBL626759,Intermediate,,,A,N,1,10881,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,1,CHEMBL626760,Intermediate,,,A,N,1,10882,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL626394,Intermediate,,,A,N,1,10883,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,1,CHEMBL626395,Intermediate,,,A,N,1,10884,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,1,CHEMBL626396,Intermediate,,,A,N,1,10885,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL626397,Intermediate,,,A,N,1,10886,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,1,CHEMBL626398,Intermediate,,,A,N,1,10887,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL626399,Intermediate,,,A,N,1,10888,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,1,CHEMBL874653,Intermediate,,,A,N,1,10889,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL626400,Intermediate,,,A,N,1,10890,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,1,CHEMBL626401,Intermediate,,,A,N,1,10891,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL626402,Intermediate,,,A,N,1,10892,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL626403,Intermediate,,,A,N,1,10893,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL626404,Intermediate,,,A,N,1,10894,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,1,CHEMBL626405,Intermediate,,,A,N,1,10895,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL625529,Intermediate,,,A,N,1,10896,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,1,CHEMBL625530,Intermediate,,,A,N,1,10897,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL625531,Intermediate,,,A,N,1,10898,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL625532,Intermediate,,,A,N,1,10899,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL625533,Intermediate,,,A,N,1,10900,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,1,CHEMBL875474,Intermediate,,,A,N,1,10901,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL625534,Intermediate,,,A,N,1,10902,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,1,CHEMBL625535,Intermediate,,,A,N,1,10903,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL625536,Intermediate,,,A,N,1,10904,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL625537,Intermediate,,,A,N,1,10905,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL625538,Intermediate,,,A,N,1,10906,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,1,CHEMBL625539,Intermediate,,,A,N,1,10907,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL625540,Intermediate,,,A,N,1,10908,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,1,CHEMBL625541,Intermediate,,,A,N,1,10909,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL625542,Intermediate,,,A,N,1,10910,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL625543,Intermediate,,,A,N,1,10911,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL625544,Intermediate,,,A,N,1,10912,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,1,CHEMBL625545,Intermediate,,,A,N,1,10913,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,1,CHEMBL625546,Intermediate,,,A,N,1,10914,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,1,CHEMBL625547,Intermediate,,,A,N,1,10915,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL625548,Intermediate,,,A,N,1,10916,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL625549,Intermediate,,,A,N,1,10917,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,1,CHEMBL625550,Intermediate,,,A,N,1,10918,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL625551,Intermediate,,,A,N,1,10919,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL875475,Intermediate,,,A,N,1,10920,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL625552,Intermediate,,,A,N,1,10921,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,1,CHEMBL625553,Intermediate,,,A,N,1,10922,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL625554,Intermediate,,,A,N,1,10923,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,1,CHEMBL625555,Intermediate,,,A,N,1,10924,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL625556,Intermediate,,,A,N,1,10925,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,1,CHEMBL624986,Intermediate,,,A,N,1,10926,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,1,CHEMBL624987,Intermediate,,,A,N,1,10927,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL624988,Intermediate,,,A,N,1,10928,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,1,CHEMBL624989,Intermediate,,,A,N,1,10929,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,1,CHEMBL624990,Intermediate,,,A,N,1,10930,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,1,CHEMBL874391,Intermediate,,,A,N,1,10931,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,1,CHEMBL624991,Intermediate,,,A,N,1,10932,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,1,CHEMBL624992,Intermediate,,,A,N,1,10933,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,1,CHEMBL624993,Intermediate,,,A,N,1,10934,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,1,CHEMBL624994,Intermediate,,,A,N,1,10935,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,1,CHEMBL624995,Intermediate,,,A,N,1,10936,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,1,CHEMBL624996,Intermediate,,,A,N,1,10937,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,1,CHEMBL624997,Intermediate,,,A,N,1,10938,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,1,CHEMBL624998,Intermediate,,,A,N,1,10939,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,1,CHEMBL624999,Intermediate,,,A,N,1,10940,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,1,CHEMBL882955,Intermediate,,,A,N,1,10941,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,1,CHEMBL625000,Intermediate,,,A,N,1,10942,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,1,CHEMBL625001,Intermediate,,,A,N,1,10943,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,1,CHEMBL625089,Intermediate,,,A,N,1,10944,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,1,CHEMBL625090,Intermediate,,,A,N,1,10945,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,1,CHEMBL625091,Intermediate,,,A,N,1,10946,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,1,CHEMBL625092,Intermediate,,,A,N,1,10947,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,1,CHEMBL625093,Intermediate,,,A,N,1,10948,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,1,CHEMBL625094,Intermediate,,,A,N,1,10949,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,1,CHEMBL625095,Intermediate,,,A,N,1,10950,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Compound was evaluated for its bioavailability in the dogs,,1,CHEMBL625096,Intermediate,,,A,N,1,10951,,Canis lupus familiaris,In vivo,,50588,,2249,9615.0,,,BAO_0000218,
Compound was evaluated for its bioavailability in the rats,,1,CHEMBL625097,Intermediate,,,A,N,1,10952,,Rattus norvegicus,In vivo,,50597,,2249,10116.0,,,BAO_0000218,
Compound was evaluated for oral bioavailability,,0,CHEMBL882956,Autocuration,,,A,U,1,10953,,,In vivo,,22224,,17515,,,,BAO_0000218,
Compound was evaluated for percentage of Oral bioavailability in rats,,1,CHEMBL625098,Intermediate,,,A,N,1,10954,,Rattus norvegicus,In vivo,,50597,,14541,10116.0,,,BAO_0000218,
Bioavailability in guinea pig,,0,CHEMBL625099,Autocuration,,,A,U,1,10955,,Cavia porcellus,In vivo,,22224,,12797,10141.0,,,BAO_0000218,
Compound was evaluated for the oral bioavailability in rat,,1,CHEMBL625100,Intermediate,,,A,N,1,10956,,Rattus norvegicus,In vivo,,50597,,12797,10116.0,,,BAO_0000218,
Compound was evaluated for the oral bioavailability in dog,,1,CHEMBL625101,Intermediate,,,A,N,1,10957,,Canis lupus familiaris,In vivo,,50588,,12797,9615.0,,,BAO_0000218,
Compound was evaluated for the oral bioavailability in rat,,1,CHEMBL874396,Intermediate,,,A,N,1,10958,,Rattus norvegicus,In vivo,,50597,,12797,10116.0,,,BAO_0000218,
Bioavailability in dog (dosed i.v.),,0,CHEMBL625102,Autocuration,,,F,U,1,10959,,Canis lupus familiaris,In vivo,,22224,,11727,9615.0,,,BAO_0000218,
Compound was tested for in vivo bioavailability in dog,,1,CHEMBL625103,Intermediate,,,A,N,1,10960,,Canis lupus familiaris,In vivo,,50588,,13249,9615.0,,,BAO_0000218,
Compound was tested for in vivo bioavailability in hamsters,,1,CHEMBL625104,Intermediate,,,A,N,1,10961,,Cricetinae,In vivo,,100712,,13249,10026.0,,,BAO_0000218,
Compound was tested for in vivo bioavailability in monkey,,0,CHEMBL625105,Autocuration,,,A,U,1,10962,,Simiiformes,In vivo,,22224,,13249,314293.0,,,BAO_0000218,
Compound was tested for in vivo bioavailability in rat,,1,CHEMBL625106,Intermediate,,,A,N,1,10963,,Rattus norvegicus,In vivo,,50597,,13249,10116.0,,,BAO_0000218,
Oral bioavailability in mouse,,0,CHEMBL625107,Autocuration,,,A,U,1,10964,,Mus musculus,In vivo,,22224,,9552,10090.0,,,BAO_0000218,
Compound was tested for percent of oral bioavailability in mice; 56-74,,1,CHEMBL625108,Intermediate,,,A,N,1,10965,,Mus musculus,In vivo,,50594,,9552,10090.0,,,BAO_0000218,
Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,0,CHEMBL625109,Autocuration,,,A,U,1,10966,,Mus musculus,In vivo,,22224,,14839,10090.0,,,BAO_0000218,
Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,0,CHEMBL625110,Autocuration,,,A,U,1,10967,,Macaca fascicularis,In vivo,,22224,,14839,9541.0,,,BAO_0000218,
Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,0,CHEMBL625111,Autocuration,,,A,U,1,10968,,Macaca fascicularis,In vivo,,22224,,14839,9541.0,,,BAO_0000218,
Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,1,CHEMBL625112,Intermediate,,,A,N,1,10969,,Mus musculus,In vivo,,50594,,14839,10090.0,,,BAO_0000218,
Oral bioavailability in nude mice,,1,CHEMBL875334,Intermediate,,,A,N,1,10970,,Mus musculus,In vivo,,50594,,14839,10090.0,,,BAO_0000218,
Bioavailability in monkey (i.d. dosing),,0,CHEMBL628617,Autocuration,,,A,U,1,10971,,Primates,In vivo,,22224,,11219,9443.0,,,BAO_0000218,
Bioavailability in rat,,0,CHEMBL628618,Autocuration,,,A,U,1,10972,,Rattus norvegicus,In vivo,,22224,,9552,10116.0,,,BAO_0000218,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,0,CHEMBL628619,Autocuration,,,A,U,1,10973,,,In vivo,,22224,,11732,,,,BAO_0000218,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,0,CHEMBL628620,Autocuration,,,A,U,1,10974,,,In vivo,,22224,,11732,,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,1,CHEMBL628621,Intermediate,,,A,N,1,10975,,Macaca fascicularis,In vivo,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,1,CHEMBL628622,Intermediate,,,A,N,1,10976,,Macaca fascicularis,In vivo,,100710,,14839,9541.0,,,BAO_0000218,
"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,1,CHEMBL628623,Intermediate,,,A,N,1,10977,,Macaca fascicularis,In vivo,,100710,,14839,9541.0,,,BAO_0000218,
Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,1,CHEMBL628624,Intermediate,,,A,N,1,10978,1969.0,Macaca fascicularis,In vivo,,100710,,14839,9541.0,,Plasma,BAO_0000218,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,1,CHEMBL628625,Intermediate,,,A,N,1,10979,1969.0,Mus musculus,In vivo,,50594,,14839,10090.0,,Plasma,BAO_0000218,
Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,1,CHEMBL628626,Intermediate,,,A,N,1,10980,1969.0,Macaca fascicularis,In vivo,,100710,,14839,9541.0,,Plasma,BAO_0000218,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,1,CHEMBL627041,Intermediate,,,A,N,1,10981,1969.0,Mus musculus,In vivo,,50594,,14839,10090.0,,Plasma,BAO_0000218,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,1,CHEMBL627042,Intermediate,,,A,N,1,10982,1969.0,Mus musculus,In vivo,,50594,,14839,10090.0,,Plasma,BAO_0000218,
Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,1,CHEMBL627043,Intermediate,,,A,N,1,10983,1969.0,Mus musculus,In vivo,,50594,,14839,10090.0,,Plasma,BAO_0000218,
In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,0,CHEMBL627044,Autocuration,,,A,U,1,10984,1969.0,,In vivo,,22224,,13932,,,Plasma,BAO_0000218,
Cmax in mouse plasma,,1,CHEMBL627045,Intermediate,,,A,N,1,10985,1969.0,Mus musculus,In vivo,,50594,,11637,10090.0,,Plasma,BAO_0000218,
Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,0,CHEMBL627046,Autocuration,,,A,U,1,10986,1969.0,,In vivo,,22224,,11637,,,Plasma,BAO_0000218,
Maximal plasma concentration in rat,,1,CHEMBL627047,Intermediate,,,A,N,1,10987,1969.0,Rattus norvegicus,In vivo,,50597,,13960,10116.0,,Plasma,BAO_0000218,
Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,1,CHEMBL627048,Intermediate,,,A,N,1,10988,1969.0,Rattus norvegicus,In vivo,,50597,,15905,10116.0,,Plasma,BAO_0000218,
Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,1,CHEMBL627049,Intermediate,,,A,N,1,10989,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,1,CHEMBL627050,Intermediate,,,A,N,1,10990,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,1,CHEMBL627051,Intermediate,,,A,N,1,10991,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,1,CHEMBL627052,Intermediate,,,A,N,1,10992,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,1,CHEMBL627053,Intermediate,,,A,N,1,10993,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,1,CHEMBL627054,Intermediate,,,A,N,1,10994,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,1,CHEMBL627055,Intermediate,,,A,N,1,10995,,Mus musculus,In vivo,,50594,,15011,10090.0,,,BAO_0000218,
Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,1,CHEMBL627056,Intermediate,,,A,N,1,10996,,Mus musculus,In vivo,,50594,,15011,10090.0,,,BAO_0000218,
Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,1,CHEMBL627057,Intermediate,,,A,N,1,10997,,Mus musculus,In vivo,,50594,,15011,10090.0,,,BAO_0000218,
Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,1,CHEMBL627058,Intermediate,,,A,N,1,10998,,Mus musculus,In vivo,,50594,,15011,10090.0,,,BAO_0000218,
Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,1,CHEMBL626211,Intermediate,,,A,N,1,10999,,Mus musculus,In vivo,,50594,,15011,10090.0,,,BAO_0000218,
Maximum Concentration of the compound.,,0,CHEMBL626212,Autocuration,,,A,U,1,11000,,,In vivo,,22224,,10291,,,,BAO_0000218,
Maximum Concentration was measured after iv administration into Beagle dog,,1,CHEMBL626213,Intermediate,,,A,N,1,11001,,Canis lupus familiaris,In vivo,,50588,,14599,9615.0,,,BAO_0000218,
Maximum Concentration was measured after iv administration into Beagle dog.,,1,CHEMBL626214,Intermediate,,,A,N,1,11002,,Canis lupus familiaris,In vivo,,50588,,14599,9615.0,,,BAO_0000218,
Maximum Concentration was measured after po administration into Beagle dog,,1,CHEMBL626215,Intermediate,,,A,N,1,11003,,Canis lupus familiaris,In vivo,,50588,,14599,9615.0,,,BAO_0000218,
Maximum Concentration was measured after po administration into Beagle dog.,,1,CHEMBL626216,Intermediate,,,A,N,1,11004,,Canis lupus familiaris,In vivo,,50588,,14599,9615.0,,,BAO_0000218,
Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,0,CHEMBL626217,Autocuration,,,A,U,1,11005,178.0,,In vivo,,22224,,12767,,,Blood,BAO_0000218,
Maximum blood level reached after an iv dose of 12.2 uM/kg,,0,CHEMBL626218,Autocuration,,,A,U,1,11006,178.0,,In vivo,,22224,,12767,,,Blood,BAO_0000218,
Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,0,CHEMBL626219,Autocuration,,,A,U,1,11007,178.0,,In vivo,,22224,,12767,,,Blood,BAO_0000218,
Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,0,CHEMBL626220,Autocuration,,,A,U,1,11008,178.0,,In vivo,,22224,,12767,,,Blood,BAO_0000218,
Maximum blood level reached after an oral dose of 5.0 mg/kg,,0,CHEMBL626221,Autocuration,,,A,U,1,11009,178.0,,In vivo,,22224,,12767,,,Blood,BAO_0000218,
Maximum blood level reached at dose of 10.6 uM/kg orally,,0,CHEMBL626222,Autocuration,,,A,U,1,11010,178.0,,In vivo,,22224,,12767,,,Blood,BAO_0000218,
Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,1,CHEMBL626223,Intermediate,,,A,N,1,11011,,Cavia porcellus,In vivo,,50512,,14706,10141.0,,,BAO_0000218,
Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,1,CHEMBL626224,Intermediate,,,A,N,1,11012,,Cavia porcellus,In vivo,,50512,,14706,10141.0,,,BAO_0000218,
Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,1,CHEMBL626225,Intermediate,,,A,N,1,11013,955.0,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,Brain,BAO_0000218,
Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,1,CHEMBL626226,Intermediate,,,A,N,1,11014,955.0,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,Brain,BAO_0000218,
Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,1,CHEMBL626227,Intermediate,,,A,N,1,11015,955.0,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,Brain,BAO_0000218,
Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,1,CHEMBL626228,Intermediate,,,A,N,1,11016,955.0,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,Brain,BAO_0000218,
Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,1,CHEMBL626229,Intermediate,,,A,N,1,11017,,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,,BAO_0000218,
Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,1,CHEMBL626921,Intermediate,,,A,N,1,11018,,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,,BAO_0000218,
Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,1,CHEMBL876793,Intermediate,,,A,N,1,11019,,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,,BAO_0000218,
Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,1,CHEMBL625309,Intermediate,,,A,N,1,11020,,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,,BAO_0000218,
Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,1,CHEMBL625310,Intermediate,,,A,N,1,11021,,Bacillus subtilis,In vivo,,50278,,10524,1423.0,,,BAO_0000218,
Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,0,CHEMBL625311,Autocuration,,,A,U,1,11022,,Simiiformes,In vivo,,22224,,11871,314293.0,,,BAO_0000218,
Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,1,CHEMBL625312,Intermediate,,,A,N,1,11023,,Rattus norvegicus,In vivo,,50597,,11871,10116.0,,,BAO_0000218,
Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,0,CHEMBL625313,Autocuration,,,A,U,1,11024,,,In vivo,,22224,,3437,,,,BAO_0000218,
Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,1,CHEMBL625314,Intermediate,,,A,N,1,11025,,Mus musculus,In vivo,,50594,,12038,10090.0,,,BAO_0000218,
Maximum concentration in male rats after iv administration of 20 mg/kg,,1,CHEMBL625315,Intermediate,,,A,N,1,11026,,Rattus norvegicus,In vivo,,50597,,12038,10116.0,,,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,1,CHEMBL625316,Intermediate,,,A,N,1,11027,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,1,CHEMBL625317,Intermediate,,,A,N,1,11028,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,1,CHEMBL625318,Intermediate,,,A,N,1,11029,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,1,CHEMBL625319,Intermediate,,,A,N,1,11030,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,1,CHEMBL625320,Intermediate,,,A,N,1,11031,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,1,CHEMBL625321,Intermediate,,,A,N,1,11032,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,1,CHEMBL625322,Intermediate,,,A,N,1,11033,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,1,CHEMBL876801,Intermediate,,,A,N,1,11034,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,1,CHEMBL625323,Intermediate,,,A,N,1,11035,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,1,CHEMBL625324,Intermediate,,,A,N,1,11036,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,1,CHEMBL625325,Intermediate,,,A,N,1,11037,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,1,CHEMBL625326,Intermediate,,,A,N,1,11038,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,1,CHEMBL625327,Intermediate,,,A,N,1,11039,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,1,CHEMBL625328,Intermediate,,,A,N,1,11040,2107.0,Rattus norvegicus,,,50597,,8418,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,1,CHEMBL625329,Intermediate,,,A,N,1,11041,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,1,CHEMBL625330,Intermediate,,,A,N,1,11042,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,1,CHEMBL627774,Intermediate,,,A,N,1,11043,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,1,CHEMBL627775,Intermediate,,,A,N,1,11044,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,1,CHEMBL627949,Intermediate,,,A,N,1,11045,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,1,CHEMBL627950,Intermediate,,,A,N,1,11046,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,1,CHEMBL627951,Intermediate,,,A,N,1,11047,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,1,CHEMBL627952,Intermediate,,,A,N,1,11048,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,1,CHEMBL627953,Intermediate,,,A,N,1,11049,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,1,CHEMBL627954,Intermediate,,,A,N,1,11050,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,1,CHEMBL627955,Intermediate,,,A,N,1,11051,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,1,CHEMBL627956,Intermediate,,,A,N,1,11052,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,1,CHEMBL876802,Intermediate,,,A,N,1,11053,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,1,CHEMBL627957,Intermediate,,,A,N,1,11054,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,1,CHEMBL627958,Intermediate,,,A,N,1,11055,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,1,CHEMBL627959,Intermediate,,,A,N,1,11056,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,1,CHEMBL627960,Intermediate,,,A,N,1,11057,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,1,CHEMBL627961,Intermediate,,,A,N,1,11058,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,1,CHEMBL627962,Intermediate,,,A,N,1,11059,2048.0,Rattus norvegicus,,,50597,,8418,10116.0,,Lung,BAO_0000218,
Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,1,CHEMBL627963,Intermediate,,,A,N,1,11060,,Rattus norvegicus,,,50597,,9796,10116.0,,,BAO_0000218,
Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL624759,Intermediate,,,A,N,1,11061,,Rattus norvegicus,,,50597,,9796,10116.0,,,BAO_0000218,
Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,1,CHEMBL624760,Intermediate,,,A,N,1,11062,,Rattus norvegicus,,,50597,,9796,10116.0,,,BAO_0000218,
Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL624761,Intermediate,,,A,N,1,11063,,Rattus norvegicus,,,50597,,9796,10116.0,,,BAO_0000218,
Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL877607,Intermediate,,,A,N,1,11064,,Rattus norvegicus,,,50597,,9796,10116.0,,,BAO_0000218,
Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,1,CHEMBL624762,Intermediate,,,A,N,1,11065,2107.0,Rattus norvegicus,,,50597,,9796,10116.0,,Liver,BAO_0000218,
Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL624763,Intermediate,,,A,N,1,11066,2107.0,Rattus norvegicus,,,50597,,9796,10116.0,,Liver,BAO_0000218,
Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,1,CHEMBL624764,Intermediate,,,A,N,1,11067,2107.0,Rattus norvegicus,,,50597,,9796,10116.0,,Liver,BAO_0000218,
Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL624765,Intermediate,,,A,N,1,11068,2107.0,Rattus norvegicus,,,50597,,9796,10116.0,,Liver,BAO_0000218,
Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL624766,Intermediate,,,A,N,1,11069,2107.0,Rattus norvegicus,,,50597,,9796,10116.0,,Liver,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL624767,Intermediate,,,A,N,1,11070,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,1,CHEMBL624768,Intermediate,,,A,N,1,11071,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,1,CHEMBL624769,Intermediate,,,A,N,1,11072,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL624770,Intermediate,,,A,N,1,11073,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,1,CHEMBL624771,Intermediate,,,A,N,1,11074,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL624772,Intermediate,,,A,N,1,11075,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,1,CHEMBL624773,Intermediate,,,A,N,1,11076,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL624774,Intermediate,,,A,N,1,11077,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,1,CHEMBL624775,Intermediate,,,A,N,1,11078,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL624776,Intermediate,,,A,N,1,11079,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL624777,Intermediate,,,A,N,1,11080,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL624778,Intermediate,,,A,N,1,11081,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,1,CHEMBL624779,Intermediate,,,A,N,1,11082,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL624780,Intermediate,,,A,N,1,11083,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL624781,Intermediate,,,A,N,1,11084,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL877608,Intermediate,,,A,N,1,11085,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,1,CHEMBL624782,Intermediate,,,A,N,1,11086,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL624783,Intermediate,,,A,N,1,11087,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,1,CHEMBL624784,Intermediate,,,A,N,1,11088,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL624785,Intermediate,,,A,N,1,11089,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,1,CHEMBL624786,Intermediate,,,A,N,1,11090,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL624787,Intermediate,,,A,N,1,11091,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL628676,Intermediate,,,A,N,1,11092,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,1,CHEMBL621842,Intermediate,,,A,N,1,11093,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL621843,Intermediate,,,A,N,1,11094,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,1,CHEMBL623873,Intermediate,,,A,N,1,11095,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL623874,Intermediate,,,A,N,1,11096,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL623875,Intermediate,,,A,N,1,11097,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL623876,Intermediate,,,A,N,1,11098,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,1,CHEMBL623877,Intermediate,,,A,N,1,11099,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,1,CHEMBL623878,Intermediate,,,A,N,1,11100,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,1,CHEMBL623879,Intermediate,,,A,N,1,11101,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL623880,Intermediate,,,A,N,1,11102,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL623881,Intermediate,,,A,N,1,11103,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,1,CHEMBL623957,Intermediate,,,A,N,1,11104,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL623958,Intermediate,,,A,N,1,11105,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL623959,Intermediate,,,A,N,1,11106,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL623960,Intermediate,,,A,N,1,11107,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,1,CHEMBL623961,Intermediate,,,A,N,1,11108,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL623962,Intermediate,,,A,N,1,11109,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,1,CHEMBL624676,Intermediate,,,A,N,1,11110,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL624677,Intermediate,,,A,N,1,11111,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,1,CHEMBL624678,Intermediate,,,A,N,1,11112,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,1,CHEMBL624679,Intermediate,,,A,N,1,11113,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL624680,Intermediate,,,A,N,1,11114,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,0,CHEMBL624849,Autocuration,,,A,U,1,11115,,,In vivo,,22224,,11732,,,,BAO_0000218,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,0,CHEMBL624850,Autocuration,,,A,U,1,11116,,,In vivo,,22224,,11732,,,,BAO_0000218,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,0,CHEMBL874399,Autocuration,,,A,U,1,11117,,,In vivo,,22224,,11732,,,,BAO_0000218,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,0,CHEMBL624851,Autocuration,,,A,U,1,11118,,,In vivo,,22224,,11732,,,,BAO_0000218,
Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,0,CHEMBL624852,Autocuration,,,A,U,1,11119,,,In vivo,,22224,,11732,,,,BAO_0000218,
Oral bioavailability in rat (dose 10 mg/kg),,0,CHEMBL624853,Autocuration,,,A,U,1,11120,,Rattus norvegicus,In vivo,,22224,,13359,10116.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley),,0,CHEMBL624854,Autocuration,,,A,U,1,11121,,Rattus norvegicus,In vivo,,22224,,16618,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,0,CHEMBL624855,Autocuration,,,A,U,1,11122,,Rattus norvegicus,In vivo,,22224,,13960,10116.0,,,BAO_0000218,
Oral bioavailability in rats was determined in vivo,,0,CHEMBL624856,Autocuration,,,A,U,1,11123,,Rattus norvegicus,In vivo,,22224,,13917,10116.0,,,BAO_0000218,
Oral bioavailability in dog,,0,CHEMBL882957,Autocuration,,,A,U,1,11124,,Canis lupus familiaris,In vivo,,22224,,14266,9615.0,,,BAO_0000218,
Oral bioavailability of compound in monkey,,0,CHEMBL624857,Autocuration,,,A,U,1,11125,,Simiiformes,In vivo,,22224,,12359,314293.0,,,BAO_0000218,
Oral bioavailability of compound in rat,,1,CHEMBL622202,Intermediate,,,A,N,1,11126,,Rattus norvegicus,In vivo,,50597,,12359,10116.0,,,BAO_0000218,
Bioavailability in rat of PMEA prodrug,,0,CHEMBL622203,Autocuration,,,A,U,1,11127,,Rattus norvegicus,In vivo,,22224,,12359,10116.0,,,BAO_0000218,
Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,1,CHEMBL625522,Intermediate,,,A,N,1,11128,,Rattus norvegicus,In vivo,,50597,,12359,10116.0,,,BAO_0000218,
Serum conc at 3 hours following 25 mg/kg dose,,0,CHEMBL622868,Autocuration,,,A,U,1,11129,,Macaca mulatta,In vivo,,22224,,10791,9544.0,,,BAO_0000218,
Urine conc 0-5 hours following 25 mg/kg dose,,0,CHEMBL622869,Autocuration,,,A,U,1,11130,1088.0,Macaca mulatta,In vivo,,22224,,10791,9544.0,,Urine,BAO_0000218,
Urine conc 0-24 hours following 25 mg/kg dose,,0,CHEMBL622870,Autocuration,,,A,U,1,11131,1088.0,Macaca mulatta,In vivo,,22224,,10791,9544.0,,Urine,BAO_0000218,
Oral bioavailability in African green monkeys; 20-25,,0,CHEMBL622871,Autocuration,,,A,U,1,11132,,Chlorocebus aethiops,In vivo,,22224,,138,9534.0,,,BAO_0000218,
Oral bioavailability in cynomolgus monkey.,,1,CHEMBL620560,Intermediate,,,A,N,1,11133,,Macaca fascicularis,In vivo,,100710,,14521,9541.0,,,BAO_0000218,
Oral bioavailability in dog,,0,CHEMBL620561,Autocuration,,,A,U,1,11134,,Canis lupus familiaris,In vivo,,22224,,13953,9615.0,,,BAO_0000218,
Oral bioavailability in dog at 10 mg/kg oral dose,,1,CHEMBL620562,Intermediate,,,A,N,1,11135,,Canis lupus familiaris,In vivo,,50588,,12836,9615.0,,,BAO_0000218,
Oral bioavailability in hamster at 10 mg/kg oral dose,,1,CHEMBL620563,Intermediate,,,A,N,1,11136,,Cricetinae,In vivo,,100712,,12836,10026.0,,,BAO_0000218,
Oral bioavailability in rat at 10 mg/kg oral dose,,1,CHEMBL620564,Intermediate,,,A,N,1,11137,,Rattus norvegicus,In vivo,,50597,,12836,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,0,CHEMBL872265,Autocuration,,,A,U,1,11138,,Rattus norvegicus,In vivo,,22224,,14521,10116.0,,,BAO_0000218,
Oral bioavailability in rat,,0,CHEMBL620565,Autocuration,,,A,U,1,11139,,Rattus norvegicus,In vivo,,22224,,13953,10116.0,,,BAO_0000218,
Oral bioavailability,,0,CHEMBL620566,Autocuration,,,A,U,1,11140,,Eutheria,In vivo,,22224,,6799,9347.0,,,BAO_0000218,
Oral bioavailability was determined; range 49-102%,,0,CHEMBL620567,Autocuration,,,A,U,1,11141,,,In vivo,,22224,,11311,,,,BAO_0000218,
Oral bioavailability was determined in dogs,,1,CHEMBL620568,Intermediate,,,A,N,1,11142,,Canis lupus familiaris,In vivo,,50588,,4013,9615.0,,,BAO_0000218,
Oral bioavailability in rat,,0,CHEMBL620569,Autocuration,,,A,U,1,11143,,Rattus norvegicus,In vivo,,22224,,4013,10116.0,,,BAO_0000218,
Oral bioavailability,,0,CHEMBL620570,Autocuration,,,A,U,1,11144,,Eutheria,In vivo,,22224,,17591,9347.0,,,BAO_0000218,
Oral bioavailability was determined; Not orally available,,0,CHEMBL620571,Autocuration,,,A,U,1,11145,,,In vivo,,22224,,17591,,,,BAO_0000218,
Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,1,CHEMBL620572,Intermediate,,,A,N,1,11146,,Mus musculus,In vivo,,50594,,15011,10090.0,,,BAO_0000218,
Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,0,CHEMBL620573,Autocuration,,,A,U,1,11147,,Mus musculus,In vivo,,22224,,15011,10090.0,,,BAO_0000218,
Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,0,CHEMBL620574,Autocuration,,,A,U,1,11148,,Mus musculus,In vivo,,22224,,15011,10090.0,,,BAO_0000218,
Oral bioavailability in Rhesus monkey,,0,CHEMBL620575,Autocuration,,,A,U,1,11149,,Macaca mulatta,In vivo,,22224,,9552,9544.0,,,BAO_0000218,
Oral bioavailability in dog (female mongrel),,0,CHEMBL620576,Autocuration,,,A,U,1,11150,,Canis lupus familiaris,In vivo,,22224,,9552,9615.0,,,BAO_0000218,
Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,0,CHEMBL875846,Autocuration,,,A,U,1,11151,,,In vivo,,22224,,3639,,,,BAO_0000218,
Oral bioavailability in dog,,0,CHEMBL620577,Autocuration,,,A,U,1,11152,,Canis lupus familiaris,In vivo,,22224,,13397,9615.0,,,BAO_0000218,
Percentage Bioavailability was evaluated.,,0,CHEMBL620578,Autocuration,,,A,U,1,11153,,,In vivo,,22224,,3031,,,,BAO_0000218,
Bioavailability in rat administered i.d.,,0,CHEMBL620579,Autocuration,,,A,U,1,11154,,Rattus norvegicus,In vivo,,22224,,12818,10116.0,,,BAO_0000218,
Bioavailability,,0,CHEMBL621248,Autocuration,,,A,U,1,11155,,Eutheria,In vivo,,22224,,4847,9347.0,,,BAO_0000218,
Bioavailability in dog (male Beagle) i.v. administration,,0,CHEMBL625390,Autocuration,,,A,U,1,11156,,Canis lupus familiaris,In vivo,,22224,,12421,9615.0,,,BAO_0000218,
"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,0,CHEMBL625391,Autocuration,,,A,U,1,11157,,Rattus norvegicus,In vivo,,22224,,11966,10116.0,,,BAO_0000218,
Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,0,CHEMBL872266,Autocuration,,,A,U,1,11158,,Primates,In vivo,,22224,,11218,9443.0,,,BAO_0000218,
Oral bioavailability in rat (Sprague-Dawley) (male),,0,CHEMBL625392,Autocuration,,,A,U,1,11159,,Rattus norvegicus,In vivo,,22224,,13129,10116.0,,,BAO_0000218,
The oral bioavailability was measured on rats after oral administration,,1,CHEMBL625393,Intermediate,,,A,N,1,11160,,Rattus norvegicus,In vivo,,50597,,12350,10116.0,,,BAO_0000218,
Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,1,CHEMBL625394,Intermediate,,,A,N,1,11161,,Rattus norvegicus,In vivo,,50597,,2231,10116.0,,,BAO_0000218,
Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,1,CHEMBL625395,Intermediate,,,A,N,1,11162,,Macaca mulatta,In vivo,,50797,,2231,9544.0,,,BAO_0000218,
Bioavailability in rat (dose 10 mg/kg i.d.),,0,CHEMBL625396,Autocuration,,,A,U,1,11163,,Rattus norvegicus,In vivo,,22224,,12187,10116.0,,,BAO_0000218,
Bioavailability in dog (male Beagle) i.v. administration,,0,CHEMBL625397,Autocuration,,,A,U,1,11164,,Canis lupus familiaris,In vivo,,22224,,12421,9615.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625398,Intermediate,,,A,N,1,11165,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625399,Intermediate,,,A,N,1,11166,178.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Blood,BAO_0000218,
Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL626074,Intermediate,,,A,N,1,11167,2037.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Cerebellum,BAO_0000218,
Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL626075,Intermediate,,,A,N,1,11168,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,1,CHEMBL626076,Intermediate,,,A,N,1,11169,1969.0,Rattus norvegicus,In vivo,,50597,,2231,10116.0,,Plasma,BAO_0000218,
Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,1,CHEMBL626077,Intermediate,,,A,N,1,11170,1969.0,Macaca mulatta,In vivo,,50797,,2231,9544.0,,Plasma,BAO_0000218,
Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,1,CHEMBL626078,Intermediate,,,A,N,1,11171,178.0,Rattus norvegicus,In vivo,,50597,,12178,10116.0,,Blood,BAO_0000218,
Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,0,CHEMBL625846,Autocuration,,,A,U,1,11172,178.0,,In vivo,,22224,,12178,,,Blood,BAO_0000218,
Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,0,CHEMBL625847,Autocuration,,,A,U,1,11173,178.0,,In vivo,,22224,,12178,,,Blood,BAO_0000218,
Maximum concentration observed in rats at an oral dose of 50 mg/kg,,1,CHEMBL625848,Expert,,,A,N,1,11174,,Rattus norvegicus,In vivo,,50597,,15633,10116.0,,,BAO_0000218,
Maximum concentration of compound in plasma administered orally to rats,,1,CHEMBL625849,Intermediate,,,A,N,1,11175,1969.0,Rattus norvegicus,In vivo,,50597,,14258,10116.0,,Plasma,BAO_0000218,
"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,1,CHEMBL626023,Intermediate,,,A,N,1,11176,1969.0,Canis lupus familiaris,In vivo,,50588,,14224,9615.0,,Plasma,BAO_0000218,
"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,1,CHEMBL626024,Intermediate,,,A,N,1,11177,1969.0,Canis lupus familiaris,In vivo,,50588,,14224,9615.0,,Plasma,BAO_0000218,
"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,1,CHEMBL626025,Intermediate,,,A,N,1,11178,1969.0,Canis lupus familiaris,In vivo,,50588,,14224,9615.0,,Plasma,BAO_0000218,
Maximum concentration after 10 mg/kg by oral administration,,0,CHEMBL626026,Autocuration,,,A,U,1,11179,,,In vivo,,22224,,5566,,,,BAO_0000218,
Maximum concentration at a dose of 1.5 mg/kg,,0,CHEMBL626027,Autocuration,,,A,U,1,11180,,,In vivo,,22224,,16935,,,,BAO_0000218,
Maximum concentration at a dose of 2.0 mg/kg,,0,CHEMBL626028,Autocuration,,,A,U,1,11181,,,In vivo,,22224,,16935,,,,BAO_0000218,
Maximum concentration in dog plasma,,1,CHEMBL626029,Intermediate,,,A,N,1,11182,1969.0,Canis lupus familiaris,In vivo,,50588,,14224,9615.0,,Plasma,BAO_0000218,
Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,0,CHEMBL626030,Autocuration,,,A,U,1,11183,1969.0,,In vivo,,22224,,12536,,,Plasma,BAO_0000218,
Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,0,CHEMBL626031,Autocuration,,,A,U,1,11184,1969.0,,In vivo,,22224,,12536,,,Plasma,BAO_0000218,
Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,0,CHEMBL626032,Autocuration,,,A,U,1,11185,1969.0,,In vivo,,22224,,12536,,,Plasma,BAO_0000218,
Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,0,CHEMBL626033,Autocuration,,,A,U,1,11186,1969.0,,In vivo,,22224,,12536,,,Plasma,BAO_0000218,
Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,0,CHEMBL626034,Autocuration,,,A,U,1,11187,1969.0,,In vivo,,22224,,12536,,,Plasma,BAO_0000218,
Maximum concentration in plasma after oral administration in dog (25 mg/kg),,1,CHEMBL626035,Intermediate,,,A,N,1,11188,1969.0,Canis lupus familiaris,In vivo,,50588,,9994,9615.0,,Plasma,BAO_0000218,
Maximum concentration in plasma at Tmax,,0,CHEMBL626036,Autocuration,,,A,U,1,11189,1969.0,,In vivo,,22224,,1434,,,Plasma,BAO_0000218,
Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,1,CHEMBL626037,Expert,,,A,N,1,11190,1969.0,Canis lupus familiaris,In vivo,,50588,,12836,9615.0,,Plasma,BAO_0000218,
Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,1,CHEMBL626038,Intermediate,,,A,N,1,11191,1969.0,Cricetinae,In vivo,,100712,,12836,10026.0,,Plasma,BAO_0000218,
Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,1,CHEMBL626039,Intermediate,,,A,N,1,11192,1969.0,Rattus norvegicus,In vivo,,50597,,12836,10116.0,,Plasma,BAO_0000218,
Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,1,CHEMBL626040,Intermediate,,,A,N,1,11193,1969.0,Rattus norvegicus,In vivo,,50597,,12545,10116.0,,Plasma,BAO_0000218,
Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,1,CHEMBL626041,Intermediate,,,A,N,1,11194,1969.0,Oryctolagus cuniculus,In vivo,,50592,,13856,9986.0,,Plasma,BAO_0000218,
Maximum concentration was calculated,,0,CHEMBL626042,Autocuration,,,A,U,1,11195,,,In vivo,,22224,,3550,,,,BAO_0000218,
Maximum concentration was calculated.,,0,CHEMBL626043,Autocuration,,,A,U,1,11196,,,In vivo,,22224,,2632,,,,BAO_0000218,
Maximum concentration at a peroral dose of 10 mg/kg,,0,CHEMBL626044,Autocuration,,,A,U,1,11197,,,In vivo,,22224,,5566,,,,BAO_0000218,
Maximum concentration of the drug at 10 uM/dg administered perorally,,0,CHEMBL626045,Autocuration,,,A,U,1,11198,,,In vivo,,22224,,11883,,,,BAO_0000218,
Maximum concentration of the drug at 2 uM/dg administered intravenously,,0,CHEMBL626046,Autocuration,,,A,U,1,11199,,,In vivo,,22224,,11883,,,,BAO_0000218,
"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,1,CHEMBL626047,Intermediate,,,A,N,1,11200,1969.0,Canis lupus familiaris,In vivo,,50588,,14122,9615.0,,Plasma,BAO_0000218,
"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,1,CHEMBL626048,Intermediate,,,A,N,1,11201,1969.0,Cricetinae,In vivo,,100712,,14122,10026.0,,Plasma,BAO_0000218,
"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,1,CHEMBL626049,Intermediate,,,A,N,1,11202,1969.0,Rattus norvegicus,In vivo,,50597,,14122,10116.0,,Plasma,BAO_0000218,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,1,CHEMBL626050,Intermediate,,,A,N,1,11203,1969.0,Rattus norvegicus,In vivo,,50597,,12542,10116.0,,Plasma,BAO_0000218,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,1,CHEMBL874541,Intermediate,,,A,N,1,11204,1969.0,Canis lupus familiaris,In vivo,,50588,,12542,9615.0,,Plasma,BAO_0000218,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,1,CHEMBL622826,Intermediate,,,A,N,1,11205,1969.0,Cricetinae,In vivo,,100712,,12542,10026.0,,Plasma,BAO_0000218,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,1,CHEMBL622827,Intermediate,,,A,N,1,11206,1969.0,Cricetinae,In vivo,,100712,,12542,10026.0,,Plasma,BAO_0000218,
Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,1,CHEMBL622828,Intermediate,,,A,N,1,11207,1969.0,Rattus norvegicus,In vivo,,50597,,12542,10116.0,,Plasma,BAO_0000218,
Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,1,CHEMBL622829,Intermediate,,,A,N,1,11208,1969.0,Rattus norvegicus,In vivo,,50597,,14080,10116.0,,Plasma,BAO_0000218,
Maximum concentration reached following intravenous administration in male rat,,1,CHEMBL876806,Intermediate,,,A,N,1,11209,,Rattus norvegicus,In vivo,,50597,,11911,10116.0,,,BAO_0000218,
Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,1,CHEMBL622830,Intermediate,,,A,N,1,11210,,Canis lupus familiaris,In vivo,,50588,,13204,9615.0,,,BAO_0000218,
Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,1,CHEMBL622831,Intermediate,,,A,N,1,11211,,Rattus norvegicus,In vivo,,50597,,13204,10116.0,,,BAO_0000218,
Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,1,CHEMBL626794,Intermediate,,,A,N,1,11212,,Canis lupus familiaris,In vivo,,50588,,14346,9615.0,,,BAO_0000218,
Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,1,CHEMBL626795,Intermediate,,,A,N,1,11213,,Rattus norvegicus,In vivo,,50597,,14346,10116.0,,,BAO_0000218,
Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,1,CHEMBL626796,Intermediate,,,A,N,1,11214,,Rattus norvegicus,In vivo,,50597,,14346,10116.0,,,BAO_0000218,
Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,1,CHEMBL626797,Intermediate,,,A,N,1,11215,,Rattus norvegicus,In vivo,,50597,,14346,10116.0,,,BAO_0000218,
Maximum drug concentration is determined after oral dosing in rats.,,1,CHEMBL626798,Intermediate,,,A,N,1,11216,,Rattus norvegicus,In vivo,,50597,,14127,10116.0,,,BAO_0000218,
Maximum observed concentration in oral (5 mg/kg) fasted dogs,,1,CHEMBL626799,Intermediate,,,A,N,1,11217,,Canis lupus familiaris,In vivo,,50588,,14339,9615.0,,,BAO_0000218,
Maximum observed concentration in oral (5 mg/kg) fed dogs,,1,CHEMBL626800,Intermediate,,,A,N,1,11218,,Canis lupus familiaris,In vivo,,50588,,14339,9615.0,,,BAO_0000218,
Maximum plasma concentration,,0,CHEMBL626801,Autocuration,,,A,U,1,11219,1969.0,,In vivo,,22224,,13494,,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,1,CHEMBL876816,Intermediate,,,A,N,1,11220,1969.0,Rattus norvegicus,In vivo,,50597,,14925,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,1,CHEMBL626802,Intermediate,,,A,N,1,11221,1969.0,Rattus norvegicus,In vivo,,50597,,14474,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,1,CHEMBL626803,Intermediate,,,A,N,1,11222,1969.0,Canis lupus familiaris,In vivo,,50588,,14474,9615.0,,Plasma,BAO_0000218,
Maximum plasma concentration following oral administration of 30 umol/kg,,0,CHEMBL626804,Autocuration,,,A,U,1,11223,1969.0,,In vivo,,22224,,13917,,,Plasma,BAO_0000218,
Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,1,CHEMBL626805,Intermediate,,,A,N,1,11224,1969.0,Rattus norvegicus,,,50597,,9796,10116.0,,Plasma,BAO_0000218,
Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,1,CHEMBL626309,Intermediate,,,A,N,1,11225,1969.0,Rattus norvegicus,,,50597,,9796,10116.0,,Plasma,BAO_0000218,
Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,1,CHEMBL626310,Intermediate,,,A,N,1,11226,1969.0,Rattus norvegicus,,,50597,,9796,10116.0,,Plasma,BAO_0000218,
Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL626311,Intermediate,,,A,N,1,11227,1969.0,Rattus norvegicus,,,50597,,9796,10116.0,,Plasma,BAO_0000218,
Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL626312,Intermediate,,,A,N,1,11228,1969.0,Rattus norvegicus,,,50597,,9796,10116.0,,Plasma,BAO_0000218,
Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL626313,Intermediate,,,A,N,1,11229,995.0,Rattus norvegicus,,,50597,,9796,10116.0,,Uterus,BAO_0000218,
Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,1,CHEMBL626314,Intermediate,,,A,N,1,11230,995.0,Rattus norvegicus,,,50597,,9796,10116.0,,Uterus,BAO_0000218,
Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,1,CHEMBL626315,Intermediate,,,A,N,1,11231,995.0,Rattus norvegicus,,,50597,,9796,10116.0,,Uterus,BAO_0000218,
Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL626316,Intermediate,,,A,N,1,11232,995.0,Rattus norvegicus,,,50597,,9796,10116.0,,Uterus,BAO_0000218,
Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,1,CHEMBL626317,Intermediate,,,A,N,1,11233,995.0,Rattus norvegicus,,,50597,,9796,10116.0,,Uterus,BAO_0000218,
Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,1,CHEMBL626318,Intermediate,,,A,N,1,11234,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,1,CHEMBL626319,Intermediate,,,A,N,1,11235,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,1,CHEMBL626320,Intermediate,,,A,N,1,11236,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,1,CHEMBL875053,Intermediate,,,A,N,1,11237,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,1,CHEMBL626321,Intermediate,,,A,N,1,11238,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,1,CHEMBL626322,Intermediate,,,A,N,1,11239,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,1,CHEMBL626323,Intermediate,,,A,N,1,11240,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,1,CHEMBL626324,Intermediate,,,A,N,1,11241,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,1,CHEMBL626325,Intermediate,,,A,N,1,11242,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,1,CHEMBL626326,Intermediate,,,A,N,1,11243,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,1,CHEMBL626327,Intermediate,,,A,N,1,11244,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,1,CHEMBL626328,Intermediate,,,A,N,1,11245,,Rattus norvegicus,,,50597,,8363,10116.0,,,BAO_0000218,
"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,1,CHEMBL626329,Intermediate,,,A,N,1,11246,178.0,Rattus norvegicus,,,50597,,8684,10116.0,,Blood,BAO_0000218,
"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,1,CHEMBL626330,Intermediate,,,A,N,1,11247,178.0,Rattus norvegicus,,,50597,,8684,10116.0,,Blood,BAO_0000218,
"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL626331,Intermediate,,,A,N,1,11248,178.0,Rattus norvegicus,,,50597,,8684,10116.0,,Blood,BAO_0000218,
"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL626332,Intermediate,,,A,N,1,11249,178.0,Rattus norvegicus,,,50597,,8684,10116.0,,Blood,BAO_0000218,
"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,1,CHEMBL626333,Intermediate,,,A,N,1,11250,178.0,Rattus norvegicus,,,50597,,8684,10116.0,,Blood,BAO_0000218,
"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL626334,Intermediate,,,A,N,1,11251,178.0,Rattus norvegicus,,,50597,,8684,10116.0,,Blood,BAO_0000218,
"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL626335,Intermediate,,,A,N,1,11252,178.0,Rattus norvegicus,,,50597,,8684,10116.0,,Blood,BAO_0000218,
"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL624798,Intermediate,,,A,N,1,11253,178.0,Rattus norvegicus,,,50597,,8684,10116.0,,Blood,BAO_0000218,
"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,1,CHEMBL624799,Intermediate,,,A,N,1,11254,955.0,Rattus norvegicus,,,50597,,8684,10116.0,,Brain,BAO_0000218,
"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,1,CHEMBL624800,Intermediate,,,A,N,1,11255,955.0,Rattus norvegicus,,,50597,,8684,10116.0,,Brain,BAO_0000218,
"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,1,CHEMBL624801,Intermediate,,,A,N,1,11256,955.0,Rattus norvegicus,,,50597,,8684,10116.0,,Brain,BAO_0000218,
"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,1,CHEMBL624802,Intermediate,,,A,N,1,11257,955.0,Rattus norvegicus,,,50597,,8684,10116.0,,Brain,BAO_0000218,
"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,1,CHEMBL624803,Intermediate,,,A,N,1,11258,955.0,Rattus norvegicus,,,50597,,8684,10116.0,,Brain,BAO_0000218,
"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,1,CHEMBL624804,Intermediate,,,A,N,1,11259,955.0,Rattus norvegicus,,,50597,,8684,10116.0,,Brain,BAO_0000218,
"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,1,CHEMBL624805,Intermediate,,,A,N,1,11260,955.0,Rattus norvegicus,,,50597,,8684,10116.0,,Brain,BAO_0000218,
"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,1,CHEMBL624806,Intermediate,,,A,N,1,11261,955.0,Rattus norvegicus,,,50597,,8684,10116.0,,Brain,BAO_0000218,
"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,1,CHEMBL624807,Intermediate,,,A,N,1,11262,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL624808,Intermediate,,,A,N,1,11263,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL624809,Intermediate,,,A,N,1,11264,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,1,CHEMBL624810,Intermediate,,,A,N,1,11265,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL877618,Intermediate,,,A,N,1,11266,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,1,CHEMBL624811,Intermediate,,,A,N,1,11267,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL624812,Intermediate,,,A,N,1,11268,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL624813,Intermediate,,,A,N,1,11269,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,1,CHEMBL624814,Intermediate,,,A,N,1,11270,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL624815,Intermediate,,,A,N,1,11271,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL624816,Intermediate,,,A,N,1,11272,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,1,CHEMBL624817,Intermediate,,,A,N,1,11273,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL624818,Intermediate,,,A,N,1,11274,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,1,CHEMBL624819,Intermediate,,,A,N,1,11275,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,1,CHEMBL624820,Intermediate,,,A,N,1,11276,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL624821,Intermediate,,,A,N,1,11277,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,1,CHEMBL624822,Intermediate,,,A,N,1,11278,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL624823,Intermediate,,,A,N,1,11279,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Observed diffusion coefficient in organic solvent for Escherichia coli,,1,CHEMBL624824,Intermediate,,,A,N,1,11280,,Escherichia coli,,,50212,,15599,562.0,,,BAO_0000218,
"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,CHEMBL624825,Intermediate,,,A,N,1,11281,178.0,Rattus norvegicus,,,50597,,9614,10116.0,,Blood,BAO_0000218,
"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,CHEMBL624826,Intermediate,,,A,N,1,11282,178.0,Rattus norvegicus,,,50597,,9614,10116.0,,Blood,BAO_0000218,
"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,CHEMBL876817,Intermediate,,,A,N,1,11283,2081.0,Rattus norvegicus,,,50597,,9614,10116.0,,Cardiac atrium,BAO_0000218,
"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,CHEMBL624827,Intermediate,,,A,N,1,11284,2081.0,Rattus norvegicus,,,50597,,9614,10116.0,,Cardiac atrium,BAO_0000218,
"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,CHEMBL624828,Intermediate,,,A,N,1,11285,,Rattus norvegicus,,,50597,,9614,10116.0,,,BAO_0000218,
"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,CHEMBL624829,Intermediate,,,A,N,1,11286,,Rattus norvegicus,,,50597,,9614,10116.0,,,BAO_0000218,
"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,CHEMBL624830,Intermediate,,,A,N,1,11287,2107.0,Rattus norvegicus,,,50597,,9614,10116.0,,Liver,BAO_0000218,
"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,CHEMBL624831,Intermediate,,,A,N,1,11288,2107.0,Rattus norvegicus,,,50597,,9614,10116.0,,Liver,BAO_0000218,
"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,CHEMBL624832,Intermediate,,,A,N,1,11289,2081.0,Rattus norvegicus,,,50597,,9614,10116.0,,Cardiac atrium,BAO_0000218,
"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,CHEMBL624833,Intermediate,,,A,N,1,11290,2081.0,Rattus norvegicus,,,50597,,9614,10116.0,,Cardiac atrium,BAO_0000218,
"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,CHEMBL624834,Intermediate,,,A,N,1,11291,,Rattus norvegicus,,,50597,,9614,10116.0,,,BAO_0000218,
"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,CHEMBL624835,Intermediate,,,A,N,1,11292,,Rattus norvegicus,,,50597,,9614,10116.0,,,BAO_0000218,
"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,CHEMBL624836,Intermediate,,,A,N,1,11293,2106.0,Rattus norvegicus,,,50597,,9614,10116.0,,Spleen,BAO_0000218,
"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,CHEMBL624837,Intermediate,,,A,N,1,11294,2106.0,Rattus norvegicus,,,50597,,9614,10116.0,,Spleen,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,1,CHEMBL624838,Intermediate,,,A,N,1,11295,178.0,Rattus norvegicus,,,50597,,9071,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,1,CHEMBL622188,Intermediate,,,A,N,1,11296,178.0,Rattus norvegicus,,,50597,,9071,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,1,CHEMBL622189,Intermediate,,,A,N,1,11297,948.0,Rattus norvegicus,,,50597,,9071,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,1,CHEMBL622190,Intermediate,,,A,N,1,11298,948.0,Rattus norvegicus,,,50597,,9071,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,1,CHEMBL625170,Intermediate,,,A,N,1,11299,948.0,Rattus norvegicus,,,50597,,9071,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,1,CHEMBL625171,Intermediate,,,A,N,1,11300,2113.0,Rattus norvegicus,,,50597,,9071,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,1,CHEMBL625172,Intermediate,,,A,N,1,11301,2113.0,Rattus norvegicus,,,50597,,9071,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,1,CHEMBL625173,Intermediate,,,A,N,1,11302,2113.0,Rattus norvegicus,,,50597,,9071,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,1,CHEMBL625174,Intermediate,,,A,N,1,11303,2107.0,Rattus norvegicus,,,50597,,9071,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,1,CHEMBL625175,Intermediate,,,A,N,1,11304,2107.0,Rattus norvegicus,,,50597,,9071,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,1,CHEMBL625176,Intermediate,,,A,N,1,11305,2107.0,Rattus norvegicus,,,50597,,9071,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,1,CHEMBL625177,Intermediate,,,A,N,1,11306,2048.0,Rattus norvegicus,,,50597,,9071,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,1,CHEMBL625178,Intermediate,,,A,N,1,11307,2048.0,Rattus norvegicus,,,50597,,9071,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,1,CHEMBL625179,Intermediate,,,A,N,1,11308,2048.0,Rattus norvegicus,,,50597,,9071,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,1,CHEMBL625180,Intermediate,,,A,N,1,11309,2048.0,Rattus norvegicus,,,50597,,9071,10116.0,,Lung,BAO_0000218,
"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,0,CHEMBL625181,Autocuration,,,A,U,1,11310,,,,,22224,,10677,,,,BAO_0000218,
Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,1,CHEMBL625182,Intermediate,,,A,N,1,11311,1088.0,Mus musculus,,,50594,,9750,10090.0,,Urine,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,1,CHEMBL625183,Intermediate,,,A,N,1,11312,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,1,CHEMBL875848,Intermediate,,,A,N,1,11313,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,1,CHEMBL622260,Intermediate,,,A,N,1,11314,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,1,CHEMBL622261,Intermediate,,,A,N,1,11315,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,1,CHEMBL622262,Intermediate,,,A,N,1,11316,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,1,CHEMBL622263,Intermediate,,,A,N,1,11317,2113.0,Rattus norvegicus,,,50597,,8319,10116.0,,Kidney,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,1,CHEMBL622418,Intermediate,,,A,N,1,11318,2113.0,Rattus norvegicus,,,50597,,8319,10116.0,,Kidney,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,1,CHEMBL622419,Intermediate,,,A,N,1,11319,2107.0,Rattus norvegicus,,,50597,,8319,10116.0,,Liver,BAO_0000218,
Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL623388,Intermediate,,,A,N,1,11320,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL623389,Intermediate,,,A,N,1,11321,2107.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Liver,BAO_0000218,
Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL623390,Intermediate,,,A,N,1,11322,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL623391,Intermediate,,,A,N,1,11323,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL623392,Intermediate,,,A,N,1,11324,178.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Blood,BAO_0000218,
Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL623393,Intermediate,,,A,N,1,11325,2037.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Cerebellum,BAO_0000218,
Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL623394,Intermediate,,,A,N,1,11326,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL618885,Intermediate,,,A,N,1,11327,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL618886,Intermediate,,,A,N,1,11328,2107.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Liver,BAO_0000218,
Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL618887,Intermediate,,,A,N,1,11329,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL619535,Intermediate,,,A,N,1,11330,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL619536,Intermediate,,,A,N,1,11331,178.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Blood,BAO_0000218,
Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL619537,Intermediate,,,A,N,1,11332,2037.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Cerebellum,BAO_0000218,
Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL619705,Intermediate,,,A,N,1,11333,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL619706,Intermediate,,,A,N,1,11334,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL619707,Intermediate,,,A,N,1,11335,2107.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Liver,BAO_0000218,
Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL619708,Intermediate,,,A,N,1,11336,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625219,Intermediate,,,A,N,1,11337,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625220,Intermediate,,,A,N,1,11338,178.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Blood,BAO_0000218,
Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625221,Intermediate,,,A,N,1,11339,2037.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Cerebellum,BAO_0000218,
Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625222,Intermediate,,,A,N,1,11340,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625223,Intermediate,,,A,N,1,11341,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625224,Intermediate,,,A,N,1,11342,2107.0,Mus musculus,In vivo,,50594,,13256,10090.0,,Liver,BAO_0000218,
Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,1,CHEMBL625225,Intermediate,,,A,N,1,11343,,Mus musculus,In vivo,,50594,,13256,10090.0,,,BAO_0000218,
Biodistribution in Rat blood after 24 hours of iv administration,,1,CHEMBL625226,Intermediate,,,A,N,1,11344,178.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Blood,BAO_0000218,
Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,1,CHEMBL625227,Intermediate,,,A,N,1,11345,178.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Blood,BAO_0000218,
Biodistribution in Rat blood after 30 minutes of iv administration,,1,CHEMBL625228,Intermediate,,,A,N,1,11346,178.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Blood,BAO_0000218,
Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,1,CHEMBL875354,Intermediate,,,A,N,1,11347,178.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Blood,BAO_0000218,
Biodistribution in Rat blood after 5 minutes of iv administration,,1,CHEMBL625229,Intermediate,,,A,N,1,11348,178.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Blood,BAO_0000218,
Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,1,CHEMBL625230,Intermediate,,,A,N,1,11349,178.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Blood,BAO_0000218,
Biodistribution in Rat heart after 24 hours of iv administration,,1,CHEMBL625231,Intermediate,,,A,N,1,11350,948.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Heart,BAO_0000218,
Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,1,CHEMBL625900,Intermediate,,,A,N,1,11351,948.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Heart,BAO_0000218,
Biodistribution in Rat heart after 30 minutes of iv administration,,1,CHEMBL625901,Intermediate,,,A,N,1,11352,948.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Heart,BAO_0000218,
Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,1,CHEMBL625902,Intermediate,,,A,N,1,11353,948.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Heart,BAO_0000218,
Biodistribution in Rat heart after 5 minutes of iv administration,,1,CHEMBL625903,Intermediate,,,A,N,1,11354,948.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Heart,BAO_0000218,
Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,1,CHEMBL625904,Intermediate,,,A,N,1,11355,948.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Heart,BAO_0000218,
Biodistribution in Rat liver after 24 hours of iv administration,,1,CHEMBL625905,Intermediate,,,A,N,1,11356,2107.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Liver,BAO_0000218,
Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,1,CHEMBL627861,Intermediate,,,A,N,1,11357,2107.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Liver,BAO_0000218,
Biodistribution in Rat liver after 30 minutes of iv administration,,1,CHEMBL627862,Intermediate,,,A,N,1,11358,2107.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Liver,BAO_0000218,
Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,1,CHEMBL627863,Intermediate,,,A,N,1,11359,2107.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Liver,BAO_0000218,
Biodistribution in Rat liver after 30 minutes of iv administration,,1,CHEMBL627769,Intermediate,,,A,N,1,11360,2107.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Liver,BAO_0000218,
Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,1,CHEMBL627770,Intermediate,,,A,N,1,11361,1969.0,Canis lupus familiaris,In vivo,,50588,,13249,9615.0,,Plasma,BAO_0000218,
Cmax in cynomolgus monkey (PO dose),,1,CHEMBL627771,Intermediate,,,A,N,1,11362,,Macaca fascicularis,In vivo,,100710,,13622,9541.0,,,BAO_0000218,
Cmax in rat (PO dose),,1,CHEMBL627772,Intermediate,,,A,N,1,11363,,Rattus norvegicus,In vivo,,50597,,13622,10116.0,,,BAO_0000218,
Cmax in rat (PO dose),,1,CHEMBL627773,Intermediate,,,A,N,1,11364,,Rattus norvegicus,In vivo,,50597,,13622,10116.0,,,BAO_0000218,
Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,1,CHEMBL621922,Intermediate,,,A,N,1,11365,1969.0,Rattus norvegicus,In vivo,,50597,,13494,10116.0,,Plasma,BAO_0000218,
Cmax in rat plasma after oral dose (10 mg/kg),,1,CHEMBL621923,Intermediate,,,A,N,1,11366,1969.0,Rattus norvegicus,In vivo,,50597,,12170,10116.0,,Plasma,BAO_0000218,
Cmax in plasma after oral dose (10 mg/kg),,0,CHEMBL621924,Autocuration,,,A,U,1,11367,1969.0,,In vivo,,22224,,12170,,,Plasma,BAO_0000218,
Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,1,CHEMBL621925,Intermediate,,,A,N,1,11368,1969.0,Canis lupus familiaris,In vivo,,50588,,17025,9615.0,,Plasma,BAO_0000218,
Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,0,CHEMBL621926,Autocuration,,,A,U,1,11369,1969.0,Simiiformes,In vivo,,22224,,17025,314293.0,,Plasma,BAO_0000218,
Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,1,CHEMBL621927,Intermediate,,,A,N,1,11370,1969.0,Oryctolagus cuniculus,In vivo,,50592,,17025,9986.0,,Plasma,BAO_0000218,
Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,1,CHEMBL621928,Intermediate,,,A,N,1,11371,1969.0,Rattus norvegicus,In vivo,,50597,,17025,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,1,CHEMBL621929,Intermediate,,,A,N,1,11372,1969.0,Rattus norvegicus,In vivo,,50597,,14187,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,1,CHEMBL621930,Intermediate,,,A,N,1,11373,1969.0,Mus musculus,In vivo,,50594,,14816,10090.0,,Plasma,BAO_0000218,
Maximum plasma concentration after oral dosing in rat,,1,CHEMBL621931,Intermediate,,,A,N,1,11374,1969.0,Rattus norvegicus,In vivo,,50597,,17820,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,0,CHEMBL621932,Autocuration,,,A,U,1,11375,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,0,CHEMBL621933,Autocuration,,,A,U,1,11376,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,1,CHEMBL621934,Intermediate,,,A,N,1,11377,1969.0,Canis lupus familiaris,In vivo,,50588,,14691,9615.0,,Plasma,BAO_0000218,
Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,1,CHEMBL621935,Intermediate,,,A,N,1,11378,1969.0,Canis lupus familiaris,In vivo,,50588,,14691,9615.0,,Plasma,BAO_0000218,
Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,1,CHEMBL621936,Intermediate,,,A,N,1,11379,1969.0,Rattus norvegicus,In vivo,,50597,,13375,10116.0,,Plasma,BAO_0000218,
Maximum plasma concentration was determined,,0,CHEMBL621937,Autocuration,,,A,U,1,11380,1969.0,,In vivo,,22224,,6236,,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,CHEMBL621938,Autocuration,,,A,U,1,11381,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,CHEMBL621939,Autocuration,,,A,U,1,11382,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,0,CHEMBL621940,Autocuration,,,A,U,1,11383,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,0,CHEMBL621941,Autocuration,,,A,U,1,11384,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,0,CHEMBL621942,Autocuration,,,A,U,1,11385,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,0,CHEMBL626178,Autocuration,,,A,U,1,11386,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,0,CHEMBL626179,Autocuration,,,A,U,1,11387,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,0,CHEMBL626180,Autocuration,,,A,U,1,11388,1969.0,,In vivo,,22224,,14380,,,Plasma,BAO_0000218,
Plasma Cmax in rat (PO dose),,1,CHEMBL626181,Intermediate,,,A,N,1,11389,1969.0,Rattus norvegicus,In vivo,,50597,,13622,10116.0,,Plasma,BAO_0000218,
Maximum serum concentration after po dose of 5.22 mg/kg in rats,,1,CHEMBL626182,Intermediate,,,A,N,1,11390,,Rattus norvegicus,In vivo,,50597,,15372,10116.0,,,BAO_0000218,
Maximum serum concentration after po dose of 5.46 mg/kg in rats,,1,CHEMBL626183,Intermediate,,,A,N,1,11391,,Rattus norvegicus,In vivo,,50597,,15372,10116.0,,,BAO_0000218,
Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,1,CHEMBL626184,Intermediate,,,A,N,1,11392,,Rattus norvegicus,In vivo,,50597,,15372,10116.0,,,BAO_0000218,
Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,1,CHEMBL626185,Intermediate,,,A,N,1,11393,,Rattus norvegicus,In vivo,,50597,,15372,10116.0,,,BAO_0000218,
Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,1,CHEMBL626186,Intermediate,,,A,N,1,11394,1969.0,Canis lupus familiaris,In vivo,,50588,,14925,9615.0,,Plasma,BAO_0000218,
Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,1,CHEMBL877589,Intermediate,,,A,N,1,11395,1969.0,Canis lupus familiaris,In vivo,,50588,,14925,9615.0,,Plasma,BAO_0000218,
Maximum concentration of the drug at 1 uM/dg administered intravenously,,0,CHEMBL626187,Autocuration,,,A,U,1,11396,,,In vivo,,22224,,11883,,,,BAO_0000218,
Maximum concentration of the drug at 20 uM/dg administered perorally,,0,CHEMBL626188,Autocuration,,,A,U,1,11397,,,In vivo,,22224,,11883,,,,BAO_0000218,
Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,0,CHEMBL626189,Autocuration,,,A,U,1,11398,,,In vivo,,22224,,13391,,,,BAO_0000218,
Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,0,CHEMBL626855,Autocuration,,,A,U,1,11399,178.0,,In vivo,,22224,,13391,,,Blood,BAO_0000218,
Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,0,CHEMBL623781,Autocuration,,,A,U,1,11400,178.0,,In vivo,,22224,,13391,,,Blood,BAO_0000218,
Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,0,CHEMBL623782,Autocuration,,,A,U,1,11401,178.0,,In vivo,,22224,,13391,,,Blood,BAO_0000218,
Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,1,CHEMBL623783,Intermediate,,,A,N,1,11402,1969.0,Rattus norvegicus,In vivo,,50597,,16360,10116.0,,Plasma,BAO_0000218,
Cmax in dog plasma after 1mg/kg oral dose,,1,CHEMBL623784,Intermediate,,,A,N,1,11403,1969.0,Canis lupus familiaris,In vivo,,50588,,3673,9615.0,,Plasma,BAO_0000218,
Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,1,CHEMBL623785,Intermediate,,,A,N,1,11404,1969.0,Canis lupus familiaris,In vivo,,50588,,14431,9615.0,,Plasma,BAO_0000218,
Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,1,CHEMBL623786,Intermediate,,,A,N,1,11405,1969.0,Rattus norvegicus,In vivo,,50597,,14431,10116.0,,Plasma,BAO_0000218,
Oral maximum concentration in rat,,1,CHEMBL623787,Intermediate,,,A,N,1,11406,,Rattus norvegicus,In vivo,,50597,,14964,10116.0,,,BAO_0000218,
Oral maximum concentration in rat,,1,CHEMBL623788,Intermediate,,,A,N,1,11407,,Rattus norvegicus,In vivo,,50597,,14964,10116.0,,,BAO_0000218,
Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,1,CHEMBL623789,Intermediate,,,A,N,1,11408,1969.0,Mus musculus,In vivo,,50594,,14209,10090.0,,Plasma,BAO_0000218,
Peak concentration in blood after intravenous administration to mice,,1,CHEMBL623790,Intermediate,,,A,N,1,11409,178.0,Mus musculus,In vivo,,50594,,11355,10090.0,,Blood,BAO_0000218,
Peak concentration in blood after peroral administration to mice,,1,CHEMBL623791,Intermediate,,,A,N,1,11410,178.0,Mus musculus,In vivo,,50594,,11355,10090.0,,Blood,BAO_0000218,
Peak concentration in rat plasma was determined,,1,CHEMBL623792,Intermediate,,,A,N,1,11411,1969.0,Rattus norvegicus,In vivo,,50597,,11966,10116.0,,Plasma,BAO_0000218,
Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,0,CHEMBL623793,Autocuration,,,A,U,1,11412,1969.0,Simiiformes,In vivo,,22224,,8918,314293.0,,Plasma,BAO_0000218,
Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,1,CHEMBL623794,Intermediate,,,A,N,1,11413,1969.0,Mus musculus,In vivo,,50594,,8918,10090.0,,Plasma,BAO_0000218,
Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,1,CHEMBL623795,Intermediate,,,A,N,1,11414,1969.0,Rattus norvegicus,In vivo,,50597,,8918,10116.0,,Plasma,BAO_0000218,
"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL623796,Intermediate,,,A,N,1,11415,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,1,CHEMBL623797,Intermediate,,,A,N,1,11416,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL623798,Intermediate,,,A,N,1,11417,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL623799,Intermediate,,,A,N,1,11418,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,1,CHEMBL624490,Intermediate,,,A,N,1,11419,160.0,Rattus norvegicus,,,50597,,8684,10116.0,,Intestine,BAO_0000218,
"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL624491,Intermediate,,,A,N,1,11420,160.0,Rattus norvegicus,,,50597,,8684,10116.0,,Intestine,BAO_0000218,
"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL624492,Intermediate,,,A,N,1,11421,160.0,Rattus norvegicus,,,50597,,8684,10116.0,,Intestine,BAO_0000218,
"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,1,CHEMBL624493,Intermediate,,,A,N,1,11422,160.0,Rattus norvegicus,,,50597,,8684,10116.0,,Intestine,BAO_0000218,
"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL877595,Intermediate,,,A,N,1,11423,160.0,Rattus norvegicus,,,50597,,8684,10116.0,,Intestine,BAO_0000218,
"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,1,CHEMBL624494,Intermediate,,,A,N,1,11424,160.0,Rattus norvegicus,,,50597,,8684,10116.0,,Intestine,BAO_0000218,
"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL624495,Intermediate,,,A,N,1,11425,160.0,Rattus norvegicus,,,50597,,8684,10116.0,,Intestine,BAO_0000218,
"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL624681,Intermediate,,,A,N,1,11426,160.0,Rattus norvegicus,,,50597,,8684,10116.0,,Intestine,BAO_0000218,
"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,1,CHEMBL624682,Intermediate,,,A,N,1,11427,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL624683,Intermediate,,,A,N,1,11428,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL624684,Intermediate,,,A,N,1,11429,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,1,CHEMBL624685,Intermediate,,,A,N,1,11430,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL624686,Intermediate,,,A,N,1,11431,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,1,CHEMBL624687,Intermediate,,,A,N,1,11432,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL624688,Intermediate,,,A,N,1,11433,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL627161,Intermediate,,,A,N,1,11434,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,1,CHEMBL622127,Intermediate,,,A,N,1,11435,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL622128,Intermediate,,,A,N,1,11436,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL874384,Intermediate,,,A,N,1,11437,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,1,CHEMBL624898,Intermediate,,,A,N,1,11438,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL624899,Intermediate,,,A,N,1,11439,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,1,CHEMBL624900,Intermediate,,,A,N,1,11440,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL624901,Intermediate,,,A,N,1,11441,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL624902,Intermediate,,,A,N,1,11442,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,1,CHEMBL624903,Intermediate,,,A,N,1,11443,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL624904,Intermediate,,,A,N,1,11444,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL624905,Intermediate,,,A,N,1,11445,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,1,CHEMBL624906,Intermediate,,,A,N,1,11446,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL624907,Intermediate,,,A,N,1,11447,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,1,CHEMBL624908,Intermediate,,,A,N,1,11448,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL624909,Intermediate,,,A,N,1,11449,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL624910,Intermediate,,,A,N,1,11450,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,1,CHEMBL624911,Intermediate,,,A,N,1,11451,2385.0,Rattus norvegicus,,,50597,,8684,10116.0,,Muscle tissue,BAO_0000218,
"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL874388,Intermediate,,,A,N,1,11452,2385.0,Rattus norvegicus,,,50597,,8684,10116.0,,Muscle tissue,BAO_0000218,
"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL624912,Intermediate,,,A,N,1,11453,2385.0,Rattus norvegicus,,,50597,,8684,10116.0,,Muscle tissue,BAO_0000218,
"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,1,CHEMBL622930,Intermediate,,,A,N,1,11454,2385.0,Rattus norvegicus,,,50597,,8684,10116.0,,Muscle tissue,BAO_0000218,
"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL623121,Intermediate,,,A,N,1,11455,2385.0,Rattus norvegicus,,,50597,,8684,10116.0,,Muscle tissue,BAO_0000218,
"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,1,CHEMBL623122,Intermediate,,,A,N,1,11456,2385.0,Rattus norvegicus,,,50597,,8684,10116.0,,Muscle tissue,BAO_0000218,
"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL623123,Intermediate,,,A,N,1,11457,2385.0,Rattus norvegicus,,,50597,,8684,10116.0,,Muscle tissue,BAO_0000218,
"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL623124,Intermediate,,,A,N,1,11458,2385.0,Rattus norvegicus,,,50597,,8684,10116.0,,Muscle tissue,BAO_0000218,
"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,1,CHEMBL623125,Intermediate,,,A,N,1,11459,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL623126,Intermediate,,,A,N,1,11460,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL623127,Intermediate,,,A,N,1,11461,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,1,CHEMBL623128,Intermediate,,,A,N,1,11462,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL623129,Intermediate,,,A,N,1,11463,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,1,CHEMBL623130,Intermediate,,,A,N,1,11464,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL623131,Intermediate,,,A,N,1,11465,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL623132,Intermediate,,,A,N,1,11466,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,1,CHEMBL623133,Intermediate,,,A,N,1,11467,2107.0,Rattus norvegicus,,,50597,,8319,10116.0,,Liver,BAO_0000218,
The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,1,CHEMBL623134,Intermediate,,,A,N,1,11468,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,1,CHEMBL874389,Intermediate,,,A,N,1,11469,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,1,CHEMBL623135,Intermediate,,,A,N,1,11470,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,1,CHEMBL623136,Intermediate,,,A,N,1,11471,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,1,CHEMBL623137,Intermediate,,,A,N,1,11472,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,1,CHEMBL623138,Intermediate,,,A,N,1,11473,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,1,CHEMBL623139,Intermediate,,,A,N,1,11474,2113.0,Rattus norvegicus,,,50597,,8319,10116.0,,Kidney,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,1,CHEMBL623140,Intermediate,,,A,N,1,11475,2113.0,Rattus norvegicus,,,50597,,8319,10116.0,,Kidney,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,1,CHEMBL623141,Intermediate,,,A,N,1,11476,2107.0,Rattus norvegicus,,,50597,,8319,10116.0,,Liver,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,1,CHEMBL623142,Intermediate,,,A,N,1,11477,2107.0,Rattus norvegicus,,,50597,,8319,10116.0,,Liver,BAO_0000218,
The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,1,CHEMBL623143,Intermediate,,,A,N,1,11478,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,1,CHEMBL623144,Intermediate,,,A,N,1,11479,1088.0,Mus musculus,,,50594,,14571,10090.0,,Urine,BAO_0000218,
The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,1,CHEMBL623405,Intermediate,,,A,N,1,11480,1088.0,Rattus norvegicus,,,50597,,14571,10116.0,,Urine,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,1,CHEMBL624074,Intermediate,,,A,N,1,11481,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,1,CHEMBL624075,Intermediate,,,A,N,1,11482,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,1,CHEMBL624076,Intermediate,,,A,N,1,11483,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,1,CHEMBL624077,Intermediate,,,A,N,1,11484,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,1,CHEMBL624078,Intermediate,,,A,N,1,11485,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,1,CHEMBL624079,Intermediate,,,A,N,1,11486,2113.0,Rattus norvegicus,,,50597,,8319,10116.0,,Kidney,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,1,CHEMBL624261,Intermediate,,,A,N,1,11487,2113.0,Rattus norvegicus,,,50597,,8319,10116.0,,Kidney,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,1,CHEMBL624262,Intermediate,,,A,N,1,11488,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,1,CHEMBL624263,Intermediate,,,A,N,1,11489,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,1,CHEMBL624264,Intermediate,,,A,N,1,11490,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,1,CHEMBL624265,Intermediate,,,A,N,1,11491,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,1,CHEMBL624266,Intermediate,,,A,N,1,11492,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,1,CHEMBL624267,Intermediate,,,A,N,1,11493,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,1,CHEMBL624268,Intermediate,,,A,N,1,11494,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,1,CHEMBL875227,Intermediate,,,A,N,1,11495,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,1,CHEMBL624269,Intermediate,,,A,N,1,11496,2113.0,Rattus norvegicus,,,50597,,8319,10116.0,,Kidney,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,1,CHEMBL624270,Intermediate,,,A,N,1,11497,2113.0,Rattus norvegicus,,,50597,,8319,10116.0,,Kidney,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,1,CHEMBL624271,Intermediate,,,A,N,1,11498,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,1,CHEMBL624272,Intermediate,,,A,N,1,11499,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,1,CHEMBL624273,Intermediate,,,A,N,1,11500,,Rattus norvegicus,,,50597,,8319,10116.0,,,BAO_0000218,
Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,1,CHEMBL624274,Intermediate,,,A,N,1,11501,1088.0,Rattus norvegicus,,,50597,,12064,10116.0,,Urine,BAO_0000218,
Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,1,CHEMBL624275,Intermediate,,,A,N,1,11502,1088.0,Rattus norvegicus,,,50597,,12064,10116.0,,Urine,BAO_0000218,
Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,1,CHEMBL624276,Intermediate,,,A,N,1,11503,1088.0,Rattus norvegicus,,,50597,,12064,10116.0,,Urine,BAO_0000218,
Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,1,CHEMBL624277,Intermediate,,,A,N,1,11504,1088.0,Rattus norvegicus,,,50597,,12038,10116.0,,Urine,BAO_0000218,
% dose converted to 2-amino-5-chlorophenyl sulfate,,0,CHEMBL624278,Autocuration,,,A,U,1,11505,,,,,22224,,14314,,,,BAO_0000019,
% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,0,CHEMBL624279,Autocuration,,,A,U,1,11506,,,,,22224,,14314,,,,BAO_0000019,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,1,CHEMBL624280,Intermediate,,,A,N,1,11507,1988.0,Rattus norvegicus,,,50597,,11488,10116.0,,Feces,BAO_0000218,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,1,CHEMBL624281,Intermediate,,,A,N,1,11508,1988.0,Rattus norvegicus,,,50597,,11488,10116.0,,Feces,BAO_0000218,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,1,CHEMBL622933,Intermediate,,,A,N,1,11509,1988.0,Rattus norvegicus,,,50597,,11488,10116.0,,Feces,BAO_0000218,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,1,CHEMBL622934,Intermediate,,,A,N,1,11510,1988.0,Rattus norvegicus,,,50597,,11488,10116.0,,Feces,BAO_0000218,
Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,1,CHEMBL622935,Intermediate,,,A,N,1,11511,2107.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Liver,BAO_0000218,
Biodistribution in Rat liver after 5 minutes of iv administration,,1,CHEMBL622936,Intermediate,,,A,N,1,11512,2107.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Liver,BAO_0000218,
Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,1,CHEMBL875228,Intermediate,,,A,N,1,11513,2107.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Liver,BAO_0000218,
Biodistribution in Rat lung after 24 hours of iv administration,,1,CHEMBL622937,Intermediate,,,A,N,1,11514,2048.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Lung,BAO_0000218,
Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,1,CHEMBL622938,Intermediate,,,A,N,1,11515,2048.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Lung,BAO_0000218,
Biodistribution in Rat lung after 30 minutes of iv administration,,1,CHEMBL619736,Intermediate,,,A,N,1,11516,2048.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Lung,BAO_0000218,
Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,1,CHEMBL625117,Intermediate,,,A,N,1,11517,2048.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Lung,BAO_0000218,
Biodistribution in Rat lung after 5 minutes of iv administration,,1,CHEMBL625118,Intermediate,,,A,N,1,11518,2048.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Lung,BAO_0000218,
Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,1,CHEMBL625119,Intermediate,,,A,N,1,11519,2048.0,Rattus norvegicus,In vivo,,50597,,8829,10116.0,,Lung,BAO_0000218,
"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,1,CHEMBL625120,Intermediate,,,A,N,1,11520,2037.0,Rattus norvegicus,In vivo,,50597,,14972,10116.0,,Cerebellum,BAO_0000218,
"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,1,CHEMBL625121,Intermediate,,,A,N,1,11521,,Rattus norvegicus,In vivo,,50597,,14972,10116.0,,,BAO_0000218,
"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,1,CHEMBL625122,Intermediate,,,A,N,1,11522,10000006.0,Rattus norvegicus,In vivo,,50597,,14972,10116.0,,Thalamus,BAO_0000218,
Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL622204,Intermediate,,,A,N,1,11523,178.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Blood,BAO_0000218,
Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL877503,Intermediate,,,A,N,1,11524,178.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Blood,BAO_0000218,
Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL627127,Intermediate,,,A,N,1,11525,178.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Blood,BAO_0000218,
Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,0,CHEMBL627128,Autocuration,,,A,U,1,11526,10000000.0,,In vivo,,22224,,14608,,,Hippocampus,BAO_0000218,
Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,0,CHEMBL627129,Autocuration,,,A,U,1,11527,10000000.0,,In vivo,,22224,,14608,,,Hippocampus,BAO_0000218,
Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,0,CHEMBL627130,Autocuration,,,A,U,1,11528,10000000.0,,In vivo,,22224,,14608,,,Hippocampus,BAO_0000218,
Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL627131,Intermediate,,,A,N,1,11529,955.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Brain,BAO_0000218,
Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL627132,Intermediate,,,A,N,1,11530,955.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Brain,BAO_0000218,
Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL627133,Intermediate,,,A,N,1,11531,955.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Brain,BAO_0000218,
Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL627134,Intermediate,,,A,N,1,11532,2037.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Cerebellum,BAO_0000218,
Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL627135,Intermediate,,,A,N,1,11533,2037.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Cerebellum,BAO_0000218,
Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL627136,Intermediate,,,A,N,1,11534,2037.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Cerebellum,BAO_0000218,
Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL628435,Intermediate,,,A,N,1,11535,,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,,BAO_0000218,
Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL628436,Intermediate,,,A,N,1,11536,,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,,BAO_0000218,
Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL628437,Intermediate,,,A,N,1,11537,,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,,BAO_0000218,
Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL628438,Intermediate,,,A,N,1,11538,948.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Heart,BAO_0000218,
Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL628439,Intermediate,,,A,N,1,11539,948.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Heart,BAO_0000218,
Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL628440,Intermediate,,,A,N,1,11540,948.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Heart,BAO_0000218,
Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL628441,Intermediate,,,A,N,1,11541,10000000.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Hippocampus,BAO_0000218,
Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL628442,Intermediate,,,A,N,1,11542,10000000.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Hippocampus,BAO_0000218,
Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL628443,Intermediate,,,A,N,1,11543,10000000.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Hippocampus,BAO_0000218,
Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL628444,Intermediate,,,A,N,1,11544,2113.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Kidney,BAO_0000218,
Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL628445,Intermediate,,,A,N,1,11545,2113.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Kidney,BAO_0000218,
Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL877504,Intermediate,,,A,N,1,11546,2113.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Kidney,BAO_0000218,
Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL628446,Intermediate,,,A,N,1,11547,2107.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Liver,BAO_0000218,
Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL626874,Intermediate,,,A,N,1,11548,2107.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Liver,BAO_0000218,
Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL626875,Intermediate,,,A,N,1,11549,2107.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Liver,BAO_0000218,
Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL626876,Intermediate,,,A,N,1,11550,2048.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Lung,BAO_0000218,
Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL626877,Intermediate,,,A,N,1,11551,2048.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Lung,BAO_0000218,
Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL626878,Intermediate,,,A,N,1,11552,2048.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Lung,BAO_0000218,
Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL626879,Intermediate,,,A,N,1,11553,2385.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Muscle tissue,BAO_0000218,
Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,0,CHEMBL626880,Autocuration,,,A,U,1,11554,1969.0,Simiiformes,In vivo,,22224,,8918,314293.0,,Plasma,BAO_0000218,
Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,1,CHEMBL626881,Intermediate,,,A,N,1,11555,1969.0,Mus musculus,In vivo,,50594,,8918,10090.0,,Plasma,BAO_0000218,
Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,1,CHEMBL626882,Intermediate,,,A,N,1,11556,1969.0,Rattus norvegicus,In vivo,,50597,,8918,10116.0,,Plasma,BAO_0000218,
Peak plasma concentration was measured in dogs,,1,CHEMBL626883,Intermediate,,,A,N,1,11557,1969.0,Canis lupus familiaris,In vivo,,50588,,14470,9615.0,,Plasma,BAO_0000218,
Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,CHEMBL626884,Intermediate,,,A,N,1,11558,,Rattus norvegicus,In vivo,,50597,,14393,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,1,CHEMBL626885,Intermediate,,,A,N,1,11559,,Rattus norvegicus,In vivo,,50597,,14886,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,1,CHEMBL626886,Intermediate,,,A,N,1,11560,,Rattus norvegicus,In vivo,,50597,,14886,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,1,CHEMBL626887,Intermediate,,,A,N,1,11561,,Rattus norvegicus,In vivo,,50597,,14886,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,CHEMBL626888,Intermediate,,,A,N,1,11562,,Rattus norvegicus,In vivo,,50597,,14393,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,1,CHEMBL626889,Intermediate,,,A,N,1,11563,,Canis lupus familiaris,In vivo,,50588,,13465,9615.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,0,CHEMBL626761,Autocuration,,,A,U,1,11564,,Simiiformes,In vivo,,22224,,13465,314293.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,1,CHEMBL626762,Intermediate,,,A,N,1,11565,,Canis lupus familiaris,In vivo,,50588,,13465,9615.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,1,CHEMBL626763,Intermediate,,,A,N,1,11566,,Canis lupus familiaris,In vivo,,50588,,13465,9615.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,1,CHEMBL626764,Intermediate,,,A,N,1,11567,,Rattus norvegicus,In vivo,,50597,,13465,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,1,CHEMBL626765,Intermediate,,,A,N,1,11568,,Rattus norvegicus,In vivo,,50597,,13465,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,1,CHEMBL626766,Intermediate,,,A,N,1,11569,,Canis lupus familiaris,In vivo,,50588,,13465,9615.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,1,CHEMBL626767,Intermediate,,,A,N,1,11570,,Rattus norvegicus,In vivo,,50597,,13465,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,1,CHEMBL626768,Intermediate,,,A,N,1,11571,,Rattus norvegicus,In vivo,,50597,,13465,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,1,CHEMBL626769,Intermediate,,,A,N,1,11572,,Canis lupus familiaris,In vivo,,50588,,13465,9615.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,1,CHEMBL874463,Intermediate,,,A,N,1,11573,,Canis lupus familiaris,In vivo,,50588,,13465,9615.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,0,CHEMBL626770,Autocuration,,,A,U,1,11574,,Simiiformes,In vivo,,22224,,13465,314293.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,0,CHEMBL626771,Autocuration,,,A,U,1,11575,,Simiiformes,In vivo,,22224,,13465,314293.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,1,CHEMBL626772,Intermediate,,,A,N,1,11576,,Rattus norvegicus,In vivo,,50597,,13465,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,1,CHEMBL626773,Intermediate,,,A,N,1,11577,,Macaca fascicularis,In vivo,,100710,,14731,9541.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,1,CHEMBL626774,Intermediate,,,A,N,1,11578,,Mus musculus,In vivo,,50594,,14731,10090.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,1,CHEMBL626775,Intermediate,,,A,N,1,11579,,Canis lupus familiaris,In vivo,,50588,,13376,9615.0,,,BAO_0000218,
Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,1,CHEMBL626776,Intermediate,,,A,N,1,11580,,Canis lupus familiaris,In vivo,,50588,,13376,9615.0,,,BAO_0000218,
Maximum concentration (Cmax) in rat when administered orally,,1,CHEMBL626777,Intermediate,,,A,N,1,11581,,Rattus norvegicus,In vivo,,50597,,14443,10116.0,,,BAO_0000218,
Maximal concentration in monkey plasma after 25 mg/kg oral dose,,0,CHEMBL626778,Autocuration,,,A,U,1,11582,1969.0,Simiiformes,In vivo,,22224,,13465,314293.0,,Plasma,BAO_0000218,
"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,0,CHEMBL626779,Autocuration,,,A,U,1,11583,,Rattus norvegicus,In vivo,,22224,,16359,10116.0,,,BAO_0000218,
"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,0,CHEMBL626780,Autocuration,,,A,U,1,11584,,Rattus norvegicus,In vivo,,22224,,16359,10116.0,,,BAO_0000218,
Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,0,CHEMBL626781,Autocuration,,,A,U,1,11585,1969.0,,In vivo,,22224,,15618,,,Plasma,BAO_0000218,
Pharmacokinetic profile Cmax was evaluated in rats,,1,CHEMBL632164,Intermediate,,,A,N,1,11586,,Rattus norvegicus,In vivo,,50597,,14554,10116.0,,,BAO_0000218,
Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,1,CHEMBL632165,Intermediate,,,A,N,1,11587,,Canis lupus familiaris,In vivo,,50588,,11537,9615.0,,,BAO_0000218,
Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,1,CHEMBL632166,Intermediate,,,A,N,1,11588,,Mus musculus,In vivo,,50594,,11537,10090.0,,,BAO_0000218,
Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,1,CHEMBL632167,Intermediate,,,A,N,1,11589,,Canis lupus familiaris,In vivo,,50588,,11537,9615.0,,,BAO_0000218,
Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,1,CHEMBL632168,Intermediate,,,A,N,1,11590,,Mus musculus,In vivo,,50594,,11537,10090.0,,,BAO_0000218,
Cmax in rat plasma,,0,CHEMBL632169,Autocuration,,,A,U,1,11591,1969.0,Rattus norvegicus,In vivo,,22224,,2021,10116.0,,Plasma,BAO_0000218,
Cmax in dog plasma after 30mg/kg oral dose,,1,CHEMBL632170,Intermediate,,,A,N,1,11592,1969.0,Canis lupus familiaris,In vivo,,50588,,5932,9615.0,,Plasma,BAO_0000218,
Cmax in rat plasma after 30mg/kg oral dose,,1,CHEMBL632171,Intermediate,,,A,N,1,11593,1969.0,Rattus norvegicus,In vivo,,50597,,5932,10116.0,,Plasma,BAO_0000218,
Plasma level in rats at 30 mg/kg,,1,CHEMBL632172,Intermediate,,,A,N,1,11594,1969.0,Rattus norvegicus,In vivo,,50597,,17320,10116.0,,Plasma,BAO_0000218,
Tested for maximum plasma concentration in mice,,1,CHEMBL632173,Intermediate,,,A,N,1,11595,1969.0,Mus musculus,In vivo,,50594,,15831,10090.0,,Plasma,BAO_0000218,
"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL632174,Intermediate,,,A,N,1,11596,,Rattus norvegicus,In vivo,,50597,,15078,10116.0,,,BAO_0000218,
The Cmax values in female wistar rats.,,1,CHEMBL632175,Intermediate,,,A,N,1,11597,,Rattus norvegicus,In vivo,,50597,,14941,10116.0,,,BAO_0000218,
The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,1,CHEMBL632176,Intermediate,,,A,N,1,11598,1969.0,Canis lupus familiaris,In vivo,,50588,,15343,9615.0,,Plasma,BAO_0000218,
The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,1,CHEMBL632177,Intermediate,,,A,N,1,11599,1969.0,Rattus norvegicus,In vivo,,50597,,15343,10116.0,,Plasma,BAO_0000218,
The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,1,CHEMBL632178,Intermediate,,,A,N,1,11600,1969.0,Rattus norvegicus,In vivo,,50597,,14856,10116.0,,Plasma,BAO_0000218,
The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,1,CHEMBL632179,Intermediate,,,A,N,1,11601,,Rattus norvegicus,In vivo,,50597,,13129,10116.0,,,BAO_0000218,
The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,1,CHEMBL632180,Intermediate,,,A,N,1,11602,178.0,Rattus norvegicus,In vivo,,50597,,13098,10116.0,,Blood,BAO_0000218,
The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,1,CHEMBL632181,Intermediate,,,A,N,1,11603,178.0,Rattus norvegicus,In vivo,,50597,,13098,10116.0,,Blood,BAO_0000218,
The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,1,CHEMBL632182,Intermediate,,,A,N,1,11604,178.0,Rattus norvegicus,In vivo,,50597,,13098,10116.0,,Blood,BAO_0000218,
The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,0,CHEMBL632183,Autocuration,,,A,U,1,11605,178.0,Mus musculus,In vivo,,22224,,15478,10090.0,,Blood,BAO_0000218,
The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,1,CHEMBL632184,Intermediate,,,A,N,1,11606,,Canis lupus familiaris,In vivo,,50588,,15341,9615.0,,,BAO_0000218,
The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,1,CHEMBL874470,Intermediate,,,A,N,1,11607,,Rattus norvegicus,In vivo,,50597,,15341,10116.0,,,BAO_0000218,
"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,1,CHEMBL631302,Intermediate,,,A,N,1,11608,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL631303,Intermediate,,,A,N,1,11609,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL631304,Intermediate,,,A,N,1,11610,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,1,CHEMBL631305,Intermediate,,,A,N,1,11611,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL631306,Intermediate,,,A,N,1,11612,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,1,CHEMBL631307,Intermediate,,,A,N,1,11613,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL631308,Intermediate,,,A,N,1,11614,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL625557,Intermediate,,,A,N,1,11615,,Rattus norvegicus,,,50597,,8684,10116.0,,,BAO_0000218,
"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,1,CHEMBL625558,Intermediate,,,A,N,1,11616,2106.0,Rattus norvegicus,,,50597,,8684,10116.0,,Spleen,BAO_0000218,
"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL625559,Intermediate,,,A,N,1,11617,2106.0,Rattus norvegicus,,,50597,,8684,10116.0,,Spleen,BAO_0000218,
"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL625560,Intermediate,,,A,N,1,11618,2106.0,Rattus norvegicus,,,50597,,8684,10116.0,,Spleen,BAO_0000218,
"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,1,CHEMBL625561,Intermediate,,,A,N,1,11619,2106.0,Rattus norvegicus,,,50597,,8684,10116.0,,Spleen,BAO_0000218,
"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL625562,Intermediate,,,A,N,1,11620,2106.0,Rattus norvegicus,,,50597,,8684,10116.0,,Spleen,BAO_0000218,
"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,1,CHEMBL875320,Intermediate,,,A,N,1,11621,2106.0,Rattus norvegicus,,,50597,,8684,10116.0,,Spleen,BAO_0000218,
"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL625563,Intermediate,,,A,N,1,11622,2106.0,Rattus norvegicus,,,50597,,8684,10116.0,,Spleen,BAO_0000218,
"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL625564,Intermediate,,,A,N,1,11623,2106.0,Rattus norvegicus,,,50597,,8684,10116.0,,Spleen,BAO_0000218,
"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,1,CHEMBL625565,Intermediate,,,A,N,1,11624,995.0,Rattus norvegicus,,,50597,,8684,10116.0,,Uterus,BAO_0000218,
"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,1,CHEMBL625566,Intermediate,,,A,N,1,11625,995.0,Rattus norvegicus,,,50597,,8684,10116.0,,Uterus,BAO_0000218,
"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,1,CHEMBL625567,Intermediate,,,A,N,1,11626,995.0,Rattus norvegicus,,,50597,,8684,10116.0,,Uterus,BAO_0000218,
"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,1,CHEMBL625568,Intermediate,,,A,N,1,11627,995.0,Rattus norvegicus,,,50597,,8684,10116.0,,Uterus,BAO_0000218,
"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,1,CHEMBL628217,Intermediate,,,A,N,1,11628,995.0,Rattus norvegicus,,,50597,,8684,10116.0,,Uterus,BAO_0000218,
"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,1,CHEMBL628218,Intermediate,,,A,N,1,11629,995.0,Rattus norvegicus,,,50597,,8684,10116.0,,Uterus,BAO_0000218,
"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,1,CHEMBL628219,Intermediate,,,A,N,1,11630,995.0,Rattus norvegicus,,,50597,,8684,10116.0,,Uterus,BAO_0000218,
"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,1,CHEMBL628220,Intermediate,,,A,N,1,11631,995.0,Rattus norvegicus,,,50597,,8684,10116.0,,Uterus,BAO_0000218,
Distribution in the blood after 120 min of intravenous administration,,0,CHEMBL628221,Autocuration,,,A,U,1,11632,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the blood after 15 min of intravenous administration,,0,CHEMBL628222,Autocuration,,,A,U,1,11633,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the blood after 30 min of intravenous administration,,0,CHEMBL628223,Autocuration,,,A,U,1,11634,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the blood after 5 min of intravenous administration,,0,CHEMBL628224,Autocuration,,,A,U,1,11635,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the blood after 60 min of intravenous administration,,0,CHEMBL628225,Autocuration,,,A,U,1,11636,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the blood after 90 min of intravenous administration,,0,CHEMBL628226,Autocuration,,,A,U,1,11637,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the bone after 120 min of intravenous administration,,0,CHEMBL628227,Autocuration,,,A,U,1,11638,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the bone after 15 min of intravenous administration,,0,CHEMBL875481,Autocuration,,,A,U,1,11639,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the bone after 30 min of intravenous administration,,0,CHEMBL628228,Autocuration,,,A,U,1,11640,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the bone after 5 min of intravenous administration,,0,CHEMBL628229,Autocuration,,,A,U,1,11641,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the bone after 60 min of intravenous administration,,0,CHEMBL628230,Autocuration,,,A,U,1,11642,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the bone after 90 min of intravenous administration,,0,CHEMBL628231,Autocuration,,,A,U,1,11643,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the heart after 120 min of intravenous administration,,0,CHEMBL628232,Autocuration,,,A,U,1,11644,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the heart after 15 min of intravenous administration,,0,CHEMBL628233,Autocuration,,,A,U,1,11645,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the heart after 30 min of intravenous administration,,0,CHEMBL628234,Autocuration,,,A,U,1,11646,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the heart after 5 min of intravenous administration,,0,CHEMBL628235,Autocuration,,,A,U,1,11647,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the heart after 60 min of intravenous administration,,0,CHEMBL628236,Autocuration,,,A,U,1,11648,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the heart after 90 min of intravenous administration,,0,CHEMBL628237,Autocuration,,,A,U,1,11649,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the kidneys after 120 min of intravenous administration,,0,CHEMBL628238,Autocuration,,,A,U,1,11650,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the kidneys after 15 min of intravenous administration,,0,CHEMBL628239,Autocuration,,,A,U,1,11651,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the kidneys after 30 min of intravenous administration,,0,CHEMBL628240,Autocuration,,,A,U,1,11652,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the kidneys after 5 min of intravenous administration,,0,CHEMBL628241,Autocuration,,,A,U,1,11653,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the kidneys after 60 min of intravenous administration,,0,CHEMBL628242,Autocuration,,,A,U,1,11654,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the kidneys after 90 min of intravenous administration,,0,CHEMBL875482,Autocuration,,,A,U,1,11655,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the liver after 120 min of intravenous administration,,0,CHEMBL628243,Autocuration,,,A,U,1,11656,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the liver after 15 min of intravenous administration,,0,CHEMBL628244,Autocuration,,,A,U,1,11657,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the liver after 30 min of intravenous administration,,0,CHEMBL628245,Autocuration,,,A,U,1,11658,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the liver after 5 min of intravenous administration,,0,CHEMBL628246,Autocuration,,,A,U,1,11659,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the liver after 60 min of intravenous administration,,0,CHEMBL628247,Autocuration,,,A,U,1,11660,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the liver after 90 min of intravenous administration,,0,CHEMBL628248,Autocuration,,,A,U,1,11661,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the lung after 120 min of intravenous administration,,0,CHEMBL628249,Autocuration,,,A,U,1,11662,,,,,22224,,8926,,,,BAO_0000019,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,1,CHEMBL625452,Intermediate,,,A,N,1,11663,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,1,CHEMBL625453,Intermediate,,,A,N,1,11664,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,1,CHEMBL625454,Intermediate,,,A,N,1,11665,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,1,CHEMBL623844,Intermediate,,,A,N,1,11666,,Mus musculus,,,50594,,14839,10090.0,,,BAO_0000218,
Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,1,CHEMBL623845,Intermediate,,,A,N,1,11667,,Rattus norvegicus,,,50597,,12178,10116.0,,,BAO_0000218,
Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,1,CHEMBL623846,Intermediate,,,A,N,1,11668,,Rattus norvegicus,,,50597,,12178,10116.0,,,BAO_0000218,
Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,0,CHEMBL623847,Autocuration,,,A,U,1,11669,,,,,22224,,12178,,,,BAO_0000218,
Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,1,CHEMBL623848,Intermediate,,,A,N,1,11670,,Macaca fascicularis,,,100710,,12186,9541.0,,,BAO_0000218,
Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,1,CHEMBL623849,Intermediate,,,A,N,1,11671,,Macaca fascicularis,,,100710,,12186,9541.0,,,BAO_0000218,
Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,1,CHEMBL623850,Intermediate,,,A,N,1,11672,,Macaca fascicularis,,,100710,,12186,9541.0,,,BAO_0000218,
Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,1,CHEMBL623851,Intermediate,,,A,N,1,11673,,Macaca fascicularis,,,100710,,12186,9541.0,,,BAO_0000218,
Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,0,CHEMBL623852,Autocuration,,,A,U,1,11674,,Simiiformes,,,22224,,12187,314293.0,,,BAO_0000218,
Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,1,CHEMBL624551,Intermediate,,,A,N,1,11675,,Mustela putorius furo,,,50506,,12187,9669.0,,,BAO_0000218,
"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,1,CHEMBL624552,Intermediate,,,A,N,1,11676,,Mustela putorius furo,,,50506,,12187,9669.0,,,BAO_0000218,
Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,0,CHEMBL624553,Autocuration,,,A,U,1,11677,,Simiiformes,,,22224,,12187,314293.0,,,BAO_0000218,
Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,0,CHEMBL624554,Autocuration,,,A,U,1,11678,,Simiiformes,,,22224,,12187,314293.0,,,BAO_0000218,
Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,1,CHEMBL624555,Intermediate,,,A,N,1,11679,,Rattus norvegicus,,,50597,,12187,10116.0,,,BAO_0000218,
"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,1,CHEMBL624741,Intermediate,,,A,N,1,11680,,Rattus norvegicus,,,50597,,12187,10116.0,,,BAO_0000218,
"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,1,CHEMBL624742,Intermediate,,,A,N,1,11681,,Canis lupus familiaris,,,50588,,14122,9615.0,,,BAO_0000218,
"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,1,CHEMBL624743,Intermediate,,,A,N,1,11682,,Cricetinae,,,100712,,14122,10026.0,,,BAO_0000218,
"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,1,CHEMBL877606,Intermediate,,,A,N,1,11683,,Rattus norvegicus,,,50597,,14122,10116.0,,,BAO_0000218,
Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,0,CHEMBL624744,Autocuration,,,A,U,1,11684,,,,,22224,,13391,,,,BAO_0000218,
Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,0,CHEMBL624745,Autocuration,,,A,U,1,11685,178.0,,,,22224,,13391,,,Blood,BAO_0000218,
Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,0,CHEMBL624746,Autocuration,,,A,U,1,11686,178.0,,,,22224,,13391,,,Blood,BAO_0000218,
Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,0,CHEMBL624747,Autocuration,,,A,U,1,11687,178.0,,,,22224,,13391,,,Blood,BAO_0000218,
Oral absorption expressed as Area under curve was determined,,0,CHEMBL624748,Autocuration,,,A,U,1,11688,,,,,22224,,16360,,,,BAO_0000019,
Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,1,CHEMBL622504,Intermediate,,,A,N,1,11689,,Canis lupus familiaris,,,50588,,3673,9615.0,,,BAO_0000218,
"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,1,CHEMBL622505,Intermediate,,,A,N,1,11690,,Canis lupus familiaris,,,50588,,14122,9615.0,,,BAO_0000218,
"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,1,CHEMBL622506,Intermediate,,,A,N,1,11691,,Cricetinae,,,100712,,14122,10026.0,,,BAO_0000218,
"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,1,CHEMBL622507,Intermediate,,,A,N,1,11692,,Cricetinae,,,100712,,14122,10026.0,,,BAO_0000218,
"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,1,CHEMBL622508,Intermediate,,,A,N,1,11693,,Rattus norvegicus,,,50597,,14122,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,0,CHEMBL622509,Autocuration,,,A,U,1,11694,,,,,22224,,13889,,,,BAO_0000019,
Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,CHEMBL622510,Intermediate,,,A,N,1,11695,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,1,CHEMBL622511,Intermediate,,,A,N,1,11696,,Rattus norvegicus,,,50597,,17279,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,1,CHEMBL622512,Intermediate,,,A,N,1,11697,,Macaca fascicularis,,,100710,,14548,9541.0,,,BAO_0000218,
Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,1,CHEMBL622513,Intermediate,,,A,N,1,11698,,Macaca fascicularis,,,100710,,14548,9541.0,,,BAO_0000218,
Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,1,CHEMBL622514,Intermediate,,,A,N,1,11699,,Macaca fascicularis,,,100710,,14548,9541.0,,,BAO_0000218,
Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,1,CHEMBL622515,Intermediate,,,A,N,1,11700,,Canis lupus familiaris,,,50588,,14548,9615.0,,,BAO_0000218,
Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,1,CHEMBL622516,Intermediate,,,A,N,1,11701,,Canis lupus familiaris,,,50588,,14548,9615.0,,,BAO_0000218,
Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,1,CHEMBL622517,Intermediate,,,A,N,1,11702,,Rattus norvegicus,,,50597,,14548,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,1,CHEMBL622518,Intermediate,,,A,N,1,11703,,Rattus norvegicus,,,50597,,14548,10116.0,,,BAO_0000218,
Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,1,CHEMBL622519,Intermediate,,,A,N,1,11704,,Rattus norvegicus,,,50597,,14548,10116.0,,,BAO_0000218,
Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL622520,Intermediate,,,A,N,1,11705,2385.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL622521,Intermediate,,,A,N,1,11706,2385.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL625113,Intermediate,,,A,N,1,11707,14.0,Mus musculus,In vivo,,50594,,14608,10090.0,,Zone of skin,BAO_0000218,
Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL625114,Intermediate,,,A,N,1,11708,14.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Zone of skin,BAO_0000218,
Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL874397,Intermediate,,,A,N,1,11709,14.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Zone of skin,BAO_0000218,
Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL625115,Intermediate,,,A,N,1,11710,2106.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Spleen,BAO_0000218,
Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL625116,Intermediate,,,A,N,1,11711,2106.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Spleen,BAO_0000218,
Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL623932,Intermediate,,,A,N,1,11712,2106.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Spleen,BAO_0000218,
Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL623933,Intermediate,,,A,N,1,11713,2435.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Striatum,BAO_0000218,
Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL623934,Intermediate,,,A,N,1,11714,2435.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Striatum,BAO_0000218,
Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL623935,Intermediate,,,A,N,1,11715,2435.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Striatum,BAO_0000218,
Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,1,CHEMBL623936,Intermediate,,,A,N,1,11716,2046.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,1,CHEMBL623937,Intermediate,,,A,N,1,11717,2046.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,1,CHEMBL623938,Intermediate,,,A,N,1,11718,2046.0,Rattus norvegicus,In vivo,,50597,,14608,10116.0,,Thyroid gland,BAO_0000218,
In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,CHEMBL623939,Intermediate,,,A,N,1,11719,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,1,CHEMBL623940,Intermediate,,,A,N,1,11720,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,CHEMBL623941,Intermediate,,,A,N,1,11721,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL627216,Intermediate,,,A,N,1,11722,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL623942,Intermediate,,,A,N,1,11723,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,CHEMBL618793,Intermediate,,,A,N,1,11724,955.0,Mus musculus,,,50594,,15383,10090.0,,Brain,BAO_0000218,
In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL618794,Intermediate,,,A,N,1,11725,955.0,Mus musculus,,,50594,,15383,10090.0,,Brain,BAO_0000218,
In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL618795,Intermediate,,,A,N,1,11726,955.0,Mus musculus,,,50594,,15383,10090.0,,Brain,BAO_0000218,
In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL618796,Intermediate,,,A,N,1,11727,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL618797,Intermediate,,,A,N,1,11728,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,1,CHEMBL618798,Intermediate,,,A,N,1,11729,2113.0,Mus musculus,,,50594,,15383,10090.0,,Kidney,BAO_0000218,
In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,CHEMBL618799,Intermediate,,,A,N,1,11730,2113.0,Mus musculus,,,50594,,15383,10090.0,,Kidney,BAO_0000218,
In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,1,CHEMBL618800,Intermediate,,,A,N,1,11731,2113.0,Mus musculus,,,50594,,15383,10090.0,,Kidney,BAO_0000218,
In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,CHEMBL618801,Intermediate,,,A,N,1,11732,2113.0,Mus musculus,,,50594,,15383,10090.0,,Kidney,BAO_0000218,
In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL618802,Intermediate,,,A,N,1,11733,2113.0,Mus musculus,,,50594,,15383,10090.0,,Kidney,BAO_0000218,
In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL618803,Intermediate,,,A,N,1,11734,2113.0,Mus musculus,,,50594,,15383,10090.0,,Kidney,BAO_0000218,
In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,1,CHEMBL618804,Intermediate,,,A,N,1,11735,2107.0,Mus musculus,,,50594,,15383,10090.0,,Liver,BAO_0000218,
In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,CHEMBL618805,Intermediate,,,A,N,1,11736,2107.0,Mus musculus,,,50594,,15383,10090.0,,Liver,BAO_0000218,
In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,1,CHEMBL618806,Intermediate,,,A,N,1,11737,2107.0,Mus musculus,,,50594,,15383,10090.0,,Liver,BAO_0000218,
In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,CHEMBL618807,Intermediate,,,A,N,1,11738,2107.0,Mus musculus,,,50594,,15383,10090.0,,Liver,BAO_0000218,
In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL618808,Intermediate,,,A,N,1,11739,2107.0,Mus musculus,,,50594,,15383,10090.0,,Liver,BAO_0000218,
In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL618809,Intermediate,,,A,N,1,11740,2107.0,Mus musculus,,,50594,,15383,10090.0,,Liver,BAO_0000218,
In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,CHEMBL618810,Intermediate,,,A,N,1,11741,2385.0,Mus musculus,,,50594,,15383,10090.0,,Muscle tissue,BAO_0000218,
In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,1,CHEMBL618811,Intermediate,,,A,N,1,11742,2385.0,Mus musculus,,,50594,,15383,10090.0,,Muscle tissue,BAO_0000218,
In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,CHEMBL875844,Intermediate,,,A,N,1,11743,2385.0,Mus musculus,,,50594,,15383,10090.0,,Muscle tissue,BAO_0000218,
In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL618812,Intermediate,,,A,N,1,11744,2385.0,Mus musculus,,,50594,,15383,10090.0,,Muscle tissue,BAO_0000218,
In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL618813,Intermediate,,,A,N,1,11745,2385.0,Mus musculus,,,50594,,15383,10090.0,,Muscle tissue,BAO_0000218,
In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,CHEMBL618814,Intermediate,,,A,N,1,11746,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL618815,Intermediate,,,A,N,1,11747,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL618816,Intermediate,,,A,N,1,11748,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL618817,Intermediate,,,A,N,1,11749,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL620544,Intermediate,,,A,N,1,11750,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,1,CHEMBL626230,Intermediate,,,A,N,1,11751,,Rattus norvegicus,In vivo,,50597,,15341,10116.0,,,BAO_0000218,
The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,1,CHEMBL626231,Intermediate,,,A,N,1,11752,,Rattus norvegicus,In vivo,,50597,,15341,10116.0,,,BAO_0000218,
The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,1,CHEMBL626232,Intermediate,,,A,N,1,11753,,Rattus norvegicus,In vivo,,50597,,15341,10116.0,,,BAO_0000218,
The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,1,CHEMBL626233,Intermediate,,,A,N,1,11754,1969.0,Canis lupus familiaris,In vivo,,50588,,14906,9615.0,,Plasma,BAO_0000218,
The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,1,CHEMBL626234,Intermediate,,,A,N,1,11755,1969.0,Rattus norvegicus,In vivo,,50597,,14906,10116.0,,Plasma,BAO_0000218,
The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,1,CHEMBL875341,Intermediate,,,A,N,1,11756,1969.0,Rattus norvegicus,In vivo,,50597,,14906,10116.0,,Plasma,BAO_0000218,
The maximum plasma concentration (100 mg/kg) administered orally in human,,1,CHEMBL626235,Intermediate,,,A,N,1,11757,1969.0,Homo sapiens,In vivo,,50587,,14215,9606.0,,Plasma,BAO_0000218,
The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,0,CHEMBL626236,Autocuration,,,A,U,1,11758,1969.0,Callithrix,In vivo,,22224,,14215,9481.0,,Plasma,BAO_0000218,
The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,0,CHEMBL626237,Autocuration,,,A,U,1,11759,1969.0,Simiiformes,In vivo,,22224,,14215,314293.0,,Plasma,BAO_0000218,
The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,1,CHEMBL626238,Intermediate,,,A,N,1,11760,1969.0,Canis lupus familiaris,In vivo,,50588,,14215,9615.0,,Plasma,BAO_0000218,
The maximum plasma concentration (200 mg/kg) administered orally in human,,1,CHEMBL622412,Intermediate,,,A,N,1,11761,1969.0,Homo sapiens,In vivo,,50587,,14215,9606.0,,Plasma,BAO_0000218,
The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,1,CHEMBL623114,Intermediate,,,A,N,1,11762,1969.0,Rattus norvegicus,In vivo,,50597,,14215,10116.0,,Plasma,BAO_0000218,
The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,0,CHEMBL623115,Autocuration,,,A,U,1,11763,1969.0,Callithrix,In vivo,,22224,,14215,9481.0,,Plasma,BAO_0000218,
The maximum plasma concentration (25 mg/kg) administered orally in monkey,,0,CHEMBL623116,Autocuration,,,A,U,1,11764,1969.0,Simiiformes,In vivo,,22224,,14215,314293.0,,Plasma,BAO_0000218,
The maximum plasma concentration (30 mg/kg) administered orally in dog,,0,CHEMBL623117,Autocuration,,,A,U,1,11765,1969.0,Canis lupus familiaris,In vivo,,22224,,14215,9615.0,,Plasma,BAO_0000218,
The maximum plasma concentration (400 mg/kg) administered orally in human,,1,CHEMBL623118,Intermediate,,,A,N,1,11766,1969.0,Homo sapiens,In vivo,,50587,,14215,9606.0,,Plasma,BAO_0000218,
The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,1,CHEMBL623119,Intermediate,,,A,N,1,11767,1969.0,Rattus norvegicus,In vivo,,50597,,14215,10116.0,,Plasma,BAO_0000218,
The maximum plasma concentration (50 mg/kg) administered orally in rat,,1,CHEMBL623120,Intermediate,,,A,N,1,11768,1969.0,Rattus norvegicus,In vivo,,50597,,14215,10116.0,,Plasma,BAO_0000218,
The maximum plasma concentration (800 mg/kg) administered orally in human,,1,CHEMBL623286,Intermediate,,,A,N,1,11769,1969.0,Homo sapiens,In vivo,,50587,,14215,9606.0,,Plasma,BAO_0000218,
The maximum plasma concentration was measured on rats,,1,CHEMBL623287,Intermediate,,,A,N,1,11770,1969.0,Rattus norvegicus,In vivo,,50597,,14067,10116.0,,Plasma,BAO_0000218,
The maximum plasma concentration was measured on rats after oral administration,,1,CHEMBL623288,Intermediate,,,A,N,1,11771,1969.0,Rattus norvegicus,In vivo,,50597,,12350,10116.0,,Plasma,BAO_0000218,
Plasma drug Cmax in rat (PO dose),,1,CHEMBL623289,Intermediate,,,A,N,1,11772,1969.0,Rattus norvegicus,In vivo,,50597,,14813,10116.0,,Plasma,BAO_0000218,
Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,0,CHEMBL623290,Autocuration,,,A,U,1,11773,,,In vivo,,22224,,12536,,,,BAO_0000218,
maximum Plasma concentration in Dog was determined after Peroral administration,,1,CHEMBL623291,Intermediate,,,A,N,1,11774,1969.0,Canis lupus familiaris,In vivo,,50588,,14169,9615.0,,Plasma,BAO_0000218,
maximum Plasma concentration in Rats was determined after Peroral administration,,1,CHEMBL623292,Intermediate,,,A,N,1,11775,1969.0,Rattus norvegicus,In vivo,,50597,,14169,10116.0,,Plasma,BAO_0000218,
maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,1,CHEMBL623293,Intermediate,,,A,N,1,11776,1969.0,Canis lupus familiaris,In vivo,,50588,,15604,9615.0,,Plasma,BAO_0000218,
maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,0,CHEMBL623294,Autocuration,,,A,U,1,11777,1969.0,Simiiformes,In vivo,,22224,,15604,314293.0,,Plasma,BAO_0000218,
maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,1,CHEMBL623295,Intermediate,,,A,N,1,11778,1969.0,Rattus norvegicus,In vivo,,50597,,15604,10116.0,,Plasma,BAO_0000218,
maximum concentration was measured when administered through oral route in mice,,1,CHEMBL623296,Intermediate,,,A,N,1,11779,,Mus musculus,In vivo,,50594,,14387,10090.0,,,BAO_0000218,
Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,1,CHEMBL875349,Intermediate,,,A,N,1,11780,,Mus musculus,,,50594,,15115,10090.0,,,BAO_0000218,
Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,0,CHEMBL623297,Autocuration,,,A,U,1,11781,,Simiiformes,,,22224,,15115,314293.0,,,BAO_0000019,
Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,0,CHEMBL623298,Autocuration,,,A,U,1,11782,,Simiiformes,,,22224,,15115,314293.0,,,BAO_0000019,
Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,0,CHEMBL623299,Autocuration,,,A,U,1,11783,,Simiiformes,,,22224,,15115,314293.0,,,BAO_0000019,
Pharmacokinetic parameter was evaluated in rats,,1,CHEMBL623300,Intermediate,,,A,N,1,11784,,Rattus norvegicus,,,50597,,16359,10116.0,,,BAO_0000218,
Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,1,CHEMBL623301,Intermediate,,,A,N,1,11785,,Mus musculus,,,50594,,12829,10090.0,,,BAO_0000218,
Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,1,CHEMBL623302,Intermediate,,,A,N,1,11786,,Mus musculus,,,50594,,12829,10090.0,,,BAO_0000218,
Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,1,CHEMBL623303,Intermediate,,,A,N,1,11787,,Mus musculus,,,50594,,12829,10090.0,,,BAO_0000218,
Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,1,CHEMBL623304,Intermediate,,,A,N,1,11788,,Mus musculus,,,50594,,12829,10090.0,,,BAO_0000218,
Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,1,CHEMBL623305,Intermediate,,,A,N,1,11789,,Mus musculus,,,50594,,12829,10090.0,,,BAO_0000218,
Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,1,CHEMBL623306,Intermediate,,,A,N,1,11790,1969.0,Rattus norvegicus,,,50597,,15137,10116.0,,Plasma,BAO_0000218,
Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,1,CHEMBL623307,Intermediate,,,A,N,1,11791,1969.0,Rattus norvegicus,,,50597,,15137,10116.0,,Plasma,BAO_0000218,
Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,1,CHEMBL623308,Intermediate,,,A,N,1,11792,1969.0,Rattus norvegicus,,,50597,,15137,10116.0,,Plasma,BAO_0000218,
Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,1,CHEMBL623309,Intermediate,,,A,N,1,11793,1969.0,Mus musculus,,,50594,,15137,10090.0,,Plasma,BAO_0000218,
Plasma Concentration after 120 min of oral administration to mice,,1,CHEMBL623310,Intermediate,,,A,N,1,11794,,Mus musculus,,,50594,,13509,10090.0,,,BAO_0000218,
Plasma Concentration after 30 min of oral administration to mice,,1,CHEMBL623311,Intermediate,,,A,N,1,11795,,Mus musculus,,,50594,,13509,10090.0,,,BAO_0000218,
Plasma Concentration after 60 min of oral administration to mice,,1,CHEMBL623312,Intermediate,,,A,N,1,11796,,Macaca fascicularis,,,100710,,13509,9541.0,,,BAO_0000218,
Plasma Concentration after 60 min of oral administration to mice; Not determined,,1,CHEMBL875350,Intermediate,,,A,N,1,11797,,Mus musculus,,,50594,,13509,10090.0,,,BAO_0000218,
Plasma Concentration after 90 min of oral administration to mice,,1,CHEMBL628635,Intermediate,,,A,N,1,11798,,Mus musculus,,,50594,,13509,10090.0,,,BAO_0000218,
Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,1,CHEMBL628636,Intermediate,,,A,N,1,11799,,Rattus norvegicus,,,50597,,12064,10116.0,,,BAO_0000218,
Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,1,CHEMBL628637,Intermediate,,,A,N,1,11800,,Rattus norvegicus,,,50597,,12064,10116.0,,,BAO_0000218,
Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,1,CHEMBL628058,Intermediate,,,A,N,1,11801,,Rattus norvegicus,,,50597,,12064,10116.0,,,BAO_0000218,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,1,CHEMBL628059,Intermediate,,,A,N,1,11802,,Rattus norvegicus,,,50597,,10677,10116.0,,,BAO_0000218,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,1,CHEMBL628060,Intermediate,,,A,N,1,11803,,Rattus norvegicus,,,50597,,10677,10116.0,,,BAO_0000218,
Distribution in the lung after 15 min of intravenous administration,,0,CHEMBL628061,Autocuration,,,A,U,1,11804,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the lung after 30 min of intravenous administration,,0,CHEMBL628062,Autocuration,,,A,U,1,11805,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the lung after 5 min of intravenous administration,,0,CHEMBL628063,Autocuration,,,A,U,1,11806,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the lung after 60 min of intravenous administration,,0,CHEMBL628064,Autocuration,,,A,U,1,11807,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the lung after 90 min of intravenous administration,,0,CHEMBL628065,Autocuration,,,A,U,1,11808,,,,,22224,,8926,,,,BAO_0000019,
Distribution in the muscle after 120 min of intravenous administration,,0,CHEMBL628066,Autocuration,,,A,U,1,11809,2385.0,,,,22224,,8926,,,Muscle tissue,BAO_0000019,
Distribution in the muscle after 15 min of intravenous administration,,0,CHEMBL628067,Autocuration,,,A,U,1,11810,2385.0,,,,22224,,8926,,,Muscle tissue,BAO_0000019,
Distribution in the muscle after 30 min of intravenous administration,,1,CHEMBL874646,Intermediate,,,A,N,1,11811,2385.0,Mus musculus,,,50594,,8926,10090.0,,Muscle tissue,BAO_0000218,
Distribution in the muscle after 5 min of intravenous administration,,0,CHEMBL628068,Autocuration,,,A,U,1,11812,2385.0,,,,22224,,8926,,,Muscle tissue,BAO_0000019,
Distribution in the muscle after 60 min of intravenous administration,,0,CHEMBL628069,Autocuration,,,A,U,1,11813,2385.0,,,,22224,,8926,,,Muscle tissue,BAO_0000019,
Distribution in the muscle after 90 min of intravenous administration,,0,CHEMBL628070,Autocuration,,,A,U,1,11814,2385.0,,,,22224,,8926,,,Muscle tissue,BAO_0000019,
Distribution in the spleen after 120 min of intravenous administration,,0,CHEMBL628071,Autocuration,,,A,U,1,11815,2106.0,,,,22224,,8926,,,Spleen,BAO_0000019,
Distribution in the spleen after 15 min of intravenous administration,,0,CHEMBL628072,Autocuration,,,A,U,1,11816,2106.0,,,,22224,,8926,,,Spleen,BAO_0000019,
Distribution in the spleen after 30 min of intravenous administration,,0,CHEMBL628073,Autocuration,,,A,U,1,11817,2106.0,,,,22224,,8926,,,Spleen,BAO_0000019,
Distribution in the spleen after 5 min of intravenous administration,,0,CHEMBL628074,Autocuration,,,A,U,1,11818,2106.0,,,,22224,,8926,,,Spleen,BAO_0000019,
Distribution in the spleen after 60 min of intravenous administration,,0,CHEMBL628075,Autocuration,,,A,U,1,11819,2106.0,,,,22224,,8926,,,Spleen,BAO_0000019,
Distribution in the spleen after 90 min of intravenous administration,,0,CHEMBL628076,Autocuration,,,A,U,1,11820,2106.0,,,,22224,,8926,,,Spleen,BAO_0000019,
Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,1,CHEMBL628077,Intermediate,,,A,N,1,11821,1235.0,Rattus norvegicus,,,50597,,7570,10116.0,,Adrenal cortex,BAO_0000218,
Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,1,CHEMBL628078,Intermediate,,,A,N,1,11822,178.0,Rattus norvegicus,,,50597,,7570,10116.0,,Blood,BAO_0000218,
Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,1,CHEMBL628079,Intermediate,,,A,N,1,11823,2107.0,Rattus norvegicus,,,50597,,7570,10116.0,,Liver,BAO_0000218,
Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,1,CHEMBL628080,Intermediate,,,A,N,1,11824,992.0,Rattus norvegicus,,,50597,,7570,10116.0,,Female gonad,BAO_0000218,
Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,1,CHEMBL628081,Intermediate,,,A,N,1,11825,2046.0,Rattus norvegicus,,,50597,,7570,10116.0,,Thyroid gland,BAO_0000218,
Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,1,CHEMBL628082,Intermediate,,,A,N,1,11826,1235.0,Rattus norvegicus,,,50597,,7570,10116.0,,Adrenal cortex,BAO_0000218,
Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,1,CHEMBL874647,Intermediate,,,A,N,1,11827,178.0,Rattus norvegicus,,,50597,,7570,10116.0,,Blood,BAO_0000218,
Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,1,CHEMBL626406,Intermediate,,,A,N,1,11828,2107.0,Rattus norvegicus,,,50597,,7570,10116.0,,Liver,BAO_0000218,
Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,1,CHEMBL626407,Intermediate,,,A,N,1,11829,992.0,Rattus norvegicus,,,50597,,7570,10116.0,,Female gonad,BAO_0000218,
Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,1,CHEMBL626408,Intermediate,,,A,N,1,11830,2046.0,Rattus norvegicus,,,50597,,7570,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,1,CHEMBL626409,Intermediate,,,A,N,1,11831,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,1,CHEMBL626410,Intermediate,,,A,N,1,11832,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,1,CHEMBL626411,Intermediate,,,A,N,1,11833,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,1,CHEMBL626412,Intermediate,,,A,N,1,11834,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,1,CHEMBL626413,Intermediate,,,A,N,1,11835,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,1,CHEMBL626414,Intermediate,,,A,N,1,11836,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,1,CHEMBL626415,Intermediate,,,A,N,1,11837,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,1,CHEMBL626416,Intermediate,,,A,N,1,11838,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,1,CHEMBL627062,Intermediate,,,A,N,1,11839,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,1,CHEMBL627063,Intermediate,,,A,N,1,11840,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,1,CHEMBL627064,Intermediate,,,A,N,1,11841,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,1,CHEMBL627227,Intermediate,,,A,N,1,11842,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,1,CHEMBL627228,Intermediate,,,A,N,1,11843,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,1,CHEMBL627229,Intermediate,,,A,N,1,11844,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,1,CHEMBL625792,Intermediate,,,A,N,1,11845,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,1,CHEMBL625793,Intermediate,,,A,N,1,11846,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,1,CHEMBL625794,Intermediate,,,A,N,1,11847,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,1,CHEMBL625795,Intermediate,,,A,N,1,11848,178.0,Rattus norvegicus,,,50597,,8608,10116.0,,Blood,BAO_0000218,
Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,1,CHEMBL625796,Intermediate,,,A,N,1,11849,,Mus musculus,,,50594,,13792,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,1,CHEMBL625797,Intermediate,,,A,N,1,11850,,Canis lupus familiaris,,,50588,,13376,9615.0,,,BAO_0000218,
Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,1,CHEMBL625798,Intermediate,,,A,N,1,11851,,Canis lupus familiaris,,,50588,,13376,9615.0,,,BAO_0000218,
Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,CHEMBL875613,Autocuration,,,A,U,1,11852,,,,,22224,,14380,,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,CHEMBL625799,Autocuration,,,A,U,1,11853,,,,,22224,,14380,,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,0,CHEMBL625800,Autocuration,,,A,U,1,11854,,,,,22224,,14380,,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,0,CHEMBL625801,Autocuration,,,A,U,1,11855,,,,,22224,,14380,,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,0,CHEMBL625802,Autocuration,,,A,U,1,11856,,,,,22224,,14380,,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,0,CHEMBL625803,Autocuration,,,A,U,1,11857,,,,,22224,,14380,,,,BAO_0000218,
Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,0,CHEMBL625804,Autocuration,,,A,U,1,11858,,,,,22224,,14380,,,,BAO_0000019,
Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,0,CHEMBL622530,Autocuration,,,A,U,1,11859,,,,,22224,,14380,,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,1,CHEMBL622531,Intermediate,,,A,N,1,11860,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,1,CHEMBL622532,Intermediate,,,A,N,1,11861,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,1,CHEMBL623176,Intermediate,,,A,N,1,11862,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,1,CHEMBL623177,Intermediate,,,A,N,1,11863,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,1,CHEMBL623178,Intermediate,,,A,N,1,11864,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,1,CHEMBL623179,Intermediate,,,A,N,1,11865,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,1,CHEMBL623180,Intermediate,,,A,N,1,11866,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,1,CHEMBL623181,Intermediate,,,A,N,1,11867,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,1,CHEMBL624131,Intermediate,,,A,N,1,11868,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,1,CHEMBL624132,Intermediate,,,A,N,1,11869,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,1,CHEMBL624133,Intermediate,,,A,N,1,11870,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,1,CHEMBL624846,Intermediate,,,A,N,1,11871,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,1,CHEMBL624847,Intermediate,,,A,N,1,11872,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,1,CHEMBL624848,Intermediate,,,A,N,1,11873,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,1,CHEMBL625012,Intermediate,,,A,N,1,11874,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,1,CHEMBL625013,Intermediate,,,A,N,1,11875,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,1,CHEMBL625014,Intermediate,,,A,N,1,11876,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,1,CHEMBL625015,Intermediate,,,A,N,1,11877,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,1,CHEMBL625016,Intermediate,,,A,N,1,11878,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,1,CHEMBL625017,Intermediate,,,A,N,1,11879,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,1,CHEMBL625018,Intermediate,,,A,N,1,11880,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,1,CHEMBL625019,Intermediate,,,A,N,1,11881,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,1,CHEMBL625020,Intermediate,,,A,N,1,11882,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,1,CHEMBL625021,Intermediate,,,A,N,1,11883,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,CHEMBL625022,Intermediate,,,A,N,1,11884,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,1,CHEMBL625023,Intermediate,,,A,N,1,11885,,Mus musculus,,,50594,,14731,10090.0,,,BAO_0000218,
Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,1,CHEMBL625024,Intermediate,,,A,N,1,11886,,Macaca fascicularis,,,100710,,14731,9541.0,,,BAO_0000218,
Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,1,CHEMBL627626,Intermediate,,,A,N,1,11887,,Macaca fascicularis,,,100710,,14731,9541.0,,,BAO_0000218,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,0,CHEMBL627627,Autocuration,,,A,U,1,11888,955.0,,,,22224,,13758,,,Brain,BAO_0000218,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,0,CHEMBL627628,Autocuration,,,A,U,1,11889,1977.0,,,,22224,,13758,,,Serum,BAO_0000218,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,0,CHEMBL627629,Autocuration,,,A,U,1,11890,955.0,,,,22224,,13758,,,Brain,BAO_0000218,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,0,CHEMBL627630,Autocuration,,,A,U,1,11891,1977.0,,,,22224,,13758,,,Serum,BAO_0000218,
Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,0,CHEMBL627631,Autocuration,,,A,U,1,11892,,,,,22224,,16359,,,,BAO_0000019,
Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,0,CHEMBL629515,Autocuration,,,A,U,1,11893,,,,,22224,,16359,,,,BAO_0000218,
In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,CHEMBL629516,Intermediate,,,A,N,1,11894,2106.0,Mus musculus,,,50594,,15383,10090.0,,Spleen,BAO_0000218,
In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL629517,Intermediate,,,A,N,1,11895,2106.0,Mus musculus,,,50594,,15383,10090.0,,Spleen,BAO_0000218,
In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL629518,Intermediate,,,A,N,1,11896,2106.0,Mus musculus,,,50594,,15383,10090.0,,Spleen,BAO_0000218,
In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,CHEMBL877499,Intermediate,,,A,N,1,11897,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,CHEMBL629519,Intermediate,,,A,N,1,11898,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,CHEMBL629520,Intermediate,,,A,N,1,11899,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,CHEMBL629521,Intermediate,,,A,N,1,11900,,Mus musculus,,,50594,,15383,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,1,CHEMBL629522,Intermediate,,,A,N,1,11901,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,1,CHEMBL629523,Intermediate,,,A,N,1,11902,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,1,CHEMBL629524,Intermediate,,,A,N,1,11903,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,1,CHEMBL629525,Intermediate,,,A,N,1,11904,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,1,CHEMBL629526,Intermediate,,,A,N,1,11905,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,1,CHEMBL629527,Intermediate,,,A,N,1,11906,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,1,CHEMBL629528,Intermediate,,,A,N,1,11907,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,1,CHEMBL629529,Intermediate,,,A,N,1,11908,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,1,CHEMBL629530,Intermediate,,,A,N,1,11909,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,1,CHEMBL629531,Intermediate,,,A,N,1,11910,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,1,CHEMBL628656,Intermediate,,,A,N,1,11911,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,1,CHEMBL628657,Intermediate,,,A,N,1,11912,,Mus musculus,,,50594,,14439,10090.0,,,BAO_0000218,
"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL628658,Intermediate,,,A,N,1,11913,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL628659,Intermediate,,,A,N,1,11914,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL877500,Intermediate,,,A,N,1,11915,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL628660,Intermediate,,,A,N,1,11916,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL628661,Intermediate,,,A,N,1,11917,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL628662,Intermediate,,,A,N,1,11918,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL628663,Intermediate,,,A,N,1,11919,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL628664,Intermediate,,,A,N,1,11920,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL628665,Intermediate,,,A,N,1,11921,178.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Blood,BAO_0000218,
"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL628666,Intermediate,,,A,N,1,11922,178.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Blood,BAO_0000218,
"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL628667,Intermediate,,,A,N,1,11923,178.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Blood,BAO_0000218,
"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL628668,Intermediate,,,A,N,1,11924,178.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Blood,BAO_0000218,
"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL628669,Intermediate,,,A,N,1,11925,178.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Blood,BAO_0000218,
"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL628670,Intermediate,,,A,N,1,11926,178.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Blood,BAO_0000218,
"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL628671,Intermediate,,,A,N,1,11927,178.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Blood,BAO_0000218,
"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL628672,Intermediate,,,A,N,1,11928,10000001.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Bone,BAO_0000218,
"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL630300,Intermediate,,,A,N,1,11929,10000001.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Bone,BAO_0000218,
"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL629787,Intermediate,,,A,N,1,11930,10000001.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Bone,BAO_0000218,
"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL629788,Intermediate,,,A,N,1,11931,10000001.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Bone,BAO_0000218,
"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL629789,Intermediate,,,A,N,1,11932,955.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Brain,BAO_0000218,
"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL629790,Intermediate,,,A,N,1,11933,955.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Brain,BAO_0000218,
"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL629791,Intermediate,,,A,N,1,11934,955.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Brain,BAO_0000218,
"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL629792,Intermediate,,,A,N,1,11935,955.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Brain,BAO_0000218,
"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL629793,Intermediate,,,A,N,1,11936,955.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Brain,BAO_0000218,
"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL629794,Intermediate,,,A,N,1,11937,955.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Brain,BAO_0000218,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,1,CHEMBL874459,Intermediate,,,A,N,1,11938,,Rattus norvegicus,,,50597,,10677,10116.0,,,BAO_0000218,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,1,CHEMBL629795,Intermediate,,,A,N,1,11939,,Rattus norvegicus,,,50597,,10677,10116.0,,,BAO_0000218,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,1,CHEMBL629796,Intermediate,,,A,N,1,11940,,Rattus norvegicus,,,50597,,10677,10116.0,,,BAO_0000218,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,1,CHEMBL629797,Intermediate,,,A,N,1,11941,,Rattus norvegicus,,,50597,,10677,10116.0,,,BAO_0000218,
Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,1,CHEMBL629798,Intermediate,,,A,N,1,11942,,Rattus norvegicus,,,50597,,10677,10116.0,,,BAO_0000218,
Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL629799,Intermediate,,,A,N,1,11943,2369.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Adrenal gland,BAO_0000218,
Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629800,Intermediate,,,A,N,1,11944,2369.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Adrenal gland,BAO_0000218,
Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629801,Intermediate,,,A,N,1,11945,2369.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Adrenal gland,BAO_0000218,
Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,1,CHEMBL629802,Intermediate,,,A,N,1,11946,2369.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Adrenal gland,BAO_0000218,
Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629803,Intermediate,,,A,N,1,11947,2369.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Adrenal gland,BAO_0000218,
Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL629804,Intermediate,,,A,N,1,11948,178.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Blood,BAO_0000218,
Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629805,Intermediate,,,A,N,1,11949,178.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Blood,BAO_0000218,
Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,1,CHEMBL629806,Intermediate,,,A,N,1,11950,178.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Blood,BAO_0000218,
Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629807,Intermediate,,,A,N,1,11951,178.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Blood,BAO_0000218,
Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629808,Intermediate,,,A,N,1,11952,178.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Blood,BAO_0000218,
Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL629809,Intermediate,,,A,N,1,11953,955.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Brain,BAO_0000218,
Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629810,Intermediate,,,A,N,1,11954,955.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Brain,BAO_0000218,
Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,1,CHEMBL629811,Intermediate,,,A,N,1,11955,955.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Brain,BAO_0000218,
Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629812,Intermediate,,,A,N,1,11956,955.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Brain,BAO_0000218,
Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,1,CHEMBL629813,Intermediate,,,A,N,1,11957,955.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Brain,BAO_0000218,
Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL874460,Intermediate,,,A,N,1,11958,955.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Brain,BAO_0000218,
Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL629814,Intermediate,,,A,N,1,11959,,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,,BAO_0000218,
Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629815,Intermediate,,,A,N,1,11960,,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,,BAO_0000218,
Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629816,Intermediate,,,A,N,1,11961,,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,,BAO_0000218,
Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL629817,Intermediate,,,A,N,1,11962,,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,,BAO_0000218,
Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL626643,Intermediate,,,A,N,1,11963,2113.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Kidney,BAO_0000218,
Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL626644,Intermediate,,,A,N,1,11964,2113.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Kidney,BAO_0000218,
Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL626806,Intermediate,,,A,N,1,11965,2113.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Kidney,BAO_0000218,
Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL626807,Intermediate,,,A,N,1,11966,2113.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Kidney,BAO_0000218,
Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL627261,Intermediate,,,A,N,1,11967,2107.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Liver,BAO_0000218,
Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627262,Intermediate,,,A,N,1,11968,2107.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Liver,BAO_0000218,
Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627263,Intermediate,,,A,N,1,11969,2107.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Liver,BAO_0000218,
Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627264,Intermediate,,,A,N,1,11970,2107.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Liver,BAO_0000218,
Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL627265,Intermediate,,,A,N,1,11971,2048.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Lung,BAO_0000218,
Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627266,Intermediate,,,A,N,1,11972,2048.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Lung,BAO_0000218,
Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627267,Intermediate,,,A,N,1,11973,2048.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Lung,BAO_0000218,
Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627268,Intermediate,,,A,N,1,11974,2048.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Lung,BAO_0000218,
Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL627269,Intermediate,,,A,N,1,11975,2385.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627270,Intermediate,,,A,N,1,11976,2385.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Muscle tissue,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,1,CHEMBL627271,Intermediate,,,A,N,1,11977,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,1,CHEMBL627946,Intermediate,,,A,N,1,11978,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,1,CHEMBL875472,Intermediate,,,A,N,1,11979,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,1,CHEMBL627947,Intermediate,,,A,N,1,11980,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,1,CHEMBL627948,Intermediate,,,A,N,1,11981,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,1,CHEMBL628113,Intermediate,,,A,N,1,11982,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,1,CHEMBL628114,Intermediate,,,A,N,1,11983,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,1,CHEMBL628115,Intermediate,,,A,N,1,11984,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,1,CHEMBL628116,Intermediate,,,A,N,1,11985,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,1,CHEMBL628117,Intermediate,,,A,N,1,11986,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,1,CHEMBL628118,Intermediate,,,A,N,1,11987,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,1,CHEMBL628119,Intermediate,,,A,N,1,11988,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,1,CHEMBL628120,Intermediate,,,A,N,1,11989,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,1,CHEMBL628121,Intermediate,,,A,N,1,11990,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,1,CHEMBL628122,Intermediate,,,A,N,1,11991,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,1,CHEMBL627297,Intermediate,,,A,N,1,11992,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,1,CHEMBL627298,Intermediate,,,A,N,1,11993,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,1,CHEMBL627299,Intermediate,,,A,N,1,11994,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,1,CHEMBL627300,Intermediate,,,A,N,1,11995,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,1,CHEMBL627301,Intermediate,,,A,N,1,11996,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,1,CHEMBL627302,Intermediate,,,A,N,1,11997,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,1,CHEMBL627303,Intermediate,,,A,N,1,11998,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,1,CHEMBL627304,Intermediate,,,A,N,1,11999,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,1,CHEMBL627305,Intermediate,,,A,N,1,12000,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,1,CHEMBL627306,Intermediate,,,A,N,1,12001,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,1,CHEMBL623982,Intermediate,,,A,N,1,12002,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,1,CHEMBL623983,Intermediate,,,A,N,1,12003,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,1,CHEMBL623984,Intermediate,,,A,N,1,12004,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,1,CHEMBL623985,Intermediate,,,A,N,1,12005,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,1,CHEMBL623986,Intermediate,,,A,N,1,12006,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,1,CHEMBL623987,Intermediate,,,A,N,1,12007,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,1,CHEMBL623988,Intermediate,,,A,N,1,12008,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,1,CHEMBL623989,Intermediate,,,A,N,1,12009,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,1,CHEMBL622215,Intermediate,,,A,N,1,12010,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,1,CHEMBL622216,Intermediate,,,A,N,1,12011,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,1,CHEMBL877481,Intermediate,,,A,N,1,12012,,Rattus norvegicus,,,50597,,8608,10116.0,,,BAO_0000218,
Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,0,CHEMBL622217,Autocuration,,,A,U,1,12013,,,,,22224,,16359,,,,BAO_0000218,
Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,1,CHEMBL622218,Intermediate,,,A,N,1,12014,,Mus musculus,,,50594,,13701,10090.0,,,BAO_0000218,
Pharmacokinetic profile AUC was evaluated in rats,,1,CHEMBL622219,Intermediate,,,A,N,1,12015,,Rattus norvegicus,,,50597,,14554,10116.0,,,BAO_0000218,
Pharmacokinetic property (Area under curve),,0,CHEMBL622220,Autocuration,,,A,U,1,12016,,,,,22224,,6241,,,,BAO_0000019,
"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,1,CHEMBL622221,Intermediate,,,A,N,1,12017,,Canis lupus familiaris,,,50588,,11537,9615.0,,,BAO_0000218,
"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,1,CHEMBL622222,Intermediate,,,A,N,1,12018,,Mus musculus,,,50594,,11537,10090.0,,,BAO_0000218,
"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,1,CHEMBL622223,Intermediate,,,A,N,1,12019,,Canis lupus familiaris,,,50588,,11537,9615.0,,,BAO_0000218,
"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,1,CHEMBL622224,Intermediate,,,A,N,1,12020,,Mus musculus,,,50594,,11537,10090.0,,,BAO_0000218,
Plasma concentration (AUC) was determined,,0,CHEMBL622225,Autocuration,,,A,U,1,12021,,,,,22224,,13118,,,,BAO_0000019,
Plasma concentration (AUC) was determined; Not detectable,,0,CHEMBL622226,Autocuration,,,A,U,1,12022,,,,,22224,,13118,,,,BAO_0000019,
Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,1,CHEMBL624154,Intermediate,,,A,N,1,12023,,Cavia porcellus,,,50512,,9562,10141.0,,,BAO_0000218,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,1,CHEMBL624155,Intermediate,,,A,N,1,12024,,Rattus norvegicus,,,50597,,10363,10116.0,,,BAO_0000218,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,1,CHEMBL624156,Intermediate,,,A,N,1,12025,,Rattus norvegicus,,,50597,,10363,10116.0,,,BAO_0000218,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,1,CHEMBL624157,Intermediate,,,A,N,1,12026,,Rattus norvegicus,,,50597,,10363,10116.0,,,BAO_0000218,
Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,1,CHEMBL624158,Intermediate,,,A,N,1,12027,,Rattus norvegicus,,,50597,,10363,10116.0,,,BAO_0000218,
Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,1,CHEMBL624159,Intermediate,,,A,N,1,12028,,Rattus norvegicus,,,50597,,12504,10116.0,,,BAO_0000218,
Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,1,CHEMBL624160,Intermediate,,,A,N,1,12029,,Rattus norvegicus,,,50597,,12504,10116.0,,,BAO_0000218,
Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,1,CHEMBL624161,Intermediate,,,A,N,1,12030,,Rattus norvegicus,,,50597,,12504,10116.0,,,BAO_0000218,
Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,1,CHEMBL624162,Intermediate,,,A,N,1,12031,,Rattus norvegicus,,,50597,,12504,10116.0,,,BAO_0000218,
Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,1,CHEMBL624163,Intermediate,,,A,N,1,12032,,Canis lupus familiaris,,,50588,,13317,9615.0,,,BAO_0000218,
"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL624164,Intermediate,,,A,N,1,12033,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
The AUC(0-infinity) values in female wistar rats.,,1,CHEMBL624165,Intermediate,,,A,N,1,12034,,Rattus norvegicus,,,50597,,14941,10116.0,,,BAO_0000218,
"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL624166,Intermediate,,,A,N,1,12035,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,1,CHEMBL624167,Intermediate,,,A,N,1,12036,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
The AUC(0-t)values in female wistar rats.,,1,CHEMBL624168,Intermediate,,,A,N,1,12037,,Rattus norvegicus,,,50597,,14941,10116.0,,,BAO_0000218,
The Area under the concentration time curve of compound was measured on rats,,1,CHEMBL624169,Intermediate,,,A,N,1,12038,,Rattus norvegicus,,,50597,,14067,10116.0,,,BAO_0000218,
The area under curve (100 mg/kg) administered orally in humans,,1,CHEMBL624170,Intermediate,,,A,N,1,12039,,Homo sapiens,,,50587,,14215,9606.0,,,BAO_0000218,
The area under curve (12.5 mg/kg) administered intravenously in marmoset,,0,CHEMBL624171,Autocuration,,,A,U,1,12040,,Callithrix,,,22224,,14215,9481.0,,,BAO_0000218,
The area under curve (12.5 mg/kg) administered intravenously in monkey,,0,CHEMBL624172,Autocuration,,,A,U,1,12041,,Simiiformes,,,22224,,14215,314293.0,,,BAO_0000218,
The area under curve (15 mg/kg) administered intravenously in dog,,1,CHEMBL624173,Intermediate,,,A,N,1,12042,,Canis lupus familiaris,,,50588,,14215,9615.0,,,BAO_0000218,
The area under curve (200 mg/kg) administered orally in humans,,1,CHEMBL877488,Intermediate,,,A,N,1,12043,,Homo sapiens,,,50587,,14215,9606.0,,,BAO_0000218,
The area under curve (25 mg/kg) administered intravenously in rat,,1,CHEMBL624174,Intermediate,,,A,N,1,12044,,Rattus norvegicus,,,50597,,14215,10116.0,,,BAO_0000218,
The area under curve (25 mg/kg) administered orally in marmoset,,0,CHEMBL624175,Autocuration,,,A,U,1,12045,,Callithrix,,,22224,,14215,9481.0,,,BAO_0000218,
The area under curve (25 mg/kg) administered orally in monkey,,0,CHEMBL624176,Autocuration,,,A,U,1,12046,,Simiiformes,,,22224,,14215,314293.0,,,BAO_0000218,
The area under curve (30 mg/kg) administered orally in dog,,1,CHEMBL624177,Intermediate,,,A,N,1,12047,,Canis lupus familiaris,,,50588,,14215,9615.0,,,BAO_0000218,
The area under curve (400 mg/kg) administered orally in humans,,1,CHEMBL624178,Intermediate,,,A,N,1,12048,,Homo sapiens,,,50587,,14215,9606.0,,,BAO_0000218,
The area under curve (50 mg/kg) administered orally in fasted rat,,1,CHEMBL624179,Intermediate,,,A,N,1,12049,,Rattus norvegicus,,,50597,,14215,10116.0,,,BAO_0000218,
The area under curve (50 mg/kg) administered orally in rat,,1,CHEMBL627689,Intermediate,,,A,N,1,12050,,Rattus norvegicus,,,50597,,14215,10116.0,,,BAO_0000218,
The area under curve (800 mg/kg) administered orally in humans,,1,CHEMBL627690,Intermediate,,,A,N,1,12051,,Homo sapiens,,,50587,,14215,9606.0,,,BAO_0000218,
The compound was evaluated for area under the curve,,0,CHEMBL627691,Autocuration,,,A,U,1,12052,,,,,22224,,11324,,,,BAO_0000019,
The compound was evaluated for area under the curve in marmosets,,0,CHEMBL627692,Autocuration,,,A,U,1,12053,,Callithrix,,,22224,,11324,9481.0,,,BAO_0000019,
The compound was evaluated for area under the curve in marmosets,,0,CHEMBL627693,Autocuration,,,A,U,1,12054,,Callithrix,,,22224,,11324,9481.0,,,BAO_0000019,
The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,1,CHEMBL627694,Intermediate,,,A,N,1,12055,,Rattus norvegicus,,,50597,,13875,10116.0,,,BAO_0000218,
The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,1,CHEMBL627695,Intermediate,,,A,N,1,12056,,Rattus norvegicus,,,50597,,13875,10116.0,,,BAO_0000218,
The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,0,CHEMBL627696,Autocuration,,,A,U,1,12057,,,,,22224,,13875,,,,BAO_0000218,
The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,1,CHEMBL627697,Intermediate,,,A,N,1,12058,,Rattus norvegicus,,,50597,,13875,10116.0,,,BAO_0000218,
The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,1,CHEMBL627698,Intermediate,,,A,N,1,12059,,Rattus norvegicus,,,50597,,13875,10116.0,,,BAO_0000218,
The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,1,CHEMBL627699,Intermediate,,,A,N,1,12060,,Rattus norvegicus,,,50597,,13875,10116.0,,,BAO_0000218,
Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,1,CHEMBL627700,Intermediate,,,A,N,1,12061,,Rattus norvegicus,,,50597,,13807,10116.0,,,BAO_0000218,
Total drug exposure is determined after oral dosing in rats.,,1,CHEMBL627701,Intermediate,,,A,N,1,12062,,Rattus norvegicus,,,50597,,14127,10116.0,,,BAO_0000218,
Total drug exposure (5 mg/kg) when administered intravenously,,0,CHEMBL627702,Autocuration,,,A,U,1,12063,,,,,22224,,15116,,,,BAO_0000218,
Total drug exposure (5 mg/kg) when administered orally,,0,CHEMBL627703,Autocuration,,,A,U,1,12064,,,,,22224,,15116,,,,BAO_0000218,
area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,0,CHEMBL626873,Autocuration,,,A,U,1,12065,,Simiiformes,,,22224,,15604,314293.0,,,BAO_0000218,
area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,1,CHEMBL629583,Intermediate,,,A,N,1,12066,,Rattus norvegicus,,,50597,,15604,10116.0,,,BAO_0000218,
area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,1,CHEMBL629584,Intermediate,,,A,N,1,12067,,Canis lupus familiaris,,,50588,,15604,9615.0,,,BAO_0000218,
area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,1,CHEMBL629585,Intermediate,,,A,N,1,12068,,Canis lupus familiaris,,,50588,,15604,9615.0,,,BAO_0000218,
"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL629586,Intermediate,,,A,N,1,12069,955.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Brain,BAO_0000218,
"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL629587,Intermediate,,,A,N,1,12070,955.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Brain,BAO_0000218,
"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL629588,Intermediate,,,A,N,1,12071,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL629589,Intermediate,,,A,N,1,12072,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL629590,Intermediate,,,A,N,1,12073,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL629591,Intermediate,,,A,N,1,12074,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL629592,Intermediate,,,A,N,1,12075,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL629593,Intermediate,,,A,N,1,12076,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL629594,Intermediate,,,A,N,1,12077,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL629595,Intermediate,,,A,N,1,12078,948.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Heart,BAO_0000218,
"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL630290,Intermediate,,,A,N,1,12079,948.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Heart,BAO_0000218,
"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL627137,Intermediate,,,A,N,1,12080,948.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Heart,BAO_0000218,
"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL627138,Intermediate,,,A,N,1,12081,948.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Heart,BAO_0000218,
"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL627139,Intermediate,,,A,N,1,12082,948.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Heart,BAO_0000218,
"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL627140,Intermediate,,,A,N,1,12083,948.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Heart,BAO_0000218,
"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL627141,Intermediate,,,A,N,1,12084,948.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Heart,BAO_0000218,
"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL627142,Intermediate,,,A,N,1,12085,2113.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Kidney,BAO_0000218,
"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL627143,Intermediate,,,A,N,1,12086,2113.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Kidney,BAO_0000218,
"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL874449,Intermediate,,,A,N,1,12087,2113.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Kidney,BAO_0000218,
"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL627144,Intermediate,,,A,N,1,12088,2113.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Kidney,BAO_0000218,
"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL627145,Intermediate,,,A,N,1,12089,2113.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Kidney,BAO_0000218,
"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL627146,Intermediate,,,A,N,1,12090,2113.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Kidney,BAO_0000218,
"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL627147,Intermediate,,,A,N,1,12091,2113.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Kidney,BAO_0000218,
"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL627148,Intermediate,,,A,N,1,12092,2107.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Liver,BAO_0000218,
"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL627149,Intermediate,,,A,N,1,12093,2048.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Lung,BAO_0000218,
"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL632160,Intermediate,,,A,N,1,12094,2048.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Lung,BAO_0000218,
"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL632161,Intermediate,,,A,N,1,12095,2048.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Lung,BAO_0000218,
"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL632162,Intermediate,,,A,N,1,12096,2048.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Lung,BAO_0000218,
"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL632163,Intermediate,,,A,N,1,12097,2048.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Lung,BAO_0000218,
"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL874469,Intermediate,,,A,N,1,12098,2048.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Lung,BAO_0000218,
"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL627182,Intermediate,,,A,N,1,12099,2048.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Lung,BAO_0000218,
"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,1,CHEMBL627183,Intermediate,,,A,N,1,12100,2385.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL627184,Intermediate,,,A,N,1,12101,2385.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL627185,Intermediate,,,A,N,1,12102,2385.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL627186,Intermediate,,,A,N,1,12103,2385.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL627187,Intermediate,,,A,N,1,12104,2385.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL627188,Intermediate,,,A,N,1,12105,2385.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL627189,Intermediate,,,A,N,1,12106,2385.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Muscle tissue,BAO_0000218,
"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL627190,Intermediate,,,A,N,1,12107,,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,,BAO_0000218,
"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,1,CHEMBL627191,Intermediate,,,A,N,1,12108,2107.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Liver,BAO_0000218,
"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,1,CHEMBL627192,Intermediate,,,A,N,1,12109,2107.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Liver,BAO_0000218,
"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,1,CHEMBL627193,Intermediate,,,A,N,1,12110,2107.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Liver,BAO_0000218,
Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,1,CHEMBL874590,Intermediate,,,A,N,1,12111,2385.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627194,Intermediate,,,A,N,1,12112,2385.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627195,Intermediate,,,A,N,1,12113,2385.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL627196,Intermediate,,,A,N,1,12114,992.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Female gonad,BAO_0000218,
Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627197,Intermediate,,,A,N,1,12115,992.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Female gonad,BAO_0000218,
Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627198,Intermediate,,,A,N,1,12116,992.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Female gonad,BAO_0000218,
Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,1,CHEMBL627199,Intermediate,,,A,N,1,12117,992.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Female gonad,BAO_0000218,
Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627200,Intermediate,,,A,N,1,12118,992.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Female gonad,BAO_0000218,
Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL627201,Intermediate,,,A,N,1,12119,1969.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Plasma,BAO_0000218,
Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627202,Intermediate,,,A,N,1,12120,1969.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Plasma,BAO_0000218,
Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627203,Intermediate,,,A,N,1,12121,1969.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Plasma,BAO_0000218,
Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627204,Intermediate,,,A,N,1,12122,1969.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Plasma,BAO_0000218,
Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL627205,Intermediate,,,A,N,1,12123,2106.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Spleen,BAO_0000218,
Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627206,Intermediate,,,A,N,1,12124,2106.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Spleen,BAO_0000218,
Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627207,Intermediate,,,A,N,1,12125,2106.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Spleen,BAO_0000218,
Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627208,Intermediate,,,A,N,1,12126,2106.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Spleen,BAO_0000218,
Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL627209,Intermediate,,,A,N,1,12127,2046.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627210,Intermediate,,,A,N,1,12128,2046.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627211,Intermediate,,,A,N,1,12129,2046.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL627212,Intermediate,,,A,N,1,12130,2046.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,1,CHEMBL627213,Intermediate,,,A,N,1,12131,995.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Uterus,BAO_0000218,
Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,1,CHEMBL626599,Intermediate,,,A,N,1,12132,995.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Uterus,BAO_0000218,
Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,1,CHEMBL626600,Intermediate,,,A,N,1,12133,995.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Uterus,BAO_0000218,
Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,1,CHEMBL626601,Intermediate,,,A,N,1,12134,995.0,Rattus norvegicus,In vivo,,50597,,10911,10116.0,,Uterus,BAO_0000218,
C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,0,CHEMBL627484,Autocuration,,,A,U,1,12135,,,,,22224,,8081,,,,BAO_0000019,
Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,1,CHEMBL627485,Intermediate,,,A,N,1,12136,1969.0,Macaca fascicularis,,,100710,,17248,9541.0,,Plasma,BAO_0000218,
Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,1,CHEMBL628147,Intermediate,,,A,N,1,12137,1969.0,Macaca fascicularis,,,100710,,17248,9541.0,,Plasma,BAO_0000218,
Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,1,CHEMBL628148,Intermediate,,,A,N,1,12138,1969.0,Macaca fascicularis,,,100710,,17248,9541.0,,Plasma,BAO_0000218,
Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,1,CHEMBL628149,Intermediate,,,A,N,1,12139,1969.0,Canis lupus familiaris,,,50588,,17248,9615.0,,Plasma,BAO_0000218,
Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,1,CHEMBL628150,Intermediate,,,A,N,1,12140,1969.0,Canis lupus familiaris,,,50588,,17248,9615.0,,Plasma,BAO_0000218,
Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,1,CHEMBL628318,Intermediate,,,A,N,1,12141,1969.0,Canis lupus familiaris,,,50588,,17248,9615.0,,Plasma,BAO_0000218,
Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,1,CHEMBL628319,Intermediate,,,A,N,1,12142,1969.0,Canis lupus familiaris,,,50588,,17248,9615.0,,Plasma,BAO_0000218,
"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,1,CHEMBL875609,Intermediate,,,A,N,1,12143,,Canis lupus familiaris,,,50588,,15592,9615.0,,,BAO_0000218,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,0,CHEMBL628320,Autocuration,,,A,U,1,12144,,,,,22224,,7040,,,,BAO_0000019,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,0,CHEMBL628321,Autocuration,,,A,U,1,12145,,,,,22224,,7040,,,,BAO_0000019,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,0,CHEMBL628322,Autocuration,,,A,U,1,12146,,,,,22224,,7040,,,,BAO_0000019,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,0,CHEMBL628323,Autocuration,,,A,U,1,12147,,,,,22224,,7040,,,,BAO_0000019,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,0,CHEMBL628324,Autocuration,,,A,U,1,12148,,,,,22224,,7040,,,,BAO_0000019,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,0,CHEMBL628325,Autocuration,,,A,U,1,12149,,,,,22224,,7040,,,,BAO_0000019,
Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,0,CHEMBL628326,Autocuration,,,A,U,1,12150,,,,,22224,,7040,,,,BAO_0000019,
"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,1,CHEMBL628327,Intermediate,,,A,N,1,12151,1236.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Adrenal medulla,BAO_0000218,
"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,1,CHEMBL628328,Intermediate,,,A,N,1,12152,1236.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Adrenal medulla,BAO_0000218,
"Concentration of compound in blood of dog 1, after administering intravenously",,1,CHEMBL628329,Intermediate,,,A,N,1,12153,178.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Blood,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,1,CHEMBL628330,Intermediate,,,A,N,1,12154,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,1,CHEMBL628331,Intermediate,,,A,N,1,12155,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,1,CHEMBL628332,Intermediate,,,A,N,1,12156,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,1,CHEMBL628333,Intermediate,,,A,N,1,12157,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,1,CHEMBL628334,Intermediate,,,A,N,1,12158,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,1,CHEMBL628335,Intermediate,,,A,N,1,12159,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,1,CHEMBL628336,Intermediate,,,A,N,1,12160,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,1,CHEMBL628337,Intermediate,,,A,N,1,12161,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,1,CHEMBL628338,Intermediate,,,A,N,1,12162,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,1,CHEMBL875610,Intermediate,,,A,N,1,12163,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,1,CHEMBL628339,Intermediate,,,A,N,1,12164,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,1,CHEMBL628340,Intermediate,,,A,N,1,12165,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,1,CHEMBL628341,Intermediate,,,A,N,1,12166,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,1,CHEMBL622214,Intermediate,,,A,N,1,12167,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,1,CHEMBL623167,Intermediate,,,A,N,1,12168,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,1,CHEMBL623168,Intermediate,,,A,N,1,12169,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,1,CHEMBL623169,Intermediate,,,A,N,1,12170,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,1,CHEMBL623170,Intermediate,,,A,N,1,12171,2107.0,Rattus norvegicus,,,50597,,8608,10116.0,,Liver,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,1,CHEMBL627224,Intermediate,,,A,N,1,12172,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,1,CHEMBL875634,Intermediate,,,A,N,1,12173,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,1,CHEMBL627225,Intermediate,,,A,N,1,12174,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,1,CHEMBL627226,Intermediate,,,A,N,1,12175,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,1,CHEMBL626083,Intermediate,,,A,N,1,12176,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,1,CHEMBL626084,Intermediate,,,A,N,1,12177,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,1,CHEMBL626085,Intermediate,,,A,N,1,12178,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,1,CHEMBL626086,Intermediate,,,A,N,1,12179,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,1,CHEMBL626087,Intermediate,,,A,N,1,12180,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,1,CHEMBL626088,Intermediate,,,A,N,1,12181,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,1,CHEMBL626089,Intermediate,,,A,N,1,12182,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,1,CHEMBL626090,Intermediate,,,A,N,1,12183,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,1,CHEMBL626091,Intermediate,,,A,N,1,12184,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,1,CHEMBL626092,Intermediate,,,A,N,1,12185,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,1,CHEMBL626093,Intermediate,,,A,N,1,12186,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,1,CHEMBL626094,Intermediate,,,A,N,1,12187,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,1,CHEMBL626095,Intermediate,,,A,N,1,12188,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,1,CHEMBL626096,Intermediate,,,A,N,1,12189,2048.0,Rattus norvegicus,,,50597,,8608,10116.0,,Lung,BAO_0000218,
area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,0,CHEMBL626097,Autocuration,,,A,U,1,12190,,Simiiformes,,,22224,,15604,314293.0,,,BAO_0000218,
area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,1,CHEMBL626098,Intermediate,,,A,N,1,12191,,Rattus norvegicus,,,50597,,15604,10116.0,,,BAO_0000218,
compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,0,CHEMBL626099,Autocuration,,,A,U,1,12192,1969.0,,,,22224,,1806,,,Plasma,BAO_0000218,
compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,0,CHEMBL626100,Autocuration,,,A,U,1,12193,1969.0,,,,22224,,1806,,,Plasma,BAO_0000218,
AUC 0-inf in dog,,1,CHEMBL626101,Intermediate,,,A,N,1,12194,1969.0,Canis lupus familiaris,,,50588,,17237,9615.0,,Plasma,BAO_0000218,
AUC 0-inf in guinea pig,,1,CHEMBL626102,Intermediate,,,A,N,1,12195,1969.0,Cavia porcellus,,,50512,,17237,10141.0,,Plasma,BAO_0000218,
AUC 0-t in dog,,1,CHEMBL626103,Intermediate,,,A,N,1,12196,1969.0,Canis lupus familiaris,,,50588,,17237,9615.0,,Plasma,BAO_0000218,
AUC 0-t in guinea pig,,1,CHEMBL628391,Intermediate,,,A,N,1,12197,1969.0,Cavia porcellus,,,50512,,17237,10141.0,,Plasma,BAO_0000218,
The compound was tested for brain to plasma partition in rat,,1,CHEMBL628392,Intermediate,,,A,N,1,12198,,Rattus norvegicus,,,50597,,15194,10116.0,,,BAO_0000218,
The compound was tested for brain to plasma partition in rat.,,1,CHEMBL628393,Intermediate,,,A,N,1,12199,,Rattus norvegicus,,,50597,,15194,10116.0,,,BAO_0000218,
Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,0,CHEMBL628394,Autocuration,,,A,U,1,12200,178.0,,,,22224,,8787,,,Blood,BAO_0000019,
Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,1,CHEMBL628395,Intermediate,,,A,N,1,12201,,Canis lupus familiaris,,,50588,,17025,9615.0,,,BAO_0000218,
Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,0,CHEMBL628396,Autocuration,,,A,U,1,12202,,Simiiformes,,,22224,,17025,314293.0,,,BAO_0000218,
Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,1,CHEMBL628397,Intermediate,,,A,N,1,12203,,Oryctolagus cuniculus,,,50592,,17025,9986.0,,,BAO_0000218,
Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,1,CHEMBL628398,Intermediate,,,A,N,1,12204,,Rattus norvegicus,,,50597,,17025,10116.0,,,BAO_0000218,
Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,1,CHEMBL628399,Intermediate,,,A,N,1,12205,,Macaca mulatta,,,50797,,4236,9544.0,,,BAO_0000218,
The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,1,CHEMBL628400,Intermediate,,,A,N,1,12206,,Canis lupus familiaris,,,50588,,15343,9615.0,,,BAO_0000218,
The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,1,CHEMBL874907,Intermediate,,,A,N,1,12207,,Rattus norvegicus,,,50597,,15343,10116.0,,,BAO_0000218,
Area under curve of the compound was determined,,0,CHEMBL628401,Autocuration,,,A,U,1,12208,,,,,22224,,17720,,,,BAO_0000019,
AUC in monkeys at a dose of 1 mg/kg,,0,CHEMBL628402,Autocuration,,,A,U,1,12209,1969.0,Simiiformes,,,22224,,17788,314293.0,,Plasma,BAO_0000218,
AUC in rats at a dose of 1 mg/kg,,1,CHEMBL628403,Intermediate,,,A,N,1,12210,1969.0,Rattus norvegicus,,,50597,,17788,10116.0,,Plasma,BAO_0000218,
Compound was evaluated for the overall absorbance loss at pH of 2,,0,CHEMBL628404,Autocuration,,,A,U,1,12211,,,,,22224,,8778,,,,BAO_0000019,
Compound was evaluated for the overall absorbance loss at pH of 4,,0,CHEMBL628405,Autocuration,,,A,U,1,12212,,,,,22224,,8778,,,,BAO_0000019,
Compound was evaluated for the overall absorbance loss at pH of 7,,0,CHEMBL628406,Autocuration,,,A,U,1,12213,,,,,22224,,8778,,,,BAO_0000019,
Compound was evaluated for its absorption in the rats,,1,CHEMBL628407,Intermediate,,,A,N,1,12214,,Rattus norvegicus,,,50597,,2249,10116.0,,,BAO_0000218,
Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,1,CHEMBL628408,Intermediate,,,A,N,1,12215,1088.0,Rattus norvegicus,,,50597,,8881,10116.0,,Urine,BAO_0000218,
Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,1,CHEMBL629171,Intermediate,,,A,N,1,12216,1088.0,Rattus norvegicus,,,50597,,8881,10116.0,,Urine,BAO_0000218,
Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,1,CHEMBL629172,Intermediate,,,A,N,1,12217,1088.0,Rattus norvegicus,,,50597,,8881,10116.0,,Urine,BAO_0000218,
Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,1,CHEMBL629173,Intermediate,,,A,N,1,12218,1088.0,Rattus norvegicus,,,50597,,8881,10116.0,,Urine,BAO_0000218,
In vitro percent permeability into rat ileum,,1,CHEMBL629174,Intermediate,,,A,N,1,12219,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 10-17,,1,CHEMBL629175,Intermediate,,,A,N,1,12220,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 10-18,,1,CHEMBL629176,Intermediate,,,A,N,1,12221,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 10-19,,1,CHEMBL629177,Intermediate,,,A,N,1,12222,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 12-15,,1,CHEMBL629178,Intermediate,,,A,N,1,12223,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 13-19,,1,CHEMBL631869,Intermediate,,,A,N,1,12224,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 14-17,,1,CHEMBL631870,Intermediate,,,A,N,1,12225,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 15-18,,1,CHEMBL631871,Intermediate,,,A,N,1,12226,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 2-5,,1,CHEMBL631872,Intermediate,,,A,N,1,12227,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 23-42,,0,CHEMBL875775,Autocuration,,,A,U,1,12228,2116.0,,,,22224,,15286,,,Ileum,BAO_0000221,
In vitro percent permeability into rat ileum; Range is 28-36,,1,CHEMBL631873,Intermediate,,,A,N,1,12229,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 29-35,,1,CHEMBL631874,Intermediate,,,A,N,1,12230,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 46-66,,1,CHEMBL631875,Intermediate,,,A,N,1,12231,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 50-68,,1,CHEMBL631876,Intermediate,,,A,N,1,12232,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; Range is 78-81,,1,CHEMBL631877,Intermediate,,,A,N,1,12233,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,1,CHEMBL631878,Intermediate,,,A,N,1,12234,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; nd indicates not detected,,1,CHEMBL631879,Intermediate,,,A,N,1,12235,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; nt indicates not detected,,1,CHEMBL631880,Intermediate,,,A,N,1,12236,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
In vitro percent permeability into rat ileum; nt indicates not tested,,1,CHEMBL631881,Intermediate,,,A,N,1,12237,,Rattus norvegicus,,,50597,,15286,10116.0,,,BAO_0000218,
Compound was tested for oral absorption in bile-duct cannulated rats,,1,CHEMBL631882,Intermediate,,,A,N,1,12238,,Rattus norvegicus,,,50597,,13770,10116.0,,,BAO_0000218,
Compound was tested for oral absorption in bile-duct cannulated rats.,,1,CHEMBL630749,Intermediate,,,A,N,1,12239,,Rattus norvegicus,,,50597,,13770,10116.0,,,BAO_0000218,
Oral absorption using Caco-2 cell monolayers.,,1,CHEMBL630750,Intermediate,,,A,N,1,12240,,Homo sapiens,,,50587,,5202,9606.0,,,BAO_0000218,
Percent of the drug absorbed after administration to humans was determined,,1,CHEMBL630253,Intermediate,,,A,N,1,12241,,Homo sapiens,,,50587,,14920,9606.0,,,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,1,CHEMBL630254,Intermediate,,,A,N,1,12242,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,1,CHEMBL630255,Intermediate,,,A,N,1,12243,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,1,CHEMBL630256,Intermediate,,,A,N,1,12244,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,1,CHEMBL875781,Intermediate,,,A,N,1,12245,2107.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Liver,BAO_0000218,
"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,1,CHEMBL630257,Intermediate,,,A,N,1,12246,2107.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Liver,BAO_0000218,
"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,1,CHEMBL630258,Intermediate,,,A,N,1,12247,2107.0,Rattus norvegicus,In vivo,,50597,,13751,10116.0,,Liver,BAO_0000218,
"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,1,CHEMBL630259,Intermediate,,,A,N,1,12248,,Rattus norvegicus,,,50597,,15807,10116.0,,,BAO_0000218,
"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,1,CHEMBL630260,Intermediate,,,A,N,1,12249,2435.0,Rattus norvegicus,,,50597,,15807,10116.0,,Striatum,BAO_0000218,
"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,1,CHEMBL630261,Intermediate,,,A,N,1,12250,2435.0,Rattus norvegicus,,,50597,,15807,10116.0,,Striatum,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,1,CHEMBL630262,Intermediate,,,A,N,1,12251,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,1,CHEMBL630263,Intermediate,,,A,N,1,12252,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,1,CHEMBL630264,Intermediate,,,A,N,1,12253,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,1,CHEMBL630265,Intermediate,,,A,N,1,12254,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,1,CHEMBL630266,Intermediate,,,A,N,1,12255,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,1,CHEMBL630267,Intermediate,,,A,N,1,12256,2113.0,Rattus norvegicus,,,50597,,14950,10116.0,,Kidney,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,1,CHEMBL630268,Intermediate,,,A,N,1,12257,2113.0,Rattus norvegicus,,,50597,,14950,10116.0,,Kidney,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,1,CHEMBL630269,Intermediate,,,A,N,1,12258,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,1,CHEMBL630270,Intermediate,,,A,N,1,12259,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,1,CHEMBL630141,Intermediate,,,A,N,1,12260,2048.0,Rattus norvegicus,,,50597,,14950,10116.0,,Lung,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,1,CHEMBL630142,Intermediate,,,A,N,1,12261,2048.0,Rattus norvegicus,,,50597,,14950,10116.0,,Lung,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,1,CHEMBL630143,Intermediate,,,A,N,1,12262,2385.0,Rattus norvegicus,,,50597,,14950,10116.0,,Muscle tissue,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,1,CHEMBL630144,Intermediate,,,A,N,1,12263,2385.0,Rattus norvegicus,,,50597,,14950,10116.0,,Muscle tissue,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,1,CHEMBL630145,Intermediate,,,A,N,1,12264,2367.0,Rattus norvegicus,,,50597,,14950,10116.0,,Prostate gland,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,1,CHEMBL630146,Intermediate,,,A,N,1,12265,2367.0,Rattus norvegicus,,,50597,,14950,10116.0,,Prostate gland,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,1,CHEMBL630147,Intermediate,,,A,N,1,12266,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,1,CHEMBL630148,Intermediate,,,A,N,1,12267,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,1,CHEMBL630149,Intermediate,,,A,N,1,12268,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,1,CHEMBL630150,Intermediate,,,A,N,1,12269,2106.0,Rattus norvegicus,,,50597,,14950,10116.0,,Spleen,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,1,CHEMBL630151,Intermediate,,,A,N,1,12270,2106.0,Rattus norvegicus,,,50597,,14950,10116.0,,Spleen,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,1,CHEMBL632031,Intermediate,,,A,N,1,12271,2046.0,Rattus norvegicus,,,50597,,14950,10116.0,,Thyroid gland,BAO_0000218,
Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,1,CHEMBL632032,Intermediate,,,A,N,1,12272,2046.0,Rattus norvegicus,,,50597,,14950,10116.0,,Thyroid gland,BAO_0000218,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,1,CHEMBL632033,Intermediate,,,A,N,1,12273,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,1,CHEMBL632034,Intermediate,,,A,N,1,12274,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,1,CHEMBL632035,Intermediate,,,A,N,1,12275,2385.0,Rattus norvegicus,,,50597,,14950,10116.0,,Muscle tissue,BAO_0000218,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,1,CHEMBL632036,Intermediate,,,A,N,1,12276,,Rattus norvegicus,,,50597,,14950,10116.0,,,BAO_0000218,
Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,1,CHEMBL632037,Intermediate,,,A,N,1,12277,2046.0,Rattus norvegicus,,,50597,,14950,10116.0,,Thyroid gland,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,1,CHEMBL632038,Intermediate,,,A,N,1,12278,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,1,CHEMBL632039,Intermediate,,,A,N,1,12279,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,1,CHEMBL632040,Intermediate,,,A,N,1,12280,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,1,CHEMBL632041,Intermediate,,,A,N,1,12281,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
"Concentration of compound in blood of dog 2, after administering intravenously",,1,CHEMBL632042,Intermediate,,,A,N,1,12282,178.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Blood,BAO_0000218,
"Concentration of compound in left ventricle of dog 1, after administering intravenously",,1,CHEMBL632043,Intermediate,,,A,N,1,12283,,Canis lupus familiaris,,,50588,,9614,9615.0,,,BAO_0000218,
"Concentration of compound in left ventricle of dog 2, after administering intravenously",,1,CHEMBL632044,Intermediate,,,A,N,1,12284,,Canis lupus familiaris,,,50588,,9614,9615.0,,,BAO_0000218,
"Concentration of compound in liver of dog 1, after administering intravenously",,1,CHEMBL632045,Intermediate,,,A,N,1,12285,2107.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Liver,BAO_0000218,
"Concentration of compound in liver of dog 2, after administering intravenously",,1,CHEMBL632046,Intermediate,,,A,N,1,12286,2107.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Liver,BAO_0000218,
"Concentration of compound in lung of dog 1, after administering intravenously",,1,CHEMBL632047,Intermediate,,,A,N,1,12287,2048.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Lung,BAO_0000218,
"Concentration of compound in lung of dog 2, after administering intravenously",,1,CHEMBL632048,Intermediate,,,A,N,1,12288,2048.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Lung,BAO_0000218,
"Concentration of compound in muscle of dog 1, after administering intravenously",,1,CHEMBL632049,Intermediate,,,A,N,1,12289,2385.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Muscle tissue,BAO_0000218,
"Concentration of compound in muscle of dog 2, after administering intravenously",,1,CHEMBL876418,Intermediate,,,A,N,1,12290,2385.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Muscle tissue,BAO_0000218,
"Concentration of compound in spleen of dog 1,after administering intravenously",,1,CHEMBL632050,Intermediate,,,A,N,1,12291,2106.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Spleen,BAO_0000218,
"Concentration of compound in spleen of dog 2, after administering intravenously",,1,CHEMBL632051,Intermediate,,,A,N,1,12292,2106.0,Canis lupus familiaris,,,50588,,9614,9615.0,,Spleen,BAO_0000218,
Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,0,CHEMBL632052,Autocuration,,,F,U,1,12293,,,,,22224,,10353,,,,BAO_0000218,
Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,0,CHEMBL632053,Autocuration,,,F,U,1,12294,,,,,22224,,10353,,,,BAO_0000218,
Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,0,CHEMBL632054,Autocuration,,,A,U,1,12295,,,,,22224,,10353,,,,BAO_0000218,
Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,0,CHEMBL632055,Autocuration,,,F,U,1,12296,,,,,22224,,10353,,,,BAO_0000218,
Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,0,CHEMBL631181,Autocuration,,,F,U,1,12297,,,,,22224,,10353,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,0,CHEMBL631182,Autocuration,,,A,U,1,12298,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,CHEMBL631183,Autocuration,,,A,U,1,12299,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,CHEMBL631184,Autocuration,,,A,U,1,12300,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,CHEMBL629774,Autocuration,,,A,U,1,12301,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,CHEMBL629775,Autocuration,,,A,U,1,12302,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,CHEMBL876549,Autocuration,,,A,U,1,12303,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,CHEMBL628172,Autocuration,,,A,U,1,12304,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,CHEMBL628173,Autocuration,,,A,U,1,12305,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,0,CHEMBL628174,Autocuration,,,A,U,1,12306,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,0,CHEMBL628175,Autocuration,,,A,U,1,12307,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,CHEMBL628176,Autocuration,,,A,U,1,12308,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,CHEMBL628177,Autocuration,,,A,U,1,12309,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,CHEMBL628178,Autocuration,,,A,U,1,12310,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,CHEMBL628179,Autocuration,,,A,U,1,12311,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,0,CHEMBL628180,Autocuration,,,A,U,1,12312,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,0,CHEMBL628181,Autocuration,,,A,U,1,12313,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,CHEMBL628182,Autocuration,,,A,U,1,12314,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,CHEMBL628183,Autocuration,,,A,U,1,12315,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,0,CHEMBL628184,Autocuration,,,A,U,1,12316,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,CHEMBL628185,Autocuration,,,A,U,1,12317,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,CHEMBL875617,Autocuration,,,A,U,1,12318,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,0,CHEMBL628186,Autocuration,,,A,U,1,12319,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,CHEMBL628187,Autocuration,,,A,U,1,12320,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,CHEMBL628188,Autocuration,,,A,U,1,12321,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,0,CHEMBL628189,Autocuration,,,A,U,1,12322,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,0,CHEMBL628190,Autocuration,,,A,U,1,12323,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,CHEMBL628191,Autocuration,,,A,U,1,12324,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,0,CHEMBL626513,Autocuration,,,A,U,1,12325,,,,,22224,,9196,,,,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,1,CHEMBL626514,Intermediate,,,A,N,1,12326,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,1,CHEMBL626515,Intermediate,,,A,N,1,12327,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,1,CHEMBL626516,Intermediate,,,A,N,1,12328,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,1,CHEMBL626517,Intermediate,,,A,N,1,12329,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,1,CHEMBL626518,Intermediate,,,A,N,1,12330,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,1,CHEMBL626519,Intermediate,,,A,N,1,12331,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,1,CHEMBL626520,Intermediate,,,A,N,1,12332,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,1,CHEMBL626521,Intermediate,,,A,N,1,12333,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,1,CHEMBL626522,Intermediate,,,A,N,1,12334,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,1,CHEMBL626523,Intermediate,,,A,N,1,12335,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,1,CHEMBL626524,Intermediate,,,A,N,1,12336,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,1,CHEMBL626688,Intermediate,,,A,N,1,12337,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,1,CHEMBL626689,Intermediate,,,A,N,1,12338,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,1,CHEMBL626690,Intermediate,,,A,N,1,12339,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,1,CHEMBL626691,Intermediate,,,A,N,1,12340,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,1,CHEMBL627319,Intermediate,,,A,N,1,12341,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,1,CHEMBL624052,Intermediate,,,A,N,1,12342,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,1,CHEMBL624053,Intermediate,,,A,N,1,12343,2046.0,Rattus norvegicus,,,50597,,8608,10116.0,,Thyroid gland,BAO_0000218,
In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL624054,Intermediate,,,A,N,1,12344,,Rattus norvegicus,,,50597,,8085,10116.0,,,BAO_0000218,
In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL624055,Intermediate,,,A,N,1,12345,,Rattus norvegicus,,,50597,,8085,10116.0,,,BAO_0000218,
In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL624056,Intermediate,,,A,N,1,12346,,Rattus norvegicus,,,50597,,8085,10116.0,,,BAO_0000218,
In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL624057,Intermediate,,,A,N,1,12347,995.0,Rattus norvegicus,,,50597,,8085,10116.0,,Uterus,BAO_0000218,
In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL622281,Intermediate,,,A,N,1,12348,995.0,Rattus norvegicus,,,50597,,8085,10116.0,,Uterus,BAO_0000218,
In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL622282,Intermediate,,,A,N,1,12349,995.0,Rattus norvegicus,,,50597,,8085,10116.0,,Uterus,BAO_0000218,
In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL622283,Intermediate,,,A,N,1,12350,995.0,Rattus norvegicus,,,50597,,8085,10116.0,,Uterus,BAO_0000218,
In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL622284,Intermediate,,,A,N,1,12351,995.0,Rattus norvegicus,,,50597,,8085,10116.0,,Uterus,BAO_0000218,
In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL622285,Intermediate,,,A,N,1,12352,995.0,Rattus norvegicus,,,50597,,8085,10116.0,,Uterus,BAO_0000218,
In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,CHEMBL622286,Intermediate,,,A,N,1,12353,995.0,Rattus norvegicus,,,50597,,8085,10116.0,,Uterus,BAO_0000218,
Distribution coefficient (D %) between octanol and buffer of pH 7.4,,0,CHEMBL622287,Autocuration,,,P,U,1,12354,,,,,22224,,7657,,,,BAO_0000100,
Partition coefficient (logD7.4),,1,CHEMBL622288,Intermediate,,,A,N,1,12355,,Mus musculus,,,50594,,8935,10090.0,,,BAO_0000218,
"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,1,CHEMBL622289,Intermediate,,,A,N,1,12356,,Mus musculus,,,50594,,13792,10090.0,,,BAO_0000218,
"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,1,CHEMBL622290,Intermediate,,,A,N,1,12357,955.0,Mus musculus,,,50594,,13792,10090.0,,Brain,BAO_0000218,
Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,1,CHEMBL622291,Intermediate,,,A,N,1,12358,,Mus musculus,,,50594,,13792,10090.0,,,BAO_0000218,
Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,1,CHEMBL622292,Intermediate,,,A,N,1,12359,955.0,Mus musculus,,,50594,,13792,10090.0,,Brain,BAO_0000218,
"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,1,CHEMBL622293,Intermediate,,,A,N,1,12360,,Mus musculus,,,50594,,13792,10090.0,,,BAO_0000218,
"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,1,CHEMBL622294,Intermediate,,,A,N,1,12361,955.0,Mus musculus,,,50594,,13792,10090.0,,Brain,BAO_0000218,
Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,1,CHEMBL622295,Intermediate,,,A,N,1,12362,,Mus musculus,,,50594,,13792,10090.0,,,BAO_0000218,
Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,1,CHEMBL622296,Intermediate,,,A,N,1,12363,955.0,Rattus norvegicus,,,50597,,13792,10116.0,,Brain,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,1,CHEMBL874409,Intermediate,,,A,N,1,12364,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,1,CHEMBL622297,Intermediate,,,A,N,1,12365,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,1,CHEMBL622298,Intermediate,,,A,N,1,12366,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,1,CHEMBL622299,Intermediate,,,A,N,1,12367,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,1,CHEMBL622300,Intermediate,,,A,N,1,12368,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,1,CHEMBL622301,Intermediate,,,A,N,1,12369,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,1,CHEMBL622302,Intermediate,,,A,N,1,12370,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,1,CHEMBL622303,Intermediate,,,A,N,1,12371,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,1,CHEMBL622304,Intermediate,,,A,N,1,12372,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,1,CHEMBL622305,Intermediate,,,A,N,1,12373,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,1,CHEMBL622306,Intermediate,,,A,N,1,12374,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,1,CHEMBL626864,Intermediate,,,A,N,1,12375,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,1,CHEMBL626865,Intermediate,,,A,N,1,12376,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,1,CHEMBL626866,Intermediate,,,A,N,1,12377,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,1,CHEMBL626867,Intermediate,,,A,N,1,12378,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,1,CHEMBL626868,Intermediate,,,A,N,1,12379,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,1,CHEMBL626869,Intermediate,,,A,N,1,12380,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,1,CHEMBL626870,Intermediate,,,A,N,1,12381,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,1,CHEMBL626871,Intermediate,,,A,N,1,12382,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,1,CHEMBL626872,Intermediate,,,A,N,1,12383,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,1,CHEMBL632185,Intermediate,,,A,N,1,12384,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,1,CHEMBL632186,Intermediate,,,A,N,1,12385,1969.0,Rattus norvegicus,,,50597,,14103,10116.0,,Plasma,BAO_0000218,
Amount of acetic acid produced by the compound,,0,CHEMBL629310,Autocuration,,,A,U,1,12386,,,,,22224,,12904,,,,BAO_0000019,
Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,0,CHEMBL629311,Autocuration,,,A,U,1,12387,,,,,22224,,12904,,,,BAO_0000019,
Log of (Cbrain/Cblood) in rats,,1,CHEMBL629312,Intermediate,,,A,N,1,12388,,Rattus norvegicus,,,50597,,9663,10116.0,,,BAO_0000218,
Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,0,CHEMBL629313,Autocuration,,,A,U,1,12389,,,,,22224,,7652,,,,BAO_0000221,
Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,CHEMBL629314,Autocuration,,,A,U,1,12390,,,,,22224,,7652,,,,BAO_0000221,
Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,0,CHEMBL629315,Autocuration,,,A,U,1,12391,,,,,22224,,7652,,,,BAO_0000221,
Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,0,CHEMBL629316,Autocuration,,,B,U,1,12392,,,,,22224,,7652,,,,BAO_0000219,
Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,CHEMBL629317,Autocuration,,,A,U,1,12393,,,,,22224,,7652,,,,BAO_0000221,
Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,0,CHEMBL629318,Autocuration,,,A,U,1,12394,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,0,CHEMBL877497,Autocuration,,,A,U,1,12395,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,0,CHEMBL629319,Autocuration,,,A,U,1,12396,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,CHEMBL629320,Autocuration,,,A,U,1,12397,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,0,CHEMBL629496,Autocuration,,,A,U,1,12398,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,0,CHEMBL629497,Autocuration,,,A,U,1,12399,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,0,CHEMBL629498,Autocuration,,,A,U,1,12400,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,0,CHEMBL629499,Autocuration,,,A,U,1,12401,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,0,CHEMBL629500,Autocuration,,,A,U,1,12402,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,0,CHEMBL629501,Autocuration,,,A,U,1,12403,,,,,22224,,7652,,,,BAO_0000019,
Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,0,CHEMBL629502,Autocuration,,,A,U,1,12404,,,,,22224,,7652,,,,BAO_0000019,
Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,0,CHEMBL629503,Autocuration,,,F,U,1,12405,,,In vivo,,22224,,8267,,,,BAO_0000218,
Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,1,CHEMBL629504,Intermediate,,,A,N,1,12406,,Canis lupus familiaris,,,50588,,8267,9615.0,,,BAO_0000218,
Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,0,CHEMBL629505,Autocuration,,,A,U,1,12407,,,,,22224,,14479,,,,BAO_0000019,
Compound was evaluated for total body clearance,,0,CHEMBL629506,Autocuration,,,A,U,1,12408,,,,,22224,,17515,,,,BAO_0000019,
Compound was evaluated for volume of distribution at steady state,,0,CHEMBL629507,Autocuration,,,A,U,1,12409,,,,,22224,,17515,,,,BAO_0000019,
Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,0,CHEMBL877498,Autocuration,,,A,U,1,12410,,,,,22224,,8142,,,,BAO_0000019,
Percentage of the diamine which is monoprotonated at pH 7.4,,0,CHEMBL629508,Autocuration,,,A,U,1,12411,,,,,22224,,14849,,,,BAO_0000019,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,0,CHEMBL629509,Autocuration,,,A,U,1,12412,,,,,22224,,7653,,,,BAO_0000019,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,1,CHEMBL629510,Intermediate,,,A,N,1,12413,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,1,CHEMBL629511,Intermediate,,,A,N,1,12414,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,1,CHEMBL629512,Intermediate,,,A,N,1,12415,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,1,CHEMBL629513,Intermediate,,,A,N,1,12416,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,1,CHEMBL629514,Intermediate,,,A,N,1,12417,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,1,CHEMBL628447,Intermediate,,,A,N,1,12418,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,1,CHEMBL628448,Intermediate,,,A,N,1,12419,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,1,CHEMBL628449,Intermediate,,,A,N,1,12420,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,1,CHEMBL631119,Intermediate,,,A,N,1,12421,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,1,CHEMBL631120,Intermediate,,,A,N,1,12422,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,1,CHEMBL631121,Intermediate,,,A,N,1,12423,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,1,CHEMBL874458,Intermediate,,,A,N,1,12424,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,1,CHEMBL631122,Intermediate,,,A,N,1,12425,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,1,CHEMBL631123,Intermediate,,,A,N,1,12426,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,1,CHEMBL631124,Intermediate,,,A,N,1,12427,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,1,CHEMBL631125,Intermediate,,,A,N,1,12428,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,1,CHEMBL631290,Intermediate,,,A,N,1,12429,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,1,CHEMBL631291,Intermediate,,,A,N,1,12430,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,1,CHEMBL631292,Intermediate,,,A,N,1,12431,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,1,CHEMBL631293,Intermediate,,,A,N,1,12432,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,1,CHEMBL631294,Intermediate,,,A,N,1,12433,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,1,CHEMBL631295,Intermediate,,,A,N,1,12434,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,1,CHEMBL631296,Intermediate,,,A,N,1,12435,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,1,CHEMBL631297,Intermediate,,,A,N,1,12436,178.0,Rattus norvegicus,,,50597,,8631,10116.0,,Blood,BAO_0000218,
Maximum biodistribution (Bmax) was determined.,,0,CHEMBL631298,Autocuration,,,A,U,1,12437,,,,,22224,,10263,,,,BAO_0000218,
Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,1,CHEMBL631299,Intermediate,,,A,N,1,12438,,Mus musculus,,,50594,,12364,10090.0,,,BAO_0000218,
Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,1,CHEMBL631300,Intermediate,,,A,N,1,12439,,Mus musculus,,,50594,,12364,10090.0,,,BAO_0000218,
Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,1,CHEMBL631301,Intermediate,,,A,N,1,12440,,Mus musculus,,,50594,,12364,10090.0,,,BAO_0000218,
Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,1,CHEMBL630291,Intermediate,,,A,N,1,12441,,Mus musculus,,,50594,,12364,10090.0,,,BAO_0000218,
Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,CHEMBL630292,Autocuration,,,A,U,1,12442,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,0,CHEMBL630293,Autocuration,,,A,U,1,12443,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,0,CHEMBL630294,Autocuration,,,A,U,1,12444,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,0,CHEMBL630295,Autocuration,,,A,U,1,12445,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,0,CHEMBL630296,Autocuration,,,A,U,1,12446,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,0,CHEMBL626782,Autocuration,,,A,U,1,12447,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,0,CHEMBL626783,Autocuration,,,A,U,1,12448,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,CHEMBL626784,Autocuration,,,A,U,1,12449,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,0,CHEMBL626785,Autocuration,,,A,U,1,12450,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,0,CHEMBL626786,Autocuration,,,A,U,1,12451,,,,,22224,,14793,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,CHEMBL626787,Autocuration,,,A,U,1,12452,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,0,CHEMBL626788,Autocuration,,,A,U,1,12453,,,,,22224,,9196,,,,BAO_0000218,
Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,CHEMBL625927,Autocuration,,,A,U,1,12454,,,,,22224,,9196,,,,BAO_0000218,
Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL625928,Intermediate,,,A,N,1,12455,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,CHEMBL625929,Intermediate,,,A,N,1,12456,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,1,CHEMBL625930,Intermediate,,,A,N,1,12457,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,1,CHEMBL625931,Intermediate,,,A,N,1,12458,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,1,CHEMBL627230,Intermediate,,,A,N,1,12459,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627231,Intermediate,,,A,N,1,12460,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,CHEMBL627232,Intermediate,,,A,N,1,12461,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,1,CHEMBL627233,Intermediate,,,A,N,1,12462,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL875470,Intermediate,,,A,N,1,12463,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627234,Intermediate,,,A,N,1,12464,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627235,Intermediate,,,A,N,1,12465,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627236,Intermediate,,,A,N,1,12466,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627237,Intermediate,,,A,N,1,12467,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627238,Intermediate,,,A,N,1,12468,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627239,Intermediate,,,A,N,1,12469,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627240,Intermediate,,,A,N,1,12470,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627241,Intermediate,,,A,N,1,12471,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627242,Intermediate,,,A,N,1,12472,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,1,CHEMBL627243,Intermediate,,,A,N,1,12473,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,CHEMBL627244,Intermediate,,,A,N,1,12474,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627245,Intermediate,,,A,N,1,12475,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627246,Intermediate,,,A,N,1,12476,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627247,Intermediate,,,A,N,1,12477,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627248,Intermediate,,,A,N,1,12478,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627249,Intermediate,,,A,N,1,12479,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL625569,Intermediate,,,A,N,1,12480,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL625570,Intermediate,,,A,N,1,12481,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL625571,Intermediate,,,A,N,1,12482,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,CHEMBL625572,Intermediate,,,A,N,1,12483,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,CHEMBL625573,Intermediate,,,A,N,1,12484,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,1,CHEMBL625574,Intermediate,,,A,N,1,12485,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,CHEMBL626245,Intermediate,,,A,N,1,12486,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL626246,Intermediate,,,A,N,1,12487,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,CHEMBL626247,Autocuration,,,A,U,1,12488,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,CHEMBL626248,Autocuration,,,A,U,1,12489,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,0,CHEMBL626249,Autocuration,,,A,U,1,12490,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,CHEMBL626420,Autocuration,,,A,U,1,12491,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,CHEMBL626421,Autocuration,,,A,U,1,12492,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,CHEMBL626422,Autocuration,,,A,U,1,12493,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,CHEMBL626423,Autocuration,,,A,U,1,12494,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,CHEMBL626424,Autocuration,,,A,U,1,12495,,,,,22224,,9196,,,,BAO_0000218,
Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,1,CHEMBL626425,Intermediate,,,A,N,1,12496,,Canis lupus familiaris,,,50588,,12023,9615.0,,,BAO_0000218,
Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,1,CHEMBL875476,Intermediate,,,A,N,1,12497,,Rattus norvegicus,,,50597,,12023,10116.0,,,BAO_0000218,
Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,1,CHEMBL626426,Intermediate,,,A,N,1,12498,,Macaca fascicularis,,,100710,,12023,9541.0,,,BAO_0000218,
Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,0,CHEMBL626427,Autocuration,,,P,U,1,12499,,,,,22224,,10580,,,,BAO_0000100,
Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,0,CHEMBL626428,Autocuration,,,P,U,1,12500,,,,,22224,,10580,,,,BAO_0000100,
Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,0,CHEMBL626429,Autocuration,,,A,U,1,12501,,,,,22224,,16032,,,,BAO_0000019,
Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,0,CHEMBL625025,Autocuration,,,A,U,1,12502,1088.0,,,,22224,,16032,,,Urine,BAO_0000019,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,CHEMBL625026,Intermediate,,,A,N,1,12503,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,CHEMBL625027,Intermediate,,,A,N,1,12504,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,CHEMBL874410,Intermediate,,,A,N,1,12505,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,CHEMBL625028,Intermediate,,,A,N,1,12506,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,CHEMBL625029,Intermediate,,,A,N,1,12507,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,CHEMBL625030,Intermediate,,,A,N,1,12508,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL625031,Intermediate,,,A,N,1,12509,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,CHEMBL625032,Intermediate,,,A,N,1,12510,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,CHEMBL625033,Intermediate,,,A,N,1,12511,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,CHEMBL625034,Intermediate,,,A,N,1,12512,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,CHEMBL624872,Intermediate,,,A,N,1,12513,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,CHEMBL624873,Intermediate,,,A,N,1,12514,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,CHEMBL624874,Intermediate,,,A,N,1,12515,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,CHEMBL624875,Intermediate,,,A,N,1,12516,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,CHEMBL624876,Intermediate,,,A,N,1,12517,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,CHEMBL624877,Intermediate,,,A,N,1,12518,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,CHEMBL624878,Intermediate,,,A,N,1,12519,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,CHEMBL624879,Intermediate,,,A,N,1,12520,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL624880,Intermediate,,,A,N,1,12521,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,1,CHEMBL624881,Intermediate,,,A,N,1,12522,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,1,CHEMBL624882,Intermediate,,,A,N,1,12523,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,CHEMBL624883,Intermediate,,,A,N,1,12524,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,CHEMBL624884,Intermediate,,,A,N,1,12525,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,CHEMBL624885,Intermediate,,,A,N,1,12526,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,CHEMBL624886,Intermediate,,,A,N,1,12527,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,CHEMBL624887,Intermediate,,,A,N,1,12528,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,CHEMBL624888,Intermediate,,,A,N,1,12529,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,CHEMBL624889,Intermediate,,,A,N,1,12530,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,CHEMBL624890,Intermediate,,,A,N,1,12531,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL621964,Intermediate,,,A,N,1,12532,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,CHEMBL621965,Intermediate,,,A,N,1,12533,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,CHEMBL621966,Intermediate,,,A,N,1,12534,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,CHEMBL621967,Intermediate,,,A,N,1,12535,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,CHEMBL622164,Intermediate,,,A,N,1,12536,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,0,CHEMBL623097,Autocuration,,,A,U,1,12537,,,,,22224,,7653,,,,BAO_0000019,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,0,CHEMBL623098,Autocuration,,,A,U,1,12538,,,,,22224,,7653,,,,BAO_0000019,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,0,CHEMBL623099,Autocuration,,,A,U,1,12539,,,,,22224,,7653,,,,BAO_0000019,
Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,0,CHEMBL623100,Autocuration,,,A,U,1,12540,,,,,22224,,7653,,,,BAO_0000019,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,1,CHEMBL628673,Intermediate,,,A,N,1,12541,,Rattus norvegicus,,,50597,,9104,10116.0,,,BAO_0000218,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,1,CHEMBL628674,Intermediate,,,A,N,1,12542,,Rattus norvegicus,,,50597,,9104,10116.0,,,BAO_0000218,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,1,CHEMBL628675,Intermediate,,,A,N,1,12543,,Rattus norvegicus,,,50597,,9104,10116.0,,,BAO_0000218,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,1,CHEMBL627644,Intermediate,,,A,N,1,12544,,Rattus norvegicus,,,50597,,9104,10116.0,,,BAO_0000218,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,1,CHEMBL627645,Intermediate,,,A,N,1,12545,,Rattus norvegicus,,,50597,,9104,10116.0,,,BAO_0000218,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,1,CHEMBL627646,Intermediate,,,A,N,1,12546,,Rattus norvegicus,,,50597,,9104,10116.0,,,BAO_0000218,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,1,CHEMBL627647,Intermediate,,,A,N,1,12547,,Rattus norvegicus,,,50597,,9104,10116.0,,,BAO_0000218,
"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,1,CHEMBL627648,Intermediate,,,A,N,1,12548,,Rattus norvegicus,,,50597,,9104,10116.0,,,BAO_0000218,
Free level in rat plasma,,1,CHEMBL627649,Intermediate,,,A,N,1,12549,,Rattus norvegicus,,,50597,,12902,10116.0,,,BAO_0000218,
Level reaching in blood plasma of rat or human was determined,,0,CHEMBL628313,Autocuration,,,A,U,1,12550,,,,,22224,,6614,,,,BAO_0000019,
Log (Cbrain/Cblood) in rats,,1,CHEMBL628314,Intermediate,,,A,N,1,12551,,Rattus norvegicus,,,50597,,9663,10116.0,,,BAO_0000218,
Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,0,CHEMBL628315,Autocuration,,,A,U,1,12552,,,,,22224,,17658,,,,BAO_0000019,
Mean percentage of compound transport through membrane; expressed as membrane transport,,0,CHEMBL628316,Autocuration,,,A,U,1,12553,,,,,22224,,17658,,,,BAO_0000019,
Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,0,CHEMBL628317,Autocuration,,,A,U,1,12554,,,,,22224,,14314,,,,BAO_0000218,
Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,0,CHEMBL628473,Autocuration,,,A,U,1,12555,,,,,22224,,7385,,,,BAO_0000019,
"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,0,CHEMBL628474,Autocuration,,,A,U,1,12556,,,,,22224,,7385,,,,BAO_0000019,
Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,0,CHEMBL628475,Autocuration,,,A,U,1,12557,,,,,22224,,7385,,,,BAO_0000019,
Net water uptake by a carrier mediated transport (%cm) mechanism,,0,CHEMBL628476,Autocuration,,,A,U,1,12558,,,,,22224,,1329,,,,BAO_0000019,
Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,0,CHEMBL628477,Autocuration,,,A,U,1,12559,,Simiiformes,,,22224,,12187,314293.0,,,BAO_0000218,
Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,1,CHEMBL628478,Intermediate,,,A,N,1,12560,,Mustela putorius furo,,,50506,,12187,9669.0,,,BAO_0000218,
"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,1,CHEMBL628479,Intermediate,,,A,N,1,12561,,Mustela putorius furo,,,50506,,12187,9669.0,,,BAO_0000218,
Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,0,CHEMBL628480,Autocuration,,,A,U,1,12562,,Simiiformes,,,22224,,12187,314293.0,,,BAO_0000218,
"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,0,CHEMBL628481,Autocuration,,,A,U,1,12563,,Simiiformes,,,22224,,12187,314293.0,,,BAO_0000218,
Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,1,CHEMBL628482,Intermediate,,,A,N,1,12564,,Rattus norvegicus,,,50597,,12187,10116.0,,,BAO_0000218,
"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,1,CHEMBL628483,Intermediate,,,A,N,1,12565,,Rattus norvegicus,,,50597,,12187,10116.0,,,BAO_0000218,
"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,1,CHEMBL628484,Intermediate,,,A,N,1,12566,1969.0,Rattus norvegicus,,,50597,,9278,10116.0,,Plasma,BAO_0000218,
"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,1,CHEMBL628485,Intermediate,,,A,N,1,12567,1969.0,Rattus norvegicus,,,50597,,9278,10116.0,,Plasma,BAO_0000218,
"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,1,CHEMBL628486,Intermediate,,,A,N,1,12568,1969.0,Macaca fascicularis,,,100710,,9278,9541.0,,Plasma,BAO_0000218,
"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,1,CHEMBL628487,Intermediate,,,A,N,1,12569,1969.0,Homo sapiens,,,50587,,9278,9606.0,,Plasma,BAO_0000218,
"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,1,CHEMBL628488,Intermediate,,,A,N,1,12570,1969.0,Rattus norvegicus,,,50597,,9278,10116.0,,Plasma,BAO_0000218,
"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,1,CHEMBL628489,Intermediate,,,A,N,1,12571,1969.0,Rattus norvegicus,,,50597,,9278,10116.0,,Plasma,BAO_0000218,
"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,1,CHEMBL628490,Intermediate,,,A,N,1,12572,1969.0,Rattus norvegicus,,,50597,,9278,10116.0,,Plasma,BAO_0000218,
Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,1,CHEMBL628491,Intermediate,,,A,N,1,12573,,Macaca fascicularis,,,100710,,12186,9541.0,,,BAO_0000218,
Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,1,CHEMBL877507,Intermediate,,,A,N,1,12574,,Macaca fascicularis,,,100710,,12186,9541.0,,,BAO_0000218,
Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,0,CHEMBL628492,Autocuration,,,A,U,1,12575,,,,,22224,,12186,,,,BAO_0000218,
% metabolized in monkey S-9 after 2 hours (10 ug/mL),,0,CHEMBL628493,Autocuration,,,A,U,1,12576,,Simiiformes,,,22224,,12041,314293.0,,,BAO_0000019,
% metabolized in monkey S-9 after 2 hours (1 ug/ml),,0,CHEMBL628494,Autocuration,,,A,U,1,12577,,Simiiformes,,,22224,,12041,314293.0,,,BAO_0000019,
% metabolized in monkey S-9 after 2 hours (10 ug/ml),,0,CHEMBL628495,Autocuration,,,A,U,1,12578,,Simiiformes,,,22224,,12041,314293.0,,,BAO_0000019,
Permeability in Caco-2 assay at 10E-6,,1,CHEMBL628496,Intermediate,,,A,N,1,12579,,Homo sapiens,,,50587,,6737,9606.0,,,BAO_0000218,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,0,CHEMBL628497,Autocuration,,,A,U,1,12580,955.0,,,,22224,,13758,,,Brain,BAO_0000218,
Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,0,CHEMBL628498,Autocuration,,,A,U,1,12581,955.0,,,,22224,,13758,,,Brain,BAO_0000218,
Plasma protein binding was determined,,0,CHEMBL628499,Autocuration,,,A,U,1,12582,,,,,22224,,5676,,,,BAO_0000019,
Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,0,CHEMBL627656,Autocuration,,,A,U,1,12583,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,CHEMBL627657,Autocuration,,,A,U,1,12584,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,0,CHEMBL626808,Autocuration,,,A,U,1,12585,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,0,CHEMBL626809,Autocuration,,,A,U,1,12586,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,0,CHEMBL626810,Autocuration,,,A,U,1,12587,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,CHEMBL626811,Autocuration,,,A,U,1,12588,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,0,CHEMBL874465,Autocuration,,,A,U,1,12589,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,0,CHEMBL626812,Autocuration,,,A,U,1,12590,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,0,CHEMBL626813,Autocuration,,,A,U,1,12591,,,,,22224,,14793,,,,BAO_0000218,
Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,0,CHEMBL626814,Autocuration,,,A,U,1,12592,,,,,22224,,14793,,,,BAO_0000218,
Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,0,CHEMBL626815,Autocuration,,,A,U,1,12593,,,,,22224,,14000,,,,BAO_0000019,
Partition coefficient (logP),,0,CHEMBL628566,Autocuration,,,A,U,1,12594,,,,,22224,,5948,,,,BAO_0000019,
Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,CHEMBL628567,Autocuration,,,P,U,1,12595,,,,,22229,,13824,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL628568,Autocuration,,,P,U,1,12596,,,,,22229,,10778,,,,BAO_0000100,
C max in dog,,1,CHEMBL628569,Intermediate,,,A,N,1,12597,,Canis lupus familiaris,In vivo,,50588,,17237,9615.0,,,BAO_0000218,
C max in guinea pig,,1,CHEMBL628570,Intermediate,,,A,N,1,12598,,Cavia porcellus,In vivo,,50512,,17237,10141.0,,,BAO_0000218,
C max value was evaluated,,0,CHEMBL628571,Autocuration,,,A,U,1,12599,,,In vivo,,22224,,2809,,,,BAO_0000218,
Cmax value after oral dose of 0.1 mg//kg,,0,CHEMBL628572,Autocuration,,,A,U,1,12600,,,In vivo,,22224,,11954,,,,BAO_0000218,
Cmax value after oral dose of 0.3 mg/kg,,0,CHEMBL628573,Autocuration,,,A,U,1,12601,,,In vivo,,22224,,11954,,,,BAO_0000218,
Cmax value after oral dose of 1 mg/kg,,0,CHEMBL628574,Autocuration,,,A,U,1,12602,,,In vivo,,22224,,11954,,,,BAO_0000218,
Cmax value after oral dose of 10 mg/kg,,0,CHEMBL628575,Autocuration,,,A,U,1,12603,,,In vivo,,22224,,11954,,,,BAO_0000218,
Cmax value after oral dose of 23.4 mg/kg,,0,CHEMBL628576,Autocuration,,,A,U,1,12604,,,In vivo,,22224,,11954,,,,BAO_0000218,
Cmax value after oral dose of 3 mg/kg,,0,CHEMBL628577,Autocuration,,,A,U,1,12605,,,In vivo,,22224,,11954,,,,BAO_0000218,
Cmax value after oral dose of 3.87 mg/kg,,0,CHEMBL628578,Autocuration,,,A,U,1,12606,,,In vivo,,22224,,11954,,,,BAO_0000218,
Cmax value in female Beagle dogs,,1,CHEMBL874466,Intermediate,,,A,N,1,12607,,Canis lupus familiaris,In vivo,,50588,,12768,9615.0,,,BAO_0000218,
Cmax value in male rats,,1,CHEMBL628579,Intermediate,,,A,N,1,12608,,Rattus norvegicus,In vivo,,50597,,12768,10116.0,,,BAO_0000218,
Cmax value in rat plasma when administered 20 mg/kg perorally,,1,CHEMBL628580,Intermediate,,,A,N,1,12609,1969.0,Rattus norvegicus,In vivo,,50597,,12780,10116.0,,Plasma,BAO_0000218,
Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,1,CHEMBL628581,Intermediate,,,A,N,1,12610,1969.0,Canis lupus familiaris,In vivo,,50588,,15592,9615.0,,Plasma,BAO_0000218,
Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,1,CHEMBL628582,Intermediate,,,A,N,1,12611,1969.0,Canis lupus familiaris,In vivo,,50588,,15592,9615.0,,Plasma,BAO_0000218,
Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,1,CHEMBL628583,Intermediate,,,A,N,1,12612,,Canis lupus familiaris,,,50588,,17025,9615.0,,,BAO_0000218,
Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,0,CHEMBL625782,Autocuration,,,A,U,1,12613,,Simiiformes,,,22224,,17025,314293.0,,,BAO_0000218,
Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,1,CHEMBL625783,Intermediate,,,A,N,1,12614,,Oryctolagus cuniculus,,,50592,,17025,9986.0,,,BAO_0000218,
Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,1,CHEMBL625784,Intermediate,,,A,N,1,12615,,Rattus norvegicus,,,50597,,17025,10116.0,,,BAO_0000218,
Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,1,CHEMBL625785,Intermediate,,,A,N,1,12616,1969.0,Macaca mulatta,,,50797,,4236,9544.0,,Plasma,BAO_0000218,
C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,1,CHEMBL625786,Intermediate,,,A,N,1,12617,,Rattus norvegicus,,,50597,,15791,10116.0,,,BAO_0000218,
C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,0,CHEMBL874467,Autocuration,,,A,U,1,12618,,,,,22224,,11149,,,,BAO_0000019,
"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,1,CHEMBL625787,Intermediate,,,A,N,1,12619,,Canis lupus familiaris,,,50588,,15592,9615.0,,,BAO_0000218,
cytotoxicity against HIV protease enzyme.,,1,CHEMBL625964,Intermediate,,,A,N,1,12620,,Human immunodeficiency virus,,,50677,,15778,12721.0,,,BAO_0000218,
Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,1,CHEMBL625965,Intermediate,,,A,N,1,12621,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
Apparent clearance in mice after oral administration of 100 mg/kg of dose,,1,CHEMBL625966,Intermediate,,,A,N,1,12622,,Mus musculus,,,50594,,12745,10090.0,,,BAO_0000218,
The plasma clearance in dog.,,1,CHEMBL625967,Intermediate,,,A,N,1,12623,1969.0,Canis lupus familiaris,In vivo,,50588,,13941,9615.0,,Plasma,BAO_0000218,
The plasma clearance in rat.,,1,CHEMBL625968,Intermediate,,,A,N,1,12624,1969.0,Rattus norvegicus,In vivo,,50597,,13941,10116.0,,Plasma,BAO_0000218,
Clearance from plasma in male Sprague-Dawley rats,,1,CHEMBL625969,Intermediate,,,A,N,1,12625,1969.0,Rattus norvegicus,In vivo,,50597,,16449,10116.0,,Plasma,BAO_0000218,
Clearance from plasma in male cynomolgus monkeys,,1,CHEMBL625970,Intermediate,,,A,N,1,12626,1969.0,Macaca fascicularis,In vivo,,100710,,16449,9541.0,,Plasma,BAO_0000218,
"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,1,CHEMBL625971,Intermediate,,,A,N,1,12627,1969.0,Canis lupus familiaris,In vivo,,50588,,14224,9615.0,,Plasma,BAO_0000218,
Clearance of compound in dog plasma,,1,CHEMBL625972,Intermediate,,,A,N,1,12628,1969.0,Canis lupus familiaris,In vivo,,50588,,14224,9615.0,,Plasma,BAO_0000218,
Clearance of compound in human plasma,,1,CHEMBL625973,Intermediate,,,A,N,1,12629,1969.0,Homo sapiens,In vivo,,50587,,14224,9606.0,,Plasma,BAO_0000218,
Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,1,CHEMBL625974,Intermediate,,,A,N,1,12630,,Canis lupus familiaris,In vivo,,50588,,14317,9615.0,,,BAO_0000218,
Clearance of compound when administered intravenously as an individual dose to a single dog.,,1,CHEMBL625975,Intermediate,,,A,N,1,12631,,Canis lupus familiaris,In vivo,,50588,,14317,9615.0,,,BAO_0000218,
"Clearance (10 mg/kg, intravenously) in dog plasma",,1,CHEMBL625976,Intermediate,,,A,N,1,12632,1969.0,Canis lupus familiaris,In vivo,,50588,,14224,9615.0,,Plasma,BAO_0000218,
Clearance value in dog,,1,CHEMBL625977,Intermediate,,,A,N,1,12633,,Canis lupus familiaris,In vivo,,50588,,17237,9615.0,,,BAO_0000218,
Clearance value in guinea pig,,1,CHEMBL625978,Intermediate,,,A,N,1,12634,,Cavia porcellus,In vivo,,50512,,17237,10141.0,,,BAO_0000218,
Clearance values in rats after iv administration.,,1,CHEMBL874468,Intermediate,,,A,N,1,12635,,Rattus norvegicus,In vivo,,50597,,14187,10116.0,,,BAO_0000218,
Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,0,CHEMBL625421,Autocuration,,,A,U,1,12636,1969.0,,In vivo,,22224,,4806,,,Plasma,BAO_0000218,
In vivo clearance (5 mg/kg) was determined in rabbits,,1,CHEMBL625422,Intermediate,,,A,N,1,12637,,Oryctolagus cuniculus,In vivo,,50592,,15025,9986.0,,,BAO_0000218,
Plasma Clearance rate was determined for the compound in rats,,1,CHEMBL625423,Intermediate,,,A,N,1,12638,,Rattus norvegicus,In vivo,,50597,,13197,10116.0,,,BAO_0000218,
Plasma Clearance rate was determined for the compound in squirrel monkeys,,0,CHEMBL625424,Autocuration,,,A,U,1,12639,,Saimiri,In vivo,,22224,,13197,9520.0,,,BAO_0000218,
Plasma clearance in rat,,1,CHEMBL625425,Intermediate,,,A,N,1,12640,,Rattus norvegicus,In vivo,,50597,,13960,10116.0,,,BAO_0000218,
Plasma clearance of the compound,,0,CHEMBL625426,Autocuration,,,A,U,1,12641,,,In vivo,,22224,,17820,,,,BAO_0000218,
Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,1,CHEMBL625427,Intermediate,,,A,N,1,12642,,Cavia porcellus,In vivo,,50512,,14706,10141.0,,,BAO_0000218,
Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,1,CHEMBL625428,Intermediate,,,A,N,1,12643,,Cavia porcellus,In vivo,,50512,,14706,10141.0,,,BAO_0000218,
Plasma clearance was determined,,0,CHEMBL625429,Autocuration,,,A,U,1,12644,,,In vivo,,22224,,6504,,,,BAO_0000218,
Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,1,CHEMBL625430,Intermediate,,,A,N,1,12645,,Canis lupus familiaris,In vivo,,50588,,14925,9615.0,,,BAO_0000218,
Plasma clearance rate was determined for the compound in rats,,1,CHEMBL625431,Intermediate,,,A,N,1,12646,,Rattus norvegicus,In vivo,,50597,,13197,10116.0,,,BAO_0000218,
Plasma clearance rate was determined for the compound in squirrel monkeys,,0,CHEMBL627307,Autocuration,,,A,U,1,12647,,Saimiri,In vivo,,22224,,13197,9520.0,,,BAO_0000218,
Slow clearance (CL) was determined,,0,CHEMBL627308,Autocuration,,,A,U,1,12648,,,In vivo,,22224,,3437,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,CHEMBL627309,Autocuration,,,A,U,1,12649,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,0,CHEMBL627310,Autocuration,,,A,U,1,12650,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,0,CHEMBL627311,Autocuration,,,A,U,1,12651,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,CHEMBL627312,Autocuration,,,A,U,1,12652,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,0,CHEMBL627313,Autocuration,,,A,U,1,12653,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,CHEMBL627314,Autocuration,,,A,U,1,12654,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,CHEMBL627315,Autocuration,,,A,U,1,12655,,,,,22224,,9196,,,,BAO_0000218,
Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,CHEMBL627316,Autocuration,,,A,U,1,12656,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,CHEMBL627317,Autocuration,,,A,U,1,12657,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,CHEMBL627318,Autocuration,,,A,U,1,12658,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,0,CHEMBL627999,Autocuration,,,A,U,1,12659,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,CHEMBL628000,Autocuration,,,A,U,1,12660,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,CHEMBL628001,Autocuration,,,A,U,1,12661,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,CHEMBL628002,Autocuration,,,A,U,1,12662,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,CHEMBL625610,Autocuration,,,A,U,1,12663,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,CHEMBL625611,Autocuration,,,A,U,1,12664,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,0,CHEMBL625612,Autocuration,,,A,U,1,12665,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,0,CHEMBL625613,Autocuration,,,A,U,1,12666,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,CHEMBL875479,Autocuration,,,A,U,1,12667,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,CHEMBL625614,Autocuration,,,A,U,1,12668,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,CHEMBL625615,Autocuration,,,A,U,1,12669,,,,,22224,,9196,,,,BAO_0000218,
Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,0,CHEMBL626302,Autocuration,,,A,U,1,12670,,,,,22224,,9196,,,,BAO_0000218,
Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL626303,Intermediate,,,A,N,1,12671,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,CHEMBL627420,Intermediate,,,A,N,1,12672,178.0,Rattus norvegicus,,,50597,,8374,10116.0,,Blood,BAO_0000218,
Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,1,CHEMBL627421,Intermediate,,,A,N,1,12673,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,1,CHEMBL625695,Intermediate,,,A,N,1,12674,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,1,CHEMBL625696,Intermediate,,,A,N,1,12675,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Distribution of compound in mice brain was measured after 1 hr,,1,CHEMBL875606,Intermediate,,,A,N,1,12676,955.0,Mus musculus,,,50594,,10009,10090.0,,Brain,BAO_0000218,
Distribution of compound in mice brain was measured after 24 hr r,,1,CHEMBL625697,Intermediate,,,A,N,1,12677,955.0,Mus musculus,,,50594,,10009,10090.0,,Brain,BAO_0000218,
Distribution of compound in mice brain was measured after 2 hr,,1,CHEMBL625698,Intermediate,,,A,N,1,12678,955.0,Mus musculus,,,50594,,10009,10090.0,,Brain,BAO_0000218,
Distribution of compound in mice brain was measured after 3 hr,,1,CHEMBL625699,Intermediate,,,A,N,1,12679,955.0,Mus musculus,,,50594,,10009,10090.0,,Brain,BAO_0000218,
Distribution of compound in mice brain was measured after 6 hr,,1,CHEMBL625700,Intermediate,,,A,N,1,12680,955.0,Mus musculus,,,50594,,10009,10090.0,,Brain,BAO_0000218,
Distribution of compound in mice liver was measured after 1 hr,,1,CHEMBL625701,Intermediate,,,A,N,1,12681,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,1,CHEMBL625702,Intermediate,,,A,N,1,12682,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
Distribution of compound in mice liver was measured after 2 hr,,1,CHEMBL625703,Intermediate,,,A,N,1,12683,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
Distribution of compound in mice liver was measured after 3 hr,,1,CHEMBL625704,Intermediate,,,A,N,1,12684,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
Distribution of compound in mice liver was measured after 6 hr,,1,CHEMBL625705,Intermediate,,,A,N,1,12685,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
Distribution in dog adrenal medulla 30 min after administration.,,1,CHEMBL625706,Intermediate,,,A,N,1,12686,1236.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Adrenal medulla,BAO_0000218,
Distribution in dog adrenal medulla 72 hours after administration.,,1,CHEMBL625707,Intermediate,,,A,N,1,12687,1236.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Adrenal medulla,BAO_0000218,
Distribution in female dog Ovary 24 hours after administration.,,1,CHEMBL625708,Intermediate,,,A,N,1,12688,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog Ovary 72 hours after administration.,,1,CHEMBL625709,Intermediate,,,A,N,1,12689,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog adipose 24 hours after administration.,,1,CHEMBL624180,Intermediate,,,A,N,1,12690,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog adipose 72 hours after administration.,,1,CHEMBL624181,Intermediate,,,A,N,1,12691,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog adrenal cortex 72 hours after administration.,,1,CHEMBL624182,Intermediate,,,A,N,1,12692,1235.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Adrenal cortex,BAO_0000218,
Distribution in female dog adrenal cortex 72 hours after administration.,,1,CHEMBL624183,Intermediate,,,A,N,1,12693,1235.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Adrenal cortex,BAO_0000218,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,CHEMBL624184,Intermediate,,,A,N,1,12694,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,CHEMBL877489,Intermediate,,,A,N,1,12695,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL624185,Intermediate,,,A,N,1,12696,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,CHEMBL624186,Intermediate,,,A,N,1,12697,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,CHEMBL624187,Intermediate,,,A,N,1,12698,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,CHEMBL624188,Intermediate,,,A,N,1,12699,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,CHEMBL624189,Intermediate,,,A,N,1,12700,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,CHEMBL624190,Intermediate,,,A,N,1,12701,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,CHEMBL624191,Intermediate,,,A,N,1,12702,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,CHEMBL624192,Intermediate,,,A,N,1,12703,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,CHEMBL624193,Intermediate,,,A,N,1,12704,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,CHEMBL624194,Intermediate,,,A,N,1,12705,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,CHEMBL624891,Intermediate,,,A,N,1,12706,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,CHEMBL624892,Intermediate,,,A,N,1,12707,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,CHEMBL624893,Intermediate,,,A,N,1,12708,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL627632,Intermediate,,,A,N,1,12709,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,CHEMBL627633,Intermediate,,,A,N,1,12710,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,CHEMBL627634,Intermediate,,,A,N,1,12711,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,CHEMBL627635,Intermediate,,,A,N,1,12712,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,CHEMBL627636,Intermediate,,,A,N,1,12713,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,CHEMBL626816,Intermediate,,,A,N,1,12714,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,CHEMBL626817,Intermediate,,,A,N,1,12715,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,CHEMBL626818,Intermediate,,,A,N,1,12716,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,CHEMBL626819,Intermediate,,,A,N,1,12717,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,CHEMBL626820,Intermediate,,,A,N,1,12718,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL626821,Intermediate,,,A,N,1,12719,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,CHEMBL626822,Intermediate,,,A,N,1,12720,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,CHEMBL626823,Intermediate,,,A,N,1,12721,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,CHEMBL626824,Intermediate,,,A,N,1,12722,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,CHEMBL626825,Intermediate,,,A,N,1,12723,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,CHEMBL626826,Intermediate,,,A,N,1,12724,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,CHEMBL626827,Intermediate,,,A,N,1,12725,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,CHEMBL626828,Intermediate,,,A,N,1,12726,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,CHEMBL626829,Intermediate,,,A,N,1,12727,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL626830,Intermediate,,,A,N,1,12728,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,CHEMBL627150,Intermediate,,,A,N,1,12729,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL627151,Intermediate,,,A,N,1,12730,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,CHEMBL627152,Intermediate,,,A,N,1,12731,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,CHEMBL627153,Intermediate,,,A,N,1,12732,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Rate of acetate production by the compound was determined,,0,CHEMBL627154,Autocuration,,,A,U,1,12733,,,,,22224,,12904,,,,BAO_0000019,
Rate of acetate production by the compound was determined; Not determined,,0,CHEMBL627155,Autocuration,,,A,U,1,12734,,,,,22224,,12904,,,,BAO_0000019,
Rate of hydrolysis of nitrocefin by compound was evaluated in water,,0,CHEMBL627156,Autocuration,,,A,U,1,12735,,,,,22224,,3730,,,,BAO_0000019,
Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,0,CHEMBL627157,Autocuration,,,A,U,1,12736,,,,,22224,,3627,,,,BAO_0000019,
Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,1,CHEMBL627158,Intermediate,,,A,N,1,12737,,Oryctolagus cuniculus,,,50592,,13799,9986.0,,,BAO_0000218,
Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,1,CHEMBL627159,Intermediate,,,A,N,1,12738,1969.0,Oryctolagus cuniculus,,,50592,,13799,9986.0,,Plasma,BAO_0000218,
Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,1,CHEMBL627160,Intermediate,,,A,N,1,12739,,Mus musculus,,,50594,,13799,10090.0,,,BAO_0000218,
Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,1,CHEMBL628540,Intermediate,,,A,N,1,12740,,Rattus norvegicus,,,50597,,13799,10116.0,,,BAO_0000218,
Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,1,CHEMBL628541,Intermediate,,,A,N,1,12741,1969.0,Rattus norvegicus,,,50597,,13799,10116.0,,Plasma,BAO_0000218,
Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,1,CHEMBL628542,Intermediate,,,A,N,1,12742,1969.0,Rattus norvegicus,,,50597,,13799,10116.0,,Plasma,BAO_0000218,
Solubility after at a pH 1.2,,0,CHEMBL628543,Autocuration,,,P,U,1,12743,,,,,22229,,6629,,,,BAO_0000100,
Solubility after at pH 1.2,,0,CHEMBL628544,Autocuration,,,P,U,1,12744,,,,,22229,,6629,,,,BAO_0000100,
Solubility after injection of water,,0,CHEMBL628545,Autocuration,,,P,U,1,12745,,,,,22229,,6629,,,,BAO_0000100,
Statistical significance of IC 50 values; Expressed as R value,,0,CHEMBL628546,Autocuration,,,A,U,1,12746,,,,,22224,,14000,,,,BAO_0000019,
Systemic availability with respect to methyldopa was determined,,0,CHEMBL874455,Autocuration,,,A,U,1,12747,,,,,22224,,8267,,,,BAO_0000019,
Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,1,CHEMBL628547,Intermediate,,,A,N,1,12748,,Rattus norvegicus,,,50597,,13799,10116.0,,,BAO_0000218,
Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,1,CHEMBL628548,Intermediate,,,A,N,1,12749,1969.0,Rattus norvegicus,,,50597,,13799,10116.0,,Plasma,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,1,CHEMBL628549,Intermediate,,,A,N,1,12750,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,1,CHEMBL628550,Intermediate,,,A,N,1,12751,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,1,CHEMBL628551,Intermediate,,,A,N,1,12752,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,1,CHEMBL628552,Intermediate,,,A,N,1,12753,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,1,CHEMBL628553,Intermediate,,,A,N,1,12754,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,1,CHEMBL628554,Intermediate,,,A,N,1,12755,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,1,CHEMBL628555,Intermediate,,,A,N,1,12756,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,1,CHEMBL628556,Intermediate,,,A,N,1,12757,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,1,CHEMBL628557,Intermediate,,,A,N,1,12758,2113.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Kidney,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,1,CHEMBL628558,Intermediate,,,A,N,1,12759,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,1,CHEMBL628559,Intermediate,,,A,N,1,12760,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,1,CHEMBL628560,Intermediate,,,A,N,1,12761,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,1,CHEMBL874456,Intermediate,,,A,N,1,12762,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,1,CHEMBL628561,Intermediate,,,A,N,1,12763,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,1,CHEMBL628562,Intermediate,,,A,N,1,12764,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,1,CHEMBL628563,Intermediate,,,A,N,1,12765,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,1,CHEMBL628564,Intermediate,,,A,N,1,12766,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,1,CHEMBL628565,Intermediate,,,A,N,1,12767,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,1,CHEMBL631248,Intermediate,,,A,N,1,12768,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,1,CHEMBL631249,Intermediate,,,A,N,1,12769,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,1,CHEMBL627214,Intermediate,,,A,N,1,12770,2113.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Kidney,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,1,CHEMBL874591,Intermediate,,,A,N,1,12771,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,1,CHEMBL627215,Intermediate,,,A,N,1,12772,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,1,CHEMBL625471,Intermediate,,,A,N,1,12773,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,1,CHEMBL625472,Intermediate,,,A,N,1,12774,,Oryctolagus cuniculus,,,50592,,7132,9986.0,,,BAO_0000218,
Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,1,CHEMBL625473,Intermediate,,,A,N,1,12775,,Oryctolagus cuniculus,,,50592,,7132,9986.0,,,BAO_0000218,
Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,1,CHEMBL625474,Intermediate,,,A,N,1,12776,,Canis lupus familiaris,In vivo,,50588,,13317,9615.0,,,BAO_0000218,
The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,1,CHEMBL625475,Intermediate,,,A,N,1,12777,,Canis lupus familiaris,In vivo,,50588,,15341,9615.0,,,BAO_0000218,
The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,1,CHEMBL625476,Intermediate,,,A,N,1,12778,,Rattus norvegicus,In vivo,,50597,,15341,10116.0,,,BAO_0000218,
The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,1,CHEMBL625477,Intermediate,,,A,N,1,12779,,Rattus norvegicus,In vivo,,50597,,15341,10116.0,,,BAO_0000218,
The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,1,CHEMBL625478,Intermediate,,,A,N,1,12780,,Rattus norvegicus,In vivo,,50597,,15341,10116.0,,,BAO_0000218,
The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,1,CHEMBL625479,Intermediate,,,A,N,1,12781,,Rattus norvegicus,In vitro,,50597,,12801,10116.0,,esophageal tunica muscularis mucosae,BAO_0000218,
The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,1,CHEMBL625480,Intermediate,,,A,N,1,12782,,Rattus norvegicus,In vitro,,50597,,12801,10116.0,,esophageal tunica muscularis mucosae,BAO_0000218,
The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,1,CHEMBL625481,Intermediate,,,A,N,1,12783,1969.0,Rattus norvegicus,In vivo,,50597,,14856,10116.0,,Plasma,BAO_0000218,
Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,1,CHEMBL625482,Intermediate,,,A,N,1,12784,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,1,CHEMBL625483,Intermediate,,,A,N,1,12785,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,1,CHEMBL625484,Intermediate,,,A,N,1,12786,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,1,CHEMBL625485,Intermediate,,,A,N,1,12787,,Rattus norvegicus,In vivo,,50597,,14062,10116.0,,,BAO_0000218,
Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,1,CHEMBL625486,Intermediate,,,A,N,1,12788,1969.0,Canis lupus familiaris,In vivo,,50588,,14346,9615.0,,Plasma,BAO_0000218,
Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,1,CHEMBL625487,Intermediate,,,A,N,1,12789,1969.0,Rattus norvegicus,In vivo,,50597,,14346,10116.0,,Plasma,BAO_0000218,
Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,1,CHEMBL625488,Intermediate,,,A,N,1,12790,1969.0,Rattus norvegicus,In vivo,,50597,,14346,10116.0,,Plasma,BAO_0000218,
Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,1,CHEMBL625489,Intermediate,,,A,N,1,12791,1969.0,Rattus norvegicus,In vivo,,50597,,14346,10116.0,,Plasma,BAO_0000218,
Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,1,CHEMBL625490,Intermediate,,,A,N,1,12792,1969.0,Rattus norvegicus,In vivo,,50597,,14346,10116.0,,Plasma,BAO_0000218,
Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,1,CHEMBL625491,Intermediate,,,A,N,1,12793,1969.0,Canis lupus familiaris,In vivo,,50588,,14346,9615.0,,Plasma,BAO_0000218,
Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,1,CHEMBL625492,Intermediate,,,A,N,1,12794,1969.0,Rattus norvegicus,In vivo,,50597,,14346,10116.0,,Plasma,BAO_0000218,
plasma clearance in human,,1,CHEMBL625493,Intermediate,,,A,N,1,12795,1969.0,Homo sapiens,In vivo,,50587,,15711,9606.0,,Plasma,BAO_0000218,
Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,1,CHEMBL625494,Intermediate,,,A,N,1,12796,,Rattus norvegicus,In vivo,,50597,,14886,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,1,CHEMBL625495,Intermediate,,,A,N,1,12797,,Rattus norvegicus,In vivo,,50597,,14886,10116.0,,,BAO_0000218,
Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,1,CHEMBL625496,Intermediate,,,A,N,1,12798,,Rattus norvegicus,In vivo,,50597,,14886,10116.0,,,BAO_0000218,
1-Octanol/water partition coefficient measured at 7.4,,0,CHEMBL625497,Autocuration,,,P,U,1,12799,,,,,22229,,4115,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625498,Autocuration,,,P,U,1,12800,,,,,22229,,13733,,,,BAO_0000100,
Partition coefficient (logP),,0,CHEMBL625499,Autocuration,,,A,U,1,12801,,,,,22224,,12102,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL625500,Autocuration,,,P,U,1,12802,,,,,22229,,12676,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625501,Autocuration,,,P,U,1,12803,,,,,22229,,13733,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625502,Autocuration,,,P,U,1,12804,,,,,22229,,13740,,,,BAO_0000100,
Calculated partition coefficient (clogP) (relative to BAY K 8644),,0,CHEMBL625503,Autocuration,,,P,U,1,12805,,,,,22229,,12766,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625504,Autocuration,,,P,U,1,12806,,,,,22229,,2764,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625505,Autocuration,,,P,U,1,12807,,,,,22229,,12355,,,,BAO_0000100,
Calculated partition coefficient of the compound,,0,CHEMBL625506,Autocuration,,,P,U,1,12808,,,,,22229,,11314,,,,BAO_0000100,
Partition coefficient (logP),,0,CHEMBL625507,Autocuration,,,A,U,1,12809,,,,,22224,,12706,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL625508,Autocuration,,,P,U,1,12810,,,,,22229,,12645,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625509,Autocuration,,,P,U,1,12811,,,,,22229,,13668,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625510,Autocuration,,,P,U,1,12812,,,,,22229,,12819,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL883125,Autocuration,,,P,U,1,12813,,,,,22229,,13668,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625511,Autocuration,,,P,U,1,12814,,,,,22229,,13017,,,,BAO_0000100,
Partition coefficient of the compound,,0,CHEMBL874650,Autocuration,,,A,U,1,12815,,,,,22224,,2448,,,,BAO_0000019,
Partition coefficient of the compound,,0,CHEMBL625512,Autocuration,,,A,U,1,12816,,,,,22224,,11526,,,,BAO_0000019,
Partition coefficient of compound was determined,,0,CHEMBL625513,Autocuration,,,A,U,1,12817,,,,,22224,,12426,,,,BAO_0000019,
Partition coefficient was determined,,0,CHEMBL625514,Autocuration,,,A,U,1,12818,,,,,22224,,2448,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL625515,Autocuration,,,P,U,1,12819,,,,,22229,,12001,,,,BAO_0000100,
partition coefficient of compound was determined,,0,CHEMBL625516,Autocuration,,,P,U,1,12820,,,,,22229,,12426,,,,BAO_0000100,
The total body administered intravenously in dog,,1,CHEMBL625517,Intermediate,,,A,N,1,12821,,Canis lupus familiaris,In vivo,,50588,,13204,9615.0,,,BAO_0000218,
The total body administered intravenously in rats,,1,CHEMBL625518,Intermediate,,,A,N,1,12822,,Rattus norvegicus,In vivo,,50597,,13204,10116.0,,,BAO_0000218,
Time taken for the administration to female NIH mice weighing 25-30 g.,,1,CHEMBL625519,Intermediate,,,A,N,1,12823,,Mus musculus,,,50594,,13889,10090.0,,,BAO_0000218,
Time taken for the administration,,0,CHEMBL625520,Autocuration,,,A,U,1,12824,,,,,22224,,13889,,,,BAO_0000019,
Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,1,CHEMBL874651,Intermediate,,,A,N,1,12825,,Canis lupus familiaris,In vivo,,50588,,17025,9615.0,,,BAO_0000218,
Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,0,CHEMBL625521,Autocuration,,,A,U,1,12826,,Simiiformes,In vivo,,22224,,17025,314293.0,,,BAO_0000218,
Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,1,CHEMBL623171,Intermediate,,,A,N,1,12827,,Oryctolagus cuniculus,In vivo,,50592,,17025,9986.0,,,BAO_0000218,
Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,1,CHEMBL623853,Intermediate,,,A,N,1,12828,,Rattus norvegicus,In vivo,,50597,,17025,10116.0,,,BAO_0000218,
Plasma clearance for the compound was determined.,,0,CHEMBL623854,Autocuration,,,A,U,1,12829,,,,,22224,,15067,,,,BAO_0000019,
CLog P value of the compound,,0,CHEMBL874405,Autocuration,,,P,U,1,12830,,,,,22224,,3091,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL623855,Autocuration,,,P,U,1,12831,,,,,22229,,15592,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL623856,Autocuration,,,P,U,1,12832,,,,,22229,,14738,,,,BAO_0000100,
ClogP value of the compound; nd ='no data',,0,CHEMBL623857,Autocuration,,,P,U,1,12833,,,,,22224,,14738,,,,BAO_0000100,
ClogP value of the compound; nd ='not determined',,0,CHEMBL623858,Autocuration,,,P,U,1,12834,,,,,22224,,14738,,,,BAO_0000100,
CLog P was determined,,0,CHEMBL623859,Autocuration,,,P,U,1,12835,,,,,22224,,6076,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL839829,Autocuration,,,P,U,1,12836,,,,,22229,,17840,,,,BAO_0000100,
CLogP was calculated,,0,CHEMBL623860,Autocuration,,,A,U,1,12837,,,,,22224,,13589,,,,BAO_0000019,
CLogP value was determined,,0,CHEMBL623861,Autocuration,,,A,U,1,12838,,,,,22224,,17655,,,,BAO_0000019,
CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,0,CHEMBL623862,Autocuration,,,A,U,1,12839,,,,,22224,,5867,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL874406,Autocuration,,,P,U,1,12840,,,,,22229,,5867,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL623863,Autocuration,,,P,U,1,12841,,,,,22229,,10783,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624021,Autocuration,,,P,U,1,12842,,,,,22229,,14849,,,,BAO_0000100,
Distribution in female dog adrenal medulla 24 hours after administration.,,1,CHEMBL624022,Intermediate,,,A,N,1,12843,1236.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Adrenal medulla,BAO_0000218,
Distribution in female dog adrenal medulla 72 hours after administration.,,1,CHEMBL624023,Intermediate,,,A,N,1,12844,1236.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Adrenal medulla,BAO_0000218,
Distribution in female dog bile 24 hours after administration.,,1,CHEMBL624024,Intermediate,,,A,N,1,12845,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog bile 72 hr after administration.,,1,CHEMBL624025,Intermediate,,,A,N,1,12846,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog blood 24 hours after administration.,,1,CHEMBL624026,Intermediate,,,A,N,1,12847,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog blood 72 hours after administration.,,1,CHEMBL624027,Intermediate,,,A,N,1,12848,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog heart 24 hours after administration.,,1,CHEMBL624028,Intermediate,,,A,N,1,12849,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog heart 72 hours after administration.,,1,CHEMBL624029,Intermediate,,,A,N,1,12850,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog kidney 24 hours after administration.,,1,CHEMBL624030,Intermediate,,,A,N,1,12851,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog kidney 72 hours after administration.,,1,CHEMBL624031,Intermediate,,,A,N,1,12852,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog large intestine 24 hours after administration.,,1,CHEMBL624032,Intermediate,,,A,N,1,12853,160.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Intestine,BAO_0000218,
Distribution in female dog large intestine 72 hours after administration.,,1,CHEMBL874407,Intermediate,,,A,N,1,12854,160.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Intestine,BAO_0000218,
Distribution in female dog liver 24 hours after administration.,,1,CHEMBL624033,Intermediate,,,A,N,1,12855,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog liver 72 hours after administration.,,1,CHEMBL624034,Intermediate,,,A,N,1,12856,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog lung 24 hours after administration.,,1,CHEMBL624035,Intermediate,,,A,N,1,12857,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog lung 72 hours after administration.,,1,CHEMBL624036,Intermediate,,,A,N,1,12858,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog muscle 24 hours after administration.,,1,CHEMBL624037,Intermediate,,,A,N,1,12859,2385.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Muscle tissue,BAO_0000218,
Distribution in female dog muscle 72 hours after administration.,,1,CHEMBL624038,Intermediate,,,A,N,1,12860,2385.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Muscle tissue,BAO_0000218,
Distribution in female dog pancreas 24 hours after administration.,,1,CHEMBL624039,Intermediate,,,A,N,1,12861,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog pancreas 72 hours after administration.,,1,CHEMBL624040,Intermediate,,,A,N,1,12862,,Canis lupus familiaris,,,50588,,8170,9615.0,,,BAO_0000218,
Distribution in female dog small intestine 24 hours after administration.,,1,CHEMBL624041,Intermediate,,,A,N,1,12863,160.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Intestine,BAO_0000218,
Distribution in female dog small intestine 72 hours after administration.,,1,CHEMBL624042,Intermediate,,,A,N,1,12864,160.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Intestine,BAO_0000218,
Distribution in female dog spleen 24 hours after administration.,,1,CHEMBL624043,Intermediate,,,A,N,1,12865,2106.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Spleen,BAO_0000218,
Distribution in female dog spleen 72 hours after administration.,,1,CHEMBL624044,Intermediate,,,A,N,1,12866,2106.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Spleen,BAO_0000218,
Distribution in female dog stomach 24 hours after administration.,,1,CHEMBL624045,Intermediate,,,A,N,1,12867,945.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Stomach,BAO_0000218,
Distribution in female dog stomach 72 hours after administration.,,1,CHEMBL624046,Intermediate,,,A,N,1,12868,945.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Stomach,BAO_0000218,
Distribution in female dog thyroid 24 hours after administration.,,1,CHEMBL624047,Intermediate,,,A,N,1,12869,2046.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Thyroid gland,BAO_0000218,
Distribution in female dog thyroid 72 hours after administration.,,1,CHEMBL624048,Intermediate,,,A,N,1,12870,2046.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Thyroid gland,BAO_0000218,
Distribution in female dog urine 24 hours after administration.,,1,CHEMBL874408,Intermediate,,,A,N,1,12871,1088.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Urine,BAO_0000218,
Distribution in female dog urine 72 hr after administration.,,1,CHEMBL624049,Intermediate,,,A,N,1,12872,1088.0,Canis lupus familiaris,,,50588,,8170,9615.0,,Urine,BAO_0000218,
Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,0,CHEMBL624050,Autocuration,,,A,U,1,12873,1969.0,,,,22224,,14283,,,Plasma,BAO_0000218,
Plasma concentration at 7 hr after intravenous dosing,,0,CHEMBL624051,Autocuration,,,A,U,1,12874,,,,,22224,,5623,,,,BAO_0000019,
Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,1,CHEMBL623278,Intermediate,,,A,N,1,12875,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,1,CHEMBL623279,Intermediate,,,A,N,1,12876,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration of 3 mg/kg iv after 1 hr in rats,,1,CHEMBL623280,Intermediate,,,A,N,1,12877,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration of 3 mg/kg iv after 2 hr in rats,,1,CHEMBL623963,Intermediate,,,A,N,1,12878,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration of 3 mg/kg iv after 4 hr in rats,,1,CHEMBL623964,Intermediate,,,A,N,1,12879,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration of 3 mg/kg iv after 6 hr in rats,,1,CHEMBL623965,Intermediate,,,A,N,1,12880,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,1,CHEMBL623966,Intermediate,,,A,N,1,12881,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,1,CHEMBL874415,Intermediate,,,A,N,1,12882,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,1,CHEMBL623967,Intermediate,,,A,N,1,12883,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,1,CHEMBL623968,Intermediate,,,A,N,1,12884,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,1,CHEMBL623969,Intermediate,,,A,N,1,12885,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,1,CHEMBL628409,Intermediate,,,A,N,1,12886,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,1,CHEMBL628410,Intermediate,,,A,N,1,12887,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,1,CHEMBL628411,Intermediate,,,A,N,1,12888,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,1,CHEMBL628412,Intermediate,,,A,N,1,12889,,Rattus norvegicus,,,50597,,13477,10116.0,,,BAO_0000218,
Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,0,CHEMBL628413,Autocuration,,,A,U,1,12890,,,,,22224,,12553,,,,BAO_0000019,
The concentration in plasmat; Not determined,,0,CHEMBL628414,Autocuration,,,A,U,1,12891,1969.0,,,,22224,,14548,,,Plasma,BAO_0000019,
Tissue level at 10 mg/kg/po in wistar rats in blood,,1,CHEMBL628415,Intermediate,,,A,N,1,12892,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
Tissue level at 10 mg/kg/po in wistar rats in brown fat,,1,CHEMBL628416,Intermediate,,,A,N,1,12893,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
Tissue level at 10 mg/kg/po in wistar rats in heart,,1,CHEMBL628417,Intermediate,,,A,N,1,12894,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
Tissue level at 10 mg/kg/po in wistar rats in liver,,1,CHEMBL874908,Intermediate,,,A,N,1,12895,2107.0,Rattus norvegicus,,,50597,,14393,10116.0,,Liver,BAO_0000218,
Tissue level at 10 mg/kg/po in wistar rats in plasma,,1,CHEMBL628418,Intermediate,,,A,N,1,12896,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,1,CHEMBL628419,Intermediate,,,A,N,1,12897,2385.0,Rattus norvegicus,,,50597,,14393,10116.0,,Muscle tissue,BAO_0000218,
Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,1,CHEMBL628420,Intermediate,,,A,N,1,12898,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
Water solubility at 37 degree C.,,0,CHEMBL628421,Autocuration,,,A,U,1,12899,,,,,22224,,1629,,,,BAO_0000019,
Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,0,CHEMBL626726,Autocuration,,,P,U,1,12900,,,,,22229,,8194,,,,BAO_0000100,
Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,CHEMBL626727,Autocuration,,,P,U,1,12901,,,,,22229,,8194,,,,BAO_0000100,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,CHEMBL626728,Intermediate,,,A,N,1,12902,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,CHEMBL626729,Intermediate,,,A,N,1,12903,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,CHEMBL626730,Intermediate,,,A,N,1,12904,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,CHEMBL626731,Intermediate,,,A,N,1,12905,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,CHEMBL626732,Intermediate,,,A,N,1,12906,178.0,Rattus norvegicus,,,50597,,8594,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,CHEMBL626733,Intermediate,,,A,N,1,12907,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,CHEMBL626734,Intermediate,,,A,N,1,12908,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,CHEMBL626735,Intermediate,,,A,N,1,12909,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,CHEMBL874909,Intermediate,,,A,N,1,12910,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,CHEMBL626736,Intermediate,,,A,N,1,12911,948.0,Rattus norvegicus,,,50597,,8594,10116.0,,Heart,BAO_0000218,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,CHEMBL626737,Intermediate,,,A,N,1,12912,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,CHEMBL630999,Intermediate,,,A,N,1,12913,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,CHEMBL631000,Intermediate,,,A,N,1,12914,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,CHEMBL631001,Intermediate,,,A,N,1,12915,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,CHEMBL631002,Intermediate,,,A,N,1,12916,2113.0,Rattus norvegicus,,,50597,,8594,10116.0,,Kidney,BAO_0000218,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,CHEMBL631003,Intermediate,,,A,N,1,12917,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,CHEMBL631004,Intermediate,,,A,N,1,12918,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,CHEMBL631005,Intermediate,,,A,N,1,12919,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,CHEMBL631006,Intermediate,,,A,N,1,12920,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,CHEMBL631007,Intermediate,,,A,N,1,12921,2107.0,Rattus norvegicus,,,50597,,8594,10116.0,,Liver,BAO_0000218,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,CHEMBL631008,Intermediate,,,A,N,1,12922,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,CHEMBL631009,Intermediate,,,A,N,1,12923,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,CHEMBL631010,Intermediate,,,A,N,1,12924,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,CHEMBL631011,Intermediate,,,A,N,1,12925,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,CHEMBL631012,Intermediate,,,A,N,1,12926,2048.0,Rattus norvegicus,,,50597,,8594,10116.0,,Lung,BAO_0000218,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,CHEMBL630271,Intermediate,,,A,N,1,12927,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,CHEMBL630272,Intermediate,,,A,N,1,12928,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,CHEMBL630273,Intermediate,,,A,N,1,12929,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,CHEMBL630274,Intermediate,,,A,N,1,12930,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,CHEMBL630275,Intermediate,,,A,N,1,12931,2046.0,Rattus norvegicus,,,50597,,8594,10116.0,,Thyroid gland,BAO_0000218,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,1,CHEMBL875782,Intermediate,,,A,N,1,12932,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,1,CHEMBL630276,Intermediate,,,A,N,1,12933,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,1,CHEMBL630277,Intermediate,,,A,N,1,12934,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,1,CHEMBL630278,Intermediate,,,A,N,1,12935,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,1,CHEMBL630279,Intermediate,,,A,N,1,12936,,Rattus norvegicus,,,50597,,8594,10116.0,,,BAO_0000218,
Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,0,CHEMBL630280,Autocuration,,,A,U,1,12937,,,,,22224,,8151,,,,BAO_0000019,
Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,0,CHEMBL630281,Autocuration,,,A,U,1,12938,,,,,22224,,8151,,,,BAO_0000019,
Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,1,CHEMBL630282,Intermediate,,,A,N,1,12939,,Oryctolagus cuniculus,,,50592,,7132,9986.0,,,BAO_0000218,
Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,1,CHEMBL630283,Intermediate,,,A,N,1,12940,,Oryctolagus cuniculus,,,50592,,7132,9986.0,,,BAO_0000218,
Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,0,CHEMBL630284,Autocuration,,,A,U,1,12941,,,,,22224,,5797,,,,BAO_0000019,
Alkylating activity was determined,,0,CHEMBL630285,Autocuration,,,A,U,1,12942,,,,,22224,,7849,,,,BAO_0000019,
Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,0,CHEMBL630286,Autocuration,,,A,U,1,12943,,,,,22224,,14220,,,,BAO_0000251,Microsomes
"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,1,CHEMBL630069,Intermediate,,,A,N,1,12944,,Oryctolagus cuniculus,,,50592,,8650,9986.0,,,BAO_0000218,
"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,1,CHEMBL630070,Intermediate,,,A,N,1,12945,,Oryctolagus cuniculus,,,50592,,8650,9986.0,,,BAO_0000218,
"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,1,CHEMBL630071,Intermediate,,,A,N,1,12946,,Oryctolagus cuniculus,,,50592,,8650,9986.0,,,BAO_0000218,
"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,1,CHEMBL630072,Intermediate,,,A,N,1,12947,,Oryctolagus cuniculus,,,50592,,8650,9986.0,,,BAO_0000218,
"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,1,CHEMBL875110,Intermediate,,,A,N,1,12948,,Oryctolagus cuniculus,,,50592,,8650,9986.0,,,BAO_0000218,
Compound was tested for antidiuretic activity in rats,,1,CHEMBL630073,Intermediate,,,A,N,1,12949,,Rattus norvegicus,,,50597,,7116,10116.0,,,BAO_0000218,
Compound was tested for inactivation kinetic values,,0,CHEMBL630074,Autocuration,,,A,U,1,12950,,,,,22224,,14131,,,,BAO_0000019,
Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,0,CHEMBL630075,Autocuration,,,A,U,1,12951,,,In vivo,,22224,,7415,,,,BAO_0000218,
Dissociation rate calculated from the first-order equation using the t1/2 value,,0,CHEMBL630076,Autocuration,,,A,U,1,12952,,,,,22224,,13178,,,,BAO_0000019,
Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,0,CHEMBL630077,Autocuration,,,P,U,1,12953,,,,,22229,,8815,,,,BAO_0000100,
Aqueous solubility was measured,,0,CHEMBL630078,Autocuration,,,P,U,1,12954,,,,,22229,,1450,,,,BAO_0000100,
Aqueous solubility was measured at a pH 4,,0,CHEMBL630079,Autocuration,,,P,U,1,12955,,,,,22229,,1450,,,,BAO_0000100,
Aqueous solubility (pH 7),,0,CHEMBL630080,Autocuration,,,P,U,1,12956,,,,,22229,,1450,,,,BAO_0000100,
Aqueous solubility was measured at a pH 9,,0,CHEMBL630081,Autocuration,,,P,U,1,12957,,,,,22229,,1450,,,,BAO_0000100,
"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,0,CHEMBL630082,Autocuration,,,A,U,1,12958,,,,,22224,,12711,,,,BAO_0000019,
"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,0,CHEMBL630083,Autocuration,,,A,U,1,12959,,,,,22224,,12711,,,,BAO_0000019,
"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,0,CHEMBL630084,Autocuration,,,A,U,1,12960,,,,,22224,,12711,,,,BAO_0000019,
Aqueous solubility of the compound,,0,CHEMBL629198,Autocuration,,,P,U,1,12961,,,,,22229,,15032,,,,BAO_0000100,
Aqueous solubility at 37 degree Celsius at pH 7.38,,0,CHEMBL629199,Autocuration,,,P,U,1,12962,,,,,22229,,9964,,,,BAO_0000100,
Aqueous solubility in pH 7.4 phosphate buffer,,0,CHEMBL629200,Autocuration,,,P,U,1,12963,,,,,22229,,14962,,,,BAO_0000100,
Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,1,CHEMBL629201,Intermediate,,,A,N,1,12964,,Canis lupus familiaris,,,50588,,12487,9615.0,,,BAO_0000218,
Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,1,CHEMBL629202,Intermediate,,,A,N,1,12965,,Canis lupus familiaris,,,50588,,12487,9615.0,,,BAO_0000218,
Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,1,CHEMBL875111,Intermediate,,,A,N,1,12966,,Homo sapiens,,,50587,,10026,9606.0,,,BAO_0000218,
Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,1,CHEMBL629203,Intermediate,,,A,N,1,12967,,Homo sapiens,,,50587,,10026,9606.0,,,BAO_0000218,
The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,1,CHEMBL629204,Intermediate,,,A,N,1,12968,,Homo sapiens,,,50587,,10026,9606.0,,,BAO_0000218,
The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,1,CHEMBL629205,Intermediate,,,A,N,1,12969,,Homo sapiens,,,50587,,10026,9606.0,,,BAO_0000218,
The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,1,CHEMBL629206,Intermediate,,,A,N,1,12970,,Homo sapiens,,,50587,,10026,9606.0,,,BAO_0000218,
The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,0,CHEMBL631185,Autocuration,,,A,U,1,12971,,,,,22224,,10026,,,,BAO_0000019,
Compound was evaluated for the average bile flow rat in rats,,1,CHEMBL631186,Intermediate,,,A,N,1,12972,,Rattus norvegicus,,,50597,,7415,10116.0,,,BAO_0000218,
"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,1,CHEMBL631187,Intermediate,,,A,N,1,12973,,Oryctolagus cuniculus,,,50592,,17025,9986.0,,,BAO_0000218,
"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,1,CHEMBL631188,Intermediate,,,A,N,1,12974,,Oryctolagus cuniculus,,,50592,,17025,9986.0,,,BAO_0000218,
Average half life period was determined,,0,CHEMBL876419,Autocuration,,,A,U,1,12975,,,,,22224,,10184,,,,BAO_0000019,
Average half life period was determined,,0,CHEMBL631189,Autocuration,,,A,U,1,12976,,,,,22224,,10184,,,,BAO_0000019,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,1,CHEMBL631190,Intermediate,,,A,N,1,12977,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,1,CHEMBL631191,Intermediate,,,A,N,1,12978,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,1,CHEMBL631192,Intermediate,,,A,N,1,12979,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,1,CHEMBL632400,Intermediate,,,A,N,1,12980,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,1,CHEMBL630564,Intermediate,,,A,N,1,12981,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,1,CHEMBL630565,Intermediate,,,A,N,1,12982,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,1,CHEMBL630566,Intermediate,,,A,N,1,12983,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,1,CHEMBL631229,Intermediate,,,A,N,1,12984,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,1,CHEMBL631230,Intermediate,,,A,N,1,12985,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Calculated partition coefficient (clogP),,0,CHEMBL876428,Autocuration,,,P,U,1,12986,,,,,22229,,6030,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL631231,Autocuration,,,P,U,1,12987,,,,,22229,,6147,,,,BAO_0000100,
Calculated partition coefficient (clogP) (MacLogP),,0,CHEMBL631232,Autocuration,,,P,U,1,12988,,,,,22229,,14556,,,,BAO_0000100,
Hydrophilicity was determined,,0,CHEMBL631233,Autocuration,,,A,U,1,12989,,,,,22224,,768,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL631234,Autocuration,,,P,U,1,12990,,,,,22229,,14452,,,,BAO_0000100,
Increased absorption was determined,,0,CHEMBL883126,Autocuration,,,A,U,1,12991,,,,,22224,,5237,,,,BAO_0000019,
Lipophilicity value was evaluated,,0,CHEMBL631235,Autocuration,,,P,U,1,12992,,,,,22224,,14378,,,,BAO_0000100,
Log P value of the compound.,,0,CHEMBL631236,Autocuration,,,P,U,1,12993,,,,,22224,,14418,,,,BAO_0000100,
Partition coefficient of compound was determined,,0,CHEMBL631237,Autocuration,,,A,U,1,12994,,,,,22224,,5249,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL631238,Autocuration,,,P,U,1,12995,,,,,22229,,14621,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL876429,Autocuration,,,P,U,1,12996,,,,,22229,,12542,,,,BAO_0000100,
Partition coefficient was measured by medchem software; Not calculated,,0,CHEMBL631414,Autocuration,,,A,U,1,12997,,,,,22224,,12542,,,,BAO_0000019,
Partition coefficient was measured by octanol-water using standard shake-flask method,,0,CHEMBL631415,Autocuration,,,P,U,1,12998,,,,,22224,,12542,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL631416,Autocuration,,,P,U,1,12999,,,,,22229,,15462,,,,BAO_0000100,
Partition coefficient (logP),,0,CHEMBL631417,Autocuration,,,A,U,1,13000,,,,,22224,,14884,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL631418,Autocuration,,,P,U,1,13001,,,,,22229,,16526,,,,BAO_0000100,
The Octanol/Water partition coefficient CLogP,,0,CHEMBL631419,Autocuration,,,P,U,1,13002,,,,,22229,,13693,,,,BAO_0000100,
The pharmacokinetic parameter C Log p was reported,,0,CHEMBL631420,Autocuration,,,A,U,1,13003,,,,,22224,,13693,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL631421,Autocuration,,,P,U,1,13004,,,,,22229,,13779,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL631422,Autocuration,,,P,U,1,13005,,,,,22229,,14772,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL631423,Autocuration,,,P,U,1,13006,,,,,22229,,14393,,,,BAO_0000100,
Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,1,CHEMBL876430,Intermediate,,,A,N,1,13007,1969.0,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,1,CHEMBL631424,Intermediate,,,A,N,1,13008,1969.0,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Compound was administered intravenously in dog to evaluate plasma clearance values,,1,CHEMBL631425,Intermediate,,,A,N,1,13009,1969.0,Canis lupus familiaris,In vivo,,50588,,13744,9615.0,,Plasma,BAO_0000218,
Compound was administered intravenously in monkey to evaluate plasma clearance values,,0,CHEMBL631426,Autocuration,,,A,U,1,13010,1969.0,Simiiformes,In vivo,,22224,,13744,314293.0,,Plasma,BAO_0000218,
Compound was administered intravenously in mouse to evaluate plasma clearance values,,1,CHEMBL631427,Intermediate,,,A,N,1,13011,1969.0,Mus musculus,In vivo,,50594,,13744,10090.0,,Plasma,BAO_0000218,
Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,1,CHEMBL631428,Intermediate,,,A,N,1,13012,1969.0,Canis lupus familiaris,In vivo,,50588,,13207,9615.0,,Plasma,BAO_0000218,
Intrinsic clearance in Rhesus liver microsome,,1,CHEMBL631429,Intermediate,,,A,N,1,13013,2107.0,Macaca mulatta,In vitro,,50797,,5669,9544.0,,Liver,BAO_0000218,Microsomes
Intrinsic clearance in dog liver microsome,,1,CHEMBL631430,Intermediate,,,A,N,1,13014,2107.0,Canis lupus familiaris,In vitro,,50588,,5669,9615.0,,Liver,BAO_0000218,Microsomes
Intrinsic clearance in rat liver microsome,,1,CHEMBL631431,Intermediate,,,A,N,1,13015,2107.0,Rattus norvegicus,In vitro,,50597,,5669,10116.0,,Liver,BAO_0000218,Microsomes
Low plasma clearance was calculated in rhesus monkey,,1,CHEMBL631432,Intermediate,,,A,N,1,13016,1969.0,Macaca mulatta,In vivo,,50797,,4853,9544.0,,Plasma,BAO_0000218,
Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,1,CHEMBL631433,Intermediate,,,A,N,1,13017,,Canis lupus familiaris,In vivo,,50588,,16452,9615.0,,,BAO_0000218,
Plasma clearance after intravenous dose of 0.3 mg/kg,,0,CHEMBL631434,Autocuration,,,A,U,1,13018,,,In vivo,,22224,,11954,,,,BAO_0000218,
Plasma clearance after intravenous dose of 1 mg/kg,,0,CHEMBL631435,Autocuration,,,A,U,1,13019,,,In vivo,,22224,,11954,,,,BAO_0000218,
Plasma clearance after intravenous dose of 3 mg/kg,,0,CHEMBL631436,Autocuration,,,A,U,1,13020,,,In vivo,,22224,,11954,,,,BAO_0000218,
Plasma clearance after intravenous dose of 3.87 mg/kg,,0,CHEMBL631437,Autocuration,,,A,U,1,13021,,,In vivo,,22224,,11954,,,,BAO_0000218,
Plasma clearance after peroral administration at 10 mpk in Rat,,1,CHEMBL631438,Intermediate,,,A,N,1,13022,,Rattus norvegicus,In vivo,,50597,,5669,10116.0,,,BAO_0000218,
Plasma clearance after peroral administration at 10 mpk in Rhesus,,1,CHEMBL876431,Intermediate,,,A,N,1,13023,,Macaca mulatta,In vivo,,50797,,5669,9544.0,,,BAO_0000218,
Plasma clearance after peroral administration at 10 mpk in dog,,1,CHEMBL631439,Intermediate,,,A,N,1,13024,,Canis lupus familiaris,In vivo,,50588,,5669,9615.0,,,BAO_0000218,
Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,1,CHEMBL631440,Intermediate,,,A,N,1,13025,,Rattus norvegicus,In vivo,,50597,,13662,10116.0,,,BAO_0000218,
Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,0,CHEMBL631441,Autocuration,,,A,U,1,13026,,,,,22224,,8272,,,,BAO_0000019,
Critical Micellar concentration was determined,,0,CHEMBL631442,Autocuration,,,A,U,1,13027,,,,,22224,,13410,,,,BAO_0000019,
Critical Micellar concentration of the compound. was determined,,0,CHEMBL626525,Autocuration,,,A,U,1,13028,,,,,22224,,13410,,,,BAO_0000019,
Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,0,CHEMBL627168,Autocuration,,,A,U,1,13029,,,,,22224,,12628,,,,BAO_0000019,
Critical micellar concentration was measured in water by the dye solubilization method,,0,CHEMBL875618,Autocuration,,,A,U,1,13030,,,,,22224,,9675,,,,BAO_0000019,
Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,0,CHEMBL626612,Autocuration,,,B,U,1,13031,,,,,22224,,12628,,,,BAO_0000019,
CMR value (relative to BAY K 8644),,0,CHEMBL626613,Autocuration,,,A,U,1,13032,,,,,22224,,12766,,,,BAO_0000019,
Carbamoylating activity was determined,,0,CHEMBL626614,Autocuration,,,A,U,1,13033,,,,,22224,,7849,,,,BAO_0000019,
Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,0,CHEMBL626615,Autocuration,,,A,U,1,13034,,Simiiformes,,,22224,,12187,314293.0,,,BAO_0000218,
Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,0,CHEMBL626616,Autocuration,,,A,U,1,13035,,,,,22224,,2040,,,,BAO_0000019,
Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,0,CHEMBL626617,Autocuration,,,A,U,1,13036,,,,,22224,,2040,,,,BAO_0000019,
Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,1,CHEMBL626618,Intermediate,,,A,N,1,13037,1969.0,Canis lupus familiaris,In vivo,,50588,,14180,9615.0,,Plasma,BAO_0000218,
Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,1,CHEMBL626619,Intermediate,,,A,N,1,13038,1969.0,Rattus norvegicus,In vivo,,50597,,14180,10116.0,,Plasma,BAO_0000218,
"Clearance rate at 0.46 mg/kg, iv, in dogs",,1,CHEMBL626620,Intermediate,,,A,N,1,13039,,Canis lupus familiaris,In vivo,,50588,,14474,9615.0,,,BAO_0000218,
"Clearance rate at 5.5 mg/kg, iv, in rat",,1,CHEMBL626621,Intermediate,,,A,N,1,13040,,Rattus norvegicus,In vivo,,50597,,14474,10116.0,,,BAO_0000218,
Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,1,CHEMBL626622,Intermediate,,,A,N,1,13041,,Macaca fascicularis,In vivo,,100710,,14548,9541.0,,,BAO_0000218,
Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,1,CHEMBL626623,Intermediate,,,A,N,1,13042,,Macaca fascicularis,In vivo,,100710,,14548,9541.0,,,BAO_0000218,
Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,1,CHEMBL626624,Intermediate,,,A,N,1,13043,,Canis lupus familiaris,In vivo,,50588,,14548,9615.0,,,BAO_0000218,
Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,1,CHEMBL626625,Intermediate,,,A,N,1,13044,,Rattus norvegicus,In vivo,,50597,,14548,10116.0,,,BAO_0000218,
Clearance rate constant using isolated perfused rat liver (IPRL) assay,,1,CHEMBL626626,Intermediate,,,A,N,1,13045,2107.0,Rattus norvegicus,Ex vivo,,50597,,6125,10116.0,,Liver,BAO_0000218,
Tested for the total clearance of the compound,,0,CHEMBL626627,Autocuration,,,A,U,1,13046,,,In vivo,,22224,,6874,,,,BAO_0000218,
The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,1,CHEMBL626628,Intermediate,,,A,N,1,13047,,Canis lupus familiaris,In vivo,,50588,,15343,9615.0,,,BAO_0000218,
Total body clearance was determined,,0,CHEMBL626629,Autocuration,,,A,U,1,13048,,,In vivo,,22224,,6236,,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,1,CHEMBL626630,Intermediate,,,A,N,1,13049,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,1,CHEMBL626631,Intermediate,,,A,N,1,13050,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,0,CHEMBL626632,Autocuration,,,P,U,1,13051,,,,,22229,,8194,,,,BAO_0000100,
Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,CHEMBL626633,Autocuration,,,P,U,1,13052,,,,,22229,,8194,,,,BAO_0000100,
Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,0,CHEMBL626634,Autocuration,,,P,U,1,13053,,,,,22229,,8194,,,,BAO_0000100,
Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,0,CHEMBL626635,Autocuration,,,P,U,1,13054,,,,,22229,,8194,,,,BAO_0000100,
Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,CHEMBL626636,Autocuration,,,P,U,1,13055,,,,,22229,,8194,,,,BAO_0000100,
Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,0,CHEMBL626637,Autocuration,,,P,U,1,13056,,,,,22229,,8194,,,,BAO_0000100,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,1,CHEMBL626638,Intermediate,,,A,N,1,13057,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,1,CHEMBL626639,Intermediate,,,A,N,1,13058,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,1,CHEMBL626640,Intermediate,,,A,N,1,13059,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,1,CHEMBL626641,Intermediate,,,A,N,1,13060,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,1,CHEMBL627272,Intermediate,,,A,N,1,13061,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,1,CHEMBL627273,Intermediate,,,A,N,1,13062,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,1,CHEMBL627441,Intermediate,,,A,N,1,13063,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,1,CHEMBL628355,Intermediate,,,A,N,1,13064,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,1,CHEMBL628356,Intermediate,,,A,N,1,13065,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,1,CHEMBL628357,Intermediate,,,A,N,1,13066,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,1,CHEMBL628358,Intermediate,,,A,N,1,13067,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,1,CHEMBL622307,Intermediate,,,A,N,1,13068,,Pneumocystis carinii,,,50339,,13273,4754.0,,,BAO_0000218,
Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,0,CHEMBL622527,Autocuration,,,A,U,1,13069,,,,,22224,,13118,,,,BAO_0000019,
Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,0,CHEMBL622528,Autocuration,,,A,U,1,13070,,,,,22224,,13118,,,,BAO_0000019,
Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,0,CHEMBL622529,Autocuration,,,A,U,1,13071,,,,,22224,,13118,,,,BAO_0000019,
Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,0,CHEMBL622992,Autocuration,,,A,U,1,13072,,,,,22224,,13118,,,,BAO_0000019,
Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,0,CHEMBL622993,Autocuration,,,A,U,1,13073,,,,,22224,,13118,,,,BAO_0000019,
Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,0,CHEMBL622994,Autocuration,,,A,U,1,13074,,,,,22224,,13118,,,,BAO_0000019,
"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,1,CHEMBL622995,Intermediate,,,A,N,1,13075,,Rattus norvegicus,,,50597,,10633,10116.0,,,BAO_0000218,
"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,1,CHEMBL622996,Intermediate,,,A,N,1,13076,,Rattus norvegicus,,,50597,,10633,10116.0,,,BAO_0000218,
"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,1,CHEMBL622997,Intermediate,,,A,N,1,13077,,Rattus norvegicus,,,50597,,10633,10116.0,,,BAO_0000218,
"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,1,CHEMBL622998,Intermediate,,,A,N,1,13078,,Rattus norvegicus,,,50597,,10633,10116.0,,,BAO_0000218,
Cp max following ip administration at 1 mg/kg,,0,CHEMBL622999,Autocuration,,,A,U,1,13079,,,,,22224,,5767,,,,BAO_0000218,
Maximum concentration in plasma was reported at 0.5 hour,,0,CHEMBL623000,Autocuration,,,A,U,1,13080,1969.0,,In vivo,,22224,,3302,,,Plasma,BAO_0000218,
Maximum concentration in plasma was reported at 2 hour,,0,CHEMBL623001,Autocuration,,,A,U,1,13081,1969.0,,In vivo,,22224,,3302,,,Plasma,BAO_0000218,
Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,1,CHEMBL623002,Intermediate,,,A,N,1,13082,,Mus musculus,,,50594,,12467,10090.0,,,BAO_0000218,
Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,0,CHEMBL623003,Autocuration,,,P,U,1,13083,,,,,22229,,11778,,,,BAO_0000100,
Steady state concentration was evaluated,,0,CHEMBL623004,Autocuration,,,A,U,1,13084,,,,,22224,,4321,,,,BAO_0000019,
Partition coefficient (logP),,0,CHEMBL623005,Autocuration,,,A,U,1,13085,,,,,22224,,14884,,,,BAO_0000019,
Partition coefficient (logD7.4),,0,CHEMBL623006,Autocuration,,,A,U,1,13086,,,,,22224,,15234,,,,BAO_0000019,
Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,1,CHEMBL623007,Intermediate,,,A,N,1,13087,2107.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Liver,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,1,CHEMBL623008,Intermediate,,,A,N,1,13088,10000001.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Bone,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,1,CHEMBL876654,Intermediate,,,A,N,1,13089,2037.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Cerebellum,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,1,CHEMBL623009,Intermediate,,,A,N,1,13090,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,1,CHEMBL623010,Intermediate,,,A,N,1,13091,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,1,CHEMBL623011,Intermediate,,,A,N,1,13092,948.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Heart,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,1,CHEMBL623012,Intermediate,,,A,N,1,13093,160.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Intestine,BAO_0000218,
Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,0,CHEMBL623013,Autocuration,,,A,U,1,13094,,,,,22224,,8151,,,,BAO_0000019,
Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,0,CHEMBL623014,Autocuration,,,A,U,1,13095,,,,,22224,,8151,,,,BAO_0000019,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,0,CHEMBL623015,Autocuration,,,A,U,1,13096,1088.0,,,,22224,,8151,,,Urine,BAO_0000019,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,0,CHEMBL623016,Autocuration,,,A,U,1,13097,1088.0,,,,22224,,8151,,,Urine,BAO_0000019,
Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,0,CHEMBL624858,Autocuration,,,A,U,1,13098,1088.0,,,,22224,,8151,,,Urine,BAO_0000019,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,1,CHEMBL624859,Intermediate,,,A,N,1,13099,,Rattus norvegicus,,,50597,,8151,10116.0,,,BAO_0000218,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,1,CHEMBL624860,Intermediate,,,A,N,1,13100,,Rattus norvegicus,,,50597,,8151,10116.0,,,BAO_0000218,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,1,CHEMBL624861,Intermediate,,,A,N,1,13101,,Rattus norvegicus,,,50597,,8151,10116.0,,,BAO_0000218,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,1,CHEMBL624862,Intermediate,,,A,N,1,13102,,Rattus norvegicus,,,50597,,8151,10116.0,,,BAO_0000218,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,1,CHEMBL624863,Intermediate,,,A,N,1,13103,,Rattus norvegicus,,,50597,,8151,10116.0,,,BAO_0000218,
Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,1,CHEMBL876655,Intermediate,,,A,N,1,13104,,Rattus norvegicus,,,50597,,8151,10116.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,1,CHEMBL624864,Intermediate,,,A,N,1,13105,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,1,CHEMBL624865,Intermediate,,,A,N,1,13106,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,1,CHEMBL624866,Intermediate,,,A,N,1,13107,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,1,CHEMBL624867,Expert,,,F,N,1,13108,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,1,CHEMBL624868,Intermediate,,,A,N,1,13109,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,1,CHEMBL628450,Intermediate,,,A,N,1,13110,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,1,CHEMBL628451,Intermediate,,,A,N,1,13111,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,1,CHEMBL628452,Intermediate,,,A,N,1,13112,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,1,CHEMBL628453,Intermediate,,,A,N,1,13113,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,1,CHEMBL628454,Intermediate,,,A,N,1,13114,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,1,CHEMBL628455,Intermediate,,,A,N,1,13115,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,1,CHEMBL628456,Intermediate,,,A,N,1,13116,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,1,CHEMBL628457,Intermediate,,,A,N,1,13117,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,1,CHEMBL877505,Intermediate,,,A,N,1,13118,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,1,CHEMBL628458,Intermediate,,,A,N,1,13119,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,1,CHEMBL628459,Intermediate,,,A,N,1,13120,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,1,CHEMBL628460,Intermediate,,,A,N,1,13121,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,1,CHEMBL628461,Intermediate,,,A,N,1,13122,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,0,CHEMBL628462,Autocuration,,,B,U,1,13123,,,,,22224,,6996,,,,BAO_0000218,
Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,1,CHEMBL628463,Intermediate,,,A,N,1,13124,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,1,CHEMBL625666,Expert,,,F,N,1,13125,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,0,CHEMBL625667,Autocuration,,,B,U,1,13126,,,,,22224,,6996,,,,BAO_0000218,
Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,1,CHEMBL625668,Expert,,,A,N,1,13127,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,1,CHEMBL625669,Intermediate,,,A,N,1,13128,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,0,CHEMBL625670,Autocuration,,,A,U,1,13129,,,,,22224,,7114,,,,BAO_0000019,
Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,1,CHEMBL625671,Intermediate,,,A,N,1,13130,,Rattus norvegicus,,,50597,,7114,10116.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,1,CHEMBL625672,Intermediate,,,A,N,1,13131,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,1,CHEMBL625673,Intermediate,,,A,N,1,13132,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,1,CHEMBL625674,Intermediate,,,A,N,1,13133,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,1,CHEMBL625675,Intermediate,,,A,N,1,13134,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,1,CHEMBL627637,Intermediate,,,A,N,1,13135,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,1,CHEMBL627638,Intermediate,,,A,N,1,13136,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,1,CHEMBL627639,Intermediate,,,A,N,1,13137,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,1,CHEMBL627640,Intermediate,,,A,N,1,13138,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,1,CHEMBL627641,Intermediate,,,A,N,1,13139,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,1,CHEMBL627642,Intermediate,,,A,N,1,13140,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,1,CHEMBL877506,Intermediate,,,A,N,1,13141,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,1,CHEMBL627275,Intermediate,,,A,N,1,13142,,Mus musculus,,,50594,,8613,10090.0,,,BAO_0000218,
"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,1,CHEMBL627643,Intermediate,,,A,N,1,13143,,Mustela putorius furo,,,50506,,11219,9669.0,,,BAO_0000218,
"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,1,CHEMBL631246,Intermediate,,,A,N,1,13144,,Mustela putorius furo,,,50506,,11219,9669.0,,,BAO_0000218,
"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,1,CHEMBL631247,Intermediate,,,A,N,1,13145,,Mustela putorius furo,,,50506,,11219,9669.0,,,BAO_0000218,
Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,1,CHEMBL629532,Intermediate,,,A,N,1,13146,,Mustela putorius furo,,,50506,,11219,9669.0,,,BAO_0000218,
Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,1,CHEMBL629533,Intermediate,,,A,N,1,13147,,Mustela putorius furo,,,50506,,11219,9669.0,,,BAO_0000218,
Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,1,CHEMBL629534,Intermediate,,,A,N,1,13148,,Mustela putorius furo,,,50506,,11219,9669.0,,,BAO_0000218,
Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,1,CHEMBL629535,Intermediate,,,A,N,1,13149,,Mustela putorius furo,,,50506,,11219,9669.0,,,BAO_0000218,
Pharmacokinetic parameter :drug bound to plasma was reported,,0,CHEMBL625932,Autocuration,,,A,U,1,13150,,,,,22224,,14837,,,,BAO_0000019,
compound was evaluated for drug bound in plasma,,0,CHEMBL625933,Autocuration,,,A,U,1,13151,,,,,22224,,14837,,,,BAO_0000019,
The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,1,CHEMBL625934,Intermediate,,,A,N,1,13152,,Rattus norvegicus,,,50597,,15343,10116.0,,,BAO_0000218,
Bioavailability,,0,CHEMBL625935,Autocuration,,,A,U,1,13153,,Eutheria,,,22224,,13761,9347.0,,,BAO_0000218,
Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,1,CHEMBL625936,Intermediate,,,A,N,1,13154,,Rattus norvegicus,,,50597,,14810,10116.0,,,BAO_0000218,
Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,1,CHEMBL625937,Intermediate,,,A,N,1,13155,,Rattus norvegicus,,,50597,,14810,10116.0,,,BAO_0000218,
Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,1,CHEMBL625938,Intermediate,,,A,N,1,13156,,Canis lupus familiaris,,,50588,,13249,9615.0,,,BAO_0000218,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,1,CHEMBL625939,Intermediate,,,A,N,1,13157,1970.0,Rattus norvegicus,,,50597,,9267,10116.0,,Bile,BAO_0000218,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,1,CHEMBL625940,Intermediate,,,A,N,1,13158,1970.0,Rattus norvegicus,,,50597,,9267,10116.0,,Bile,BAO_0000218,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,1,CHEMBL874464,Intermediate,,,A,N,1,13159,1970.0,Rattus norvegicus,,,50597,,9267,10116.0,,Bile,BAO_0000218,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,1,CHEMBL625941,Intermediate,,,A,N,1,13160,1970.0,Rattus norvegicus,,,50597,,9267,10116.0,,Bile,BAO_0000218,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,1,CHEMBL625942,Intermediate,,,A,N,1,13161,1970.0,Rattus norvegicus,,,50597,,9267,10116.0,,Bile,BAO_0000218,
Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,1,CHEMBL625943,Intermediate,,,A,N,1,13162,1970.0,Rattus norvegicus,,,50597,,9267,10116.0,,Bile,BAO_0000218,
In vitro protein binding in human serum at 5 ug/ml,,1,CHEMBL625944,Intermediate,,,A,N,1,13163,1977.0,Homo sapiens,,,50587,,15549,9606.0,,Serum,BAO_0000218,
Serum protein binding ability was measured,,0,CHEMBL625945,Autocuration,,,A,U,1,13164,,,,,22224,,10929,,,,BAO_0000019,
The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,0,CHEMBL625946,Autocuration,,,A,U,1,13165,,,,,22224,,15444,,,,BAO_0000019,
Oral bioavailability in dog,,0,CHEMBL625947,Autocuration,,,A,U,1,13166,,Canis lupus familiaris,In vivo,,22224,,12860,9615.0,,,BAO_0000218,
% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,1,CHEMBL625948,Intermediate,,,A,N,1,13167,,Rattus norvegicus,In vivo,,50597,,12170,10116.0,,,BAO_0000218,
Absolute oral bioavailability at an iv dose of 14 mg/kg,,0,CHEMBL625949,Autocuration,,,A,U,1,13168,,,In vivo,,22224,,15173,,,,BAO_0000218,
Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,0,CHEMBL625950,Autocuration,,,A,U,1,13169,,,In vivo,,22224,,15173,,,,BAO_0000218,
Oral bioavailability (dose 15 mg/kg i.v.),,0,CHEMBL625951,Autocuration,,,A,U,1,13170,,Eutheria,In vivo,,22224,,15173,9347.0,,,BAO_0000218,
Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,0,CHEMBL625952,Autocuration,,,A,U,1,13171,,,In vivo,,22224,,15173,,,,BAO_0000218,
Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,0,CHEMBL625953,Autocuration,,,A,U,1,13172,,,In vivo,,22224,,15173,,,,BAO_0000218,
Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,0,CHEMBL625954,Autocuration,,,A,U,1,13173,,,In vivo,,22224,,15173,,,,BAO_0000218,
Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,0,CHEMBL882959,Autocuration,,,A,U,1,13174,,,In vivo,,22224,,15173,,,,BAO_0000218,
Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,1,CHEMBL625955,Intermediate,,,A,N,1,13175,,Canis lupus familiaris,In vivo,,50588,,11767,9615.0,,,BAO_0000218,
Bioavailability in ferret,,0,CHEMBL625956,Autocuration,,,A,U,1,13176,,Mustela putorius furo,In vivo,,22224,,11219,9669.0,,,BAO_0000218,
Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,1,CHEMBL625957,Intermediate,,,A,N,1,13177,,Macaca fascicularis,In vivo,,100710,,12186,9541.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,1,CHEMBL625958,Intermediate,,,A,N,1,13178,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,1,CHEMBL625959,Intermediate,,,A,N,1,13179,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,1,CHEMBL626642,Intermediate,,,A,N,1,13180,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,1,CHEMBL631330,Intermediate,,,A,N,1,13181,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,1,CHEMBL631331,Intermediate,,,A,N,1,13182,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,1,CHEMBL631332,Intermediate,,,A,N,1,13183,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,1,CHEMBL631333,Intermediate,,,A,N,1,13184,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,1,CHEMBL632018,Intermediate,,,A,N,1,13185,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,1,CHEMBL632019,Intermediate,,,A,N,1,13186,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,1,CHEMBL632020,Intermediate,,,A,N,1,13187,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,1,CHEMBL632021,Intermediate,,,A,N,1,13188,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,1,CHEMBL632022,Intermediate,,,A,N,1,13189,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,1,CHEMBL632023,Intermediate,,,A,N,1,13190,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,1,CHEMBL632024,Intermediate,,,A,N,1,13191,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,1,CHEMBL874472,Intermediate,,,A,N,1,13192,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,1,CHEMBL632025,Intermediate,,,A,N,1,13193,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,1,CHEMBL632026,Intermediate,,,A,N,1,13194,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,1,CHEMBL632027,Intermediate,,,A,N,1,13195,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,1,CHEMBL632028,Intermediate,,,A,N,1,13196,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,1,CHEMBL626430,Intermediate,,,A,N,1,13197,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,1,CHEMBL626431,Intermediate,,,A,N,1,13198,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,1,CHEMBL626432,Intermediate,,,A,N,1,13199,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,1,CHEMBL626433,Intermediate,,,A,N,1,13200,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,1,CHEMBL626434,Intermediate,,,A,N,1,13201,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,1,CHEMBL627280,Intermediate,,,A,N,1,13202,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,1,CHEMBL627281,Intermediate,,,A,N,1,13203,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,1,CHEMBL627282,Intermediate,,,A,N,1,13204,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Total body clearance was measured at given dose,,0,CHEMBL627283,Autocuration,,,A,U,1,13205,,,,,22224,,7199,,,,BAO_0000019,
Total body clearance was measured at given dose.,,0,CHEMBL627284,Autocuration,,,A,U,1,13206,,,,,22224,,7199,,,,BAO_0000218,
Metabolic clearance from the body in rat,,1,CHEMBL627285,Intermediate,,,A,N,1,13207,,Rattus norvegicus,,,50597,,7095,10116.0,,,BAO_0000218,
Renal clearance from the body,,0,CHEMBL627286,Autocuration,,,A,U,1,13208,,,In vivo,,22224,,7095,,,,BAO_0000218,
Renal clearance from the body in rat,,1,CHEMBL875477,Intermediate,,,A,N,1,13209,,Rattus norvegicus,In vivo,,50597,,7095,10116.0,,,BAO_0000218,
Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,1,CHEMBL627287,Intermediate,,,A,N,1,13210,,Rattus norvegicus,In vivo,,50597,,12528,10116.0,,,BAO_0000218,
Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,1,CHEMBL627288,Intermediate,,,A,N,1,13211,,Canis lupus familiaris,In vivo,,50588,,12528,9615.0,,,BAO_0000218,
Total clearance from the body in rat,,1,CHEMBL627289,Intermediate,,,A,N,1,13212,,Rattus norvegicus,,,50597,,7095,10116.0,,,BAO_0000218,
Clearance into cortex from rat plasma or PBS,,1,CHEMBL627290,Intermediate,,,A,N,1,13213,1969.0,Rattus norvegicus,In vivo,,50597,,14223,10116.0,,Plasma,BAO_0000218,
Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,0,CHEMBL627291,Autocuration,,,A,U,1,13214,,,In vivo,,22224,,13569,,,,BAO_0000218,
Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,0,CHEMBL627292,Autocuration,,,A,U,1,13215,,,In vivo,,22224,,13569,,,,BAO_0000218,
Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,0,CHEMBL627293,Autocuration,,,A,U,1,13216,,,In vivo,,22224,,13569,,,,BAO_0000218,
Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,0,CHEMBL627294,Autocuration,,,A,U,1,13217,,,In vivo,,22224,,13569,,,,BAO_0000218,
Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,0,CHEMBL875478,Autocuration,,,A,U,1,13218,,,In vivo,,22224,,13569,,,,BAO_0000218,
Clearance was determined,,0,CHEMBL627295,Autocuration,,,A,U,1,13219,,,In vivo,,22224,,13979,,,,BAO_0000218,
Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,1,CHEMBL627296,Intermediate,,,A,N,1,13220,,Mus musculus,In vivo,,50594,,14315,10090.0,,,BAO_0000218,
Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,1,CHEMBL626119,Intermediate,,,A,N,1,13221,,Oryctolagus cuniculus,In vivo,,50592,,14315,9986.0,,,BAO_0000218,
Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,1,CHEMBL626120,Intermediate,,,A,N,1,13222,,Rattus norvegicus,In vivo,,50597,,14315,10116.0,,,BAO_0000218,
Clearance in rat after iv dose (100 ug/kg),,1,CHEMBL626121,Intermediate,,,A,N,1,13223,,Rattus norvegicus,In vivo,,50597,,12174,10116.0,,,BAO_0000218,
Clearance in guinea pig,,0,CHEMBL626122,Autocuration,,,A,U,1,13224,,Cavia porcellus,In vivo,,22224,,12797,10141.0,,,BAO_0000218,
Compound was evaluated for clearance in rat,,1,CHEMBL626123,Intermediate,,,A,N,1,13225,,Rattus norvegicus,In vivo,,50597,,12797,10116.0,,,BAO_0000218,
Compound was evaluated for the clearance in dog,,1,CHEMBL623456,Intermediate,,,A,N,1,13226,,Canis lupus familiaris,In vivo,,50588,,12797,9615.0,,,BAO_0000218,
Compound was evaluated for the clearance in rat,,1,CHEMBL623457,Intermediate,,,A,N,1,13227,,Rattus norvegicus,In vivo,,50597,,12797,10116.0,,,BAO_0000218,
Compound was tested in vivo for clearance after iv administration in the rat,,1,CHEMBL623458,Intermediate,,,A,N,1,13228,,Rattus norvegicus,In vivo,,50597,,11500,10116.0,,,BAO_0000218,
IV clearance determined at an iv dose of 14 mg/kg,,0,CHEMBL623459,Autocuration,,,A,U,1,13229,,,In vivo,,22224,,15173,,,,BAO_0000218,
IV clearance determined at an iv dose of 15.2 mg/kg,,0,CHEMBL875484,Autocuration,,,A,U,1,13230,,,In vivo,,22224,,15173,,,,BAO_0000218,
IV clearance determined at an iv dose of 15 mg/kg,,0,CHEMBL623460,Autocuration,,,A,U,1,13231,,,In vivo,,22224,,15173,,,,BAO_0000218,
IV clearance determined at an peroral dose of 30 mg/kg.,,0,CHEMBL623461,Autocuration,,,A,U,1,13232,,,In vivo,,22224,,15173,,,,BAO_0000218,
IV clearance determined at an peroral dose of 30.2 mg/kg.,,0,CHEMBL623462,Autocuration,,,A,U,1,13233,,,In vivo,,22224,,15173,,,,BAO_0000218,
IV clearance determined at an peroral dose of 30.3 mg/kg.,,0,CHEMBL627386,Autocuration,,,A,U,1,13234,,,In vivo,,22224,,15173,,,,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,1,CHEMBL627387,Intermediate,,,A,N,1,13235,2113.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Kidney,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,1,CHEMBL627388,Intermediate,,,A,N,1,13236,2107.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Liver,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,1,CHEMBL627389,Intermediate,,,A,N,1,13237,2048.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Lung,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,1,CHEMBL627390,Intermediate,,,A,N,1,13238,2385.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,1,CHEMBL627391,Intermediate,,,A,N,1,13239,1969.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Plasma,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,1,CHEMBL627392,Intermediate,,,A,N,1,13240,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,1,CHEMBL627393,Intermediate,,,A,N,1,13241,2106.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Spleen,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,1,CHEMBL627394,Intermediate,,,A,N,1,13242,3126.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Trachea,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,1,CHEMBL627395,Intermediate,,,A,N,1,13243,10000001.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Bone,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,1,CHEMBL875485,Intermediate,,,A,N,1,13244,2037.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Cerebellum,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,1,CHEMBL627396,Intermediate,,,A,N,1,13245,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,1,CHEMBL627397,Intermediate,,,A,N,1,13246,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,1,CHEMBL627398,Intermediate,,,A,N,1,13247,948.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Heart,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,1,CHEMBL627399,Intermediate,,,A,N,1,13248,10000001.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Bone,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,1,CHEMBL627400,Intermediate,,,A,N,1,13249,2113.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Kidney,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,1,CHEMBL627401,Intermediate,,,A,N,1,13250,2107.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Liver,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,1,CHEMBL627402,Intermediate,,,A,N,1,13251,2048.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Lung,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,1,CHEMBL627403,Intermediate,,,A,N,1,13252,2385.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,1,CHEMBL627404,Intermediate,,,A,N,1,13253,1969.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Plasma,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,1,CHEMBL623101,Intermediate,,,A,N,1,13254,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,1,CHEMBL877480,Intermediate,,,A,N,1,13255,2106.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Spleen,BAO_0000218,
Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,1,CHEMBL623102,Intermediate,,,A,N,1,13256,3126.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Trachea,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,1,CHEMBL623103,Intermediate,,,A,N,1,13257,10000001.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Bone,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,1,CHEMBL623104,Intermediate,,,A,N,1,13258,2037.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Cerebellum,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,1,CHEMBL623105,Intermediate,,,A,N,1,13259,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,1,CHEMBL623106,Intermediate,,,A,N,1,13260,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,1,CHEMBL623107,Intermediate,,,A,N,1,13261,948.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Heart,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,1,CHEMBL623108,Intermediate,,,A,N,1,13262,160.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Intestine,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,1,CHEMBL623109,Intermediate,,,A,N,1,13263,2113.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Kidney,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,1,CHEMBL623110,Intermediate,,,A,N,1,13264,2107.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Liver,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,1,CHEMBL623111,Intermediate,,,A,N,1,13265,2048.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Lung,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,1,CHEMBL625060,Intermediate,,,A,N,1,13266,2385.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,1,CHEMBL625061,Intermediate,,,A,N,1,13267,1969.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Plasma,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,1,CHEMBL625062,Intermediate,,,A,N,1,13268,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,1,CHEMBL625063,Intermediate,,,A,N,1,13269,2106.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Spleen,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,1,CHEMBL625064,Intermediate,,,A,N,1,13270,3126.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Trachea,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,1,CHEMBL625065,Intermediate,,,A,N,1,13271,10000001.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Bone,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,1,CHEMBL625066,Intermediate,,,A,N,1,13272,2037.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Cerebellum,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,1,CHEMBL625067,Intermediate,,,A,N,1,13273,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,1,CHEMBL625068,Intermediate,,,A,N,1,13274,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,1,CHEMBL622159,Intermediate,,,A,N,1,13275,948.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Heart,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,1,CHEMBL622160,Intermediate,,,A,N,1,13276,160.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Intestine,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,1,CHEMBL622161,Intermediate,,,A,N,1,13277,2113.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Kidney,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,1,CHEMBL622162,Intermediate,,,A,N,1,13278,2048.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Lung,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,1,CHEMBL622163,Intermediate,,,A,N,1,13279,2385.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,1,CHEMBL622313,Intermediate,,,A,N,1,13280,1969.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Plasma,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,1,CHEMBL622314,Intermediate,,,A,N,1,13281,,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,1,CHEMBL622315,Intermediate,,,A,N,1,13282,2106.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Spleen,BAO_0000218,
Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,1,CHEMBL622316,Intermediate,,,A,N,1,13283,3126.0,Rattus norvegicus,In vivo,,50597,,14198,10116.0,,Trachea,BAO_0000218,
Normal diffusion coefficient in water for Escherichia coli,,1,CHEMBL877486,Intermediate,,,A,N,1,13284,,Escherichia coli,,,50212,,15599,562.0,,,BAO_0000218,
Average max percent decrease in RVR (renal vascular resistance) was determined,,0,CHEMBL622317,Autocuration,,,A,U,1,13285,,,,,22224,,8204,,,,BAO_0000019,
Average max percent decrease in RVR (renal vascular resistance) was determined.,,0,CHEMBL622318,Autocuration,,,A,U,1,13286,,,,,22224,,8204,,,,BAO_0000019,
In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,0,CHEMBL622319,Autocuration,,,A,U,1,13287,,,,,22224,,6154,,,,BAO_0000019,
In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,0,CHEMBL622320,Autocuration,,,A,U,1,13288,,,,,22224,,6154,,,,BAO_0000019,
In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,0,CHEMBL622321,Autocuration,,,A,U,1,13289,,,,,22224,,6154,,,,BAO_0000019,
In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,0,CHEMBL622322,Autocuration,,,A,U,1,13290,,,,,22224,,6154,,,,BAO_0000019,
Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,0,CHEMBL622323,Autocuration,,,A,U,1,13291,,,,,22224,,7114,,,,BAO_0000019,
Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,1,CHEMBL622324,Intermediate,,,A,N,1,13292,,Rattus norvegicus,,,50597,,7114,10116.0,,,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,1,CHEMBL622325,Intermediate,,,A,N,1,13293,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,1,CHEMBL622326,Intermediate,,,A,N,1,13294,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,1,CHEMBL877487,Intermediate,,,A,N,1,13295,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,1,CHEMBL622327,Intermediate,,,A,N,1,13296,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,1,CHEMBL622328,Intermediate,,,A,N,1,13297,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,1,CHEMBL622329,Intermediate,,,A,N,1,13298,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,1,CHEMBL622330,Intermediate,,,A,N,1,13299,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,1,CHEMBL622331,Intermediate,,,A,N,1,13300,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,1,CHEMBL622332,Intermediate,,,A,N,1,13301,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,1,CHEMBL622333,Intermediate,,,A,N,1,13302,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,0,CHEMBL627658,Autocuration,,,A,U,1,13303,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,0,CHEMBL630428,Autocuration,,,A,U,1,13304,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,0,CHEMBL630429,Autocuration,,,A,U,1,13305,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,0,CHEMBL630430,Autocuration,,,A,U,1,13306,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,0,CHEMBL630431,Autocuration,,,A,U,1,13307,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,1,CHEMBL630432,Intermediate,,,A,N,1,13308,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,1,CHEMBL630433,Intermediate,,,A,N,1,13309,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,1,CHEMBL630434,Intermediate,,,A,N,1,13310,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,1,CHEMBL629372,Intermediate,,,A,N,1,13311,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,1,CHEMBL629553,Intermediate,,,A,N,1,13312,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,1,CHEMBL629554,Intermediate,,,A,N,1,13313,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,1,CHEMBL874447,Intermediate,,,A,N,1,13314,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,1,CHEMBL629555,Intermediate,,,A,N,1,13315,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,1,CHEMBL629556,Intermediate,,,A,N,1,13316,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,1,CHEMBL629557,Intermediate,,,A,N,1,13317,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,1,CHEMBL629558,Intermediate,,,A,N,1,13318,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,1,CHEMBL629559,Intermediate,,,A,N,1,13319,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,1,CHEMBL629560,Intermediate,,,A,N,1,13320,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,1,CHEMBL629561,Intermediate,,,A,N,1,13321,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,1,CHEMBL629562,Intermediate,,,A,N,1,13322,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,1,CHEMBL629563,Intermediate,,,A,N,1,13323,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,1,CHEMBL629564,Intermediate,,,A,N,1,13324,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,1,CHEMBL629565,Intermediate,,,A,N,1,13325,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,1,CHEMBL629566,Intermediate,,,A,N,1,13326,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,1,CHEMBL629567,Intermediate,,,A,N,1,13327,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,1,CHEMBL629568,Intermediate,,,A,N,1,13328,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,1,CHEMBL629569,Intermediate,,,A,N,1,13329,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,1,CHEMBL629570,Intermediate,,,A,N,1,13330,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,0,CHEMBL629571,Autocuration,,,A,U,1,13331,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,0,CHEMBL629572,Autocuration,,,A,U,1,13332,,Rattus norvegicus,In vivo,,22224,,12170,10116.0,,,BAO_0000218,
% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,0,CHEMBL629573,Autocuration,,,A,U,1,13333,,Rattus norvegicus,In vivo,,22224,,12170,10116.0,,,BAO_0000218,
Bioavailability (dose 20 mg/kg),,0,CHEMBL629574,Autocuration,,,A,U,1,13334,,Eutheria,In vivo,,22224,,4985,9347.0,,,BAO_0000218,
Bioavailability in dog,,0,CHEMBL629575,Autocuration,,,A,U,1,13335,,Canis lupus familiaris,In vivo,,22224,,15145,9615.0,,,BAO_0000218,
Bioavailability in rat (Sprague-Dawley) (male),,0,CHEMBL874448,Autocuration,,,A,U,1,13336,,Rattus norvegicus,In vivo,,22224,,14080,10116.0,,,BAO_0000218,
Bioavailability in monkey (dose 10 mg/kg i.d.),,0,CHEMBL629576,Autocuration,,,A,U,1,13337,,Primates,In vivo,,22224,,11219,9443.0,,,BAO_0000218,
Bioavailability in rat,,0,CHEMBL629577,Autocuration,,,A,U,1,13338,,Rattus norvegicus,In vivo,,22224,,15145,10116.0,,,BAO_0000218,
Bioavailability in rat,,0,CHEMBL629578,Autocuration,,,A,U,1,13339,,Rattus norvegicus,In vivo,,22224,,15145,10116.0,,,BAO_0000218,
Bioavailability in dog (dose 3.0 mg/kg p.o.),,0,CHEMBL629579,Autocuration,,,A,U,1,13340,,Canis lupus familiaris,In vivo,,22224,,1202,9615.0,,,BAO_0000218,
Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,0,CHEMBL882958,Autocuration,,,A,U,1,13341,,Canis lupus familiaris,In vivo,,22224,,1202,9615.0,,,BAO_0000218,
Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,1,CHEMBL629580,Intermediate,,,A,N,1,13342,,Pan troglodytes,In vivo,,50505,,1202,9598.0,,,BAO_0000218,
Bioavailability,,0,CHEMBL629581,Autocuration,,,A,U,1,13343,,Eutheria,In vivo,,22224,,4026,9347.0,,,BAO_0000218,
Bioavailability in squirrel monkey,,0,CHEMBL629582,Autocuration,,,A,U,1,13344,,Saimiri,In vivo,,22224,,1492,9520.0,,,BAO_0000218,
Bioavailability was evaluated in dog,,1,CHEMBL628522,Intermediate,,,A,N,1,13345,,Canis lupus familiaris,In vivo,,50588,,12793,9615.0,,,BAO_0000218,
Bioavailability was evaluated in hamster,,1,CHEMBL625432,Intermediate,,,A,N,1,13346,,Cricetinae,In vivo,,100712,,12793,10026.0,,,BAO_0000218,
Bioavailability in rat,,0,CHEMBL625433,Autocuration,,,A,U,1,13347,,Rattus norvegicus,In vivo,,22224,,12793,10116.0,,,BAO_0000218,
Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,1,CHEMBL625434,Intermediate,,,A,N,1,13348,1969.0,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,1,CHEMBL625435,Intermediate,,,A,N,1,13349,1969.0,Rattus norvegicus,In vivo,,50597,,14793,10116.0,,Plasma,BAO_0000218,
Bioavailability in rat (dose 10 mg/kg p.o.),,0,CHEMBL625436,Autocuration,,,A,U,1,13350,,Rattus norvegicus,In vivo,,22224,,14793,10116.0,,,BAO_0000218,
Bioavailability was measured in cynomolgus monkeys.,,1,CHEMBL874588,Intermediate,,,A,N,1,13351,,Macaca fascicularis,In vivo,,100710,,14731,9541.0,,,BAO_0000218,
Bioavailability was measured in nude mice.,,1,CHEMBL625437,Intermediate,,,A,N,1,13352,,Mus musculus,In vivo,,50594,,14731,10090.0,,,BAO_0000218,
Bioavailability in ferret (dose 10 mg/kg i.d.),,0,CHEMBL625438,Autocuration,,,A,U,1,13353,,Mustela putorius furo,In vivo,,22224,,12187,9669.0,,,BAO_0000218,
Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,0,CHEMBL625439,Autocuration,,,A,U,1,13354,,Simiiformes,In vivo,,22224,,12187,314293.0,,,BAO_0000218,
"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,0,CHEMBL625440,Autocuration,,,A,U,1,13355,,Simiiformes,In vivo,,22224,,12187,314293.0,,,BAO_0000218,
Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,0,CHEMBL625441,Autocuration,,,A,U,1,13356,,Simiiformes,In vivo,,22224,,12187,314293.0,,,BAO_0000218,
Bioavailability in rat (dose 10 mg/kg i.d.),,0,CHEMBL625442,Autocuration,,,A,U,1,13357,,Rattus norvegicus,In vivo,,22224,,12187,10116.0,,,BAO_0000218,
"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,1,CHEMBL625443,Intermediate,,,A,N,1,13358,,Rattus norvegicus,In vivo,,50597,,12187,10116.0,,,BAO_0000218,
Bioavailability was determined; extremely poor,,0,CHEMBL625444,Autocuration,,,A,U,1,13359,,,In vivo,,22224,,17431,,,,BAO_0000218,
% bioavailability in mice after oral administration of prodrug,,1,CHEMBL625445,Intermediate,,,A,N,1,13360,,Mus musculus,In vivo,,50594,,13318,10090.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,1,CHEMBL625446,Intermediate,,,A,N,1,13361,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,1,CHEMBL882960,Intermediate,,,A,N,1,13362,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,1,CHEMBL625447,Intermediate,,,A,N,1,13363,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,1,CHEMBL625448,Intermediate,,,A,N,1,13364,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,1,CHEMBL625449,Intermediate,,,A,N,1,13365,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,1,CHEMBL874589,Intermediate,,,A,N,1,13366,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,1,CHEMBL625450,Intermediate,,,A,N,1,13367,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,1,CHEMBL625451,Intermediate,,,A,N,1,13368,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,1,CHEMBL626584,Intermediate,,,A,N,1,13369,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,1,CHEMBL626585,Intermediate,,,A,N,1,13370,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,1,CHEMBL626586,Intermediate,,,A,N,1,13371,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,1,CHEMBL626587,Intermediate,,,A,N,1,13372,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,1,CHEMBL626588,Intermediate,,,A,N,1,13373,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,1,CHEMBL626589,Intermediate,,,A,N,1,13374,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,1,CHEMBL626590,Intermediate,,,A,N,1,13375,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,1,CHEMBL626591,Intermediate,,,A,N,1,13376,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,1,CHEMBL627181,Intermediate,,,A,N,1,13377,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,1,CHEMBL628083,Intermediate,,,A,N,1,13378,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
IV clearance determined at an peroral dose of 15 mg/kg.,,0,CHEMBL628084,Autocuration,,,A,U,1,13379,,,In vivo,,22224,,15173,,,,BAO_0000218,
Mouse oral clearance was measured against Hymenolepiasis nana.,,1,CHEMBL628085,Expert,,,F,N,1,13380,,Hymenolepis nana,In vivo,,50064,,7732,102285.0,,,BAO_0000218,
Mouse oral clearance was measured against Nematospiroides dubius,,1,CHEMBL628086,Expert,,,F,N,1,13381,,Heligmosomoides polygyrus,In vivo,,50545,,7732,6339.0,,,BAO_0000218,
Mouse oral clearance was measured against N. dubius; NT is Not Tested,,0,CHEMBL628087,Autocuration,,,F,U,1,13382,,,In vivo,,22224,,7732,,,,BAO_0000218,
Mouse oral clearance was measured against N. nana; NT is Not Tested,,1,CHEMBL628088,Intermediate,,,A,N,1,13383,,Mus musculus,In vivo,,50594,,7732,10090.0,,,BAO_0000218,
Mouse oral clearance was measured against N. nana; NT is Not Tested,,0,CHEMBL628089,Autocuration,,,B,U,1,13384,,,In vivo,,22224,,7732,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,0,CHEMBL628090,Autocuration,,,A,U,1,13385,,,In vivo,,22224,,8328,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,0,CHEMBL628091,Autocuration,,,A,U,1,13386,,,In vivo,,22224,,8328,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,0,CHEMBL628092,Autocuration,,,A,U,1,13387,,,In vivo,,22224,,8328,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,0,CHEMBL628093,Autocuration,,,A,U,1,13388,,,In vivo,,22224,,8328,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,0,CHEMBL875607,Autocuration,,,A,U,1,13389,,,In vivo,,22224,,8328,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,0,CHEMBL625710,Autocuration,,,A,U,1,13390,,,In vivo,,22224,,8328,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,0,CHEMBL625711,Autocuration,,,A,U,1,13391,,,In vivo,,22224,,8328,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,0,CHEMBL625712,Autocuration,,,A,U,1,13392,,,In vivo,,22224,,8328,,,,BAO_0000218,
Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,0,CHEMBL625713,Autocuration,,,A,U,1,13393,,,In vivo,,22224,,8328,,,,BAO_0000218,
Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,1,CHEMBL625714,Intermediate,,,A,N,1,13394,,Canis lupus familiaris,In vivo,,50588,,13376,9615.0,,,BAO_0000218,
Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,1,CHEMBL625715,Intermediate,,,A,N,1,13395,,Macaca mulatta,In vivo,,50797,,13477,9544.0,,,BAO_0000218,
Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,1,CHEMBL625716,Intermediate,,,A,N,1,13396,,Rattus norvegicus,In vivo,,50597,,13477,10116.0,,,BAO_0000218,
Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,1,CHEMBL625717,Intermediate,,,A,N,1,13397,,Rattus norvegicus,In vivo,,50597,,13477,10116.0,,,BAO_0000218,
Plasma clearance was determined for the compound in rats,,1,CHEMBL625718,Intermediate,,,A,N,1,13398,,Rattus norvegicus,In vivo,,50597,,13313,10116.0,,,BAO_0000218,
Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,1,CHEMBL625719,Intermediate,,,A,N,1,13399,,Rattus norvegicus,In vivo,,50597,,12504,10116.0,,,BAO_0000218,
Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,1,CHEMBL625720,Intermediate,,,A,N,1,13400,,Rattus norvegicus,In vivo,,50597,,12504,10116.0,,,BAO_0000218,
Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,1,CHEMBL625721,Intermediate,,,A,N,1,13401,,Rattus norvegicus,In vivo,,50597,,12504,10116.0,,,BAO_0000218,
Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,1,CHEMBL625722,Intermediate,,,A,N,1,13402,,Rattus norvegicus,In vivo,,50597,,12504,10116.0,,,BAO_0000218,
The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,1,CHEMBL625723,Intermediate,,,A,N,1,13403,,Rattus norvegicus,In vivo,,50597,,13129,10116.0,,,BAO_0000218,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,1,CHEMBL625724,Intermediate,,,A,N,1,13404,,Heligmosomoides polygyrus,In vivo,,50545,,7732,6339.0,,,BAO_0000218,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,1,CHEMBL625725,Intermediate,,,A,N,1,13405,,Heligmosomoides polygyrus,In vivo,,50545,,7732,6339.0,,,BAO_0000218,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,1,CHEMBL625726,Intermediate,,,A,N,1,13406,,Heligmosomoides polygyrus,In vivo,,50545,,7732,6339.0,,,BAO_0000218,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,1,CHEMBL875608,Intermediate,,,A,N,1,13407,,Heligmosomoides polygyrus,In vivo,,50545,,7732,6339.0,,,BAO_0000218,
Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,1,CHEMBL625727,Intermediate,,,A,N,1,13408,,Heligmosomoides polygyrus,In vivo,,50545,,7732,6339.0,,,BAO_0000218,
Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,0,CHEMBL625728,Autocuration,,,A,U,1,13409,1088.0,Rattus norvegicus,In vivo,,22224,,9278,10116.0,,Urine,BAO_0000218,
Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,0,CHEMBL625729,Autocuration,,,A,U,1,13410,,Rattus norvegicus,In vivo,,22224,,9278,10116.0,,,BAO_0000218,
Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,0,CHEMBL625730,Autocuration,,,A,U,1,13411,,Rattus norvegicus,In vivo,,22224,,9278,10116.0,,,BAO_0000218,
Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,0,CHEMBL625731,Autocuration,,,A,U,1,13412,1088.0,Rattus norvegicus,In vivo,,22224,,9278,10116.0,,Urine,BAO_0000218,
Urinary clearance was determined in rat at 25 mg/kg os dosage,,0,CHEMBL626417,Autocuration,,,A,U,1,13413,1088.0,Rattus norvegicus,In vivo,,22224,,9278,10116.0,,Urine,BAO_0000218,
Urinary clearance was determined at 100 mg/kg oral dosage in human,,1,CHEMBL626418,Intermediate,,,A,N,1,13414,1088.0,Homo sapiens,In vivo,,50587,,9278,9606.0,,Urine,BAO_0000218,
Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,1,CHEMBL626419,Intermediate,,,A,N,1,13415,1088.0,Canis lupus familiaris,In vivo,,50588,,9278,9615.0,,Urine,BAO_0000218,
Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,1,CHEMBL626592,Intermediate,,,A,N,1,13416,1969.0,Canis lupus familiaris,In vivo,,50588,,5932,9615.0,,Plasma,BAO_0000218,
Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,1,CHEMBL626593,Intermediate,,,A,N,1,13417,1969.0,Rattus norvegicus,In vivo,,50597,,5932,10116.0,,Plasma,BAO_0000218,
Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,1,CHEMBL626594,Intermediate,,,A,N,1,13418,,Rattus norvegicus,In vivo,,50597,,5182,10116.0,,,BAO_0000218,
Clearance rate in dogs,,1,CHEMBL625035,Intermediate,,,A,N,1,13419,,Canis lupus familiaris,In vivo,,50588,,10499,9615.0,,,BAO_0000218,
Compound was measured for intrinsic clearance,,0,CHEMBL625036,Autocuration,,,A,U,1,13420,,,In vitro,,22224,,6051,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL625037,Autocuration,,,P,U,1,13421,,,,,22229,,17508,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625038,Autocuration,,,P,U,1,13422,,,,,22229,,6228,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625039,Autocuration,,,P,U,1,13423,,,,,22229,,6231,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625040,Autocuration,,,P,U,1,13424,,,,,22229,,17740,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625041,Autocuration,,,P,U,1,13425,,,,,22229,,6495,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625042,Autocuration,,,P,U,1,13426,,,,,22229,,2171,,,,BAO_0000100,
Partition coefficient of the compound,,0,CHEMBL874411,Autocuration,,,A,U,1,13427,,,,,22224,,3255,,,,BAO_0000019,
Permeability,,0,CHEMBL625043,Autocuration,,,A,U,1,13428,,,,,22224,,6821,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL625044,Autocuration,,,P,U,1,13429,,,,,22229,,2685,,,,BAO_0000100,
Partition coefficient (logD),,0,CHEMBL625045,Autocuration,,,A,U,1,13430,,,,,22224,,17584,,,,BAO_0000019,
Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,CHEMBL625046,Autocuration,,,P,U,1,13431,,,,,22229,,13824,,,,BAO_0000100,
Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,CHEMBL625047,Autocuration,,,P,U,1,13432,,,,,22229,,13824,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625048,Autocuration,,,P,U,1,13433,,,,,22229,,16479,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625049,Autocuration,,,P,U,1,13434,,,,,22229,,11997,,,,BAO_0000100,
Calculated logarithm of partition coefficient (P) was determined,,0,CHEMBL625050,Autocuration,,,P,U,1,13435,,,,,22229,,2988,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625051,Autocuration,,,P,U,1,13436,,,,,22229,,931,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL874412,Autocuration,,,P,U,1,13437,,,,,22229,,4381,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625052,Autocuration,,,P,U,1,13438,,,,,22229,,4397,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL625053,Autocuration,,,P,U,1,13439,,,,,22229,,5889,,,,BAO_0000100,
In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,0,CHEMBL623250,Autocuration,,,A,U,1,13440,,,,,22224,,6154,,,,BAO_0000019,
In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,0,CHEMBL623251,Autocuration,,,A,U,1,13441,,,,,22224,,6154,,,,BAO_0000019,
In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,0,CHEMBL623252,Autocuration,,,A,U,1,13442,,,,,22224,,6154,,,,BAO_0000019,
In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,0,CHEMBL623253,Autocuration,,,A,U,1,13443,,,,,22224,,6154,,,,BAO_0000019,
In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,0,CHEMBL623254,Autocuration,,,A,U,1,13444,,,,,22224,,6154,,,,BAO_0000019,
In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,0,CHEMBL623255,Autocuration,,,A,U,1,13445,,,,,22224,,6154,,,,BAO_0000019,
Percent degradation of compound at a pH of 1 over a 18 hr period,,0,CHEMBL626831,Autocuration,,,A,U,1,13446,,,,,22224,,6887,,,,BAO_0000019,
Percent degradation of compound at pH of 1 over an 18 hr period,,0,CHEMBL877494,Autocuration,,,A,U,1,13447,,,,,22224,,6887,,,,BAO_0000019,
Delta Logarithm of Partition Coefficient value was determined.,,0,CHEMBL626832,Autocuration,,,A,U,1,13448,,,,,22224,,14116,,,,BAO_0000019,
Delta logPoct-cyc,,0,CHEMBL626833,Autocuration,,,A,U,1,13449,,,,,22224,,11137,,,,BAO_0000019,
Lipophilicity estimated on reversed phase TLC,,0,CHEMBL626834,Autocuration,,,P,U,1,13450,,,,,22224,,7230,,,,BAO_0000100,
Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,0,CHEMBL626835,Autocuration,,,A,U,1,13451,,,,,22224,,15741,,,,BAO_0000019,
Delta logPoct-cyc,,0,CHEMBL626836,Autocuration,,,A,U,1,13452,,,,,22224,,9663,,,,BAO_0000019,
Change in logarithm of partition coefficient of the compound,,0,CHEMBL626837,Autocuration,,,P,U,1,13453,,,,,22229,,9663,,,,BAO_0000100,
Delta logD (pH 6.5),,0,CHEMBL626838,Autocuration,,,A,U,1,13454,,,,,22224,,13807,,,,BAO_0000019,
"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,0,CHEMBL626839,Autocuration,,,P,U,1,13455,,,,,22224,,13807,,,,BAO_0000100,
Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,0,CHEMBL626840,Autocuration,,,A,U,1,13456,,,,,22224,,17425,,,,BAO_0000019,
Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,0,CHEMBL626841,Autocuration,,,A,U,1,13457,,,,,22224,,12143,,,,BAO_0000019,
Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,0,CHEMBL626842,Autocuration,,,A,U,1,13458,,,,,22224,,12608,,,,BAO_0000219,
Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,0,CHEMBL626843,Autocuration,,,A,U,1,13459,,,,,22224,,12608,,,,BAO_0000219,
Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,1,CHEMBL626844,Intermediate,,,A,N,1,13460,,Rattus norvegicus,,,50597,,8649,10116.0,,,BAO_0000218,
Amount of deuterium retained was reported after normal workup in rats,,1,CHEMBL877495,Intermediate,,,A,N,1,13461,,Rattus norvegicus,,,50597,,8649,10116.0,,,BAO_0000218,
Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,1,CHEMBL626845,Intermediate,,,A,N,1,13462,,Rattus norvegicus,,,50597,,8649,10116.0,,,BAO_0000218,
Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,1,CHEMBL626846,Intermediate,,,A,N,1,13463,,Rattus norvegicus,,,50597,,8649,10116.0,,,BAO_0000218,
Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,1,CHEMBL626847,Intermediate,,,A,N,1,13464,,Rattus norvegicus,,,50597,,8649,10116.0,,,BAO_0000218,
Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,1,CHEMBL628677,Intermediate,,,A,N,1,13465,,Rattus norvegicus,,,50597,,8649,10116.0,,,BAO_0000218,
Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,1,CHEMBL628678,Intermediate,,,A,N,1,13466,,Rattus norvegicus,,,50597,,8649,10116.0,,,BAO_0000218,
Compound was subjected to electrochemical oxidation,,0,CHEMBL628679,Autocuration,,,A,U,1,13467,,,,,22224,,9659,,,,BAO_0000019,
Compound was subjected to photochemical oxidation,,0,CHEMBL628680,Autocuration,,,A,U,1,13468,,,,,22224,,9659,,,,BAO_0000019,
Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,0,CHEMBL628681,Autocuration,,,A,U,1,13469,,,,,22224,,9659,,,,BAO_0000019,
Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,0,CHEMBL628682,Autocuration,,,A,U,1,13470,,,,,22224,,9659,,,,BAO_0000019,
Oxidation of compound by methemoglobin in presence of hydroperoxide,,0,CHEMBL628683,Autocuration,,,A,U,1,13471,,,,,22224,,9659,,,,BAO_0000019,
Percent diffusion through fuzzy rat skin after 48 h of incubation,,1,CHEMBL628684,Intermediate,,,A,N,1,13472,,Rattus norvegicus,,,50597,,9607,10116.0,,,BAO_0000218,
Dissociation constant (pKa),,0,CHEMBL877501,Autocuration,,,P,U,1,13473,,,,,22229,,7057,,,,BAO_0000100,
Dissociation constant value of the compound; ND means not determined.,,0,CHEMBL628685,Autocuration,,,P,U,1,13474,,,,,22224,,7057,,,,BAO_0000100,
% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,1,CHEMBL628686,Intermediate,,,A,N,1,13475,178.0,Rattus norvegicus,,,50597,,7911,10116.0,,Blood,BAO_0000218,
% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,1,CHEMBL628687,Intermediate,,,A,N,1,13476,178.0,Rattus norvegicus,,,50597,,7911,10116.0,,Blood,BAO_0000218,
% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,1,CHEMBL628688,Intermediate,,,A,N,1,13477,,Rattus norvegicus,,,50597,,7911,10116.0,,,BAO_0000218,
% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,1,CHEMBL628689,Intermediate,,,A,N,1,13478,,Rattus norvegicus,,,50597,,7911,10116.0,,,BAO_0000218,
% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,1,CHEMBL628690,Intermediate,,,A,N,1,13479,2107.0,Rattus norvegicus,,,50597,,7911,10116.0,,Liver,BAO_0000218,
% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,1,CHEMBL629363,Intermediate,,,A,N,1,13480,2107.0,Rattus norvegicus,,,50597,,7911,10116.0,,Liver,BAO_0000218,
% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,1,CHEMBL629364,Intermediate,,,A,N,1,13481,2106.0,Rattus norvegicus,,,50597,,7911,10116.0,,Spleen,BAO_0000218,
% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,1,CHEMBL629365,Intermediate,,,A,N,1,13482,2106.0,Rattus norvegicus,,,50597,,7911,10116.0,,Spleen,BAO_0000218,
% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,1,CHEMBL629366,Intermediate,,,A,N,1,13483,,Rattus norvegicus,,,50597,,7911,10116.0,,,BAO_0000218,
% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,1,CHEMBL629367,Intermediate,,,A,N,1,13484,1088.0,Rattus norvegicus,,,50597,,7911,10116.0,,Urine,BAO_0000218,
% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,1,CHEMBL629368,Intermediate,,,A,N,1,13485,1988.0,Rattus norvegicus,,,50597,,7911,10116.0,,Feces,BAO_0000218,
% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,1,CHEMBL877502,Intermediate,,,A,N,1,13486,1088.0,Rattus norvegicus,,,50597,,7911,10116.0,,Urine,BAO_0000218,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,1,CHEMBL629369,Intermediate,,,A,N,1,13487,2037.0,Mus musculus,,,50594,,13792,10090.0,,Cerebellum,BAO_0000218,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,1,CHEMBL629370,Intermediate,,,A,N,1,13488,955.0,Mus musculus,,,50594,,13792,10090.0,,Brain,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,0,CHEMBL629371,Autocuration,,,A,U,1,13489,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,0,CHEMBL626276,Autocuration,,,A,U,1,13490,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,0,CHEMBL626277,Autocuration,,,A,U,1,13491,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,0,CHEMBL631250,Autocuration,,,A,U,1,13492,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,1,CHEMBL631251,Intermediate,,,A,N,1,13493,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,1,CHEMBL631252,Intermediate,,,A,N,1,13494,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,1,CHEMBL631253,Intermediate,,,A,N,1,13495,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,1,CHEMBL631254,Intermediate,,,A,N,1,13496,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,1,CHEMBL631255,Intermediate,,,A,N,1,13497,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,1,CHEMBL631256,Intermediate,,,A,N,1,13498,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,1,CHEMBL631257,Intermediate,,,A,N,1,13499,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,1,CHEMBL628009,Intermediate,,,A,N,1,13500,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,1,CHEMBL628010,Intermediate,,,A,N,1,13501,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,1,CHEMBL628011,Intermediate,,,A,N,1,13502,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,1,CHEMBL628012,Intermediate,,,A,N,1,13503,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,1,CHEMBL628013,Intermediate,,,A,N,1,13504,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,1,CHEMBL628014,Intermediate,,,A,N,1,13505,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,1,CHEMBL628015,Intermediate,,,A,N,1,13506,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,1,CHEMBL628016,Intermediate,,,A,N,1,13507,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,1,CHEMBL874461,Intermediate,,,A,N,1,13508,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,1,CHEMBL628017,Intermediate,,,A,N,1,13509,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,1,CHEMBL628018,Intermediate,,,A,N,1,13510,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,1,CHEMBL628019,Intermediate,,,A,N,1,13511,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,1,CHEMBL628020,Intermediate,,,A,N,1,13512,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,1,CHEMBL628021,Intermediate,,,A,N,1,13513,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,1,CHEMBL628022,Intermediate,,,A,N,1,13514,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,1,CHEMBL628023,Intermediate,,,A,N,1,13515,1088.0,Canis lupus familiaris,,,50588,,8133,9615.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,0,CHEMBL628024,Autocuration,,,A,U,1,13516,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,0,CHEMBL628025,Autocuration,,,A,U,1,13517,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,0,CHEMBL628026,Autocuration,,,A,U,1,13518,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,0,CHEMBL628027,Autocuration,,,A,U,1,13519,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,0,CHEMBL628028,Autocuration,,,A,U,1,13520,1088.0,Simiiformes,,,22224,,8133,314293.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,1,CHEMBL628029,Intermediate,,,A,N,1,13521,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,1,CHEMBL628030,Intermediate,,,A,N,1,13522,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,1,CHEMBL628031,Intermediate,,,A,N,1,13523,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,1,CHEMBL628032,Intermediate,,,A,N,1,13524,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,1,CHEMBL628033,Intermediate,,,A,N,1,13525,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,1,CHEMBL628034,Intermediate,,,A,N,1,13526,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,1,CHEMBL628035,Intermediate,,,A,N,1,13527,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,1,CHEMBL628036,Intermediate,,,A,N,1,13528,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,1,CHEMBL874462,Intermediate,,,A,N,1,13529,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,1,CHEMBL628037,Intermediate,,,A,N,1,13530,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,1,CHEMBL628123,Intermediate,,,A,N,1,13531,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,1,CHEMBL628124,Intermediate,,,A,N,1,13532,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,1,CHEMBL628125,Intermediate,,,A,N,1,13533,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,1,CHEMBL628126,Intermediate,,,A,N,1,13534,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,1,CHEMBL628127,Intermediate,,,A,N,1,13535,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,1,CHEMBL628128,Intermediate,,,A,N,1,13536,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,1,CHEMBL628129,Intermediate,,,A,N,1,13537,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,1,CHEMBL628130,Intermediate,,,A,N,1,13538,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,1,CHEMBL628131,Intermediate,,,A,N,1,13539,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,1,CHEMBL628132,Intermediate,,,A,N,1,13540,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,1,CHEMBL628133,Intermediate,,,A,N,1,13541,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,1,CHEMBL628134,Intermediate,,,A,N,1,13542,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,1,CHEMBL628135,Intermediate,,,A,N,1,13543,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,1,CHEMBL628136,Intermediate,,,A,N,1,13544,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,1,CHEMBL628137,Intermediate,,,A,N,1,13545,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,1,CHEMBL628138,Intermediate,,,A,N,1,13546,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,1,CHEMBL628139,Intermediate,,,A,N,1,13547,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,1,CHEMBL628140,Intermediate,,,A,N,1,13548,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,1,CHEMBL628141,Intermediate,,,A,N,1,13549,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,1,CHEMBL628142,Intermediate,,,A,N,1,13550,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,1,CHEMBL628143,Intermediate,,,A,N,1,13551,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,1,CHEMBL628144,Intermediate,,,A,N,1,13552,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,1,CHEMBL628145,Intermediate,,,A,N,1,13553,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,1,CHEMBL628146,Intermediate,,,A,N,1,13554,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,1,CHEMBL625355,Intermediate,,,A,N,1,13555,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,1,CHEMBL625356,Intermediate,,,A,N,1,13556,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,1,CHEMBL625357,Intermediate,,,A,N,1,13557,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,1,CHEMBL625527,Intermediate,,,A,N,1,13558,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,1,CHEMBL875473,Intermediate,,,A,N,1,13559,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,1,CHEMBL625528,Intermediate,,,A,N,1,13560,,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,1,CHEMBL626304,Intermediate,,,A,N,1,13561,,Rattus norvegicus,In vivo,,50597,,9025,10116.0,,,BAO_0000218,
Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,1,CHEMBL624138,Intermediate,,,A,N,1,13562,1637.0,Canis lupus familiaris,In vivo,,50588,,9025,9615.0,,Artery,BAO_0000218,
Calculated partition coefficient (clogP),,0,CHEMBL624139,Autocuration,,,P,U,1,13563,,,,,22229,,6448,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624140,Autocuration,,,P,U,1,13564,,,,,22229,,17221,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624141,Autocuration,,,P,U,1,13565,,,,,22229,,6545,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624142,Autocuration,,,P,U,1,13566,,,,,22229,,577,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624143,Autocuration,,,P,U,1,13567,,,,,22229,,6285,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624144,Autocuration,,,P,U,1,13568,,,,,22229,,6500,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624145,Autocuration,,,P,U,1,13569,,,,,22229,,6716,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624146,Autocuration,,,P,U,1,13570,,,,,22229,,13658,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624147,Autocuration,,,P,U,1,13571,,,,,22229,,6549,,,,BAO_0000100,
Calculated partition coefficient (clogP) (MacLogP),,0,CHEMBL883123,Autocuration,,,P,U,1,13572,,,,,22229,,14685,,,,BAO_0000100,
Partition coefficient (logP),,0,CHEMBL624148,Autocuration,,,A,U,1,13573,,,,,22224,,6893,,,,BAO_0000019,
Kinetic parameter was determined,,0,CHEMBL874416,Autocuration,,,A,U,1,13574,,,,,22224,,3687,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL624149,Autocuration,,,P,U,1,13575,,,,,22229,,4207,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL624150,Autocuration,,,P,U,1,13576,,,,,22229,,4626,,,,BAO_0000100,
Lipophilicity was determined,,0,CHEMBL624151,Autocuration,,,P,U,1,13577,,,,,22224,,1021,,,,BAO_0000100,
Lipophilicity was determined,,0,CHEMBL624152,Autocuration,,,P,U,1,13578,,,,,22224,,3777,,,,BAO_0000100,
Lipophilicity was determined,,0,CHEMBL622139,Autocuration,,,P,U,1,13579,,,,,22224,,17533,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL622140,Autocuration,,,P,U,1,13580,,,,,22229,,6524,,,,BAO_0000100,
Lipophilicity was determined,,0,CHEMBL622141,Autocuration,,,P,U,1,13581,,,,,22224,,17533,,,,BAO_0000100,
Lipophilicity in octanol-water,,0,CHEMBL622142,Autocuration,,,P,U,1,13582,,,,,22224,,6480,,,,BAO_0000100,
Calculated partition coefficient (clogP),,0,CHEMBL622143,Autocuration,,,P,U,1,13583,,,,,22229,,17606,,,,BAO_0000100,
Octanol-water partition coefficient was determined,,0,CHEMBL622144,Autocuration,,,P,U,1,13584,,,,,22229,,6863,,,,BAO_0000100,
Partition coefficient (logP),,0,CHEMBL877473,Autocuration,,,A,U,1,13585,,,,,22224,,1356,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL622145,Autocuration,,,P,U,1,13586,,,,,22229,,3326,,,,BAO_0000100,
Partition coefficient was determined; ND means not determined,,0,CHEMBL622146,Autocuration,,,A,U,1,13587,,,,,22224,,1356,,,,BAO_0000019,
Calculated partition coefficient (clogP),,0,CHEMBL622147,Autocuration,,,P,U,1,13588,,,,,22229,,12984,,,,BAO_0000100,
Partition coefficient of the compound,,0,CHEMBL622148,Autocuration,,,A,U,1,13589,,,,,22224,,17363,,,,BAO_0000019,
Permeability was determined,,0,CHEMBL883124,Autocuration,,,A,U,1,13590,,,,,22224,,6827,,,,BAO_0000019,
The compound was evaluated for the partition coefficient,,0,CHEMBL622149,Autocuration,,,P,U,1,13591,,,,,22229,,261,,,,BAO_0000100,
Partition coefficient (logP),,0,CHEMBL622150,Autocuration,,,A,U,1,13592,,,,,22224,,2685,,,,BAO_0000019,
The lipophilicity was reported,,0,CHEMBL622151,Autocuration,,,P,U,1,13593,,,,,22224,,414,,,,BAO_0000100,
logarithm of the octanol-water partition coefficient for the compound,,0,CHEMBL622152,Autocuration,,,P,U,1,13594,,,,,22229,,15769,,,,BAO_0000100,
Clogp value was determined,,0,CHEMBL622153,Autocuration,,,A,U,1,13595,,,,,22224,,17248,,,,BAO_0000019,
Clp at a dose of 1.5 mg/kg,,0,CHEMBL877474,Autocuration,,,A,U,1,13596,,,In vivo,,22224,,16935,,,,BAO_0000218,
Clp at a dose of 2.0 mg/kg,,0,CHEMBL622154,Autocuration,,,A,U,1,13597,,,In vivo,,22224,,16935,,,,BAO_0000218,
"Clp, plasma clearance at a dose of 10 mg/kg",,0,CHEMBL622155,Autocuration,,,A,U,1,13598,1969.0,,In vivo,,22224,,14832,,,Plasma,BAO_0000218,
"Clp, plasma clearance at a dose of 50 mg/kg",,0,CHEMBL622156,Autocuration,,,A,U,1,13599,1969.0,,In vivo,,22224,,14832,,,Plasma,BAO_0000218,
Compound was tested for plasma clearance in rat,,1,CHEMBL622157,Intermediate,,,A,N,1,13600,1969.0,Rattus norvegicus,In vivo,,50597,,2399,10116.0,,Plasma,BAO_0000218,
Compound was tested for plasma clearance in rat; Not determined,,1,CHEMBL622158,Intermediate,,,A,N,1,13601,1969.0,Rattus norvegicus,In vivo,,50597,,2399,10116.0,,Plasma,BAO_0000218,
Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,1,CHEMBL622807,Intermediate,,,A,N,1,13602,,Rattus norvegicus,In vivo,,50597,,6227,10116.0,,,BAO_0000218,
Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,1,CHEMBL622808,Intermediate,,,A,N,1,13603,,Macaca mulatta,In vivo,,50797,,6227,9544.0,,,BAO_0000218,
Plasma clearance by iv administration at a dose 0.003 ug/mL,,0,CHEMBL622809,Autocuration,,,A,U,1,13604,,,In vivo,,22224,,5623,,,,BAO_0000218,
Plasma clearance determined,,0,CHEMBL622810,Autocuration,,,A,U,1,13605,,,In vivo,,22224,,4854,,,,BAO_0000218,
Plasma clearance after iv administration at 3 mg/kg in hamster,,1,CHEMBL876653,Intermediate,,,A,N,1,13606,,Cricetinae,In vivo,,100712,,4493,10026.0,,,BAO_0000218,
Plasma clearance after iv administration at 4 mg/kg in hamster,,1,CHEMBL622811,Intermediate,,,A,N,1,13607,,Cricetinae,In vivo,,100712,,4493,10026.0,,,BAO_0000218,
Rate of clearance in rat was determined,,1,CHEMBL622986,Intermediate,,,A,N,1,13608,,Rattus norvegicus,In vivo,,50597,,14956,10116.0,,,BAO_0000218,
Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,1,CHEMBL622987,Intermediate,,,A,N,1,13609,1969.0,Rattus norvegicus,In vivo,,50597,,15372,10116.0,,Plasma,BAO_0000218,
Total plasma clearance after iv dose of 5.10 mg/kg in rats,,1,CHEMBL622988,Intermediate,,,A,N,1,13610,1969.0,Rattus norvegicus,In vivo,,50597,,15372,10116.0,,Plasma,BAO_0000218,
Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,1,CHEMBL622989,Intermediate,,,A,N,1,13611,1969.0,Rattus norvegicus,In vivo,,50597,,15372,10116.0,,Plasma,BAO_0000218,
Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,1,CHEMBL622990,Intermediate,,,A,N,1,13612,1969.0,Rattus norvegicus,In vivo,,50597,,15372,10116.0,,Plasma,BAO_0000218,
plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,0,CHEMBL622991,Autocuration,,,A,U,1,13613,1969.0,Simiiformes,In vivo,,22224,,15604,314293.0,,Plasma,BAO_0000218,
plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,1,CHEMBL622227,Intermediate,,,A,N,1,13614,1969.0,Rattus norvegicus,In vivo,,50597,,15604,10116.0,,Plasma,BAO_0000218,
plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,1,CHEMBL622228,Intermediate,,,A,N,1,13615,1969.0,Canis lupus familiaris,In vivo,,50588,,15604,9615.0,,Plasma,BAO_0000218,
Clpl value in rat,,1,CHEMBL622229,Intermediate,,,A,N,1,13616,,Rattus norvegicus,In vivo,,50597,,14964,10116.0,,,BAO_0000218,
Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,1,CHEMBL622230,Intermediate,,,A,N,1,13617,,Cavia porcellus,In vivo,,50512,,15240,10141.0,,,BAO_0000218,
Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,1,CHEMBL622231,Intermediate,,,A,N,1,13618,,Rattus norvegicus,In vivo,,50597,,16449,10116.0,,,BAO_0000218,
Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,1,CHEMBL622232,Intermediate,,,A,N,1,13619,,Macaca fascicularis,In vivo,,100710,,16449,9541.0,,,BAO_0000218,
Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,0,CHEMBL622233,Autocuration,,,A,U,1,13620,,,In vivo,,22224,,12902,,,,BAO_0000218,
Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,0,CHEMBL622234,Autocuration,,,A,U,1,13621,,,In vivo,,22224,,12902,,,,BAO_0000218,
Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,0,CHEMBL622235,Autocuration,,,A,U,1,13622,,,In vivo,,22224,,12902,,,,BAO_0000218,
Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,0,CHEMBL622236,Autocuration,,,A,U,1,13623,,,In vivo,,22224,,12902,,,,BAO_0000218,
Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,0,CHEMBL622237,Autocuration,,,A,U,1,13624,,,In vivo,,22224,,12902,,,,BAO_0000218,
Cmax in minutes at a po dose of 10.0(pmol/g/h).,,0,CHEMBL877482,Autocuration,,,A,U,1,13625,,,In vivo,,22224,,12902,,,,BAO_0000218,
Cmax in minutes at a po dose of 20.0(pmol/g/h).,,0,CHEMBL622238,Autocuration,,,A,U,1,13626,,,In vivo,,22224,,12902,,,,BAO_0000218,
Cmax in minutes at a po dose of 40.0(pmol/g/h).,,0,CHEMBL622239,Autocuration,,,A,U,1,13627,,,In vivo,,22224,,12902,,,,BAO_0000218,
Cmax was calculated as maximum concentration reached in the blood,,0,CHEMBL622240,Autocuration,,,A,U,1,13628,178.0,,In vivo,,22224,,11149,,,Blood,BAO_0000218,
Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,0,CHEMBL622241,Autocuration,,,A,U,1,13629,178.0,,In vivo,,22224,,11149,,,Blood,BAO_0000218,
Cmax was determine after peroral administration at 10 mpk in Rat,,1,CHEMBL631013,Intermediate,,,A,N,1,13630,,Rattus norvegicus,In vivo,,50597,,5669,10116.0,,,BAO_0000218,
Cmax was determine after peroral administration at 10 mpk in Rhesus,,1,CHEMBL631014,Intermediate,,,A,N,1,13631,,Macaca mulatta,In vivo,,50797,,5669,9544.0,,,BAO_0000218,
Cmax was determine after peroral administration at 10 mpk in dog,,1,CHEMBL631015,Intermediate,,,A,N,1,13632,,Canis lupus familiaris,In vivo,,50588,,5669,9615.0,,,BAO_0000218,
Cmax was determine after peroral administration at 160 mpk in Rat,,1,CHEMBL631016,Intermediate,,,A,N,1,13633,,Rattus norvegicus,In vivo,,50597,,5669,10116.0,,,BAO_0000218,
Cmax was determine after peroral administration at 20 mpk in Rat,,1,CHEMBL631017,Intermediate,,,A,N,1,13634,,Rattus norvegicus,In vivo,,50597,,5669,10116.0,,,BAO_0000218,
Cmax was determine after peroral administration at 50 mpk in Rat,,1,CHEMBL631018,Intermediate,,,A,N,1,13635,,Rattus norvegicus,In vivo,,50597,,5669,10116.0,,,BAO_0000218,
Cmax was determined,,0,CHEMBL631019,Autocuration,,,A,U,1,13636,,,In vivo,,22224,,4236,,,,BAO_0000218,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,1,CHEMBL875761,Intermediate,,,A,N,1,13637,955.0,Mus musculus,,,50594,,13792,10090.0,,Brain,BAO_0000218,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,1,CHEMBL631020,Intermediate,,,A,N,1,13638,955.0,Mus musculus,,,50594,,13792,10090.0,,Brain,BAO_0000218,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,1,CHEMBL631669,Intermediate,,,A,N,1,13639,955.0,Mus musculus,,,50594,,13792,10090.0,,Brain,BAO_0000218,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,1,CHEMBL631670,Intermediate,,,A,N,1,13640,955.0,Mus musculus,,,50594,,13792,10090.0,,Brain,BAO_0000218,
Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,1,CHEMBL631671,Intermediate,,,A,N,1,13641,2435.0,Mus musculus,,,50594,,13792,10090.0,,Striatum,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,1,CHEMBL631672,Intermediate,,,A,N,1,13642,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,1,CHEMBL631673,Intermediate,,,A,N,1,13643,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,1,CHEMBL631856,Intermediate,,,A,N,1,13644,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,1,CHEMBL631857,Intermediate,,,A,N,1,13645,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,1,CHEMBL631858,Intermediate,,,A,N,1,13646,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,1,CHEMBL631859,Intermediate,,,A,N,1,13647,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,1,CHEMBL631860,Intermediate,,,A,N,1,13648,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,1,CHEMBL631861,Intermediate,,,A,N,1,13649,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,1,CHEMBL631862,Intermediate,,,A,N,1,13650,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,1,CHEMBL631863,Intermediate,,,A,N,1,13651,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,1,CHEMBL631864,Intermediate,,,A,N,1,13652,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,1,CHEMBL631865,Intermediate,,,A,N,1,13653,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,1,CHEMBL631866,Intermediate,,,A,N,1,13654,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,1,CHEMBL629360,Intermediate,,,A,N,1,13655,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,1,CHEMBL629361,Intermediate,,,A,N,1,13656,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,1,CHEMBL629362,Intermediate,,,A,N,1,13657,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,1,CHEMBL630740,Intermediate,,,A,N,1,13658,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,1,CHEMBL630741,Intermediate,,,A,N,1,13659,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,1,CHEMBL630742,Intermediate,,,A,N,1,13660,178.0,Rattus norvegicus,,,50597,,8418,10116.0,,Blood,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,1,CHEMBL630743,Intermediate,,,A,N,1,13661,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,1,CHEMBL630744,Intermediate,,,A,N,1,13662,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,1,CHEMBL630745,Intermediate,,,A,N,1,13663,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,1,CHEMBL630746,Intermediate,,,A,N,1,13664,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,1,CHEMBL630747,Intermediate,,,A,N,1,13665,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,1,CHEMBL630748,Intermediate,,,A,N,1,13666,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,1,CHEMBL632056,Intermediate,,,A,N,1,13667,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,1,CHEMBL632057,Intermediate,,,A,N,1,13668,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,1,CHEMBL632058,Intermediate,,,A,N,1,13669,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,1,CHEMBL632059,Intermediate,,,A,N,1,13670,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,1,CHEMBL632060,Intermediate,,,A,N,1,13671,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,1,CHEMBL632061,Intermediate,,,A,N,1,13672,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,1,CHEMBL629207,Intermediate,,,A,N,1,13673,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,1,CHEMBL629208,Intermediate,,,A,N,1,13674,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,1,CHEMBL629209,Intermediate,,,A,N,1,13675,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,1,CHEMBL629210,Intermediate,,,A,N,1,13676,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,1,CHEMBL629211,Intermediate,,,A,N,1,13677,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,1,CHEMBL629212,Intermediate,,,A,N,1,13678,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,1,CHEMBL629213,Intermediate,,,A,N,1,13679,,Rattus norvegicus,,,50597,,8418,10116.0,,,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,1,CHEMBL629214,Intermediate,,,A,N,1,13680,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,1,CHEMBL629215,Intermediate,,,A,N,1,13681,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,1,CHEMBL635154,Intermediate,,,A,N,1,13682,1088.0,Rattus norvegicus,,,50597,,8133,10116.0,,Urine,BAO_0000218,
Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,1,CHEMBL629216,Intermediate,,,A,N,1,13683,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,1,CHEMBL629217,Intermediate,,,A,N,1,13684,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL629218,Intermediate,,,A,N,1,13685,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,1,CHEMBL629219,Intermediate,,,A,N,1,13686,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL629220,Intermediate,,,A,N,1,13687,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL629221,Intermediate,,,A,N,1,13688,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL631127,Intermediate,,,A,N,1,13689,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,1,CHEMBL631128,Intermediate,,,A,N,1,13690,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL631129,Intermediate,,,A,N,1,13691,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,1,CHEMBL631130,Intermediate,,,A,N,1,13692,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL631131,Intermediate,,,A,N,1,13693,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL631132,Intermediate,,,A,N,1,13694,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL631133,Intermediate,,,A,N,1,13695,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,1,CHEMBL631134,Intermediate,,,A,N,1,13696,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL875120,Intermediate,,,A,N,1,13697,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,1,CHEMBL631135,Intermediate,,,A,N,1,13698,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL631136,Intermediate,,,A,N,1,13699,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL631137,Intermediate,,,A,N,1,13700,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL631138,Intermediate,,,A,N,1,13701,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,1,CHEMBL631139,Intermediate,,,A,N,1,13702,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL631140,Intermediate,,,A,N,1,13703,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,1,CHEMBL631141,Intermediate,,,A,N,1,13704,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,1,CHEMBL631142,Intermediate,,,A,N,1,13705,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,1,CHEMBL631143,Intermediate,,,A,N,1,13706,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,CHEMBL631144,Intermediate,,,A,N,1,13707,,Rattus norvegicus,,,50597,,6996,10116.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,1,CHEMBL631145,Intermediate,,,A,N,1,13708,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,1,CHEMBL631146,Intermediate,,,A,N,1,13709,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,1,CHEMBL631147,Intermediate,,,A,N,1,13710,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL631148,Intermediate,,,A,N,1,13711,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL631149,Intermediate,,,A,N,1,13712,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,1,CHEMBL631150,Intermediate,,,A,N,1,13713,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL631151,Intermediate,,,A,N,1,13714,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL631152,Intermediate,,,A,N,1,13715,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL631443,Intermediate,,,A,N,1,13716,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,1,CHEMBL631444,Intermediate,,,A,N,1,13717,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL631445,Intermediate,,,A,N,1,13718,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,1,CHEMBL631446,Intermediate,,,A,N,1,13719,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,1,CHEMBL631447,Intermediate,,,A,N,1,13720,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,1,CHEMBL631448,Intermediate,,,A,N,1,13721,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,1,CHEMBL631449,Intermediate,,,A,N,1,13722,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,1,CHEMBL631450,Intermediate,,,A,N,1,13723,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,1,CHEMBL629724,Intermediate,,,A,N,1,13724,,Canis lupus familiaris,,,50588,,6996,9615.0,,,BAO_0000218,
"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL629725,Intermediate,,,A,N,1,13725,14.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Zone of skin,BAO_0000218,
"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL629726,Intermediate,,,A,N,1,13726,14.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Zone of skin,BAO_0000218,
"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL629727,Intermediate,,,A,N,1,13727,2106.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Spleen,BAO_0000218,
"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630404,Intermediate,,,A,N,1,13728,2106.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Spleen,BAO_0000218,
"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630405,Intermediate,,,A,N,1,13729,2106.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Spleen,BAO_0000218,
"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630406,Intermediate,,,A,N,1,13730,2106.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Spleen,BAO_0000218,
"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630407,Intermediate,,,A,N,1,13731,945.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Stomach,BAO_0000218,
"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630573,Intermediate,,,A,N,1,13732,945.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Stomach,BAO_0000218,
"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630574,Intermediate,,,A,N,1,13733,945.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Stomach,BAO_0000218,
"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630575,Intermediate,,,A,N,1,13734,945.0,Mus musculus,In vivo,,50594,,9716,10090.0,,Stomach,BAO_0000218,
"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630576,Intermediate,,,A,N,1,13735,,Mus musculus,In vivo,,50594,,9716,10090.0,,,BAO_0000218,
"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630577,Intermediate,,,A,N,1,13736,,Mus musculus,In vivo,,50594,,9716,10090.0,,,BAO_0000218,
"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630578,Intermediate,,,A,N,1,13737,,Mus musculus,In vivo,,50594,,9716,10090.0,,,BAO_0000218,
"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,1,CHEMBL630579,Intermediate,,,A,N,1,13738,,Mus musculus,In vivo,,50594,,9716,10090.0,,,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,1,CHEMBL630580,Intermediate,,,A,N,1,13739,2113.0,Mus musculus,,,50594,,12192,10090.0,,Kidney,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,1,CHEMBL630581,Intermediate,,,A,N,1,13740,2113.0,Mus musculus,,,50594,,12192,10090.0,,Kidney,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,1,CHEMBL630582,Intermediate,,,A,N,1,13741,2113.0,Mus musculus,,,50594,,12192,10090.0,,Kidney,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,1,CHEMBL630583,Intermediate,,,A,N,1,13742,,Mus musculus,,,50594,,12192,10090.0,,,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,1,CHEMBL630584,Intermediate,,,A,N,1,13743,,Mus musculus,,,50594,,12192,10090.0,,,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,1,CHEMBL630585,Intermediate,,,A,N,1,13744,,Mus musculus,,,50594,,12192,10090.0,,,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,1,CHEMBL630586,Intermediate,,,A,N,1,13745,,Mus musculus,,,50594,,12192,10090.0,,,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,1,CHEMBL630587,Intermediate,,,A,N,1,13746,,Mus musculus,,,50594,,12192,10090.0,,,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,1,CHEMBL630588,Intermediate,,,A,N,1,13747,,Mus musculus,,,50594,,12192,10090.0,,,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,1,CHEMBL630589,Intermediate,,,A,N,1,13748,,Mus musculus,,,50594,,12192,10090.0,,,BAO_0000218,
Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,1,CHEMBL630590,Intermediate,,,A,N,1,13749,,Mus musculus,,,50594,,12192,10090.0,,,BAO_0000218,
Removal of 238-Plutonium(IV) in feces at 24 h,,0,CHEMBL630591,Autocuration,,,A,U,1,13750,1988.0,,,,22224,,12192,,,Feces,BAO_0000019,
Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,0,CHEMBL630592,Autocuration,,,A,U,1,13751,1988.0,,,,22224,,12192,,,Feces,BAO_0000019,
Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,0,CHEMBL630593,Autocuration,,,A,U,1,13752,,,,,22224,,12192,,,,BAO_0000019,
Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,0,CHEMBL630594,Autocuration,,,A,U,1,13753,,,,,22224,,12192,,,,BAO_0000019,
Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,0,CHEMBL630595,Autocuration,,,A,U,1,13754,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,0,CHEMBL630596,Autocuration,,,A,U,1,13755,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine after 0-24 h,,0,CHEMBL630597,Autocuration,,,A,U,1,13756,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,0,CHEMBL630598,Autocuration,,,A,U,1,13757,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine after 0-4 h,,0,CHEMBL630599,Autocuration,,,A,U,1,13758,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,0,CHEMBL630600,Autocuration,,,A,U,1,13759,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine after 4-24 h,,0,CHEMBL630601,Autocuration,,,A,U,1,13760,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,0,CHEMBL630602,Autocuration,,,A,U,1,13761,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,0,CHEMBL630603,Autocuration,,,A,U,1,13762,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,0,CHEMBL630604,Autocuration,,,A,U,1,13763,1088.0,,,,22224,,12192,,,Urine,BAO_0000019,
Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL624869,Intermediate,,,A,N,1,13764,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL624870,Intermediate,,,A,N,1,13765,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL623189,Intermediate,,,A,N,1,13766,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623190,Intermediate,,,A,N,1,13767,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623191,Intermediate,,,A,N,1,13768,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623192,Intermediate,,,A,N,1,13769,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623193,Intermediate,,,A,N,1,13770,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL623194,Intermediate,,,A,N,1,13771,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623195,Intermediate,,,A,N,1,13772,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623196,Intermediate,,,A,N,1,13773,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,1,CHEMBL623197,Intermediate,,,A,N,1,13774,,Rattus norvegicus,,,50597,,11836,10116.0,,,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,1,CHEMBL623198,Intermediate,,,A,N,1,13775,,Rattus norvegicus,,,50597,,11836,10116.0,,,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,1,CHEMBL623199,Intermediate,,,A,N,1,13776,,Rattus norvegicus,,,50597,,11836,10116.0,,,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,1,CHEMBL623200,Intermediate,,,A,N,1,13777,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,1,CHEMBL623201,Intermediate,,,A,N,1,13778,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,1,CHEMBL623202,Intermediate,,,A,N,1,13779,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,1,CHEMBL623203,Intermediate,,,A,N,1,13780,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,1,CHEMBL623204,Intermediate,,,A,N,1,13781,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,1,CHEMBL623205,Intermediate,,,A,N,1,13782,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,1,CHEMBL623206,Intermediate,,,A,N,1,13783,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,1,CHEMBL623207,Intermediate,,,A,N,1,13784,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,1,CHEMBL623208,Intermediate,,,A,N,1,13785,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,1,CHEMBL623209,Intermediate,,,A,N,1,13786,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,1,CHEMBL623210,Intermediate,,,A,N,1,13787,2385.0,Rattus norvegicus,,,50597,,11836,10116.0,,Muscle tissue,BAO_0000218,
Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,1,CHEMBL623211,Intermediate,,,A,N,1,13788,,Rattus norvegicus,,,50597,,11836,10116.0,,,BAO_0000218,
Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,1,CHEMBL623212,Intermediate,,,A,N,1,13789,995.0,Rattus norvegicus,,,50597,,11836,10116.0,,Uterus,BAO_0000218,
Tested in vitro for intrinsic activity relative to quinpirole,,0,CHEMBL623213,Autocuration,,,A,U,1,13790,,,,,22224,,12640,,,,BAO_0000019,
"Relative ion enhancement, determined in pulsed ultrafiltration",,0,CHEMBL623214,Autocuration,,,A,U,1,13791,,,,,22224,,14218,,,,BAO_0000019,
% ionization at the pH 7.4 at 37 degree Centigrade,,0,CHEMBL623215,Autocuration,,,A,U,1,13792,,,,,22224,,11296,,,,BAO_0000019,
Percentage ionization was measured,,0,CHEMBL623216,Autocuration,,,A,U,1,13793,,,,,22224,,10929,,,,BAO_0000019,
Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,1,CHEMBL623217,Intermediate,,,A,N,1,13794,,Bos taurus,,,50591,,13841,9913.0,,,BAO_0000218,
Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,0,CHEMBL623218,Autocuration,,,A,U,1,13795,,,,,22224,,10431,,,,BAO_0000019,
Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,0,CHEMBL623913,Autocuration,,,A,U,1,13796,,,,,22224,,10431,,,,BAO_0000019,
Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,0,CHEMBL623914,Autocuration,,,A,U,1,13797,,,,,22224,,10431,,,,BAO_0000019,
Compound was evaluated for the partition coefficient in octanol/water,,0,CHEMBL623915,Autocuration,,,P,U,1,13798,,,,,22229,,8826,,,,BAO_0000100,
Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,0,CHEMBL624080,Autocuration,,,P,U,1,13799,,,,,22229,,8826,,,,BAO_0000100,
Equilibrium constant measured by the pulse radiolysis at pH 7,,0,CHEMBL624081,Autocuration,,,A,U,1,13800,,,,,22224,,9884,,,,BAO_0000019,
In vitro hydrolytic rate constant determined in human blood,,1,CHEMBL624082,Intermediate,,,A,N,1,13801,,Homo sapiens,,,50587,,9827,9606.0,,,BAO_0000218,
In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,1,CHEMBL625054,Intermediate,,,A,N,1,13802,,Homo sapiens,,,50587,,10009,9606.0,,,BAO_0000218,
In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,0,CHEMBL877485,Autocuration,,,A,U,1,13803,,,,,22224,,10009,,,,BAO_0000019,
In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,1,CHEMBL625055,Intermediate,,,A,N,1,13804,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,1,CHEMBL625056,Intermediate,,,A,N,1,13805,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
In vitro oxidation of compound in presence of human plasma,,1,CHEMBL625057,Intermediate,,,A,N,1,13806,,Homo sapiens,,,50587,,10009,9606.0,,,BAO_0000218,
In vitro oxidation of compound in presence of hydrogen peroxide,,0,CHEMBL625058,Autocuration,,,A,U,1,13807,,,,,22224,,10009,,,,BAO_0000019,
In vitro oxidation of compound in presence of mouse brain homogenate,,1,CHEMBL625059,Intermediate,,,A,N,1,13808,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
In vitro oxidation of compound in presence of mouse liver homogenate,,1,CHEMBL629536,Intermediate,,,A,N,1,13809,,Mus musculus,,,50594,,10009,10090.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,1,CHEMBL629537,Intermediate,,,A,N,1,13810,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,1,CHEMBL629538,Intermediate,,,A,N,1,13811,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,1,CHEMBL629539,Intermediate,,,A,N,1,13812,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,1,CHEMBL874445,Intermediate,,,A,N,1,13813,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,1,CHEMBL629540,Intermediate,,,A,N,1,13814,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,1,CHEMBL629541,Intermediate,,,A,N,1,13815,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,1,CHEMBL629542,Intermediate,,,A,N,1,13816,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,1,CHEMBL630243,Intermediate,,,A,N,1,13817,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,1,CHEMBL630244,Intermediate,,,A,N,1,13818,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,1,CHEMBL630245,Intermediate,,,A,N,1,13819,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,1,CHEMBL630246,Intermediate,,,A,N,1,13820,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,1,CHEMBL630247,Intermediate,,,A,N,1,13821,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,1,CHEMBL630248,Intermediate,,,A,N,1,13822,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Biodistribution in rat blood at 240 minutes after dose administration.,,1,CHEMBL630249,Intermediate,,,A,N,1,13823,178.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood at 30 minutes after dose administration.,,1,CHEMBL630250,Intermediate,,,A,N,1,13824,178.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood at 360 minutes after dose administration.,,1,CHEMBL630251,Intermediate,,,A,N,1,13825,178.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood at 3 hr after dose administration.,,1,CHEMBL630252,Intermediate,,,A,N,1,13826,178.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood at 60 minutes after dose administration.,,1,CHEMBL630408,Intermediate,,,A,N,1,13827,178.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Blood,BAO_0000218,
Biodistribution in rat cerebellum at 120 minutes after dose administration.,,1,CHEMBL630409,Intermediate,,,A,N,1,13828,2037.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Cerebellum,BAO_0000218,
Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,1,CHEMBL874446,Intermediate,,,A,N,1,13829,2037.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Cerebellum,BAO_0000218,
Biodistribution in rat cerebellum at 15 minutes after dose administration.,,1,CHEMBL630410,Intermediate,,,A,N,1,13830,2037.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Cerebellum,BAO_0000218,
Biodistribution in rat cerebellum at 240 minutes after dose administration.,,1,CHEMBL630411,Intermediate,,,A,N,1,13831,2037.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Cerebellum,BAO_0000218,
Biodistribution in rat cerebellum at 30 minutes after dose administration.,,1,CHEMBL630412,Intermediate,,,A,N,1,13832,2037.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Cerebellum,BAO_0000218,
Biodistribution in rat cerebellum at 360 minutes after dose administration.,,1,CHEMBL630413,Intermediate,,,A,N,1,13833,2037.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Cerebellum,BAO_0000218,
Biodistribution in rat cerebellum at 3 hr after dose administration.,,1,CHEMBL630414,Intermediate,,,A,N,1,13834,2037.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Cerebellum,BAO_0000218,
Biodistribution in rat cerebellum at 60 minutes after dose administration.,,1,CHEMBL630415,Intermediate,,,A,N,1,13835,2037.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Cerebellum,BAO_0000218,
Biodistribution in rat cortex at 120 minutes after dose administration.,,1,CHEMBL630416,Intermediate,,,A,N,1,13836,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat cortex at 1440 minutes after dose administration.,,1,CHEMBL630417,Intermediate,,,A,N,1,13837,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat cortex at 15 minutes after dose administration.,,1,CHEMBL630418,Intermediate,,,A,N,1,13838,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat cortex at 240 minutes after dose administration.,,1,CHEMBL630419,Intermediate,,,A,N,1,13839,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat cortex at 30 minutes after dose administration.,,1,CHEMBL630420,Intermediate,,,A,N,1,13840,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat cortex at 360 minutes after dose administration.,,1,CHEMBL630421,Intermediate,,,A,N,1,13841,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat cortex at 3 hr after dose administration.,,1,CHEMBL630422,Intermediate,,,A,N,1,13842,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat cortex at 60 minutes after dose administration.,,1,CHEMBL630423,Intermediate,,,A,N,1,13843,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat heart at 120 minutes after dose administration.,,1,CHEMBL630424,Intermediate,,,A,N,1,13844,948.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart at 15 minutes after dose administration.,,1,CHEMBL630425,Intermediate,,,A,N,1,13845,948.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart at 240 minutes after dose administration.,,1,CHEMBL629462,Intermediate,,,A,N,1,13846,948.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart at 30 minutes after dose administration.,,1,CHEMBL630426,Intermediate,,,A,N,1,13847,948.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart at 360 minutes after dose administration.,,1,CHEMBL630427,Intermediate,,,A,N,1,13848,948.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart at 3 hr after dose administration.,,1,CHEMBL625877,Intermediate,,,A,N,1,13849,948.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart at 60 minutes after dose administration.,,1,CHEMBL625878,Intermediate,,,A,N,1,13850,948.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Heart,BAO_0000218,
Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,1,CHEMBL625879,Intermediate,,,A,N,1,13851,10000000.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Hippocampus,BAO_0000218,
Biodistribution in rat hippocampus at 240 minutes after dose administration.,,1,CHEMBL625880,Intermediate,,,A,N,1,13852,10000000.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Hippocampus,BAO_0000218,
Biodistribution in rat hippocampus at 30 minutes after dose administration.,,1,CHEMBL625881,Intermediate,,,A,N,1,13853,10000000.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Hippocampus,BAO_0000218,
Biodistribution in rat hippocampus at 360 minutes after dose administration.,,1,CHEMBL625882,Intermediate,,,A,N,1,13854,10000000.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Hippocampus,BAO_0000218,
Biodistribution in rat hippocampus at 15 minutes after dose administration.,,1,CHEMBL625883,Intermediate,,,A,N,1,13855,10000000.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Hippocampus,BAO_0000218,
Biodistribution in rat kidney at 120 minutes after dose administration.,,1,CHEMBL625884,Intermediate,,,A,N,1,13856,2113.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney at 1440 minutes after dose administration.,,1,CHEMBL625885,Intermediate,,,A,N,1,13857,2113.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney at 15 minutes after dose administration.,,1,CHEMBL628649,Intermediate,,,A,N,1,13858,2113.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney at 240 minutes after dose administration.,,1,CHEMBL628650,Intermediate,,,A,N,1,13859,2113.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney at 30 minutes after dose administration.,,1,CHEMBL628651,Intermediate,,,A,N,1,13860,2113.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney at 360 minutes after dose administration.,,1,CHEMBL628652,Intermediate,,,A,N,1,13861,2113.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney at 60 minutes after dose administration.,,1,CHEMBL628653,Intermediate,,,A,N,1,13862,2113.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat liver at 120 minutes after dose administration.,,1,CHEMBL628654,Intermediate,,,A,N,1,13863,2107.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver at 1440 minutes after dose administration.,,1,CHEMBL628655,Intermediate,,,A,N,1,13864,2107.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver at 15 minutes after dose administration.,,1,CHEMBL625238,Intermediate,,,A,N,1,13865,2107.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver at 240 minutes after dose administration.,,1,CHEMBL625239,Intermediate,,,A,N,1,13866,2107.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver at 30 minutes after dose administration.,,1,CHEMBL625240,Intermediate,,,A,N,1,13867,2107.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver at 360 minutes after dose administration.,,1,CHEMBL625241,Intermediate,,,A,N,1,13868,2107.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver at 60 minutes after dose administration.,,1,CHEMBL625242,Intermediate,,,A,N,1,13869,2107.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Liver,BAO_0000218,
Biodistribution in rat lung at 120 minutes after dose administration.,,1,CHEMBL874587,Intermediate,,,A,N,1,13870,2048.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Lung,BAO_0000218,
Biodistribution in rat lung at 1440 minutes after dose administration.,,1,CHEMBL625405,Intermediate,,,A,N,1,13871,2048.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Lung,BAO_0000218,
Biodistribution in rat lung at 15 minutes after dose administration.,,1,CHEMBL625406,Intermediate,,,A,N,1,13872,2048.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Lung,BAO_0000218,
Biodistribution in rat lung at 240 minutes after dose administration.,,1,CHEMBL625407,Intermediate,,,A,N,1,13873,2048.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Lung,BAO_0000218,
Biodistribution in rat lung at 30 minutes after dose administration.,,1,CHEMBL625408,Intermediate,,,A,N,1,13874,2048.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Lung,BAO_0000218,
Biodistribution in rat lung at 360 minutes after dose administration.,,1,CHEMBL625409,Intermediate,,,A,N,1,13875,2048.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Lung,BAO_0000218,
Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,1,CHEMBL625410,Intermediate,,,A,N,1,13876,1515.0,Rattus norvegicus,,,50597,,12361,10116.0,,Thoracic aorta,BAO_0000218,
Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,1,CHEMBL625411,Intermediate,,,A,N,1,13877,1515.0,Rattus norvegicus,,,50597,,12361,10116.0,,Thoracic aorta,BAO_0000218,
Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,1,CHEMBL625412,Intermediate,,,A,N,1,13878,1515.0,Rattus norvegicus,,,50597,,12361,10116.0,,Thoracic aorta,BAO_0000218,
Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,1,CHEMBL625413,Intermediate,,,A,N,1,13879,1515.0,Rattus norvegicus,,,50597,,12361,10116.0,,Thoracic aorta,BAO_0000218,
Percent of maximal contractile response to compound in rat thoracic aorta strips v,,1,CHEMBL625414,Intermediate,,,A,N,1,13880,1515.0,Rattus norvegicus,,,50597,,12361,10116.0,,Thoracic aorta,BAO_0000218,
Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,1,CHEMBL625415,Intermediate,,,A,N,1,13881,1515.0,Rattus norvegicus,,,50597,,12361,10116.0,,Thoracic aorta,BAO_0000218,
Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,1,CHEMBL625416,Intermediate,,,A,N,1,13882,1515.0,Rattus norvegicus,,,50597,,12361,10116.0,,Thoracic aorta,BAO_0000218,
% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,1,CHEMBL625417,Intermediate,,,A,N,1,13883,1088.0,Rattus norvegicus,,,50597,,12712,10116.0,,Urine,BAO_0000218,
Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,1,CHEMBL625418,Intermediate,,,A,N,1,13884,1988.0,Rattus norvegicus,,,50597,,7415,10116.0,,Feces,BAO_0000218,
Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,1,CHEMBL625419,Intermediate,,,A,N,1,13885,1088.0,Rattus norvegicus,,,50597,,7415,10116.0,,Urine,BAO_0000218,
Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,1,CHEMBL625420,Intermediate,,,A,N,1,13886,,Rattus norvegicus,,,50597,,7415,10116.0,,,BAO_0000218,
Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,1,CHEMBL626996,Intermediate,,,A,N,1,13887,,Rattus norvegicus,,,50597,,7415,10116.0,,,BAO_0000218,
"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,1,CHEMBL626997,Intermediate,,,A,N,1,13888,1988.0,Rattus norvegicus,,,50597,,7415,10116.0,,Feces,BAO_0000218,
"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,1,CHEMBL626998,Intermediate,,,A,N,1,13889,1088.0,Rattus norvegicus,,,50597,,7415,10116.0,,Urine,BAO_0000218,
"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,1,CHEMBL626999,Intermediate,,,A,N,1,13890,,Rattus norvegicus,,,50597,,7415,10116.0,,,BAO_0000218,
faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,1,CHEMBL627000,Intermediate,,,A,N,1,13891,,Mus musculus,,,50594,,8050,10090.0,,,BAO_0000218,
fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,1,CHEMBL627001,Intermediate,,,A,N,1,13892,,Mus musculus,,,50594,,8050,10090.0,,,BAO_0000218,
fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,1,CHEMBL627002,Intermediate,,,A,N,1,13893,,Mus musculus,,,50594,,8050,10090.0,,,BAO_0000218,
fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,1,CHEMBL627003,Intermediate,,,A,N,1,13894,,Mus musculus,,,50594,,8050,10090.0,,,BAO_0000218,
urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,1,CHEMBL627004,Intermediate,,,A,N,1,13895,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,1,CHEMBL627005,Intermediate,,,A,N,1,13896,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,1,CHEMBL874594,Intermediate,,,A,N,1,13897,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,1,CHEMBL627006,Intermediate,,,A,N,1,13898,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,1,CHEMBL627007,Intermediate,,,A,N,1,13899,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,1,CHEMBL627884,Intermediate,,,A,N,1,13900,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,1,CHEMBL627885,Intermediate,,,A,N,1,13901,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,1,CHEMBL627886,Intermediate,,,A,N,1,13902,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,1,CHEMBL627887,Intermediate,,,A,N,1,13903,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,1,CHEMBL627888,Intermediate,,,A,N,1,13904,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,1,CHEMBL628057,Intermediate,,,A,N,1,13905,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,1,CHEMBL627405,Intermediate,,,A,N,1,13906,1088.0,Mus musculus,,,50594,,8050,10090.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,1,CHEMBL627406,Intermediate,,,A,N,1,13907,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,1,CHEMBL627407,Intermediate,,,A,N,1,13908,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,1,CHEMBL627408,Intermediate,,,A,N,1,13909,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,1,CHEMBL627409,Intermediate,,,A,N,1,13910,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,1,CHEMBL875486,Intermediate,,,A,N,1,13911,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,1,CHEMBL627410,Intermediate,,,A,N,1,13912,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,1,CHEMBL627411,Intermediate,,,A,N,1,13913,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,1,CHEMBL627412,Intermediate,,,A,N,1,13914,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,1,CHEMBL627413,Intermediate,,,A,N,1,13915,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,1,CHEMBL627414,Intermediate,,,A,N,1,13916,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,1,CHEMBL627415,Intermediate,,,A,N,1,13917,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,1,CHEMBL627416,Intermediate,,,A,N,1,13918,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,1,CHEMBL627417,Intermediate,,,A,N,1,13919,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,1,CHEMBL627418,Intermediate,,,A,N,1,13920,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,1,CHEMBL627419,Intermediate,,,A,N,1,13921,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,1,CHEMBL627320,Intermediate,,,A,N,1,13922,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,1,CHEMBL627321,Intermediate,,,A,N,1,13923,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627322,Intermediate,,,A,N,1,13924,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627323,Intermediate,,,A,N,1,13925,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL627491,Intermediate,,,A,N,1,13926,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627492,Intermediate,,,A,N,1,13927,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627493,Intermediate,,,A,N,1,13928,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627494,Intermediate,,,A,N,1,13929,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627495,Intermediate,,,A,N,1,13930,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL627496,Intermediate,,,A,N,1,13931,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627497,Intermediate,,,A,N,1,13932,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627498,Intermediate,,,A,N,1,13933,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627499,Intermediate,,,A,N,1,13934,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL627500,Intermediate,,,A,N,1,13935,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL627501,Intermediate,,,A,N,1,13936,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625616,Intermediate,,,A,N,1,13937,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625617,Intermediate,,,A,N,1,13938,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625618,Intermediate,,,A,N,1,13939,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625619,Intermediate,,,A,N,1,13940,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL625620,Intermediate,,,A,N,1,13941,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625621,Intermediate,,,A,N,1,13942,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625622,Intermediate,,,A,N,1,13943,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625788,Intermediate,,,A,N,1,13944,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625789,Intermediate,,,A,N,1,13945,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL625790,Intermediate,,,A,N,1,13946,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL625791,Intermediate,,,A,N,1,13947,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL622334,Intermediate,,,A,N,1,13948,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL622335,Intermediate,,,A,N,1,13949,2046.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL622336,Intermediate,,,A,N,1,13950,2046.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL622337,Intermediate,,,A,N,1,13951,2046.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL622338,Intermediate,,,A,N,1,13952,2046.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL622339,Intermediate,,,A,N,1,13953,2046.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL624153,Intermediate,,,A,N,1,13954,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL628430,Intermediate,,,A,N,1,13955,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL628431,Intermediate,,,A,N,1,13956,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL628432,Intermediate,,,A,N,1,13957,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL628433,Intermediate,,,A,N,1,13958,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,1,CHEMBL628434,Intermediate,,,A,N,1,13959,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,1,CHEMBL626789,Intermediate,,,A,N,1,13960,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,1,CHEMBL626790,Intermediate,,,A,N,1,13961,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,1,CHEMBL626791,Intermediate,,,A,N,1,13962,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,1,CHEMBL626792,Intermediate,,,A,N,1,13963,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,1,CHEMBL626793,Intermediate,,,A,N,1,13964,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,1,CHEMBL627436,Intermediate,,,A,N,1,13965,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,1,CHEMBL627437,Intermediate,,,A,N,1,13966,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,1,CHEMBL627438,Intermediate,,,A,N,1,13967,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,1,CHEMBL627439,Intermediate,,,A,N,1,13968,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,1,CHEMBL627440,Intermediate,,,A,N,1,13969,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,1,CHEMBL627602,Intermediate,,,A,N,1,13970,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,1,CHEMBL627603,Intermediate,,,A,N,1,13971,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,1,CHEMBL627604,Intermediate,,,A,N,1,13972,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,1,CHEMBL627605,Intermediate,,,A,N,1,13973,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,1,CHEMBL627606,Intermediate,,,A,N,1,13974,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,1,CHEMBL627607,Intermediate,,,A,N,1,13975,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,1,CHEMBL627608,Intermediate,,,A,N,1,13976,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,1,CHEMBL627609,Intermediate,,,A,N,1,13977,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,1,CHEMBL627610,Intermediate,,,A,N,1,13978,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,1,CHEMBL627611,Intermediate,,,A,N,1,13979,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,1,CHEMBL627612,Intermediate,,,A,N,1,13980,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Octanol:water partition coefficient is evaluated,,0,CHEMBL627613,Autocuration,,,P,U,1,13981,,,,,22229,,8362,,,,BAO_0000100,
Partition coefficient in 1-octanol/water system,,0,CHEMBL627614,Autocuration,,,P,U,1,13982,,,,,22224,,8257,,,,BAO_0000100,
Partition coefficient in 1-octanol/water system measured using radio active compounds,,0,CHEMBL627615,Autocuration,,,P,U,1,13983,,,,,22224,,8257,,,,BAO_0000100,
Partition coefficient in octanol/water system was determined,,0,CHEMBL627616,Autocuration,,,P,U,1,13984,,,,,22224,,9468,,,,BAO_0000100,
Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,0,CHEMBL627617,Autocuration,,,P,U,1,13985,,,,,22224,,9468,,,,BAO_0000100,
Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,0,CHEMBL627618,Autocuration,,,A,U,1,13986,,,,,22224,,10568,,,,BAO_0000019,
"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,0,CHEMBL627619,Autocuration,,,A,U,1,13987,,,,,22224,,10568,,,,BAO_0000019,
Pseudo-first-order rate constant of the compound,,0,CHEMBL627620,Autocuration,,,A,U,1,13988,,,,,22224,,15359,,,,BAO_0000019,
Pseudo-first-order rate constant with 1-min time point,,0,CHEMBL627621,Autocuration,,,A,U,1,13989,,,,,22224,,15359,,,,BAO_0000019,
Pseudo-first-order rate constant without 1-min time point,,0,CHEMBL627622,Autocuration,,,A,U,1,13990,,,,,22224,,15359,,,,BAO_0000019,
Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,0,CHEMBL627623,Autocuration,,,A,U,1,13991,,,,,22224,,10431,,,,BAO_0000019,
Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,0,CHEMBL627624,Autocuration,,,A,U,1,13992,,,,,22224,,10431,,,,BAO_0000019,
Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,0,CHEMBL627625,Autocuration,,,A,U,1,13993,,,,,22224,,10431,,,,BAO_0000019,
Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,0,CHEMBL628523,Autocuration,,,A,U,1,13994,,,,,22224,,15704,,,,BAO_0000019,
The alkaline hydrolysis second order rate constant(K OH) of the compound,,0,CHEMBL628524,Autocuration,,,A,U,1,13995,,,,,22224,,15287,,,,BAO_0000019,
The efflux rate constant of the compound,,0,CHEMBL628525,Autocuration,,,A,U,1,13996,,,,,22224,,7516,,,,BAO_0000019,
The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,CHEMBL625732,Autocuration,,,A,U,1,13997,,,,,22224,,12973,,,,BAO_0000019,
The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,CHEMBL625733,Autocuration,,,A,U,1,13998,,,,,22224,,12973,,,,BAO_0000019,
The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,CHEMBL625734,Autocuration,,,F,U,1,13999,,,,,22224,,12973,,,,BAO_0000019,
The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,0,CHEMBL625913,Autocuration,,,A,U,1,14000,,,,,22224,,12973,,,,BAO_0000019,
Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,0,CHEMBL625914,Autocuration,,,A,U,1,14001,,,,,22224,,8696,,,,BAO_0000019,
Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,0,CHEMBL625915,Autocuration,,,A,U,1,14002,,,,,22224,,15052,,,,BAO_0000019,
Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,0,CHEMBL625916,Autocuration,,,A,U,1,14003,,,,,22224,,15052,,,,BAO_0000019,
Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,0,CHEMBL625917,Autocuration,,,A,U,1,14004,,,,,22224,,10503,,,,BAO_0000019,
"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL625918,Autocuration,,,A,U,1,14005,,,,,22224,,8354,,,,BAO_0000019,
"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL625919,Autocuration,,,A,U,1,14006,,,,,22224,,8354,,,,BAO_0000019,
"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL625920,Autocuration,,,A,U,1,14007,,,,,22224,,8354,,,,BAO_0000019,
"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL874453,Autocuration,,,A,U,1,14008,,,,,22224,,8354,,,,BAO_0000019,
"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,0,CHEMBL625921,Autocuration,,,A,U,1,14009,,,,,22224,,8354,,,,BAO_0000019,
Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,0,CHEMBL625922,Autocuration,,,A,U,1,14010,,,,,22224,,10503,,,,BAO_0000019,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL625923,Autocuration,,,A,U,1,14011,,,,,22224,,8354,,,,BAO_0000019,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL625924,Autocuration,,,A,U,1,14012,,,,,22224,,8354,,,,BAO_0000019,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL625925,Autocuration,,,A,U,1,14013,,,,,22224,,8354,,,,BAO_0000019,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL625926,Autocuration,,,A,U,1,14014,,,,,22224,,8354,,,,BAO_0000019,
Biodistribution in rat lung at 60 minutes after dose administration.,,1,CHEMBL627704,Intermediate,,,A,N,1,14015,2048.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Lung,BAO_0000218,
Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,1,CHEMBL627705,Intermediate,,,A,N,1,14016,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,1,CHEMBL627706,Intermediate,,,A,N,1,14017,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,1,CHEMBL627707,Intermediate,,,A,N,1,14018,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,1,CHEMBL627708,Intermediate,,,A,N,1,14019,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,1,CHEMBL628361,Intermediate,,,A,N,1,14020,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,1,CHEMBL628362,Intermediate,,,A,N,1,14021,,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,,BAO_0000218,
Biodistribution in rat striatum at 120 minutes after dose administration.,,1,CHEMBL628363,Intermediate,,,A,N,1,14022,2435.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Striatum,BAO_0000218,
Biodistribution in rat striatum at 1440 minutes after dose administration.,,1,CHEMBL628364,Intermediate,,,A,N,1,14023,2435.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Striatum,BAO_0000218,
Biodistribution in rat striatum at 15 minutes after dose administration.,,1,CHEMBL628365,Intermediate,,,A,N,1,14024,2435.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Striatum,BAO_0000218,
Biodistribution in rat striatum at 240 minutes after dose administration.,,1,CHEMBL874454,Intermediate,,,A,N,1,14025,2435.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Striatum,BAO_0000218,
Biodistribution in rat striatum at 30 minutes after dose administration.,,1,CHEMBL628531,Intermediate,,,A,N,1,14026,2435.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Striatum,BAO_0000218,
Biodistribution in rat striatum at 360 minutes after dose administration.,,1,CHEMBL628532,Intermediate,,,A,N,1,14027,2435.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Striatum,BAO_0000218,
Biodistribution in rat striatum at 3 hr after dose administration.,,1,CHEMBL628533,Intermediate,,,A,N,1,14028,2435.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Striatum,BAO_0000218,
Biodistribution in rat striatum at 60 minutes after dose administration.,,1,CHEMBL628534,Intermediate,,,A,N,1,14029,2435.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Striatum,BAO_0000218,
Biodistribution in rat thyroid at 120 minutes after dose administration.,,1,CHEMBL628535,Intermediate,,,A,N,1,14030,2046.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in rat thyroid at 1440 minutes after dose administration.,,1,CHEMBL628536,Intermediate,,,A,N,1,14031,2046.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in rat thyroid at 15 minutes after dose administration.,,1,CHEMBL628537,Intermediate,,,A,N,1,14032,2046.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in rat thyroid at 240 minutes after dose administration.,,1,CHEMBL628538,Intermediate,,,A,N,1,14033,2046.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in rat thyroid at 30 minutes after dose administration.,,1,CHEMBL628539,Intermediate,,,A,N,1,14034,2046.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in rat thyroid at 360 minutes after dose administration.,,1,CHEMBL630297,Intermediate,,,A,N,1,14035,2046.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in rat thyroid at 60 minutes after dose administration.,,1,CHEMBL630298,Intermediate,,,A,N,1,14036,2046.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Thyroid gland,BAO_0000218,
Biodistribution in rest of brain of rat 120 minutes after dose administration.,,1,CHEMBL630299,Intermediate,,,A,N,1,14037,955.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Brain,BAO_0000218,
Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,1,CHEMBL628094,Intermediate,,,A,N,1,14038,955.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Brain,BAO_0000218,
Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,1,CHEMBL628095,Intermediate,,,A,N,1,14039,955.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Brain,BAO_0000218,
Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,1,CHEMBL874648,Intermediate,,,A,N,1,14040,955.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Brain,BAO_0000218,
Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,1,CHEMBL628096,Intermediate,,,A,N,1,14041,955.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Brain,BAO_0000218,
Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,1,CHEMBL628097,Intermediate,,,A,N,1,14042,955.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Brain,BAO_0000218,
Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,1,CHEMBL628098,Intermediate,,,A,N,1,14043,955.0,Rattus norvegicus,In vivo,,50597,,13100,10116.0,,Brain,BAO_0000218,
"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,0,CHEMBL628099,Autocuration,,,A,U,1,14044,,,,,22224,,13331,,,,BAO_0000019,
"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,0,CHEMBL628100,Autocuration,,,A,U,1,14045,,,,,22224,,13331,,,,BAO_0000019,
Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,0,CHEMBL628101,Autocuration,,,A,U,1,14046,,,,,22224,,13331,,,,BAO_0000019,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,0,CHEMBL628102,Autocuration,,,A,U,1,14047,,,,,22224,,13331,,,,BAO_0000019,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,0,CHEMBL628103,Autocuration,,,A,U,1,14048,,,,,22224,,13331,,,,BAO_0000019,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,0,CHEMBL628104,Autocuration,,,A,U,1,14049,,,,,22224,,13331,,,,BAO_0000019,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,0,CHEMBL628105,Autocuration,,,A,U,1,14050,,,,,22224,,13331,,,,BAO_0000019,
"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,0,CHEMBL628106,Autocuration,,,A,U,1,14051,,,,,22224,,13331,,,,BAO_0000019,
Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,1,CHEMBL628107,Intermediate,,,A,N,1,14052,1088.0,Rattus norvegicus,,,50597,,10086,10116.0,,Urine,BAO_0000218,
Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,0,CHEMBL628108,Autocuration,,,F,U,1,14053,1088.0,,,,22224,,10086,,,Urine,BAO_0000218,
Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,1,CHEMBL628109,Intermediate,,,A,N,1,14054,1088.0,Rattus norvegicus,,,50597,,10086,10116.0,,Urine,BAO_0000218,
Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,0,CHEMBL625299,Autocuration,,,F,U,1,14055,1088.0,,,,22224,,10086,,,Urine,BAO_0000218,
Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,1,CHEMBL625300,Intermediate,,,A,N,1,14056,1088.0,Rattus norvegicus,,,50597,,10086,10116.0,,Urine,BAO_0000218,
Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,1,CHEMBL625301,Intermediate,,,A,N,1,14057,1088.0,Rattus norvegicus,,,50597,,10086,10116.0,,Urine,BAO_0000218,
Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,1,CHEMBL625302,Intermediate,,,A,N,1,14058,1088.0,Rattus norvegicus,,,50597,,10086,10116.0,,Urine,BAO_0000218,
Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,1,CHEMBL874649,Intermediate,,,A,N,1,14059,1088.0,Rattus norvegicus,,,50597,,10086,10116.0,,Urine,BAO_0000218,
In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,1,CHEMBL625303,Intermediate,,,A,N,1,14060,,Rattus norvegicus,,,50597,,13248,10116.0,,,BAO_0000218,
In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,1,CHEMBL625463,Intermediate,,,A,N,1,14061,,Rattus norvegicus,,,50597,,13248,10116.0,,,BAO_0000218,
In vitro metabolism in human liver microsomes,,1,CHEMBL625464,Intermediate,,,A,N,1,14062,2107.0,Homo sapiens,,,50587,,14527,9606.0,,Liver,BAO_0000218,
Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,1,CHEMBL625465,Intermediate,,,A,N,1,14063,,Homo sapiens,,,50587,,3008,9606.0,,,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,1,CHEMBL625466,Intermediate,,,A,N,1,14064,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,1,CHEMBL625467,Intermediate,,,A,N,1,14065,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,1,CHEMBL625468,Intermediate,,,A,N,1,14066,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,1,CHEMBL625469,Intermediate,,,A,N,1,14067,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,1,CHEMBL625470,Intermediate,,,A,N,1,14068,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,1,CHEMBL632418,Intermediate,,,A,N,1,14069,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,1,CHEMBL627250,Intermediate,,,A,N,1,14070,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,1,CHEMBL627251,Intermediate,,,A,N,1,14071,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,1,CHEMBL627252,Intermediate,,,A,N,1,14072,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,1,CHEMBL627253,Intermediate,,,A,N,1,14073,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,1,CHEMBL627254,Intermediate,,,A,N,1,14074,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,1,CHEMBL875471,Intermediate,,,A,N,1,14075,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,1,CHEMBL627255,Intermediate,,,A,N,1,14076,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,1,CHEMBL627256,Intermediate,,,A,N,1,14077,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,1,CHEMBL627257,Intermediate,,,A,N,1,14078,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,1,CHEMBL627258,Intermediate,,,A,N,1,14079,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,1,CHEMBL627259,Intermediate,,,A,N,1,14080,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,1,CHEMBL627260,Intermediate,,,A,N,1,14081,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,1,CHEMBL623256,Intermediate,,,A,N,1,14082,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,1,CHEMBL874413,Intermediate,,,A,N,1,14083,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,1,CHEMBL623257,Intermediate,,,A,N,1,14084,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,1,CHEMBL623258,Intermediate,,,A,N,1,14085,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,1,CHEMBL623259,Intermediate,,,A,N,1,14086,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,1,CHEMBL623260,Intermediate,,,A,N,1,14087,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,1,CHEMBL623261,Intermediate,,,A,N,1,14088,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,1,CHEMBL623262,Intermediate,,,A,N,1,14089,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,1,CHEMBL623263,Intermediate,,,A,N,1,14090,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,1,CHEMBL623264,Intermediate,,,A,N,1,14091,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,1,CHEMBL623265,Intermediate,,,A,N,1,14092,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,1,CHEMBL623266,Intermediate,,,A,N,1,14093,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,1,CHEMBL623267,Intermediate,,,A,N,1,14094,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,1,CHEMBL623268,Intermediate,,,A,N,1,14095,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,1,CHEMBL623269,Intermediate,,,A,N,1,14096,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,1,CHEMBL623270,Intermediate,,,A,N,1,14097,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,1,CHEMBL623271,Intermediate,,,A,N,1,14098,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,1,CHEMBL623272,Intermediate,,,A,N,1,14099,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,1,CHEMBL623273,Intermediate,,,A,N,1,14100,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,1,CHEMBL623274,Intermediate,,,A,N,1,14101,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,1,CHEMBL874414,Intermediate,,,A,N,1,14102,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,1,CHEMBL623275,Intermediate,,,A,N,1,14103,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,1,CHEMBL629150,Intermediate,,,A,N,1,14104,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,1,CHEMBL623276,Intermediate,,,A,N,1,14105,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,1,CHEMBL623277,Intermediate,,,A,N,1,14106,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,1,CHEMBL623112,Intermediate,,,A,N,1,14107,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,1,CHEMBL623113,Intermediate,,,A,N,1,14108,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,1,CHEMBL623800,Intermediate,,,A,N,1,14109,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,1,CHEMBL623801,Intermediate,,,A,N,1,14110,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,1,CHEMBL623802,Intermediate,,,A,N,1,14111,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623803,Intermediate,,,A,N,1,14112,995.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Uterus,BAO_0000218,
Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623970,Intermediate,,,A,N,1,14113,995.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Uterus,BAO_0000218,
Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL623971,Intermediate,,,A,N,1,14114,995.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Uterus,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,1,CHEMBL623972,Intermediate,,,A,N,1,14115,178.0,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,Blood,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,1,CHEMBL623973,Intermediate,,,A,N,1,14116,178.0,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,Blood,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,1,CHEMBL623974,Intermediate,,,A,N,1,14117,178.0,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,Blood,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,1,CHEMBL623975,Intermediate,,,A,N,1,14118,178.0,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,Blood,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,1,CHEMBL623976,Intermediate,,,A,N,1,14119,955.0,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,Brain,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,1,CHEMBL623977,Intermediate,,,A,N,1,14120,955.0,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,Brain,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,1,CHEMBL623978,Intermediate,,,A,N,1,14121,955.0,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,Brain,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,1,CHEMBL623979,Intermediate,,,A,N,1,14122,955.0,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,Brain,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,1,CHEMBL623980,Intermediate,,,A,N,1,14123,,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,1,CHEMBL623981,Intermediate,,,A,N,1,14124,,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,1,CHEMBL626278,Intermediate,,,A,N,1,14125,,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,,BAO_0000218,
Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,1,CHEMBL626279,Intermediate,,,A,N,1,14126,,Rattus norvegicus,In vivo,,50597,,14045,10116.0,,,BAO_0000218,
Biodistribution in mice bladder plus excreted urine was determined,,1,CHEMBL626280,Intermediate,,,A,N,1,14127,,Mus musculus,In vivo,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse blood, 10 minutes post injection",,1,CHEMBL626281,Intermediate,,,A,N,1,14128,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse blood, 30 minutes post injection",,1,CHEMBL626282,Intermediate,,,A,N,1,14129,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse blood, 5 minutes post injection",,1,CHEMBL626283,Intermediate,,,A,N,1,14130,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse blood, 60 minutes post injection",,1,CHEMBL626284,Intermediate,,,A,N,1,14131,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse brain, 10 minutes post injection",,1,CHEMBL626285,Intermediate,,,A,N,1,14132,955.0,Mus musculus,,,50594,,14045,10090.0,,Brain,BAO_0000218,
"Percentage biodistribution in mouse brain, 30 minutes post injection",,1,CHEMBL626286,Intermediate,,,A,N,1,14133,955.0,Mus musculus,,,50594,,14045,10090.0,,Brain,BAO_0000218,
"Percentage biodistribution in mouse brain, 5 minutes post injection",,1,CHEMBL626287,Intermediate,,,A,N,1,14134,955.0,Mus musculus,,,50594,,14045,10090.0,,Brain,BAO_0000218,
"Percentage biodistribution in mouse brain, 60 minutes post injection",,1,CHEMBL626288,Intermediate,,,A,N,1,14135,955.0,Mus musculus,,,50594,,14045,10090.0,,Brain,BAO_0000218,
"Percentage biodistribution in mouse heart, 10 minutes post injection",,1,CHEMBL626289,Intermediate,,,A,N,1,14136,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse heart, 30 minutes post injection",,1,CHEMBL626290,Intermediate,,,A,N,1,14137,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse heart, 5 minutes post injection",,1,CHEMBL626291,Intermediate,,,A,N,1,14138,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse heart, 60 minutes post injection",,1,CHEMBL839888,Intermediate,,,A,N,1,14139,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mouse intestine, 10 minutes post injection",,1,CHEMBL626292,Intermediate,,,A,N,1,14140,160.0,Mus musculus,,,50594,,14045,10090.0,,Intestine,BAO_0000218,
"Percentage biodistribution in mouse intestine, 30 minutes post injection",,1,CHEMBL626293,Intermediate,,,A,N,1,14141,160.0,Mus musculus,,,50594,,14045,10090.0,,Intestine,BAO_0000218,
"Percentage biodistribution in mouse intestine, 5 minutes post injection",,1,CHEMBL626294,Intermediate,,,A,N,1,14142,160.0,Mus musculus,,,50594,,14045,10090.0,,Intestine,BAO_0000218,
"Percentage biodistribution in mouse intestine, 60 minutes post injection",,1,CHEMBL626295,Intermediate,,,A,N,1,14143,160.0,Mus musculus,,,50594,,14045,10090.0,,Intestine,BAO_0000218,
"Percentage biodistribution in mouse liver, 10 minutes post injection",,1,CHEMBL627659,Intermediate,,,A,N,1,14144,2107.0,Mus musculus,,,50594,,14045,10090.0,,Liver,BAO_0000218,
"Percentage biodistribution in mouse liver, 30 minutes of post injection",,1,CHEMBL627660,Intermediate,,,A,N,1,14145,2107.0,Mus musculus,,,50594,,14045,10090.0,,Liver,BAO_0000218,
"Percentage biodistribution in mouse liver, 5 minutes post injection",,1,CHEMBL627661,Intermediate,,,A,N,1,14146,2107.0,Mus musculus,,,50594,,14045,10090.0,,Liver,BAO_0000218,
Biodistribution in mice liver at 60 minutes of post injection,,1,CHEMBL627662,Intermediate,,,A,N,1,14147,2107.0,Mus musculus,In vivo,,50594,,14045,10090.0,,Liver,BAO_0000218,
Biodistribution in mice lungs at 10 min of post injection,,1,CHEMBL627663,Intermediate,,,A,N,1,14148,2048.0,Mus musculus,In vivo,,50594,,14045,10090.0,,Lung,BAO_0000218,
"Percentage biodistribution in mouse lung, 30 minutes post injection",,1,CHEMBL627664,Intermediate,,,A,N,1,14149,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
"Percentage biodistribution in mousee lung, 5 minutes post injection",,1,CHEMBL627665,Intermediate,,,A,N,1,14150,,Mus musculus,,,50594,,14045,10090.0,,,BAO_0000218,
Biodistribution in mice lungs at 60 min of post injection,,1,CHEMBL627666,Intermediate,,,A,N,1,14151,2048.0,Mus musculus,In vivo,,50594,,14045,10090.0,,Lung,BAO_0000218,
Percentage biodistribution in mouse spleen,,1,CHEMBL627667,Intermediate,,,A,N,1,14152,2106.0,Mus musculus,,,50594,,14045,10090.0,,Spleen,BAO_0000218,
Percentage biodistribution in mouse stomach,,1,CHEMBL627668,Intermediate,,,A,N,1,14153,945.0,Mus musculus,,,50594,,14045,10090.0,,Stomach,BAO_0000218,
Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,1,CHEMBL627669,Intermediate,,,A,N,1,14154,1088.0,Mus musculus,,,50594,,11745,10090.0,,Urine,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,0,CHEMBL627670,Autocuration,,,A,U,1,14155,1255.0,,In vivo,,22224,,13257,,,Urinary bladder,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,0,CHEMBL627671,Autocuration,,,A,U,1,14156,178.0,,In vivo,,22224,,13257,,,Blood,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,0,CHEMBL627672,Autocuration,,,A,U,1,14157,1474.0,,In vivo,,22224,,13257,,,Bone element,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,0,CHEMBL627673,Autocuration,,,A,U,1,14158,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,0,CHEMBL627674,Autocuration,,,A,U,1,14159,2113.0,,In vivo,,22224,,13257,,,Kidney,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,0,CHEMBL627675,Autocuration,,,A,U,1,14160,2107.0,,In vivo,,22224,,13257,,,Liver,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,0,CHEMBL627676,Autocuration,,,A,U,1,14161,2048.0,,In vivo,,22224,,13257,,,Lung,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,0,CHEMBL627677,Autocuration,,,A,U,1,14162,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,0,CHEMBL627678,Autocuration,,,A,U,1,14163,,,,,22224,,8354,,,,BAO_0000019,
Affinity for protein binding expressed as association constant in fresh rat serum,,1,CHEMBL627679,Intermediate,,,A,N,1,14164,1977.0,Rattus norvegicus,,,50597,,7095,10116.0,,Serum,BAO_0000218,
Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,0,CHEMBL627680,Autocuration,,,A,U,1,14165,,,,,22224,,12185,,,,BAO_0000019,
Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,0,CHEMBL627681,Autocuration,,,A,U,1,14166,,,,,22224,,12185,,,,BAO_0000019,
Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,0,CHEMBL627682,Autocuration,,,A,U,1,14167,,,,,22224,,12185,,,,BAO_0000019,
Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,0,CHEMBL627683,Autocuration,,,A,U,1,14168,,,,,22224,,12185,,,,BAO_0000019,
The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,0,CHEMBL627684,Autocuration,,,A,U,1,14169,,,,,22224,,12686,,,,BAO_0000019,
"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,0,CHEMBL874441,Autocuration,,,A,U,1,14170,,,,,22224,,12686,,,,BAO_0000019,
The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,0,CHEMBL627685,Autocuration,,,A,U,1,14171,,,,,22224,,12686,,,,BAO_0000019,
"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,0,CHEMBL627686,Autocuration,,,A,U,1,14172,,,,,22224,,12686,,,,BAO_0000019,
Apparent rate constant Koff for inactivation of dTMP synthase.,,0,CHEMBL627687,Autocuration,,,A,U,1,14173,,,,,22224,,8057,,,,BAO_0000019,
The irreversible inhibitor activity by second order rate equation.,,0,CHEMBL627688,Autocuration,,,A,U,1,14174,,,,,22224,,15778,,,,BAO_0000019,
Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,1,CHEMBL628038,Intermediate,,,A,N,1,14175,,Rattus norvegicus,,,50597,,12375,10116.0,,,BAO_0000218,
Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,1,CHEMBL628039,Intermediate,,,A,N,1,14176,,Rattus norvegicus,,,50597,,12375,10116.0,,,BAO_0000218,
Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,1,CHEMBL628040,Intermediate,,,A,N,1,14177,,Rattus norvegicus,,,50597,,12375,10116.0,,,BAO_0000218,
Dissociation rate calculated from the first-order equation using t1/2 value,,0,CHEMBL628041,Autocuration,,,A,U,1,14178,,,,,22224,,13588,,,,BAO_0000019,
The compound was tested for Binding constant against DNA,,0,CHEMBL630226,Autocuration,,,A,U,1,14179,,,,,22224,,15039,,,,BAO_0000019,
First order rate constant for cyclization of the compound,,0,CHEMBL628042,Autocuration,,,A,U,1,14180,,,,,22224,,9500,,,,BAO_0000019,
First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,0,CHEMBL625232,Autocuration,,,A,U,1,14181,,,,,22224,,10014,,,,BAO_0000019,
First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,0,CHEMBL625233,Autocuration,,,A,U,1,14182,,,,,22224,,10014,,,,BAO_0000019,
Hydrolysis rate constant was determined,,0,CHEMBL625979,Autocuration,,,A,U,1,14183,,,,,22224,,568,,,,BAO_0000019,
Observed first order rate constant,,0,CHEMBL625980,Autocuration,,,A,U,1,14184,,,,,22224,,10026,,,,BAO_0000019,
Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,CHEMBL625981,Autocuration,,,A,U,1,14185,,,,,22224,,10281,,,,BAO_0000019,
Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,CHEMBL625982,Autocuration,,,A,U,1,14186,,,,,22224,,10281,,,,BAO_0000019,
Second-order rate constant for attack on PNPA at 25 degree Centigrade,,0,CHEMBL625983,Autocuration,,,A,U,1,14187,,,,,22224,,9680,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625984,Autocuration,,,A,U,1,14188,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625985,Autocuration,,,A,U,1,14189,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625986,Autocuration,,,A,U,1,14190,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625987,Autocuration,,,A,U,1,14191,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625988,Autocuration,,,A,U,1,14192,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625989,Autocuration,,,A,U,1,14193,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625990,Autocuration,,,A,U,1,14194,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625991,Autocuration,,,A,U,1,14195,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625992,Autocuration,,,A,U,1,14196,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL625993,Autocuration,,,A,U,1,14197,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL631973,Autocuration,,,A,U,1,14198,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632143,Autocuration,,,A,U,1,14199,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632144,Autocuration,,,A,U,1,14200,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632145,Autocuration,,,A,U,1,14201,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632146,Autocuration,,,A,U,1,14202,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632147,Autocuration,,,A,U,1,14203,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632148,Autocuration,,,A,U,1,14204,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632149,Autocuration,,,A,U,1,14205,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632150,Autocuration,,,A,U,1,14206,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL632151,Autocuration,,,A,U,1,14207,,,,,22224,,13028,,,,BAO_0000019,
Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,1,CHEMBL632152,Intermediate,,,A,N,1,14208,,Homo sapiens,,,50587,,3008,9606.0,,,BAO_0000218,
Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,1,CHEMBL632153,Intermediate,,,A,N,1,14209,,Homo sapiens,,,50587,,4509,9606.0,,,BAO_0000218,
Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,1,CHEMBL632154,Intermediate,,,A,N,1,14210,,Homo sapiens,,,50587,,4509,9606.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,1,CHEMBL632155,Intermediate,,,A,N,1,14211,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,1,CHEMBL632156,Intermediate,,,A,N,1,14212,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,1,CHEMBL632157,Intermediate,,,A,N,1,14213,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,1,CHEMBL632158,Intermediate,,,A,N,1,14214,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,1,CHEMBL632159,Intermediate,,,A,N,1,14215,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,1,CHEMBL626305,Intermediate,,,A,N,1,14216,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,1,CHEMBL626306,Intermediate,,,A,N,1,14217,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,1,CHEMBL626307,Intermediate,,,A,N,1,14218,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,1,CHEMBL626308,Intermediate,,,A,N,1,14219,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,1,CHEMBL626479,Intermediate,,,A,N,1,14220,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,1,CHEMBL626480,Intermediate,,,A,N,1,14221,,Human herpesvirus 1,,,50602,,8613,10298.0,,,BAO_0000218,
Calculated partition coefficient (clogP) (MlogP),,0,CHEMBL626481,Autocuration,,,P,U,1,14222,,,,,22229,,6021,,,,BAO_0000100,
Equipotent potent ratio relative to carbachol (nicotinic activity),,0,CHEMBL626482,Autocuration,,,A,U,1,14223,,,,,22224,,9348,,,,BAO_0000019,
"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,1,CHEMBL626483,Intermediate,,,A,N,1,14224,,Canis lupus familiaris,,,50588,,15592,9615.0,,,BAO_0000218,
"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,1,CHEMBL626484,Intermediate,,,A,N,1,14225,,Canis lupus familiaris,,,50588,,15592,9615.0,,,BAO_0000218,
Solubility at pH 7.4 in micro g/mL;NA denotes available,,0,CHEMBL626485,Autocuration,,,P,U,1,14226,,,,,22229,,15592,,,,BAO_0000100,
Solubility at pH 7.4 in micro g/mL;NA denotes not available,,0,CHEMBL626486,Autocuration,,,P,U,1,14227,,,,,22229,,15592,,,,BAO_0000100,
Solubility at pH 7.4 in ug/mL;NA denotes not available,,0,CHEMBL626487,Autocuration,,,P,U,1,14228,,,,,22229,,15592,,,,BAO_0000100,
Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,1,CHEMBL626488,Intermediate,,,A,N,1,14229,1969.0,Canis lupus familiaris,In vivo,,50588,,15592,9615.0,,Plasma,BAO_0000218,
Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,1,CHEMBL626489,Intermediate,,,A,N,1,14230,1977.0,Rattus norvegicus,,,50597,,7095,10116.0,,Serum,BAO_0000218,
Area under the MAP curve measured over 5 min; ND means Not determined,,0,CHEMBL626490,Autocuration,,,A,U,1,14231,,,,,22224,,16618,,,,BAO_0000019,
Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,0,CHEMBL626491,Autocuration,,,P,U,1,14232,,,,,22224,,16835,,,,BAO_0000100,
The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,0,CHEMBL626492,Autocuration,,,P,U,1,14233,,,,,22229,,15284,,,,BAO_0000100,
Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,0,CHEMBL626493,Autocuration,,,A,U,1,14234,,,,,22224,,15750,,,,BAO_0000019,
Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,1,CHEMBL626494,Intermediate,,,A,N,1,14235,,Rattus norvegicus,In vivo,,50597,,16618,10116.0,,,BAO_0000218,
Half life after oral tested,,0,CHEMBL626495,Autocuration,,,A,U,1,14236,,,In vivo,,22224,,16618,,,,BAO_0000218,
Half life was determined in plasma of rat; NT indicates not tested,,1,CHEMBL626496,Intermediate,,,A,N,1,14237,1969.0,Rattus norvegicus,,,50597,,15812,10116.0,,Plasma,BAO_0000218,
Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,1,CHEMBL626497,Intermediate,,,A,N,1,14238,,Rattus norvegicus,In vivo,,50597,,16618,10116.0,,,BAO_0000218,
Oral bioavailability after oral tested,,0,CHEMBL626498,Autocuration,,,A,U,1,14239,,,In vivo,,22224,,16618,,,,BAO_0000218,
The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,1,CHEMBL626499,Intermediate,,,A,N,1,14240,,Rattus norvegicus,,,50597,,13098,10116.0,,,BAO_0000218,
The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,1,CHEMBL626500,Intermediate,,,A,N,1,14241,,Rattus norvegicus,,,50597,,13098,10116.0,,,BAO_0000218,
half life was determined in plasma of rat; NT indicates not tested,,1,CHEMBL626501,Intermediate,,,A,N,1,14242,1969.0,Rattus norvegicus,,,50597,,15812,10116.0,,Plasma,BAO_0000218,
half life was determined in plasma of rat; NT means not tested,,1,CHEMBL626502,Intermediate,,,A,N,1,14243,1969.0,Rattus norvegicus,,,50597,,15812,10116.0,,Plasma,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,1,CHEMBL626503,Intermediate,,,A,N,1,14244,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); inactive,,1,CHEMBL626504,Intermediate,,,A,N,1,14245,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,1,CHEMBL626505,Intermediate,,,A,N,1,14246,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,1,CHEMBL626506,Intermediate,,,A,N,1,14247,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,1,CHEMBL626507,Intermediate,,,A,N,1,14248,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,1,CHEMBL626508,Intermediate,,,A,N,1,14249,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,1,CHEMBL626509,Intermediate,,,A,N,1,14250,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,1,CHEMBL875480,Intermediate,,,A,N,1,14251,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,1,CHEMBL626510,Intermediate,,,A,N,1,14252,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,1,CHEMBL626511,Intermediate,,,A,N,1,14253,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,1,CHEMBL626512,Intermediate,,,A,N,1,14254,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,1,CHEMBL628208,Intermediate,,,A,N,1,14255,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,1,CHEMBL628209,Intermediate,,,A,N,1,14256,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,1,CHEMBL628210,Intermediate,,,A,N,1,14257,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,1,CHEMBL628211,Intermediate,,,A,N,1,14258,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,1,CHEMBL628212,Intermediate,,,A,N,1,14259,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,1,CHEMBL628213,Intermediate,,,A,N,1,14260,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,1,CHEMBL628214,Intermediate,,,A,N,1,14261,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,1,CHEMBL628215,Intermediate,,,A,N,1,14262,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,1,CHEMBL628216,Intermediate,,,A,N,1,14263,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,1,CHEMBL626595,Intermediate,,,A,N,1,14264,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,1,CHEMBL626596,Intermediate,,,A,N,1,14265,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,1,CHEMBL626597,Intermediate,,,A,N,1,14266,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,1,CHEMBL626598,Intermediate,,,A,N,1,14267,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,1,CHEMBL622242,Intermediate,,,A,N,1,14268,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,1,CHEMBL622243,Intermediate,,,A,N,1,14269,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,1,CHEMBL622244,Intermediate,,,A,N,1,14270,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,1,CHEMBL622245,Intermediate,,,A,N,1,14271,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,1,CHEMBL622246,Intermediate,,,A,N,1,14272,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,1,CHEMBL622247,Intermediate,,,A,N,1,14273,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,1,CHEMBL622248,Intermediate,,,A,N,1,14274,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,1,CHEMBL877483,Intermediate,,,A,N,1,14275,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,1,CHEMBL622249,Intermediate,,,A,N,1,14276,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,1,CHEMBL622250,Intermediate,,,A,N,1,14277,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,1,CHEMBL622251,Intermediate,,,A,N,1,14278,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,1,CHEMBL622252,Intermediate,,,A,N,1,14279,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,1,CHEMBL622253,Intermediate,,,A,N,1,14280,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,1,CHEMBL622254,Intermediate,,,A,N,1,14281,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,1,CHEMBL622255,Intermediate,,,A,N,1,14282,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,1,CHEMBL622256,Intermediate,,,A,N,1,14283,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,1,CHEMBL622257,Intermediate,,,A,N,1,14284,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,1,CHEMBL622258,Intermediate,,,A,N,1,14285,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,1,CHEMBL622259,Intermediate,,,A,N,1,14286,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,1,CHEMBL622927,Intermediate,,,A,N,1,14287,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,1,CHEMBL622928,Intermediate,,,A,N,1,14288,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,1,CHEMBL622929,Intermediate,,,A,N,1,14289,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,1,CHEMBL623182,Intermediate,,,A,N,1,14290,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,1,CHEMBL623183,Intermediate,,,A,N,1,14291,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,1,CHEMBL623184,Intermediate,,,A,N,1,14292,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,1,CHEMBL623185,Intermediate,,,A,N,1,14293,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,1,CHEMBL877484,Intermediate,,,A,N,1,14294,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,1,CHEMBL627274,Intermediate,,,A,N,1,14295,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,1,CHEMBL623186,Intermediate,,,A,N,1,14296,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,1,CHEMBL623187,Intermediate,,,A,N,1,14297,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,1,CHEMBL623188,Intermediate,,,A,N,1,14298,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,1,CHEMBL628055,Intermediate,,,A,N,1,14299,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,1,CHEMBL628056,Intermediate,,,A,N,1,14300,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,1,CHEMBL628200,Intermediate,,,A,N,1,14301,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,1,CHEMBL628201,Intermediate,,,A,N,1,14302,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,1,CHEMBL628202,Intermediate,,,A,N,1,14303,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,1,CHEMBL628203,Intermediate,,,A,N,1,14304,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,1,CHEMBL628204,Intermediate,,,A,N,1,14305,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,1,CHEMBL628205,Intermediate,,,A,N,1,14306,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,1,CHEMBL628206,Intermediate,,,A,N,1,14307,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,0,CHEMBL628207,Autocuration,,,A,U,1,14308,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,0,CHEMBL627220,Autocuration,,,A,U,1,14309,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,0,CHEMBL627221,Autocuration,,,A,U,1,14310,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,0,CHEMBL627222,Autocuration,,,A,U,1,14311,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,0,CHEMBL627223,Autocuration,,,A,U,1,14312,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,0,CHEMBL632062,Autocuration,,,A,U,1,14313,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,0,CHEMBL632063,Autocuration,,,A,U,1,14314,2106.0,,In vivo,,22224,,13257,,,Spleen,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,0,CHEMBL632064,Autocuration,,,A,U,1,14315,1255.0,,In vivo,,22224,,13257,,,Urinary bladder,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,0,CHEMBL632065,Autocuration,,,A,U,1,14316,178.0,,In vivo,,22224,,13257,,,Blood,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,0,CHEMBL632066,Autocuration,,,A,U,1,14317,1474.0,,In vivo,,22224,,13257,,,Bone element,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,0,CHEMBL632067,Autocuration,,,A,U,1,14318,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,0,CHEMBL629188,Autocuration,,,A,U,1,14319,2113.0,,In vivo,,22224,,13257,,,Kidney,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,0,CHEMBL629189,Autocuration,,,A,U,1,14320,2107.0,,In vivo,,22224,,13257,,,Liver,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,0,CHEMBL629190,Autocuration,,,A,U,1,14321,2048.0,,In vivo,,22224,,13257,,,Lung,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,0,CHEMBL629191,Autocuration,,,A,U,1,14322,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,0,CHEMBL629192,Autocuration,,,A,U,1,14323,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,0,CHEMBL629193,Autocuration,,,A,U,1,14324,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,0,CHEMBL629194,Autocuration,,,A,U,1,14325,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,0,CHEMBL629195,Autocuration,,,A,U,1,14326,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,0,CHEMBL629373,Autocuration,,,A,U,1,14327,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,0,CHEMBL629374,Autocuration,,,A,U,1,14328,2106.0,,In vivo,,22224,,13257,,,Spleen,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,0,CHEMBL629375,Autocuration,,,A,U,1,14329,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,0,CHEMBL629376,Autocuration,,,A,U,1,14330,1255.0,,In vivo,,22224,,13257,,,Urinary bladder,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,0,CHEMBL629377,Autocuration,,,A,U,1,14331,178.0,,In vivo,,22224,,13257,,,Blood,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,0,CHEMBL629378,Autocuration,,,A,U,1,14332,1474.0,,In vivo,,22224,,13257,,,Bone element,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,0,CHEMBL629379,Autocuration,,,A,U,1,14333,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,0,CHEMBL629151,Autocuration,,,A,U,1,14334,2113.0,,In vivo,,22224,,13257,,,Kidney,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,0,CHEMBL629152,Autocuration,,,A,U,1,14335,2107.0,,In vivo,,22224,,13257,,,Liver,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,0,CHEMBL629153,Autocuration,,,A,U,1,14336,2048.0,,In vivo,,22224,,13257,,,Lung,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,0,CHEMBL629154,Autocuration,,,A,U,1,14337,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,0,CHEMBL629155,Autocuration,,,A,U,1,14338,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,0,CHEMBL629156,Autocuration,,,A,U,1,14339,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,0,CHEMBL629157,Autocuration,,,A,U,1,14340,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,0,CHEMBL629158,Autocuration,,,A,U,1,14341,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,0,CHEMBL629159,Autocuration,,,A,U,1,14342,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,0,CHEMBL629160,Autocuration,,,A,U,1,14343,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,0,CHEMBL629161,Autocuration,,,A,U,1,14344,2106.0,,In vivo,,22224,,13257,,,Spleen,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,0,CHEMBL629162,Autocuration,,,A,U,1,14345,1255.0,,In vivo,,22224,,13257,,,Urinary bladder,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,0,CHEMBL629163,Autocuration,,,A,U,1,14346,178.0,,In vivo,,22224,,13257,,,Blood,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,0,CHEMBL629164,Autocuration,,,A,U,1,14347,1474.0,,In vivo,,22224,,13257,,,Bone element,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,0,CHEMBL629165,Autocuration,,,A,U,1,14348,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,0,CHEMBL629166,Autocuration,,,A,U,1,14349,2107.0,,In vivo,,22224,,13257,,,Liver,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,0,CHEMBL629167,Autocuration,,,A,U,1,14350,2048.0,,In vivo,,22224,,13257,,,Lung,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,0,CHEMBL629168,Autocuration,,,A,U,1,14351,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,0,CHEMBL629169,Autocuration,,,A,U,1,14352,,,,,22224,,2193,,,,BAO_0000019,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,0,CHEMBL629170,Autocuration,,,A,U,1,14353,,,,,22224,,2193,,,,BAO_0000019,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,0,CHEMBL631153,Autocuration,,,A,U,1,14354,,,,,22224,,2193,,,,BAO_0000019,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,0,CHEMBL875121,Autocuration,,,A,U,1,14355,,,,,22224,,2193,,,,BAO_0000019,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,0,CHEMBL631154,Autocuration,,,A,U,1,14356,,,,,22224,,2193,,,,BAO_0000019,
Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,0,CHEMBL631155,Autocuration,,,A,U,1,14357,,,,,22224,,2193,,,,BAO_0000019,
Hydrolysis rate constant was determined,,0,CHEMBL631156,Autocuration,,,A,U,1,14358,,,,,22224,,568,,,,BAO_0000019,
"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,0,CHEMBL631157,Autocuration,,,A,U,1,14359,,,,,22224,,9680,,,,BAO_0000019,
"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,0,CHEMBL631158,Autocuration,,,A,U,1,14360,,,,,22224,,9680,,,,BAO_0000019,
"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,0,CHEMBL631159,Autocuration,,,A,U,1,14361,,,,,22224,,9680,,,,BAO_0000019,
Observed second order rate constant,,0,CHEMBL631160,Autocuration,,,A,U,1,14362,,,,,22224,,10026,,,,BAO_0000019,
Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,CHEMBL631161,Autocuration,,,A,U,1,14363,,,,,22224,,10281,,,,BAO_0000019,
Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,0,CHEMBL631162,Autocuration,,,A,U,1,14364,,,,,22224,,10014,,,,BAO_0000019,
Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,0,CHEMBL630313,Autocuration,,,A,U,1,14365,,,,,22224,,10014,,,,BAO_0000019,
"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,0,CHEMBL630314,Autocuration,,,A,U,1,14366,,,,,22224,,9680,,,,BAO_0000019,
"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,0,CHEMBL630315,Autocuration,,,A,U,1,14367,,,,,22224,,9680,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630316,Autocuration,,,A,U,1,14368,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630986,Autocuration,,,A,U,1,14369,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630987,Autocuration,,,A,U,1,14370,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630988,Autocuration,,,A,U,1,14371,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630989,Autocuration,,,A,U,1,14372,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630990,Autocuration,,,A,U,1,14373,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630991,Autocuration,,,A,U,1,14374,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630992,Autocuration,,,A,U,1,14375,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630993,Autocuration,,,A,U,1,14376,,,,,22224,,13028,,,,BAO_0000019,
Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,CHEMBL630994,Autocuration,,,A,U,1,14377,,,,,22224,,13028,,,,BAO_0000019,
Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,1,CHEMBL630995,Intermediate,,,A,N,1,14378,,Rattus norvegicus,,,50597,,10014,10116.0,,,BAO_0000218,
Association constant for compound at 31 degree C was determined,,0,CHEMBL629252,Autocuration,,,A,U,1,14379,,,,,22224,,9962,,,,BAO_0000019,
Calculated antagonist equilibrium dissociation constant of the compound,,0,CHEMBL629253,Autocuration,,,A,U,1,14380,,,,,22224,,12029,,,,BAO_0000019,
Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,0,CHEMBL629944,Autocuration,,,A,U,1,14381,,,,,22224,,12029,,,,BAO_0000019,
Dissociation constants vs LTE4 on guinea pig trachea,,1,CHEMBL629945,Intermediate,,,A,N,1,14382,3126.0,Cavia porcellus,,,50512,,10583,10141.0,,Trachea,BAO_0000218,
"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,0,CHEMBL629946,Autocuration,,,A,U,1,14383,,,,,22224,,568,,,,BAO_0000019,
"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,0,CHEMBL629947,Autocuration,,,A,U,1,14384,,,,,22224,,568,,,,BAO_0000019,
"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,0,CHEMBL629948,Autocuration,,,A,U,1,14385,,,,,22224,,568,,,,BAO_0000019,
"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,0,CHEMBL856024,Autocuration,,,A,U,1,14386,,,,,22224,,568,,,,BAO_0000019,
Affinity constant KD value was derived from TMP,,0,CHEMBL629949,Autocuration,,,A,U,1,14387,,,,,22224,,7493,,,,BAO_0000019,
Apparent dissociation (binding) rate constant was evaluated,,0,CHEMBL629950,Autocuration,,,A,U,1,14388,,,,,22224,,8371,,,,BAO_0000019,
Dissociation constant (KD) of the compound,,0,CHEMBL630127,Autocuration,,,P,U,1,14389,,,,,22224,,13114,,,,BAO_0000100,
Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,0,CHEMBL630128,Autocuration,,,P,U,1,14390,,,,,22224,,15515,,,,BAO_0000100,
Dissociation constant from ESR titration experiments,,0,CHEMBL630129,Autocuration,,,P,U,1,14391,,,,,22224,,522,,,,BAO_0000100,
Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,0,CHEMBL630130,Autocuration,,,,U,1,14392,,,,,22224,,13888,,,,BAO_0000019,
Dissociation constant was evaluated.,,0,CHEMBL875234,Autocuration,,,P,U,1,14393,,,,,22224,,2616,,,,BAO_0000100,
Dissociation constant was reported,,0,CHEMBL630131,Autocuration,,,P,U,1,14394,,,,,22224,,3798,,,,BAO_0000100,
Dissociation constant was determined in rat pituitary cells.,,1,CHEMBL630132,Intermediate,,,A,N,1,14395,,Rattus norvegicus,,,50597,,8731,10116.0,,,BAO_0000218,
Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,0,CHEMBL630133,Autocuration,,,A,U,1,14396,,,,,22224,,11892,,,,BAO_0000019,
Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,0,CHEMBL630134,Autocuration,,,A,U,1,14397,,,,,22224,,11892,,,,BAO_0000019,
Equilibrium dissociation constant of the compound,,0,CHEMBL630135,Autocuration,,,A,U,1,14398,,,,,22224,,2582,,,,BAO_0000019,
Equilibrium dissociation constant was determined,,0,CHEMBL630136,Autocuration,,,A,U,1,14399,,,,,22224,,11892,,,,BAO_0000019,
Kinetic constant KD was evaluated,,0,CHEMBL630137,Autocuration,,,A,U,1,14400,,,,,22224,,13396,,,,BAO_0000019,
Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,0,CHEMBL630138,Autocuration,,,A,U,1,14401,,,,,22224,,603,,,,BAO_0000019,
Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,0,CHEMBL630139,Autocuration,,,A,U,1,14402,,,,,22224,,15673,,,,BAO_0000019,
Rate constant for hydrolysis in aqueous acetone.,,0,CHEMBL630140,Autocuration,,,A,U,1,14403,,,,,22224,,10368,,,,BAO_0000019,
Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,0,CHEMBL875235,Autocuration,,,A,U,1,14404,,,,,22224,,14228,,,,BAO_0000019,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,1,CHEMBL876439,Intermediate,,,A,N,1,14405,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,1,CHEMBL630605,Intermediate,,,A,N,1,14406,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,1,CHEMBL630606,Intermediate,,,A,N,1,14407,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,1,CHEMBL630607,Intermediate,,,A,N,1,14408,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,1,CHEMBL630608,Intermediate,,,A,N,1,14409,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,1,CHEMBL630609,Intermediate,,,A,N,1,14410,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,1,CHEMBL630610,Intermediate,,,A,N,1,14411,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,1,CHEMBL630611,Intermediate,,,A,N,1,14412,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,1,CHEMBL629552,Intermediate,,,A,N,1,14413,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,1,CHEMBL629733,Intermediate,,,A,N,1,14414,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,1,CHEMBL629734,Intermediate,,,A,N,1,14415,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,1,CHEMBL629735,Intermediate,,,A,N,1,14416,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,1,CHEMBL629736,Intermediate,,,A,N,1,14417,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,1,CHEMBL629737,Intermediate,,,A,N,1,14418,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,1,CHEMBL629738,Intermediate,,,A,N,1,14419,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,1,CHEMBL629739,Intermediate,,,A,N,1,14420,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,1,CHEMBL629740,Intermediate,,,A,N,1,14421,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,1,CHEMBL629741,Intermediate,,,A,N,1,14422,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,1,CHEMBL629742,Intermediate,,,A,N,1,14423,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,1,CHEMBL629743,Intermediate,,,A,N,1,14424,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,1,CHEMBL629744,Intermediate,,,A,N,1,14425,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,1,CHEMBL629745,Intermediate,,,A,N,1,14426,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,1,CHEMBL629746,Intermediate,,,A,N,1,14427,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,1,CHEMBL629747,Intermediate,,,A,N,1,14428,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,1,CHEMBL629748,Intermediate,,,A,N,1,14429,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,1,CHEMBL629749,Intermediate,,,A,N,1,14430,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,1,CHEMBL629750,Intermediate,,,A,N,1,14431,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,1,CHEMBL629751,Intermediate,,,A,N,1,14432,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,1,CHEMBL629752,Intermediate,,,A,N,1,14433,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,1,CHEMBL629753,Intermediate,,,A,N,1,14434,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,1,CHEMBL629754,Intermediate,,,A,N,1,14435,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,1,CHEMBL629755,Intermediate,,,A,N,1,14436,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,1,CHEMBL629756,Intermediate,,,A,N,1,14437,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,1,CHEMBL629757,Intermediate,,,A,N,1,14438,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,1,CHEMBL629758,Intermediate,,,A,N,1,14439,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,1,CHEMBL629759,Intermediate,,,A,N,1,14440,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,1,CHEMBL629760,Intermediate,,,A,N,1,14441,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,1,CHEMBL876443,Intermediate,,,A,N,1,14442,,Rattus norvegicus,,,50597,,11510,10116.0,,,BAO_0000218,
Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,1,CHEMBL629761,Intermediate,,,A,N,1,14443,,Canis lupus familiaris,,,50588,,8310,9615.0,,,BAO_0000218,
Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,1,CHEMBL629762,Intermediate,,,A,N,1,14444,,Canis lupus familiaris,,,50588,,8310,9615.0,,,BAO_0000218,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,1,CHEMBL629763,Intermediate,,,A,N,1,14445,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,1,CHEMBL629764,Intermediate,,,A,N,1,14446,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,1,CHEMBL629765,Intermediate,,,A,N,1,14447,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,1,CHEMBL629766,Intermediate,,,A,N,1,14448,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,1,CHEMBL629767,Intermediate,,,A,N,1,14449,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,1,CHEMBL629768,Intermediate,,,A,N,1,14450,,Canis lupus familiaris,,,50588,,8310,9615.0,,,BAO_0000218,
Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,1,CHEMBL629769,Intermediate,,,A,N,1,14451,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,1,CHEMBL629770,Intermediate,,,A,N,1,14452,,Canis lupus familiaris,,,50588,,8310,9615.0,,,BAO_0000218,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,1,CHEMBL629771,Intermediate,,,A,N,1,14453,,Canis lupus familiaris,,,50588,,8310,9615.0,,,BAO_0000218,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,1,CHEMBL629772,Intermediate,,,A,N,1,14454,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,1,CHEMBL629773,Intermediate,,,A,N,1,14455,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,1,CHEMBL625455,Intermediate,,,A,N,1,14456,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,1,CHEMBL625456,Intermediate,,,A,N,1,14457,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,1,CHEMBL625457,Intermediate,,,A,N,1,14458,,Mus musculus,,,50594,,8310,10090.0,,,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,1,CHEMBL625458,Intermediate,,,A,N,1,14459,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,1,CHEMBL625459,Intermediate,,,A,N,1,14460,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,1,CHEMBL875483,Intermediate,,,A,N,1,14461,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,1,CHEMBL634779,Intermediate,,,A,N,1,14462,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,1,CHEMBL625460,Intermediate,,,A,N,1,14463,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,1,CHEMBL626117,Intermediate,,,A,N,1,14464,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,1,CHEMBL626118,Intermediate,,,A,N,1,14465,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,1,CHEMBL628342,Intermediate,,,A,N,1,14466,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,1,CHEMBL628343,Intermediate,,,A,N,1,14467,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,1,CHEMBL628344,Intermediate,,,A,N,1,14468,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,1,CHEMBL628345,Intermediate,,,A,N,1,14469,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,1,CHEMBL628346,Intermediate,,,A,N,1,14470,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,1,CHEMBL628347,Intermediate,,,A,N,1,14471,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,1,CHEMBL628348,Intermediate,,,A,N,1,14472,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,1,CHEMBL628349,Intermediate,,,A,N,1,14473,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,1,CHEMBL875611,Intermediate,,,A,N,1,14474,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,1,CHEMBL628350,Intermediate,,,A,N,1,14475,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,1,CHEMBL628351,Intermediate,,,A,N,1,14476,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,1,CHEMBL628352,Intermediate,,,A,N,1,14477,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,1,CHEMBL628353,Intermediate,,,A,N,1,14478,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,1,CHEMBL628354,Intermediate,,,A,N,1,14479,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,1,CHEMBL626667,Intermediate,,,A,N,1,14480,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,1,CHEMBL626668,Intermediate,,,A,N,1,14481,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,1,CHEMBL626669,Intermediate,,,A,N,1,14482,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,1,CHEMBL626670,Intermediate,,,A,N,1,14483,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,1,CHEMBL626671,Intermediate,,,A,N,1,14484,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,1,CHEMBL626672,Intermediate,,,A,N,1,14485,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,1,CHEMBL626673,Intermediate,,,A,N,1,14486,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,1,CHEMBL626674,Intermediate,,,A,N,1,14487,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,1,CHEMBL626675,Intermediate,,,A,N,1,14488,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,1,CHEMBL626676,Intermediate,,,A,N,1,14489,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,1,CHEMBL626677,Intermediate,,,A,N,1,14490,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,1,CHEMBL626678,Intermediate,,,A,N,1,14491,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,1,CHEMBL626679,Intermediate,,,A,N,1,14492,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,1,CHEMBL875612,Intermediate,,,A,N,1,14493,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,1,CHEMBL626680,Intermediate,,,A,N,1,14494,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,1,CHEMBL626681,Intermediate,,,A,N,1,14495,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,1,CHEMBL626682,Intermediate,,,A,N,1,14496,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,1,CHEMBL626683,Intermediate,,,A,N,1,14497,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,1,CHEMBL626684,Intermediate,,,A,N,1,14498,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,1,CHEMBL626685,Intermediate,,,A,N,1,14499,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,1,CHEMBL626686,Intermediate,,,A,N,1,14500,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,1,CHEMBL626687,Intermediate,,,A,N,1,14501,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,1,CHEMBL624978,Intermediate,,,A,N,1,14502,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,1,CHEMBL624979,Intermediate,,,A,N,1,14503,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,1,CHEMBL624980,Intermediate,,,A,N,1,14504,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,1,CHEMBL624981,Intermediate,,,A,N,1,14505,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,1,CHEMBL624982,Intermediate,,,A,N,1,14506,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,0,CHEMBL627564,Autocuration,,,A,U,1,14507,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,0,CHEMBL627565,Autocuration,,,A,U,1,14508,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,0,CHEMBL627566,Autocuration,,,A,U,1,14509,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,0,CHEMBL627567,Autocuration,,,A,U,1,14510,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,0,CHEMBL627568,Autocuration,,,A,U,1,14511,2106.0,,In vivo,,22224,,13257,,,Spleen,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,0,CHEMBL627569,Autocuration,,,A,U,1,14512,2113.0,,In vivo,,22224,,13257,,,Kidney,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,0,CHEMBL627570,Autocuration,,,A,U,1,14513,1255.0,,In vivo,,22224,,13257,,,Urinary bladder,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,0,CHEMBL627571,Autocuration,,,A,U,1,14514,178.0,,In vivo,,22224,,13257,,,Blood,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,0,CHEMBL627572,Autocuration,,,A,U,1,14515,1474.0,,In vivo,,22224,,13257,,,Bone element,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,0,CHEMBL627573,Autocuration,,,A,U,1,14516,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,0,CHEMBL627574,Autocuration,,,A,U,1,14517,2113.0,,In vivo,,22224,,13257,,,Kidney,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,0,CHEMBL627575,Autocuration,,,A,U,1,14518,2107.0,,In vivo,,22224,,13257,,,Liver,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,0,CHEMBL627576,Autocuration,,,A,U,1,14519,2048.0,,In vivo,,22224,,13257,,,Lung,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,0,CHEMBL627577,Autocuration,,,A,U,1,14520,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,0,CHEMBL627578,Autocuration,,,A,U,1,14521,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,0,CHEMBL627579,Autocuration,,,A,U,1,14522,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,0,CHEMBL627580,Autocuration,,,A,U,1,14523,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,0,CHEMBL627581,Autocuration,,,A,U,1,14524,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,0,CHEMBL627582,Autocuration,,,A,U,1,14525,,,In vivo,,22224,,13257,,,,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,0,CHEMBL627583,Autocuration,,,A,U,1,14526,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,0,CHEMBL627584,Autocuration,,,A,U,1,14527,2106.0,,In vivo,,22224,,13257,,,Spleen,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,0,CHEMBL627585,Autocuration,,,A,U,1,14528,2367.0,,In vivo,,22224,,13257,,,Prostate gland,BAO_0000218,
%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,0,CHEMBL627586,Autocuration,,,A,U,1,14529,2385.0,,In vivo,,22224,,13257,,,Muscle tissue,BAO_0000218,
Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,1,CHEMBL627587,Intermediate,,,A,N,1,14530,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL627588,Intermediate,,,A,N,1,14531,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,1,CHEMBL628250,Intermediate,,,A,N,1,14532,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL628251,Intermediate,,,A,N,1,14533,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,1,CHEMBL628252,Intermediate,,,A,N,1,14534,10000000.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hippocampus,BAO_0000218,
Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL628253,Intermediate,,,A,N,1,14535,10000000.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hippocampus,BAO_0000218,
Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,1,CHEMBL628254,Intermediate,,,A,N,1,14536,1898.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hypothalamus,BAO_0000218,
Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL877493,Intermediate,,,A,N,1,14537,1898.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hypothalamus,BAO_0000218,
Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL628255,Intermediate,,,A,N,1,14538,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL628256,Intermediate,,,A,N,1,14539,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL628257,Intermediate,,,A,N,1,14540,10000000.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hippocampus,BAO_0000218,
Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL628258,Intermediate,,,A,N,1,14541,1898.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hypothalamus,BAO_0000218,
Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL628259,Intermediate,,,A,N,1,14542,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL628429,Intermediate,,,A,N,1,14543,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,1,CHEMBL626862,Intermediate,,,A,N,1,14544,10000000.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hippocampus,BAO_0000218,
Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,1,CHEMBL626863,Intermediate,,,A,N,1,14545,1898.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hypothalamus,BAO_0000218,
Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,1,CHEMBL625886,Intermediate,,,A,N,1,14546,2037.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Cerebellum,BAO_0000218,
Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,1,CHEMBL625887,Intermediate,,,A,N,1,14547,2037.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Cerebellum,BAO_0000218,
Biodistribution of the [11C]-radiolabeled compound in rat cortex,,1,CHEMBL625888,Intermediate,,,A,N,1,14548,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,1,CHEMBL625889,Intermediate,,,A,N,1,14549,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,1,CHEMBL625890,Intermediate,,,A,N,1,14550,10000000.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hippocampus,BAO_0000218,
Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,1,CHEMBL625891,Intermediate,,,A,N,1,14551,10000000.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hippocampus,BAO_0000218,
Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,1,CHEMBL625892,Intermediate,,,A,N,1,14552,1898.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hypothalamus,BAO_0000218,
Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,1,CHEMBL625893,Intermediate,,,A,N,1,14553,1898.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hypothalamus,BAO_0000218,
Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,1,CHEMBL625894,Intermediate,,,A,N,1,14554,2037.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Cerebellum,BAO_0000218,
Biodistribution of the [18F]-radiolabeled compound in rat cortex,,1,CHEMBL625895,Intermediate,,,A,N,1,14555,,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,,BAO_0000218,
Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,CHEMBL625896,Autocuration,,,A,U,1,14556,,,,,22224,,12404,,,,BAO_0000019,
"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,0,CHEMBL625897,Autocuration,,,A,U,1,14557,,,,,22224,,568,,,,BAO_0000019,
"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,0,CHEMBL625898,Autocuration,,,A,U,1,14558,,,,,22224,,568,,,,BAO_0000019,
"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,0,CHEMBL625899,Autocuration,,,A,U,1,14559,,,,,22224,,568,,,,BAO_0000019,
Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,CHEMBL626124,Autocuration,,,A,U,1,14560,,,,,22224,,12404,,,,BAO_0000019,
Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,1,CHEMBL628500,Intermediate,,,A,N,1,14561,,Escherichia coli,,,50212,,7624,562.0,,,BAO_0000218,
"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,1,CHEMBL857856,Intermediate,,,A,N,1,14562,,Rattus norvegicus,,,50597,,7624,10116.0,,,BAO_0000218,
"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,1,CHEMBL628501,Intermediate,,,A,N,1,14563,,Rattus norvegicus,,,50597,,7624,10116.0,,,BAO_0000218,
"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,0,CHEMBL628502,Autocuration,,,A,U,1,14564,,,,,22224,,4643,,,,BAO_0000019,
Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,0,CHEMBL628503,Autocuration,,,A,U,1,14565,,,,,22224,,11532,,,,BAO_0000019,
Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,0,CHEMBL628504,Autocuration,,,A,U,1,14566,,,,,22224,,11018,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,0,CHEMBL628505,Autocuration,,,A,U,1,14567,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,0,CHEMBL874452,Autocuration,,,A,U,1,14568,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,0,CHEMBL628506,Autocuration,,,A,U,1,14569,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,0,CHEMBL628507,Autocuration,,,A,U,1,14570,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,0,CHEMBL628508,Autocuration,,,A,U,1,14571,,,,,22224,,2276,,,,BAO_0000019,
Michaelis constant (KM) was evaluated,,0,CHEMBL628509,Autocuration,,,A,U,1,14572,,,,,22224,,8949,,,,BAO_0000019,
Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,CHEMBL628510,Autocuration,,,A,U,1,14573,,,,,22224,,12404,,,,BAO_0000019,
Substrate concentration for half maximal velocity was reported for rat hexokinase I,,0,CHEMBL628511,Autocuration,,,B,U,1,14574,,,,,22224,,7625,,,,BAO_0000019,
Substrate concentration for half maximal velocity was reported for rat hexokinase II,,0,CHEMBL628512,Autocuration,,,B,U,1,14575,,,,,22224,,7625,,,,BAO_0000019,
Substrate concentration for half maximal velocity was reported for rat hexokinase III,,0,CHEMBL628513,Autocuration,,,B,U,1,14576,,,,,22224,,7625,,,,BAO_0000019,
Substrate concentration for half maximal velocity was reported for yeast hexokinase,,0,CHEMBL628514,Autocuration,,,B,U,1,14577,,,,,22224,,7625,,,,BAO_0000019,
Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,0,CHEMBL628515,Autocuration,,,A,U,1,14578,,,,,22224,,12908,,,,BAO_0000019,
Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,0,CHEMBL628516,Autocuration,,,A,U,1,14579,,,,,22224,,10368,,,,BAO_0000019,
Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,0,CHEMBL628517,Autocuration,,,A,U,1,14580,,,,,22224,,13108,,,,BAO_0000019,
its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,0,CHEMBL628518,Autocuration,,,A,U,1,14581,,,,,22224,,13108,,,,BAO_0000019,
Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,0,CHEMBL628519,Autocuration,,,A,U,1,14582,,,,,22224,,15217,,,,BAO_0000019,
Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,0,CHEMBL628520,Autocuration,,,A,U,1,14583,,,,,22224,,15217,,,,BAO_0000019,
Binding constant was determined,,0,CHEMBL628521,Autocuration,,,A,U,1,14584,,,,,22224,,10933,,,,BAO_0000019,
Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,0,CHEMBL630443,Autocuration,,,A,U,1,14585,,,,,22224,,2363,,,,BAO_0000019,
Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,0,CHEMBL630444,Autocuration,,,A,U,1,14586,,,,,22224,,2363,,,,BAO_0000019,
Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,0,CHEMBL857732,Autocuration,,,A,U,1,14587,,,,,22224,,2276,,,,BAO_0000019,
Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,0,CHEMBL630445,Autocuration,,,P,U,1,14588,,,,,22224,,14915,,,,BAO_0000100,
Catalytic rate constant of the compound,,0,CHEMBL630446,Autocuration,,,A,U,1,14589,,,,,22224,,8847,,,,BAO_0000019,
inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,0,CHEMBL630447,Autocuration,,,B,U,1,14590,,,,,22224,,15357,,,,BAO_0000019,
Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,0,CHEMBL630448,Autocuration,,,A,U,1,14591,,,,,22224,,2869,,,,BAO_0000019,
Catalytic rate constant against phospholipase A2 was determined,,0,CHEMBL630449,Autocuration,,,A,U,1,14592,,,,,22224,,3484,,,,BAO_0000019,
"Compound was evaluated for catalytic constant, Kcat",,0,CHEMBL630450,Autocuration,,,A,U,1,14593,,,,,22224,,1373,,,,BAO_0000019,
Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,0,CHEMBL630451,Autocuration,,,A,U,1,14594,,,,,22224,,8142,,,,BAO_0000019,
Kcat calculated from 0.693/T1/2,,0,CHEMBL630452,Autocuration,,,A,U,1,14595,,,,,22224,,14131,,,,BAO_0000019,
Kcat was determined,,0,CHEMBL630453,Autocuration,,,A,U,1,14596,,,,,22224,,17269,,,,BAO_0000019,
Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,0,CHEMBL630454,Autocuration,,,A,U,1,14597,,,,,22224,,3485,,,,BAO_0000019,
Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,0,CHEMBL630455,Autocuration,,,A,U,1,14598,,,,,22224,,3485,,,,BAO_0000019,
Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,0,CHEMBL631487,Autocuration,,,A,U,1,14599,,,,,22224,,3485,,,,BAO_0000019,
Kcat value was determined,,0,CHEMBL631488,Autocuration,,,A,U,1,14600,,,,,22224,,5962,,,,BAO_0000019,
Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,0,CHEMBL876440,Autocuration,,,A,U,1,14601,,,,,22224,,3133,,,,BAO_0000019,
Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,0,CHEMBL631489,Autocuration,,,A,U,1,14602,,,,,22224,,3133,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,0,CHEMBL857742,Autocuration,,,A,U,1,14603,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,0,CHEMBL631490,Autocuration,,,A,U,1,14604,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,0,CHEMBL631491,Autocuration,,,A,U,1,14605,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,0,CHEMBL631492,Autocuration,,,A,U,1,14606,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,0,CHEMBL631493,Autocuration,,,A,U,1,14607,,,,,22224,,2276,,,,BAO_0000019,
Kinetic parameter for rate of conversion to PABA was determined,,0,CHEMBL631494,Autocuration,,,A,U,1,14608,,,,,22224,,4892,,,,BAO_0000019,
Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,0,CHEMBL631495,Autocuration,,,A,U,1,14609,,,,,22224,,3133,,,,BAO_0000019,
"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,1,CHEMBL631496,Intermediate,,,A,N,1,14610,1988.0,Rattus norvegicus,,,50597,,11488,10116.0,,Feces,BAO_0000218,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,1,CHEMBL631497,Intermediate,,,A,N,1,14611,1088.0,Rattus norvegicus,,,50597,,11488,10116.0,,Urine,BAO_0000218,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,1,CHEMBL631498,Intermediate,,,A,N,1,14612,1088.0,Rattus norvegicus,,,50597,,11488,10116.0,,Urine,BAO_0000218,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,1,CHEMBL629776,Intermediate,,,A,N,1,14613,1088.0,Rattus norvegicus,,,50597,,11488,10116.0,,Urine,BAO_0000218,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,1,CHEMBL629777,Intermediate,,,A,N,1,14614,1088.0,Rattus norvegicus,,,50597,,11488,10116.0,,Urine,BAO_0000218,
"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,1,CHEMBL629778,Intermediate,,,A,N,1,14615,1088.0,Rattus norvegicus,,,50597,,11488,10116.0,,Urine,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,1,CHEMBL630456,Intermediate,,,A,N,1,14616,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,1,CHEMBL630457,Intermediate,,,A,N,1,14617,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,1,CHEMBL630458,Intermediate,,,A,N,1,14618,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,1,CHEMBL630459,Intermediate,,,A,N,1,14619,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,1,CHEMBL630460,Intermediate,,,A,N,1,14620,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,1,CHEMBL876550,Intermediate,,,A,N,1,14621,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,1,CHEMBL630461,Intermediate,,,A,N,1,14622,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,1,CHEMBL630462,Intermediate,,,A,N,1,14623,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,1,CHEMBL630463,Intermediate,,,A,N,1,14624,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,1,CHEMBL630464,Intermediate,,,A,N,1,14625,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,1,CHEMBL630465,Intermediate,,,A,N,1,14626,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,1,CHEMBL630466,Intermediate,,,A,N,1,14627,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,1,CHEMBL630467,Intermediate,,,A,N,1,14628,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,1,CHEMBL630633,Intermediate,,,A,N,1,14629,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,1,CHEMBL630634,Intermediate,,,A,N,1,14630,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,1,CHEMBL630635,Intermediate,,,A,N,1,14631,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,1,CHEMBL630636,Intermediate,,,A,N,1,14632,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,1,CHEMBL630637,Intermediate,,,A,N,1,14633,,Rattus norvegicus,,,50597,,11488,10116.0,,,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,1,CHEMBL630638,Intermediate,,,A,N,1,14634,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,1,CHEMBL630639,Intermediate,,,A,N,1,14635,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,1,CHEMBL630640,Intermediate,,,A,N,1,14636,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,1,CHEMBL876551,Intermediate,,,A,N,1,14637,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,1,CHEMBL630641,Intermediate,,,A,N,1,14638,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,1,CHEMBL630642,Intermediate,,,A,N,1,14639,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,1,CHEMBL630643,Intermediate,,,A,N,1,14640,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,1,CHEMBL630644,Intermediate,,,A,N,1,14641,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,1,CHEMBL630645,Intermediate,,,A,N,1,14642,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,1,CHEMBL625599,Intermediate,,,A,N,1,14643,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,1,CHEMBL625600,Intermediate,,,A,N,1,14644,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,1,CHEMBL625601,Intermediate,,,A,N,1,14645,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,1,CHEMBL625602,Intermediate,,,A,N,1,14646,1988.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Feces,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,1,CHEMBL627470,Intermediate,,,A,N,1,14647,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,1,CHEMBL627471,Intermediate,,,A,N,1,14648,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,1,CHEMBL627472,Intermediate,,,A,N,1,14649,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,1,CHEMBL627473,Intermediate,,,A,N,1,14650,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,1,CHEMBL627474,Intermediate,,,A,N,1,14651,1088.0,Oryctolagus cuniculus,,,50592,,7132,9986.0,,Urine,BAO_0000218,
Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL627475,Intermediate,,,A,N,1,14652,178.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Blood,BAO_0000218,
Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL627476,Intermediate,,,A,N,1,14653,178.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Blood,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,1,CHEMBL627477,Intermediate,,,A,N,1,14654,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,1,CHEMBL627478,Intermediate,,,A,N,1,14655,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,1,CHEMBL627479,Intermediate,,,A,N,1,14656,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,1,CHEMBL627480,Intermediate,,,A,N,1,14657,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,1,CHEMBL627481,Intermediate,,,A,N,1,14658,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,1,CHEMBL627482,Intermediate,,,A,N,1,14659,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,1,CHEMBL627483,Intermediate,,,A,N,1,14660,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,1,CHEMBL875636,Intermediate,,,A,N,1,14661,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,1,CHEMBL625764,Intermediate,,,A,N,1,14662,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,1,CHEMBL625765,Intermediate,,,A,N,1,14663,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,1,CHEMBL625766,Intermediate,,,A,N,1,14664,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,1,CHEMBL625767,Intermediate,,,A,N,1,14665,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,1,CHEMBL625768,Intermediate,,,A,N,1,14666,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,1,CHEMBL625769,Intermediate,,,A,N,1,14667,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,1,CHEMBL625770,Intermediate,,,A,N,1,14668,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,1,CHEMBL625771,Intermediate,,,A,N,1,14669,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,1,CHEMBL625772,Intermediate,,,A,N,1,14670,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,1,CHEMBL625773,Intermediate,,,A,N,1,14671,1088.0,Canis lupus familiaris,,,50588,,12582,9615.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,1,CHEMBL625774,Intermediate,,,A,N,1,14672,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,1,CHEMBL625775,Intermediate,,,A,N,1,14673,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,1,CHEMBL625776,Intermediate,,,A,N,1,14674,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,1,CHEMBL625777,Intermediate,,,A,N,1,14675,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,1,CHEMBL625778,Intermediate,,,A,N,1,14676,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,1,CHEMBL625779,Intermediate,,,A,N,1,14677,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,1,CHEMBL625780,Intermediate,,,A,N,1,14678,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,1,CHEMBL625781,Intermediate,,,A,N,1,14679,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,1,CHEMBL875637,Intermediate,,,A,N,1,14680,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,1,CHEMBL626473,Intermediate,,,A,N,1,14681,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,1,CHEMBL626474,Intermediate,,,A,N,1,14682,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,1,CHEMBL626475,Intermediate,,,A,N,1,14683,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,1,CHEMBL626476,Intermediate,,,A,N,1,14684,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,1,CHEMBL634397,Intermediate,,,A,N,1,14685,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,1,CHEMBL626477,Intermediate,,,A,N,1,14686,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,1,CHEMBL631069,Intermediate,,,A,N,1,14687,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,1,CHEMBL631070,Intermediate,,,A,N,1,14688,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,1,CHEMBL631071,Intermediate,,,A,N,1,14689,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,1,CHEMBL631072,Intermediate,,,A,N,1,14690,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,1,CHEMBL631073,Intermediate,,,A,N,1,14691,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,1,CHEMBL631074,Intermediate,,,A,N,1,14692,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,1,CHEMBL631075,Intermediate,,,A,N,1,14693,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,1,CHEMBL631725,Intermediate,,,A,N,1,14694,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,1,CHEMBL631726,Intermediate,,,A,N,1,14695,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,1,CHEMBL631727,Intermediate,,,A,N,1,14696,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,1,CHEMBL631728,Intermediate,,,A,N,1,14697,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,1,CHEMBL631729,Intermediate,,,A,N,1,14698,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,1,CHEMBL631730,Intermediate,,,A,N,1,14699,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,1,CHEMBL631731,Intermediate,,,A,N,1,14700,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,1,CHEMBL631910,Intermediate,,,A,N,1,14701,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,1,CHEMBL631911,Intermediate,,,A,N,1,14702,10000000.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hippocampus,BAO_0000218,
Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,1,CHEMBL631912,Intermediate,,,A,N,1,14703,1898.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hypothalamus,BAO_0000218,
Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,1,CHEMBL631913,Intermediate,,,A,N,1,14704,1898.0,Rattus norvegicus,In vivo,,50597,,15413,10116.0,,Hypothalamus,BAO_0000218,
Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631914,Intermediate,,,A,N,1,14705,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631915,Intermediate,,,A,N,1,14706,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL875778,Intermediate,,,A,N,1,14707,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631916,Intermediate,,,A,N,1,14708,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631917,Intermediate,,,A,N,1,14709,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631918,Intermediate,,,A,N,1,14710,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631919,Intermediate,,,A,N,1,14711,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL631920,Intermediate,,,A,N,1,14712,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631921,Intermediate,,,A,N,1,14713,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631922,Intermediate,,,A,N,1,14714,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL631923,Intermediate,,,A,N,1,14715,178.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Blood,BAO_0000218,
Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631924,Intermediate,,,A,N,1,14716,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630234,Intermediate,,,A,N,1,14717,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL630235,Intermediate,,,A,N,1,14718,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630236,Intermediate,,,A,N,1,14719,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630237,Intermediate,,,A,N,1,14720,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630238,Intermediate,,,A,N,1,14721,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630239,Intermediate,,,A,N,1,14722,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL630303,Intermediate,,,A,N,1,14723,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630304,Intermediate,,,A,N,1,14724,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630305,Intermediate,,,A,N,1,14725,,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630306,Intermediate,,,A,N,1,14726,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630307,Intermediate,,,A,N,1,14727,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL630308,Intermediate,,,A,N,1,14728,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630309,Intermediate,,,A,N,1,14729,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL629309,Intermediate,,,A,N,1,14730,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL629993,Intermediate,,,A,N,1,14731,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL629994,Intermediate,,,A,N,1,14732,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL629995,Intermediate,,,A,N,1,14733,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631993,Intermediate,,,A,N,1,14734,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631994,Intermediate,,,A,N,1,14735,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631995,Intermediate,,,A,N,1,14736,2113.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Kidney,BAO_0000218,
Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL631996,Intermediate,,,A,N,1,14737,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631997,Intermediate,,,A,N,1,14738,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631998,Intermediate,,,A,N,1,14739,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631999,Intermediate,,,A,N,1,14740,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL632000,Intermediate,,,A,N,1,14741,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL632001,Intermediate,,,A,N,1,14742,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL874424,Intermediate,,,A,N,1,14743,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL632002,Intermediate,,,A,N,1,14744,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL632003,Intermediate,,,A,N,1,14745,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,0,CHEMBL632004,Autocuration,,,A,U,1,14746,,,,,22224,,3133,,,,BAO_0000019,
Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,0,CHEMBL632005,Autocuration,,,A,U,1,14747,,,,,22224,,2742,,,,BAO_0000019,
Compound was tested for amidase rate in the presence of N62C screen enzyme,,0,CHEMBL632006,Autocuration,,,A,U,1,14748,,,,,22224,,2742,,,,BAO_0000019,
Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,0,CHEMBL632007,Autocuration,,,A,U,1,14749,,,,,22224,,2742,,,,BAO_0000019,
Compound was tested for amidase rate in the presence of S166C screen enzyme,,0,CHEMBL632008,Autocuration,,,A,U,1,14750,,,,,22224,,2742,,,,BAO_0000019,
Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,0,CHEMBL632009,Autocuration,,,A,U,1,14751,,,,,22224,,2742,,,,BAO_0000019,
Compound was tested for esterase rate in the presence of N62C screen enzyme,,0,CHEMBL632010,Autocuration,,,A,U,1,14752,,,,,22224,,2742,,,,BAO_0000019,
Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,0,CHEMBL857750,Autocuration,,,A,U,1,14753,,,,,22224,,2742,,,,BAO_0000019,
Compound was tested for esterase rate in the presence of S166C screen enzyme,,0,CHEMBL632011,Autocuration,,,A,U,1,14754,,,,,22224,,2742,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,CHEMBL632012,Autocuration,,,A,U,1,14755,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,CHEMBL632013,Autocuration,,,A,U,1,14756,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,0,CHEMBL632014,Autocuration,,,A,U,1,14757,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,CHEMBL629622,Autocuration,,,A,U,1,14758,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,CHEMBL629623,Autocuration,,,A,U,1,14759,,,,,22224,,2276,,,,BAO_0000019,
"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,0,CHEMBL629624,Autocuration,,,A,U,1,14760,,,,,22224,,2276,,,,BAO_0000019,
Ratio of Kcat to that of Km was determined,,0,CHEMBL629625,Autocuration,,,A,U,1,14761,,,,,22224,,17269,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,0,CHEMBL629626,Autocuration,,,A,U,1,14762,,,,,22224,,2276,,,,BAO_0000019,
"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,0,CHEMBL629627,Autocuration,,,A,U,1,14763,,,,,22224,,2276,,,,BAO_0000019,
"Compound was evaluated for constant, Kd",,0,CHEMBL629628,Autocuration,,,A,U,1,14764,,,,,22224,,15917,,,,BAO_0000019,
Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,0,CHEMBL629629,Autocuration,,,A,U,1,14765,,,,,22224,,10933,,,,BAO_0000019,
Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,0,CHEMBL629630,Autocuration,,,A,U,1,14766,,,,,22224,,10933,,,,BAO_0000019,
Dissociation Constant of compound determined,,0,CHEMBL856030,Autocuration,,,A,U,1,14767,,,,,22224,,14293,,,,BAO_0000019,
Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,0,CHEMBL629631,Autocuration,,,B,U,1,14768,,,,,22224,,6698,,,,BAO_0000019,
Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,0,CHEMBL629632,Autocuration,,,B,U,1,14769,,,,,22224,,6698,,,,BAO_0000019,
Dissociation constant of compound with Fructose was determined,,0,CHEMBL629633,Autocuration,,,P,U,1,14770,,,,,22224,,4318,,,,BAO_0000100,
Dissociation constant of compound with Fructose was determined; Not determined,,0,CHEMBL629634,Autocuration,,,P,U,1,14771,,,,,22224,,4318,,,,BAO_0000100,
Dissociation constant of compound with Lactulose was determined,,0,CHEMBL629635,Autocuration,,,P,U,1,14772,,,,,22224,,4318,,,,BAO_0000100,
Dissociation constant of compound with Lactulose was determined; Not determined,,0,CHEMBL629636,Autocuration,,,P,U,1,14773,,,,,22224,,4318,,,,BAO_0000100,
Dissociation constant of the Compound,,0,CHEMBL629637,Autocuration,,,P,U,1,14774,,,,,22224,,14959,,,,BAO_0000100,
Dissociation constant by non-linear regression analysis,,0,CHEMBL629638,Autocuration,,,P,U,1,14775,,,,,22224,,5913,,,,BAO_0000100,
Dissociation constant was determined,,0,CHEMBL629639,Autocuration,,,P,U,1,14776,,,,,22224,,14218,,,,BAO_0000100,
Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,0,CHEMBL629640,Autocuration,,,P,U,1,14777,,,,,22224,,10689,,,,BAO_0000100,
Dissociation constant was determined,,0,CHEMBL629641,Autocuration,,,P,U,1,14778,,,,,22224,,13925,,,,BAO_0000100,
Dissociation constant was determined,,0,CHEMBL631344,Autocuration,,,P,U,1,14779,,,,,22224,,16359,,,,BAO_0000100,
Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,1,CHEMBL631345,Intermediate,,,A,N,1,14780,2385.0,Rattus norvegicus,,,50597,,10944,10116.0,,Muscle tissue,BAO_0000218,
The dissociation constant determined by fluorescence displacement assay,,0,CHEMBL631346,Autocuration,,,A,U,1,14781,,,,,22224,,11080,,,,BAO_0000019,
kd value surface plasmon resonance (SPR) method,,0,CHEMBL631524,Autocuration,,,A,U,1,14782,,,,,22224,,17805,,,,BAO_0000019,
Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,1,CHEMBL631525,Intermediate,,,A,N,1,14783,2385.0,Rattus norvegicus,,,50597,,10944,10116.0,,Muscle tissue,BAO_0000218,
First dissociation constant of the binding of compound to V30M TTR,,0,CHEMBL631526,Autocuration,,,F,U,1,14784,,,,,22224,,16645,,,,BAO_0000019,
Second dissociation constant of the binding of compound to V30M TTR,,0,CHEMBL631527,Autocuration,,,F,U,1,14785,,,,,22224,,16645,,,,BAO_0000019,
"Compound was evaluated for equilibrium constant, Ke",,0,CHEMBL631528,Autocuration,,,A,U,1,14786,,,,,22224,,7793,,,,BAO_0000019,
Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,0,CHEMBL631529,Autocuration,,,A,U,1,14787,1898.0,,,,22224,,12199,,,Hypothalamus,BAO_0000019,
Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,0,CHEMBL631530,Autocuration,,,A,U,1,14788,1898.0,,,,22224,,12199,,,Hypothalamus,BAO_0000019,
Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,0,CHEMBL631531,Autocuration,,,A,U,1,14789,,,,,22224,,9680,,,,BAO_0000019,
Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,0,CHEMBL631532,Autocuration,,,A,U,1,14790,,,,,22224,,9680,,,,BAO_0000019,
Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,0,CHEMBL631533,Autocuration,,,A,U,1,14791,,,,,22224,,9680,,,,BAO_0000019,
In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,1,CHEMBL876552,Intermediate,,,A,N,1,14792,,Mus musculus,,,50594,,13758,10090.0,,,BAO_0000218,
In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,1,CHEMBL631534,Intermediate,,,A,N,1,14793,,Mus musculus,,,50594,,13758,10090.0,,,BAO_0000218,
In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,1,CHEMBL631535,Intermediate,,,A,N,1,14794,,Mus musculus,,,50594,,13758,10090.0,,,BAO_0000218,
In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,1,CHEMBL631536,Intermediate,,,A,N,1,14795,,Mus musculus,,,50594,,13758,10090.0,,,BAO_0000218,
In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,1,CHEMBL631537,Intermediate,,,A,N,1,14796,,Mus musculus,,,50594,,13758,10090.0,,,BAO_0000218,
In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,1,CHEMBL631538,Intermediate,,,A,N,1,14797,,Mus musculus,,,50594,,13758,10090.0,,,BAO_0000218,
In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,1,CHEMBL631539,Intermediate,,,A,N,1,14798,,Mus musculus,,,50594,,13758,10090.0,,,BAO_0000218,
In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,1,CHEMBL631540,Intermediate,,,A,N,1,14799,,Mus musculus,,,50594,,13758,10090.0,,,BAO_0000218,
Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,CHEMBL625637,Intermediate,,,A,N,1,14800,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,CHEMBL625638,Intermediate,,,A,N,1,14801,,Rattus norvegicus,,,50597,,14393,10116.0,,,BAO_0000218,
"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,1,CHEMBL625639,Intermediate,,,A,N,1,14802,,Rattus norvegicus,,,50597,,15078,10116.0,,,BAO_0000218,
Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625640,Intermediate,,,A,N,1,14803,955.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Brain,BAO_0000218,
Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625641,Intermediate,,,A,N,1,14804,955.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Brain,BAO_0000218,
Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625642,Intermediate,,,A,N,1,14805,948.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Heart,BAO_0000218,
Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625643,Intermediate,,,A,N,1,14806,948.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Heart,BAO_0000218,
Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625644,Intermediate,,,A,N,1,14807,2113.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625645,Intermediate,,,A,N,1,14808,2113.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Kidney,BAO_0000218,
Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625646,Intermediate,,,A,N,1,14809,2107.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Liver,BAO_0000218,
Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625647,Intermediate,,,A,N,1,14810,2107.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Liver,BAO_0000218,
Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625648,Intermediate,,,A,N,1,14811,2048.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Lung,BAO_0000218,
Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625649,Intermediate,,,A,N,1,14812,2048.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Lung,BAO_0000218,
Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625650,Intermediate,,,A,N,1,14813,2385.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625651,Intermediate,,,A,N,1,14814,2385.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625652,Intermediate,,,A,N,1,14815,14.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Zone of skin,BAO_0000218,
Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625653,Intermediate,,,A,N,1,14816,14.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Zone of skin,BAO_0000218,
Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625654,Intermediate,,,A,N,1,14817,2106.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Spleen,BAO_0000218,
Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,1,CHEMBL625655,Intermediate,,,A,N,1,14818,2106.0,Rattus norvegicus,In vivo,,50597,,13925,10116.0,,Spleen,BAO_0000218,
Biodistribution of Compound in rat blood after 15 minutes of administration,,1,CHEMBL625656,Intermediate,,,A,N,1,14819,178.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Blood,BAO_0000218,
Biodistribution of Compound in rat blood after 2 minutes of administration,,1,CHEMBL625657,Intermediate,,,A,N,1,14820,178.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Blood,BAO_0000218,
Biodistribution of Compound in rat brain after 15 minutes of administration,,1,CHEMBL625658,Intermediate,,,A,N,1,14821,955.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Brain,BAO_0000218,
Biodistribution of Compound in rat brain after 2 minutes of administration,,1,CHEMBL625659,Intermediate,,,A,N,1,14822,955.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Brain,BAO_0000218,
Biodistribution of Compound in rat heart after 15 minutes of administration,,1,CHEMBL625660,Intermediate,,,A,N,1,14823,948.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Heart,BAO_0000218,
Biodistribution of Compound in rat heart after 2 minutes of administration,,1,CHEMBL625661,Intermediate,,,A,N,1,14824,948.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Heart,BAO_0000218,
Biodistribution of Compound in rat liver after 15 minutes of administration,,1,CHEMBL625662,Intermediate,,,A,N,1,14825,2107.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Liver,BAO_0000218,
Biodistribution of Compound in rat liver after 2 minutes of administration,,1,CHEMBL625663,Intermediate,,,A,N,1,14826,2107.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Liver,BAO_0000218,
Biodistribution of Compound in rat lung after 15 minutes of administration,,1,CHEMBL875621,Intermediate,,,A,N,1,14827,2048.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Lung,BAO_0000218,
Biodistribution of Compound in rat lung after 2 minutes of administration,,1,CHEMBL628382,Intermediate,,,A,N,1,14828,2048.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Lung,BAO_0000218,
Biodistribution of Compound in rat muscle after 15 minutes of administration,,1,CHEMBL628383,Intermediate,,,A,N,1,14829,2385.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution of Compound in rat muscle after 2 minutes of administration,,1,CHEMBL628384,Intermediate,,,A,N,1,14830,2385.0,Rattus norvegicus,In vivo,,50597,,9712,10116.0,,Muscle tissue,BAO_0000218,
Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,1,CHEMBL628385,Intermediate,,,A,N,1,14831,,Rattus norvegicus,,,50597,,13925,10116.0,,,BAO_0000218,
Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,1,CHEMBL875753,Intermediate,,,A,N,1,14832,,Rattus norvegicus,,,50597,,13925,10116.0,,,BAO_0000218,
Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,1,CHEMBL628386,Intermediate,,,A,N,1,14833,,Rattus norvegicus,,,50597,,13925,10116.0,,,BAO_0000218,
Organ distribution in rat blood 2 minutes after intravenous injection,,1,CHEMBL628387,Intermediate,,,A,N,1,14834,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat blood 2 hr after intravenous injection,,1,CHEMBL628388,Intermediate,,,A,N,1,14835,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat blood 30 minutes after intravenous injection,,1,CHEMBL628389,Intermediate,,,A,N,1,14836,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat blood 30 min after intravenous injection,,1,CHEMBL632756,Intermediate,,,A,N,1,14837,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat brain 2 minutes after intravenous injection,,1,CHEMBL628390,Intermediate,,,A,N,1,14838,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat brain 2 hr after intravenous injection,,1,CHEMBL631811,Intermediate,,,A,N,1,14839,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat brain 30 minutes after intravenous injection,,1,CHEMBL631812,Intermediate,,,A,N,1,14840,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat heart 2 minutes after intravenous injection,,1,CHEMBL631813,Intermediate,,,A,N,1,14841,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat heart 2 hr after intravenous injection,,1,CHEMBL631814,Intermediate,,,A,N,1,14842,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat heart 30 minutes after intravenous injection,,1,CHEMBL631815,Intermediate,,,A,N,1,14843,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat kidney 2 minutes after intravenous injection,,1,CHEMBL631816,Intermediate,,,A,N,1,14844,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat kidney 2 hr after intravenous injection,,1,CHEMBL875758,Intermediate,,,A,N,1,14845,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat kidney 30 minutes after intravenous injection,,1,CHEMBL631817,Intermediate,,,A,N,1,14846,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat liver 2 minutes after intravenous injection,,1,CHEMBL631818,Intermediate,,,A,N,1,14847,2107.0,Rattus norvegicus,,,50597,,6941,10116.0,,Liver,BAO_0000218,
Organ distribution in rat liver 2 hr after intravenous injection,,1,CHEMBL631819,Intermediate,,,A,N,1,14848,2107.0,Rattus norvegicus,,,50597,,6941,10116.0,,Liver,BAO_0000218,
Organ distribution in rat liver 30 minutes after intravenous injection,,1,CHEMBL631820,Intermediate,,,A,N,1,14849,2107.0,Rattus norvegicus,,,50597,,6941,10116.0,,Liver,BAO_0000218,
Organ distribution in rat lung 2 minutes after intravenous injection,,1,CHEMBL631821,Intermediate,,,A,N,1,14850,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat lung 2 hr after intravenous injection,,1,CHEMBL631822,Intermediate,,,A,N,1,14851,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat lung 30 minutes after intravenous injection,,1,CHEMBL631823,Intermediate,,,A,N,1,14852,,Rattus norvegicus,,,50597,,6941,10116.0,,,BAO_0000218,
Organ distribution in rat muscle 2 minutes after intravenous injection,,1,CHEMBL631824,Intermediate,,,A,N,1,14853,2385.0,Rattus norvegicus,,,50597,,6941,10116.0,,Muscle tissue,BAO_0000218,
Organ distribution in rat muscle 2 hr after intravenous injection,,1,CHEMBL631825,Intermediate,,,A,N,1,14854,2385.0,Rattus norvegicus,,,50597,,6941,10116.0,,Muscle tissue,BAO_0000218,
Organ distribution in rat muscle 30 minutes after intravenous injection,,1,CHEMBL631826,Intermediate,,,A,N,1,14855,2385.0,Rattus norvegicus,,,50597,,6941,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,1,CHEMBL631827,Intermediate,,,A,N,1,14856,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,1,CHEMBL631828,Intermediate,,,A,N,1,14857,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,1,CHEMBL631829,Intermediate,,,A,N,1,14858,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,1,CHEMBL875759,Intermediate,,,A,N,1,14859,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,1,CHEMBL631830,Intermediate,,,A,N,1,14860,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,1,CHEMBL631831,Intermediate,,,A,N,1,14861,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,1,CHEMBL631832,Intermediate,,,A,N,1,14862,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,1,CHEMBL631833,Intermediate,,,A,N,1,14863,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,1,CHEMBL631834,Intermediate,,,A,N,1,14864,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,1,CHEMBL631835,Intermediate,,,A,N,1,14865,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,1,CHEMBL631836,Intermediate,,,A,N,1,14866,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,1,CHEMBL631837,Intermediate,,,A,N,1,14867,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,1,CHEMBL631838,Intermediate,,,A,N,1,14868,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,1,CHEMBL631839,Intermediate,,,A,N,1,14869,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,1,CHEMBL631840,Intermediate,,,A,N,1,14870,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,1,CHEMBL631841,Intermediate,,,A,N,1,14871,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,1,CHEMBL631842,Intermediate,,,A,N,1,14872,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,1,CHEMBL631843,Intermediate,,,A,N,1,14873,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,1,CHEMBL631844,Intermediate,,,A,N,1,14874,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,1,CHEMBL631845,Intermediate,,,A,N,1,14875,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,1,CHEMBL631846,Intermediate,,,A,N,1,14876,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,1,CHEMBL875760,Intermediate,,,A,N,1,14877,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,1,CHEMBL632199,Intermediate,,,A,N,1,14878,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,1,CHEMBL631847,Intermediate,,,A,N,1,14879,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,1,CHEMBL631848,Intermediate,,,A,N,1,14880,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,1,CHEMBL628707,Intermediate,,,A,N,1,14881,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,1,CHEMBL628708,Intermediate,,,A,N,1,14882,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,1,CHEMBL628709,Intermediate,,,A,N,1,14883,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,1,CHEMBL628710,Intermediate,,,A,N,1,14884,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,1,CHEMBL628711,Intermediate,,,A,N,1,14885,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,1,CHEMBL628712,Intermediate,,,A,N,1,14886,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,1,CHEMBL628713,Intermediate,,,A,N,1,14887,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,1,CHEMBL628714,Intermediate,,,A,N,1,14888,1088.0,Rattus norvegicus,,,50597,,12582,10116.0,,Urine,BAO_0000218,
"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,1,CHEMBL628715,Intermediate,,,A,N,1,14889,,Rattus norvegicus,,,50597,,7415,10116.0,,,BAO_0000218,
Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,0,CHEMBL629179,Autocuration,,,A,U,1,14890,,,,,22224,,7313,,,,BAO_0000019,
Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,0,CHEMBL629180,Autocuration,,,A,U,1,14891,,,,,22224,,7313,,,,BAO_0000019,
Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,0,CHEMBL875108,Autocuration,,,A,U,1,14892,,,,,22224,,7313,,,,BAO_0000019,
Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,0,CHEMBL629181,Autocuration,,,A,U,1,14893,1235.0,,,,22224,,7570,,,Adrenal cortex,BAO_0000019,
Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,0,CHEMBL629182,Autocuration,,,A,U,1,14894,1235.0,,,,22224,,7570,,,Adrenal cortex,BAO_0000019,
Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,0,CHEMBL629183,Autocuration,,,A,U,1,14895,,,,,22224,,7570,,,,BAO_0000019,
Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,0,CHEMBL629184,Autocuration,,,A,U,1,14896,,,,,22224,,7570,,,,BAO_0000019,
Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,0,CHEMBL629185,Autocuration,,,A,U,1,14897,1235.0,,,,22224,,7570,,,Adrenal cortex,BAO_0000019,
Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,0,CHEMBL629186,Autocuration,,,A,U,1,14898,1235.0,,,,22224,,7570,,,Adrenal cortex,BAO_0000019,
Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,0,CHEMBL629187,Autocuration,,,A,U,1,14899,,,,,22224,,7570,,,,BAO_0000019,
Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,0,CHEMBL629887,Autocuration,,,A,U,1,14900,,,,,22224,,7570,,,,BAO_0000019,
Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,0,CHEMBL629888,Autocuration,,,A,U,1,14901,,,,,22224,,7570,,,,BAO_0000019,
Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,0,CHEMBL629889,Autocuration,,,A,U,1,14902,,,,,22224,,7570,,,,BAO_0000019,
Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,0,CHEMBL629890,Autocuration,,,A,U,1,14903,1235.0,,,,22224,,7570,,,Adrenal cortex,BAO_0000019,
Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,0,CHEMBL629891,Autocuration,,,A,U,1,14904,,,,,22224,,7570,,,,BAO_0000019,
Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,0,CHEMBL629892,Autocuration,,,A,U,1,14905,,,,,22224,,7570,,,,BAO_0000019,
Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,0,CHEMBL629893,Autocuration,,,A,U,1,14906,1235.0,,,,22224,,7570,,,Adrenal cortex,BAO_0000019,
Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,0,CHEMBL629894,Autocuration,,,A,U,1,14907,,,,,22224,,7570,,,,BAO_0000019,
Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,0,CHEMBL629895,Autocuration,,,A,U,1,14908,,,,,22224,,7570,,,,BAO_0000019,
"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,0,CHEMBL875109,Autocuration,,,A,U,1,14909,,Canis lupus familiaris,In vivo,,22224,,14122,9615.0,,,BAO_0000218,
Absolute bioavailability in male cynomolgus monkeys,,0,CHEMBL629896,Autocuration,,,A,U,1,14910,,Macaca fascicularis,In vivo,,22224,,16449,9541.0,,,BAO_0000218,
Absolute bioavailability in maleSprague-Dawley rats,,0,CHEMBL629897,Autocuration,,,A,U,1,14911,,Rattus norvegicus,In vivo,,22224,,16449,10116.0,,,BAO_0000218,
Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL629898,Intermediate,,,A,N,1,14912,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630057,Intermediate,,,A,N,1,14913,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630058,Intermediate,,,A,N,1,14914,2107.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Liver,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630059,Intermediate,,,A,N,1,14915,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630060,Intermediate,,,A,N,1,14916,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL630061,Intermediate,,,A,N,1,14917,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630062,Intermediate,,,A,N,1,14918,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630063,Intermediate,,,A,N,1,14919,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630064,Intermediate,,,A,N,1,14920,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630065,Intermediate,,,A,N,1,14921,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL630066,Intermediate,,,A,N,1,14922,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630067,Intermediate,,,A,N,1,14923,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630068,Intermediate,,,A,N,1,14924,2048.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Lung,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631113,Intermediate,,,A,N,1,14925,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631114,Intermediate,,,A,N,1,14926,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL631115,Intermediate,,,A,N,1,14927,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL631116,Intermediate,,,A,N,1,14928,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630528,Intermediate,,,A,N,1,14929,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630529,Intermediate,,,A,N,1,14930,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630530,Intermediate,,,A,N,1,14931,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL630531,Intermediate,,,A,N,1,14932,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630532,Intermediate,,,A,N,1,14933,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630533,Intermediate,,,A,N,1,14934,2385.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Muscle tissue,BAO_0000218,
Biodistribution in normal mice blood after 120 hr,,1,CHEMBL630534,Intermediate,,,A,N,1,14935,178.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Blood,BAO_0000218,
Biodistribution in normal mice blood after 24 hr,,1,CHEMBL630535,Intermediate,,,A,N,1,14936,178.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Blood,BAO_0000218,
Biodistribution in normal mice blood after 4 hr,,1,CHEMBL630536,Intermediate,,,A,N,1,14937,178.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Blood,BAO_0000218,
Biodistribution in normal mice bone after 120 hr,,1,CHEMBL630537,Intermediate,,,A,N,1,14938,10000001.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Bone,BAO_0000218,
Biodistribution in normal mice bone after 24 hr,,1,CHEMBL630538,Intermediate,,,A,N,1,14939,10000001.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Bone,BAO_0000218,
Biodistribution in normal mice bone after 4 hr,,1,CHEMBL630539,Intermediate,,,A,N,1,14940,10000001.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Bone,BAO_0000218,
Biodistribution in normal mice heart after 120 hr,,1,CHEMBL630540,Intermediate,,,A,N,1,14941,948.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Heart,BAO_0000218,
Biodistribution in normal mice heart after 24 hr,,1,CHEMBL630541,Intermediate,,,A,N,1,14942,948.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Heart,BAO_0000218,
Biodistribution in normal mice heart after 4 hr,,1,CHEMBL630542,Intermediate,,,A,N,1,14943,948.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Heart,BAO_0000218,
Biodistribution in normal mice kidney after 120 hr,,1,CHEMBL630543,Intermediate,,,A,N,1,14944,2113.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Kidney,BAO_0000218,
Biodistribution in normal mice kidney after 24 hr,,1,CHEMBL630544,Intermediate,,,A,N,1,14945,2113.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Kidney,BAO_0000218,
Biodistribution in normal mice kidney after 4 hr,,1,CHEMBL630545,Intermediate,,,A,N,1,14946,2113.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Kidney,BAO_0000218,
Biodistribution in normal mice liver after 120 hr,,1,CHEMBL630546,Intermediate,,,A,N,1,14947,2107.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Liver,BAO_0000218,
Biodistribution in normal mice liver after 24 hr,,1,CHEMBL630547,Intermediate,,,A,N,1,14948,2107.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Liver,BAO_0000218,
Biodistribution in normal mice liver after 4 hr,,1,CHEMBL630548,Intermediate,,,A,N,1,14949,2107.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Liver,BAO_0000218,
Biodistribution in normal mice spleen after 120 hr,,1,CHEMBL630549,Intermediate,,,A,N,1,14950,2106.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Spleen,BAO_0000218,
Biodistribution in normal mice spleen after 24 hr,,1,CHEMBL630550,Intermediate,,,A,N,1,14951,2106.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Spleen,BAO_0000218,
Biodistribution in normal mice spleen after 4 hr,,1,CHEMBL876426,Intermediate,,,A,N,1,14952,2106.0,Mus musculus,In vivo,,50594,,15045,10090.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630551,Intermediate,,,A,N,1,14953,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630552,Intermediate,,,A,N,1,14954,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL630553,Intermediate,,,A,N,1,14955,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630554,Intermediate,,,A,N,1,14956,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630555,Intermediate,,,A,N,1,14957,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630556,Intermediate,,,A,N,1,14958,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630557,Intermediate,,,A,N,1,14959,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,1,CHEMBL630558,Intermediate,,,A,N,1,14960,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630559,Intermediate,,,A,N,1,14961,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL630560,Intermediate,,,A,N,1,14962,2106.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Spleen,BAO_0000218,
Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,1,CHEMBL876427,Intermediate,,,A,N,1,14963,2046.0,Rattus norvegicus,In vivo,,50597,,12017,10116.0,,Thyroid gland,BAO_0000218,
The Kel values in female wistar rats.,,1,CHEMBL630561,Intermediate,,,A,N,1,14964,,Rattus norvegicus,,,50597,,14941,10116.0,,,BAO_0000218,
The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,0,CHEMBL630562,Autocuration,,,A,U,1,14965,,,,,22224,,4646,,,,BAO_0000019,
Hydrolysis rate constant of the compound,,0,CHEMBL630563,Autocuration,,,A,U,1,14966,,,,,22224,,8847,,,,BAO_0000019,
Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,0,CHEMBL629673,Autocuration,,,P,U,1,14967,,,,,22229,,11778,,,,BAO_0000100,
"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,0,CHEMBL629674,Autocuration,,,A,U,1,14968,,,,,22224,,2363,,,,BAO_0000019,
"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,0,CHEMBL629675,Autocuration,,,A,U,1,14969,,,,,22224,,2363,,,,BAO_0000019,
"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,0,CHEMBL629676,Autocuration,,,A,U,1,14970,,,,,22224,,2363,,,,BAO_0000019,
"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,0,CHEMBL629677,Autocuration,,,A,U,1,14971,,,,,22224,,2363,,,,BAO_0000019,
Apparent inactivation rate constant was evaluated,,0,CHEMBL629678,Autocuration,,,A,U,1,14972,,,,,22224,,8371,,,,BAO_0000019,
Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,0,CHEMBL629679,Autocuration,,,A,U,1,14973,,,,,22224,,14883,,,,BAO_0000019,
Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,0,CHEMBL629680,Autocuration,,,A,U,1,14974,,,,,22224,,14883,,,,BAO_0000019,
Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,0,CHEMBL629681,Autocuration,,,A,U,1,14975,,,,,22224,,4643,,,,BAO_0000019,
Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,0,CHEMBL629682,Autocuration,,,A,U,1,14976,,,,,22224,,3519,,,,BAO_0000019,
DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,0,CHEMBL629683,Autocuration,,,A,U,1,14977,,,,,22224,,10600,,,,BAO_0000019,
Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,0,CHEMBL629684,Autocuration,,,F,U,1,14978,,,,,22224,,8501,,,,BAO_0000019,
Dissociation constant was determined,,0,CHEMBL629685,Autocuration,,,P,U,1,14979,,,,,22224,,8505,,,,BAO_0000100,
Dissociation constant was determined,,0,CHEMBL629686,Autocuration,,,P,U,1,14980,,,,,22224,,9778,,,,BAO_0000100,
Dissociation constant at pH 7.4,,0,CHEMBL872932,Autocuration,,,P,U,1,14981,,,,,22224,,9778,,,,BAO_0000100,
Dissociation constant in presence of 1 mM dithiothreitol,,0,CHEMBL629687,Autocuration,,,P,U,1,14982,,,,,22224,,9778,,,,BAO_0000100,
Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,0,CHEMBL872931,Autocuration,,,A,U,1,14983,,,,,22224,,13007,,,,BAO_0000019,
Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,0,CHEMBL628151,Autocuration,,,A,U,1,14984,,,,,22224,,13007,,,,BAO_0000019,
Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,0,CHEMBL628152,Autocuration,,,A,U,1,14985,,,,,22224,,13007,,,,BAO_0000019,
Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,0,CHEMBL628153,Autocuration,,,A,U,1,14986,,,,,22224,,13007,,,,BAO_0000019,
Kinetic constant for aromatization of androstenedione,,0,CHEMBL628154,Autocuration,,,A,U,1,14987,,,,,22224,,11482,,,,BAO_0000019,
Kinetic constant for aromatization of testosterone,,0,CHEMBL628155,Autocuration,,,A,U,1,14988,,,,,22224,,11482,,,,BAO_0000019,
Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,0,CHEMBL628156,Autocuration,,,A,U,1,14989,,,,,22224,,2303,,,,BAO_0000019,
Local inhibition constant was determined,,0,CHEMBL628157,Autocuration,,,A,U,1,14990,,,,,22224,,11964,,,,BAO_0000019,
Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,1,CHEMBL857533,Intermediate,,,A,N,1,14991,,Saccharomyces cerevisiae,,,50347,,3140,4932.0,,,BAO_0000218,
Dissociation constant value of the compound,,0,CHEMBL628158,Autocuration,,,P,U,1,14992,,,,,22224,,10650,,,,BAO_0000100,
In vitro permeability through cornea without epithelium,,0,CHEMBL628159,Autocuration,,,A,U,1,14993,964.0,,,,22224,,4667,,,Cornea,BAO_0000019,
In vitro permeability through intact cornea,,0,CHEMBL875616,Autocuration,,,A,U,1,14994,964.0,,,,22224,,4667,,,Cornea,BAO_0000019,
Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,1,CHEMBL628160,Intermediate,,,A,N,1,14995,964.0,Oryctolagus cuniculus,,,50592,,9199,9986.0,,Cornea,BAO_0000218,
Rate of enzyme inactivation for the compound was determined,,0,CHEMBL628161,Autocuration,,,A,U,1,14996,,,,,22224,,11966,,,,BAO_0000019,
In vitro permeability through cornea without epithelium,,0,CHEMBL628162,Autocuration,,,A,U,1,14997,964.0,,,,22224,,4667,,,Cornea,BAO_0000019,
In vitro permeability through intact cornea,,0,CHEMBL628163,Autocuration,,,A,U,1,14998,964.0,,,,22224,,4667,,,Cornea,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628164,Autocuration,,,A,U,1,14999,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628165,Autocuration,,,A,U,1,15000,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628166,Autocuration,,,A,U,1,15001,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628167,Autocuration,,,A,U,1,15002,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628168,Autocuration,,,A,U,1,15003,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628169,Autocuration,,,A,U,1,15004,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628170,Autocuration,,,A,U,1,15005,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628171,Autocuration,,,A,U,1,15006,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL627434,Autocuration,,,A,U,1,15007,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL627435,Autocuration,,,A,U,1,15008,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628110,Autocuration,,,A,U,1,15009,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628111,Autocuration,,,A,U,1,15010,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628112,Autocuration,,,A,U,1,15011,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628260,Autocuration,,,A,U,1,15012,,,,,22224,,8354,,,,BAO_0000019,
"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,CHEMBL628261,Autocuration,,,A,U,1,15013,,,,,22224,,8354,,,,BAO_0000019,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,1,CHEMBL628262,Intermediate,,,A,N,1,15014,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,1,CHEMBL628263,Intermediate,,,A,N,1,15015,,Homo sapiens,In vivo,,50587,,14439,9606.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,1,CHEMBL628264,Intermediate,,,A,N,1,15016,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,1,CHEMBL628265,Intermediate,,,A,N,1,15017,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,1,CHEMBL628266,Intermediate,,,A,N,1,15018,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,1,CHEMBL628267,Intermediate,,,A,N,1,15019,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,1,CHEMBL628268,Intermediate,,,A,N,1,15020,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,1,CHEMBL628269,Intermediate,,,A,N,1,15021,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,1,CHEMBL628270,Intermediate,,,A,N,1,15022,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,1,CHEMBL628271,Intermediate,,,A,N,1,15023,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,1,CHEMBL628272,Intermediate,,,A,N,1,15024,,Mus musculus,In vivo,,50594,,14439,10090.0,,,BAO_0000218,
